data_2akl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2akl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.491 HD11 HD22 ' A' ' 23' ' ' LEU . 11.2 mt . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 41.8 Cg_endo -64.89 160.01 43.19 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.319 2.013 . . . . 0.0 111.423 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.78 -169.69 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.079 1.853 . . . . 0.0 112.161 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.528 ' C ' ' H ' ' A' ' 10' ' ' GLN . 8.4 t -97.35 123.61 52.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.19 11.31 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.961 2.441 . . . . 0.0 111.806 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 8' ' ' CYS . 37.8 mt-30 -122.73 -34.7 3.18 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.9 m -112.68 -45.13 3.25 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.785 -0.572 . . . . 0.0 110.489 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 12.91 7.49 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.02 0.914 . . . . 0.0 110.511 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.603 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 20.9 p -67.12 -32.19 73.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.926 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 84.85 5.76 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.011 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.603 ' HD1' ' HB2' ' A' ' 13' ' ' SER . 83.7 m-85 -82.7 47.32 1.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.689 0.757 . . . . 0.0 109.804 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -102.65 150.23 23.65 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.121 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.4 p90 -142.0 169.11 18.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.68 117.78 35.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.178 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 t70 -110.04 74.76 0.9 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.99 -102.8 2.72 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.208 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.85 18.69 15.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.08 -175.42 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.491 HD22 HD11 ' A' ' 5' ' ' LEU . 5.8 mt -108.93 133.99 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 31' ' ' GLU . 49.9 t -118.66 128.04 75.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -97.9 108.34 45.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.33 -7.21 20.84 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.596 2.197 . . . . 0.0 111.387 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -79.22 -67.48 0.75 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.65 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.05 9.19 29.0 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.297 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.14 46.79 12.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 112.007 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -144.18 125.91 15.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.415 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB3' HG21 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -93.44 149.03 21.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.553 176.287 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -153.27 161.84 41.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -119.58 129.94 25.1 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 12.0 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.893 2.396 . . . . 0.0 112.826 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.532 HG12 HD12 ' A' ' 87' ' ' LEU . 6.2 t . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.776 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -69.69 119.37 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.191 0.307 . . . . 0.0 110.655 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.669 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.7 OUTLIER -106.78 146.35 30.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.524 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.473 ' OD1' HG21 ' A' ' 111' ' ' VAL . 12.8 m-20 -90.0 175.51 7.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.621 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 7.0 t -74.37 -4.0 33.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.094 0.95 . . . . 0.0 110.12 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.5 t -87.88 -14.42 9.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.0 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.77 7.97 68.03 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.823 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.484 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -104.48 164.54 11.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.678 178.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.419 HG21 ' HG3' ' A' ' 48' ' ' LYS . 4.7 t -109.65 140.14 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.045 -173.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 113' ' ' LYS . 24.9 mt -95.73 172.73 7.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.332 0.587 . . . . 0.0 111.136 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.3 tt0 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.712 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.492 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 13.6 t70 -69.13 94.96 0.71 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.193 0.52 . . . . 0.0 109.617 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.65 -11.0 6.72 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.2 t70 -72.04 169.51 15.82 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.304 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.659 HG21 ' HB3' ' A' ' 83' ' ' LYS . 3.0 m -100.49 135.43 41.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 82' ' ' VAL . 1.8 pp -121.42 163.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.0 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -150.27 119.91 7.0 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.172 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.827 HG13 HG11 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -60.76 128.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -98.92 17.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 4.3 mptp? -142.09 166.57 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.547 -0.721 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -77.12 105.89 8.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.102 0.953 . . . . 0.0 111.101 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 2.4 mm? -114.84 126.44 54.82 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.675 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.87 171.7 14.18 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' A' ' 72' ' ' SER . 40.2 t -126.78 120.56 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.51 -45.0 69.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.64 -10.39 57.95 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.932 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB2' HG11 ' A' ' 69' ' ' VAL . 26.1 m -111.93 153.65 26.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.951 0.405 . . . . 0.0 111.144 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -71.04 -12.01 61.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.9 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mp -79.44 137.92 37.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.213 0.53 . . . . 0.0 111.121 -174.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.13 127.21 66.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.193 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.827 HG11 HG13 ' A' ' 63' ' ' VAL . 69.7 t -81.97 116.42 26.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.479 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.432 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -109.07 149.2 29.64 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.516 -176.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -50.04 97.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.838 0.828 . . . . 0.0 110.266 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.69 3.43 5.05 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.081 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 m -62.57 105.76 0.68 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 122.071 0.938 . . . . 0.0 110.163 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -88.36 116.85 26.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 -174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 61' ' ' ILE . 93.5 t -129.09 110.16 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.659 ' HB3' HG21 ' A' ' 60' ' ' THR . 26.2 pttm -102.07 165.77 10.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.908 0.385 . . . . 0.0 111.624 -174.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.549 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 63.57 44.06 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.739 175.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 55' ' ' LEU . 39.6 pt -65.83 174.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.048 0.928 . . . . 0.0 113.064 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 2.2 tpp180 -122.56 123.93 42.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.941 -1.482 . . . . 0.0 108.236 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.532 HD12 HG12 ' A' ' 46' ' ' VAL . 42.5 mt -83.0 119.39 24.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.54 HG21 ' O ' ' A' ' 93' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--N 1.319 -0.726 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.54 ' O ' HG21 ' A' ' 88' ' ' VAL . 9.4 m-20 . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.776 HG13 HG21 ' A' ' 47' ' ' ILE . 3.9 mp -110.55 116.6 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 170.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 28.1 t70 -94.1 130.36 40.3 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.457 ' HB2' HG12 ' A' ' 82' ' ' VAL . 24.8 p -144.22 154.58 43.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.567 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 98.7 mttt -121.18 129.5 53.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.0 mt -121.37 118.93 57.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.419 -170.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.11 120.91 8.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.743 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.35 -80.77 0.31 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.1 pt -74.93 -46.03 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.733 0.301 . . . . 0.0 111.476 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.27 -150.84 20.86 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.89 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.86 146.82 24.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.656 0.265 . . . . 0.0 110.85 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.9 ttt -142.31 163.39 32.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.236 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.25 140.03 49.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.6 mt -120.04 144.1 47.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.121 0.486 . . . . 0.0 111.419 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 16.9 ttmt -80.89 118.76 22.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.977 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.669 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 3.3 m -49.08 -37.59 21.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.48 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' SER . 27.7 mt-10 -72.08 -8.62 55.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.279 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.46 ' O ' HD12 ' A' ' 64' ' ' ILE . 33.9 m-85 -113.46 -0.62 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.174 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 21.9 m -113.51 171.69 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.798 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 13.5 ttt180 -150.29 138.21 20.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.641 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.501 ' HB2' HD23 ' A' ' 55' ' ' LEU . 26.5 ttpt -62.88 117.11 5.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.857 165.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -55.59 -56.05 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.14 -0.05 13.03 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.325 176.431 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 31.9 mt . . . . . 0 C--O 1.233 0.202 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 61.1 Cg_endo -69.43 158.35 57.72 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.868 1.712 . . . . 0.0 110.742 171.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.06 -167.51 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.461 2.107 . . . . 0.0 112.4 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.4 t -98.36 125.68 42.34 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.522 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.44 7.76 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.804 2.336 . . . . 0.0 112.314 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.454 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 36.9 mt-30 -119.36 -38.44 3.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.8 m -107.23 -46.95 3.77 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.311 0.577 . . . . 0.0 109.917 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.36 0.81 2.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.414 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 m -57.88 -77.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.354 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 171.15 -21.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 73.2 m-85 -78.87 36.99 0.29 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -167.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -101.01 144.34 30.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.263 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -146.12 173.41 12.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HB3' HD13 ' A' ' 5' ' ' LEU . 1.2 pm0 -101.7 119.42 38.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.571 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 15.7 t70 -120.18 75.42 1.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.12 -119.64 6.58 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.903 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.64 16.46 25.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.723 0.297 . . . . 0.0 111.72 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.24 -176.54 5.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.737 0.303 . . . . 0.0 110.293 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.556 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 17.0 mt -111.69 130.7 55.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.17 127.94 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.2 t -102.6 103.98 35.56 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -70.07 -9.86 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.836 2.357 . . . . 0.0 110.65 176.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.605 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 74.0 tt0 -70.08 -65.02 0.78 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.991 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -95.12 11.41 32.31 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 43.69 19.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 111.824 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HB3' HE22 ' A' ' 10' ' ' GLN . 54.3 t60 -150.1 136.33 18.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.928 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.63 166.77 10.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -162.3 161.85 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -112.93 124.73 31.06 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.5 Cg_endo . . . . . 0 C--N 1.345 0.39 0 C-N-CA 123.304 2.669 . . . . 0.0 113.815 -168.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG12 HD12 ' A' ' 87' ' ' LEU . 2.8 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 88' ' ' VAL . 3.1 mm -91.17 138.1 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.709 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.5 ttmt -121.06 149.49 42.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.316 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.627 ' OD1' HG21 ' A' ' 111' ' ' VAL . 6.8 m-20 -90.05 -179.79 5.77 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.273 0.559 . . . . 0.0 111.542 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 28.4 t -83.85 -3.21 57.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.014 0.911 . . . . 0.0 110.005 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 112' ' ' ARG . 4.6 t -92.39 -14.42 8.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.819 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.62 3.28 59.67 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.688 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -87.68 163.39 16.57 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.933 0.873 . . . . 0.0 111.423 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.416 HG23 ' HG3' ' A' ' 48' ' ' LYS . 2.6 t -117.69 135.18 58.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.663 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -95.79 -157.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 111.278 -172.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.573 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 5.9 tt0 -159.56 146.34 16.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -70.59 97.85 1.39 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.811 0.815 . . . . 0.0 110.012 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 125.34 -6.6 8.09 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.941 -176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.573 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 40.9 t0 -73.87 167.8 20.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.719 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.2 m -110.88 134.2 52.74 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.47 171.86 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -150.12 119.34 6.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.789 0.328 . . . . 0.0 111.56 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.624 HG12 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -59.82 132.16 24.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 122.886 0.474 . . . . 0.0 110.155 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.662 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -104.68 19.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.662 ' HD2' HG12 ' A' ' 64' ' ' ILE . 4.9 mptp? -138.26 161.88 35.76 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -84.83 101.4 12.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.294 171.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD21 ' CG ' ' A' ' 110' ' ' PHE . 6.3 mp -112.96 145.66 40.41 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.86 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.37 173.97 8.42 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.876 0.369 . . . . 0.0 111.238 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 60.7 t -126.68 137.78 56.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -104.03 138.51 40.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.97 -37.45 3.5 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.36 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -110.56 155.62 22.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -80.35 -0.96 39.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.478 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 2.2 mm? -80.91 141.64 34.36 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.195 0.521 . . . . 0.0 111.409 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.2 t -112.71 134.83 54.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.466 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.624 HG13 HG12 ' A' ' 63' ' ' VAL . 78.6 t -83.68 99.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.028 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.15 148.64 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.265 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.55 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.98 96.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 122.038 0.923 . . . . 0.0 111.063 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.93 3.95 3.47 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.123 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.1 m -62.17 104.5 0.49 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.522 0.677 . . . . 0.0 110.294 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -87.17 116.2 25.08 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.651 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 96' ' ' CYS . 18.2 t -125.31 116.58 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 pttm -104.71 162.51 13.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.564 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 66.81 38.65 3.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.341 170.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.5 pt -67.58 -178.72 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 122.168 0.985 . . . . 0.0 113.486 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 16.5 tpp180 -130.05 129.63 43.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.611 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.463 HD12 HG12 ' A' ' 46' ' ' VAL . 82.3 mt -84.88 123.74 30.82 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.747 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.798 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.747 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.4 m-20 . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.528 ' CD1' HG23 ' A' ' 111' ' ' VAL . 51.6 mt -125.96 117.41 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.328 0.585 . . . . 0.0 111.334 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 26.2 t70 -94.57 131.97 39.76 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.544 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.524 ' HB2' HG12 ' A' ' 82' ' ' VAL . 27.8 p -134.16 138.83 45.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.857 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -112.58 127.13 56.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.11 109.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.893 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.58 94.98 2.23 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.42 -56.39 0.31 Allowed Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.207 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 102' ' ' GLY . 48.1 pt -104.39 -42.28 7.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.339 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.447 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 143.09 -158.87 27.35 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.024 -0.607 . . . . 0.0 111.698 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.2 144.42 26.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.728 0.299 . . . . 0.0 110.629 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.3 tpt -134.64 155.58 50.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.856 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -101.41 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.915 177.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 99.0 mt -130.85 136.6 48.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.674 0.75 . . . . 0.0 111.504 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.584 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 30.9 mttm -84.82 114.68 22.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.463 175.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.709 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.7 p -53.5 -35.76 60.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.137 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.584 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 5.9 pt-20 -61.31 -14.73 29.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.497 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.518 ' O ' HD13 ' A' ' 64' ' ' ILE . 56.6 m-85 -112.72 2.3 16.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.969 -0.457 . . . . 0.0 112.224 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.627 HG21 ' OD1' ' A' ' 49' ' ' ASP . 17.8 m -114.14 170.3 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.38 0.609 . . . . 0.0 112.297 -173.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.505 ' HB2' HG22 ' A' ' 51' ' ' VAL . 7.5 ttt180 -142.09 141.22 32.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.291 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.536 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 36.1 tttp -71.03 140.76 50.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.369 176.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.0 t -105.03 -49.41 9.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.285 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.78 31.45 73.07 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.814 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.992 179.812 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.684 0.278 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.78 161.48 45.28 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.501 2.134 . . . . 0.0 111.201 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.28 -167.03 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.354 2.036 . . . . 0.0 111.769 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 10.7 t -98.47 129.2 30.89 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.628 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.98 8.47 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.581 2.188 . . . . 0.0 111.34 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.638 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 13.3 mt-30 -119.36 -38.45 3.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.555 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.4 m -108.63 -52.89 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.589 0.709 . . . . 0.0 109.53 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 71.76 3.22 4.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.474 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.668 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 14.8 m -59.5 -77.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.615 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 13' ' ' SER . 16.3 pt-20 176.91 -15.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.513 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 25.8 m-85 -81.81 32.74 0.37 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.386 0.539 . . . . 0.0 112.007 -169.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -91.9 135.72 33.71 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.0 p90 -143.62 170.07 16.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -98.66 118.92 36.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.722 0.296 . . . . 0.0 111.296 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 32.9 t70 -123.3 86.15 2.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 171.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.61 -111.79 3.99 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.406 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.1 18.86 18.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.7 -175.08 5.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 110.39 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 32' ' ' TRP . 43.9 mt -110.1 131.24 55.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.633 174.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.513 HG12 ' HG3' ' A' ' 31' ' ' GLU . 57.6 t -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.936 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 41.7 t -104.24 103.16 37.09 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.2 Cg_endo -69.73 -15.43 37.18 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.366 2.044 . . . . 0.0 109.645 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.936 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 28.2 tt0 -64.16 -44.46 92.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.657 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.414 ' SG ' ' NE2' ' A' ' 10' ' ' GLN . 22.4 p -118.06 11.83 13.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 171.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.21 47.19 14.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -143.61 131.49 21.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.493 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HG3' HG12 ' A' ' 24' ' ' VAL . 2.0 mp0 -91.73 145.34 24.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.446 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.456 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -150.16 160.99 43.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.222 0.534 . . . . 0.0 110.933 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -118.15 124.51 28.61 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 18.3 Cg_endo . . . . . 0 C--N 1.34 0.106 0 C-N-CA 122.672 2.248 . . . . 0.0 111.745 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.489 HG13 HD11 ' A' ' 87' ' ' LEU . 10.3 t . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.502 HD13 ' O ' ' A' ' 88' ' ' VAL . 2.2 mm -101.34 140.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.529 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -107.13 179.71 4.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.886 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.801 ' OD2' HD12 ' A' ' 55' ' ' LEU . 84.0 m-20 -120.35 -179.65 4.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.26 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 8.6 t -75.44 -6.44 50.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.257 1.027 . . . . 0.0 109.161 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.509 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 4.2 t -92.53 -15.55 8.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.884 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.38 -1.4 76.32 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.2 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.509 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -88.54 161.04 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.237 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.51 HG23 ' HG3' ' A' ' 48' ' ' LYS . 16.6 t -115.04 135.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.48 -173.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.801 HD12 ' OD2' ' A' ' 49' ' ' ASP . 3.1 mp -103.18 -178.19 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 110.853 -168.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.52 ' HA ' HD13 ' A' ' 87' ' ' LEU . 8.5 tt0 -132.07 157.82 43.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.425 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -73.87 133.85 43.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 172.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 90.07 -9.47 77.25 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.573 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.06 169.2 18.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.709 0.29 . . . . 0.0 110.909 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 4.6 m -105.02 135.98 45.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.425 ' CG2' HD13 ' A' ' 85' ' ' ILE . 1.8 pp -124.04 168.96 15.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.42 ' N ' HD11 ' A' ' 61' ' ' ILE . 2.8 m -150.14 117.92 6.22 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.48 0.312 . . . . 0.0 110.675 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.695 HG12 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.01 131.24 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 176.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.527 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -100.11 16.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -135.73 158.15 45.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -85.94 104.83 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.983 0.897 . . . . 0.0 111.361 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.436 HD12 ' CB ' ' A' ' 110' ' ' PHE . 18.5 mt -119.98 146.44 45.84 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.474 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -85.62 175.13 8.94 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.378 0.608 . . . . 0.0 111.415 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 76' ' ' VAL . 85.3 t -120.99 128.82 76.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -92.08 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.314 0.506 . . . . 0.0 110.635 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.35 -21.22 22.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.588 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -115.95 157.94 23.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -87.59 5.47 39.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.039 0.447 . . . . 0.0 110.867 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.73 136.6 34.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.565 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.32 134.79 44.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.166 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.695 HG12 HG12 ' A' ' 63' ' ' VAL . 59.2 t -85.92 101.71 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.536 0.684 . . . . 0.0 109.665 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.65 148.46 25.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.438 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.92 96.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.874 0.845 . . . . 0.0 110.647 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.04 6.22 4.06 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.9 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.0 m -62.19 103.97 0.43 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.695 0.76 . . . . 0.0 109.669 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.75 111.85 23.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 96' ' ' CYS . 46.2 t -117.62 115.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 50.1 pttt -101.8 149.87 23.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.779 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 46.7 m-80 68.91 48.05 0.75 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.098 0.874 . . . . 0.0 111.245 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.604 HG22 ' SG ' ' A' ' 96' ' ' CYS . 44.5 pt -66.58 -175.53 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 122.064 0.935 . . . . 0.0 112.085 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -136.24 129.21 31.22 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.276 173.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.52 HD13 ' HA ' ' A' ' 56' ' ' GLN . 60.9 mt -83.06 122.55 28.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.502 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.082 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.355 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.9 m-20 . . . . . 0 C--O 1.222 -0.38 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.622 ' CD1' HG22 ' A' ' 111' ' ' VAL . 42.5 mt -124.31 112.43 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.617 0.722 . . . . 0.0 112.004 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.18 133.77 40.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.662 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.604 ' SG ' HG22 ' A' ' 85' ' ' ILE . 16.1 m -143.75 146.37 33.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.339 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -106.12 129.63 54.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.707 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.44 HD13 ' HE2' ' A' ' 104' ' ' MET . 18.3 mt -130.24 107.35 14.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -76.18 96.07 3.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.03 -63.64 0.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.168 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 pt -98.56 -42.25 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.65 27.49 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.76 145.75 32.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.819 ' HE1' HD22 ' A' ' 106' ' ' LEU . 51.5 ttp -135.2 155.37 50.77 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.524 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.18 142.6 43.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.892 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.819 HD22 ' HE1' ' A' ' 104' ' ' MET . 85.1 mt -124.74 139.42 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.732 0.777 . . . . 0.0 111.872 -172.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -76.8 116.4 17.43 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.892 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.8 t -46.89 -42.7 17.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.961 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 50' ' ' SER . 9.5 mt-10 -67.87 -13.34 62.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.778 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.473 ' O ' HD11 ' A' ' 64' ' ' ILE . 42.0 m-85 -113.03 3.16 16.02 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.622 HG22 ' CD1' ' A' ' 94' ' ' ILE . 32.9 m -114.24 168.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.294 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.474 ' HD2' HG21 ' A' ' 51' ' ' VAL . 18.4 ttt180 -149.24 128.44 12.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.53 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 9.9 tttp -59.5 132.78 55.03 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.478 173.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.7 -56.08 10.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.75 -8.09 19.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.417 177.405 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 20.5 mt . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 72.6 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.378 2.052 . . . . 0.0 111.033 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.5 -163.93 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.578 2.185 . . . . 0.0 112.709 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 5.0 t -98.88 128.24 32.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.1 8.55 1.04 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.789 2.326 . . . . 0.0 112.464 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.45 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 44.7 mt-30 -119.18 -37.84 3.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.9 m -110.03 -45.99 3.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.984 0.421 . . . . 0.0 109.886 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.86 2.23 3.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.592 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -48.47 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 169.86 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HE1' ' HB2' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -87.57 57.42 4.39 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.867 0.841 . . . . 0.0 110.765 -168.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -105.84 140.47 38.82 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.305 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 37.5 p90 -141.16 171.18 14.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.432 ' CD ' HD12 ' A' ' 5' ' ' LEU . 1.3 pm0 -100.94 114.56 28.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.928 0.394 . . . . 0.0 110.755 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.553 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 26.7 t70 -113.38 83.03 1.77 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.08 -108.35 3.65 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.339 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.87 19.65 16.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -170.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 31' ' ' GLU . 1.4 pt? -162.3 -174.68 4.17 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.54 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 8.3 mt -106.39 132.58 52.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 31' ' ' GLU . 58.0 t -117.76 129.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 53.0 t -100.71 109.97 59.23 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.64 -16.31 46.44 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.703 2.268 . . . . 0.0 111.193 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.624 ' HB2' ' HE1' ' A' ' 15' ' ' TYR . 9.9 tp10 -69.36 -73.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.558 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -88.12 10.35 19.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 45.47 16.48 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -144.61 129.45 18.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.85 0.357 . . . . 0.0 110.23 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB3' HD12 ' A' ' 22' ' ' LEU . 1.9 mp0 -90.42 152.68 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.429 ' NE1' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -155.26 161.31 41.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.3 m -121.66 130.42 24.78 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.54 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 14.3 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 123.412 2.741 . . . . 0.0 113.295 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.433 HG13 HD13 ' A' ' 87' ' ' LEU . 7.3 t . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.447 HG23 HG13 ' A' ' 94' ' ' ILE . 6.9 mm -93.35 138.75 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.617 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.4 ttmt -127.75 142.65 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.719 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.534 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 71.4 m-20 -100.28 -179.42 4.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.2 t -77.29 -5.65 50.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.867 0.842 . . . . 0.0 110.533 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.9 t -88.57 -16.1 8.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.727 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.8 -3.23 67.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.171 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.534 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -87.07 149.37 24.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.643 0.735 . . . . 0.0 111.859 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.526 HG23 ' HG3' ' A' ' 48' ' ' LYS . 3.6 t -104.7 136.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.345 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.596 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.1 mp -100.35 179.74 4.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.449 -169.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.444 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 12.4 tt0 -132.0 156.17 46.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.251 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -69.74 138.34 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 82.21 -4.91 74.52 Favored Glycine 0 C--N 1.316 -0.562 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.538 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -72.78 171.53 12.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.727 0.299 . . . . 0.0 110.337 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 91.9 m -109.27 137.15 47.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.9 169.54 12.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -149.4 117.17 6.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.942 0.401 . . . . 0.0 110.859 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -62.15 128.9 24.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.572 HG12 ' CD ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -100.51 15.56 4.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.572 ' CD ' HG12 ' A' ' 64' ' ' ILE . 2.4 mptm? -135.79 165.1 26.4 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.588 -0.695 . . . . 0.0 109.168 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.85 116.05 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.802 0.811 . . . . 0.0 111.51 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.08 147.6 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.281 174.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.28 175.32 6.89 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.117 -0.364 . . . . 0.0 110.343 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.49 134.49 61.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 2.2 mmmp? -43.14 -88.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.46 21.78 42.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.383 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 m -122.67 153.62 39.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.898 0.38 . . . . 0.0 110.627 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -83.31 6.57 19.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.1 131.23 34.76 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 120.865 0.364 . . . . 0.0 110.052 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.7 t -100.67 133.53 43.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.454 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 63' ' ' VAL . 53.8 t -85.85 99.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.38 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.11 152.09 25.0 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.684 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -52.12 97.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.918 0.866 . . . . 0.0 110.991 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.65 4.73 3.81 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.491 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.0 m -62.38 105.68 0.65 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.672 0.748 . . . . 0.0 110.627 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.31 113.34 24.6 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.052 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.468 HG12 ' HB2' ' A' ' 96' ' ' CYS . 43.0 t -122.02 117.01 50.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 13.4 ptmm? -106.23 153.68 21.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.199 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.5 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 71.95 42.38 0.61 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.337 173.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.6 pt -67.27 -177.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 122.25 1.024 . . . . 0.0 113.602 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -128.9 126.21 39.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.765 -1.561 . . . . 0.0 108.429 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.433 HD13 HG13 ' A' ' 46' ' ' VAL . 81.8 mt -80.26 122.87 27.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 93' ' ' ASP . 2.6 t . . . . . 0 C--N 1.316 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.488 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.526 ' O ' HG21 ' A' ' 88' ' ' VAL . 10.7 m-20 . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 121.445 0.64 . . . . 0.0 111.543 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.577 ' CD1' HG21 ' A' ' 111' ' ' VAL . 63.4 mt -114.33 116.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.146 171.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -94.69 133.27 38.54 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.357 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.468 ' HB2' HG12 ' A' ' 82' ' ' VAL . 27.1 p -145.46 159.86 42.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.609 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -118.36 134.57 54.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.006 176.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.0 mt -120.57 107.16 20.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.934 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -63.35 107.17 1.03 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.94 -46.34 0.86 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.937 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.3 pt -117.98 -38.83 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.69 0.281 . . . . 0.0 110.826 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.85 -157.09 24.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.378 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.8 149.62 23.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.969 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -153.99 171.54 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.468 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 19.0 ptmt -120.74 151.27 39.76 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.717 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.1 mt -127.32 140.32 52.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.27 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.422 ' HD3' ' CE2' ' A' ' 110' ' ' PHE . 76.5 tttt -82.31 117.61 22.52 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.132 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.617 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 1.4 p -50.86 -37.06 41.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.625 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -69.5 -7.33 37.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.309 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.51 ' O ' HD11 ' A' ' 64' ' ' ILE . 66.6 m-85 -113.46 -2.87 13.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.761 -0.587 . . . . 0.0 112.001 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 m -116.94 173.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 112.38 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.489 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.8 ttt180 -143.22 137.19 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.023 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.596 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 14.3 tttp -70.55 135.81 48.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.695 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.77 -58.56 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.905 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.75 34.93 3.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.235 178.915 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.777 0.323 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.69 161.83 42.88 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.863 2.375 . . . . 0.0 111.748 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -64.57 -169.43 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.353 2.036 . . . . 0.0 112.385 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -98.81 129.13 30.57 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.969 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HG3' ' CE3' ' A' ' 32' ' ' TRP . 55.8 Cg_endo -69.11 7.25 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.692 2.261 . . . . 0.0 112.214 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.528 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 44.5 mt-30 -117.7 -39.32 3.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.479 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.402 ' C ' ' H ' ' A' ' 13' ' ' SER . 59.7 m -106.2 -45.83 4.21 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 70.44 -3.3 1.91 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.851 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.7 m -55.34 -77.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.711 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.507 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.2 pt-20 164.31 -7.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.69 0.618 . . . . 0.0 112.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.661 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 61.1 m-85 -80.64 41.56 0.56 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 111.406 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -104.24 148.1 26.72 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.453 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 41.2 p90 -148.9 174.79 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.92 117.76 34.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.808 0.337 . . . . 0.0 111.108 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.532 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 14.7 t70 -115.75 79.07 1.24 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.97 -107.97 3.59 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.319 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.19 17.71 19.27 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -157.75 -175.46 5.39 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 16.2 mt -107.92 130.06 55.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 31' ' ' GLU . 52.2 t -116.9 127.39 74.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.2 t -102.7 105.41 44.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 44.8 Cg_endo -69.76 -12.5 33.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.565 2.177 . . . . 0.0 110.785 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 36.0 tt0 -68.7 -59.06 3.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.081 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.09 14.52 31.7 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.6 27.77 16.35 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -140.66 142.25 34.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.402 ' HB3' HG21 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -98.15 177.38 5.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.492 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -172.28 161.88 5.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -119.07 129.85 25.17 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.492 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 12.2 Cg_endo . . . . . 0 C--N 1.342 0.197 0 C-N-CA 123.274 2.649 . . . . 0.0 113.338 -170.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.601 HG21 HG13 ' A' ' 94' ' ' ILE . 5.3 mm -76.97 137.38 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.823 -170.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.505 ' HG3' HG23 ' A' ' 54' ' ' VAL . 1.6 ttmt -124.86 177.37 6.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.661 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 19.2 m-20 -113.16 179.26 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.531 ' HB3' HD13 ' A' ' 64' ' ' ILE . 44.8 t -82.16 -8.29 59.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.015 171.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 2.9 t -91.07 -17.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.141 -1.39 . . . . 0.0 109.347 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.68 -0.8 52.57 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.235 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.507 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -83.46 167.33 17.55 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.022 0.915 . . . . 0.0 111.283 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.505 HG23 ' HG3' ' A' ' 48' ' ' LYS . 10.0 t -116.84 136.53 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.775 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.04 175.83 6.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.342 0.591 . . . . 0.0 110.64 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -131.4 151.12 51.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.024 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 15.6 t70 -72.62 91.92 1.48 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 133.69 -14.29 4.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.75 169.11 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.7 0.286 . . . . 0.0 111.013 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 22.2 m -100.12 137.27 38.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 pp -125.81 165.43 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.172 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.4 m -147.31 125.39 12.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.052 0.453 . . . . 0.0 111.894 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.546 HG13 HG11 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -67.77 129.57 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.587 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.72 19.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.2 mptm? -138.69 160.81 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.964 0.802 . . . . 0.0 108.876 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -87.67 114.07 23.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.141 0.972 . . . . 0.0 112.433 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 3.8 mp -124.88 149.74 47.21 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.308 170.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -89.41 179.07 6.16 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.778 -0.576 . . . . 0.0 111.153 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.621 HG23 HG22 ' A' ' 76' ' ' VAL . 9.6 t -132.05 130.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 141.15 33.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.32 -16.35 3.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.881 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.9 p -106.7 172.79 6.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.136 0.493 . . . . 0.0 111.158 -175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -97.12 16.79 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mp -91.75 171.79 8.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -159.27 117.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.621 HG22 HG23 ' A' ' 69' ' ' VAL . 93.9 t -82.01 94.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.785 0.802 . . . . 0.0 109.497 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 146.78 32.93 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -47.98 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.937 0.875 . . . . 0.0 110.896 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.09 7.74 3.96 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.179 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.4 m -62.7 104.21 0.51 Allowed 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 121.694 0.759 . . . . 0.0 109.52 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.2 113.93 26.34 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.346 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -132.02 118.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 61.9 pttt -110.04 170.39 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.559 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 89.9 m-20 66.82 34.17 5.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.216 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.2 pt -64.57 175.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 122.195 0.997 . . . . 0.0 113.513 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -119.16 122.18 41.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.232 174.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.83 118.92 18.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 93' ' ' ASP . 5.3 t . . . . . 0 C--N 1.319 -0.717 0 CA-C-O 121.633 0.73 . . . . 0.0 111.637 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.561 ' O ' HG21 ' A' ' 88' ' ' VAL . 16.6 m-20 . . . . . 0 C--O 1.224 -0.241 0 CA-C-O 121.377 0.608 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.601 HG13 HG21 ' A' ' 47' ' ' ILE . 4.9 mp -105.44 119.91 55.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.464 172.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.3 t70 -94.31 130.78 40.47 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.887 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.6 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.1 p -140.37 151.4 44.94 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.284 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -105.43 122.13 45.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.432 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.0 mt -122.63 107.78 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.255 0.55 . . . . 0.0 110.585 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -69.34 105.72 2.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.522 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.3 -37.96 0.79 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.234 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 pt -132.28 -38.49 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.863 0.363 . . . . 0.0 110.688 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.89 -153.67 23.92 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.734 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.57 24.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.722 0.261 . . . . 0.0 110.698 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.453 ' HG2' ' N ' ' A' ' 105' ' ' LYS . 49.4 ttm -142.0 164.05 31.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.143 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.532 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -117.57 139.08 51.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.05 138.76 52.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.499 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 14.6 tptm -72.25 125.03 26.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.884 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -52.1 -27.63 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.179 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.558 ' HG2' ' HG3' ' A' ' 107' ' ' LYS . 10.9 pt-20 -87.1 -5.27 59.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.997 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.418 ' O ' HD11 ' A' ' 64' ' ' ILE . 35.5 m-85 -116.59 7.69 13.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.341 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.508 HG12 HD11 ' A' ' 94' ' ' ILE . 34.0 m -111.91 162.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.41 ' CG ' HG23 ' A' ' 51' ' ' VAL . 28.2 ttt180 -141.25 135.26 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.97 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -67.46 140.88 57.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.178 0.513 . . . . 0.0 110.914 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.99 -69.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.816 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.99 51.14 9.34 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.838 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.0 m . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.071 178.866 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 60.9 mt . . . . . 0 C--O 1.234 0.262 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 68.5 Cg_endo -71.2 159.99 50.33 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.264 1.976 . . . . 0.0 111.264 175.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.73 -163.67 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.649 2.233 . . . . 0.0 112.376 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 7.9 t -98.49 127.64 35.4 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.693 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 7.89 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.329 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.445 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 9.7 tt0 -122.05 -32.84 3.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.278 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.14 -45.25 3.62 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.667 -0.645 . . . . 0.0 109.984 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t30 69.95 -2.81 1.92 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.698 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.9 p -45.27 -77.06 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 13' ' ' SER . 10.7 pt-20 161.85 -15.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.808 0.693 . . . . 0.0 111.06 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.598 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m-85 -81.97 45.57 0.93 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.374 0.606 . . . . 0.0 111.043 -171.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -104.85 143.2 33.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.693 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.74 176.6 10.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.31 126.77 53.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.382 0.611 . . . . 0.0 110.819 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.27 82.07 1.75 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.112 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -112.58 4.33 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.39 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.79 17.32 22.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -154.0 -174.57 5.01 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 15.9 mt -114.5 136.46 52.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.737 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -127.87 142.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.861 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 46.6 t -104.62 106.99 56.9 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.8 Cg_endo -66.88 -14.0 42.09 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.763 2.309 . . . . 0.0 111.423 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 29.8 tt0 -73.15 -61.32 1.86 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.02 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.9 p -97.81 10.9 38.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.33 45.41 20.16 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -135.88 124.12 23.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.729 0.299 . . . . 0.0 110.516 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.737 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 34.6 mt-10 -93.3 143.57 26.14 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.11 161.99 41.79 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 120.807 0.337 . . . . 0.0 110.121 -176.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 p -112.05 132.76 21.88 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.539 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 9.9 Cg_endo . . . . . 0 C--N 1.345 0.368 0 C-N-CA 123.336 2.69 . . . . 0.0 113.284 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 87' ' ' LEU . 13.7 p . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.587 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.144 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.505 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -107.27 177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 0.0 111.202 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.58 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 6.6 m-20 -118.22 174.45 6.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.867 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.556 ' HB3' HD12 ' A' ' 64' ' ' ILE . 27.5 t -70.62 -7.11 41.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.836 0.827 . . . . 0.0 110.696 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.473 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.0 t -88.93 -16.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.854 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 2.22 65.35 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.668 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -93.66 162.82 13.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.332 0.587 . . . . 0.0 111.477 178.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 t -114.46 136.25 51.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.454 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 61' ' ' ILE . 13.1 mt -93.57 174.96 6.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.398 0.618 . . . . 0.0 112.002 -170.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.3 tt0 -125.64 147.18 49.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.581 175.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.4 105.68 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.045 0.926 . . . . 0.0 109.436 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 114.14 -2.46 23.99 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.0 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.8 t70 -76.59 169.31 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.6 m -105.53 137.03 44.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.489 HG23 HD23 ' A' ' 55' ' ' LEU . 2.0 pp -120.7 166.4 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -148.08 119.84 8.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.929 0.395 . . . . 0.0 110.773 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.621 HG12 HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -62.39 126.34 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' A' ' 50' ' ' SER . 0.2 OUTLIER -100.12 17.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.227 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.544 ' HD3' HG12 ' A' ' 64' ' ' ILE . 1.8 mppt? -141.77 165.18 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.75 -0.594 . . . . 0.0 109.517 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.505 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.0 p-10 -83.21 113.94 21.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.596 0.713 . . . . 0.0 111.484 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.559 HD22 ' CD1' ' A' ' 110' ' ' PHE . 23.9 mt -126.53 140.44 52.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.694 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -91.22 174.16 7.54 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.225 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 72' ' ' SER . 38.7 t -124.91 126.37 71.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -88.49 -36.19 16.59 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.14 -32.37 52.63 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.125 -1.035 . . . . 0.0 111.575 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.489 ' HB2' HG13 ' A' ' 69' ' ' VAL . 37.2 m -107.04 175.74 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.343 -0.429 . . . . 0.0 111.145 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -98.19 -4.78 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.058 0.456 . . . . 0.0 110.561 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mp -77.3 143.25 38.97 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.829 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.64 125.73 66.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.284 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.621 HG11 HG12 ' A' ' 63' ' ' VAL . 69.5 t -78.72 116.7 22.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.557 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.416 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -111.76 147.45 35.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.41 -175.096 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.534 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.31 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.924 0.868 . . . . 0.0 110.654 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.28 7.51 3.96 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.716 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -62.84 104.64 0.57 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.536 0.684 . . . . 0.0 109.657 174.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -89.67 115.83 27.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.847 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 96' ' ' CYS . 38.5 t -125.01 115.16 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 21.4 ptmt -99.87 157.15 16.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.382 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.581 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 93.6 m-20 66.27 45.17 2.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.659 173.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.1 pt -65.57 176.22 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 122.0 0.905 . . . . 0.0 113.38 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 21.8 tpp180 -130.26 131.95 45.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.831 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.452 HD13 HG21 ' A' ' 46' ' ' VAL . 15.8 mt -79.18 114.7 18.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.54 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.222 -0.386 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.587 HG13 HG21 ' A' ' 47' ' ' ILE . 3.7 mp -112.15 117.21 54.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.98 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.2 t70 -93.78 131.68 38.91 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.621 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.542 ' HB2' HG12 ' A' ' 82' ' ' VAL . 18.3 p -144.74 156.15 43.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.91 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 131.39 55.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.893 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.44 110.5 27.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.944 0.402 . . . . 0.0 110.028 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.16 102.94 1.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.299 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.09 -42.86 0.8 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.634 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.31 -42.19 2.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.06 0.457 . . . . 0.0 110.398 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.05 -154.17 23.75 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.86 149.44 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.312 0.556 . . . . 0.0 110.453 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.1 ttp -146.45 165.08 30.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.049 0.452 . . . . 0.0 110.95 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -114.03 138.65 50.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.866 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 81.0 mt -119.15 142.11 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.311 0.577 . . . . 0.0 111.437 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 66.1 mmtt -80.65 124.72 29.24 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.042 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.4 t -48.96 -43.66 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.981 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.449 ' C ' ' HB2' ' A' ' 50' ' ' SER . 1.5 pm0 -74.71 0.44 15.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.576 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.559 ' CD1' HD22 ' A' ' 67' ' ' LEU . 76.8 m-85 -119.72 2.64 11.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.45 -0.781 . . . . 0.0 112.993 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 34.1 m -114.04 172.93 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.193 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.443 ' CG ' HG23 ' A' ' 51' ' ' VAL . 10.9 ttt-85 -149.83 138.1 20.53 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.58 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -73.97 120.44 19.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.15 -46.55 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.907 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.49 11.35 82.11 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.177 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.228 -179.304 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.402 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 84.9 mt . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -67.75 155.12 71.2 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 121.81 1.673 . . . . 0.0 111.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.58 -170.85 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.71 2.273 . . . . 0.0 112.371 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -97.94 123.41 51.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.767 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.16 6.96 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.814 2.343 . . . . 0.0 112.269 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.476 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 49.2 mt-30 -115.36 -38.7 3.74 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.388 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -109.42 -48.19 3.28 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 72.03 -1.97 2.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.81 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 23.5 p -48.73 -76.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.53 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.5 pt-20 164.98 -13.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.584 0.553 . . . . 0.0 111.589 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.574 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 56.6 m-85 -78.7 35.32 0.24 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.083 0.468 . . . . 0.0 111.541 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 14' ' ' GLU . 3.0 m -97.83 138.94 34.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.047 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -147.26 174.8 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.06 130.84 55.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.254 0.55 . . . . 0.0 110.97 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -122.87 84.47 2.27 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.535 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.91 -110.27 3.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.363 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.09 19.92 17.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.872 -171.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.59 -173.82 4.57 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.569 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 23.7 mt -114.21 137.42 51.79 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.83 142.41 43.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.0 t -106.3 106.7 58.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.908 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 39.0 Cg_endo -67.84 -10.16 27.93 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.804 2.336 . . . . 0.0 111.212 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 31.6 tt0 -75.74 -61.41 1.93 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.679 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.58 9.78 42.47 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.37 26.55 15.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -123.12 133.68 54.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.113 0.482 . . . . 0.0 111.214 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.28 162.6 14.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.607 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -162.09 162.54 28.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.0 t -109.65 134.84 20.46 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.569 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.2 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 C-N-CA 122.489 2.126 . . . . 0.0 112.533 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.501 HG12 HD11 ' A' ' 87' ' ' LEU . 20.3 t . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.488 HG23 ' CG1' ' A' ' 94' ' ' ILE . 5.9 mm -85.22 134.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.807 0.337 . . . . 0.0 110.987 -174.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -112.18 149.36 32.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.211 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.554 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.6 m-20 -94.97 177.88 5.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.797 0.332 . . . . 0.0 110.633 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 32.8 t -72.57 -7.44 50.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.965 0.888 . . . . 0.0 110.536 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG21 ' CG ' ' A' ' 112' ' ' ARG . 3.0 t -88.23 -14.42 9.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.944 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.58 1.74 68.22 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.631 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -94.5 159.2 15.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.371 0.605 . . . . 0.0 111.6 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.8 t -108.75 135.14 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.053 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 61' ' ' ILE . 12.7 mt -92.14 178.96 5.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.053 0.454 . . . . 0.0 110.715 -175.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.935 ' HG2' ' HB2' ' A' ' 59' ' ' ASP . 9.1 pt20 -126.03 154.77 42.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' HD3' ' A' ' 86' ' ' ARG . 19.4 t70 -66.59 104.4 1.27 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 112.71 -0.28 26.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.787 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.935 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 2.7 t0 -78.96 171.59 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 33.0 m -106.22 137.52 44.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.465 HG21 HD21 ' A' ' 55' ' ' LEU . 2.1 pp -120.82 167.71 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.6 m -149.38 117.17 6.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.824 0.345 . . . . 0.0 110.382 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.742 HG12 HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -59.69 128.89 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.439 176.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.533 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -100.65 17.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -137.38 161.91 35.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.678 -0.639 . . . . 0.0 109.321 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.502 ' O ' HD22 ' A' ' 67' ' ' LEU . 10.2 p-10 -84.13 109.77 17.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.744 0.783 . . . . 0.0 111.467 170.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.502 HD22 ' O ' ' A' ' 66' ' ' ASP . 21.7 mt -127.05 145.93 50.55 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.616 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -90.51 174.75 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.948 -0.47 . . . . 0.0 111.382 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 72' ' ' SER . 49.7 t -123.25 130.21 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -73.76 -63.31 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.165 0.439 . . . . 0.0 112.016 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.57 -23.01 76.81 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.37 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.461 ' HB2' HG12 ' A' ' 69' ' ' VAL . 66.9 m -112.59 151.02 30.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -74.47 -0.22 16.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.17 0.51 . . . . 0.0 110.959 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.436 ' CD2' HG22 ' A' ' 101' ' ' ILE . 3.1 mm? -78.55 143.39 36.56 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.474 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -107.55 134.61 48.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.804 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.742 HG13 HG12 ' A' ' 63' ' ' VAL . 75.5 t -89.2 101.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.6 147.89 27.13 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.593 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.3 p -51.45 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.855 0.836 . . . . 0.0 110.935 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.84 4.52 4.21 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.914 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.5 105.02 0.57 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 110.368 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -91.47 114.16 26.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 96' ' ' CYS . 43.2 t -122.08 118.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.861 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.1 ptmt -98.53 156.22 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.435 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.474 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 85.3 m-20 63.08 49.91 3.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.325 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.8 pt -64.86 176.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 11.7 tpp180 -131.59 121.89 25.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.269 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD11 HG12 ' A' ' 46' ' ' VAL . 22.8 mt -85.96 126.24 33.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.091 0.405 . . . . 0.0 109.919 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.763 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.64 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 5.0 m-20 . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 106' ' ' LEU . 30.9 mt -119.96 108.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.217 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 16.6 t70 -95.72 103.77 15.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.53 0.681 . . . . 0.0 109.263 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.511 ' HB2' HG12 ' A' ' 82' ' ' VAL . 28.6 p -107.35 157.79 17.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.344 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 21.6 pttp -118.03 138.47 52.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.505 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.2 104.92 14.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.86 100.54 0.21 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.176 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.16 -64.86 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.647 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 102' ' ' GLY . 40.5 pt -89.88 -46.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.383 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.444 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.15 -162.21 27.86 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 176.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -83.61 149.66 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.025 0.441 . . . . 0.0 110.985 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.464 ' HE3' HD23 ' A' ' 106' ' ' LEU . 54.9 ttp -136.82 153.51 50.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -98.84 146.44 25.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 95.5 mt -129.75 134.31 47.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.502 0.668 . . . . 0.0 111.765 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -81.28 114.73 20.27 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.596 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.651 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.4 p -52.69 -37.46 58.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.421 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 50' ' ' SER . 39.1 mt-10 -71.37 -3.84 22.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.863 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.451 ' O ' HD13 ' A' ' 64' ' ' ILE . 66.6 m-85 -118.58 4.5 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.4 m -117.24 175.28 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.935 0.398 . . . . 0.0 112.064 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.459 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.4 ttt180 -147.7 141.59 25.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.562 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HB2' HD23 ' A' ' 55' ' ' LEU . 85.2 tttt -72.52 121.9 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.995 174.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.08 -54.59 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.031 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.71 -9.34 55.38 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.571 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.344 179.004 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.22 157.76 56.4 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.276 1.984 . . . . 0.0 111.243 176.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -66.3 -168.01 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 44.5 t -99.55 123.87 46.49 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.713 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.26 5.53 1.85 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.32 2.013 . . . . 0.0 111.724 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.666 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 42.2 mt-30 -105.44 -47.19 4.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.48 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -124.32 -33.42 3.05 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.891 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 70.81 11.84 7.15 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.402 0.62 . . . . 0.0 111.026 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 38.7 m -58.0 -25.76 61.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.285 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 13' ' ' SER . 89.2 mt-10 86.39 10.42 0.21 Allowed 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 111.504 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.428 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 85.5 m-85 -89.11 52.1 2.31 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.558 0.694 . . . . 0.0 109.387 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 m -105.24 149.8 25.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.713 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 48.3 p90 -150.52 177.1 10.34 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.83 128.24 52.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.794 0.33 . . . . 0.0 110.175 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -113.78 25.68 11.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.75 -114.82 0.85 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.388 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.88 14.38 29.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.645 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.433 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.2 pt? -150.0 -175.69 5.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.042 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mt -118.23 141.07 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.88 147.02 33.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.792 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 43.6 t -101.74 111.48 64.05 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HD3' ' CE2' ' A' ' 17' ' ' TYR . 23.6 Cg_endo -62.01 -22.64 74.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.882 2.388 . . . . 0.0 111.454 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.486 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 22.4 tt0 -76.79 -59.61 2.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.022 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.9 m -76.86 -4.85 45.82 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.63 37.32 28.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -141.25 135.22 30.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.011 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB3' HD13 ' A' ' 22' ' ' LEU . 21.6 mp0 -91.87 160.88 15.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.013 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -159.55 162.0 35.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.368 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -117.53 134.18 23.19 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo . . . . . 0 CA--C 1.531 0.342 0 C-N-CA 122.607 2.205 . . . . 0.0 113.352 -176.226 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 120.937 0.398 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.528 HG22 HG12 ' A' ' 94' ' ' ILE . 32.3 mm -73.54 122.02 25.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.404 -174.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 6.1 ttmt -119.03 137.39 53.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.613 -177.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.579 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 80.8 m-20 -92.88 -175.84 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.345 -169.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 16.7 t -77.1 -5.9 50.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.219 1.009 . . . . 0.0 110.269 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 112' ' ' ARG . 6.5 t -89.02 -21.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.18 -6.46 68.86 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.821 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.579 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -79.13 146.35 33.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.539 0.685 . . . . 0.0 111.179 178.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.409 HG21 ' HG3' ' A' ' 48' ' ' LYS . 4.3 t -102.94 134.74 43.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.522 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.642 ' HA ' ' HD2' ' A' ' 113' ' ' LYS . 7.1 mp -96.42 173.61 7.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.28 -169.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.549 ' NE2' ' H ' ' A' ' 57' ' ' ASP . 29.9 tp60 -126.04 149.26 48.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.373 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.549 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 13.4 t70 -65.15 130.16 42.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.27 -4.55 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.231 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 56' ' ' GLN . 1.1 t70 -73.52 175.73 6.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.129 0.465 . . . . 0.0 110.911 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.0 m -106.31 138.69 42.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.73 166.14 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -150.47 113.84 4.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.717 0.294 . . . . 0.0 110.512 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -61.05 125.82 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.521 HD11 ' O ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -97.43 14.35 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.499 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 2.4 mptm? -137.81 160.71 38.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.16 116.17 24.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.547 0.689 . . . . 0.0 111.848 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 5.1 mp -129.63 146.51 51.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.973 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -92.76 179.38 5.5 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.507 -0.746 . . . . 0.0 110.574 173.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.94 128.2 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -91.6 136.95 32.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.698 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 -27.19 3.36 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.494 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.653 ' HB3' HD22 ' A' ' 74' ' ' LEU . 66.2 m -105.32 155.36 19.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.624 0.249 . . . . 0.0 110.374 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -84.15 12.23 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.234 0.54 . . . . 0.0 110.374 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.653 HD22 ' HB3' ' A' ' 72' ' ' SER . 3.9 mm? -78.35 170.83 15.99 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.002 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -158.93 117.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -171.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.561 HG13 HG13 ' A' ' 63' ' ' VAL . 86.5 t -91.73 95.92 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.599 0.714 . . . . 0.0 110.564 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.24 145.8 33.77 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.038 -0.414 . . . . 0.0 111.17 -176.048 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -47.63 98.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 124.074 0.858 . . . . 0.0 111.392 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.07 7.14 3.76 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.262 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.0 m -63.07 104.19 0.54 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.759 0.79 . . . . 0.0 110.032 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.92 114.59 27.19 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.098 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 96' ' ' CYS . 39.4 t -131.37 121.06 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.662 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 56.8 pttt -107.9 166.99 10.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.731 0.777 . . . . 0.0 112.959 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.504 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER 71.1 36.7 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.203 172.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.3 pt -66.71 -178.11 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.764 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 0.3 OUTLIER -130.63 131.05 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.895 174.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.7 110.83 6.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.513 -173.269 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.422 ' O ' HD11 ' A' ' 47' ' ' ILE . 37.2 m-20 . . . . . 0 C--O 1.217 -0.61 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.541 ' CD1' HG22 ' A' ' 111' ' ' VAL . 69.7 mt -140.62 126.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.694 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.8 t70 -93.04 126.29 38.06 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.554 ' HB2' HG13 ' A' ' 82' ' ' VAL . 20.1 p -134.58 141.6 46.7 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.009 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 84' ' ' ASN . 11.4 ptpt -98.93 114.73 27.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.49 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.7 mt -116.98 104.94 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.403 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -47.66 130.35 14.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.639 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.2 -73.93 0.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.864 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 102' ' ' GLY . 32.6 pt -80.67 -46.27 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.774 0.321 . . . . 0.0 111.203 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.443 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 134.44 -146.33 18.33 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -88.57 155.97 19.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.101 0.45 . . . . 0.0 111.031 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.0 ttp -149.37 164.61 34.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.21 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 72.6 mttt -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.704 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.13 153.86 20.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.116 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HD2' ' HA ' ' A' ' 107' ' ' LYS . 13.5 tptt -83.9 114.22 21.52 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.072 174.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.639 ' HA ' HG21 ' A' ' 111' ' ' VAL . 88.7 p -53.88 -39.54 65.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.132 0.968 . . . . 0.0 109.627 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 50' ' ' SER . 41.1 mt-10 -64.86 -3.39 3.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.539 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.521 ' O ' HD11 ' A' ' 64' ' ' ILE . 35.7 m-85 -117.23 0.74 12.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 171.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.2 m -121.24 178.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.467 0.651 . . . . 0.0 112.396 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.482 ' HD2' HG23 ' A' ' 51' ' ' VAL . 6.9 ttt180 -144.11 133.12 22.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.944 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.642 ' HD2' ' HA ' ' A' ' 55' ' ' LEU . 88.0 tttt -65.87 121.3 14.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.526 173.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.6 -65.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.29 33.01 6.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.804 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.507 -0.759 . . . . 0.0 110.189 -179.825 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.596 0.236 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.7 160.21 46.86 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.643 2.229 . . . . 0.0 111.345 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.56 -166.44 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.0 112.432 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 8.5 t -98.17 121.95 55.62 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.11 6.61 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.681 2.254 . . . . 0.0 112.199 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.548 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 9.1 tt0 -119.89 -34.28 3.77 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -112.22 -43.53 3.53 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.816 0.735 . . . . 0.0 110.15 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.7 t30 73.19 2.9 4.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.889 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 23.3 p -65.0 -35.44 81.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.696 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 13' ' ' SER . 2.4 mt-10 85.74 25.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.13 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -70.92 2.25 4.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.788 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -58.42 145.73 37.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.807 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 46.3 p90 -153.27 174.82 13.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.85 111.36 23.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.104 0.478 . . . . 0.0 111.26 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.495 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.9 t0 -108.49 74.16 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.39 -112.82 4.56 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.828 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.69 16.96 23.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -172.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -156.01 -174.45 4.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.415 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 mt -110.51 134.23 52.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' A' ' 31' ' ' GLU . 85.9 t -118.66 132.45 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 122.114 -0.366 . . . . 0.0 110.208 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -99.45 109.88 56.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.44 -3.09 12.32 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.815 2.343 . . . . 0.0 112.109 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.82 -61.07 1.77 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.26 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -93.05 12.04 25.49 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 121.748 -0.595 . . . . 0.0 112.524 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.92 31.76 18.06 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -138.96 131.95 29.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.792 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.416 ' HG3' HG13 ' A' ' 24' ' ' VAL . 1.1 mp0 -91.6 171.0 9.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.516 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -167.36 161.5 14.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.9 m -124.81 125.23 25.47 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 C--O 1.234 0.313 0 C-N-CA 122.905 2.404 . . . . 0.0 112.869 -172.887 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.412 HD12 ' O ' ' A' ' 88' ' ' VAL . 16.3 mm -78.58 132.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.424 -172.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.1 ttmt -122.47 135.67 54.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.063 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.536 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 84.0 m-20 -99.17 -178.99 4.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 23.1 t -74.06 -5.31 40.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.786 0.803 . . . . 0.0 110.971 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 4.4 t -87.71 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.487 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.11 -8.86 63.17 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.448 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.536 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -80.32 148.68 30.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.781 0.801 . . . . 0.0 112.07 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG21 ' HG3' ' A' ' 48' ' ' LYS . 3.7 t -102.88 137.26 31.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.044 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.802 ' HG ' ' HG3' ' A' ' 113' ' ' LYS . 7.3 mp -95.84 174.0 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.469 0.652 . . . . 0.0 111.925 -169.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 30.1 tp60 -122.32 139.08 54.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.406 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' N ' HE21 ' A' ' 56' ' ' GLN . 22.7 t70 -66.56 102.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.34 -2.52 20.51 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.574 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 1.3 t70 -77.18 175.21 9.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 10.3 m -103.67 139.07 39.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.99 166.73 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -149.04 117.04 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.767 0.317 . . . . 0.0 110.474 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.705 HG12 HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.54 124.86 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.525 ' HA ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -96.46 13.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.565 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.613 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -134.74 159.1 42.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.188 0.518 . . . . 0.0 109.742 -172.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.05 103.43 7.98 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.66 0.743 . . . . 0.0 111.544 170.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 65' ' ' LYS . 2.2 mm? -115.68 128.91 56.26 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.145 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -88.06 174.09 8.48 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 120.911 -1.118 . . . . 0.0 109.573 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.63 123.68 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -79.72 -41.99 25.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.34 -20.45 66.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.558 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.2 m -113.8 173.69 6.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 m -98.28 2.1 47.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.15 0.5 . . . . 0.0 110.363 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.9 141.08 36.43 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.314 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.92 140.8 27.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.163 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.705 HG11 HG12 ' A' ' 63' ' ' VAL . 69.8 t -99.4 119.9 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.2 149.93 36.91 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.829 -175.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.525 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -49.39 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.539 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.09 5.14 3.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.635 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.1 m -62.33 105.16 0.57 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.811 0.815 . . . . 0.0 110.224 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -93.53 112.95 24.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.976 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.545 HG13 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -124.45 119.35 56.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.374 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 16.8 pttm -106.19 159.45 16.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 65.4 43.94 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.892 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 45.5 pt -64.89 -179.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 6.2 tpp180 -125.52 125.38 43.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.281 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.33 118.05 21.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 93' ' ' ASP . 1.9 t . . . . . 0 C--N 1.318 -0.779 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.543 ' O ' HG21 ' A' ' 88' ' ' VAL . 53.4 m-20 . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.832 0.825 . . . . 0.0 112.725 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.572 ' CD1' HG21 ' A' ' 111' ' ' VAL . 49.1 mt -115.52 119.93 63.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.475 174.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.28 135.93 36.27 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.545 ' HB2' HG13 ' A' ' 82' ' ' VAL . 22.1 p -143.13 153.68 43.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.775 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -110.56 125.35 53.27 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -126.16 115.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.726 0.298 . . . . 0.0 110.478 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.14 104.49 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.086 0.47 . . . . 0.0 110.54 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.57 -44.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.066 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.1 pt -125.51 -38.55 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.905 0.383 . . . . 0.0 110.496 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.25 -151.38 21.44 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.26 145.24 30.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.4 tpt -136.34 156.63 48.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.434 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -108.64 128.5 54.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.713 178.011 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -115.35 140.99 48.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.43 0.633 . . . . 0.0 111.292 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -78.74 113.97 17.26 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.674 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.591 ' HA ' HG23 ' A' ' 111' ' ' VAL . 4.3 p -52.42 -38.81 59.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.77 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' SER . 33.2 mt-10 -60.08 -15.13 20.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.64 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.48 ' O ' HD13 ' A' ' 64' ' ' ILE . 27.6 m-85 -114.96 4.86 14.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.506 -0.478 . . . . 0.0 112.085 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.3 m -126.1 179.11 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.394 0.616 . . . . 0.0 112.422 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.541 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 9.7 ttt180 -145.86 137.82 25.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.802 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 2.0 ttpp -73.3 125.01 26.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.786 173.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.81 -61.26 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.46 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.97 40.34 8.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.7 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.817 -178.161 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 21.3 mt . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.61 158.24 47.62 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.504 2.136 . . . . 0.0 110.989 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.28 -166.6 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.369 2.046 . . . . 0.0 112.057 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.0 t -97.93 120.89 59.11 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.508 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 9.24 0.31 Allowed 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.801 2.334 . . . . 0.0 112.141 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 33.8 mt-30 -117.6 -35.19 4.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.4 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.53 -48.53 3.07 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 121.0 0.429 . . . . 0.0 110.123 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.5 t30 69.9 -3.05 1.83 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.025 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -53.29 -76.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.944 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 173.06 -19.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.715 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 93.3 m-85 -82.5 48.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.051 0.453 . . . . 0.0 111.637 -167.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.4 m -109.23 146.25 34.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.334 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.4 p90 -152.88 178.45 9.65 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -103.58 118.78 37.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.001 0.429 . . . . 0.0 110.762 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.483 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 37.8 t70 -116.78 80.86 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.99 -113.03 4.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.213 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.26 21.45 16.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -172.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -158.47 -175.01 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.342 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 17.0 mt -107.25 130.29 54.77 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 19' ' ' ASP . 52.9 t -118.0 132.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 O-C-N 122.103 -0.373 . . . . 0.0 110.43 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.0 t -103.35 105.16 45.27 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.715 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 40.1 Cg_endo -68.14 -11.07 30.87 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 111.176 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.598 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.2 tp10 -72.52 -66.49 0.65 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.675 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -95.35 12.54 28.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.91 32.6 20.01 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.109 0.481 . . . . 0.0 111.915 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.422 ' HB3' HE22 ' A' ' 10' ' ' GLN . 40.2 t60 -136.64 133.24 36.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.193 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.87 167.47 9.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.798 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -165.57 162.2 18.91 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 t -116.93 136.92 23.39 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.6 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.798 2.332 . . . . 0.0 112.97 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.498 HG12 HD23 ' A' ' 87' ' ' LEU . 1.4 mm -80.45 130.62 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.925 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 3.5 ttmt -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.565 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 14.3 m-20 -106.08 170.48 7.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 9.2 t -82.65 -9.95 59.15 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.096 0.95 . . . . 0.0 110.236 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.544 HG11 ' ND2' ' A' ' 53' ' ' ASN . 2.6 p -89.09 4.13 5.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.403 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.88 80.74 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.552 -1.203 . . . . 0.0 113.511 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.544 ' ND2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -103.62 161.96 13.46 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.327 -178.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.414 HG21 ' HE2' ' A' ' 48' ' ' LYS . 11.6 t -102.4 142.85 15.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.175 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.544 HD23 HG22 ' A' ' 61' ' ' ILE . 17.9 mt -94.48 174.97 6.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 111.319 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.424 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 14.0 tt0 -138.53 159.49 41.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.483 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 10.0 p-10 -69.69 130.47 42.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.416 0.627 . . . . 0.0 109.712 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 91.57 -7.94 79.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.173 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.47 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 1.7 t70 -77.98 167.39 21.55 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.318 -0.519 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.2 m -96.53 140.08 31.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.953 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.544 HG22 HD23 ' A' ' 55' ' ' LEU . 2.0 pp -123.86 165.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.082 0.468 . . . . 0.0 110.069 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.8 m -149.72 121.12 7.9 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.755 HG12 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.28 127.58 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.538 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -99.34 17.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.502 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.6 mptm? -140.81 161.46 37.75 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.459 -0.775 . . . . 0.0 109.041 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.538 ' O ' HD21 ' A' ' 67' ' ' LEU . 5.0 p-10 -81.28 115.25 20.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.706 0.765 . . . . 0.0 111.926 172.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 13.7 mt -130.17 144.19 51.22 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.064 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -95.14 178.59 5.49 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.866 -0.521 . . . . 0.0 111.14 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 72' ' ' SER . 47.0 t -127.45 127.63 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -82.26 -45.72 14.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -170.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.4 -26.28 57.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.567 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.795 ' HB3' HD23 ' A' ' 74' ' ' LEU . 58.3 m -110.03 165.73 11.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -86.7 11.99 11.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.785 0.803 . . . . 0.0 109.201 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.795 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.12 172.71 12.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.962 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.2 t -159.03 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -166.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.755 HG12 HG12 ' A' ' 63' ' ' VAL . 85.1 t -93.27 96.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.89 0.852 . . . . 0.0 110.611 -173.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.4 pptp? -102.64 146.18 28.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.153 -175.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.57 97.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.913 0.863 . . . . 0.0 110.774 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.36 3.36 4.3 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.013 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 62' ' ' THR . 94.9 m -62.12 103.81 0.41 Allowed 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 121.868 0.842 . . . . 0.0 109.65 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -90.85 114.74 27.24 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.226 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 96' ' ' CYS . 42.6 t -126.14 113.72 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.6 ptmt -96.59 161.47 13.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.032 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.569 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 86.7 m-20 63.52 44.92 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.839 0.712 . . . . 0.0 111.526 174.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.415 HD12 ' CG2' ' A' ' 61' ' ' ILE . 34.2 pt -65.7 175.64 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.911 0.862 . . . . 0.0 113.042 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 19.3 tpp180 -130.17 129.89 44.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.378 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.498 HD23 HG12 ' A' ' 47' ' ' ILE . 63.0 mt -81.17 113.07 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 120.967 0.413 . . . . 0.0 110.833 -174.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.8 m-20 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.0 113.63 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.743 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 36.6 t70 -94.69 136.9 34.47 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.47 ' HB2' HG12 ' A' ' 82' ' ' VAL . 17.4 p -138.03 143.46 40.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.505 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.71 121.01 43.83 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.53 107.32 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.62 117.25 6.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.86 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.15 -65.26 0.57 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.477 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.456 HG23 HD22 ' A' ' 74' ' ' LEU . 26.7 pt -95.78 -47.65 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.88 0.371 . . . . 0.0 110.369 178.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.44 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.99 -161.18 28.12 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.39 148.33 26.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.702 0.287 . . . . 0.0 111.009 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 43.9 ttm -138.79 158.09 44.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.318 . . . . 0.0 110.58 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.94 134.88 54.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.087 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.2 mt -118.83 142.44 47.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.203 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.518 ' HB3' ' OE1' ' A' ' 109' ' ' GLU . 30.0 mtpt -74.41 130.86 40.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.966 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.7 t -59.49 -32.98 70.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.478 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.518 ' OE1' ' HB3' ' A' ' 107' ' ' LYS . 3.4 pm0 -85.55 -0.16 54.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.424 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 33.3 m-85 -115.8 3.06 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.891 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 28.9 m -111.8 168.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.269 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.494 ' HG3' HG13 ' A' ' 51' ' ' VAL . 25.1 ttt180 -150.64 132.49 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.282 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.534 ' HB2' HD22 ' A' ' 55' ' ' LEU . 88.2 tttt -65.48 121.08 14.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 174.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.1 t -85.47 -48.76 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.81 85.3 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.867 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.909 -179.369 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 30.2 mt . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.471 0.177 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 54.3 Cg_endo -69.22 160.0 51.57 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.215 1.943 . . . . 0.0 111.139 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.22 -172.39 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.357 2.038 . . . . 0.0 112.031 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.09 127.03 38.05 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.57 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.69 6.82 1.46 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.541 2.16 . . . . 0.0 111.722 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.618 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 40.0 mt-30 -115.54 -39.21 3.59 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.431 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 m -109.67 -52.01 2.82 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.908 0.385 . . . . 0.0 110.268 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.74 -0.82 3.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.611 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.61 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 45.2 m -60.87 -78.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.994 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.1 pt-20 176.77 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.711 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 23.8 m-85 -82.2 33.58 0.4 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.584 0.629 . . . . 0.0 111.827 -171.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -91.48 135.22 34.0 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.766 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE1' ' HD3' ' A' ' 26' ' ' PRO . 22.0 p90 -146.04 170.17 17.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 123.85 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.83 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -120.03 79.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.09 -112.9 4.52 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.076 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.03 16.13 25.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.12 -175.5 5.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.725 0.298 . . . . 0.0 110.248 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.504 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 19.9 mt -110.05 129.15 55.73 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.871 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -123.59 138.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.958 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 47.1 t -110.72 104.2 55.66 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.352 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 56.1 Cg_endo -70.78 -9.81 26.49 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.836 2.358 . . . . 0.0 109.913 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.958 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -70.75 -45.13 65.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.206 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.0 p -117.88 15.17 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.08 39.9 28.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.157 0.435 . . . . 0.0 111.874 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.78 127.62 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.85 0.357 . . . . 0.0 111.399 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.871 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 27.1 mt-10 -91.18 156.37 17.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.129 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.39 162.24 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.438 . . . . 0.0 110.726 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -110.44 130.87 22.41 Favored Pre-proline 0 C--N 1.317 -0.845 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.504 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 18.4 Cg_endo . . . . . 0 CA--C 1.529 0.264 0 C-N-CA 122.887 2.391 . . . . 0.0 113.576 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.506 HG21 HD12 ' A' ' 87' ' ' LEU . 7.8 p . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.494 ' CG2' ' HG ' ' A' ' 108' ' ' SER . 4.4 mm -85.75 138.77 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.456 0.17 . . . . 0.0 110.649 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -109.62 155.78 21.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.119 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 5.0 m-20 -98.73 167.19 10.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.682 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.748 ' OG ' HD11 ' A' ' 64' ' ' ILE . 89.8 p -76.68 -10.63 59.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.904 0.859 . . . . 0.0 110.867 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.505 HG12 ' ND2' ' A' ' 53' ' ' ASN . 2.1 p -85.4 1.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.451 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.23 7.15 73.62 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.504 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.505 ' ND2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -108.45 168.39 9.36 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.942 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' HG3' ' A' ' 48' ' ' LYS . 9.4 t -113.7 142.51 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.931 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' A' ' 113' ' ' LYS . 13.9 mt -96.64 175.95 6.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.547 0.689 . . . . 0.0 111.204 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.469 ' HB3' ' OD1' ' A' ' 59' ' ' ASP . 16.8 tt0 -131.91 154.21 49.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.632 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -67.54 96.46 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.955 0.407 . . . . 0.0 109.944 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.83 -7.11 6.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.974 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.469 ' OD1' ' HB3' ' A' ' 56' ' ' GLN . 32.0 m-20 -71.13 165.27 23.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.112 0.482 . . . . 0.0 111.167 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 2.8 m -99.37 136.09 39.83 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.44 HG21 HD22 ' A' ' 55' ' ' LEU . 1.9 pp -120.76 166.01 15.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.0 m -150.46 118.78 6.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.851 175.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.712 HG13 HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -60.73 126.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.295 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.748 HD11 ' OG ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -99.54 19.01 2.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.538 ' HD2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -143.48 166.41 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.592 -0.692 . . . . 0.0 109.332 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.77 113.96 21.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.894 0.854 . . . . 0.0 111.343 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.444 HD21 ' CG ' ' A' ' 110' ' ' PHE . 7.2 mp -126.0 141.19 52.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.485 175.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -88.52 171.37 10.12 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.31 173.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.492 ' CG2' HG23 ' A' ' 76' ' ' VAL . 47.8 t -120.25 133.55 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -78.57 -57.49 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.78 -17.55 79.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.968 -0.635 . . . . 0.0 113.094 -174.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.478 ' HB2' HG13 ' A' ' 69' ' ' VAL . 55.5 m -115.0 155.13 27.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.746 0.308 . . . . 0.0 110.869 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -79.79 -1.13 37.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.46 HD23 HD11 ' A' ' 101' ' ' ILE . 9.5 mp -78.83 146.61 33.6 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.9 t -107.78 134.3 50.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.318 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 63' ' ' VAL . 63.1 t -84.1 104.25 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 149.87 25.48 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.469 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.73 96.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.99 0.9 . . . . 0.0 111.083 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.64 5.82 3.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.057 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' THR . 90.1 m -62.58 104.07 0.48 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 121.717 0.77 . . . . 0.0 109.87 176.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.25 121.3 33.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.174 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 96' ' ' CYS . 30.6 t -133.88 116.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.627 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 51.9 pttt -100.35 158.88 15.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.726 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.49 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 56.0 m-80 63.32 47.49 3.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.8 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -64.88 178.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 122.005 0.907 . . . . 0.0 113.347 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.632 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 11.0 tpp85 -129.96 124.65 33.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.823 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.506 HD12 HG21 ' A' ' 46' ' ' VAL . 34.5 mt -78.92 116.05 18.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.6 t . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.384 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.46 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.545 ' CD1' HG22 ' A' ' 111' ' ' VAL . 36.6 mt -144.34 120.61 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 33.9 t70 -95.53 136.72 35.56 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.167 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.499 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -154.18 163.26 40.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.704 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 87.9 tttt -124.7 147.26 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.976 0.417 . . . . 0.0 110.04 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.32 105.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.57 103.87 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.795 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 144.27 -70.3 0.4 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.215 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.46 HD11 HD23 ' A' ' 74' ' ' LEU . 25.4 pt -84.77 -46.5 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.542 0.21 . . . . 0.0 111.173 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.405 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 146.94 -162.62 28.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.893 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.757 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -86.72 149.91 24.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.829 0.315 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.487 ' HE1' HG21 ' A' ' 69' ' ' VAL . 28.4 ttt -140.29 156.89 46.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.946 0.403 . . . . 0.0 110.671 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -113.83 139.03 49.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.583 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 53.9 mt -123.08 141.16 52.27 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.669 0.747 . . . . 0.0 111.732 -170.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -84.83 119.61 25.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.973 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.67 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -47.82 -39.71 19.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.7 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.77 -11.15 33.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.61 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.451 ' O ' HD12 ' A' ' 64' ' ' ILE . 86.4 m-85 -112.91 1.8 15.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.545 HG22 ' CD1' ' A' ' 94' ' ' ILE . 13.5 m -113.4 169.51 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.37 -172.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.537 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -155.13 129.77 9.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.07 179.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HB2' HD21 ' A' ' 55' ' ' LEU . 88.7 tttt -59.97 123.25 16.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.786 0.327 . . . . 0.0 110.31 171.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -60.53 -44.8 97.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.429 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.98 -21.13 3.01 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.184 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.236 -0.887 . . . . 0.0 109.47 176.19 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.411 HD21 HD11 ' A' ' 23' ' ' LEU . 16.2 mt . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.47 155.95 54.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.925 1.75 . . . . 0.0 110.783 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.84 -175.44 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.31 2.007 . . . . 0.0 111.882 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 4.7 t -97.65 123.0 53.56 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.46 10.94 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.73 2.287 . . . . 0.0 111.919 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.576 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 36.5 mt-30 -118.9 -40.57 2.84 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.147 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.4 m -108.98 -50.86 2.95 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.185 0.516 . . . . 0.0 110.265 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 t30 70.78 2.07 4.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.871 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 4.8 m -58.95 -78.34 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.3 pt-20 175.66 -18.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.7 m-85 -79.21 31.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.132 -169.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 14' ' ' GLU . 2.6 m -94.17 136.19 34.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.825 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -139.05 169.87 17.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.19 122.03 45.71 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.11 0.481 . . . . 0.0 111.205 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -111.27 71.75 0.75 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.53 -107.99 3.53 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.382 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.9 19.4 19.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -171.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.41 -179.44 8.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.171 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.7 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -109.24 134.03 52.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.433 HG11 ' HB3' ' A' ' 31' ' ' GLU . 57.7 t -115.14 127.15 72.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 49.4 t -103.95 103.91 40.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 53.4 Cg_endo -71.61 -8.88 24.06 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.549 2.166 . . . . 0.0 110.412 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 20.2 tt0 -69.27 -62.59 1.32 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.017 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.2 p -98.47 9.59 42.8 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.71 46.05 12.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.771 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.44 ' HB3' HE22 ' A' ' 10' ' ' GLN . 3.6 t-80 -150.59 135.02 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB3' HG11 ' A' ' 24' ' ' VAL . 10.1 pt-20 -114.36 163.53 15.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.733 0.301 . . . . 0.0 110.882 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.562 ' NE1' HD21 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -163.11 162.64 25.77 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 t -112.18 139.79 22.86 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.7 ' HD3' ' CD2' ' A' ' 23' ' ' LEU . 19.7 Cg_endo . . . . . 0 C--N 1.349 0.593 0 C-N-CA 122.403 2.069 . . . . 0.0 112.452 -173.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.475 HG13 HD13 ' A' ' 87' ' ' LEU . 15.8 t . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.557 HG21 HG13 ' A' ' 94' ' ' ILE . 2.5 mm -86.18 135.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.52 177.36 4.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 6.3 m-20 -114.42 169.99 8.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.611 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.648 ' OG ' HD13 ' A' ' 64' ' ' ILE . 90.3 p -70.47 -6.23 34.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.123 0.963 . . . . 0.0 110.51 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.1 t -86.45 -13.52 10.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.642 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.79 5.68 64.33 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.886 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.46 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -97.1 168.24 10.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.543 0.687 . . . . 0.0 111.561 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.41 HG22 ' HG3' ' A' ' 48' ' ' LYS . 16.4 t -113.97 144.64 21.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.787 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.627 HD23 ' HZ1' ' A' ' 113' ' ' LYS . 24.2 mt -101.1 173.2 6.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.647 . . . . 0.0 111.69 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 33.7 tp60 -124.89 145.71 49.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 15.1 t70 -71.23 97.1 1.49 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.496 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 123.51 -6.5 9.15 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 42.2 t0 -68.62 166.53 17.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.899 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 34.5 m -104.89 136.51 44.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.462 HG23 HD21 ' A' ' 55' ' ' LEU . 1.8 pp -123.71 171.85 12.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -150.19 123.34 8.87 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 0.0 111.102 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -65.8 126.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.648 HD13 ' OG ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -97.7 14.06 4.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HG3' HG12 ' A' ' 64' ' ' ILE . 54.8 mttt -143.64 164.99 28.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.094 0.861 . . . . 0.0 109.634 -176.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.69 117.15 24.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.082 0.944 . . . . 0.0 112.648 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.6 mp -134.79 150.66 50.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.307 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.32 178.27 5.89 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.703 -0.623 . . . . 0.0 111.502 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 74' ' ' LEU . 46.7 t -120.06 129.07 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -56.51 108.36 0.48 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.22 3.88 26.57 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.005 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m -101.0 166.69 10.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.982 0.42 . . . . 0.0 111.122 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 p -84.92 -3.84 58.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.56 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 75' ' ' VAL . 12.1 tp -81.85 171.66 14.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.661 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.503 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 70.0 t -158.72 120.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -169.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.646 HG12 HG13 ' A' ' 63' ' ' VAL . 64.9 t -89.65 97.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.715 0.769 . . . . 0.0 110.61 -174.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.459 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.21 145.47 34.2 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.329 -176.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -48.01 97.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.868 0.842 . . . . 0.0 111.19 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.52 4.09 4.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.251 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -62.53 104.95 0.57 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 122.089 0.947 . . . . 0.0 110.009 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -89.35 120.75 30.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.895 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 96' ' ' CYS . 22.2 t -131.9 113.41 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.398 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.7 ptmt -100.55 154.04 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.714 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.496 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 50.6 m-80 62.76 53.22 2.56 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.038 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 55' ' ' LEU . 32.4 pt -64.56 174.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 121.815 0.817 . . . . 0.0 112.43 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 20.4 tpp180 -129.22 123.01 30.89 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.879 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.475 HD13 HG13 ' A' ' 46' ' ' VAL . 39.7 mt -78.24 113.39 16.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.658 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.021 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 88' ' ' VAL . 8.3 m-20 . . . . . 0 C--O 1.224 -0.282 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.557 HG13 HG21 ' A' ' 47' ' ' ILE . 2.8 mp -110.41 113.1 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 170.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 15.5 t70 -95.0 138.96 32.03 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.555 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -147.35 156.52 42.98 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.406 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -116.64 130.03 56.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.406 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.46 109.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.87 97.31 1.8 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.287 0.565 . . . . 0.0 110.134 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.93 -40.53 0.42 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 102' ' ' GLY . 43.2 pt -122.62 -37.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 138.15 -150.99 21.23 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -91.01 149.13 21.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.759 0.314 . . . . 0.0 110.744 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.3 ttt -140.57 159.75 41.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.187 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -116.78 143.23 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.2 mt -125.73 146.91 49.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.294 0.568 . . . . 0.0 111.984 -169.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.606 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 1.7 mptm? -75.26 128.33 35.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.855 174.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.6 t -53.31 -40.8 65.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 8.6 pt-20 -66.88 -12.29 58.8 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.066 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.553 ' O ' HD11 ' A' ' 64' ' ' ILE . 64.7 m-85 -111.87 4.8 18.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.459 -0.776 . . . . 0.0 112.777 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 24.2 m -114.4 169.84 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.505 -173.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 15.8 ttt180 -147.88 142.59 26.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.639 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.832 ' HB2' ' HZ1' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -65.58 140.83 58.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.254 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.0 t -107.84 -57.83 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 170.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.57 -3.51 71.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.744 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.337 -178.918 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.421 HD12 HD22 ' A' ' 23' ' ' LEU . 72.8 mt . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.65 158.29 56.22 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.155 1.903 . . . . 0.0 111.131 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.18 -171.65 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.446 ' C ' ' H ' ' A' ' 10' ' ' GLN . 33.8 t -99.1 122.04 53.64 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.205 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.84 7.49 0.58 Allowed 'Trans proline' 0 C--O 1.23 0.113 0 C-N-CA 122.613 2.208 . . . . 0.0 112.284 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' A' ' 8' ' ' CYS . 8.4 tt0 -113.94 -39.54 3.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.095 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -126.14 -35.15 2.46 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.553 -0.717 . . . . 0.0 111.468 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t30 72.53 1.84 4.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.92 0.488 . . . . 0.0 111.634 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.562 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 4.8 m -53.93 -78.43 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 171.85 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.164 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.774 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 79.0 m-85 -118.06 24.95 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.296 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.54 132.38 37.89 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.389 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 38.3 p90 -144.9 171.27 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -100.8 117.54 35.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.884 0.373 . . . . 0.0 110.715 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.564 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 35.1 t70 -115.69 69.99 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.02 -113.44 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.91 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.48 18.91 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.883 0.373 . . . . 0.0 111.645 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -154.96 -174.83 5.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.349 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 24.1 mt -113.46 137.1 52.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 31' ' ' GLU . 46.1 t -121.27 136.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 122.231 -0.293 . . . . 0.0 110.375 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 48.6 t -102.58 105.14 42.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.349 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.774 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 20.8 Cg_endo -61.64 -25.45 79.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.63 2.22 . . . . 0.0 111.66 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.13 -58.95 3.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.7 m -75.92 -9.13 58.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.7 39.54 24.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 111.466 -173.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -149.17 136.92 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.534 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB3' HG21 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -103.69 174.76 5.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -178.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -166.94 161.87 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.6 t -106.18 135.11 19.5 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.567 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.9 Cg_endo . . . . . 0 C--N 1.343 0.241 0 C-N-CA 122.868 2.379 . . . . 0.0 112.855 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.557 HG21 HG13 ' A' ' 94' ' ' ILE . 5.1 mm -81.3 139.85 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HG3' HG23 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -114.8 176.25 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.3 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -112.05 172.41 6.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.25 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.642 ' OG ' HD12 ' A' ' 64' ' ' ILE . 81.6 p -74.66 -8.33 56.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.039 0.923 . . . . 0.0 110.678 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.433 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -89.24 -11.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.406 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.65 -2.63 64.85 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.773 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.433 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -91.52 166.39 12.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.775 0.798 . . . . 0.0 111.584 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.436 HG23 ' HG3' ' A' ' 48' ' ' LYS . 11.3 t -117.05 139.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.923 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD22 HG23 ' A' ' 61' ' ' ILE . 17.8 mt -94.9 172.98 7.82 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.238 0.542 . . . . 0.0 110.564 -173.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -129.36 150.48 50.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.617 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -69.71 96.02 0.93 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 0.0 109.929 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 124.67 -7.83 8.31 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.045 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.452 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 2.1 t0 -72.16 175.81 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 25.3 m -105.46 137.19 43.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.508 HG23 HD22 ' A' ' 55' ' ' LEU . 1.5 pp -123.35 164.49 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.772 0.32 . . . . 0.0 110.279 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -148.53 124.88 10.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 174.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.734 HG13 HG11 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -66.71 124.79 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.642 HD12 ' OG ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -96.13 17.19 2.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.879 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 6.7 mttt -143.5 163.71 32.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.03 0.832 . . . . 0.0 109.643 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.539 ' O ' HD21 ' A' ' 67' ' ' LEU . 2.5 p-10 -83.67 115.89 22.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.087 0.946 . . . . 0.0 111.995 173.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.2 mt -129.17 143.92 51.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.359 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -91.87 178.31 5.93 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.618 -0.676 . . . . 0.0 110.525 173.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.446 HG21 HG23 ' A' ' 76' ' ' VAL . 8.0 t -129.15 130.4 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -78.63 -60.04 2.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -172.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.69 37.62 3.35 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.515 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.428 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 69.6 m -144.73 166.85 24.03 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -95.62 2.88 54.36 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.4 mp -78.6 175.25 10.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.452 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.8 t -158.69 116.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.734 HG11 HG13 ' A' ' 63' ' ' VAL . 88.1 t -87.32 98.56 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-O 121.682 0.753 . . . . 0.0 110.753 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -105.83 145.01 31.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.41 -175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -48.65 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.925 0.869 . . . . 0.0 111.228 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.23 5.5 4.67 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.072 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.47 104.39 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.807 0.813 . . . . 0.0 109.555 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -94.79 115.02 26.99 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.431 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.572 ' CG1' ' HB2' ' A' ' 96' ' ' CYS . 68.0 t -132.22 117.31 32.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.8 pttt -107.89 169.67 8.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.682 0.753 . . . . 0.0 112.903 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.51 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 69.62 36.13 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.426 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 55' ' ' LEU . 37.2 pt -60.74 175.83 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.617 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 9.0 tpp85 -131.25 123.08 27.65 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.156 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.1 mt -75.25 109.08 8.46 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 95' ' ' ASP . 2.6 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -170.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 88' ' ' VAL . 19.9 m-20 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.633 ' CD1' HG21 ' A' ' 111' ' ' VAL . 25.7 mt -110.4 129.69 65.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.435 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.554 ' HB2' HG21 ' A' ' 88' ' ' VAL . 9.9 t70 -96.42 132.81 41.57 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.572 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 27.6 p -138.27 145.21 41.01 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.832 -168.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' HG12 ' A' ' 82' ' ' VAL . 96.3 mttt -93.45 107.84 19.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.498 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.6 mt -104.51 155.32 6.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -101.09 130.5 47.14 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.64 -52.42 0.77 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.988 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.7 pt -95.83 -40.32 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.96 -138.32 10.49 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.791 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -100.34 159.68 14.94 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.11 0.455 . . . . 0.0 111.377 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 38.8 ttm -154.2 165.75 35.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.121 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 80.6 mttt -113.69 126.08 54.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.572 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.44 146.72 39.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.644 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 25.9 ttmt -76.68 125.25 28.93 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.218 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.1 t -47.94 -37.96 15.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.093 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.644 ' HG2' ' HG2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -75.41 -5.33 44.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.879 ' HD1' ' HD3' ' A' ' 65' ' ' LYS . 30.7 m-85 -113.72 7.44 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.531 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.633 HG21 ' CD1' ' A' ' 94' ' ' ILE . 30.3 m -116.62 171.83 5.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -174.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -150.32 133.83 16.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.012 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 87.4 tttt -70.46 120.38 16.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 t -93.86 -70.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.52 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.72 -42.33 1.52 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.769 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.291 -179.351 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 18' ' ' GLU . 52.7 mt . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.709 0.29 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.63 162.49 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.042 2.495 . . . . 0.0 111.714 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.39 -169.45 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 t -98.68 130.68 27.32 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.9 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.96 8.98 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.638 2.225 . . . . 0.0 112.553 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -123.04 -37.08 2.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.393 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.423 ' C ' ' H ' ' A' ' 13' ' ' SER . 56.6 m -107.04 -45.94 4.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.24 -9.66 0.86 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 1.4 m -43.86 -75.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.004 0.522 . . . . 0.0 111.974 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.0 pt-20 159.04 -3.49 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.005 0.816 . . . . 0.0 111.569 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.577 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 63.2 m-85 -77.26 34.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.628 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 14' ' ' GLU . 2.9 m -100.85 141.08 34.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.159 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -151.89 177.15 10.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.469 ' HG2' HD12 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -110.42 124.61 52.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.418 0.628 . . . . 0.0 111.61 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.66 70.05 0.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.674 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.19 -107.66 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.112 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.8 18.03 21.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -159.96 -174.32 4.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.159 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.92 134.45 53.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.496 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -124.97 141.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 50.4 t -104.63 105.81 51.94 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.758 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.7 Cg_endo -66.85 -14.26 43.09 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.658 2.239 . . . . 0.0 110.968 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.463 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 33.2 tt0 -70.29 -58.97 3.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.633 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.34 10.29 39.24 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.5 46.11 12.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -142.91 127.41 17.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.678 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 2.3 mp0 -91.4 157.07 17.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.023 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -159.07 162.08 36.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -115.98 127.76 26.51 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 CA--C 1.528 0.223 0 C-N-CA 122.786 2.324 . . . . 0.0 113.192 -175.396 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.711 HG12 HG22 ' A' ' 54' ' ' VAL . 5.5 t . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.153 0.502 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.567 HG21 HG13 ' A' ' 94' ' ' ILE . 2.1 mm -91.09 131.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.413 -170.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.51 176.58 6.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 111.84 -179.226 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 15.2 m-20 -116.23 178.26 4.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.109 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.543 ' HB3' HD13 ' A' ' 64' ' ' ILE . 9.3 t -77.03 -5.22 47.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.243 1.02 . . . . 0.0 109.968 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.47 HG21 ' CG ' ' A' ' 112' ' ' ARG . 2.5 t -91.03 -8.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.602 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.28 -6.22 78.26 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.714 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.42 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -90.3 165.41 13.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 110.941 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 46' ' ' VAL . 2.9 p -119.79 147.63 23.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.917 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.809 ' HA ' ' HD3' ' A' ' 113' ' ' LYS . 1.8 mt -96.54 178.23 5.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.411 -169.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -127.79 147.95 50.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.585 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 13.3 t70 -69.19 99.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.8 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.77 -6.91 9.58 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.523 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.91 175.44 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.96 0.41 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 41.4 m -103.01 137.47 41.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.595 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.531 HG22 HD21 ' A' ' 55' ' ' LEU . 1.4 pp -121.84 164.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.415 HG22 ' HA2' ' A' ' 79' ' ' GLY . 2.7 m -149.16 117.95 6.65 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.12 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.637 HG12 HG13 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.48 129.45 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.552 ' HA ' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -102.86 17.19 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.53 ' HD3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -140.7 164.46 30.14 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.76 0.709 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.657 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -82.94 118.44 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.885 0.85 . . . . 0.0 112.656 174.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 66' ' ' ASP . 11.7 mt -135.4 142.29 45.63 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.758 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -92.54 178.32 5.85 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.399 -0.813 . . . . 0.0 111.29 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.76 131.98 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 70' ' ' LYS . 17.0 tptm -93.02 130.2 38.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.82 18.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.083 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.672 ' HB3' HD22 ' A' ' 74' ' ' LEU . 39.5 m -115.37 155.97 26.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.689 0.28 . . . . 0.0 110.816 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -85.18 18.88 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.603 0.716 . . . . 0.0 109.943 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.672 HD22 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -79.36 171.87 14.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.258 175.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.3 t -159.29 118.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -169.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.637 HG13 HG12 ' A' ' 63' ' ' VAL . 84.8 t -92.13 95.16 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.069 0.938 . . . . 0.0 109.95 -175.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 146.41 34.44 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.252 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -46.54 97.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.097 0.873 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.415 ' HA2' HG22 ' A' ' 62' ' ' THR . . . 130.04 2.73 5.07 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.487 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.5 m -61.85 104.51 0.46 Allowed 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.904 0.859 . . . . 0.0 109.732 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -90.77 115.62 27.99 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.034 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 96' ' ' CYS . 77.7 t -131.91 113.45 22.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.213 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 60.1 pttt -107.88 164.05 12.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.329 0.585 . . . . 0.0 112.324 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.577 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 47.3 m-80 70.26 42.04 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.892 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.3 pt -65.39 175.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.987 0.899 . . . . 0.0 112.904 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.585 ' HD3' ' OD2' ' A' ' 57' ' ' ASP . 7.3 tpp180 -126.66 126.07 42.94 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.212 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 47' ' ' ILE . 38.1 mt -81.54 117.5 21.98 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -176.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.761 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.0 m-20 . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.567 HG13 HG21 ' A' ' 47' ' ' ILE . 9.6 mt -114.44 115.53 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.7 t70 -96.39 134.06 40.01 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.516 ' HB2' HG12 ' A' ' 82' ' ' VAL . 24.4 p -129.88 134.91 47.8 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.779 -176.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -101.29 111.66 23.95 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.79 108.5 25.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.956 0.408 . . . . 0.0 110.858 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.81 101.46 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.938 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.31 -39.42 0.76 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.493 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.414 HD12 ' HG ' ' A' ' 74' ' ' LEU . 23.8 pt -130.35 -39.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.62 -149.02 20.01 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -91.31 148.53 22.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.965 0.412 . . . . 0.0 110.939 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.476 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 50.7 ttm -136.3 157.24 47.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.194 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.498 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -99.86 141.82 32.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.698 175.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 93.7 mt -132.48 138.08 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.172 0.511 . . . . 0.0 111.492 -176.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 43.5 mtpt -81.95 125.79 31.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.423 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.3 t -48.07 -42.62 29.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.945 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.17 -7.76 20.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.091 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.498 ' HD1' ' HE3' ' A' ' 65' ' ' LYS . 33.6 m-85 -115.93 2.4 13.52 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 33.8 m -113.33 170.13 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.47 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.2 ttt-85 -150.87 131.32 13.79 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.819 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.809 ' HD3' ' HA ' ' A' ' 55' ' ' LEU . 35.1 ttpt -75.94 123.64 26.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 110.554 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.6 t -76.21 -41.4 37.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.577 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.46 11.15 80.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.975 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.8 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.889 179.296 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.28 160.92 47.42 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.606 2.204 . . . . 0.0 111.609 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.46 -172.8 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.344 2.03 . . . . 0.0 111.79 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.5 t -97.89 125.93 42.46 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.34 10.87 0.39 Allowed 'Trans proline' 0 N--CA 1.469 0.052 0 C-N-CA 122.547 2.165 . . . . 0.0 111.81 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.516 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 34.9 mt-30 -125.3 -31.11 3.08 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.991 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.8 m -116.07 -40.25 3.32 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.843 -0.536 . . . . 0.0 110.37 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 75.76 -26.83 0.19 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.272 1.029 . . . . 0.0 113.004 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 m -45.7 -77.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 173.59 30.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.594 0.712 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.712 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 64.7 m-85 -96.63 27.8 3.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.125 -172.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 m -101.91 141.42 34.79 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.451 174.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.8 p90 -148.12 175.82 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.17 121.41 45.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.75 0.705 . . . . 0.0 111.487 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.424 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 33.0 t70 -113.52 75.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.269 0.556 . . . . 0.0 109.59 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.18 -108.75 3.63 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.118 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.24 20.38 18.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.49 -174.17 4.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.571 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 25.0 mt -109.06 136.57 48.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.731 174.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.434 HG13 ' HG3' ' A' ' 31' ' ' GLU . 60.2 t -122.19 131.35 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 122.296 -0.253 . . . . 0.0 110.385 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -101.28 108.96 57.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.712 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 58.7 Cg_endo -71.7 -8.42 23.09 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.907 2.404 . . . . 0.0 111.216 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.52 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 13.8 tp10 -75.87 -70.49 0.43 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.313 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.12 10.55 23.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.33 41.34 23.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.092 0.472 . . . . 0.0 111.992 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.41 ' HB3' HE22 ' A' ' 10' ' ' GLN . 17.8 t-160 -138.74 128.46 24.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.867 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.434 ' HG3' HG13 ' A' ' 24' ' ' VAL . 2.2 mp0 -91.1 161.31 15.15 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.84 161.52 17.84 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 120.947 0.404 . . . . 0.0 110.41 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 t -115.14 137.91 23.23 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.571 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 11.5 Cg_endo . . . . . 0 C--N 1.343 0.264 0 C-N-CA 123.169 2.579 . . . . 0.0 113.219 -173.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.403 HG12 ' CG1' ' A' ' 54' ' ' VAL . 14.5 t . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 9.6 mm -75.58 137.83 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.627 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.1 OUTLIER -119.17 156.6 29.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.0 176.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.527 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 5.9 m-20 -96.92 -179.01 4.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.224 -176.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 30.7 t -80.13 -6.54 57.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.964 0.888 . . . . 0.0 109.538 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.498 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.7 t -90.95 -17.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.716 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.13 3.14 57.92 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.211 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.498 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -84.31 167.44 16.57 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.036 0.922 . . . . 0.0 110.819 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 48' ' ' LYS . 24.0 t -117.05 139.28 44.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.887 -1.96 . . . . 0.0 108.255 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 2.1 mm? -97.33 174.55 6.64 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.37 0.605 . . . . 0.0 110.704 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.544 ' NE2' ' H ' ' A' ' 57' ' ' ASP . 30.4 tp60 -125.24 145.67 49.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.703 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 14.9 t70 -67.76 99.51 0.82 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.62 -7.21 9.63 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.17 174.99 5.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.944 0.402 . . . . 0.0 110.937 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.5 m -106.91 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.67 166.89 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.1 m -150.54 119.1 6.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.851 0.358 . . . . 0.0 111.355 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -63.66 126.65 22.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.6 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.19 22.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.609 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -143.24 159.53 42.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.48 100.53 11.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.952 0.882 . . . . 0.0 112.707 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 110' ' ' PHE . 6.6 mp -110.63 153.71 24.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.038 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -98.76 179.33 4.69 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.777 0.322 . . . . 0.0 111.385 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 72' ' ' SER . 33.7 m -119.55 147.2 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.677 ' HG3' ' H ' ' A' ' 71' ' ' GLY . 18.2 ptmt -77.84 -76.81 0.17 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.677 ' H ' ' HG3' ' A' ' 70' ' ' LYS . . . -92.07 47.96 2.69 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.969 -173.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.555 ' HB2' ' CG2' ' A' ' 69' ' ' VAL . 74.6 m -144.33 176.76 9.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.7 m -104.96 6.43 33.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.604 1.192 . . . . 0.0 108.03 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.495 ' O ' HG22 ' A' ' 69' ' ' VAL . 4.5 mm? -77.91 176.67 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.224 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.1 t -160.02 113.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 63' ' ' VAL . 87.2 t -85.68 93.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.56 0.695 . . . . 0.0 109.503 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 148.15 28.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -171.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -48.29 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.92 0.867 . . . . 0.0 111.348 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.59 8.0 3.28 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.107 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 62' ' ' THR . 85.7 m -63.92 103.19 0.55 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 122.153 0.978 . . . . 0.0 109.653 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.664 ' HZ2' ' HB3' ' A' ' 81' ' ' LYS . 5.6 ttpm? -92.5 110.48 21.89 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.096 -174.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 96' ' ' CYS . 56.8 t -126.49 117.88 49.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.758 177.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 55.6 pttt -105.1 163.02 12.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.662 . . . . 0.0 112.11 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.625 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.8 OUTLIER 67.81 42.87 1.86 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.298 174.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.481 HG21 ' HB3' ' A' ' 96' ' ' CYS . 36.1 pt -65.63 -175.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.703 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 12.2 tpp85 -135.01 122.82 22.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.423 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.0 mt -76.4 118.91 19.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.879 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 121.319 0.58 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 108' ' ' SER . 63.6 mt -142.72 125.66 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.204 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 4.5 t70 -104.98 139.04 40.27 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.481 ' HB3' HG21 ' A' ' 85' ' ' ILE . 27.2 p -155.05 165.56 36.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -112.07 135.77 52.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.499 ' HB ' ' CG1' ' A' ' 101' ' ' ILE . 2.2 mm -100.84 98.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.9 105.88 0.14 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.723 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.25 0.68 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.356 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.499 ' CG1' ' HB ' ' A' ' 98' ' ' ILE . 34.2 pt -96.07 -42.63 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.443 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 145.06 -166.11 27.59 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.0 148.38 24.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.998 0.899 . . . . 0.0 110.874 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.3 ttm -140.02 158.61 43.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -117.05 138.37 51.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.5 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -123.96 147.88 47.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.434 -171.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 13.6 tptm -84.82 122.37 29.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.812 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.554 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -50.97 -39.76 56.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.745 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 50' ' ' SER . 10.4 pt-20 -66.02 -9.05 26.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.294 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.622 ' CD2' HD23 ' A' ' 67' ' ' LEU . 42.1 m-85 -110.74 0.62 17.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.165 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 15.4 m -112.5 170.77 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.458 ' HD2' HG21 ' A' ' 51' ' ' VAL . 22.0 ttt180 -145.66 138.28 25.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.457 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 87.8 tttt -68.83 119.13 12.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.612 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.17 -47.36 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.02 48.63 25.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.052 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.427 -178.397 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.11 156.9 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.223 1.949 . . . . 0.0 111.133 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.49 -163.3 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.9 2.4 . . . . 0.0 112.603 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.4 t -98.32 130.56 28.03 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.402 ' HG3' ' CE3' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -70.47 5.28 2.03 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.287 . . . . 0.0 112.927 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -121.2 -35.13 3.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.241 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.492 ' C ' ' H ' ' A' ' 13' ' ' SER . 58.0 m -104.79 -47.31 4.08 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.49 -0.756 . . . . 0.0 109.511 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.54 -2.35 1.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.08 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 11' ' ' CYS . 15.0 p -48.32 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.095 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.2 pt-20 170.03 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.263 0.352 . . . . 0.0 111.681 -173.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.652 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 80.8 m-85 -77.79 39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -171.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -103.28 143.31 32.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.515 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CE1' ' HD3' ' A' ' 26' ' ' PRO . 23.6 p90 -153.88 176.73 11.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.71 123.47 47.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.838 0.352 . . . . 0.0 111.441 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -121.17 86.43 2.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.43 -116.16 5.01 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.132 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.77 18.23 22.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.902 0.382 . . . . 0.0 111.789 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.4 -173.49 4.52 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 mt -112.86 138.39 49.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -126.75 142.75 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 51.7 t -104.5 105.48 50.2 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.733 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.7 Cg_endo -65.84 -15.95 51.02 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.816 2.344 . . . . 0.0 111.512 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.434 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.1 tt0 -71.21 -61.39 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.93 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -98.82 12.76 34.69 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.95 29.54 17.81 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -135.75 133.92 38.49 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.131 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.633 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.4 mp0 -95.11 171.68 8.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.642 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.402 ' CE3' ' HG3' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -166.22 161.83 17.09 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.932 0.396 . . . . 0.0 110.558 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -115.57 113.79 42.65 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--O 1.232 0.189 0 C-N-CA 123.201 2.601 . . . . 0.0 113.195 -168.02 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.562 HG21 HG13 ' A' ' 94' ' ' ILE . 3.0 mm -89.93 135.44 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.079 -172.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.724 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -115.0 145.71 41.99 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.593 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 70.4 m-20 -104.5 179.43 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.515 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 5.0 t -73.93 -9.22 58.42 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.93 0.872 . . . . 0.0 110.315 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.1 t -84.91 -18.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.657 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.58 12.7 60.66 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.5 -175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.593 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -99.72 153.38 19.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.257 0.551 . . . . 0.0 111.112 178.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.41 133.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.328 -175.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.551 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.3 mp -96.67 175.17 6.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.25 0.548 . . . . 0.0 111.724 -168.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -124.81 146.98 48.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.666 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 17.8 t70 -70.65 102.21 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 0.0 110.625 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.48 -3.98 13.53 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.27 171.61 10.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.969 -0.615 . . . . 0.0 110.833 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 31.1 m -104.75 137.64 42.25 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -121.16 168.56 13.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.7 m -148.96 118.3 6.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.888 0.375 . . . . 0.0 110.868 175.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 1.1 p -62.91 129.48 26.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.551 ' HA ' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -95.14 10.41 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.442 ' HG2' HG12 ' A' ' 64' ' ' ILE . 74.9 mmtt -138.0 171.1 14.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 119.83 1.195 . . . . 0.0 110.255 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.78 112.23 22.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.496 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.9 mp -130.23 143.44 50.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.984 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -90.99 178.76 5.92 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.793 -0.567 . . . . 0.0 110.343 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 74' ' ' LEU . 57.8 t -122.24 115.68 46.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -79.16 117.87 20.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -166.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.9 45.76 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.08 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -110.86 172.86 6.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.343 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -98.01 9.16 43.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.532 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 75' ' ' VAL . 14.8 tp -78.85 170.66 16.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.734 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.481 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 72.5 t -158.13 117.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -168.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.499 HG12 HG11 ' A' ' 63' ' ' VAL . 94.3 t -93.48 95.76 5.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.851 0.834 . . . . 0.0 110.544 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.12 151.61 27.04 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.473 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -52.18 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.824 0.821 . . . . 0.0 110.817 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.16 4.89 3.16 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.174 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.5 m -61.92 104.74 0.49 Allowed 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 122.032 0.92 . . . . 0.0 110.148 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.423 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 30.0 ttpt -89.97 112.65 24.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.921 -175.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 96' ' ' CYS . 39.1 t -123.67 114.39 41.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 ptmt -104.28 151.29 23.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.642 -175.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 68.88 47.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 124.33 1.019 . . . . 0.0 111.468 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.3 pt -65.89 -179.5 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.058 0.932 . . . . 0.0 113.193 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.666 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 19.4 tpt180 -129.15 122.37 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.636 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 47' ' ' ILE . 79.6 mt -83.07 119.64 24.75 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.951 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -175.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 88' ' ' VAL . 6.0 m-20 . . . . . 0 C--O 1.225 -0.224 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.562 HG13 HG21 ' A' ' 47' ' ' ILE . 38.1 mt -120.09 113.69 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.322 174.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 13.4 t70 -95.63 139.79 31.38 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.802 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.476 ' HB2' HG12 ' A' ' 82' ' ' VAL . 24.7 p -149.39 159.79 43.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.069 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 14.2 mptt -112.32 135.13 53.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.661 HD12 ' HE1' ' A' ' 104' ' ' MET . 1.8 mm -114.07 109.01 26.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.6 102.02 0.13 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.94 -66.48 0.51 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.829 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.659 HD13 HG13 ' A' ' 98' ' ' ILE . 45.7 pt -86.9 -48.82 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.524 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 141.63 -157.72 26.34 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -176.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -77.37 144.03 38.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 117.939 0.869 . . . . 0.0 110.529 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.698 ' HE3' HD23 ' A' ' 106' ' ' LEU . 52.9 ttp -133.69 151.88 51.75 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.411 ' HD3' ' N ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -112.11 140.67 46.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.698 HD23 ' HE3' ' A' ' 104' ' ' MET . 82.1 mt -120.96 139.58 53.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.464 0.649 . . . . 0.0 111.528 -171.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 22.2 tptm -80.83 116.23 20.71 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.824 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.724 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 7.5 p -53.98 -34.52 60.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.602 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 50' ' ' SER . 37.5 mt-10 -68.94 -9.87 54.27 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.531 ' O ' HD13 ' A' ' 64' ' ' ILE . 63.8 m-85 -109.41 -4.46 16.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.049 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.9 m -113.6 173.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.314 0.578 . . . . 0.0 112.12 -174.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.516 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.9 ttt180 -147.07 133.14 19.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.002 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 27.8 tttp -65.1 136.87 57.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.009 176.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.2 -56.56 5.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.588 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.54 49.62 10.98 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.063 -172.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.589 -178.015 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.0 mt . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.95 156.85 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.029 1.82 . . . . 0.0 111.344 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -73.91 -163.55 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.843 2.362 . . . . 0.0 112.7 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.9 t -98.29 124.2 47.89 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.406 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.45 11.27 0.63 Allowed 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 122.899 2.399 . . . . 0.0 111.563 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.6 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 12.1 mt-30 -120.8 -38.32 2.87 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 -178.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m -108.26 -50.29 3.06 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t30 70.0 7.18 6.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.368 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 5.1 m -54.32 -76.6 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.982 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 13' ' ' SER . 15.5 pt-20 165.66 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.327 0.392 . . . . 0.0 111.977 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.488 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 87.6 m-85 -78.43 33.67 0.2 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -169.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -95.71 139.89 31.29 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.587 0.232 . . . . 0.0 110.563 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 20.9 p90 -147.48 178.09 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.1 122.19 47.26 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.206 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.527 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 24.0 t70 -118.35 89.28 3.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.879 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.46 -106.58 3.43 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.196 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.36 17.34 17.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 31' ' ' GLU . 1.3 pt? -163.91 -175.05 3.88 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.249 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.4 mt -101.36 135.56 42.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.506 HG11 ' HG3' ' A' ' 31' ' ' GLU . 64.8 t -117.62 130.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 50.4 t -101.6 103.93 31.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 173.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.0 Cg_endo -65.89 -18.65 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.508 2.139 . . . . 0.0 110.969 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.59 -61.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.194 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.401 ' SG ' ' NE2' ' A' ' 10' ' ' GLN . 28.4 p -95.44 11.35 33.18 Favored 'General case' 0 C--O 1.23 0.055 0 O-C-N 121.649 -0.657 . . . . 0.0 112.313 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.63 26.0 15.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -125.94 135.83 52.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.506 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.506 ' HG3' HG11 ' A' ' 24' ' ' VAL . 6.2 mp0 -96.54 158.27 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.529 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -158.9 161.32 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -120.15 128.63 25.74 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 174.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.529 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 8.6 Cg_endo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 123.412 2.741 . . . . 0.0 113.215 -170.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.496 HG22 HD13 ' A' ' 87' ' ' LEU . 14.4 p . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.925 0.393 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.431 HD13 ' N ' ' A' ' 93' ' ' ASP . 6.3 mm -72.84 139.34 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.904 -172.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HG3' HG23 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -126.48 154.44 43.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.11 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 8.3 m-20 -99.95 179.99 4.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.189 0.518 . . . . 0.0 111.467 -174.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 14.7 t -82.8 -13.02 56.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.023 0.916 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.565 HG11 ' ND2' ' A' ' 53' ' ' ASN . 2.0 p -89.24 -0.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.097 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 5.37 68.6 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.277 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.565 ' ND2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -108.32 173.16 6.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.536 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 48' ' ' LYS . 4.9 t -115.17 142.31 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.254 -175.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.703 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -98.7 -177.47 3.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 110.251 -177.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.449 ' HA ' HD12 ' A' ' 87' ' ' LEU . 14.5 tt0 -136.69 163.41 30.65 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 16.5 t70 -65.26 130.73 44.38 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.83 -6.96 82.71 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.351 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.87 165.24 20.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 61.4 m -103.81 137.2 42.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.435 HG21 HD23 ' A' ' 55' ' ' LEU . 1.6 pp -117.72 164.67 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.42 HG23 ' HA2' ' A' ' 79' ' ' GLY . 3.8 m -149.92 112.12 4.65 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -59.8 129.23 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.667 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.554 ' HA ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -99.23 15.2 4.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.801 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.37 157.79 45.49 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -89.78 109.18 20.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 112.135 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.431 HD21 ' CD2' ' A' ' 110' ' ' PHE . 12.4 mt -124.59 152.44 43.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.25 177.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -95.81 178.52 5.42 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.997 -0.44 . . . . 0.0 111.291 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.11 130.81 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -74.82 128.53 35.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.837 0.351 . . . . 0.0 111.529 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.15 -13.12 3.6 Favored Glycine 0 CA--C 1.517 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.574 173.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.506 ' HB3' HD22 ' A' ' 74' ' ' LEU . 37.3 m -107.58 155.15 20.43 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.643 -0.328 . . . . 0.0 110.877 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -81.5 8.28 9.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.495 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.506 HD22 ' HB3' ' A' ' 72' ' ' SER . 3.8 mm? -78.6 170.37 16.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.604 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -159.88 117.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.604 HG11 HG13 ' A' ' 63' ' ' VAL . 86.5 t -93.66 95.69 5.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 110.368 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 150.23 27.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.048 -175.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -49.94 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.948 0.88 . . . . 0.0 110.759 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.42 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.72 4.79 4.19 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.475 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.8 m -62.36 105.32 0.6 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.871 0.843 . . . . 0.0 110.059 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -89.27 112.68 23.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.75 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.446 HG11 ' HB2' ' A' ' 96' ' ' CYS . 44.7 t -124.59 113.18 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.3 ptmt -96.12 167.76 11.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.763 -174.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.611 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 9.1 p30 60.04 39.66 19.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.943 -1.48 . . . . 0.0 112.314 170.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.3 pt -64.18 179.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 -128.69 126.84 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.077 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.496 HD13 HG22 ' A' ' 46' ' ' VAL . 58.2 mt -80.58 120.16 24.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 93' ' ' ASP . 5.3 t . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 121.114 0.483 . . . . 0.0 110.742 -172.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.665 ' O ' HG21 ' A' ' 88' ' ' VAL . 25.5 m-20 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.221 0.534 . . . . 0.0 111.473 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.598 ' CD1' HG23 ' A' ' 111' ' ' VAL . 66.7 mt -116.23 122.35 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.791 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.51 132.4 42.13 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.091 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.446 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -134.18 142.72 47.52 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -105.32 117.02 32.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.412 ' CD1' ' HE1' ' A' ' 104' ' ' MET . 44.5 mt -117.28 113.33 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.167 -171.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.28 110.64 1.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 143.95 -62.19 0.5 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.815 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 -35.85 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 0.0 111.392 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.94 -147.88 19.46 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.66 147.02 23.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 111.065 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.412 ' HE1' ' CD1' ' A' ' 98' ' ' ILE . 61.2 ttp -144.46 165.87 26.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.881 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.98 148.01 34.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.897 0.38 . . . . 0.0 110.195 177.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.0 mt -130.08 140.37 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.912 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HG3' ' OE1' ' A' ' 109' ' ' GLU . 9.3 tptp -80.0 115.07 19.37 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.675 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -50.36 -40.19 48.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 50' ' ' SER . 1.6 mp0 -69.6 -10.01 56.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.421 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 67' ' ' LEU . 75.3 m-85 -112.09 -0.12 15.74 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 35.0 m -115.62 174.5 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.259 0.552 . . . . 0.0 112.163 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.455 ' HG3' HG13 ' A' ' 51' ' ' VAL . 19.9 ttt180 -143.22 131.78 22.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.273 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.703 ' HG3' ' HA ' ' A' ' 55' ' ' LEU . 1.9 tmtp? -70.43 119.97 15.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.381 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.25 -48.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.478 ' HA2' ' HE3' ' A' ' 113' ' ' LYS . . . 88.49 44.72 5.17 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.831 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.455 177.014 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.526 HD12 HD23 ' A' ' 23' ' ' LEU . 17.8 mt . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.356 0.122 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 36.6 Cg_endo -63.45 161.63 30.57 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.551 2.167 . . . . 0.0 111.808 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HB3' ' HG3' ' A' ' 14' ' ' GLU . 11.5 Cg_exo -70.44 -170.7 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.775 2.316 . . . . 0.0 112.496 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.46 123.68 49.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.08 9.04 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.545 2.163 . . . . 0.0 111.866 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 14.5 mt-30 -119.42 -36.21 3.4 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.889 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -110.82 -46.99 3.28 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 121.265 0.555 . . . . 0.0 109.727 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.21 5.83 5.13 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.91 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 m -61.41 -27.5 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.043 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 7' ' ' PRO . 4.4 mt-10 78.06 13.54 1.63 Allowed 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 174.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -81.03 47.46 1.0 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.717 0.77 . . . . 0.0 109.039 170.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 m -99.18 147.12 25.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.961 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -148.08 173.92 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.43 116.05 31.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 0.0 110.582 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -96.94 28.27 3.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.049 0.928 . . . . 0.0 109.675 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.82 -99.7 0.41 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.546 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.27 17.64 22.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.916 0.389 . . . . 0.0 111.577 -173.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -159.83 -176.67 5.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.526 HD23 HD12 ' A' ' 5' ' ' LEU . 3.5 mt -109.98 135.04 51.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -125.76 140.52 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 0.0 109.599 177.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 45.9 t -102.36 106.19 47.37 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.475 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 25' ' ' CYS . 33.9 Cg_endo -65.2 -14.66 46.3 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.679 2.253 . . . . 0.0 111.361 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.07 -59.36 2.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.891 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.1 p -99.08 10.14 42.07 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.59 39.85 20.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -139.47 126.72 21.32 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.585 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.47 164.66 11.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.778 177.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -163.99 162.05 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.489 . . . . 0.0 111.026 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.2 t -104.68 123.26 40.79 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 C-N-CA 122.952 2.435 . . . . 0.0 113.112 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.455 HG13 HD13 ' A' ' 87' ' ' LEU . 6.1 t . . . . . 0 C--O 1.231 0.108 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 93' ' ' ASP . 2.8 mm -91.66 135.23 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.652 ' O ' ' HB2' ' A' ' 108' ' ' SER . 11.7 ttmt -121.09 155.0 35.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.587 ' OD1' HG23 ' A' ' 111' ' ' VAL . 9.0 m-20 -92.98 176.83 6.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.304 0.573 . . . . 0.0 111.449 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 13.5 t -79.0 -7.37 58.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.642 174.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.509 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.0 t -91.02 -15.37 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.347 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.98 0.39 60.16 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.509 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -83.45 162.67 20.89 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.901 0.857 . . . . 0.0 110.767 178.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.449 HG21 ' HE2' ' A' ' 48' ' ' LYS . 2.9 t -118.19 130.64 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.909 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' HD21 ' A' ' 55' ' ' LEU . 1.5 mm? -93.76 173.19 7.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.377 0.608 . . . . 0.0 110.645 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.29 150.72 48.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.692 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.574 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 17.7 t70 -67.43 99.14 0.71 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.449 . . . . 0.0 109.891 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 121.72 -7.45 10.27 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.385 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.67 167.96 14.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.698 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.5 m -106.45 131.65 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.574 HG13 HG21 ' A' ' 82' ' ' VAL . 1.9 pp -127.57 169.11 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.721 0.296 . . . . 0.0 110.311 -174.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.408 ' CG2' ' HA2' ' A' ' 79' ' ' GLY . 2.8 m -150.6 121.68 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.574 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.495 HG12 HG11 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -61.93 131.04 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 109.867 176.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.502 ' HA ' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -94.98 10.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 64' ' ' ILE . 58.1 mmtt -139.18 167.63 21.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 119.843 1.201 . . . . 0.0 110.034 -176.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.4 109.86 20.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.176 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 mp -123.95 138.54 54.45 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.466 173.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.02 177.7 5.66 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.651 -0.656 . . . . 0.0 110.265 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 72' ' ' SER . 39.0 t -128.83 120.98 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -84.77 -32.77 23.22 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.558 ' N ' ' HD3' ' A' ' 70' ' ' LYS . . . -86.4 -26.82 32.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.924 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.686 ' HB3' HD23 ' A' ' 74' ' ' LEU . 60.8 m -110.42 163.71 13.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 m -81.37 8.66 8.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.57 0.7 . . . . 0.0 109.96 173.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.686 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.93 172.35 13.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.107 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.4 t -159.35 113.81 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -166.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.495 HG11 HG12 ' A' ' 63' ' ' VAL . 94.8 t -90.97 96.78 6.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.828 0.823 . . . . 0.0 110.246 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.3 pptp? -106.04 148.2 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.502 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.54 96.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.974 0.893 . . . . 0.0 110.605 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 62' ' ' THR . . . 133.09 4.76 3.21 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.005 -177.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.7 m -63.53 103.46 0.53 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.959 0.885 . . . . 0.0 109.956 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -92.29 115.3 27.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.654 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.574 HG21 HG13 ' A' ' 61' ' ' ILE . 2.6 m -120.04 119.87 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.808 0.813 . . . . 0.0 110.519 171.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.0 pttp -103.82 148.8 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.465 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.575 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 71.54 43.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.127 0.892 . . . . 0.0 111.284 176.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.31 -178.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 122.098 0.951 . . . . 0.0 113.016 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -129.74 124.69 34.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.867 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.455 HD13 HG13 ' A' ' 46' ' ' VAL . 71.3 mt -82.63 117.51 22.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.873 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--N 1.318 -0.8 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.12 -173.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.873 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 4.6 m-20 . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.58 ' CD1' HG22 ' A' ' 111' ' ' VAL . 30.5 mt -120.94 111.06 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.557 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 24.7 t70 -94.47 135.31 36.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 p -134.42 142.07 47.02 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.955 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -104.89 119.29 38.65 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.7 mt -118.72 108.81 25.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.292 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -54.66 126.17 22.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.382 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.87 -53.45 0.78 Allowed Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 102' ' ' GLY . 40.6 pt -112.18 -39.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.782 0.325 . . . . 0.0 110.961 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 135.3 -149.21 19.89 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.98 155.01 19.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.015 0.407 . . . . 0.0 110.863 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -147.21 161.93 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.431 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -107.69 146.89 31.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.26 142.18 50.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.398 0.618 . . . . 0.0 111.452 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -78.05 120.05 22.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.671 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.652 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.9 p -57.11 -34.57 68.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.988 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 50' ' ' SER . 4.8 pm0 -70.23 -7.22 40.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.495 ' O ' HD13 ' A' ' 64' ' ' ILE . 55.0 m-85 -112.75 3.63 16.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.587 HG23 ' OD1' ' A' ' 49' ' ' ASP . 29.1 m -110.48 166.53 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.422 0.63 . . . . 0.0 112.531 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -141.3 133.51 27.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.356 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.482 ' HE3' ' CA ' ' A' ' 115' ' ' GLY . 33.0 tttp -65.95 139.49 58.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.22 -42.78 8.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.482 ' CA ' ' HE3' ' A' ' 113' ' ' LYS . . . 79.54 29.56 48.24 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.143 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.85 176.816 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 21.9 mt . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 63.2 Cg_endo -68.88 154.61 70.68 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 121.552 1.501 . . . . 0.0 110.741 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.77 -165.78 0.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.669 2.246 . . . . 0.0 112.294 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.7 t -97.75 123.26 52.41 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.046 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.39 11.21 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.895 2.397 . . . . 0.0 111.739 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.597 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 13.7 mt-30 -122.22 -37.68 2.79 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.891 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -107.09 -49.12 3.34 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.247 0.546 . . . . 0.0 109.721 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 70.51 -3.73 1.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.249 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 8.3 t -54.68 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.371 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 13' ' ' SER . 11.3 pt-20 171.68 -8.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.671 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 96.7 m-85 -78.8 35.42 0.24 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 112.017 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -97.82 134.98 40.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.307 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.459 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 27.5 p90 -145.52 171.66 14.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.12 123.22 46.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.067 0.46 . . . . 0.0 110.916 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.69 84.08 2.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.02 -114.03 4.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.225 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.93 20.66 18.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -171.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.72 -174.82 4.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.444 HD21 HD13 ' A' ' 5' ' ' LEU . 35.0 mt -110.58 135.61 50.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -126.31 140.65 48.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -107.49 106.22 57.88 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.176 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.3 Cg_endo -68.46 -14.31 39.58 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.704 2.27 . . . . 0.0 110.79 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.582 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 32.6 tt0 -66.09 -58.78 4.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.076 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.18 8.74 36.31 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.46 49.36 13.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.429 0.559 . . . . 0.0 112.112 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -147.72 128.09 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.01 171.62 8.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -168.75 162.16 11.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 m -119.81 116.31 33.08 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 C--N 1.344 0.298 0 C-N-CA 123.319 2.68 . . . . 0.0 113.106 -170.675 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.454 HG12 HD13 ' A' ' 87' ' ' LEU . 2.6 t . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.045 0.45 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 93' ' ' ASP . 2.5 mm -105.32 141.22 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.058 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.706 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -105.03 165.79 10.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.0 111.739 -178.102 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.583 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.9 m-20 -109.97 172.7 6.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.784 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.563 ' HB3' HD13 ' A' ' 64' ' ' ILE . 36.1 t -77.22 -7.46 55.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.56 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.4 p -93.2 0.31 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.257 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 4.08 69.86 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.285 171.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.56 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -105.02 168.25 9.17 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.829 -0.748 . . . . 0.0 112.14 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.66 137.08 48.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.847 -174.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.525 HD21 HG21 ' A' ' 61' ' ' ILE . 9.2 mt -89.88 172.84 8.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.581 0.705 . . . . 0.0 112.097 -171.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.458 HE21 ' HB3' ' A' ' 56' ' ' GLN . 2.2 tt0 -121.84 142.63 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.571 173.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.631 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 6.4 t70 -67.03 105.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.041 0.448 . . . . 0.0 110.375 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.411 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 114.49 -0.84 23.55 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -80.2 174.25 11.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.306 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 26.9 m -102.56 139.18 38.49 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.525 HG21 HD21 ' A' ' 55' ' ' LEU . 2.1 pp -118.66 165.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 m -147.97 118.39 7.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.835 0.35 . . . . 0.0 110.084 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.64 HG13 HG11 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.22 127.51 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.754 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.42 19.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.754 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.1 mptp? -135.62 163.93 29.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.427 ' O ' HD22 ' A' ' 67' ' ' LEU . 5.6 p-10 -86.83 113.39 22.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.933 0.873 . . . . 0.0 111.72 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.437 HD13 ' CG ' ' A' ' 110' ' ' PHE . 18.3 mt -125.4 148.05 48.94 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.98 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -98.31 177.12 5.47 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.8 170.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.15 131.42 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -83.1 -38.96 21.75 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.48 -25.03 59.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.254 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.8 m -115.11 171.6 7.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.234 0.54 . . . . 0.0 111.774 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.0 t -92.07 1.9 56.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.398 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.433 HD23 HD13 ' A' ' 101' ' ' ILE . 10.7 mp -79.68 136.49 36.81 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.464 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.03 133.69 43.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.006 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.64 HG11 HG13 ' A' ' 63' ' ' VAL . 53.5 t -89.03 100.56 10.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.615 0.722 . . . . 0.0 109.925 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -105.18 150.44 25.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.721 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -51.31 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.848 0.832 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.13 4.82 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.16 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.0 m -61.29 105.45 0.5 Allowed 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 122.147 0.975 . . . . 0.0 110.129 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -90.84 114.24 26.61 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.206 -173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 96' ' ' CYS . 21.5 t -123.72 117.26 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.027 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 11.3 ptmm? -99.92 154.03 18.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.558 -173.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.411 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 16.2 m-80 64.25 50.01 2.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.685 175.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.8 pt -65.66 177.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.826 0.822 . . . . 0.0 112.725 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.631 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 10.3 tpt180 -131.69 125.52 32.3 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.076 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.454 HD13 HG12 ' A' ' 46' ' ' VAL . 36.3 mt -84.25 118.33 24.1 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.533 ' O ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.953 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.48 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.573 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.3 m-20 . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.581 ' CD1' HG23 ' A' ' 111' ' ' VAL . 50.5 mt -121.22 116.49 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.388 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 30.8 t70 -93.96 128.42 40.27 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.77 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.593 ' HB2' HG11 ' A' ' 82' ' ' VAL . 25.3 p -130.86 137.12 49.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.071 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -107.72 118.85 37.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.469 HD12 ' HE2' ' A' ' 104' ' ' MET . 29.8 mt -117.84 108.27 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 -171.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -63.93 107.61 1.28 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.434 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.27 -45.04 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.394 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.433 HD13 HD23 ' A' ' 74' ' ' LEU . 15.6 pt -120.29 -37.54 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.87 0.366 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.27 -153.33 21.85 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.26 151.92 21.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.092 0.446 . . . . 0.0 110.503 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' MET . . . . . 0.609 ' HE1' HD21 ' A' ' 106' ' ' LEU . 54.8 ttp -143.15 164.17 30.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.95 147.92 37.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 0.0 110.379 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.609 HD21 ' HE1' ' A' ' 104' ' ' MET . 90.1 mt -129.52 144.01 51.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.791 -171.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -81.5 120.44 25.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.279 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.706 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 2.5 m -50.89 -36.91 40.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.328 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 50' ' ' SER . 42.8 mt-10 -71.32 -5.4 32.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.462 ' O ' HD11 ' A' ' 64' ' ' ILE . 55.0 m-85 -114.36 -2.75 13.2 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.857 -0.737 . . . . 0.0 112.749 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.583 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 34.8 m -113.72 172.7 3.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 25.0 ttt180 -151.74 133.94 15.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.582 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.48 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.4 tttt -65.28 123.16 18.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.19 174.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.47 -51.91 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.871 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.16 39.06 16.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.318 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.389 179.172 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.401 HD13 ' CD ' ' A' ' 18' ' ' GLU . 55.2 mt . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.49 157.45 56.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.1 1.867 . . . . 0.0 110.688 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.6 -174.64 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.093 . . . . 0.0 113.258 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.764 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 34.3 t -99.6 123.22 48.76 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.458 ' HG2' ' OE1' ' A' ' 10' ' ' GLN . 39.2 Cg_endo -70.01 7.27 1.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 121.887 1.725 . . . . 0.0 112.059 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.764 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 1.2 mp0 -103.0 -54.26 2.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.307 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 13' ' ' SER . 28.4 p -117.77 -28.29 6.01 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.0 t30 75.88 -28.55 0.18 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.287 0.635 . . . . 0.0 112.287 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 11' ' ' CYS . 63.5 p -32.5 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.574 1.171 . . . . 0.0 113.401 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.0 pt-20 169.35 -4.93 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.534 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.6 m-85 -81.16 42.41 0.65 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.27 0.557 . . . . 0.0 111.747 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -109.26 148.56 30.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.853 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -150.09 174.1 13.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.2 pm0 -102.77 115.61 30.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.377 0.608 . . . . 0.0 111.268 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.51 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 10.7 t70 -122.86 83.65 2.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.824 174.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.97 -126.38 8.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.336 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.47 17.61 23.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.962 0.41 . . . . 0.0 111.372 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.7 -174.07 4.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.1 mt -120.23 136.82 54.52 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.79 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -125.12 143.58 38.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.259 -179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.1 t -104.22 104.21 42.84 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 23.0 Cg_endo -61.49 -22.1 73.64 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.843 2.362 . . . . 0.0 111.179 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -74.15 -59.7 2.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.7 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.2 m -74.48 -9.91 59.05 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.72 44.83 25.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.314 0.578 . . . . 0.0 110.433 -170.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -145.1 122.94 11.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.79 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.6 mp0 -91.62 157.92 16.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.787 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -158.3 163.13 37.67 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.6 t -125.5 124.41 25.05 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo . . . . . 0 C--N 1.343 0.242 0 C-N-CA 123.075 2.517 . . . . 0.0 113.023 -173.392 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 120.682 0.277 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.431 HG23 ' HB3' ' A' ' 108' ' ' SER . 2.0 mm -78.79 117.01 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.429 -173.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 108' ' ' SER . 1.2 mtmt -100.01 150.11 22.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.092 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 9.2 m-20 -90.5 176.64 6.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.516 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.6 t -77.09 -7.97 56.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.722 0.772 . . . . 0.0 110.761 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.573 HG12 ' ND2' ' A' ' 53' ' ' ASN . 2.1 p -97.3 -2.25 10.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.18 0.99 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.01 3.92 79.06 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.976 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.573 ' ND2' HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -92.91 154.76 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.685 0.743 . . . . 0.0 111.017 177.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.3 109.94 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.612 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 113' ' ' LYS . 94.2 mt -58.76 145.7 39.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.383 175.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -120.51 148.94 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.709 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 1.2 t70 -63.94 126.36 27.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 88.66 2.01 79.63 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.816 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 173.64 12.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.967 0.383 . . . . 0.0 110.473 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.69 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 11.4 m -101.59 139.82 36.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.569 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.432 HG22 HD21 ' A' ' 55' ' ' LEU . 2.0 pp -124.47 165.39 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.448 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 m -150.61 115.6 5.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.438 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.65 HG13 HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.07 129.97 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.548 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -103.06 17.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.468 178.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.26 161.44 34.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.444 ' O ' HD22 ' A' ' 67' ' ' LEU . 5.5 p-10 -85.55 111.31 19.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.938 0.875 . . . . 0.0 111.156 169.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.466 HD12 ' CB ' ' A' ' 110' ' ' PHE . 20.1 mt -124.43 133.88 53.25 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.145 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -88.28 173.2 8.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.749 -0.594 . . . . 0.0 109.963 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.497 ' CG1' ' HB2' ' A' ' 72' ' ' SER . 21.7 t -128.92 120.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -93.36 -2.83 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.475 -170.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.14 26.31 6.45 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' SER . . . . . 0.497 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 58.2 m -146.49 -177.69 5.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -177.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -100.87 -12.12 19.25 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.402 HD21 HD12 ' A' ' 101' ' ' ILE . 9.8 mp -79.22 142.45 36.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.786 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.98 126.64 67.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.359 167.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.65 HG11 HG13 ' A' ' 63' ' ' VAL . 76.0 t -77.73 104.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.44 150.39 26.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.448 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.548 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -52.34 96.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 121.776 0.798 . . . . 0.0 110.501 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.32 4.13 3.68 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.23 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.8 m -62.76 105.1 0.61 Allowed 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.478 0.656 . . . . 0.0 110.67 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -91.07 120.53 32.11 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.551 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 96' ' ' CYS . 59.8 t -129.7 116.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.745 174.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.8 pttm -102.92 159.51 15.43 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.253 -175.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.575 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 46.5 m-80 65.25 48.53 2.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.453 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.9 pt -67.94 -178.95 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 11.1 tpp85 -136.44 124.39 22.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.602 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.428 ' HB3' HG12 ' A' ' 47' ' ' ILE . 36.9 mt -79.83 125.38 29.63 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.042 -0.411 . . . . 0.0 110.086 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.107 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.421 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.3 m-20 . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 111' ' ' VAL . 27.7 mt -139.36 115.17 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.07 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 20.5 t70 -92.73 133.99 35.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.313 0.578 . . . . 0.0 110.349 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.525 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -142.8 154.31 44.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.602 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 96.1 mttt -125.46 132.22 52.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mt -122.38 113.63 39.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.705 -167.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.75 100.69 0.95 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.215 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.75 -62.91 0.42 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.558 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.402 HD12 HD21 ' A' ' 74' ' ' LEU . 20.0 pt -95.9 -46.19 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.986 0.422 . . . . 0.0 110.483 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 141.76 -155.82 25.56 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.607 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -81.85 144.75 30.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.757 0.279 . . . . 0.0 110.801 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.3 ttt -138.52 158.83 43.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 110.827 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.2 OUTLIER -111.16 137.17 49.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.816 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 86.3 mt -123.85 142.01 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.493 0.664 . . . . 0.0 111.455 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -92.9 121.24 34.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.256 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.3 p -51.88 -37.56 52.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.172 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -72.06 -6.75 44.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.844 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' A' ' 67' ' ' LEU . 60.5 m-85 -111.71 -4.13 14.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.891 -0.506 . . . . 0.0 111.995 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 34.8 m -114.88 175.36 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.47 ' HG3' HG11 ' A' ' 51' ' ' VAL . 26.7 ttt180 -151.46 130.98 12.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.423 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.483 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.1 tttt -66.63 122.21 17.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.338 175.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.44 -44.28 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.271 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.87 9.81 85.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.298 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.85 -178.51 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 121.39 0.614 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.4 p -104.52 151.93 6.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.563 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -83.74 134.13 34.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.058 0.456 . . . . 0.0 111.163 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 t -94.05 17.22 12.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.331 1.062 . . . . 0.0 108.705 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.491 HD11 HD22 ' A' ' 23' ' ' LEU . 11.2 mt -87.2 160.75 48.13 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.742 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 41.8 Cg_endo -64.89 160.01 43.19 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.319 2.013 . . . . 0.0 111.423 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.78 -169.69 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.079 1.853 . . . . 0.0 112.161 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.528 ' C ' ' H ' ' A' ' 10' ' ' GLN . 8.4 t -97.35 123.61 52.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.19 11.31 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.961 2.441 . . . . 0.0 111.806 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.528 ' H ' ' C ' ' A' ' 8' ' ' CYS . 37.8 mt-30 -122.73 -34.7 3.18 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.9 m -112.68 -45.13 3.25 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.785 -0.572 . . . . 0.0 110.489 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 12.91 7.49 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.02 0.914 . . . . 0.0 110.511 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.603 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 20.9 p -67.12 -32.19 73.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.926 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 84.85 5.76 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.011 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.603 ' HD1' ' HB2' ' A' ' 13' ' ' SER . 83.7 m-85 -82.7 47.32 1.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.689 0.757 . . . . 0.0 109.804 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -102.65 150.23 23.65 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.121 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.4 p90 -142.0 169.11 18.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.68 117.78 35.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.178 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 t70 -110.04 74.76 0.9 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.99 -102.8 2.72 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.208 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.85 18.69 15.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.08 -175.42 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.491 HD22 HD11 ' A' ' 5' ' ' LEU . 5.8 mt -108.93 133.99 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 31' ' ' GLU . 49.9 t -118.66 128.04 75.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.3 t -97.9 108.34 45.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.33 -7.21 20.84 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.596 2.197 . . . . 0.0 111.387 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -79.22 -67.48 0.75 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.65 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.05 9.19 29.0 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.297 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.14 46.79 12.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 112.007 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -144.18 125.91 15.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.415 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' HB3' HG21 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -93.44 149.03 21.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.553 176.287 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -153.27 161.84 41.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.546 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 8.7 t -119.58 129.94 25.1 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 12.0 Cg_endo -54.33 -54.98 3.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.893 2.396 . . . . 0.0 112.826 -170.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.99 -35.12 10.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.516 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 37.0 tt0 -69.06 -15.06 63.36 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.305 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.84 -30.55 71.63 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.815 0.341 . . . . 0.0 110.379 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.23 -40.75 58.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 m 70.41 150.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.788 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.15 162.7 39.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.437 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 m -81.17 96.19 7.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.846 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -99.52 172.73 7.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 58.19 37.02 26.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.64 26.42 22.62 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.568 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -96.57 5.27 51.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.51 0.672 . . . . 0.0 109.694 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.532 HG12 HD12 ' A' ' 87' ' ' LEU . 6.2 t -63.65 142.09 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.115 172.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.776 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -69.69 119.37 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.191 0.307 . . . . 0.0 110.655 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.669 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.7 OUTLIER -106.78 146.35 30.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.524 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.473 ' OD1' HG21 ' A' ' 111' ' ' VAL . 12.8 m-20 -90.0 175.51 7.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.621 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 7.0 t -74.37 -4.0 33.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.094 0.95 . . . . 0.0 110.12 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.5 t -87.88 -14.42 9.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.0 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.77 7.97 68.03 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.823 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.484 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -104.48 164.54 11.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.678 178.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.419 HG21 ' HG3' ' A' ' 48' ' ' LYS . 4.7 t -109.65 140.14 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.045 -173.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 113' ' ' LYS . 24.9 mt -95.73 172.73 7.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.332 0.587 . . . . 0.0 111.136 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.3 tt0 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.712 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.492 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 13.6 t70 -69.13 94.96 0.71 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.193 0.52 . . . . 0.0 109.617 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.65 -11.0 6.72 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.2 t70 -72.04 169.51 15.82 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.304 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.659 HG21 ' HB3' ' A' ' 83' ' ' LYS . 3.0 m -100.49 135.43 41.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 82' ' ' VAL . 1.8 pp -121.42 163.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.0 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -150.27 119.91 7.0 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.172 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.827 HG13 HG11 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -60.76 128.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.747 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -98.92 17.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 4.3 mptp? -142.09 166.57 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.547 -0.721 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -77.12 105.89 8.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.102 0.953 . . . . 0.0 111.101 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.515 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 2.4 mm? -114.84 126.44 54.82 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.675 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.87 171.7 14.18 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' A' ' 72' ' ' SER . 40.2 t -126.78 120.56 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.51 -45.0 69.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.64 -10.39 57.95 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.932 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.455 ' HB2' HG11 ' A' ' 69' ' ' VAL . 26.1 m -111.93 153.65 26.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.951 0.405 . . . . 0.0 111.144 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -71.04 -12.01 61.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.9 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mp -79.44 137.92 37.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.213 0.53 . . . . 0.0 111.121 -174.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.13 127.21 66.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.193 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.827 HG11 HG13 ' A' ' 63' ' ' VAL . 69.7 t -81.97 116.42 26.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.479 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.432 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -109.07 149.2 29.64 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.516 -176.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -50.04 97.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.838 0.828 . . . . 0.0 110.266 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.69 3.43 5.05 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.081 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 m -62.57 105.76 0.68 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 122.071 0.938 . . . . 0.0 110.163 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -88.36 116.85 26.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 -174.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 61' ' ' ILE . 93.5 t -129.09 110.16 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.659 ' HB3' HG21 ' A' ' 60' ' ' THR . 26.2 pttm -102.07 165.77 10.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.908 0.385 . . . . 0.0 111.624 -174.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.549 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 63.57 44.06 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.739 175.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 55' ' ' LEU . 39.6 pt -65.83 174.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.048 0.928 . . . . 0.0 113.064 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.549 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 2.2 tpp180 -122.56 123.93 42.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.941 -1.482 . . . . 0.0 108.236 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.532 HD12 HG12 ' A' ' 46' ' ' VAL . 42.5 mt -83.0 119.39 24.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.559 HG11 ' H ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -86.87 179.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.559 ' H ' HG11 ' A' ' 88' ' ' VAL . 15.3 t70 -60.13 -49.15 78.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.844 0.354 . . . . 0.0 111.521 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . -82.3 138.59 18.68 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.677 -177.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.98 -18.33 44.99 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.475 0.655 . . . . 0.0 111.876 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.441 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 1.0 OUTLIER -100.64 51.56 0.87 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.525 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.54 ' O ' HG21 ' A' ' 88' ' ' VAL . 9.4 m-20 -161.53 102.15 1.2 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -166.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.776 HG13 HG21 ' A' ' 47' ' ' ILE . 3.9 mp -110.55 116.6 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 170.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.549 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 28.1 t70 -94.1 130.36 40.3 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.457 ' HB2' HG12 ' A' ' 82' ' ' VAL . 24.8 p -144.22 154.58 43.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.567 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 98.7 mttt -121.18 129.5 53.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.0 mt -121.37 118.93 57.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.419 -170.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.11 120.91 8.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.743 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.35 -80.77 0.31 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 26.1 pt -74.93 -46.03 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.733 0.301 . . . . 0.0 111.476 -177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.27 -150.84 20.86 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.89 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.86 146.82 24.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.656 0.265 . . . . 0.0 110.85 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.9 ttt -142.31 163.39 32.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.236 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.25 140.03 49.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.6 mt -120.04 144.1 47.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.121 0.486 . . . . 0.0 111.419 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.401 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 16.9 ttmt -80.89 118.76 22.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.977 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.669 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 3.3 m -49.08 -37.59 21.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.48 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 50' ' ' SER . 27.7 mt-10 -72.08 -8.62 55.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.279 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.46 ' O ' HD12 ' A' ' 64' ' ' ILE . 33.9 m-85 -113.46 -0.62 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.174 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 21.9 m -113.51 171.69 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.798 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.467 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 13.5 ttt180 -150.29 138.21 20.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.641 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.501 ' HB2' HD23 ' A' ' 55' ' ' LEU . 26.5 ttpt -62.88 117.11 5.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.857 165.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -55.59 -56.05 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.14 -0.05 13.03 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.325 176.431 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.966 0.413 . . . . 0.0 111.823 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.29 127.03 39.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.022 0.439 . . . . 0.0 110.659 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 m -71.24 147.08 48.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.336 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.1 p -101.05 34.99 2.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 110.627 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 31.9 mt -89.1 168.58 15.06 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.56 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 61.1 Cg_endo -69.43 158.35 57.72 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.868 1.712 . . . . 0.0 110.742 171.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -73.06 -167.51 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.461 2.107 . . . . 0.0 112.4 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.454 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.4 t -98.36 125.68 42.34 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.522 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.44 7.76 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.804 2.336 . . . . 0.0 112.314 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.454 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 36.9 mt-30 -119.36 -38.44 3.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.8 m -107.23 -46.95 3.77 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.311 0.577 . . . . 0.0 109.917 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.36 0.81 2.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.414 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 m -57.88 -77.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.354 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 171.15 -21.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 73.2 m-85 -78.87 36.99 0.29 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -167.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -101.01 144.34 30.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.263 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -146.12 173.41 12.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.433 ' HB3' HD13 ' A' ' 5' ' ' LEU . 1.2 pm0 -101.7 119.42 38.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.571 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 15.7 t70 -120.18 75.42 1.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.12 -119.64 6.58 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.903 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.64 16.46 25.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.723 0.297 . . . . 0.0 111.72 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.24 -176.54 5.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.737 0.303 . . . . 0.0 110.293 -178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.556 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 17.0 mt -111.69 130.7 55.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.17 127.94 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.2 t -102.6 103.98 35.56 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -70.07 -9.86 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.836 2.357 . . . . 0.0 110.65 176.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.605 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 74.0 tt0 -70.08 -65.02 0.78 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.991 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -95.12 11.41 32.31 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 43.69 19.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 111.824 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HB3' HE22 ' A' ' 10' ' ' GLN . 54.3 t60 -150.1 136.33 18.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.928 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.63 166.77 10.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -162.3 161.85 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.588 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.9 t -112.93 124.73 31.06 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.556 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.5 Cg_endo -57.72 -45.48 32.98 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.304 2.669 . . . . 0.0 113.815 -168.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -105.18 -32.84 8.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.911 0.386 . . . . 0.0 110.961 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.588 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 36.0 tt0 -65.42 -32.79 74.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.955 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.77 -34.61 77.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 110.738 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.09 -41.74 18.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.455 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.9 m 69.54 -67.55 0.22 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.766 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.03 135.13 43.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.929 0.395 . . . . 0.0 111.054 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 m -101.13 28.67 5.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.164 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 68.65 153.51 0.1 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.764 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -82.15 -47.0 13.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.378 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.84 106.58 0.31 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.993 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 7.4 mmpt? -89.73 -3.35 58.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.638 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG12 HD12 ' A' ' 87' ' ' LEU . 2.8 t -121.88 148.38 25.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.697 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.601 HD13 ' O ' ' A' ' 88' ' ' VAL . 3.1 mm -91.17 138.1 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.709 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.5 ttmt -121.06 149.49 42.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.316 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.627 ' OD1' HG21 ' A' ' 111' ' ' VAL . 6.8 m-20 -90.05 -179.79 5.77 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.273 0.559 . . . . 0.0 111.542 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 28.4 t -83.85 -3.21 57.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.014 0.911 . . . . 0.0 110.005 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.505 HG22 ' HB2' ' A' ' 112' ' ' ARG . 4.6 t -92.39 -14.42 8.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.819 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.62 3.28 59.67 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.688 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.536 ' ND2' ' H ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -87.68 163.39 16.57 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.933 0.873 . . . . 0.0 111.423 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.416 HG23 ' HG3' ' A' ' 48' ' ' LYS . 2.6 t -117.69 135.18 58.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.663 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -95.79 -157.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 111.278 -172.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.573 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 5.9 tt0 -159.56 146.34 16.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -70.59 97.85 1.39 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.811 0.815 . . . . 0.0 110.012 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 125.34 -6.6 8.09 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.941 -176.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.573 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 40.9 t0 -73.87 167.8 20.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.719 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.2 m -110.88 134.2 52.74 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.47 171.86 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.0 m -150.12 119.34 6.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.789 0.328 . . . . 0.0 111.56 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.624 HG12 HG13 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -59.82 132.16 24.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 122.886 0.474 . . . . 0.0 110.155 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.662 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -104.68 19.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.662 ' HD2' HG12 ' A' ' 64' ' ' ILE . 4.9 mptp? -138.26 161.88 35.76 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -84.83 101.4 12.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.294 171.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD21 ' CG ' ' A' ' 110' ' ' PHE . 6.3 mp -112.96 145.66 40.41 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.86 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.37 173.97 8.42 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.876 0.369 . . . . 0.0 111.238 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 60.7 t -126.68 137.78 56.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -104.03 138.51 40.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.97 -37.45 3.5 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.36 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -110.56 155.62 22.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -80.35 -0.96 39.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.478 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 2.2 mm? -80.91 141.64 34.36 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.195 0.521 . . . . 0.0 111.409 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.2 t -112.71 134.83 54.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.466 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.624 HG13 HG12 ' A' ' 63' ' ' VAL . 78.6 t -83.68 99.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.028 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.15 148.64 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.265 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.55 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.98 96.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 122.038 0.923 . . . . 0.0 111.063 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.93 3.95 3.47 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.123 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.1 m -62.17 104.5 0.49 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.522 0.677 . . . . 0.0 110.294 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -87.17 116.2 25.08 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.651 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' A' ' 96' ' ' CYS . 18.2 t -125.31 116.58 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 pttm -104.71 162.51 13.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.564 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 66.81 38.65 3.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.341 170.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.5 pt -67.58 -178.72 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 122.168 0.985 . . . . 0.0 113.486 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.548 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 16.5 tpp180 -130.05 129.63 43.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.611 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.463 HD12 HG12 ' A' ' 46' ' ' VAL . 82.3 mt -84.88 123.74 30.82 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.747 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -93.33 163.98 2.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.46 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.14 102.63 5.82 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.85 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 164.09 -168.27 38.47 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.951 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -102.24 -45.4 5.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.289 0.566 . . . . 0.0 111.606 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.437 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 30.7 m80 -106.91 54.17 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.502 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.747 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.4 m-20 -135.26 93.98 3.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -161.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.528 ' CD1' HG23 ' A' ' 111' ' ' VAL . 51.6 mt -125.96 117.41 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.328 0.585 . . . . 0.0 111.334 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 26.2 t70 -94.57 131.97 39.76 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.544 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.524 ' HB2' HG12 ' A' ' 82' ' ' VAL . 27.8 p -134.16 138.83 45.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.857 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -112.58 127.13 56.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.11 109.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.893 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.58 94.98 2.23 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.42 -56.39 0.31 Allowed Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.207 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.447 HG13 ' N ' ' A' ' 102' ' ' GLY . 48.1 pt -104.39 -42.28 7.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.339 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.447 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 143.09 -158.87 27.35 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.024 -0.607 . . . . 0.0 111.698 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.2 144.42 26.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.728 0.299 . . . . 0.0 110.629 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.3 tpt -134.64 155.58 50.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.856 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.407 ' H ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -101.41 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.915 177.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.51 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 99.0 mt -130.85 136.6 48.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.674 0.75 . . . . 0.0 111.504 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.584 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 30.9 mttm -84.82 114.68 22.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.463 175.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.709 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.7 p -53.5 -35.76 60.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.137 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.584 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 5.9 pt-20 -61.31 -14.73 29.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.497 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.518 ' O ' HD13 ' A' ' 64' ' ' ILE . 56.6 m-85 -112.72 2.3 16.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.969 -0.457 . . . . 0.0 112.224 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.627 HG21 ' OD1' ' A' ' 49' ' ' ASP . 17.8 m -114.14 170.3 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.38 0.609 . . . . 0.0 112.297 -173.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.505 ' HB2' HG22 ' A' ' 51' ' ' VAL . 7.5 ttt180 -142.09 141.22 32.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.291 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.536 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 36.1 tttp -71.03 140.76 50.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.369 176.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.0 t -105.03 -49.41 9.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.285 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.78 31.45 73.07 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.814 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.992 179.812 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptm . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t 50.24 40.52 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 122.085 0.945 . . . . 0.0 109.046 -172.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.541 ' HB3' ' HG ' ' A' ' 5' ' ' LEU . 16.3 m -103.32 139.54 38.61 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.362 -172.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.1 p -107.19 30.78 5.9 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.283 0.563 . . . . 0.0 110.279 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.541 ' HG ' ' HB3' ' A' ' 3' ' ' SER . 12.4 mt -63.7 146.04 97.09 Favored Pre-proline 0 CA--C 1.518 -0.275 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.277 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.78 161.48 45.28 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.501 2.134 . . . . 0.0 111.201 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.28 -167.03 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.354 2.036 . . . . 0.0 111.769 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.638 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 10.7 t -98.47 129.2 30.89 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.628 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.98 8.47 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.581 2.188 . . . . 0.0 111.34 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.638 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 13.3 mt-30 -119.36 -38.45 3.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.555 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.4 m -108.63 -52.89 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.589 0.709 . . . . 0.0 109.53 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 71.76 3.22 4.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.474 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.668 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 14.8 m -59.5 -77.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.615 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' HB3' ' O ' ' A' ' 13' ' ' SER . 16.3 pt-20 176.91 -15.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.513 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 25.8 m-85 -81.81 32.74 0.37 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.386 0.539 . . . . 0.0 112.007 -169.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -91.9 135.72 33.71 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.521 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.0 p90 -143.62 170.07 16.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -98.66 118.92 36.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.722 0.296 . . . . 0.0 111.296 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.521 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 32.9 t70 -123.3 86.15 2.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 171.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.61 -111.79 3.99 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.406 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.1 18.86 18.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.466 HD12 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.7 -175.08 5.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 110.39 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.413 ' HB2' ' CD1' ' A' ' 32' ' ' TRP . 43.9 mt -110.1 131.24 55.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.633 174.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.513 HG12 ' HG3' ' A' ' 31' ' ' GLU . 57.6 t -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.936 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 41.7 t -104.24 103.16 37.09 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.2 Cg_endo -69.73 -15.43 37.18 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.366 2.044 . . . . 0.0 109.645 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.936 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 28.2 tt0 -64.16 -44.46 92.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.657 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.414 ' SG ' ' NE2' ' A' ' 10' ' ' GLN . 22.4 p -118.06 11.83 13.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 171.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.21 47.19 14.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -143.61 131.49 21.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.493 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HG3' HG12 ' A' ' 24' ' ' VAL . 2.0 mp0 -91.73 145.34 24.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.446 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.456 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -150.16 160.99 43.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.222 0.534 . . . . 0.0 110.933 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 30.8 t -118.15 124.51 28.61 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 18.3 Cg_endo -57.95 -23.24 58.84 Favored 'Trans proline' 0 C--N 1.34 0.106 0 C-N-CA 122.672 2.248 . . . . 0.0 111.745 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -100.92 -56.64 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.89 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 39' ' ' THR . 34.0 tt0 -67.81 -19.07 65.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.069 -171.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.58 -56.14 20.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.015 0.436 . . . . 0.0 110.691 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.48 -46.32 10.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.235 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 11.1 m -114.16 155.53 25.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.851 -172.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.69 146.03 38.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.759 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.7 m -81.77 12.45 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.096 0.474 . . . . 0.0 111.416 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -106.73 141.78 37.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.956 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.563 ' OD1' ' HE2' ' A' ' 45' ' ' LYS . 9.9 t70 -156.94 -78.17 0.08 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.32 -31.63 4.38 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.58 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.563 ' HE2' ' OD1' ' A' ' 43' ' ' ASP . 33.7 mtmt -85.37 115.44 23.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.943 0.401 . . . . 0.0 110.438 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.489 HG13 HD11 ' A' ' 87' ' ' LEU . 10.3 t -131.47 149.39 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.91 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.502 HD13 ' O ' ' A' ' 88' ' ' VAL . 2.2 mm -101.34 140.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.529 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -107.13 179.71 4.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.886 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.801 ' OD2' HD12 ' A' ' 55' ' ' LEU . 84.0 m-20 -120.35 -179.65 4.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.26 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 8.6 t -75.44 -6.44 50.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.257 1.027 . . . . 0.0 109.161 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.509 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 4.2 t -92.53 -15.55 8.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.884 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.38 -1.4 76.32 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.2 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.509 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -88.54 161.04 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.237 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.51 HG23 ' HG3' ' A' ' 48' ' ' LYS . 16.6 t -115.04 135.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.48 -173.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.801 HD12 ' OD2' ' A' ' 49' ' ' ASP . 3.1 mp -103.18 -178.19 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 110.853 -168.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.52 ' HA ' HD13 ' A' ' 87' ' ' LEU . 8.5 tt0 -132.07 157.82 43.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.425 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -73.87 133.85 43.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 172.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.441 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 90.07 -9.47 77.25 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.573 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.06 169.2 18.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.709 0.29 . . . . 0.0 110.909 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.554 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 4.6 m -105.02 135.98 45.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.425 ' CG2' HD13 ' A' ' 85' ' ' ILE . 1.8 pp -124.04 168.96 15.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.42 ' N ' HD11 ' A' ' 61' ' ' ILE . 2.8 m -150.14 117.92 6.22 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.48 0.312 . . . . 0.0 110.675 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.695 HG12 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.01 131.24 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 176.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.527 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -100.11 16.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -135.73 158.15 45.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -85.94 104.83 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.983 0.897 . . . . 0.0 111.361 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.436 HD12 ' CB ' ' A' ' 110' ' ' PHE . 18.5 mt -119.98 146.44 45.84 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.474 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -85.62 175.13 8.94 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.378 0.608 . . . . 0.0 111.415 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 76' ' ' VAL . 85.3 t -120.99 128.82 76.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -92.08 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.314 0.506 . . . . 0.0 110.635 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.35 -21.22 22.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.588 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -115.95 157.94 23.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -87.59 5.47 39.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.039 0.447 . . . . 0.0 110.867 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.73 136.6 34.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.565 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.32 134.79 44.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.166 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.695 HG12 HG12 ' A' ' 63' ' ' VAL . 59.2 t -85.92 101.71 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.536 0.684 . . . . 0.0 109.665 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.65 148.46 25.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.438 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.527 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.92 96.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.874 0.845 . . . . 0.0 110.647 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.04 6.22 4.06 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.9 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.0 m -62.19 103.97 0.43 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.695 0.76 . . . . 0.0 109.669 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.75 111.85 23.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.409 HG13 ' HB3' ' A' ' 96' ' ' CYS . 46.2 t -117.62 115.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 50.1 pttt -101.8 149.87 23.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.779 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.441 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 46.7 m-80 68.91 48.05 0.75 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.098 0.874 . . . . 0.0 111.245 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.604 HG22 ' SG ' ' A' ' 96' ' ' CYS . 44.5 pt -66.58 -175.53 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 122.064 0.935 . . . . 0.0 112.085 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -136.24 129.21 31.22 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.276 173.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.52 HD13 ' HA ' ' A' ' 56' ' ' GLN . 60.9 mt -83.06 122.55 28.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.502 ' O ' HD13 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -101.7 178.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.355 -176.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -79.92 91.94 5.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.761 0.791 . . . . 0.0 112.496 -174.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.35 -173.82 42.5 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.395 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -102.33 -29.21 11.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.515 0.658 . . . . 0.0 110.736 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.449 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 52.0 m80 -108.33 52.16 0.72 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.122 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.9 m-20 -142.53 93.18 2.49 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -158.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.622 ' CD1' HG22 ' A' ' 111' ' ' VAL . 42.5 mt -124.31 112.43 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.617 0.722 . . . . 0.0 112.004 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.18 133.77 40.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.662 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.604 ' SG ' HG22 ' A' ' 85' ' ' ILE . 16.1 m -143.75 146.37 33.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.339 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -106.12 129.63 54.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.707 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.44 HD13 ' HE2' ' A' ' 104' ' ' MET . 18.3 mt -130.24 107.35 14.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -76.18 96.07 3.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.03 -63.64 0.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.168 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 pt -98.56 -42.25 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.65 27.49 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.76 145.75 32.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.819 ' HE1' HD22 ' A' ' 106' ' ' LEU . 51.5 ttp -135.2 155.37 50.77 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.524 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.18 142.6 43.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.892 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.819 HD22 ' HE1' ' A' ' 104' ' ' MET . 85.1 mt -124.74 139.42 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.732 0.777 . . . . 0.0 111.872 -172.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -76.8 116.4 17.43 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.892 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 92' ' ' HIS . 2.8 t -46.89 -42.7 17.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.961 175.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.518 ' O ' ' HB2' ' A' ' 50' ' ' SER . 9.5 mt-10 -67.87 -13.34 62.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.778 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.473 ' O ' HD11 ' A' ' 64' ' ' ILE . 42.0 m-85 -113.03 3.16 16.02 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.622 HG22 ' CD1' ' A' ' 94' ' ' ILE . 32.9 m -114.24 168.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.294 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.474 ' HD2' HG21 ' A' ' 51' ' ' VAL . 18.4 ttt180 -149.24 128.44 12.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.53 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 9.9 tttp -59.5 132.78 55.03 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.478 173.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.7 -56.08 10.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.75 -8.09 19.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.417 177.405 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.681 ' HE1' ' HA ' ' A' ' 1' ' ' MET . 1.2 tpt . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.969 0.414 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.19 134.99 54.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.666 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.6 m -67.72 145.37 54.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.88 0.371 . . . . 0.0 110.849 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 t -83.54 33.04 0.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.607 0.718 . . . . 0.0 110.741 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 20.5 mt -109.22 167.76 8.67 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.528 -174.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 72.6 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.378 2.052 . . . . 0.0 111.033 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.5 -163.93 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.578 2.185 . . . . 0.0 112.709 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 5.0 t -98.88 128.24 32.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.1 8.55 1.04 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.789 2.326 . . . . 0.0 112.464 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.45 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 44.7 mt-30 -119.18 -37.84 3.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.9 m -110.03 -45.99 3.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.984 0.421 . . . . 0.0 109.886 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.86 2.23 3.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.592 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -48.47 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 169.86 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HE1' ' HB2' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -87.57 57.42 4.39 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.867 0.841 . . . . 0.0 110.765 -168.651 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -105.84 140.47 38.82 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.305 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 37.5 p90 -141.16 171.18 14.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.432 ' CD ' HD12 ' A' ' 5' ' ' LEU . 1.3 pm0 -100.94 114.56 28.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.928 0.394 . . . . 0.0 110.755 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.553 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 26.7 t70 -113.38 83.03 1.77 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.08 -108.35 3.65 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.339 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.87 19.65 16.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -170.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD12 ' HB3' ' A' ' 31' ' ' GLU . 1.4 pt? -162.3 -174.68 4.17 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.54 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 8.3 mt -106.39 132.58 52.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 31' ' ' GLU . 58.0 t -117.76 129.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 53.0 t -100.71 109.97 59.23 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.64 -16.31 46.44 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.703 2.268 . . . . 0.0 111.193 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.624 ' HB2' ' HE1' ' A' ' 15' ' ' TYR . 9.9 tp10 -69.36 -73.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.558 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -88.12 10.35 19.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 45.47 16.48 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -144.61 129.45 18.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.85 0.357 . . . . 0.0 110.23 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HB3' HD12 ' A' ' 22' ' ' LEU . 1.9 mp0 -90.42 152.68 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.429 ' NE1' HD11 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -155.26 161.31 41.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.542 ' HB3' ' OE1' ' A' ' 36' ' ' GLU . 59.3 m -121.66 130.42 24.78 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.54 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 14.3 Cg_endo -55.53 -38.55 93.97 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.412 2.741 . . . . 0.0 113.295 -169.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.29 -36.76 3.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.5 0.667 . . . . 0.0 109.783 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.542 ' OE1' ' HB3' ' A' ' 33' ' ' SER . 17.2 mp0 -67.09 -22.71 65.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.15 -169.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.91 -33.38 75.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 110.297 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.84 -62.25 1.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.092 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 t -179.1 178.62 0.71 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.141 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.68 95.25 3.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.908 0.385 . . . . 0.0 110.573 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.5 m -100.47 14.3 31.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.455 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -130.7 141.63 50.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.113 0.483 . . . . 0.0 110.542 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -127.24 -1.45 6.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.957 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.4 41.36 2.48 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.114 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.737 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -111.74 -41.29 4.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.871 0.367 . . . . 0.0 110.414 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.433 HG13 HD13 ' A' ' 87' ' ' LEU . 7.3 t -127.39 155.4 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.087 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.447 HG23 HG13 ' A' ' 94' ' ' ILE . 6.9 mm -93.35 138.75 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.617 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.4 ttmt -127.75 142.65 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.719 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.534 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 71.4 m-20 -100.28 -179.42 4.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.2 t -77.29 -5.65 50.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.867 0.842 . . . . 0.0 110.533 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.9 t -88.57 -16.1 8.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.727 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.8 -3.23 67.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.171 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.534 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -87.07 149.37 24.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.643 0.735 . . . . 0.0 111.859 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.526 HG23 ' HG3' ' A' ' 48' ' ' LYS . 3.6 t -104.7 136.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.345 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.596 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.1 mp -100.35 179.74 4.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.449 -169.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.444 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 12.4 tt0 -132.0 156.17 46.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.251 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -69.74 138.34 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 82.21 -4.91 74.52 Favored Glycine 0 C--N 1.316 -0.562 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.538 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -72.78 171.53 12.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.727 0.299 . . . . 0.0 110.337 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.601 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 91.9 m -109.27 137.15 47.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.9 169.54 12.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -149.4 117.17 6.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.942 0.401 . . . . 0.0 110.859 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -62.15 128.9 24.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.572 HG12 ' CD ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -100.51 15.56 4.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' CD ' HG12 ' A' ' 64' ' ' ILE . 2.4 mptm? -135.79 165.1 26.4 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.588 -0.695 . . . . 0.0 109.168 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.85 116.05 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.802 0.811 . . . . 0.0 111.51 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -130.08 147.6 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.281 174.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.28 175.32 6.89 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.117 -0.364 . . . . 0.0 110.343 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.49 134.49 61.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 2.2 mmmp? -43.14 -88.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.46 21.78 42.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.383 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 m -122.67 153.62 39.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.898 0.38 . . . . 0.0 110.627 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -83.31 6.57 19.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.1 131.23 34.76 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 120.865 0.364 . . . . 0.0 110.052 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.7 t -100.67 133.53 43.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.454 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG13 HG12 ' A' ' 63' ' ' VAL . 53.8 t -85.85 99.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.38 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.11 152.09 25.0 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.684 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -52.12 97.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.918 0.866 . . . . 0.0 110.991 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.65 4.73 3.81 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.491 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 87.0 m -62.38 105.68 0.65 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.672 0.748 . . . . 0.0 110.627 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.31 113.34 24.6 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.052 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.468 HG12 ' HB2' ' A' ' 96' ' ' CYS . 43.0 t -122.02 117.01 50.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.601 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 13.4 ptmm? -106.23 153.68 21.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.199 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.5 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 71.95 42.38 0.61 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.337 173.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.6 pt -67.27 -177.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 122.25 1.024 . . . . 0.0 113.602 178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -128.9 126.21 39.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.765 -1.561 . . . . 0.0 108.429 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.433 HD13 HG13 ' A' ' 46' ' ' VAL . 81.8 mt -80.26 122.87 27.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 93' ' ' ASP . 2.6 t -76.32 132.92 32.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.488 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.14 78.68 2.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.17 -169.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.56 -65.58 0.54 Allowed Glycine 0 C--N 1.297 -1.631 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.2 169.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -79.59 151.15 30.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -84.34 45.98 1.17 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -168.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.526 ' O ' HG21 ' A' ' 88' ' ' VAL . 10.7 m-20 -98.26 165.78 11.71 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.191 0.905 . . . . 0.0 111.543 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.577 ' CD1' HG21 ' A' ' 111' ' ' VAL . 63.4 mt -114.33 116.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.146 171.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -94.69 133.27 38.54 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.357 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.468 ' HB2' HG12 ' A' ' 82' ' ' VAL . 27.1 p -145.46 159.86 42.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.609 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -118.36 134.57 54.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.006 176.4 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.0 mt -120.57 107.16 20.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.934 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -63.35 107.17 1.03 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.94 -46.34 0.86 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.937 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.3 pt -117.98 -38.83 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.69 0.281 . . . . 0.0 110.826 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.85 -157.09 24.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.378 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.8 149.62 23.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.969 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -153.99 171.54 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.468 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 19.0 ptmt -120.74 151.27 39.76 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.717 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.1 mt -127.32 140.32 52.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.27 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.422 ' HD3' ' CE2' ' A' ' 110' ' ' PHE . 76.5 tttt -82.31 117.61 22.52 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.132 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.617 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 1.4 p -50.86 -37.06 41.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.625 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -69.5 -7.33 37.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.309 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.51 ' O ' HD11 ' A' ' 64' ' ' ILE . 66.6 m-85 -113.46 -2.87 13.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.761 -0.587 . . . . 0.0 112.001 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.652 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 m -116.94 173.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 112.38 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.489 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.8 ttt180 -143.22 137.19 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.023 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.596 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 14.3 tttp -70.55 135.81 48.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.695 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.77 -58.56 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.905 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.75 34.93 3.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.235 178.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' HE3' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.88 0.371 . . . . 0.0 111.657 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.92 3.52 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.558 0.694 . . . . 0.0 110.92 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 m -66.01 138.02 57.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.909 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.3 t -103.56 16.52 26.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.558 0.694 . . . . 0.0 109.754 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.15 150.86 85.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.164 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.69 161.83 42.88 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.863 2.375 . . . . 0.0 111.748 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -64.57 -169.43 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.353 2.036 . . . . 0.0 112.385 174.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -98.81 129.13 30.57 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.969 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.435 ' HG3' ' CE3' ' A' ' 32' ' ' TRP . 55.8 Cg_endo -69.11 7.25 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.692 2.261 . . . . 0.0 112.214 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.528 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 44.5 mt-30 -117.7 -39.32 3.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.479 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.402 ' C ' ' H ' ' A' ' 13' ' ' SER . 59.7 m -106.2 -45.83 4.21 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 70.44 -3.3 1.91 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.851 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.7 m -55.34 -77.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.711 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.507 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.2 pt-20 164.31 -7.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.69 0.618 . . . . 0.0 112.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.661 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 61.1 m-85 -80.64 41.56 0.56 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 111.406 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -104.24 148.1 26.72 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.453 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 41.2 p90 -148.9 174.79 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.92 117.76 34.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.808 0.337 . . . . 0.0 111.108 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.532 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 14.7 t70 -115.75 79.07 1.24 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.97 -107.97 3.59 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.319 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.19 17.71 19.27 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -157.75 -175.46 5.39 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 16.2 mt -107.92 130.06 55.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG21 ' HB3' ' A' ' 31' ' ' GLU . 52.2 t -116.9 127.39 74.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.516 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.2 t -102.7 105.41 44.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.661 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 44.8 Cg_endo -69.76 -12.5 33.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.565 2.177 . . . . 0.0 110.785 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 36.0 tt0 -68.7 -59.06 3.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.081 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.09 14.52 31.7 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.6 27.77 16.35 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -140.66 142.25 34.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.402 ' HB3' HG21 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -98.15 177.38 5.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.492 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -172.28 161.88 5.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.588 ' HB3' ' HB2' ' A' ' 36' ' ' GLU . 1.8 t -119.07 129.85 25.17 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.492 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 12.2 Cg_endo -54.82 -47.79 24.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.274 2.649 . . . . 0.0 113.338 -170.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -104.91 -31.37 9.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.389 0.614 . . . . 0.0 110.811 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.588 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 16.8 mp0 -77.88 -3.07 39.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.542 -175.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.15 -49.78 63.58 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.68 -32.75 31.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 109.92 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.7 m 67.4 -85.17 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.58 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 175.1 50.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -174.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 p -69.03 88.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.989 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 t70 68.11 177.99 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.847 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.53 ' HB2' ' HD2' ' A' ' 45' ' ' LYS . 15.5 m-20 -109.49 -18.35 13.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.622 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.58 57.16 2.5 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.879 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' HD2' ' HB2' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -82.65 -37.36 24.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.0 110.331 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.7 p -87.91 125.98 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.601 HG21 HG13 ' A' ' 94' ' ' ILE . 5.3 mm -76.97 137.38 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.823 -170.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.505 ' HG3' HG23 ' A' ' 54' ' ' VAL . 1.6 ttmt -124.86 177.37 6.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.661 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 19.2 m-20 -113.16 179.26 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.531 ' HB3' HD13 ' A' ' 64' ' ' ILE . 44.8 t -82.16 -8.29 59.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.015 171.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 2.9 t -91.07 -17.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.141 -1.39 . . . . 0.0 109.347 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.68 -0.8 52.57 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.235 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.507 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -83.46 167.33 17.55 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.022 0.915 . . . . 0.0 111.283 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.505 HG23 ' HG3' ' A' ' 48' ' ' LYS . 10.0 t -116.84 136.53 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.775 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -97.04 175.83 6.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.342 0.591 . . . . 0.0 110.64 -172.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -131.4 151.12 51.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.024 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.524 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 15.6 t70 -72.62 91.92 1.48 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 133.69 -14.29 4.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.75 169.11 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.7 0.286 . . . . 0.0 111.013 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.652 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 22.2 m -100.12 137.27 38.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.5 pp -125.81 165.43 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.172 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.4 m -147.31 125.39 12.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.052 0.453 . . . . 0.0 111.894 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.546 HG13 HG11 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -67.77 129.57 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.611 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.587 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.72 19.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.2 mptm? -138.69 160.81 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.964 0.802 . . . . 0.0 108.876 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -87.67 114.07 23.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.141 0.972 . . . . 0.0 112.433 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 3.8 mp -124.88 149.74 47.21 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.308 170.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -89.41 179.07 6.16 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.778 -0.576 . . . . 0.0 111.153 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.621 HG23 HG22 ' A' ' 76' ' ' VAL . 9.6 t -132.05 130.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 141.15 33.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.32 -16.35 3.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.881 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.9 p -106.7 172.79 6.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.136 0.493 . . . . 0.0 111.158 -175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -97.12 16.79 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mp -91.75 171.79 8.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -159.27 117.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.621 HG22 HG23 ' A' ' 69' ' ' VAL . 93.9 t -82.01 94.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.785 0.802 . . . . 0.0 109.497 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 146.78 32.93 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -47.98 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.937 0.875 . . . . 0.0 110.896 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.09 7.74 3.96 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.179 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.4 m -62.7 104.21 0.51 Allowed 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 121.694 0.759 . . . . 0.0 109.52 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.2 113.93 26.34 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.346 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.6 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -132.02 118.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 61.9 pttt -110.04 170.39 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.559 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 89.9 m-20 66.82 34.17 5.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.216 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 23.2 pt -64.57 175.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 122.195 0.997 . . . . 0.0 113.513 -174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -119.16 122.18 41.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.232 174.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 89.7 mt -74.83 118.92 18.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 93' ' ' ASP . 5.3 t -74.45 136.67 24.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-O 121.633 0.73 . . . . 0.0 111.637 -171.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.33 33.05 0.82 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.625 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.52 -88.86 0.13 Allowed Glycine 0 C--N 1.303 -1.273 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.999 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -94.6 -179.05 4.75 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.497 ' HD2' ' HB3' ' A' ' 108' ' ' SER . 38.5 p-80 -89.09 46.58 1.4 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.763 0.316 . . . . 0.0 111.577 -175.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.561 ' O ' HG21 ' A' ' 88' ' ' VAL . 16.6 m-20 -100.49 162.89 12.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.377 0.608 . . . . 0.0 111.944 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.601 HG13 HG21 ' A' ' 47' ' ' ILE . 4.9 mp -105.44 119.91 55.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.464 172.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.3 t70 -94.31 130.78 40.47 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.887 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.6 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.1 p -140.37 151.4 44.94 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.284 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -105.43 122.13 45.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.432 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.0 mt -122.63 107.78 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.255 0.55 . . . . 0.0 110.585 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -69.34 105.72 2.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.522 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.3 -37.96 0.79 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.234 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 pt -132.28 -38.49 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.863 0.363 . . . . 0.0 110.688 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.89 -153.67 23.92 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.734 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.57 24.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.722 0.261 . . . . 0.0 110.698 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.453 ' HG2' ' N ' ' A' ' 105' ' ' LYS . 49.4 ttm -142.0 164.05 31.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.143 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.532 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -117.57 139.08 51.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.05 138.76 52.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.499 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 14.6 tptm -72.25 125.03 26.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.884 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.497 ' HB3' ' HD2' ' A' ' 92' ' ' HIS . 28.8 t -52.1 -27.63 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.179 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.558 ' HG2' ' HG3' ' A' ' 107' ' ' LYS . 10.9 pt-20 -87.1 -5.27 59.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.997 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.418 ' O ' HD11 ' A' ' 64' ' ' ILE . 35.5 m-85 -116.59 7.69 13.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.341 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.508 HG12 HD11 ' A' ' 94' ' ' ILE . 34.0 m -111.91 162.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.41 ' CG ' HG23 ' A' ' 51' ' ' VAL . 28.2 ttt180 -141.25 135.26 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.97 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -67.46 140.88 57.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.178 0.513 . . . . 0.0 110.914 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.99 -69.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.816 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.99 51.14 9.34 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.838 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.0 m . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.071 178.866 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.664 ' HE1' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.695 0.283 . . . . 0.0 110.278 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.0 t -102.35 125.25 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.685 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 t -165.15 176.28 8.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.693 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -117.24 15.16 14.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.412 0.625 . . . . 0.0 110.231 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.456 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 60.9 mt -90.15 163.17 32.72 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.143 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 68.5 Cg_endo -71.2 159.99 50.33 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.264 1.976 . . . . 0.0 111.264 175.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.73 -163.67 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.649 2.233 . . . . 0.0 112.376 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 7.9 t -98.49 127.64 35.4 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.693 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 7.89 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.329 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.445 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 9.7 tt0 -122.05 -32.84 3.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.278 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.14 -45.25 3.62 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.667 -0.645 . . . . 0.0 109.984 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t30 69.95 -2.81 1.92 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.698 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.9 p -45.27 -77.06 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB3' ' O ' ' A' ' 13' ' ' SER . 10.7 pt-20 161.85 -15.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.808 0.693 . . . . 0.0 111.06 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.598 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m-85 -81.97 45.57 0.93 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.374 0.606 . . . . 0.0 111.043 -171.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -104.85 143.2 33.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.693 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.74 176.6 10.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.31 126.77 53.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.382 0.611 . . . . 0.0 110.819 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.27 82.07 1.75 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.112 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -112.58 4.33 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.39 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.79 17.32 22.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.476 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -154.0 -174.57 5.01 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 15.9 mt -114.5 136.46 52.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.737 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -127.87 142.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.861 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 46.6 t -104.62 106.99 56.9 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.598 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.8 Cg_endo -66.88 -14.0 42.09 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.763 2.309 . . . . 0.0 111.423 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.472 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 29.8 tt0 -73.15 -61.32 1.86 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.02 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.9 p -97.81 10.9 38.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.33 45.41 20.16 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -135.88 124.12 23.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.729 0.299 . . . . 0.0 110.516 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.737 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 34.6 mt-10 -93.3 143.57 26.14 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.11 161.99 41.79 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 120.807 0.337 . . . . 0.0 110.121 -176.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.3 p -112.05 132.76 21.88 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.539 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 9.9 Cg_endo -52.95 -44.48 48.27 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.336 2.69 . . . . 0.0 113.284 -169.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.417 HD21 ' C ' ' A' ' 34' ' ' PRO . 0.9 OUTLIER -124.61 -27.58 3.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.254 0.549 . . . . 0.0 110.757 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 2.4 mp0 -67.12 -24.41 65.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.372 -176.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.48 -37.35 86.59 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.992 0.425 . . . . 0.0 110.574 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.07 -36.44 35.59 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 m 70.24 151.22 0.09 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.281 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.92 99.88 12.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.771 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.2 t -77.09 100.36 5.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.84 162.14 35.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.594 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.56 -12.88 38.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.647 0.261 . . . . 0.0 111.062 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.618 ' HA3' ' HA2' ' A' ' 90' ' ' GLY . . . 90.92 58.37 1.5 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -174.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -86.92 -28.2 22.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.741 0.305 . . . . 0.0 111.225 -174.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.452 HG21 HD13 ' A' ' 87' ' ' LEU . 13.7 p -136.59 148.12 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.936 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.587 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.144 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.505 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -107.27 177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 0.0 111.202 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.58 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 6.6 m-20 -118.22 174.45 6.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.867 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.556 ' HB3' HD12 ' A' ' 64' ' ' ILE . 27.5 t -70.62 -7.11 41.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.836 0.827 . . . . 0.0 110.696 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.473 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.0 t -88.93 -16.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.854 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 2.22 65.35 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.668 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -93.66 162.82 13.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.332 0.587 . . . . 0.0 111.477 178.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 t -114.46 136.25 51.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.454 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.489 HD23 HG23 ' A' ' 61' ' ' ILE . 13.1 mt -93.57 174.96 6.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.398 0.618 . . . . 0.0 112.002 -170.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.3 tt0 -125.64 147.18 49.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.581 175.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.4 105.68 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.045 0.926 . . . . 0.0 109.436 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.581 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 114.14 -2.46 23.99 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.0 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.459 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.8 t70 -76.59 169.31 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.6 m -105.53 137.03 44.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.489 HG23 HD23 ' A' ' 55' ' ' LEU . 2.0 pp -120.7 166.4 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -148.08 119.84 8.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.929 0.395 . . . . 0.0 110.773 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.621 HG12 HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -62.39 126.34 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.556 HD12 ' HB3' ' A' ' 50' ' ' SER . 0.2 OUTLIER -100.12 17.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.227 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.544 ' HD3' HG12 ' A' ' 64' ' ' ILE . 1.8 mppt? -141.77 165.18 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.75 -0.594 . . . . 0.0 109.517 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.505 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.0 p-10 -83.21 113.94 21.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.596 0.713 . . . . 0.0 111.484 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.559 HD22 ' CD1' ' A' ' 110' ' ' PHE . 23.9 mt -126.53 140.44 52.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.694 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -91.22 174.16 7.54 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.225 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 72' ' ' SER . 38.7 t -124.91 126.37 71.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -88.49 -36.19 16.59 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.14 -32.37 52.63 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.125 -1.035 . . . . 0.0 111.575 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.489 ' HB2' HG13 ' A' ' 69' ' ' VAL . 37.2 m -107.04 175.74 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.343 -0.429 . . . . 0.0 111.145 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -98.19 -4.78 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.058 0.456 . . . . 0.0 110.561 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mp -77.3 143.25 38.97 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.829 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.64 125.73 66.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.284 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.621 HG11 HG12 ' A' ' 63' ' ' VAL . 69.5 t -78.72 116.7 22.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.557 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.416 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -111.76 147.45 35.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.41 -175.096 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.534 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.31 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.924 0.868 . . . . 0.0 110.654 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.28 7.51 3.96 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.716 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -62.84 104.64 0.57 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.536 0.684 . . . . 0.0 109.657 174.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -89.67 115.83 27.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.847 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG12 ' HB2' ' A' ' 96' ' ' CYS . 38.5 t -125.01 115.16 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 21.4 ptmt -99.87 157.15 16.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.382 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.581 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 93.6 m-20 66.27 45.17 2.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.659 173.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 31.1 pt -65.57 176.22 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 122.0 0.905 . . . . 0.0 113.38 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.521 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 21.8 tpp180 -130.26 131.95 45.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.831 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.452 HD13 HG21 ' A' ' 46' ' ' VAL . 15.8 mt -79.18 114.7 18.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.551 ' O ' ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -115.52 126.02 72.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.344 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.88 29.05 5.6 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 154.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.618 ' HA2' ' HA3' ' A' ' 44' ' ' GLY . . . 139.42 -137.86 8.86 Favored Glycine 0 C--N 1.304 -1.2 0 C-N-CA 119.215 -1.469 . . . . 0.0 115.885 171.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -104.19 -34.62 8.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.111 -0.544 . . . . 0.0 112.079 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -105.53 55.16 0.69 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.273 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.551 ' HB3' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -163.98 98.22 0.85 Allowed 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -167.21 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.587 HG13 HG21 ' A' ' 47' ' ' ILE . 3.7 mp -112.15 117.21 54.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.98 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.2 t70 -93.78 131.68 38.91 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.621 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.542 ' HB2' HG12 ' A' ' 82' ' ' VAL . 18.3 p -144.74 156.15 43.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.91 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 131.39 55.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.893 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.44 110.5 27.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.944 0.402 . . . . 0.0 110.028 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.16 102.94 1.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.299 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.09 -42.86 0.8 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.634 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.31 -42.19 2.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.06 0.457 . . . . 0.0 110.398 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.05 -154.17 23.75 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.86 149.44 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.312 0.556 . . . . 0.0 110.453 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.1 ttp -146.45 165.08 30.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.049 0.452 . . . . 0.0 110.95 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -114.03 138.65 50.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.866 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 81.0 mt -119.15 142.11 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.311 0.577 . . . . 0.0 111.437 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 66.1 mmtt -80.65 124.72 29.24 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.042 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.4 t -48.96 -43.66 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.981 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.449 ' C ' ' HB2' ' A' ' 50' ' ' SER . 1.5 pm0 -74.71 0.44 15.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.576 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.559 ' CD1' HD22 ' A' ' 67' ' ' LEU . 76.8 m-85 -119.72 2.64 11.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.45 -0.781 . . . . 0.0 112.993 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.58 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 34.1 m -114.04 172.93 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.193 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.443 ' CG ' HG23 ' A' ' 51' ' ' VAL . 10.9 ttt-85 -149.83 138.1 20.53 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.58 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -73.97 120.44 19.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.15 -46.55 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.907 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.49 11.35 82.11 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.177 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.228 -179.304 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.5 ttp . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.04 144.87 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -67.46 130.84 44.34 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 t -147.34 10.41 0.98 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.415 0.626 . . . . 0.0 110.632 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.402 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 84.9 mt -102.0 157.21 34.13 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -67.75 155.12 71.2 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 121.81 1.673 . . . . 0.0 111.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.58 -170.85 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.71 2.273 . . . . 0.0 112.371 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -97.94 123.41 51.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.767 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.16 6.96 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.814 2.343 . . . . 0.0 112.269 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.476 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 49.2 mt-30 -115.36 -38.7 3.74 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.388 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -109.42 -48.19 3.28 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 72.03 -1.97 2.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.81 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 23.5 p -48.73 -76.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.53 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.5 pt-20 164.98 -13.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.584 0.553 . . . . 0.0 111.589 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.574 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 56.6 m-85 -78.7 35.32 0.24 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.083 0.468 . . . . 0.0 111.541 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 ' H ' ' C ' ' A' ' 14' ' ' GLU . 3.0 m -97.83 138.94 34.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.047 179.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -147.26 174.8 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.06 130.84 55.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.254 0.55 . . . . 0.0 110.97 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -122.87 84.47 2.27 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.535 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.91 -110.27 3.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.363 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.09 19.92 17.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.872 -171.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.59 -173.82 4.57 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.569 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 23.7 mt -114.21 137.42 51.79 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.83 142.41 43.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.0 t -106.3 106.7 58.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.908 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.574 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 39.0 Cg_endo -67.84 -10.16 27.93 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.804 2.336 . . . . 0.0 111.212 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.481 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 31.6 tt0 -75.74 -61.41 1.93 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.679 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.58 9.78 42.47 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.37 26.55 15.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -123.12 133.68 54.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.113 0.482 . . . . 0.0 111.214 175.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.28 162.6 14.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.607 176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -162.09 162.54 28.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.0 t -109.65 134.84 20.46 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.2 Cg_endo -60.49 -23.85 76.38 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.489 2.126 . . . . 0.0 112.533 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -131.2 -41.79 1.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 111.524 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -80.08 -0.9 37.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.04 0.447 . . . . 0.0 111.28 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.83 -5.5 38.56 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.129 -0.357 . . . . 0.0 111.042 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.15 -20.28 64.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.571 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 m -67.08 153.49 43.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.465 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.97 111.09 11.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.811 0.339 . . . . 0.0 110.636 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.7 m -81.71 100.31 9.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.042 0.449 . . . . 0.0 109.993 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.419 ' HA ' ' NZ ' ' A' ' 45' ' ' LYS . 37.0 t70 -144.68 147.99 33.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.301 0.572 . . . . 0.0 111.801 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -129.35 -41.61 1.38 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.966 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.7 39.99 0.47 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.17 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' NZ ' ' HA ' ' A' ' 42' ' ' ASP . 29.2 mtmm -110.88 -31.65 7.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.332 0.587 . . . . 0.0 109.666 174.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.501 HG12 HD11 ' A' ' 87' ' ' LEU . 20.3 t -105.33 146.78 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.211 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.488 HG23 ' CG1' ' A' ' 94' ' ' ILE . 5.9 mm -85.22 134.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.807 0.337 . . . . 0.0 110.987 -174.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.651 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -112.18 149.36 32.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.211 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.554 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.6 m-20 -94.97 177.88 5.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.797 0.332 . . . . 0.0 110.633 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.468 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 32.8 t -72.57 -7.44 50.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.965 0.888 . . . . 0.0 110.536 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG21 ' CG ' ' A' ' 112' ' ' ARG . 3.0 t -88.23 -14.42 9.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.944 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.58 1.74 68.22 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.631 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -94.5 159.2 15.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.371 0.605 . . . . 0.0 111.6 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.8 t -108.75 135.14 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.053 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 61' ' ' ILE . 12.7 mt -92.14 178.96 5.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.053 0.454 . . . . 0.0 110.715 -175.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.935 ' HG2' ' HB2' ' A' ' 59' ' ' ASP . 9.1 pt20 -126.03 154.77 42.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' HD3' ' A' ' 86' ' ' ARG . 19.4 t70 -66.59 104.4 1.27 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 112.71 -0.28 26.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.787 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.935 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 2.7 t0 -78.96 171.59 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 33.0 m -106.22 137.52 44.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.465 HG21 HD21 ' A' ' 55' ' ' LEU . 2.1 pp -120.82 167.71 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.6 m -149.38 117.17 6.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.824 0.345 . . . . 0.0 110.382 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.742 HG12 HG13 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -59.69 128.89 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.439 176.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.533 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -100.65 17.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -137.38 161.91 35.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.678 -0.639 . . . . 0.0 109.321 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.502 ' O ' HD22 ' A' ' 67' ' ' LEU . 10.2 p-10 -84.13 109.77 17.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.744 0.783 . . . . 0.0 111.467 170.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.502 HD22 ' O ' ' A' ' 66' ' ' ASP . 21.7 mt -127.05 145.93 50.55 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.616 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -90.51 174.75 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.948 -0.47 . . . . 0.0 111.382 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.461 HG12 ' HB2' ' A' ' 72' ' ' SER . 49.7 t -123.25 130.21 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -73.76 -63.31 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.165 0.439 . . . . 0.0 112.016 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.57 -23.01 76.81 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.37 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.461 ' HB2' HG12 ' A' ' 69' ' ' VAL . 66.9 m -112.59 151.02 30.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -74.47 -0.22 16.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.17 0.51 . . . . 0.0 110.959 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.436 ' CD2' HG22 ' A' ' 101' ' ' ILE . 3.1 mm? -78.55 143.39 36.56 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.474 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -107.55 134.61 48.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.804 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.742 HG13 HG12 ' A' ' 63' ' ' VAL . 75.5 t -89.2 101.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.6 147.89 27.13 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.593 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.3 p -51.45 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.855 0.836 . . . . 0.0 110.935 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.84 4.52 4.21 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.914 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.5 105.02 0.57 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 110.368 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -91.47 114.16 26.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 96' ' ' CYS . 43.2 t -122.08 118.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.861 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.1 ptmt -98.53 156.22 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.435 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.474 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 85.3 m-20 63.08 49.91 3.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.325 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.8 pt -64.86 176.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.487 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 11.7 tpp180 -131.59 121.89 25.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.269 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD11 HG12 ' A' ' 46' ' ' VAL . 22.8 mt -85.96 126.24 33.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.091 0.405 . . . . 0.0 109.919 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.64 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -103.42 -179.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.763 -178.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.49 -42.62 99.62 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -171.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.583 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . -82.72 162.12 40.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.572 -176.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -72.07 -31.47 66.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.52 0.676 . . . . 0.0 110.017 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -89.8 46.25 1.35 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.788 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.64 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 5.0 m-20 -145.57 88.02 1.82 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -164.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 106' ' ' LEU . 30.9 mt -119.96 108.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.217 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 16.6 t70 -95.72 103.77 15.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.53 0.681 . . . . 0.0 109.263 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.511 ' HB2' HG12 ' A' ' 82' ' ' VAL . 28.6 p -107.35 157.79 17.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.344 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 21.6 pttp -118.03 138.47 52.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.505 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.2 104.92 14.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.86 100.54 0.21 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.176 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.16 -64.86 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.647 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.444 HG13 ' N ' ' A' ' 102' ' ' GLY . 40.5 pt -89.88 -46.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.383 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.444 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.15 -162.21 27.86 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 176.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -83.61 149.66 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.025 0.441 . . . . 0.0 110.985 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.464 ' HE3' HD23 ' A' ' 106' ' ' LEU . 54.9 ttp -136.82 153.51 50.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -98.84 146.44 25.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 95.5 mt -129.75 134.31 47.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.502 0.668 . . . . 0.0 111.765 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -81.28 114.73 20.27 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.596 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.651 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.4 p -52.69 -37.46 58.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.421 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 50' ' ' SER . 39.1 mt-10 -71.37 -3.84 22.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.863 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.451 ' O ' HD13 ' A' ' 64' ' ' ILE . 66.6 m-85 -118.58 4.5 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.562 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.4 m -117.24 175.28 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.935 0.398 . . . . 0.0 112.064 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.459 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.4 ttt180 -147.7 141.59 25.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.562 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.405 ' HB2' HD23 ' A' ' 55' ' ' LEU . 85.2 tttt -72.52 121.9 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.995 174.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.08 -54.59 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.031 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.71 -9.34 55.38 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.571 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.344 179.004 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 121.342 0.591 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.69 126.34 47.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.57 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -88.6 70.07 8.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.181 0.515 . . . . 0.0 110.816 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.3 p -126.9 117.75 23.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.7 mt -110.1 152.3 43.03 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.825 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.22 157.76 56.4 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.276 1.984 . . . . 0.0 111.243 176.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -66.3 -168.01 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.666 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 44.5 t -99.55 123.87 46.49 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.713 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.26 5.53 1.85 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.32 2.013 . . . . 0.0 111.724 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.666 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 42.2 mt-30 -105.44 -47.19 4.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.48 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -124.32 -33.42 3.05 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.891 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 70.81 11.84 7.15 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.402 0.62 . . . . 0.0 111.026 178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.455 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 38.7 m -58.0 -25.76 61.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.285 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 13' ' ' SER . 89.2 mt-10 86.39 10.42 0.21 Allowed 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 111.504 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.428 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 85.5 m-85 -89.11 52.1 2.31 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.558 0.694 . . . . 0.0 109.387 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 m -105.24 149.8 25.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.713 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 48.3 p90 -150.52 177.1 10.34 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.83 128.24 52.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.794 0.33 . . . . 0.0 110.175 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -113.78 25.68 11.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.75 -114.82 0.85 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.388 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.88 14.38 29.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.645 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.433 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.2 pt? -150.0 -175.69 5.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.042 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mt -118.23 141.07 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.88 147.02 33.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.792 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 43.6 t -101.74 111.48 64.05 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.454 ' HD3' ' CE2' ' A' ' 17' ' ' TYR . 23.6 Cg_endo -62.01 -22.64 74.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.882 2.388 . . . . 0.0 111.454 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.486 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 22.4 tt0 -76.79 -59.61 2.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.022 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.9 m -76.86 -4.85 45.82 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.63 37.32 28.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -141.25 135.22 30.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.011 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB3' HD13 ' A' ' 22' ' ' LEU . 21.6 mp0 -91.87 160.88 15.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.013 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -159.55 162.0 35.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.368 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -117.53 134.18 23.19 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -63.93 -26.92 66.69 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.607 2.205 . . . . 0.0 113.352 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -133.63 -44.74 0.82 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.76 0.314 . . . . 0.0 111.597 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.1 -17.85 63.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.065 -174.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.69 -19.73 65.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.482 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.3 -49.31 50.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.246 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.6 p -127.94 111.6 13.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.899 0.381 . . . . 0.0 111.524 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.67 16.56 5.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.304 0.573 . . . . 0.0 110.203 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.1 m -94.83 16.71 15.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.16 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -143.03 152.97 42.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.495 ' OD2' ' HB3' ' A' ' 45' ' ' LYS . 25.5 t70 -101.87 -19.25 15.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.323 0.582 . . . . 0.0 110.675 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.72 27.7 60.43 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.695 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.495 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 57.2 pttt -97.33 -21.27 17.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.641 0.257 . . . . 0.0 111.271 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.52 134.75 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.218 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.528 HG22 HG12 ' A' ' 94' ' ' ILE . 32.3 mm -73.54 122.02 25.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.404 -174.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 6.1 ttmt -119.03 137.39 53.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.613 -177.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.579 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 80.8 m-20 -92.88 -175.84 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.345 -169.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 16.7 t -77.1 -5.9 50.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.219 1.009 . . . . 0.0 110.269 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 112' ' ' ARG . 6.5 t -89.02 -21.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.18 -6.46 68.86 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.821 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.579 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -79.13 146.35 33.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.539 0.685 . . . . 0.0 111.179 178.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.409 HG21 ' HG3' ' A' ' 48' ' ' LYS . 4.3 t -102.94 134.74 43.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.522 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.642 ' HA ' ' HD2' ' A' ' 113' ' ' LYS . 7.1 mp -96.42 173.61 7.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.28 -169.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.549 ' NE2' ' H ' ' A' ' 57' ' ' ASP . 29.9 tp60 -126.04 149.26 48.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.373 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.549 ' H ' ' NE2' ' A' ' 56' ' ' GLN . 13.4 t70 -65.15 130.16 42.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.27 -4.55 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.231 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 56' ' ' GLN . 1.1 t70 -73.52 175.73 6.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.129 0.465 . . . . 0.0 110.911 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.0 m -106.31 138.69 42.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.73 166.14 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -150.47 113.84 4.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.717 0.294 . . . . 0.0 110.512 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -61.05 125.82 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.521 HD11 ' O ' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -97.43 14.35 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.499 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 2.4 mptm? -137.81 160.71 38.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.16 116.17 24.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.547 0.689 . . . . 0.0 111.848 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.521 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 5.1 mp -129.63 146.51 51.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.973 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -92.76 179.38 5.5 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.507 -0.746 . . . . 0.0 110.574 173.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.94 128.2 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -91.6 136.95 32.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.698 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 -27.19 3.36 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.494 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.653 ' HB3' HD22 ' A' ' 74' ' ' LEU . 66.2 m -105.32 155.36 19.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.624 0.249 . . . . 0.0 110.374 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -84.15 12.23 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.234 0.54 . . . . 0.0 110.374 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.653 HD22 ' HB3' ' A' ' 72' ' ' SER . 3.9 mm? -78.35 170.83 15.99 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.002 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -158.93 117.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -171.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.561 HG13 HG13 ' A' ' 63' ' ' VAL . 86.5 t -91.73 95.92 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.599 0.714 . . . . 0.0 110.564 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.24 145.8 33.77 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.038 -0.414 . . . . 0.0 111.17 -176.048 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.512 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -47.63 98.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 124.074 0.858 . . . . 0.0 111.392 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.07 7.14 3.76 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.262 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.427 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.0 m -63.07 104.19 0.54 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.759 0.79 . . . . 0.0 110.032 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.92 114.59 27.19 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.098 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.554 HG13 ' HB2' ' A' ' 96' ' ' CYS . 39.4 t -131.37 121.06 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.662 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 56.8 pttt -107.9 166.99 10.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.731 0.777 . . . . 0.0 112.959 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.504 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER 71.1 36.7 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.203 172.345 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.3 pt -66.71 -178.11 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.764 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 0.3 OUTLIER -130.63 131.05 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.895 174.802 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.7 110.83 6.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 90' ' ' GLY . 1.5 t -77.5 148.28 6.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.513 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -78.12 -20.36 52.28 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.555 ' H ' HG12 ' A' ' 88' ' ' VAL . . . -59.29 137.01 50.48 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.571 170.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -24.23 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -166.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.505 ' O ' HG23 ' A' ' 47' ' ' ILE . 54.6 m170 -109.92 2.67 19.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.422 ' O ' HD11 ' A' ' 47' ' ' ILE . 37.2 m-20 -86.49 -169.72 2.76 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -160.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.541 ' CD1' HG22 ' A' ' 111' ' ' VAL . 69.7 mt -140.62 126.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.694 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.764 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.8 t70 -93.04 126.29 38.06 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.554 ' HB2' HG13 ' A' ' 82' ' ' VAL . 20.1 p -134.58 141.6 46.7 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.009 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.449 ' HD2' ' HB3' ' A' ' 84' ' ' ASN . 11.4 ptpt -98.93 114.73 27.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.49 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.7 mt -116.98 104.94 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.403 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -47.66 130.35 14.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.639 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.2 -73.93 0.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.864 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 102' ' ' GLY . 32.6 pt -80.67 -46.27 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.774 0.321 . . . . 0.0 111.203 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.443 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 134.44 -146.33 18.33 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -88.57 155.97 19.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.101 0.45 . . . . 0.0 111.031 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.0 ttp -149.37 164.61 34.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.21 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 72.6 mttt -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.704 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.13 153.86 20.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.116 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HD2' ' HA ' ' A' ' 107' ' ' LYS . 13.5 tptt -83.9 114.22 21.52 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.072 174.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.639 ' HA ' HG21 ' A' ' 111' ' ' VAL . 88.7 p -53.88 -39.54 65.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.132 0.968 . . . . 0.0 109.627 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 50' ' ' SER . 41.1 mt-10 -64.86 -3.39 3.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.539 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.521 ' O ' HD11 ' A' ' 64' ' ' ILE . 35.7 m-85 -117.23 0.74 12.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 171.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 19.2 m -121.24 178.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.467 0.651 . . . . 0.0 112.396 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.482 ' HD2' HG23 ' A' ' 51' ' ' VAL . 6.9 ttt180 -144.11 133.12 22.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.944 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.642 ' HD2' ' HA ' ' A' ' 55' ' ' LEU . 88.0 tttt -65.87 121.3 14.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.526 173.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.6 -65.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.29 33.01 6.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.804 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.507 -0.759 . . . . 0.0 110.189 -179.825 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.719 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 1.9 tpt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.826 0.346 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.65 135.53 13.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.929 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -73.65 120.33 19.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.521 . . . . 0.0 111.422 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -102.94 107.81 18.76 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 170.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.9 mt -101.02 151.49 37.64 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.382 -174.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.7 160.21 46.86 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.643 2.229 . . . . 0.0 111.345 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.56 -166.44 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.0 112.432 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 8.5 t -98.17 121.95 55.62 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.11 6.61 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.681 2.254 . . . . 0.0 112.199 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.548 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 9.1 tt0 -119.89 -34.28 3.77 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -112.22 -43.53 3.53 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.816 0.735 . . . . 0.0 110.15 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.7 t30 73.19 2.9 4.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.889 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 23.3 p -65.0 -35.44 81.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.696 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 13' ' ' SER . 2.4 mt-10 85.74 25.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.13 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -70.92 2.25 4.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.788 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.4 m -58.42 145.73 37.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.807 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 46.3 p90 -153.27 174.82 13.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.85 111.36 23.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.104 0.478 . . . . 0.0 111.26 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.495 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.9 t0 -108.49 74.16 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.39 -112.82 4.56 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.828 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.69 16.96 23.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -172.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -156.01 -174.45 4.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.415 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 mt -110.51 134.23 52.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.416 HG13 ' HG3' ' A' ' 31' ' ' GLU . 85.9 t -118.66 132.45 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 122.114 -0.366 . . . . 0.0 110.208 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -99.45 109.88 56.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.44 -3.09 12.32 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.815 2.343 . . . . 0.0 112.109 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.82 -61.07 1.77 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.26 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -93.05 12.04 25.49 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 121.748 -0.595 . . . . 0.0 112.524 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.92 31.76 18.06 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -138.96 131.95 29.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.792 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.416 ' HG3' HG13 ' A' ' 24' ' ' VAL . 1.1 mp0 -91.6 171.0 9.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.516 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -167.36 161.5 14.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.9 m -124.81 125.23 25.47 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.5 -36.71 97.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.905 2.404 . . . . 0.0 112.869 -172.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -124.45 -44.7 1.98 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.514 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.548 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 9.9 tp10 -60.55 -25.47 66.18 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.17 -14.34 24.45 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.987 -0.445 . . . . 0.0 111.563 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.87 -21.53 43.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.548 ' HB ' ' OE1' ' A' ' 36' ' ' GLU . 16.1 m -115.32 -70.75 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.438 ' O ' ' HG3' ' A' ' 36' ' ' GLU . . . -144.09 -160.72 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.788 0.328 . . . . 0.0 111.038 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -102.19 15.99 27.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.05 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 67.14 127.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.129 0.966 . . . . 0.0 111.525 -172.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -133.1 -34.63 1.08 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.528 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.41 16.72 1.31 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.979 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 45.1 mtpt -78.22 -29.52 48.34 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.8 t -86.97 139.69 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.412 HD12 ' O ' ' A' ' 88' ' ' VAL . 16.3 mm -78.58 132.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.424 -172.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.1 ttmt -122.47 135.67 54.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.063 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.536 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 84.0 m-20 -99.17 -178.99 4.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 23.1 t -74.06 -5.31 40.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.786 0.803 . . . . 0.0 110.971 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 4.4 t -87.71 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.487 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.11 -8.86 63.17 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.448 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.536 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -80.32 148.68 30.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.781 0.801 . . . . 0.0 112.07 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG21 ' HG3' ' A' ' 48' ' ' LYS . 3.7 t -102.88 137.26 31.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.044 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.802 ' HG ' ' HG3' ' A' ' 113' ' ' LYS . 7.3 mp -95.84 174.0 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.469 0.652 . . . . 0.0 111.925 -169.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.478 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 30.1 tp60 -122.32 139.08 54.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.406 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' N ' HE21 ' A' ' 56' ' ' GLN . 22.7 t70 -66.56 102.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 116.34 -2.52 20.51 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.574 -176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.478 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 1.3 t70 -77.18 175.21 9.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 10.3 m -103.67 139.07 39.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.99 166.73 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -149.04 117.04 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.767 0.317 . . . . 0.0 110.474 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.705 HG12 HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.54 124.86 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.525 ' HA ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -96.46 13.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.565 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.613 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -134.74 159.1 42.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.188 0.518 . . . . 0.0 109.742 -172.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.05 103.43 7.98 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.66 0.743 . . . . 0.0 111.544 170.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD21 ' HB3' ' A' ' 65' ' ' LYS . 2.2 mm? -115.68 128.91 56.26 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.145 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -88.06 174.09 8.48 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 120.911 -1.118 . . . . 0.0 109.573 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.63 123.68 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -79.72 -41.99 25.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.34 -20.45 66.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.558 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.2 m -113.8 173.69 6.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 m -98.28 2.1 47.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.15 0.5 . . . . 0.0 110.363 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.9 141.08 36.43 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.314 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.92 140.8 27.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.163 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.705 HG11 HG12 ' A' ' 63' ' ' VAL . 69.8 t -99.4 119.9 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.2 149.93 36.91 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.829 -175.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.525 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -49.39 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.539 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.09 5.14 3.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.635 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.1 m -62.33 105.16 0.57 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.811 0.815 . . . . 0.0 110.224 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -93.53 112.95 24.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.976 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.545 HG13 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -124.45 119.35 56.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.374 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 16.8 pttm -106.19 159.45 16.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 65.4 43.94 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.892 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 45.5 pt -64.89 -179.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.416 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 6.2 tpp180 -125.52 125.38 43.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.281 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.33 118.05 21.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG21 ' O ' ' A' ' 93' ' ' ASP . 1.9 t -79.7 128.14 38.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -102.55 80.22 1.9 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 123.37 1.557 . . . . 0.0 112.954 -172.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.57 -76.55 0.04 OUTLIER Glycine 0 C--N 1.296 -1.677 0 CA-C-N 112.812 -1.995 . . . . 0.0 110.3 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.457 ' CG ' ' H ' ' A' ' 92' ' ' HIS . 14.5 t70 -87.85 -167.01 1.74 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 168.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.457 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 53.5 m80 -105.66 46.66 0.91 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.718 -175.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.543 ' O ' HG21 ' A' ' 88' ' ' VAL . 53.4 m-20 -97.1 165.7 11.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.418 1.008 . . . . 0.0 112.725 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.572 ' CD1' HG21 ' A' ' 111' ' ' VAL . 49.1 mt -115.52 119.93 63.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.475 174.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.28 135.93 36.27 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.545 ' HB2' HG13 ' A' ' 82' ' ' VAL . 22.1 p -143.13 153.68 43.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.775 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -110.56 125.35 53.27 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -126.16 115.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.726 0.298 . . . . 0.0 110.478 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.14 104.49 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.086 0.47 . . . . 0.0 110.54 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.57 -44.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.066 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.1 pt -125.51 -38.55 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.905 0.383 . . . . 0.0 110.496 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.25 -151.38 21.44 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.26 145.24 30.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.4 tpt -136.34 156.63 48.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.434 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -108.64 128.5 54.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.713 178.011 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -115.35 140.99 48.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.43 0.633 . . . . 0.0 111.292 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -78.74 113.97 17.26 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.674 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.591 ' HA ' HG23 ' A' ' 111' ' ' VAL . 4.3 p -52.42 -38.81 59.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.77 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 50' ' ' SER . 33.2 mt-10 -60.08 -15.13 20.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.64 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.48 ' O ' HD13 ' A' ' 64' ' ' ILE . 27.6 m-85 -114.96 4.86 14.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.506 -0.478 . . . . 0.0 112.085 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.632 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.3 m -126.1 179.11 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.394 0.616 . . . . 0.0 112.422 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.541 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 9.7 ttt180 -145.86 137.82 25.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.802 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 2.0 ttpp -73.3 125.01 26.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.786 173.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.81 -61.26 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.46 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.97 40.34 8.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.7 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.817 -178.161 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.13 124.91 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.197 0.522 . . . . 0.0 111.137 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -148.65 86.61 1.53 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.83 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 p -117.58 -54.03 2.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.127 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 21.3 mt -83.57 151.06 61.19 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.086 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -73.61 158.24 47.62 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.504 2.136 . . . . 0.0 110.989 175.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.28 -166.6 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.369 2.046 . . . . 0.0 112.057 177.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.0 t -97.93 120.89 59.11 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.508 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 9.24 0.31 Allowed 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.801 2.334 . . . . 0.0 112.141 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 33.8 mt-30 -117.6 -35.19 4.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.4 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.53 -48.53 3.07 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 121.0 0.429 . . . . 0.0 110.123 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.5 t30 69.9 -3.05 1.83 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.025 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -53.29 -76.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.944 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 173.06 -19.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.715 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 93.3 m-85 -82.5 48.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.051 0.453 . . . . 0.0 111.637 -167.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.4 m -109.23 146.25 34.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.334 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.483 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.4 p90 -152.88 178.45 9.65 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -103.58 118.78 37.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.001 0.429 . . . . 0.0 110.762 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.483 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 37.8 t70 -116.78 80.86 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.99 -113.03 4.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.213 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.26 21.45 16.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -172.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -158.47 -175.01 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.342 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 17.0 mt -107.25 130.29 54.77 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 19' ' ' ASP . 52.9 t -118.0 132.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 O-C-N 122.103 -0.373 . . . . 0.0 110.43 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.598 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.0 t -103.35 105.16 45.27 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.715 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 40.1 Cg_endo -68.14 -11.07 30.87 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 111.176 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.598 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.2 tp10 -72.52 -66.49 0.65 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.675 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -95.35 12.54 28.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.91 32.6 20.01 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.109 0.481 . . . . 0.0 111.915 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.422 ' HB3' HE22 ' A' ' 10' ' ' GLN . 40.2 t60 -136.64 133.24 36.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.193 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.87 167.47 9.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.798 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -165.57 162.2 18.91 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.584 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 31.3 t -116.93 136.92 23.39 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.404 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.6 Cg_endo -59.46 -22.8 67.83 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.798 2.332 . . . . 0.0 112.97 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -124.19 -40.42 2.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 35.2 tt0 -67.91 -21.88 65.1 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.323 -175.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.95 -32.34 71.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.772 0.32 . . . . 0.0 110.49 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.1 -43.51 52.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.977 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t 49.25 -165.67 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 O-C-N 124.345 1.028 . . . . 0.0 112.34 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.25 41.98 22.58 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.332 0.586 . . . . 0.0 111.064 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.9 m -98.38 33.23 2.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.567 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -153.98 164.21 38.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.615 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -79.23 -30.38 43.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.946 0.403 . . . . 0.0 110.304 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.88 -28.37 16.29 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.457 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 89' ' ' ASP . 44.7 mtpt -84.25 8.78 14.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 111.849 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t -93.66 105.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.498 HG12 HD23 ' A' ' 87' ' ' LEU . 1.4 mm -80.45 130.62 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.925 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 3.5 ttmt -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.565 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 14.3 m-20 -106.08 170.48 7.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 9.2 t -82.65 -9.95 59.15 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.096 0.95 . . . . 0.0 110.236 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.544 HG11 ' ND2' ' A' ' 53' ' ' ASN . 2.6 p -89.09 4.13 5.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.403 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.88 80.74 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.552 -1.203 . . . . 0.0 113.511 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.544 ' ND2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -103.62 161.96 13.46 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.327 -178.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.414 HG21 ' HE2' ' A' ' 48' ' ' LYS . 11.6 t -102.4 142.85 15.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.175 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.544 HD23 HG22 ' A' ' 61' ' ' ILE . 17.9 mt -94.48 174.97 6.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 111.319 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.424 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 14.0 tt0 -138.53 159.49 41.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.483 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 10.0 p-10 -69.69 130.47 42.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.416 0.627 . . . . 0.0 109.712 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 91.57 -7.94 79.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.173 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.47 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 1.7 t70 -77.98 167.39 21.55 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.318 -0.519 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.2 m -96.53 140.08 31.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.953 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.544 HG22 HD23 ' A' ' 55' ' ' LEU . 2.0 pp -123.86 165.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.082 0.468 . . . . 0.0 110.069 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.8 m -149.72 121.12 7.9 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.755 HG12 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.28 127.58 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.538 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -99.34 17.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.502 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.6 mptm? -140.81 161.46 37.75 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.459 -0.775 . . . . 0.0 109.041 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.538 ' O ' HD21 ' A' ' 67' ' ' LEU . 5.0 p-10 -81.28 115.25 20.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.706 0.765 . . . . 0.0 111.926 172.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 13.7 mt -130.17 144.19 51.22 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.064 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -95.14 178.59 5.49 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.866 -0.521 . . . . 0.0 111.14 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.401 HG13 ' HB2' ' A' ' 72' ' ' SER . 47.0 t -127.45 127.63 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -82.26 -45.72 14.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -170.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.4 -26.28 57.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.567 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.795 ' HB3' HD23 ' A' ' 74' ' ' LEU . 58.3 m -110.03 165.73 11.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -86.7 11.99 11.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.785 0.803 . . . . 0.0 109.201 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.795 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.12 172.71 12.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.962 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.2 t -159.03 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -166.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.755 HG12 HG12 ' A' ' 63' ' ' VAL . 85.1 t -93.27 96.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.89 0.852 . . . . 0.0 110.611 -173.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.4 pptp? -102.64 146.18 28.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.153 -175.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.57 97.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.913 0.863 . . . . 0.0 110.774 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.36 3.36 4.3 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.013 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 62' ' ' THR . 94.9 m -62.12 103.81 0.41 Allowed 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 121.868 0.842 . . . . 0.0 109.65 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -90.85 114.74 27.24 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.226 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 96' ' ' CYS . 42.6 t -126.14 113.72 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.6 ptmt -96.59 161.47 13.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.032 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.569 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 86.7 m-20 63.52 44.92 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.839 0.712 . . . . 0.0 111.526 174.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.415 HD12 ' CG2' ' A' ' 61' ' ' ILE . 34.2 pt -65.7 175.64 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.911 0.862 . . . . 0.0 113.042 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 19.3 tpp180 -130.17 129.89 44.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.378 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.498 HD23 HG12 ' A' ' 47' ' ' ILE . 63.0 mt -81.17 113.07 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -88.63 178.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.967 0.413 . . . . 0.0 110.833 -174.408 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.528 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 5.5 m-20 -81.18 80.38 7.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.247 0.546 . . . . 0.0 110.767 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . 172.21 -175.1 45.52 Favored Glycine 0 C--N 1.304 -1.209 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -101.15 -29.62 12.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.452 0.644 . . . . 0.0 110.7 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.5 p-80 -107.03 51.69 0.73 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.287 -174.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.607 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.8 m-20 -149.67 91.79 1.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -159.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.9 mp -109.0 113.63 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.743 170.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 36.6 t70 -94.69 136.9 34.47 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.47 ' HB2' HG12 ' A' ' 82' ' ' VAL . 17.4 p -138.03 143.46 40.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.505 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.71 121.01 43.83 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.53 107.32 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.62 117.25 6.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.86 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.15 -65.26 0.57 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.477 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.456 HG23 HD22 ' A' ' 74' ' ' LEU . 26.7 pt -95.78 -47.65 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.88 0.371 . . . . 0.0 110.369 178.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.44 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.99 -161.18 28.12 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.39 148.33 26.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.702 0.287 . . . . 0.0 111.009 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 43.9 ttm -138.79 158.09 44.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.318 . . . . 0.0 110.58 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.94 134.88 54.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.087 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.2 mt -118.83 142.44 47.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.203 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.518 ' HB3' ' OE1' ' A' ' 109' ' ' GLU . 30.0 mtpt -74.41 130.86 40.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.966 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.7 t -59.49 -32.98 70.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.478 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.518 ' OE1' ' HB3' ' A' ' 107' ' ' LYS . 3.4 pm0 -85.55 -0.16 54.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.424 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 33.3 m-85 -115.8 3.06 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.891 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 28.9 m -111.8 168.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.269 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.494 ' HG3' HG13 ' A' ' 51' ' ' VAL . 25.1 ttt180 -150.64 132.49 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.282 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.534 ' HB2' HD22 ' A' ' 55' ' ' LEU . 88.2 tttt -65.48 121.08 14.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 174.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.1 t -85.47 -48.76 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.81 85.3 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.867 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.909 -179.369 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HE3' ' HB2' ' A' ' 1' ' ' MET . 23.5 ptm . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p 178.26 138.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -73.9 95.02 2.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.987 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.1 p -116.48 95.49 5.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.423 0.63 . . . . 0.0 109.896 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.427 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 30.2 mt -96.59 161.96 24.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.039 -171.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 54.3 Cg_endo -69.22 160.0 51.57 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.215 1.943 . . . . 0.0 111.139 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.22 -172.39 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.357 2.038 . . . . 0.0 112.031 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.618 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.09 127.03 38.05 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.57 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.69 6.82 1.46 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.541 2.16 . . . . 0.0 111.722 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.618 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 40.0 mt-30 -115.54 -39.21 3.59 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.431 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 m -109.67 -52.01 2.82 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.908 0.385 . . . . 0.0 110.268 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.74 -0.82 3.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.611 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.61 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 45.2 m -60.87 -78.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.994 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.1 pt-20 176.77 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.711 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 23.8 m-85 -82.2 33.58 0.4 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.584 0.629 . . . . 0.0 111.827 -171.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -91.48 135.22 34.0 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.766 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' CE1' ' HD3' ' A' ' 26' ' ' PRO . 22.0 p90 -146.04 170.17 17.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 123.85 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.83 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -120.03 79.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.09 -112.9 4.52 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.076 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.03 16.13 25.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.431 HD13 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.12 -175.5 5.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.725 0.298 . . . . 0.0 110.248 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.504 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 19.9 mt -110.05 129.15 55.73 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.871 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -123.59 138.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.037 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.958 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 47.1 t -110.72 104.2 55.66 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.352 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 56.1 Cg_endo -70.78 -9.81 26.49 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.836 2.358 . . . . 0.0 109.913 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.958 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -70.75 -45.13 65.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.206 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.0 p -117.88 15.17 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.08 39.9 28.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.157 0.435 . . . . 0.0 111.874 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.78 127.62 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.85 0.357 . . . . 0.0 111.399 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.871 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 27.1 mt-10 -91.18 156.37 17.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.129 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.39 162.24 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.438 . . . . 0.0 110.726 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -110.44 130.87 22.41 Favored Pre-proline 0 C--N 1.317 -0.845 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.504 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 18.4 Cg_endo -59.65 -34.32 96.46 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.887 2.391 . . . . 0.0 113.576 -171.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -119.43 -42.92 2.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.962 0.411 . . . . 0.0 111.113 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -63.62 -18.24 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.546 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.15 61.22 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.595 0.236 . . . . 0.0 111.397 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.77 -30.86 71.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.51 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 m 69.23 163.19 0.23 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.074 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.25 -179.85 3.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.862 0.363 . . . . 0.0 110.769 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.8 m -91.45 -177.67 4.89 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.359 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -150.87 156.56 41.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -69.02 -29.56 67.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 0.0 111.434 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.66 95.21 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.922 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.652 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.8 mmpt? -90.97 -53.19 4.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.47 0.652 . . . . 0.0 109.396 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.506 HG21 HD12 ' A' ' 87' ' ' LEU . 7.8 p -142.34 146.94 21.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.83 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.494 ' CG2' ' HG ' ' A' ' 108' ' ' SER . 4.4 mm -85.75 138.77 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.456 0.17 . . . . 0.0 110.649 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.67 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -109.62 155.78 21.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.119 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.537 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 5.0 m-20 -98.73 167.19 10.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.682 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.748 ' OG ' HD11 ' A' ' 64' ' ' ILE . 89.8 p -76.68 -10.63 59.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.904 0.859 . . . . 0.0 110.867 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.505 HG12 ' ND2' ' A' ' 53' ' ' ASN . 2.1 p -85.4 1.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.451 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.23 7.15 73.62 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.504 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.505 ' ND2' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -108.45 168.39 9.36 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.942 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.491 HG22 ' HG3' ' A' ' 48' ' ' LYS . 9.4 t -113.7 142.51 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.931 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD21 ' HB2' ' A' ' 113' ' ' LYS . 13.9 mt -96.64 175.95 6.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.547 0.689 . . . . 0.0 111.204 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.469 ' HB3' ' OD1' ' A' ' 59' ' ' ASP . 16.8 tt0 -131.91 154.21 49.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.632 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -67.54 96.46 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.955 0.407 . . . . 0.0 109.944 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.83 -7.11 6.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.974 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.469 ' OD1' ' HB3' ' A' ' 56' ' ' GLN . 32.0 m-20 -71.13 165.27 23.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.112 0.482 . . . . 0.0 111.167 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 2.8 m -99.37 136.09 39.83 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.44 HG21 HD22 ' A' ' 55' ' ' LEU . 1.9 pp -120.76 166.01 15.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.0 m -150.46 118.78 6.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.851 175.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.712 HG13 HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -60.73 126.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.295 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.748 HD11 ' OG ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -99.54 19.01 2.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.538 ' HD2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -143.48 166.41 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.592 -0.692 . . . . 0.0 109.332 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.77 113.96 21.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.894 0.854 . . . . 0.0 111.343 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.444 HD21 ' CG ' ' A' ' 110' ' ' PHE . 7.2 mp -126.0 141.19 52.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.485 175.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.437 ' HE2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -88.52 171.37 10.12 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.31 173.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.492 ' CG2' HG23 ' A' ' 76' ' ' VAL . 47.8 t -120.25 133.55 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -78.57 -57.49 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.78 -17.55 79.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.968 -0.635 . . . . 0.0 113.094 -174.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.478 ' HB2' HG13 ' A' ' 69' ' ' VAL . 55.5 m -115.0 155.13 27.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.746 0.308 . . . . 0.0 110.869 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -79.79 -1.13 37.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.46 HD23 HD11 ' A' ' 101' ' ' ILE . 9.5 mp -78.83 146.61 33.6 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.9 t -107.78 134.3 50.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.318 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.712 HG11 HG13 ' A' ' 63' ' ' VAL . 63.1 t -84.1 104.25 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 149.87 25.48 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.469 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.73 96.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.99 0.9 . . . . 0.0 111.083 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.64 5.82 3.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.057 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' THR . 90.1 m -62.58 104.07 0.48 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 121.717 0.77 . . . . 0.0 109.87 176.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.25 121.3 33.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.174 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.499 HG11 ' HB2' ' A' ' 96' ' ' CYS . 30.6 t -133.88 116.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.627 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 51.9 pttt -100.35 158.88 15.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.726 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.49 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 56.0 m-80 63.32 47.49 3.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.8 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -64.88 178.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 122.005 0.907 . . . . 0.0 113.347 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.632 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 11.0 tpp85 -129.96 124.65 33.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.823 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.506 HD12 HG21 ' A' ' 46' ' ' VAL . 34.5 mt -78.92 116.05 18.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.6 t -82.12 163.02 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.384 -176.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -76.44 89.93 3.24 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.539 0.685 . . . . 0.0 109.928 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.38 126.56 2.02 Favored Glycine 0 C--N 1.306 -1.138 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.63 -13.72 10.73 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.249 0.547 . . . . 0.0 112.237 -170.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -106.43 51.34 0.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -173.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.46 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -174.49 143.02 0.79 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 118.732 -1.187 . . . . 0.0 114.082 -170.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.545 ' CD1' HG22 ' A' ' 111' ' ' VAL . 36.6 mt -144.34 120.61 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 33.9 t70 -95.53 136.72 35.56 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.167 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.499 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -154.18 163.26 40.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.704 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.757 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 87.9 tttt -124.7 147.26 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.976 0.417 . . . . 0.0 110.04 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.32 105.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.57 103.87 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.795 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 144.27 -70.3 0.4 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.215 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.46 HD11 HD23 ' A' ' 74' ' ' LEU . 25.4 pt -84.77 -46.5 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.542 0.21 . . . . 0.0 111.173 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 146.94 -162.62 28.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.893 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.757 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -86.72 149.91 24.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.829 0.315 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.487 ' HE1' HG21 ' A' ' 69' ' ' VAL . 28.4 ttt -140.29 156.89 46.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.946 0.403 . . . . 0.0 110.671 -177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -113.83 139.03 49.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.583 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.404 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 53.9 mt -123.08 141.16 52.27 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.669 0.747 . . . . 0.0 111.732 -170.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -84.83 119.61 25.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.973 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.67 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -47.82 -39.71 19.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.7 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.77 -11.15 33.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.61 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.451 ' O ' HD12 ' A' ' 64' ' ' ILE . 86.4 m-85 -112.91 1.8 15.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.545 HG22 ' CD1' ' A' ' 94' ' ' ILE . 13.5 m -113.4 169.51 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.37 -172.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.537 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -155.13 129.77 9.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.07 179.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HB2' HD21 ' A' ' 55' ' ' LEU . 88.7 tttt -59.97 123.25 16.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.786 0.327 . . . . 0.0 110.31 171.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -60.53 -44.8 97.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.429 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.98 -21.13 3.01 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.184 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.236 -0.887 . . . . 0.0 109.47 176.19 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.812 0.339 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.23 -17.68 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.622 0.725 . . . . 0.0 110.884 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -103.27 97.02 7.16 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.697 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 p -126.25 25.27 6.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.564 0.697 . . . . 0.0 110.331 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.411 HD21 HD11 ' A' ' 23' ' ' LEU . 16.2 mt -78.48 157.79 77.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.406 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.47 155.95 54.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.925 1.75 . . . . 0.0 110.783 175.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.84 -175.44 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.31 2.007 . . . . 0.0 111.882 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.576 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 4.7 t -97.65 123.0 53.56 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.46 10.94 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.73 2.287 . . . . 0.0 111.919 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.576 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 36.5 mt-30 -118.9 -40.57 2.84 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.147 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.4 m -108.98 -50.86 2.95 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.185 0.516 . . . . 0.0 110.265 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 t30 70.78 2.07 4.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.871 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 4.8 m -58.95 -78.34 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.3 pt-20 175.66 -18.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.509 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.7 m-85 -79.21 31.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.132 -169.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 14' ' ' GLU . 2.6 m -94.17 136.19 34.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.825 178.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -139.05 169.87 17.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.19 122.03 45.71 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.11 0.481 . . . . 0.0 111.205 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -111.27 71.75 0.75 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.53 -107.99 3.53 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.382 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.9 19.4 19.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -171.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -155.41 -179.44 8.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.171 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.7 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -109.24 134.03 52.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.433 HG11 ' HB3' ' A' ' 31' ' ' GLU . 57.7 t -115.14 127.15 72.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 49.4 t -103.95 103.91 40.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.509 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 53.4 Cg_endo -71.61 -8.88 24.06 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.549 2.166 . . . . 0.0 110.412 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.487 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 20.2 tt0 -69.27 -62.59 1.32 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.017 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.2 p -98.47 9.59 42.8 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.71 46.05 12.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.771 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.44 ' HB3' HE22 ' A' ' 10' ' ' GLN . 3.6 t-80 -150.59 135.02 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HB3' HG11 ' A' ' 24' ' ' VAL . 10.1 pt-20 -114.36 163.53 15.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.733 0.301 . . . . 0.0 110.882 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.562 ' NE1' HD21 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -163.11 162.64 25.77 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.501 ' HB3' ' HB2' ' A' ' 36' ' ' GLU . 32.7 t -112.18 139.79 22.86 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.7 ' HD3' ' CD2' ' A' ' 23' ' ' LEU . 19.7 Cg_endo -58.19 -48.87 14.18 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.403 2.069 . . . . 0.0 112.452 -173.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -101.32 -37.88 8.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.48 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.521 ' HA ' ' OG1' ' A' ' 39' ' ' THR . 15.0 mm-40 -69.1 -12.28 61.54 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -174.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.35 -34.66 74.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.09 0.471 . . . . 0.0 109.951 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.22 -45.67 11.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.316 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.521 ' OG1' ' HA ' ' A' ' 36' ' ' GLU . 2.7 p -76.1 -35.82 59.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 70.26 112.12 0.05 Allowed 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.816 0.697 . . . . 0.0 111.009 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -60.6 111.57 1.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.455 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 43' ' ' ASP . 12.0 t70 -149.1 -154.22 0.54 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.448 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 33.7 t70 -59.89 -39.3 84.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 0.0 110.958 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.47 45.55 1.05 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.349 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 45' ' ' LYS . 30.5 mmmt -76.58 94.29 3.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.346 0.593 . . . . 0.0 110.632 176.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.475 HG13 HD13 ' A' ' 87' ' ' LEU . 15.8 t -130.84 155.75 42.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.637 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.557 HG21 HG13 ' A' ' 94' ' ' ILE . 2.5 mm -86.18 135.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.52 177.36 4.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 6.3 m-20 -114.42 169.99 8.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.611 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.648 ' OG ' HD13 ' A' ' 64' ' ' ILE . 90.3 p -70.47 -6.23 34.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.123 0.963 . . . . 0.0 110.51 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.1 t -86.45 -13.52 10.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.642 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.79 5.68 64.33 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.886 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.46 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -97.1 168.24 10.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.543 0.687 . . . . 0.0 111.561 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.41 HG22 ' HG3' ' A' ' 48' ' ' LYS . 16.4 t -113.97 144.64 21.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.787 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.627 HD23 ' HZ1' ' A' ' 113' ' ' LYS . 24.2 mt -101.1 173.2 6.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.647 . . . . 0.0 111.69 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 33.7 tp60 -124.89 145.71 49.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 15.1 t70 -71.23 97.1 1.49 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.496 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 123.51 -6.5 9.15 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.537 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 42.2 t0 -68.62 166.53 17.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.899 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 34.5 m -104.89 136.51 44.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.462 HG23 HD21 ' A' ' 55' ' ' LEU . 1.8 pp -123.71 171.85 12.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -150.19 123.34 8.87 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 0.0 111.102 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.646 HG13 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -65.8 126.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.648 HD13 ' OG ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -97.7 14.06 4.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.405 ' HG3' HG12 ' A' ' 64' ' ' ILE . 54.8 mttt -143.64 164.99 28.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.094 0.861 . . . . 0.0 109.634 -176.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.69 117.15 24.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.082 0.944 . . . . 0.0 112.648 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.6 mp -134.79 150.66 50.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.307 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.32 178.27 5.89 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.703 -0.623 . . . . 0.0 111.502 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.488 HG21 ' HB3' ' A' ' 74' ' ' LEU . 46.7 t -120.06 129.07 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -56.51 108.36 0.48 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.22 3.88 26.57 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.005 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m -101.0 166.69 10.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.982 0.42 . . . . 0.0 111.122 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 p -84.92 -3.84 58.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.56 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.503 ' HG ' ' H ' ' A' ' 75' ' ' VAL . 12.1 tp -81.85 171.66 14.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.661 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.503 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 70.0 t -158.72 120.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -169.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.646 HG12 HG13 ' A' ' 63' ' ' VAL . 64.9 t -89.65 97.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.715 0.769 . . . . 0.0 110.61 -174.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.459 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.21 145.47 34.2 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.329 -176.698 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.541 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -48.01 97.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.868 0.842 . . . . 0.0 111.19 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.52 4.09 4.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.251 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -62.53 104.95 0.57 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 122.089 0.947 . . . . 0.0 110.009 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -89.35 120.75 30.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.895 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' A' ' 96' ' ' CYS . 22.2 t -131.9 113.41 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.398 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.7 ptmt -100.55 154.04 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.714 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.496 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 50.6 m-80 62.76 53.22 2.56 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.038 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 55' ' ' LEU . 32.4 pt -64.56 174.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 121.815 0.817 . . . . 0.0 112.43 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 20.4 tpp180 -129.22 123.01 30.89 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.879 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.475 HD13 HG13 ' A' ' 46' ' ' VAL . 39.7 mt -78.24 113.39 16.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -91.05 176.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.021 -178.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -85.09 86.2 7.41 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.121 0.962 . . . . 0.0 111.407 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.14 -172.11 45.07 Favored Glycine 0 C--N 1.293 -1.806 0 CA-C-N 113.593 -1.639 . . . . 0.0 109.68 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.66 -20.59 14.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 118.056 0.928 . . . . 0.0 110.173 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -107.08 50.39 0.77 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.792 -175.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.547 ' O ' HG22 ' A' ' 88' ' ' VAL . 8.3 m-20 -150.8 89.78 1.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -160.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.557 HG13 HG21 ' A' ' 47' ' ' ILE . 2.8 mp -110.41 113.1 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 170.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 15.5 t70 -95.0 138.96 32.03 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.555 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -147.35 156.52 42.98 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.406 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -116.64 130.03 56.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.406 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.46 109.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.87 97.31 1.8 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.287 0.565 . . . . 0.0 110.134 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.93 -40.53 0.42 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 102' ' ' GLY . 43.2 pt -122.62 -37.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 138.15 -150.99 21.23 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.459 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -91.01 149.13 21.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.759 0.314 . . . . 0.0 110.744 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.3 ttt -140.57 159.75 41.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.187 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -116.78 143.23 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.2 mt -125.73 146.91 49.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.294 0.568 . . . . 0.0 111.984 -169.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.606 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 1.7 mptm? -75.26 128.33 35.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.855 174.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.6 t -53.31 -40.8 65.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.606 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 8.6 pt-20 -66.88 -12.29 58.8 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.066 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.553 ' O ' HD11 ' A' ' 64' ' ' ILE . 64.7 m-85 -111.87 4.8 18.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.459 -0.776 . . . . 0.0 112.777 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 24.2 m -114.4 169.84 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.505 -173.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 15.8 ttt180 -147.88 142.59 26.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.639 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.832 ' HB2' ' HZ1' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -65.58 140.83 58.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.254 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 94.0 t -107.84 -57.83 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 170.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.57 -3.51 71.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.744 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 31.1 m . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.337 -178.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.575 ' HE1' ' HA ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.7 -15.03 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.79 0.805 . . . . 0.0 110.522 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m -84.85 83.04 8.18 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.865 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -107.89 -12.98 15.08 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.433 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.421 HD12 HD22 ' A' ' 23' ' ' LEU . 72.8 mt -110.02 157.01 39.03 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.574 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -70.65 158.29 56.22 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.155 1.903 . . . . 0.0 111.131 176.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -70.18 -171.65 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.446 ' C ' ' H ' ' A' ' 10' ' ' GLN . 33.8 t -99.1 122.04 53.64 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.205 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.84 7.49 0.58 Allowed 'Trans proline' 0 C--O 1.23 0.113 0 C-N-CA 122.613 2.208 . . . . 0.0 112.284 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.446 ' H ' ' C ' ' A' ' 8' ' ' CYS . 8.4 tt0 -113.94 -39.54 3.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.095 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -126.14 -35.15 2.46 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.553 -0.717 . . . . 0.0 111.468 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t30 72.53 1.84 4.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.92 0.488 . . . . 0.0 111.634 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.562 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 4.8 m -53.93 -78.43 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 171.85 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.164 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.774 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 79.0 m-85 -118.06 24.95 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.296 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.54 132.38 37.89 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.389 172.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.564 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 38.3 p90 -144.9 171.27 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -100.8 117.54 35.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.884 0.373 . . . . 0.0 110.715 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.564 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 35.1 t70 -115.69 69.99 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.02 -113.44 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.91 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.48 18.91 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.883 0.373 . . . . 0.0 111.645 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -154.96 -174.83 5.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.349 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.567 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 24.1 mt -113.46 137.1 52.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.444 HG21 ' HB3' ' A' ' 31' ' ' GLU . 46.1 t -121.27 136.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 122.231 -0.293 . . . . 0.0 110.375 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 48.6 t -102.58 105.14 42.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.349 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.774 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 20.8 Cg_endo -61.64 -25.45 79.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.63 2.22 . . . . 0.0 111.66 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.13 -58.95 3.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.7 m -75.92 -9.13 58.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.7 39.54 24.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 111.466 -173.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -149.17 136.92 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.534 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.444 ' HB3' HG21 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -103.69 174.76 5.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -178.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -166.94 161.87 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 36' ' ' GLU . 20.6 t -106.18 135.11 19.5 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.567 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.9 Cg_endo -58.52 -52.23 5.86 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.868 2.379 . . . . 0.0 112.855 -173.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -121.98 -20.56 6.28 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.779 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 21.1 mm-40 -81.38 -14.09 57.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.585 0.231 . . . . 0.0 111.08 -175.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.89 -54.47 46.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.543 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.22 -56.78 7.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.08 121.13 12.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.212 0.53 . . . . 0.0 111.56 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . . . -137.34 32.92 2.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.471 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.5 m -70.49 103.94 2.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.654 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -121.15 4.21 10.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.98 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.436 ' OD1' HG23 ' A' ' 46' ' ' VAL . 10.9 t0 64.98 93.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.615 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 91' ' ' ASP . . . -98.03 -5.96 57.13 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.375 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -74.41 -21.04 59.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.607 0.241 . . . . 0.0 111.304 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.436 HG23 ' OD1' ' A' ' 43' ' ' ASP . 61.7 t -85.18 122.71 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.124 0.488 . . . . 0.0 109.808 175.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.557 HG21 HG13 ' A' ' 94' ' ' ILE . 5.1 mm -81.3 139.85 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HG3' HG23 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -114.8 176.25 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.3 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -112.05 172.41 6.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.25 177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.642 ' OG ' HD12 ' A' ' 64' ' ' ILE . 81.6 p -74.66 -8.33 56.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.039 0.923 . . . . 0.0 110.678 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.433 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -89.24 -11.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.406 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.65 -2.63 64.85 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.773 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.433 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -91.52 166.39 12.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.775 0.798 . . . . 0.0 111.584 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.436 HG23 ' HG3' ' A' ' 48' ' ' LYS . 11.3 t -117.05 139.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.923 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD22 HG23 ' A' ' 61' ' ' ILE . 17.8 mt -94.9 172.98 7.82 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.238 0.542 . . . . 0.0 110.564 -173.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -129.36 150.48 50.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.617 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -69.71 96.02 0.93 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 0.0 109.929 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 124.67 -7.83 8.31 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.045 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.452 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 2.1 t0 -72.16 175.81 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 25.3 m -105.46 137.19 43.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.508 HG23 HD22 ' A' ' 55' ' ' LEU . 1.5 pp -123.35 164.49 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.772 0.32 . . . . 0.0 110.279 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -148.53 124.88 10.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 174.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.734 HG13 HG11 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -66.71 124.79 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.642 HD12 ' OG ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -96.13 17.19 2.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.879 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 6.7 mttt -143.5 163.71 32.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.03 0.832 . . . . 0.0 109.643 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.539 ' O ' HD21 ' A' ' 67' ' ' LEU . 2.5 p-10 -83.67 115.89 22.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.087 0.946 . . . . 0.0 111.995 173.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.2 mt -129.17 143.92 51.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.359 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -91.87 178.31 5.93 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.618 -0.676 . . . . 0.0 110.525 173.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.446 HG21 HG23 ' A' ' 76' ' ' VAL . 8.0 t -129.15 130.4 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -78.63 -60.04 2.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -172.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.69 37.62 3.35 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.515 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.428 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 69.6 m -144.73 166.85 24.03 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -95.62 2.88 54.36 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.4 mp -78.6 175.25 10.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.452 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.8 t -158.69 116.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.734 HG11 HG13 ' A' ' 63' ' ' VAL . 88.1 t -87.32 98.56 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-O 121.682 0.753 . . . . 0.0 110.753 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.6 pptp? -105.83 145.01 31.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.41 -175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -48.65 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.925 0.869 . . . . 0.0 111.228 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.23 5.5 4.67 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.072 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.47 104.39 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.807 0.813 . . . . 0.0 109.555 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -94.79 115.02 26.99 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.431 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.572 ' CG1' ' HB2' ' A' ' 96' ' ' CYS . 68.0 t -132.22 117.31 32.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.8 pttt -107.89 169.67 8.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.682 0.753 . . . . 0.0 112.903 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.51 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 69.62 36.13 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.426 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 55' ' ' LEU . 37.2 pt -60.74 175.83 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.617 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 9.0 tpp85 -131.25 123.08 27.65 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.156 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.1 mt -75.25 109.08 8.46 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.554 HG21 ' HB2' ' A' ' 95' ' ' ASP . 2.6 t -74.32 161.44 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -170.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.76 35.01 0.19 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.868 0.842 . . . . 0.0 110.649 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.497 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -137.62 132.79 6.07 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 6.1 p-10 -66.86 -6.23 15.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -168.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -108.78 -46.0 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.454 ' O ' HG23 ' A' ' 88' ' ' VAL . 19.9 m-20 -91.46 153.3 19.92 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -158.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.633 ' CD1' HG21 ' A' ' 111' ' ' VAL . 25.7 mt -110.4 129.69 65.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.435 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.554 ' HB2' HG21 ' A' ' 88' ' ' VAL . 9.9 t70 -96.42 132.81 41.57 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.572 ' HB2' ' CG1' ' A' ' 82' ' ' VAL . 27.6 p -138.27 145.21 41.01 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.832 -168.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.519 ' O ' HG12 ' A' ' 82' ' ' VAL . 96.3 mttt -93.45 107.84 19.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.498 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.6 mt -104.51 155.32 6.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -101.09 130.5 47.14 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.64 -52.42 0.77 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.988 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.7 pt -95.83 -40.32 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -178.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.96 -138.32 10.49 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.791 -176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -100.34 159.68 14.94 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.11 0.455 . . . . 0.0 111.377 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 38.8 ttm -154.2 165.75 35.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.121 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 80.6 mttt -113.69 126.08 54.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.572 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.44 146.72 39.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.644 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 25.9 ttmt -76.68 125.25 28.93 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.218 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.1 t -47.94 -37.96 15.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.093 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.644 ' HG2' ' HG2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -75.41 -5.33 44.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.879 ' HD1' ' HD3' ' A' ' 65' ' ' LYS . 30.7 m-85 -113.72 7.44 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.531 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.633 HG21 ' CD1' ' A' ' 94' ' ' ILE . 30.3 m -116.62 171.83 5.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -174.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -150.32 133.83 16.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.012 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 87.4 tttt -70.46 120.38 16.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 t -93.86 -70.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.52 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.72 -42.33 1.52 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.769 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.291 -179.351 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' HE1' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.964 0.411 . . . . 0.0 111.487 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.463 HG12 ' HE1' ' A' ' 1' ' ' MET . 12.5 p -155.92 153.07 7.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.56 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.6 m 69.31 43.13 1.1 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.207 0.527 . . . . 0.0 111.349 175.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 t -153.24 136.76 15.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.925 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.469 HD12 ' HG2' ' A' ' 18' ' ' GLU . 52.7 mt -110.44 148.96 39.52 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.709 0.29 . . . . 0.0 110.766 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.63 162.49 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.042 2.495 . . . . 0.0 111.714 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -73.39 -169.45 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 t -98.68 130.68 27.32 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.9 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.96 8.98 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.638 2.225 . . . . 0.0 112.553 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -123.04 -37.08 2.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.393 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.423 ' C ' ' H ' ' A' ' 13' ' ' SER . 56.6 m -107.04 -45.94 4.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.24 -9.66 0.86 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 1.4 m -43.86 -75.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.004 0.522 . . . . 0.0 111.974 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.501 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.0 pt-20 159.04 -3.49 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.005 0.816 . . . . 0.0 111.569 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.577 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 63.2 m-85 -77.26 34.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.628 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 14' ' ' GLU . 2.9 m -100.85 141.08 34.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.159 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -151.89 177.15 10.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.469 ' HG2' HD12 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -110.42 124.61 52.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.418 0.628 . . . . 0.0 111.61 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.66 70.05 0.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.674 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.19 -107.66 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.112 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.8 18.03 21.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -159.96 -174.32 4.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.159 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.92 134.45 53.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.496 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -124.97 141.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 50.4 t -104.63 105.81 51.94 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.758 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.577 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.7 Cg_endo -66.85 -14.26 43.09 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.658 2.239 . . . . 0.0 110.968 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.463 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 33.2 tt0 -70.29 -58.97 3.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.633 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.34 10.29 39.24 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.5 46.11 12.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -142.91 127.41 17.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.678 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.496 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 2.3 mp0 -91.4 157.07 17.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.023 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -159.07 162.08 36.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.493 ' OG ' ' HB3' ' A' ' 36' ' ' GLU . 14.9 t -115.98 127.76 26.51 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.87 -47.79 12.17 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.786 2.324 . . . . 0.0 113.192 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -116.3 -34.64 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.493 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 26.2 tt0 -67.26 -27.14 66.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.649 0.262 . . . . 0.0 111.459 -176.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.42 -30.76 71.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.109 0.48 . . . . 0.0 110.201 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.02 -62.15 1.6 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.425 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.9 p -99.72 112.6 24.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.586 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.31 174.78 10.17 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.53 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.9 m -99.03 122.83 42.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.91 126.34 37.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.632 0.729 . . . . 0.0 111.417 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 178.66 96.07 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.514 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.2 39.44 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.346 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -99.78 -35.9 9.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.993 0.425 . . . . 0.0 110.26 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.711 HG12 HG22 ' A' ' 54' ' ' VAL . 5.5 t -108.11 125.68 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.879 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.567 HG21 HG13 ' A' ' 94' ' ' ILE . 2.1 mm -91.09 131.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.413 -170.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.561 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.51 176.58 6.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 111.84 -179.226 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.539 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 15.2 m-20 -116.23 178.26 4.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.109 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.543 ' HB3' HD13 ' A' ' 64' ' ' ILE . 9.3 t -77.03 -5.22 47.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.243 1.02 . . . . 0.0 109.968 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.47 HG21 ' CG ' ' A' ' 112' ' ' ARG . 2.5 t -91.03 -8.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.602 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.28 -6.22 78.26 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.714 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.42 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -90.3 165.41 13.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 110.941 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.711 HG22 HG12 ' A' ' 46' ' ' VAL . 2.9 p -119.79 147.63 23.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.917 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.809 ' HA ' ' HD3' ' A' ' 113' ' ' LYS . 1.8 mt -96.54 178.23 5.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.411 -169.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -127.79 147.95 50.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.585 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 13.3 t70 -69.19 99.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.8 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.77 -6.91 9.58 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.523 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.91 175.44 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.96 0.41 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.608 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 41.4 m -103.01 137.47 41.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.595 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.531 HG22 HD21 ' A' ' 55' ' ' LEU . 1.4 pp -121.84 164.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.415 HG22 ' HA2' ' A' ' 79' ' ' GLY . 2.7 m -149.16 117.95 6.65 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.12 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.637 HG12 HG13 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.48 129.45 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.552 ' HA ' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -102.86 17.19 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.53 ' HD3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -140.7 164.46 30.14 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.76 0.709 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.657 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -82.94 118.44 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.885 0.85 . . . . 0.0 112.656 174.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 66' ' ' ASP . 11.7 mt -135.4 142.29 45.63 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.758 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -92.54 178.32 5.85 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.399 -0.813 . . . . 0.0 111.29 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.76 131.98 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 70' ' ' LYS . 17.0 tptm -93.02 130.2 38.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.82 18.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.083 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.672 ' HB3' HD22 ' A' ' 74' ' ' LEU . 39.5 m -115.37 155.97 26.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.689 0.28 . . . . 0.0 110.816 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -85.18 18.88 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.603 0.716 . . . . 0.0 109.943 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.672 HD22 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -79.36 171.87 14.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.258 175.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.3 t -159.29 118.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -169.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.637 HG13 HG12 ' A' ' 63' ' ' VAL . 84.8 t -92.13 95.16 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.069 0.938 . . . . 0.0 109.95 -175.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 146.41 34.44 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.252 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.552 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -46.54 97.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.097 0.873 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.415 ' HA2' HG22 ' A' ' 62' ' ' THR . . . 130.04 2.73 5.07 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.487 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.5 m -61.85 104.51 0.46 Allowed 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.904 0.859 . . . . 0.0 109.732 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -90.77 115.62 27.99 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.034 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 96' ' ' CYS . 77.7 t -131.91 113.45 22.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.213 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 60.1 pttt -107.88 164.05 12.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.329 0.585 . . . . 0.0 112.324 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.577 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 47.3 m-80 70.26 42.04 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.892 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.3 pt -65.39 175.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.987 0.899 . . . . 0.0 112.904 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.585 ' HD3' ' OD2' ' A' ' 57' ' ' ASP . 7.3 tpp180 -126.66 126.07 42.94 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.212 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.467 HD21 HG12 ' A' ' 47' ' ' ILE . 38.1 mt -81.54 117.5 21.98 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.761 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -85.51 177.89 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -176.421 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.556 ' H ' HG13 ' A' ' 88' ' ' VAL . 30.0 t70 -89.82 84.58 6.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.408 1.099 . . . . 0.0 110.087 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.517 ' O ' HD13 ' A' ' 47' ' ' ILE . . . 159.33 141.46 3.14 Favored Glycine 0 C--N 1.294 -1.777 0 CA-C-N 113.296 -1.774 . . . . 0.0 110.431 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.25 -19.61 61.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.611 0.706 . . . . 0.0 110.944 -171.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -106.29 50.65 0.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.509 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.761 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.0 m-20 -149.5 93.24 2.03 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -163.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.567 HG13 HG21 ' A' ' 47' ' ' ILE . 9.6 mt -114.44 115.53 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.494 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.7 t70 -96.39 134.06 40.01 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.516 ' HB2' HG12 ' A' ' 82' ' ' VAL . 24.4 p -129.88 134.91 47.8 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.779 -176.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -101.29 111.66 23.95 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.79 108.5 25.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.956 0.408 . . . . 0.0 110.858 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.81 101.46 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.938 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.31 -39.42 0.76 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.493 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.414 HD12 ' HG ' ' A' ' 74' ' ' LEU . 23.8 pt -130.35 -39.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.62 -149.02 20.01 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -91.31 148.53 22.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.965 0.412 . . . . 0.0 110.939 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.476 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 50.7 ttm -136.3 157.24 47.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.194 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.498 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -99.86 141.82 32.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.698 175.614 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 93.7 mt -132.48 138.08 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.172 0.511 . . . . 0.0 111.492 -176.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 107' ' ' LYS . 43.5 mtpt -81.95 125.79 31.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.423 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.3 t -48.07 -42.62 29.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.945 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.17 -7.76 20.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.091 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.498 ' HD1' ' HE3' ' A' ' 65' ' ' LYS . 33.6 m-85 -115.93 2.4 13.52 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.539 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 33.8 m -113.33 170.13 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.47 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.2 ttt-85 -150.87 131.32 13.79 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.819 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.809 ' HD3' ' HA ' ' A' ' 55' ' ' LEU . 35.1 ttpt -75.94 123.64 26.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 110.554 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.6 t -76.21 -41.4 37.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.577 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.46 11.15 80.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.975 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.8 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.889 179.296 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HE2' ' HA ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.825 0.345 . . . . 0.0 110.299 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.447 HG23 HG23 ' A' ' 4' ' ' THR . 14.1 p -63.17 127.61 23.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.317 0.58 . . . . 0.0 110.721 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 m -95.06 60.7 2.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.283 0.563 . . . . 0.0 110.95 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.447 HG23 HG23 ' A' ' 2' ' ' VAL . 16.7 p -108.17 -1.99 19.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.945 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.73 148.17 36.81 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.618 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.28 160.92 47.42 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.606 2.204 . . . . 0.0 111.609 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.46 -172.8 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.344 2.03 . . . . 0.0 111.79 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.5 t -97.89 125.93 42.46 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.34 10.87 0.39 Allowed 'Trans proline' 0 N--CA 1.469 0.052 0 C-N-CA 122.547 2.165 . . . . 0.0 111.81 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.516 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 34.9 mt-30 -125.3 -31.11 3.08 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.991 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.8 m -116.07 -40.25 3.32 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.843 -0.536 . . . . 0.0 110.37 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 75.76 -26.83 0.19 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.272 1.029 . . . . 0.0 113.004 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 m -45.7 -77.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 173.59 30.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.594 0.712 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.712 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 64.7 m-85 -96.63 27.8 3.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.125 -172.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.7 m -101.91 141.42 34.79 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.451 174.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.424 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.8 p90 -148.12 175.82 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.17 121.41 45.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.75 0.705 . . . . 0.0 111.487 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.424 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 33.0 t70 -113.52 75.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.269 0.556 . . . . 0.0 109.59 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.18 -108.75 3.63 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.118 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.24 20.38 18.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.49 -174.17 4.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.571 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 25.0 mt -109.06 136.57 48.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.731 174.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.434 HG13 ' HG3' ' A' ' 31' ' ' GLU . 60.2 t -122.19 131.35 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 122.296 -0.253 . . . . 0.0 110.385 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -101.28 108.96 57.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.712 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 58.7 Cg_endo -71.7 -8.42 23.09 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.907 2.404 . . . . 0.0 111.216 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.52 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 13.8 tp10 -75.87 -70.49 0.43 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.313 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.12 10.55 23.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.33 41.34 23.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.092 0.472 . . . . 0.0 111.992 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.41 ' HB3' HE22 ' A' ' 10' ' ' GLN . 17.8 t-160 -138.74 128.46 24.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.867 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.434 ' HG3' HG13 ' A' ' 24' ' ' VAL . 2.2 mp0 -91.1 161.31 15.15 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.84 161.52 17.84 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 120.947 0.404 . . . . 0.0 110.41 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.534 ' OG ' ' HB3' ' A' ' 36' ' ' GLU . 32.7 t -115.14 137.91 23.23 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.571 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 11.5 Cg_endo -56.47 -33.14 91.58 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.169 2.579 . . . . 0.0 113.219 -173.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -136.98 -45.31 0.57 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.519 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.534 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -52.05 -39.67 59.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.78 -179.005 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.448 ' H ' ' HB3' ' A' ' 33' ' ' SER . . . -64.88 -25.92 68.1 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -177.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.99 -9.71 59.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.6 m -116.25 -65.93 1.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.717 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -176.26 124.74 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.295 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.0 m -72.11 97.16 1.88 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.049 0.452 . . . . 0.0 110.612 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -147.84 173.52 12.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.77 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.57 -23.98 60.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.27 0.557 . . . . 0.0 109.911 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.83 25.65 26.73 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -173.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -83.47 6.16 21.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.871 -0.665 . . . . 0.0 111.483 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.403 HG12 ' CG1' ' A' ' 54' ' ' VAL . 14.5 t -96.41 102.53 13.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.506 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 91' ' ' ASP . 9.6 mm -75.58 137.83 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.627 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.1 OUTLIER -119.17 156.6 29.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.0 176.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.527 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 5.9 m-20 -96.92 -179.01 4.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.224 -176.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.467 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 30.7 t -80.13 -6.54 57.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.964 0.888 . . . . 0.0 109.538 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.498 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.7 t -90.95 -17.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.716 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.13 3.14 57.92 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.211 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.498 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -84.31 167.44 16.57 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.036 0.922 . . . . 0.0 110.819 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 48' ' ' LYS . 24.0 t -117.05 139.28 44.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.887 -1.96 . . . . 0.0 108.255 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.428 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 2.1 mm? -97.33 174.55 6.64 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.37 0.605 . . . . 0.0 110.704 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.544 ' NE2' ' H ' ' A' ' 57' ' ' ASP . 30.4 tp60 -125.24 145.67 49.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.703 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 14.9 t70 -67.76 99.51 0.82 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.625 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.62 -7.21 9.63 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.17 174.99 5.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.944 0.402 . . . . 0.0 110.937 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.5 m -106.91 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.67 166.89 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.1 m -150.54 119.1 6.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.851 0.358 . . . . 0.0 111.355 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -63.66 126.65 22.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.6 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.19 22.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.609 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -143.24 159.53 42.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.534 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.48 100.53 11.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.952 0.882 . . . . 0.0 112.707 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.622 HD23 ' CD2' ' A' ' 110' ' ' PHE . 6.6 mp -110.63 153.71 24.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.038 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -98.76 179.33 4.69 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.777 0.322 . . . . 0.0 111.385 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 72' ' ' SER . 33.7 m -119.55 147.2 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.677 ' HG3' ' H ' ' A' ' 71' ' ' GLY . 18.2 ptmt -77.84 -76.81 0.17 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.677 ' H ' ' HG3' ' A' ' 70' ' ' LYS . . . -92.07 47.96 2.69 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.969 -173.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.555 ' HB2' ' CG2' ' A' ' 69' ' ' VAL . 74.6 m -144.33 176.76 9.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.7 m -104.96 6.43 33.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.604 1.192 . . . . 0.0 108.03 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.495 ' O ' HG22 ' A' ' 69' ' ' VAL . 4.5 mm? -77.91 176.67 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.224 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.1 t -160.02 113.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 63' ' ' VAL . 87.2 t -85.68 93.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.56 0.695 . . . . 0.0 109.503 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.48 148.15 28.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -171.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -48.29 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.92 0.867 . . . . 0.0 111.348 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.59 8.0 3.28 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.107 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 62' ' ' THR . 85.7 m -63.92 103.19 0.55 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 122.153 0.978 . . . . 0.0 109.653 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.664 ' HZ2' ' HB3' ' A' ' 81' ' ' LYS . 5.6 ttpm? -92.5 110.48 21.89 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.096 -174.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 96' ' ' CYS . 56.8 t -126.49 117.88 49.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.758 177.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 55.6 pttt -105.1 163.02 12.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.662 . . . . 0.0 112.11 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.625 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.8 OUTLIER 67.81 42.87 1.86 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.298 174.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.481 HG21 ' HB3' ' A' ' 96' ' ' CYS . 36.1 pt -65.63 -175.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.703 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 12.2 tpp85 -135.01 122.82 22.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.423 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 71.0 mt -76.4 118.91 19.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.401 HG11 ' H ' ' A' ' 89' ' ' ASP . 0.2 OUTLIER -90.1 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.879 -176.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.401 ' H ' HG11 ' A' ' 88' ' ' VAL . 4.4 m-20 -60.41 -44.72 95.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.826 0.346 . . . . 0.0 111.557 -176.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.15 132.98 11.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.274 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.447 ' O ' HG22 ' A' ' 47' ' ' ILE . 15.8 t70 -57.43 -31.77 66.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.286 0.565 . . . . 0.0 110.803 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -81.23 52.1 1.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.081 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.27 138.12 3.05 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 121.319 0.58 . . . . 0.0 112.059 -169.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 108' ' ' SER . 63.6 mt -142.72 125.66 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.204 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 4.5 t70 -104.98 139.04 40.27 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.481 ' HB3' HG21 ' A' ' 85' ' ' ILE . 27.2 p -155.05 165.56 36.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -112.07 135.77 52.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.499 ' HB ' ' CG1' ' A' ' 101' ' ' ILE . 2.2 mm -100.84 98.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.9 105.88 0.14 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.723 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.25 0.68 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.356 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.499 ' CG1' ' HB ' ' A' ' 98' ' ' ILE . 34.2 pt -96.07 -42.63 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.443 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 145.06 -166.11 27.59 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.0 148.38 24.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.998 0.899 . . . . 0.0 110.874 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.3 ttm -140.02 158.61 43.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -117.05 138.37 51.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.5 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -123.96 147.88 47.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.434 -171.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.46 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 13.6 tptm -84.82 122.37 29.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.812 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.554 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -50.97 -39.76 56.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.745 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 50' ' ' SER . 10.4 pt-20 -66.02 -9.05 26.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.294 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.622 ' CD2' HD23 ' A' ' 67' ' ' LEU . 42.1 m-85 -110.74 0.62 17.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.165 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 15.4 m -112.5 170.77 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.458 ' HD2' HG21 ' A' ' 51' ' ' VAL . 22.0 ttt180 -145.66 138.28 25.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.457 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.428 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 87.8 tttt -68.83 119.13 12.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.612 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.17 -47.36 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.02 48.63 25.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.052 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.427 -178.397 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 121.165 0.507 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 p -90.51 130.13 40.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.508 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.9 m 58.49 31.8 21.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.38 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.1 p -85.18 -39.99 17.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.128 0.49 . . . . 0.0 110.476 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt -92.61 150.68 40.18 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.11 156.9 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.223 1.949 . . . . 0.0 111.133 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.49 -163.3 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.9 2.4 . . . . 0.0 112.603 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.4 t -98.32 130.56 28.03 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.402 ' HG3' ' CE3' ' A' ' 32' ' ' TRP . 58.6 Cg_endo -70.47 5.28 2.03 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.287 . . . . 0.0 112.927 -178.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -121.2 -35.13 3.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.241 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.492 ' C ' ' H ' ' A' ' 13' ' ' SER . 58.0 m -104.79 -47.31 4.08 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.49 -0.756 . . . . 0.0 109.511 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.54 -2.35 1.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.08 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.492 ' H ' ' C ' ' A' ' 11' ' ' CYS . 15.0 p -48.32 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.095 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.2 pt-20 170.03 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.263 0.352 . . . . 0.0 111.681 -173.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.652 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 80.8 m-85 -77.79 39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -171.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -103.28 143.31 32.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.515 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.4 ' CE1' ' HD3' ' A' ' 26' ' ' PRO . 23.6 p90 -153.88 176.73 11.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -176.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.71 123.47 47.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.838 0.352 . . . . 0.0 111.441 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -121.17 86.43 2.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.43 -116.16 5.01 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.132 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.77 18.23 22.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.902 0.382 . . . . 0.0 111.789 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.4 -173.49 4.52 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 mt -112.86 138.39 49.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.633 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -126.75 142.75 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 51.7 t -104.5 105.48 50.2 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.733 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.7 Cg_endo -65.84 -15.95 51.02 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.816 2.344 . . . . 0.0 111.512 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.434 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.1 tt0 -71.21 -61.39 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.93 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -98.82 12.76 34.69 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.95 29.54 17.81 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -135.75 133.92 38.49 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.131 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.633 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.4 mp0 -95.11 171.68 8.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.642 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.402 ' CE3' ' HG3' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -166.22 161.83 17.09 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.932 0.396 . . . . 0.0 110.558 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -115.57 113.79 42.65 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.59 -56.79 2.52 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.201 2.601 . . . . 0.0 113.195 -168.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.79 -28.14 24.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.597 -173.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -76.43 -31.29 57.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.842 0.354 . . . . 0.0 110.482 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.212 174.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.92 -32.44 51.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.262 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 m 66.04 -84.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.027 175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.78 15.94 2.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.162 0.506 . . . . 0.0 110.95 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -100.23 12.0 38.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.663 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' CG ' ' H ' ' A' ' 43' ' ' ASP . 12.9 t70 60.74 -170.75 0.15 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.937 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.475 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 35.0 t70 -144.14 89.46 2.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.352 0.596 . . . . 0.0 110.397 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.03 -60.06 0.66 Allowed Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.434 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.847 ' HD3' ' HA ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -101.65 111.7 24.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.774 0.797 . . . . 0.0 111.801 -174.536 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t -142.37 143.34 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.562 HG21 HG13 ' A' ' 94' ' ' ILE . 3.0 mm -89.93 135.44 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.079 -172.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.724 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -115.0 145.71 41.99 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.593 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 70.4 m-20 -104.5 179.43 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.515 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 5.0 t -73.93 -9.22 58.42 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.93 0.872 . . . . 0.0 110.315 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.516 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.1 t -84.91 -18.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.657 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.58 12.7 60.66 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.5 -175.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.593 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -99.72 153.38 19.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.257 0.551 . . . . 0.0 111.112 178.325 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.41 133.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.328 -175.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.551 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.3 mp -96.67 175.17 6.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.25 0.548 . . . . 0.0 111.724 -168.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -124.81 146.98 48.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.666 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 17.8 t70 -70.65 102.21 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 0.0 110.625 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.48 -3.98 13.53 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.27 171.61 10.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.969 -0.615 . . . . 0.0 110.833 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 31.1 m -104.75 137.64 42.25 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -121.16 168.56 13.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.7 m -148.96 118.3 6.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.888 0.375 . . . . 0.0 110.868 175.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 1.1 p -62.91 129.48 26.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.551 ' HA ' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -95.14 10.41 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.442 ' HG2' HG12 ' A' ' 64' ' ' ILE . 74.9 mmtt -138.0 171.1 14.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 119.83 1.195 . . . . 0.0 110.255 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.78 112.23 22.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.496 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.9 mp -130.23 143.44 50.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.984 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -90.99 178.76 5.92 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.793 -0.567 . . . . 0.0 110.343 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.452 HG23 ' HB3' ' A' ' 74' ' ' LEU . 57.8 t -122.24 115.68 46.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -79.16 117.87 20.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -166.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.9 45.76 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.08 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -110.86 172.86 6.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.343 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -98.01 9.16 43.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.532 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 75' ' ' VAL . 14.8 tp -78.85 170.66 16.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.734 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.481 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 72.5 t -158.13 117.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -168.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.499 HG12 HG11 ' A' ' 63' ' ' VAL . 94.3 t -93.48 95.76 5.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.851 0.834 . . . . 0.0 110.544 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.12 151.61 27.04 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.473 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.551 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -52.18 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.824 0.821 . . . . 0.0 110.817 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.16 4.89 3.16 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.174 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.5 m -61.92 104.74 0.49 Allowed 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 122.032 0.92 . . . . 0.0 110.148 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.423 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 30.0 ttpt -89.97 112.65 24.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.921 -175.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.476 HG12 ' HB2' ' A' ' 96' ' ' CYS . 39.1 t -123.67 114.39 41.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 ptmt -104.28 151.29 23.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.642 -175.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 68.88 47.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 124.33 1.019 . . . . 0.0 111.468 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.3 pt -65.89 -179.5 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.058 0.932 . . . . 0.0 113.193 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.666 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 19.4 tpt180 -129.15 122.37 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.636 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.54 HD23 HG12 ' A' ' 47' ' ' ILE . 79.6 mt -83.07 119.64 24.75 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -96.01 169.26 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -175.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.847 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 1.3 m-20 -75.13 92.73 2.7 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.657 0.741 . . . . 0.0 111.501 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.436 ' HA3' ' OD1' ' A' ' 93' ' ' ASP . . . 171.23 -174.07 44.85 Favored Glycine 0 C--N 1.303 -1.277 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.04 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.402 ' O ' HG22 ' A' ' 47' ' ' ILE . 10.9 t70 -103.09 -25.57 13.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.623 0.725 . . . . 0.0 110.101 175.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.443 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 13.8 p-80 -108.35 50.86 0.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.931 -176.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.482 ' HB3' HG21 ' A' ' 88' ' ' VAL . 6.0 m-20 -143.94 89.65 2.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -160.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.562 HG13 HG21 ' A' ' 47' ' ' ILE . 38.1 mt -120.09 113.69 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.322 174.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 13.4 t70 -95.63 139.79 31.38 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.802 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.476 ' HB2' HG12 ' A' ' 82' ' ' VAL . 24.7 p -149.39 159.79 43.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.069 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 14.2 mptt -112.32 135.13 53.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.661 HD12 ' HE1' ' A' ' 104' ' ' MET . 1.8 mm -114.07 109.01 26.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.6 102.02 0.13 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.94 -66.48 0.51 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.829 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.659 HD13 HG13 ' A' ' 98' ' ' ILE . 45.7 pt -86.9 -48.82 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.524 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 141.63 -157.72 26.34 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -176.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -77.37 144.03 38.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 117.939 0.869 . . . . 0.0 110.529 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.698 ' HE3' HD23 ' A' ' 106' ' ' LEU . 52.9 ttp -133.69 151.88 51.75 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.411 ' HD3' ' N ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -112.11 140.67 46.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.698 HD23 ' HE3' ' A' ' 104' ' ' MET . 82.1 mt -120.96 139.58 53.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.464 0.649 . . . . 0.0 111.528 -171.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.407 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 22.2 tptm -80.83 116.23 20.71 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.824 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.724 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 7.5 p -53.98 -34.52 60.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.602 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 50' ' ' SER . 37.5 mt-10 -68.94 -9.87 54.27 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.531 ' O ' HD13 ' A' ' 64' ' ' ILE . 63.8 m-85 -109.41 -4.46 16.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.049 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.631 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.9 m -113.6 173.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.314 0.578 . . . . 0.0 112.12 -174.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.516 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.9 ttt180 -147.07 133.14 19.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.002 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 27.8 tttp -65.1 136.87 57.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.009 176.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.2 -56.56 5.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.588 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.54 49.62 10.98 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.063 -172.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.589 -178.015 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.497 ' HE2' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.143 0.497 . . . . 0.0 111.222 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.497 HG13 ' HE2' ' A' ' 1' ' ' MET . 29.6 m -117.61 153.57 19.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.825 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -148.68 101.85 3.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.017 0.437 . . . . 0.0 110.489 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.5 p -124.79 -55.17 1.62 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.016 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 51.0 mt -79.38 154.38 76.71 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.242 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -70.95 156.85 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.029 1.82 . . . . 0.0 111.344 177.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -73.91 -163.55 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.843 2.362 . . . . 0.0 112.7 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.9 t -98.29 124.2 47.89 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.406 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.45 11.27 0.63 Allowed 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 122.899 2.399 . . . . 0.0 111.563 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.6 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 12.1 mt-30 -120.8 -38.32 2.87 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 -178.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m -108.26 -50.29 3.06 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t30 70.0 7.18 6.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.368 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 5.1 m -54.32 -76.6 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.982 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 13' ' ' SER . 15.5 pt-20 165.66 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.327 0.392 . . . . 0.0 111.977 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.488 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 87.6 m-85 -78.43 33.67 0.2 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -169.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -95.71 139.89 31.29 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.587 0.232 . . . . 0.0 110.563 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 20.9 p90 -147.48 178.09 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.1 122.19 47.26 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.206 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.527 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 24.0 t70 -118.35 89.28 3.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.879 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.46 -106.58 3.43 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.196 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.36 17.34 17.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.417 HD13 ' HB3' ' A' ' 31' ' ' GLU . 1.3 pt? -163.91 -175.05 3.88 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.249 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.4 mt -101.36 135.56 42.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.506 HG11 ' HG3' ' A' ' 31' ' ' GLU . 64.8 t -117.62 130.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 50.4 t -101.6 103.93 31.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 173.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.0 Cg_endo -65.89 -18.65 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.508 2.139 . . . . 0.0 110.969 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.59 -61.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.194 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.401 ' SG ' ' NE2' ' A' ' 10' ' ' GLN . 28.4 p -95.44 11.35 33.18 Favored 'General case' 0 C--O 1.23 0.055 0 O-C-N 121.649 -0.657 . . . . 0.0 112.313 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.63 26.0 15.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -125.94 135.83 52.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.506 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.506 ' HG3' HG11 ' A' ' 24' ' ' VAL . 6.2 mp0 -96.54 158.27 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.529 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -158.9 161.32 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 1.9 p -120.15 128.63 25.74 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.529 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 8.6 Cg_endo -52.26 -47.0 29.14 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.412 2.741 . . . . 0.0 113.215 -170.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -125.62 -26.79 3.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 39' ' ' THR . 2.3 mp0 -68.96 -17.3 63.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.571 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.19 67.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.022 0.439 . . . . 0.0 110.526 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.69 -37.89 20.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.096 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -141.65 136.79 31.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.157 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.19 9.57 14.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.327 0.584 . . . . 0.0 110.5 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -82.07 115.67 21.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.071 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 t70 60.27 -150.66 0.42 Allowed 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.753 0.658 . . . . 0.0 109.226 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.69 -28.57 68.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.984 0.421 . . . . 0.0 111.067 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.27 10.87 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.609 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -64.22 -27.32 68.98 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.121 0.568 . . . . 0.0 112.053 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.496 HG22 HD13 ' A' ' 87' ' ' LEU . 14.4 p -61.47 138.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.034 -172.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.431 HD13 ' N ' ' A' ' 93' ' ' ASP . 6.3 mm -72.84 139.34 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.904 -172.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HG3' HG23 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -126.48 154.44 43.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.11 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 8.3 m-20 -99.95 179.99 4.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.189 0.518 . . . . 0.0 111.467 -174.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 14.7 t -82.8 -13.02 56.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.023 0.916 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.565 HG11 ' ND2' ' A' ' 53' ' ' ASN . 2.0 p -89.24 -0.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.097 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 5.37 68.6 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.277 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.565 ' ND2' HG11 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -108.32 173.16 6.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.536 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 48' ' ' LYS . 4.9 t -115.17 142.31 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.254 -175.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.703 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -98.7 -177.47 3.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 110.251 -177.623 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.449 ' HA ' HD12 ' A' ' 87' ' ' LEU . 14.5 tt0 -136.69 163.41 30.65 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 16.5 t70 -65.26 130.73 44.38 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.611 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.83 -6.96 82.71 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.351 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.87 165.24 20.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.631 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 61.4 m -103.81 137.2 42.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.435 HG21 HD23 ' A' ' 55' ' ' LEU . 1.6 pp -117.72 164.67 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.42 HG23 ' HA2' ' A' ' 79' ' ' GLY . 3.8 m -149.92 112.12 4.65 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -59.8 129.23 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.667 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.554 ' HA ' HG22 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -99.23 15.2 4.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.801 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.37 157.79 45.49 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -89.78 109.18 20.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 112.135 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.431 HD21 ' CD2' ' A' ' 110' ' ' PHE . 12.4 mt -124.59 152.44 43.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.25 177.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -95.81 178.52 5.42 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.997 -0.44 . . . . 0.0 111.291 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.11 130.81 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -74.82 128.53 35.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.837 0.351 . . . . 0.0 111.529 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.15 -13.12 3.6 Favored Glycine 0 CA--C 1.517 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.574 173.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.506 ' HB3' HD22 ' A' ' 74' ' ' LEU . 37.3 m -107.58 155.15 20.43 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.643 -0.328 . . . . 0.0 110.877 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -81.5 8.28 9.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.495 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.506 HD22 ' HB3' ' A' ' 72' ' ' SER . 3.8 mm? -78.6 170.37 16.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.604 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -159.88 117.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.604 HG11 HG13 ' A' ' 63' ' ' VAL . 86.5 t -93.66 95.69 5.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 110.368 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 150.23 27.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.048 -175.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.554 HG22 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -49.94 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.948 0.88 . . . . 0.0 110.759 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.42 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.72 4.79 4.19 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.475 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.8 m -62.36 105.32 0.6 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.871 0.843 . . . . 0.0 110.059 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -89.27 112.68 23.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.75 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.446 HG11 ' HB2' ' A' ' 96' ' ' CYS . 44.7 t -124.59 113.18 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.249 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.631 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.3 ptmt -96.12 167.76 11.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.763 -174.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.611 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 9.1 p30 60.04 39.66 19.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.943 -1.48 . . . . 0.0 112.314 170.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.3 pt -64.18 179.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 -128.69 126.84 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.077 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.496 HD13 HG22 ' A' ' 46' ' ' VAL . 58.2 mt -80.58 120.16 24.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.665 HG21 ' O ' ' A' ' 93' ' ' ASP . 5.3 t -76.2 134.81 28.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.114 0.483 . . . . 0.0 110.742 -172.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.22 -58.9 6.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.371 -172.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.3 -46.35 2.82 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.319 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.524 ' O ' ' HB ' ' A' ' 88' ' ' VAL . 12.3 m-20 -75.65 132.29 40.49 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -80.74 47.91 1.02 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.466 0.65 . . . . 0.0 110.175 178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.665 ' O ' HG21 ' A' ' 88' ' ' VAL . 25.5 m-20 -120.6 178.87 4.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.473 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.598 ' CD1' HG23 ' A' ' 111' ' ' VAL . 66.7 mt -116.23 122.35 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.791 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.51 132.4 42.13 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.091 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.446 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -134.18 142.72 47.52 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -105.32 117.02 32.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.412 ' CD1' ' HE1' ' A' ' 104' ' ' MET . 44.5 mt -117.28 113.33 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.167 -171.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.28 110.64 1.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 143.95 -62.19 0.5 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.815 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 -35.85 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 0.0 111.392 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.94 -147.88 19.46 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.66 147.02 23.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 111.065 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.412 ' HE1' ' CD1' ' A' ' 98' ' ' ILE . 61.2 ttp -144.46 165.87 26.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.881 -178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.98 148.01 34.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.897 0.38 . . . . 0.0 110.195 177.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.0 mt -130.08 140.37 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.912 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.444 ' HG3' ' OE1' ' A' ' 109' ' ' GLU . 9.3 tptp -80.0 115.07 19.37 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.675 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.519 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -50.36 -40.19 48.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.551 ' O ' ' HB2' ' A' ' 50' ' ' SER . 1.6 mp0 -69.6 -10.01 56.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.421 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 67' ' ' LEU . 75.3 m-85 -112.09 -0.12 15.74 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 35.0 m -115.62 174.5 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.259 0.552 . . . . 0.0 112.163 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.455 ' HG3' HG13 ' A' ' 51' ' ' VAL . 19.9 ttt180 -143.22 131.78 22.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.273 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.703 ' HG3' ' HA ' ' A' ' 55' ' ' LEU . 1.9 tmtp? -70.43 119.97 15.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.381 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.25 -48.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.478 ' HA2' ' HE3' ' A' ' 113' ' ' LYS . . . 88.49 44.72 5.17 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.831 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.455 177.014 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.468 ' HG3' HG23 ' A' ' 2' ' ' VAL . 11.7 ptm . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 121.745 0.783 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.468 HG23 ' HG3' ' A' ' 1' ' ' MET . 14.2 t -86.88 60.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 172.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -128.28 142.34 51.18 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.051 -168.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 t -132.6 30.39 4.11 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.526 HD12 HD23 ' A' ' 23' ' ' LEU . 17.8 mt -73.39 161.02 81.02 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.297 -1.319 . . . . 0.0 110.896 -174.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 36.6 Cg_endo -63.45 161.63 30.57 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.551 2.167 . . . . 0.0 111.808 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.518 ' HB3' ' HG3' ' A' ' 14' ' ' GLU . 11.5 Cg_exo -70.44 -170.7 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.775 2.316 . . . . 0.0 112.496 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.46 123.68 49.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.08 9.04 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.545 2.163 . . . . 0.0 111.866 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.586 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 14.5 mt-30 -119.42 -36.21 3.4 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.889 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -110.82 -46.99 3.28 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 121.265 0.555 . . . . 0.0 109.727 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.21 5.83 5.13 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.91 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 m -61.41 -27.5 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.043 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.518 ' HG3' ' HB3' ' A' ' 7' ' ' PRO . 4.4 mt-10 78.06 13.54 1.63 Allowed 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 174.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -81.03 47.46 1.0 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.717 0.77 . . . . 0.0 109.039 170.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 m -99.18 147.12 25.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.961 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -148.08 173.92 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.43 116.05 31.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 0.0 110.582 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -96.94 28.27 3.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.049 0.928 . . . . 0.0 109.675 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.82 -99.7 0.41 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.546 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.27 17.64 22.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.916 0.389 . . . . 0.0 111.577 -173.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -159.83 -176.67 5.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.526 HD23 HD12 ' A' ' 5' ' ' LEU . 3.5 mt -109.98 135.04 51.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -125.76 140.52 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 0.0 109.599 177.425 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 45.9 t -102.36 106.19 47.37 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.475 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 25' ' ' CYS . 33.9 Cg_endo -65.2 -14.66 46.3 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.679 2.253 . . . . 0.0 111.361 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.07 -59.36 2.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.891 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.1 p -99.08 10.14 42.07 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.59 39.85 20.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.8 t60 -139.47 126.72 21.32 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.585 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.47 164.66 11.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.778 177.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -163.99 162.05 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.489 . . . . 0.0 111.026 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.414 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 48.2 t -104.68 123.26 40.79 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.8 Cg_endo -56.82 -36.52 98.77 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.952 2.435 . . . . 0.0 113.112 -171.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -104.41 -43.89 5.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.225 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 42.0 tt0 -64.74 -27.38 68.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.355 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.75 -39.06 90.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.428 . . . . 0.0 110.602 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.53 -52.82 12.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.198 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.572 HG21 ' H ' ' A' ' 41' ' ' SER . 5.2 m -152.84 147.2 25.74 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.081 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . . . -135.08 7.69 3.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.658 0.742 . . . . 0.0 109.729 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.572 ' H ' HG21 ' A' ' 39' ' ' THR . 38.5 t -100.49 2.24 41.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.007 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -105.28 165.54 11.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.741 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.579 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 11.4 t70 -114.11 -47.68 2.93 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.11 -45.13 1.96 Allowed Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.767 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.63 ' HG3' HG22 ' A' ' 46' ' ' VAL . 20.1 pttm -100.28 -28.75 12.82 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.772 -0.252 . . . . 0.0 111.332 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.63 HG22 ' HG3' ' A' ' 45' ' ' LYS . 6.1 t -121.56 153.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 93' ' ' ASP . 2.8 mm -91.66 135.23 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.652 ' O ' ' HB2' ' A' ' 108' ' ' SER . 11.7 ttmt -121.09 155.0 35.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.587 ' OD1' HG23 ' A' ' 111' ' ' VAL . 9.0 m-20 -92.98 176.83 6.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.304 0.573 . . . . 0.0 111.449 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.456 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 13.5 t -79.0 -7.37 58.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.642 174.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.509 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.0 t -91.02 -15.37 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.347 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.98 0.39 60.16 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.509 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -83.45 162.67 20.89 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.901 0.857 . . . . 0.0 110.767 178.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.449 HG21 ' HE2' ' A' ' 48' ' ' LYS . 2.9 t -118.19 130.64 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.909 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' HD21 ' A' ' 55' ' ' LEU . 1.5 mm? -93.76 173.19 7.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.377 0.608 . . . . 0.0 110.645 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.29 150.72 48.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.692 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.574 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 17.7 t70 -67.43 99.14 0.71 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.449 . . . . 0.0 109.891 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 121.72 -7.45 10.27 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.385 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.67 167.96 14.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.698 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.5 m -106.45 131.65 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.574 HG13 HG21 ' A' ' 82' ' ' VAL . 1.9 pp -127.57 169.11 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.721 0.296 . . . . 0.0 110.311 -174.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.408 ' CG2' ' HA2' ' A' ' 79' ' ' GLY . 2.8 m -150.6 121.68 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.574 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.495 HG12 HG11 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -61.93 131.04 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 109.867 176.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.502 ' HA ' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -94.98 10.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HD3' ' O ' ' A' ' 64' ' ' ILE . 58.1 mmtt -139.18 167.63 21.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 119.843 1.201 . . . . 0.0 110.034 -176.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.4 109.86 20.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.176 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 mp -123.95 138.54 54.45 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.466 173.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.02 177.7 5.66 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.651 -0.656 . . . . 0.0 110.265 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 72' ' ' SER . 39.0 t -128.83 120.98 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.558 ' HD3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -84.77 -32.77 23.22 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.558 ' N ' ' HD3' ' A' ' 70' ' ' LYS . . . -86.4 -26.82 32.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.924 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.686 ' HB3' HD23 ' A' ' 74' ' ' LEU . 60.8 m -110.42 163.71 13.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 m -81.37 8.66 8.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.57 0.7 . . . . 0.0 109.96 173.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.686 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.93 172.35 13.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.107 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.4 t -159.35 113.81 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -166.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.495 HG11 HG12 ' A' ' 63' ' ' VAL . 94.8 t -90.97 96.78 6.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.828 0.823 . . . . 0.0 110.246 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.3 pptp? -106.04 148.2 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.502 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.54 96.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.974 0.893 . . . . 0.0 110.605 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.408 ' HA2' ' CG2' ' A' ' 62' ' ' THR . . . 133.09 4.76 3.21 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.005 -177.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 88.7 m -63.53 103.46 0.53 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.959 0.885 . . . . 0.0 109.956 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -92.29 115.3 27.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.654 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.574 HG21 HG13 ' A' ' 61' ' ' ILE . 2.6 m -120.04 119.87 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.808 0.813 . . . . 0.0 110.519 171.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.591 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.0 pttp -103.82 148.8 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.465 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.575 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 71.54 43.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.127 0.892 . . . . 0.0 111.284 176.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.31 -178.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 122.098 0.951 . . . . 0.0 113.016 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -129.74 124.69 34.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.867 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.455 HD13 HG13 ' A' ' 46' ' ' VAL . 71.3 mt -82.63 117.51 22.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.873 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -88.97 167.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.12 -173.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -79.25 70.76 5.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.687 1.232 . . . . 0.0 110.717 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.415 ' HA3' ' OD1' ' A' ' 93' ' ' ASP . . . -163.95 -167.53 24.58 Favored Glycine 0 C--N 1.296 -1.644 0 CA-C-N 113.22 -1.809 . . . . 0.0 112.773 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -102.66 -42.85 5.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.503 0.668 . . . . 0.0 110.903 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -104.24 55.06 0.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.803 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.873 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 4.6 m-20 -137.8 88.67 2.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -160.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.58 ' CD1' HG22 ' A' ' 111' ' ' VAL . 30.5 mt -120.94 111.06 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.557 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 24.7 t70 -94.47 135.31 36.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 p -134.42 142.07 47.02 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.955 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -104.89 119.29 38.65 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.7 mt -118.72 108.81 25.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.292 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -54.66 126.17 22.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.382 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.87 -53.45 0.78 Allowed Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.402 HG13 ' N ' ' A' ' 102' ' ' GLY . 40.6 pt -112.18 -39.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.782 0.325 . . . . 0.0 110.961 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.402 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 135.3 -149.21 19.89 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.98 155.01 19.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.015 0.407 . . . . 0.0 110.863 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -147.21 161.93 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.431 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -107.69 146.89 31.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.26 142.18 50.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.398 0.618 . . . . 0.0 111.452 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -78.05 120.05 22.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.671 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.652 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.9 p -57.11 -34.57 68.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.988 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.456 ' O ' ' HB2' ' A' ' 50' ' ' SER . 4.8 pm0 -70.23 -7.22 40.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.495 ' O ' HD13 ' A' ' 64' ' ' ILE . 55.0 m-85 -112.75 3.63 16.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.587 HG23 ' OD1' ' A' ' 49' ' ' ASP . 29.1 m -110.48 166.53 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.422 0.63 . . . . 0.0 112.531 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -141.3 133.51 27.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.356 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.482 ' HE3' ' CA ' ' A' ' 115' ' ' GLY . 33.0 tttp -65.95 139.49 58.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.22 -42.78 8.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.482 ' CA ' ' HE3' ' A' ' 113' ' ' LYS . . . 79.54 29.56 48.24 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.143 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.85 176.816 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptm . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.176 0.512 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.2 t -76.53 115.02 17.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.512 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -150.73 116.68 5.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.135 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.613 HG22 ' HG ' ' A' ' 5' ' ' LEU . 1.7 t -79.65 -36.11 38.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.543 0.687 . . . . 0.0 109.989 175.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.613 ' HG ' HG22 ' A' ' 4' ' ' THR . 21.9 mt -82.94 168.7 21.2 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.59 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 63.2 Cg_endo -68.88 154.61 70.68 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 121.552 1.501 . . . . 0.0 110.741 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -71.77 -165.78 0.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.669 2.246 . . . . 0.0 112.294 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.7 t -97.75 123.26 52.41 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.046 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.39 11.21 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.895 2.397 . . . . 0.0 111.739 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.597 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 13.7 mt-30 -122.22 -37.68 2.79 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.891 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -107.09 -49.12 3.34 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.247 0.546 . . . . 0.0 109.721 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 70.51 -3.73 1.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.249 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.463 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 8.3 t -54.68 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.371 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.463 ' HB3' ' O ' ' A' ' 13' ' ' SER . 11.3 pt-20 171.68 -8.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.671 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 96.7 m-85 -78.8 35.42 0.24 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 112.017 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -97.82 134.98 40.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.307 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.459 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 27.5 p90 -145.52 171.66 14.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.12 123.22 46.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.067 0.46 . . . . 0.0 110.916 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.69 84.08 2.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.02 -114.03 4.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.225 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.93 20.66 18.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -171.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.72 -174.82 4.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.444 HD21 HD13 ' A' ' 5' ' ' LEU . 35.0 mt -110.58 135.61 50.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -126.31 140.65 48.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.792 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.582 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -107.49 106.22 57.88 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.176 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.671 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.3 Cg_endo -68.46 -14.31 39.58 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.704 2.27 . . . . 0.0 110.79 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.582 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 32.6 tt0 -66.09 -58.78 4.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.076 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.18 8.74 36.31 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.46 49.36 13.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.429 0.559 . . . . 0.0 112.112 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -147.72 128.09 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.01 171.62 8.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -168.75 162.16 11.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.445 ' CB ' ' HB2' ' A' ' 36' ' ' GLU . 5.9 m -119.81 116.31 33.08 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.63 -37.19 98.15 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.319 2.68 . . . . 0.0 113.106 -170.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -112.51 -37.85 4.82 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.657 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HB2' ' CB ' ' A' ' 33' ' ' SER . 20.7 mp0 -70.0 -15.47 63.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.66 -171.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.34 -49.98 8.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.088 0.471 . . . . 0.0 110.8 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.11 -37.14 46.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.33 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 m -103.74 173.71 6.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.549 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.33 143.19 45.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.4 m -84.8 7.86 19.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.145 0.498 . . . . 0.0 111.307 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.59 155.39 22.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.441 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.5 t70 179.38 -37.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.686 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.96 47.56 0.28 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.314 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 3.3 mmpt? -97.05 -9.37 28.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.808 0.337 . . . . 0.0 110.846 -175.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.454 HG12 HD13 ' A' ' 87' ' ' LEU . 2.6 t -121.87 136.49 58.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.045 0.45 . . . . 0.0 110.96 -174.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 93' ' ' ASP . 2.5 mm -105.32 141.22 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.058 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.706 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -105.03 165.79 10.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.0 111.739 -178.102 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.583 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.9 m-20 -109.97 172.7 6.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.784 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.563 ' HB3' HD13 ' A' ' 64' ' ' ILE . 36.1 t -77.22 -7.46 55.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.56 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.4 p -93.2 0.31 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.257 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 4.08 69.86 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.285 171.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.56 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -105.02 168.25 9.17 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.829 -0.748 . . . . 0.0 112.14 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.4 t -113.66 137.08 48.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.847 -174.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.525 HD21 HG21 ' A' ' 61' ' ' ILE . 9.2 mt -89.88 172.84 8.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.581 0.705 . . . . 0.0 112.097 -171.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.458 HE21 ' HB3' ' A' ' 56' ' ' GLN . 2.2 tt0 -121.84 142.63 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.571 173.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.631 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 6.4 t70 -67.03 105.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.041 0.448 . . . . 0.0 110.375 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.411 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 114.49 -0.84 23.55 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -80.2 174.25 11.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.306 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.596 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 26.9 m -102.56 139.18 38.49 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.525 HG21 HD21 ' A' ' 55' ' ' LEU . 2.1 pp -118.66 165.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 m -147.97 118.39 7.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.835 0.35 . . . . 0.0 110.084 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.64 HG13 HG11 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.22 127.51 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.754 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.42 19.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.754 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.1 mptp? -135.62 163.93 29.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.427 ' O ' HD22 ' A' ' 67' ' ' LEU . 5.6 p-10 -86.83 113.39 22.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.933 0.873 . . . . 0.0 111.72 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.437 HD13 ' CG ' ' A' ' 110' ' ' PHE . 18.3 mt -125.4 148.05 48.94 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.98 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -98.31 177.12 5.47 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.8 170.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 57.3 t -125.15 131.42 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -83.1 -38.96 21.75 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.48 -25.03 59.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.254 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.8 m -115.11 171.6 7.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.234 0.54 . . . . 0.0 111.774 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.0 t -92.07 1.9 56.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.398 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.433 HD23 HD13 ' A' ' 101' ' ' ILE . 10.7 mp -79.68 136.49 36.81 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.464 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.03 133.69 43.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.006 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.64 HG11 HG13 ' A' ' 63' ' ' VAL . 53.5 t -89.03 100.56 10.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.615 0.722 . . . . 0.0 109.925 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -105.18 150.44 25.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.721 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -51.31 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.848 0.832 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.13 4.82 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.16 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.0 m -61.29 105.45 0.5 Allowed 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 122.147 0.975 . . . . 0.0 110.129 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -90.84 114.24 26.61 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.206 -173.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.593 HG11 ' HB2' ' A' ' 96' ' ' CYS . 21.5 t -123.72 117.26 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.027 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.596 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 11.3 ptmm? -99.92 154.03 18.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.558 -173.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.411 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 16.2 m-80 64.25 50.01 2.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.685 175.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.8 pt -65.66 177.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.826 0.822 . . . . 0.0 112.725 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.631 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 10.3 tpt180 -131.69 125.52 32.3 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.076 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.454 HD13 HG12 ' A' ' 46' ' ' VAL . 36.3 mt -84.25 118.33 24.1 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.533 ' O ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -100.06 179.16 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.48 -175.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.14 93.91 7.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.15 0.976 . . . . 0.0 111.915 -171.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.52 -174.43 37.21 Favored Glycine 0 C--N 1.298 -1.547 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.403 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.12 -20.51 14.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.782 0.791 . . . . 0.0 110.578 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -106.61 47.86 0.86 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.031 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.573 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.3 m-20 -142.0 89.81 2.21 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -160.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.581 ' CD1' HG23 ' A' ' 111' ' ' VAL . 50.5 mt -121.22 116.49 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.388 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 30.8 t70 -93.96 128.42 40.27 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.77 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.593 ' HB2' HG11 ' A' ' 82' ' ' VAL . 25.3 p -130.86 137.12 49.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.071 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -107.72 118.85 37.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.469 HD12 ' HE2' ' A' ' 104' ' ' MET . 29.8 mt -117.84 108.27 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 -171.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -63.93 107.61 1.28 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.434 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.27 -45.04 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.394 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.433 HD13 HD23 ' A' ' 74' ' ' LEU . 15.6 pt -120.29 -37.54 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.87 0.366 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.27 -153.33 21.85 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.26 151.92 21.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.092 0.446 . . . . 0.0 110.503 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.609 ' HE1' HD21 ' A' ' 106' ' ' LEU . 54.8 ttp -143.15 164.17 30.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.95 147.92 37.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 0.0 110.379 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.609 HD21 ' HE1' ' A' ' 104' ' ' MET . 90.1 mt -129.52 144.01 51.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.791 -171.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -81.5 120.44 25.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.279 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.706 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 2.5 m -50.89 -36.91 40.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.328 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 50' ' ' SER . 42.8 mt-10 -71.32 -5.4 32.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.462 ' O ' HD11 ' A' ' 64' ' ' ILE . 55.0 m-85 -114.36 -2.75 13.2 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.857 -0.737 . . . . 0.0 112.749 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.583 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 34.8 m -113.72 172.7 3.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.464 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 25.0 ttt180 -151.74 133.94 15.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.582 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.48 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.4 tttt -65.28 123.16 18.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.19 174.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.47 -51.91 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.871 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.16 39.06 16.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.318 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.389 179.172 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.927 0.394 . . . . 0.0 111.698 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 p -118.48 111.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.383 0.611 . . . . 0.0 110.569 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.6 m -75.69 142.34 42.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.903 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.2 p -97.84 0.64 47.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.349 -175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.401 HD13 ' CD ' ' A' ' 18' ' ' GLU . 55.2 mt -110.29 158.77 34.33 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.97 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.49 157.45 56.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.1 1.867 . . . . 0.0 110.688 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.6 -174.64 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.093 . . . . 0.0 113.258 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.764 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 34.3 t -99.6 123.22 48.76 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.458 ' HG2' ' OE1' ' A' ' 10' ' ' GLN . 39.2 Cg_endo -70.01 7.27 1.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 121.887 1.725 . . . . 0.0 112.059 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.764 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 1.2 mp0 -103.0 -54.26 2.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.307 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.483 ' C ' ' H ' ' A' ' 13' ' ' SER . 28.4 p -117.77 -28.29 6.01 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.0 t30 75.88 -28.55 0.18 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.287 0.635 . . . . 0.0 112.287 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 11' ' ' CYS . 63.5 p -32.5 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.574 1.171 . . . . 0.0 113.401 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.0 pt-20 169.35 -4.93 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.534 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.6 m-85 -81.16 42.41 0.65 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.27 0.557 . . . . 0.0 111.747 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -109.26 148.56 30.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.853 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' CE1' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -150.09 174.1 13.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.441 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.2 pm0 -102.77 115.61 30.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.377 0.608 . . . . 0.0 111.268 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.51 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 10.7 t70 -122.86 83.65 2.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.824 174.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.97 -126.38 8.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.336 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.47 17.61 23.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.962 0.41 . . . . 0.0 111.372 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.7 -174.07 4.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.1 mt -120.23 136.82 54.52 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.79 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -125.12 143.58 38.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.259 -179.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.1 t -104.22 104.21 42.84 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 23.0 Cg_endo -61.49 -22.1 73.64 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.843 2.362 . . . . 0.0 111.179 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -74.15 -59.7 2.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.7 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.2 m -74.48 -9.91 59.05 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.72 44.83 25.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.314 0.578 . . . . 0.0 110.433 -170.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -145.1 122.94 11.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.79 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.6 mp0 -91.62 157.92 16.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.787 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -158.3 163.13 37.67 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 22.6 t -125.5 124.41 25.05 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.57 -30.96 90.36 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.075 2.517 . . . . 0.0 113.023 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -111.86 -29.89 7.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.626 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 28.3 tt0 -90.04 -4.62 57.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.474 -173.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.22 -32.91 74.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 111.074 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.11 70.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.794 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 m 69.96 -73.85 0.09 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.226 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.86 113.49 3.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.225 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.1 m -82.59 90.17 6.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.337 0.589 . . . . 0.0 110.237 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.56 150.52 47.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.455 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -118.98 81.46 1.7 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.449 0.642 . . . . 0.0 110.513 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.28 41.88 2.04 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.447 170.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HB2' ' HZ2' ' A' ' 45' ' ' LYS . 10.2 mtmp? -104.26 -20.23 13.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.716 0.294 . . . . 0.0 110.985 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.01 139.83 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.63 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.482 HD12 ' C ' ' A' ' 90' ' ' GLY . 2.0 mm -78.79 117.01 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.429 -173.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 108' ' ' SER . 1.2 mtmt -100.01 150.11 22.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.092 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.565 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 9.2 m-20 -90.5 176.64 6.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.516 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.6 t -77.09 -7.97 56.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.722 0.772 . . . . 0.0 110.761 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.573 HG12 ' ND2' ' A' ' 53' ' ' ASN . 2.1 p -97.3 -2.25 10.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.18 0.99 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.01 3.92 79.06 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.976 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.573 ' ND2' HG12 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -92.91 154.76 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.685 0.743 . . . . 0.0 111.017 177.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.3 109.94 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.612 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 HD23 ' HB2' ' A' ' 113' ' ' LYS . 94.2 mt -58.76 145.7 39.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.383 175.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -120.51 148.94 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.709 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.412 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 1.2 t70 -63.94 126.36 27.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 88.66 2.01 79.63 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.816 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 173.64 12.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.967 0.383 . . . . 0.0 110.473 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.69 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 11.4 m -101.59 139.82 36.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.569 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.432 HG22 HD21 ' A' ' 55' ' ' LEU . 2.0 pp -124.47 165.39 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.448 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 m -150.61 115.6 5.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.438 175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.65 HG13 HG11 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.07 129.97 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.548 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -103.06 17.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.468 178.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.26 161.44 34.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.444 ' O ' HD22 ' A' ' 67' ' ' LEU . 5.5 p-10 -85.55 111.31 19.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.938 0.875 . . . . 0.0 111.156 169.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.466 HD12 ' CB ' ' A' ' 110' ' ' PHE . 20.1 mt -124.43 133.88 53.25 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.145 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -88.28 173.2 8.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.749 -0.594 . . . . 0.0 109.963 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.497 ' CG1' ' HB2' ' A' ' 72' ' ' SER . 21.7 t -128.92 120.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' HE2' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -93.36 -2.83 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.475 -170.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.14 26.31 6.45 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.497 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 58.2 m -146.49 -177.69 5.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -177.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -100.87 -12.12 19.25 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.402 HD21 HD12 ' A' ' 101' ' ' ILE . 9.8 mp -79.22 142.45 36.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.786 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.98 126.64 67.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.359 167.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.65 HG11 HG13 ' A' ' 63' ' ' VAL . 76.0 t -77.73 104.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.44 150.39 26.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.448 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.548 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -52.34 96.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 121.776 0.798 . . . . 0.0 110.501 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.32 4.13 3.68 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.23 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 89.8 m -62.76 105.1 0.61 Allowed 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.478 0.656 . . . . 0.0 110.67 176.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -91.07 120.53 32.11 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.551 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.525 HG11 ' HB2' ' A' ' 96' ' ' CYS . 59.8 t -129.7 116.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.745 174.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.69 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.8 pttm -102.92 159.51 15.43 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.253 -175.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.575 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 46.5 m-80 65.25 48.53 2.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.453 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.9 pt -67.94 -178.95 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 11.1 tpp85 -136.44 124.39 22.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.602 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.428 ' HB3' HG12 ' A' ' 47' ' ' ILE . 36.9 mt -79.83 125.38 29.63 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.042 -0.411 . . . . 0.0 110.086 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -105.74 121.68 58.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.107 -177.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 69.51 -0.76 2.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.594 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.482 ' C ' HD12 ' A' ' 47' ' ' ILE . . . 57.99 0.98 0.53 Allowed Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.178 -169.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' A' ' 92' ' ' HIS . 31.2 t70 -104.16 -98.32 0.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.479 ' HB2' ' OD2' ' A' ' 91' ' ' ASP . 1.5 t60 -109.67 53.6 0.68 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -166.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.421 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.3 m-20 -173.28 143.17 1.07 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -165.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 111' ' ' VAL . 27.7 mt -139.36 115.17 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.07 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 20.5 t70 -92.73 133.99 35.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.313 0.578 . . . . 0.0 110.349 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.525 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -142.8 154.31 44.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.602 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 96.1 mttt -125.46 132.22 52.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mt -122.38 113.63 39.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.705 -167.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.75 100.69 0.95 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.215 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.75 -62.91 0.42 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.558 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.402 HD12 HD21 ' A' ' 74' ' ' LEU . 20.0 pt -95.9 -46.19 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.986 0.422 . . . . 0.0 110.483 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 141.76 -155.82 25.56 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.607 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -81.85 144.75 30.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.757 0.279 . . . . 0.0 110.801 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.3 ttt -138.52 158.83 43.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 110.827 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.423 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.2 OUTLIER -111.16 137.17 49.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.816 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.514 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 86.3 mt -123.85 142.01 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.493 0.664 . . . . 0.0 111.455 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mptt -92.9 121.24 34.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.256 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.3 p -51.88 -37.56 52.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.172 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -72.06 -6.75 44.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.844 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.466 ' CB ' HD12 ' A' ' 67' ' ' LEU . 60.5 m-85 -111.71 -4.13 14.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.891 -0.506 . . . . 0.0 111.995 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 34.8 m -114.88 175.36 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.47 ' HG3' HG11 ' A' ' 51' ' ' VAL . 26.7 ttt180 -151.46 130.98 12.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.423 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.483 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.1 tttt -66.63 122.21 17.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.338 175.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.44 -44.28 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.271 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.87 9.81 85.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.298 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.85 -178.51 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.562 HD13 HD22 ' A' ' 23' ' ' LEU . 11.2 mt . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 41.8 Cg_endo -64.89 160.01 43.19 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.319 2.013 . . . . 0.0 111.423 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.78 -169.69 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.079 1.853 . . . . 0.0 112.161 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 8.4 t -97.35 123.61 52.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.19 11.31 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.961 2.441 . . . . 0.0 111.806 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.491 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 39.7 mt-30 -122.73 -34.7 3.18 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.9 m -112.68 -45.13 3.25 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.785 -0.572 . . . . 0.0 110.489 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 12.91 7.49 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.02 0.914 . . . . 0.0 110.511 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.602 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 20.9 p -67.12 -32.19 73.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.926 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 84.85 5.76 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.011 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.602 ' HD1' ' HB2' ' A' ' 13' ' ' SER . 83.7 m-85 -82.7 47.32 1.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.689 0.757 . . . . 0.0 109.804 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -102.65 150.23 23.65 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.121 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.4 p90 -142.0 169.11 18.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.68 117.78 35.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.178 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.532 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 t70 -110.04 74.76 0.9 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.99 -102.8 2.72 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.208 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.85 18.69 15.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.08 -175.42 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 5' ' ' LEU . 5.8 mt -108.93 133.99 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 31' ' ' GLU . 49.9 t -118.66 128.04 75.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 52.3 t -97.9 108.34 45.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.33 -7.21 20.84 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.596 2.197 . . . . 0.0 111.387 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.4 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 48.2 tt0 -79.22 -67.48 0.75 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.65 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.05 9.19 29.0 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.297 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.14 46.79 12.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 112.007 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -144.18 125.91 15.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.415 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -93.44 149.03 21.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.553 176.287 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -153.27 161.84 41.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -119.58 129.94 25.1 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.484 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 12.0 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.893 2.396 . . . . 0.0 112.826 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.59 HG13 HD13 ' A' ' 87' ' ' LEU . 6.2 t . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -69.69 119.37 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.191 0.307 . . . . 0.0 110.655 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.7 OUTLIER -106.78 146.35 30.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.524 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.47 ' OD1' HG23 ' A' ' 111' ' ' VAL . 12.8 m-20 -90.0 175.51 7.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.621 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 7.0 t -74.37 -4.0 33.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.094 0.95 . . . . 0.0 110.12 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.483 HG21 ' HD2' ' A' ' 112' ' ' ARG . 3.5 t -87.88 -14.42 9.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.0 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.77 7.97 68.03 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.823 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -104.48 164.54 11.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.678 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.443 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.7 t -109.65 140.14 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.045 -173.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.598 HD22 HG22 ' A' ' 61' ' ' ILE . 24.9 mt -95.73 172.73 7.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.332 0.587 . . . . 0.0 111.136 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.436 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 53.7 tt0 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.712 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.497 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 13.6 t70 -69.13 94.96 0.71 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.193 0.52 . . . . 0.0 109.617 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.65 -11.0 6.72 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.2 t70 -72.04 169.51 15.82 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.304 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 83' ' ' LYS . 3.0 m -100.49 135.43 41.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.598 HG22 HD22 ' A' ' 55' ' ' LEU . 1.8 pp -121.42 163.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.0 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -150.27 119.91 7.0 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.172 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.875 HG11 HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -60.76 128.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.747 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.55 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -98.92 17.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 4.3 mptp? -142.09 166.57 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.547 -0.721 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -77.12 105.89 8.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.102 0.953 . . . . 0.0 111.101 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 2.4 mm? -114.84 126.44 54.82 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.675 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.87 171.7 14.18 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.407 HG11 ' HB2' ' A' ' 72' ' ' SER . 40.2 t -126.78 120.56 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.51 -45.0 69.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.64 -10.39 57.95 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.932 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.407 ' HB2' HG11 ' A' ' 69' ' ' VAL . 26.1 m -111.93 153.65 26.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.951 0.405 . . . . 0.0 111.144 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -71.04 -12.01 61.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.9 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mp -79.44 137.92 37.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.213 0.53 . . . . 0.0 111.121 -174.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.13 127.21 66.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.193 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.875 HG12 HG11 ' A' ' 63' ' ' VAL . 69.7 t -81.97 116.42 26.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.479 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -109.07 149.2 29.64 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.516 -176.242 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -50.04 97.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.838 0.828 . . . . 0.0 110.266 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.69 3.43 5.05 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.081 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 m -62.57 105.76 0.68 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 122.071 0.938 . . . . 0.0 110.163 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -88.36 116.85 26.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 -174.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 61' ' ' ILE . 93.5 t -129.09 110.16 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.781 ' HB3' HG23 ' A' ' 60' ' ' THR . 26.2 pttm -102.07 165.77 10.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.908 0.385 . . . . 0.0 111.624 -174.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.555 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 4.3 m-20 63.57 44.06 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.739 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 55' ' ' LEU . 39.6 pt -65.83 174.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.048 0.928 . . . . 0.0 113.064 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 2.2 tpp180 -122.56 123.93 42.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.941 -1.482 . . . . 0.0 108.236 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 HG13 ' A' ' 46' ' ' VAL . 42.5 mt -83.0 119.39 24.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--N 1.319 -0.726 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 88' ' ' VAL . 9.4 m-20 . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.822 HG13 HG21 ' A' ' 47' ' ' ILE . 3.9 mp -110.55 116.6 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 170.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 28.1 t70 -94.1 130.36 40.3 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.47 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -144.22 154.58 43.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.567 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 98.7 mttt -121.18 129.5 53.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.0 mt -121.37 118.93 57.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.419 -170.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.11 120.91 8.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.743 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.35 -80.77 0.31 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 102' ' ' GLY . 26.1 pt -74.93 -46.03 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.733 0.301 . . . . 0.0 111.476 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 137.27 -150.84 20.86 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.89 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.86 146.82 24.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.656 0.265 . . . . 0.0 110.85 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.9 ttt -142.31 163.39 32.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.236 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.25 140.03 49.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.6 mt -120.04 144.1 47.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.121 0.486 . . . . 0.0 111.419 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 16.9 ttmt -80.89 118.76 22.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.977 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.689 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 3.3 m -49.08 -37.59 21.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.48 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 50' ' ' SER . 27.7 mt-10 -72.08 -8.62 55.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.279 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.454 ' CG ' HD21 ' A' ' 67' ' ' LEU . 33.9 m-85 -113.46 -0.62 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.174 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 21.9 m -113.51 171.69 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.798 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.483 ' HD2' HG21 ' A' ' 51' ' ' VAL . 13.5 ttt180 -150.29 138.21 20.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.641 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 113' ' ' LYS . 26.5 ttpt -62.88 117.11 5.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.857 165.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -55.59 -56.05 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.14 -0.05 13.03 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.325 176.431 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.572 HD13 HD22 ' A' ' 23' ' ' LEU . 31.9 mt . . . . . 0 C--O 1.233 0.202 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 61.1 Cg_endo -69.43 158.35 57.72 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.868 1.712 . . . . 0.0 110.742 171.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 6.5 Cg_exo -73.06 -167.51 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.461 2.107 . . . . 0.0 112.4 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.4 t -98.36 125.68 42.34 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.522 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.44 7.76 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.804 2.336 . . . . 0.0 112.314 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.447 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 41.1 mt-30 -119.36 -38.44 3.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.8 m -107.23 -46.95 3.77 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.311 0.577 . . . . 0.0 109.917 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.36 0.81 2.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.414 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 m -57.88 -77.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.354 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 171.15 -21.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 73.2 m-85 -78.87 36.99 0.29 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -167.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -101.01 144.34 30.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.263 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -146.12 173.41 12.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.453 ' CD ' HD11 ' A' ' 5' ' ' LEU . 1.2 pm0 -101.7 119.42 38.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.575 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 15.7 t70 -120.18 75.42 1.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.12 -119.64 6.58 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.903 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.64 16.46 25.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.723 0.297 . . . . 0.0 111.72 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.6 pt? -152.24 -176.54 5.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.737 0.303 . . . . 0.0 110.293 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 5' ' ' LEU . 17.0 mt -111.69 130.7 55.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.17 127.94 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.2 t -102.6 103.98 35.56 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -70.07 -9.86 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.836 2.357 . . . . 0.0 110.65 176.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.624 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 74.0 tt0 -70.08 -65.02 0.78 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.991 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -95.12 11.41 32.31 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 43.69 19.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 111.824 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -150.1 136.33 18.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.928 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -107.63 166.77 10.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -162.3 161.85 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -112.93 124.73 31.06 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.57 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.5 Cg_endo . . . . . 0 C--N 1.345 0.39 0 C-N-CA 123.304 2.669 . . . . 0.0 113.815 -168.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 87' ' ' LEU . 2.8 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.61 HD11 ' O ' ' A' ' 88' ' ' VAL . 3.1 mm -91.17 138.1 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.5 ttmt -121.06 149.49 42.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.316 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.588 ' OD1' HG23 ' A' ' 111' ' ' VAL . 6.8 m-20 -90.05 -179.79 5.77 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.273 0.559 . . . . 0.0 111.542 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 28.4 t -83.85 -3.21 57.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.014 0.911 . . . . 0.0 110.005 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 112' ' ' ARG . 4.6 t -92.39 -14.42 8.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.819 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.62 3.28 59.67 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.688 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.68 163.39 16.57 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.933 0.873 . . . . 0.0 111.423 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 48' ' ' LYS . 2.6 t -117.69 135.18 58.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.663 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 87' ' ' LEU . 1.4 mm? -95.79 -157.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 111.278 -172.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 44.4 tt0 -159.56 146.34 16.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -70.59 97.85 1.39 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.811 0.815 . . . . 0.0 110.012 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 125.34 -6.6 8.09 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.941 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.592 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 40.9 t0 -73.87 167.8 20.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.719 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.2 m -110.88 134.2 52.74 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.47 171.86 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 6.0 m -150.12 119.34 6.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.789 0.328 . . . . 0.0 111.56 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.651 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -59.82 132.16 24.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 122.886 0.474 . . . . 0.0 110.155 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.727 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -104.68 19.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.727 ' HD2' HG12 ' A' ' 64' ' ' ILE . 4.9 mptp? -138.26 161.88 35.76 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -84.83 101.4 12.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.294 171.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD21 ' CG ' ' A' ' 110' ' ' PHE . 6.3 mp -112.96 145.66 40.41 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.86 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.37 173.97 8.42 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.876 0.369 . . . . 0.0 111.238 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 60.7 t -126.68 137.78 56.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -104.03 138.51 40.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.97 -37.45 3.5 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.36 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -110.56 155.62 22.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -80.35 -0.96 39.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 2.2 mm? -80.91 141.64 34.36 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.195 0.521 . . . . 0.0 111.409 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.2 t -112.71 134.83 54.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.466 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.651 HG12 HG11 ' A' ' 63' ' ' VAL . 78.6 t -83.68 99.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.028 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.15 148.64 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.265 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.98 96.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 122.038 0.923 . . . . 0.0 111.063 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.93 3.95 3.47 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.123 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.1 m -62.17 104.5 0.49 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.522 0.677 . . . . 0.0 110.294 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -87.17 116.2 25.08 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.651 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG11 ' HB2' ' A' ' 96' ' ' CYS . 18.2 t -125.31 116.58 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 pttm -104.71 162.51 13.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.564 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 74.6 m-20 66.81 38.65 3.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.341 170.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.5 pt -67.58 -178.72 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 122.168 0.985 . . . . 0.0 113.486 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 16.5 tpp180 -130.05 129.63 43.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.611 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.505 HD13 HG13 ' A' ' 46' ' ' VAL . 82.3 mt -84.88 123.74 30.82 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.765 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.798 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.765 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.4 m-20 . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 106' ' ' LEU . 51.6 mt -125.96 117.41 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.328 0.585 . . . . 0.0 111.334 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 26.2 t70 -94.57 131.97 39.76 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.544 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.594 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.8 p -134.16 138.83 45.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.857 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -112.58 127.13 56.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.11 109.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.893 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.58 94.98 2.23 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.42 -56.39 0.31 Allowed Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.207 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.465 HG21 HD21 ' A' ' 74' ' ' LEU . 48.1 pt -104.39 -42.28 7.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.339 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 143.09 -158.87 27.35 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.024 -0.607 . . . . 0.0 111.698 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.2 144.42 26.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.728 0.299 . . . . 0.0 110.629 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.3 tpt -134.64 155.58 50.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.856 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.45 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -101.41 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.915 177.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 99.0 mt -130.85 136.6 48.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.674 0.75 . . . . 0.0 111.504 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.61 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 30.9 mttm -84.82 114.68 22.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.463 175.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.723 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.7 p -53.5 -35.76 60.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.137 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.61 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 5.9 pt-20 -61.31 -14.73 29.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.497 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.453 ' O ' HD13 ' A' ' 64' ' ' ILE . 56.6 m-85 -112.72 2.3 16.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.969 -0.457 . . . . 0.0 112.224 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.686 HG22 ' HA ' ' A' ' 108' ' ' SER . 17.8 m -114.14 170.3 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.38 0.609 . . . . 0.0 112.297 -173.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.495 ' HB2' HG21 ' A' ' 51' ' ' VAL . 7.5 ttt180 -142.09 141.22 32.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.291 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -71.03 140.76 50.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.369 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.0 t -105.03 -49.41 9.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.285 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.78 31.45 73.07 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.814 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.992 179.812 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.684 0.278 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.78 161.48 45.28 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.501 2.134 . . . . 0.0 111.201 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.28 -167.03 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.354 2.036 . . . . 0.0 111.769 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 10.7 t -98.47 129.2 30.89 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.628 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.98 8.47 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.581 2.188 . . . . 0.0 111.34 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.633 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 46.0 mt-30 -119.36 -38.45 3.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.555 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.4 m -108.63 -52.89 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.589 0.709 . . . . 0.0 109.53 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 71.76 3.22 4.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.474 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.684 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 14.8 m -59.5 -77.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.615 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 13' ' ' SER . 16.3 pt-20 176.91 -15.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.518 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 25.8 m-85 -81.81 32.74 0.37 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.386 0.539 . . . . 0.0 112.007 -169.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -91.9 135.72 33.71 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.0 p90 -143.62 170.07 16.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -98.66 118.92 36.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.722 0.296 . . . . 0.0 111.296 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.536 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 32.9 t70 -123.3 86.15 2.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 171.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.61 -111.79 3.99 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.406 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.1 18.86 18.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.7 -175.08 5.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 110.39 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 32' ' ' TRP . 43.9 mt -110.1 131.24 55.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.633 174.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG13 ' HG3' ' A' ' 31' ' ' GLU . 57.6 t -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.949 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 41.7 t -104.24 103.16 37.09 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.2 Cg_endo -69.73 -15.43 37.18 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.366 2.044 . . . . 0.0 109.645 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.949 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 28.2 tt0 -64.16 -44.46 92.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.657 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.4 p -118.06 11.83 13.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 171.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.21 47.19 14.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -143.61 131.49 21.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.493 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HG3' HG13 ' A' ' 24' ' ' VAL . 2.0 mp0 -91.73 145.34 24.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.446 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.445 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -150.16 160.99 43.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.222 0.534 . . . . 0.0 110.933 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -118.15 124.51 28.61 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 18.3 Cg_endo . . . . . 0 C--N 1.34 0.106 0 C-N-CA 122.672 2.248 . . . . 0.0 111.745 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.577 HG13 HD13 ' A' ' 87' ' ' LEU . 10.3 t . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.512 HD11 ' O ' ' A' ' 88' ' ' VAL . 2.2 mm -101.34 140.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -107.13 179.71 4.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.886 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.792 ' OD2' HD11 ' A' ' 55' ' ' LEU . 84.0 m-20 -120.35 -179.65 4.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.26 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 8.6 t -75.44 -6.44 50.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.257 1.027 . . . . 0.0 109.161 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.53 HG21 ' HD2' ' A' ' 112' ' ' ARG . 4.2 t -92.53 -15.55 8.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.884 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.38 -1.4 76.32 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.2 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.54 161.04 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.237 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 48' ' ' LYS . 16.6 t -115.04 135.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.48 -173.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.792 HD11 ' OD2' ' A' ' 49' ' ' ASP . 3.1 mp -103.18 -178.19 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 110.853 -168.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.533 ' HA ' HD11 ' A' ' 87' ' ' LEU . 8.5 tt0 -132.07 157.82 43.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.425 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.401 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 16.7 p-10 -73.87 133.85 43.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 172.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 90.07 -9.47 77.25 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.573 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.06 169.2 18.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.709 0.29 . . . . 0.0 110.909 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 4.6 m -105.02 135.98 45.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CG2' HD13 ' A' ' 85' ' ' ILE . 1.8 pp -124.04 168.96 15.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.8 m -150.14 117.92 6.22 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.48 0.312 . . . . 0.0 110.675 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.715 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.01 131.24 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 176.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.523 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -100.11 16.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -135.73 158.15 45.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -85.94 104.83 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.983 0.897 . . . . 0.0 111.361 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD11 ' CB ' ' A' ' 110' ' ' PHE . 18.5 mt -119.98 146.44 45.84 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.474 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -85.62 175.13 8.94 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.378 0.608 . . . . 0.0 111.415 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 76' ' ' VAL . 85.3 t -120.99 128.82 76.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -92.08 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.314 0.506 . . . . 0.0 110.635 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.35 -21.22 22.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.588 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -115.95 157.94 23.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -87.59 5.47 39.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.039 0.447 . . . . 0.0 110.867 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.73 136.6 34.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.565 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.32 134.79 44.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.166 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.715 HG12 HG11 ' A' ' 63' ' ' VAL . 59.2 t -85.92 101.71 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.536 0.684 . . . . 0.0 109.665 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.65 148.46 25.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.438 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.92 96.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.874 0.845 . . . . 0.0 110.647 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.415 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.04 6.22 4.06 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.9 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.0 m -62.19 103.97 0.43 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.695 0.76 . . . . 0.0 109.669 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.75 111.85 23.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 96' ' ' CYS . 46.2 t -117.62 115.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 50.1 pttt -101.8 149.87 23.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.779 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 46.7 m-80 68.91 48.05 0.75 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.098 0.874 . . . . 0.0 111.245 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.605 HG22 ' SG ' ' A' ' 96' ' ' CYS . 44.5 pt -66.58 -175.53 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 122.064 0.935 . . . . 0.0 112.085 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -136.24 129.21 31.22 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.276 173.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.577 HD13 HG13 ' A' ' 46' ' ' VAL . 60.9 mt -83.06 122.55 28.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.512 ' O ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.082 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.355 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.467 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.9 m-20 . . . . . 0 C--O 1.222 -0.38 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.634 ' CD1' HG21 ' A' ' 111' ' ' VAL . 42.5 mt -124.31 112.43 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.617 0.722 . . . . 0.0 112.004 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.18 133.77 40.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.662 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.605 ' SG ' HG22 ' A' ' 85' ' ' ILE . 16.1 m -143.75 146.37 33.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.339 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -106.12 129.63 54.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.707 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 mt -130.24 107.35 14.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -76.18 96.07 3.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.03 -63.64 0.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.168 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 pt -98.56 -42.25 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.65 27.49 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.76 145.75 32.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.5 ttp -135.2 155.37 50.77 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.18 142.6 43.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.892 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 85.1 mt -124.74 139.42 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.732 0.777 . . . . 0.0 111.872 -172.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -76.8 116.4 17.43 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.892 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.8 t -46.89 -42.7 17.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.961 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 50' ' ' SER . 9.5 mt-10 -67.87 -13.34 62.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.778 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.446 ' CB ' HD11 ' A' ' 67' ' ' LEU . 42.0 m-85 -113.03 3.16 16.02 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.634 HG21 ' CD1' ' A' ' 94' ' ' ILE . 32.9 m -114.24 168.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.294 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.53 ' HD2' HG21 ' A' ' 51' ' ' VAL . 18.4 ttt180 -149.24 128.44 12.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.53 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 9.9 tttp -59.5 132.78 55.03 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.478 173.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.7 -56.08 10.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.75 -8.09 19.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.417 177.405 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 23' ' ' LEU . 20.5 mt . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 72.6 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.378 2.052 . . . . 0.0 111.033 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.5 -163.93 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.578 2.185 . . . . 0.0 112.709 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 5.0 t -98.88 128.24 32.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.1 8.55 1.04 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.789 2.326 . . . . 0.0 112.464 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.444 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 50.0 mt-30 -119.18 -37.84 3.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.9 m -110.03 -45.99 3.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.984 0.421 . . . . 0.0 109.886 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.86 2.23 3.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.592 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -48.47 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 169.86 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HE1' ' HB2' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -87.57 57.42 4.39 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.867 0.841 . . . . 0.0 110.765 -168.651 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -105.84 140.47 38.82 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.305 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 37.5 p90 -141.16 171.18 14.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HB3' HD11 ' A' ' 5' ' ' LEU . 1.3 pm0 -100.94 114.56 28.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.928 0.394 . . . . 0.0 110.755 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.56 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 26.7 t70 -113.38 83.03 1.77 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.08 -108.35 3.65 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.339 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.87 19.65 16.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -170.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.551 HD11 ' HB3' ' A' ' 31' ' ' GLU . 1.4 pt? -162.3 -174.68 4.17 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 5' ' ' LEU . 8.3 mt -106.39 132.58 52.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 31' ' ' GLU . 58.0 t -117.76 129.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 53.0 t -100.71 109.97 59.23 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 38.3 Cg_endo -67.64 -16.31 46.44 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.703 2.268 . . . . 0.0 111.193 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.624 ' HB2' ' HE1' ' A' ' 15' ' ' TYR . 9.9 tp10 -69.36 -73.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.558 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -88.12 10.35 19.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 45.47 16.48 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -144.61 129.45 18.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.85 0.357 . . . . 0.0 110.23 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' HB3' HD11 ' A' ' 22' ' ' LEU . 1.9 mp0 -90.42 152.68 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.441 ' NE1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -155.26 161.31 41.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.3 m -121.66 130.42 24.78 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 14.3 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 123.412 2.741 . . . . 0.0 113.295 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 87' ' ' LEU . 7.3 t . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.492 HG21 HG13 ' A' ' 94' ' ' ILE . 6.9 mm -93.35 138.75 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.4 ttmt -127.75 142.65 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.719 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.498 ' CG ' HG23 ' A' ' 111' ' ' VAL . 71.4 m-20 -100.28 -179.42 4.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 21.2 t -77.29 -5.65 50.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.867 0.842 . . . . 0.0 110.533 -174.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.9 t -88.57 -16.1 8.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.727 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.8 -3.23 67.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.171 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -87.07 149.37 24.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.643 0.735 . . . . 0.0 111.859 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.551 HG22 ' HG3' ' A' ' 48' ' ' LYS . 3.6 t -104.7 136.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.345 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.1 mp -100.35 179.74 4.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.449 -169.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.449 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 12.4 tt0 -132.0 156.17 46.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.251 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -69.74 138.34 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 82.21 -4.91 74.52 Favored Glycine 0 C--N 1.316 -0.562 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.538 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -72.78 171.53 12.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.727 0.299 . . . . 0.0 110.337 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 91.9 m -109.27 137.15 47.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.9 169.54 12.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' THR . 3.0 m -149.4 117.17 6.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.942 0.401 . . . . 0.0 110.859 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -62.15 128.9 24.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.596 HG12 ' CD ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -100.51 15.56 4.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.596 ' CD ' HG12 ' A' ' 64' ' ' ILE . 2.4 mptm? -135.79 165.1 26.4 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.588 -0.695 . . . . 0.0 109.168 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.85 116.05 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.802 0.811 . . . . 0.0 111.51 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 110' ' ' PHE . 5.1 mp -130.08 147.6 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.281 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.28 175.32 6.89 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.117 -0.364 . . . . 0.0 110.343 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.49 134.49 61.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 2.2 mmmp? -43.14 -88.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.46 21.78 42.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.383 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 m -122.67 153.62 39.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.898 0.38 . . . . 0.0 110.627 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -83.31 6.57 19.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.1 131.23 34.76 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 120.865 0.364 . . . . 0.0 110.052 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.7 t -100.67 133.53 43.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.454 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.579 HG12 HG11 ' A' ' 63' ' ' VAL . 53.8 t -85.85 99.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.38 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.11 152.09 25.0 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.684 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -52.12 97.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.918 0.866 . . . . 0.0 110.991 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.65 4.73 3.81 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.491 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.0 m -62.38 105.68 0.65 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.672 0.748 . . . . 0.0 110.627 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.31 113.34 24.6 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.052 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 96' ' ' CYS . 43.0 t -122.02 117.01 50.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 13.4 ptmm? -106.23 153.68 21.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.199 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.497 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 4.4 m-20 71.95 42.38 0.61 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.337 173.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 94' ' ' ILE . 42.6 pt -67.27 -177.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 122.25 1.024 . . . . 0.0 113.602 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -128.9 126.21 39.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.765 -1.561 . . . . 0.0 108.429 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.444 HD13 HG13 ' A' ' 46' ' ' VAL . 81.8 mt -80.26 122.87 27.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 93' ' ' ASP . 2.6 t . . . . . 0 C--N 1.316 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.488 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 88' ' ' VAL . 10.7 m-20 . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 121.445 0.64 . . . . 0.0 111.543 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.591 ' CD1' HG21 ' A' ' 111' ' ' VAL . 63.4 mt -114.33 116.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.146 171.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -94.69 133.27 38.54 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.357 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.479 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.1 p -145.46 159.86 42.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.621 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -118.36 134.57 54.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.006 176.4 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.0 mt -120.57 107.16 20.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.934 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -63.35 107.17 1.03 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.94 -46.34 0.86 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.937 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.3 pt -117.98 -38.83 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.69 0.281 . . . . 0.0 110.826 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.85 -157.09 24.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.378 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.8 149.62 23.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.969 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -153.99 171.54 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.466 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 19.0 ptmt -120.74 151.27 39.76 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.717 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.1 mt -127.32 140.32 52.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.27 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' A' ' 110' ' ' PHE . 76.5 tttt -82.31 117.61 22.52 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.132 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.635 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 1.4 p -50.86 -37.06 41.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.625 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 50' ' ' SER . 31.2 mt-10 -69.5 -7.33 37.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.309 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 64' ' ' ILE . 66.6 m-85 -113.46 -2.87 13.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.761 -0.587 . . . . 0.0 112.001 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 m -116.94 173.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 112.38 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.479 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.8 ttt180 -143.22 137.19 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.023 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 14.3 tttp -70.55 135.81 48.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.695 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.77 -58.56 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.905 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.75 34.93 3.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.235 178.915 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.777 0.323 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.69 161.83 42.88 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.863 2.375 . . . . 0.0 111.748 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.441 ' HB2' ' HA ' ' A' ' 12' ' ' ASN . 19.8 Cg_endo -64.57 -169.43 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.353 2.036 . . . . 0.0 112.385 174.134 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -98.81 129.13 30.57 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.969 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HG3' ' CE3' ' A' ' 32' ' ' TRP . 55.8 Cg_endo -69.11 7.25 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.692 2.261 . . . . 0.0 112.214 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.524 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 47.9 mt-30 -117.7 -39.32 3.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.479 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.7 m -106.2 -45.83 4.21 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 7' ' ' PRO . 64.5 t30 70.44 -3.3 1.91 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.851 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.7 m -55.34 -77.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.711 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.2 pt-20 164.31 -7.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.69 0.618 . . . . 0.0 112.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.662 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 61.1 m-85 -80.64 41.56 0.56 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 111.406 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -104.24 148.1 26.72 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.453 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 41.2 p90 -148.9 174.79 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.92 117.76 34.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.808 0.337 . . . . 0.0 111.108 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.537 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 14.7 t70 -115.75 79.07 1.24 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.97 -107.97 3.59 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.319 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.19 17.71 19.27 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.3 pt? -157.75 -175.46 5.39 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 16.2 mt -107.92 130.06 55.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 31' ' ' GLU . 52.2 t -116.9 127.39 74.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.2 t -102.7 105.41 44.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 44.8 Cg_endo -69.76 -12.5 33.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.565 2.177 . . . . 0.0 110.785 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 36.0 tt0 -68.7 -59.06 3.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.081 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.09 14.52 31.7 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.6 27.77 16.35 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -140.66 142.25 34.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -98.15 177.38 5.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.505 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -172.28 161.88 5.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -119.07 129.85 25.17 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.505 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 12.2 Cg_endo . . . . . 0 C--N 1.342 0.197 0 C-N-CA 123.274 2.649 . . . . 0.0 113.338 -170.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.604 HG21 HG13 ' A' ' 94' ' ' ILE . 5.3 mm -76.97 137.38 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.823 -170.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 54' ' ' VAL . 1.6 ttmt -124.86 177.37 6.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.661 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 19.2 m-20 -113.16 179.26 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 44.8 t -82.16 -8.29 59.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.015 171.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 112' ' ' ARG . 2.9 t -91.07 -17.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.141 -1.39 . . . . 0.0 109.347 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.68 -0.8 52.57 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.235 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.46 167.33 17.55 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.022 0.915 . . . . 0.0 111.283 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 48' ' ' LYS . 10.0 t -116.84 136.53 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.775 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 87' ' ' LEU . 2.1 mm? -97.04 175.83 6.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.342 0.591 . . . . 0.0 110.64 -172.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -131.4 151.12 51.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.024 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 15.6 t70 -72.62 91.92 1.48 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 133.69 -14.29 4.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.75 169.11 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.7 0.286 . . . . 0.0 111.013 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 22.2 m -100.12 137.27 38.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 85' ' ' ILE . 1.5 pp -125.81 165.43 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.4 m -147.31 125.39 12.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.052 0.453 . . . . 0.0 111.894 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -67.77 129.57 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.611 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.648 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.72 19.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.648 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.2 mptm? -138.69 160.81 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.964 0.802 . . . . 0.0 108.876 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -87.67 114.07 23.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.141 0.972 . . . . 0.0 112.433 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 3.8 mp -124.88 149.74 47.21 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.308 170.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -89.41 179.07 6.16 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.778 -0.576 . . . . 0.0 111.153 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 76' ' ' VAL . 9.6 t -132.05 130.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 141.15 33.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.32 -16.35 3.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.881 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.9 p -106.7 172.79 6.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.136 0.493 . . . . 0.0 111.158 -175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -97.12 16.79 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mp -91.75 171.79 8.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -159.27 117.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.635 HG23 HG22 ' A' ' 69' ' ' VAL . 93.9 t -82.01 94.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.785 0.802 . . . . 0.0 109.497 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 146.78 32.93 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -47.98 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.937 0.875 . . . . 0.0 110.896 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.09 7.74 3.96 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.179 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.4 m -62.7 104.21 0.51 Allowed 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 121.694 0.759 . . . . 0.0 109.52 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.2 113.93 26.34 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.346 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -132.02 118.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 61.9 pttt -110.04 170.39 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.57 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 89.9 m-20 66.82 34.17 5.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.216 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 61' ' ' ILE . 23.2 pt -64.57 175.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 122.195 0.997 . . . . 0.0 113.513 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -119.16 122.18 41.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.232 174.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 55' ' ' LEU . 89.7 mt -74.83 118.92 18.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 93' ' ' ASP . 5.3 t . . . . . 0 C--N 1.319 -0.717 0 CA-C-O 121.633 0.73 . . . . 0.0 111.637 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.6 m-20 . . . . . 0 C--O 1.224 -0.241 0 CA-C-O 121.377 0.608 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.604 HG13 HG21 ' A' ' 47' ' ' ILE . 4.9 mp -105.44 119.91 55.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.464 172.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.3 t70 -94.31 130.78 40.47 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.887 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.76 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.1 p -140.37 151.4 44.94 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.284 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -105.43 122.13 45.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.432 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.0 mt -122.63 107.78 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.255 0.55 . . . . 0.0 110.585 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -69.34 105.72 2.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.522 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.3 -37.96 0.79 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.234 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 pt -132.28 -38.49 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.863 0.363 . . . . 0.0 110.688 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.89 -153.67 23.92 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.734 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.57 24.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.722 0.261 . . . . 0.0 110.698 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.462 ' HG2' ' N ' ' A' ' 105' ' ' LYS . 49.4 ttm -142.0 164.05 31.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.143 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -117.57 139.08 51.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.05 138.76 52.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.499 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 14.6 tptm -72.25 125.03 26.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.884 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -52.1 -27.63 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.179 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 107' ' ' LYS . 10.9 pt-20 -87.1 -5.27 59.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.997 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.403 ' HD2' ' HB3' ' A' ' 107' ' ' LYS . 35.5 m-85 -116.59 7.69 13.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.341 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 94' ' ' ILE . 34.0 m -111.91 162.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.421 ' CG ' HG21 ' A' ' 51' ' ' VAL . 28.2 ttt180 -141.25 135.26 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.97 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -67.46 140.88 57.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.178 0.513 . . . . 0.0 110.914 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.99 -69.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.816 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.99 51.14 9.34 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.838 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.0 m . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.071 178.866 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.466 HD13 HD22 ' A' ' 23' ' ' LEU . 60.9 mt . . . . . 0 C--O 1.234 0.262 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 68.5 Cg_endo -71.2 159.99 50.33 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.264 1.976 . . . . 0.0 111.264 175.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.73 -163.67 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.649 2.233 . . . . 0.0 112.376 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 7.9 t -98.49 127.64 35.4 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.693 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 7.89 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.329 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.456 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 56.5 tt0 -122.05 -32.84 3.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.278 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.14 -45.25 3.62 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.667 -0.645 . . . . 0.0 109.984 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t30 69.95 -2.81 1.92 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.698 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.9 p -45.27 -77.06 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 13' ' ' SER . 10.7 pt-20 161.85 -15.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.808 0.693 . . . . 0.0 111.06 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.605 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m-85 -81.97 45.57 0.93 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.374 0.606 . . . . 0.0 111.043 -171.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -104.85 143.2 33.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.693 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.74 176.6 10.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.31 126.77 53.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.382 0.611 . . . . 0.0 110.819 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.27 82.07 1.75 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.112 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -112.58 4.33 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.39 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.79 17.32 22.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -154.0 -174.57 5.01 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.554 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 15.9 mt -114.5 136.46 52.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.741 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -127.87 142.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.861 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 46.6 t -104.62 106.99 56.9 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.8 Cg_endo -66.88 -14.0 42.09 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.763 2.309 . . . . 0.0 111.423 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 29.8 tt0 -73.15 -61.32 1.86 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.02 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.9 p -97.81 10.9 38.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.33 45.41 20.16 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -135.88 124.12 23.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.729 0.299 . . . . 0.0 110.516 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.741 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 34.6 mt-10 -93.3 143.57 26.14 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.11 161.99 41.79 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 120.807 0.337 . . . . 0.0 110.121 -176.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 p -112.05 132.76 21.88 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.554 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 9.9 Cg_endo . . . . . 0 C--N 1.345 0.368 0 C-N-CA 123.336 2.69 . . . . 0.0 113.284 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 87' ' ' LEU . 13.7 p . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.681 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.144 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.516 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -107.27 177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 0.0 111.202 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 6.6 m-20 -118.22 174.45 6.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.867 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 64' ' ' ILE . 27.5 t -70.62 -7.11 41.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.836 0.827 . . . . 0.0 110.696 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.454 HG21 ' HD2' ' A' ' 112' ' ' ARG . 3.0 t -88.93 -16.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.854 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 2.22 65.35 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.668 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -93.66 162.82 13.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.332 0.587 . . . . 0.0 111.477 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 t -114.46 136.25 51.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.454 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.628 HD22 HG22 ' A' ' 61' ' ' ILE . 13.1 mt -93.57 174.96 6.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.398 0.618 . . . . 0.0 112.002 -170.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.3 tt0 -125.64 147.18 49.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.581 175.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.4 105.68 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.045 0.926 . . . . 0.0 109.436 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 114.14 -2.46 23.99 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.0 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.8 t70 -76.59 169.31 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.6 m -105.53 137.03 44.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.628 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -120.7 166.4 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -148.08 119.84 8.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.929 0.395 . . . . 0.0 110.773 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.623 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -62.39 126.34 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.107 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.624 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -100.12 17.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.227 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.575 ' HD3' HG12 ' A' ' 64' ' ' ILE . 1.8 mppt? -141.77 165.18 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.75 -0.594 . . . . 0.0 109.517 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.514 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.0 p-10 -83.21 113.94 21.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.596 0.713 . . . . 0.0 111.484 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.551 HD21 ' CD1' ' A' ' 110' ' ' PHE . 23.9 mt -126.53 140.44 52.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.694 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -91.22 174.16 7.54 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.225 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 72' ' ' SER . 38.7 t -124.91 126.37 71.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -88.49 -36.19 16.59 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.14 -32.37 52.63 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.125 -1.035 . . . . 0.0 111.575 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 69' ' ' VAL . 37.2 m -107.04 175.74 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.343 -0.429 . . . . 0.0 111.145 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -98.19 -4.78 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.058 0.456 . . . . 0.0 110.561 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mp -77.3 143.25 38.97 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.829 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.64 125.73 66.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.284 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.623 HG12 HG11 ' A' ' 63' ' ' VAL . 69.5 t -78.72 116.7 22.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.557 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -111.76 147.45 35.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.41 -175.096 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.31 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.924 0.868 . . . . 0.0 110.654 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.28 7.51 3.96 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.716 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -62.84 104.64 0.57 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.536 0.684 . . . . 0.0 109.657 174.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -89.67 115.83 27.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.847 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 96' ' ' CYS . 38.5 t -125.01 115.16 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 21.4 ptmt -99.87 157.15 16.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.382 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.589 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 15.8 m120 66.27 45.17 2.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.659 173.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.41 HD11 ' HB3' ' A' ' 55' ' ' LEU . 31.1 pt -65.57 176.22 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 122.0 0.905 . . . . 0.0 113.38 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 21.8 tpp180 -130.26 131.95 45.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.831 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.519 HD13 HG23 ' A' ' 46' ' ' VAL . 15.8 mt -79.18 114.7 18.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.571 HG23 ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.54 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.222 -0.386 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.681 HG13 HG21 ' A' ' 47' ' ' ILE . 3.7 mp -112.15 117.21 54.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.98 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.2 t70 -93.78 131.68 38.91 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.621 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.579 ' HB2' HG11 ' A' ' 82' ' ' VAL . 18.3 p -144.74 156.15 43.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.91 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 131.39 55.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.893 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.44 110.5 27.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.944 0.402 . . . . 0.0 110.028 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.16 102.94 1.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.299 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.09 -42.86 0.8 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.634 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.31 -42.19 2.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.06 0.457 . . . . 0.0 110.398 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.05 -154.17 23.75 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.86 149.44 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.312 0.556 . . . . 0.0 110.453 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.1 ttp -146.45 165.08 30.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.049 0.452 . . . . 0.0 110.95 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -114.03 138.65 50.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.866 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 81.0 mt -119.15 142.11 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.311 0.577 . . . . 0.0 111.437 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 66.1 mmtt -80.65 124.72 29.24 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.042 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.4 t -48.96 -43.66 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.981 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.452 ' C ' ' HB2' ' A' ' 50' ' ' SER . 1.5 pm0 -74.71 0.44 15.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.576 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.551 ' CD1' HD21 ' A' ' 67' ' ' LEU . 76.8 m-85 -119.72 2.64 11.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.45 -0.781 . . . . 0.0 112.993 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.59 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 34.1 m -114.04 172.93 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.193 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.454 ' HD2' HG21 ' A' ' 51' ' ' VAL . 10.9 ttt-85 -149.83 138.1 20.53 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.58 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -73.97 120.44 19.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.15 -46.55 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.907 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.49 11.35 82.11 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.177 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.228 -179.304 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 84.9 mt . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -67.75 155.12 71.2 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 121.81 1.673 . . . . 0.0 111.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.58 -170.85 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.71 2.273 . . . . 0.0 112.371 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -97.94 123.41 51.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.767 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.16 6.96 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.814 2.343 . . . . 0.0 112.269 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 49.2 mt-30 -115.36 -38.7 3.74 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.388 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -109.42 -48.19 3.28 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 72.03 -1.97 2.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.81 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 23.5 p -48.73 -76.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.53 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.5 pt-20 164.98 -13.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.584 0.553 . . . . 0.0 111.589 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 56.6 m-85 -78.7 35.32 0.24 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.083 0.468 . . . . 0.0 111.541 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -97.83 138.94 34.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.047 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -147.26 174.8 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.06 130.84 55.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.254 0.55 . . . . 0.0 110.97 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -122.87 84.47 2.27 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.535 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.91 -110.27 3.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.363 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.09 19.92 17.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.872 -171.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.59 -173.82 4.57 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.577 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 23.7 mt -114.21 137.42 51.79 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -127.83 142.41 43.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.071 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.0 t -106.3 106.7 58.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.908 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 39.0 Cg_endo -67.84 -10.16 27.93 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.804 2.336 . . . . 0.0 111.212 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.499 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 31.6 tt0 -75.74 -61.41 1.93 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.679 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.58 9.78 42.47 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.37 26.55 15.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HB3' HE22 ' A' ' 10' ' ' GLN . 47.3 m-70 -123.12 133.68 54.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.113 0.482 . . . . 0.0 111.214 175.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -91.28 162.6 14.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.607 176.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -162.09 162.54 28.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.0 t -109.65 134.84 20.46 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.577 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.2 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 C-N-CA 122.489 2.126 . . . . 0.0 112.533 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.579 HG13 HD13 ' A' ' 87' ' ' LEU . 20.3 t . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.511 HG21 ' CG1' ' A' ' 94' ' ' ILE . 5.9 mm -85.22 134.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.807 0.337 . . . . 0.0 110.987 -174.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -112.18 149.36 32.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.211 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.6 m-20 -94.97 177.88 5.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.797 0.332 . . . . 0.0 110.633 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 32.8 t -72.57 -7.44 50.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.965 0.888 . . . . 0.0 110.536 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.469 HG21 ' CG ' ' A' ' 112' ' ' ARG . 3.0 t -88.23 -14.42 9.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.944 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.58 1.74 68.22 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.631 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -94.5 159.2 15.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.371 0.605 . . . . 0.0 111.6 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.8 t -108.75 135.14 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.053 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.58 HD22 HG22 ' A' ' 61' ' ' ILE . 12.7 mt -92.14 178.96 5.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.053 0.454 . . . . 0.0 110.715 -175.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.946 ' HG2' ' HB2' ' A' ' 59' ' ' ASP . 9.1 pt20 -126.03 154.77 42.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.488 ' OD1' ' HD3' ' A' ' 86' ' ' ARG . 19.4 t70 -66.59 104.4 1.27 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 112.71 -0.28 26.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.787 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.946 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 2.7 t0 -78.96 171.59 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 33.0 m -106.22 137.52 44.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.58 HG22 HD22 ' A' ' 55' ' ' LEU . 2.1 pp -120.82 167.71 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.6 m -149.38 117.17 6.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.824 0.345 . . . . 0.0 110.382 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.752 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -59.69 128.89 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.439 176.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -100.65 17.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -137.38 161.91 35.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.678 -0.639 . . . . 0.0 109.321 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.2 p-10 -84.13 109.77 17.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.744 0.783 . . . . 0.0 111.467 170.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 66' ' ' ASP . 21.7 mt -127.05 145.93 50.55 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.616 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -90.51 174.75 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.948 -0.47 . . . . 0.0 111.382 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.46 ' CG2' HG23 ' A' ' 76' ' ' VAL . 49.7 t -123.25 130.21 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -73.76 -63.31 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.165 0.439 . . . . 0.0 112.016 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.57 -23.01 76.81 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.37 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.444 ' HB2' HG11 ' A' ' 69' ' ' VAL . 66.9 m -112.59 151.02 30.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -74.47 -0.22 16.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.17 0.51 . . . . 0.0 110.959 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.475 ' CD2' HG21 ' A' ' 101' ' ' ILE . 3.1 mm? -78.55 143.39 36.56 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.474 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -107.55 134.61 48.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.804 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.752 HG12 HG11 ' A' ' 63' ' ' VAL . 75.5 t -89.2 101.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.6 147.89 27.13 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.593 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.3 p -51.45 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.855 0.836 . . . . 0.0 110.935 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.84 4.52 4.21 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.914 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.5 105.02 0.57 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 110.368 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -91.47 114.16 26.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 96' ' ' CYS . 43.2 t -122.08 118.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.861 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.1 ptmt -98.53 156.22 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.435 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.468 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 12.0 m120 63.08 49.91 3.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.325 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.8 pt -64.86 176.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 11.7 tpp180 -131.59 121.89 25.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.269 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.579 HD13 HG13 ' A' ' 46' ' ' VAL . 22.8 mt -85.96 126.24 33.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.091 0.405 . . . . 0.0 109.919 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.763 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.671 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 5.0 m-20 . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 106' ' ' LEU . 30.9 mt -119.96 108.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.217 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 16.6 t70 -95.72 103.77 15.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.53 0.681 . . . . 0.0 109.263 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.578 ' HB2' HG11 ' A' ' 82' ' ' VAL . 28.6 p -107.35 157.79 17.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.344 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 21.6 pttp -118.03 138.47 52.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.505 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.2 104.92 14.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.86 100.54 0.21 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.176 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.16 -64.86 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.647 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.475 HG21 ' CD2' ' A' ' 74' ' ' LEU . 40.5 pt -89.88 -46.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.383 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.15 -162.21 27.86 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 176.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -83.61 149.66 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.025 0.441 . . . . 0.0 110.985 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.9 ttp -136.82 153.51 50.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -98.84 146.44 25.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 95.5 mt -129.75 134.31 47.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.502 0.668 . . . . 0.0 111.765 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -81.28 114.73 20.27 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.596 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.4 p -52.69 -37.46 58.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.421 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' SER . 39.1 mt-10 -71.37 -3.84 22.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.863 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.444 ' HB3' HD11 ' A' ' 67' ' ' LEU . 66.6 m-85 -118.58 4.5 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.4 m -117.24 175.28 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.935 0.398 . . . . 0.0 112.064 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.469 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.4 ttt180 -147.7 141.59 25.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.562 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -72.52 121.9 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.995 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.08 -54.59 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.031 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.71 -9.34 55.38 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.571 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.344 179.004 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.22 157.76 56.4 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.276 1.984 . . . . 0.0 111.243 176.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -66.3 -168.01 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 44.5 t -99.55 123.87 46.49 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.713 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.26 5.53 1.85 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.32 2.013 . . . . 0.0 111.724 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.661 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 42.2 mt-30 -105.44 -47.19 4.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.48 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -124.32 -33.42 3.05 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.891 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.416 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 8.3 t-20 70.81 11.84 7.15 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.402 0.62 . . . . 0.0 111.026 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 38.7 m -58.0 -25.76 61.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.285 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 13' ' ' SER . 89.2 mt-10 86.39 10.42 0.21 Allowed 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 111.504 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.435 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 85.5 m-85 -89.11 52.1 2.31 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.558 0.694 . . . . 0.0 109.387 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 m -105.24 149.8 25.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.713 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 48.3 p90 -150.52 177.1 10.34 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.83 128.24 52.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.794 0.33 . . . . 0.0 110.175 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -113.78 25.68 11.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.75 -114.82 0.85 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.388 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.88 14.38 29.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.645 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.2 pt? -150.0 -175.69 5.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.042 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mt -118.23 141.07 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.88 147.02 33.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.792 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 43.6 t -101.74 111.48 64.05 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' A' ' 17' ' ' TYR . 23.6 Cg_endo -62.01 -22.64 74.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.882 2.388 . . . . 0.0 111.454 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 22.4 tt0 -76.79 -59.61 2.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.022 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.9 m -76.86 -4.85 45.82 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.63 37.32 28.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -141.25 135.22 30.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.011 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HB3' HD11 ' A' ' 22' ' ' LEU . 21.6 mp0 -91.87 160.88 15.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.013 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -159.55 162.0 35.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.368 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -117.53 134.18 23.19 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo . . . . . 0 CA--C 1.531 0.342 0 C-N-CA 122.607 2.205 . . . . 0.0 113.352 -176.226 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 120.937 0.398 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.551 HG21 HG12 ' A' ' 94' ' ' ILE . 32.3 mm -73.54 122.02 25.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.404 -174.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 6.1 ttmt -119.03 137.39 53.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.613 -177.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.548 ' OD2' HD11 ' A' ' 55' ' ' LEU . 80.8 m-20 -92.88 -175.84 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.345 -169.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 16.7 t -77.1 -5.9 50.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.219 1.009 . . . . 0.0 110.269 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 112' ' ' ARG . 6.5 t -89.02 -21.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.18 -6.46 68.86 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.821 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 49' ' ' ASP . 6.2 p30 -79.13 146.35 33.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.539 0.685 . . . . 0.0 111.179 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.3 t -102.94 134.74 43.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.522 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.649 ' HA ' ' HD2' ' A' ' 113' ' ' LYS . 7.1 mp -96.42 173.61 7.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.28 -169.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 8.7 tp-100 -126.04 149.26 48.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.373 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.486 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 13.4 t70 -65.15 130.16 42.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.27 -4.55 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.231 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 56' ' ' GLN . 1.1 t70 -73.52 175.73 6.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.129 0.465 . . . . 0.0 110.911 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.0 m -106.31 138.69 42.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.73 166.14 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -150.47 113.84 4.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.717 0.294 . . . . 0.0 110.512 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -61.05 125.82 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -97.43 14.35 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.506 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 2.4 mptm? -137.81 160.71 38.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.16 116.17 24.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.547 0.689 . . . . 0.0 111.848 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 5.1 mp -129.63 146.51 51.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.973 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . 18.1 ptmt -92.76 179.38 5.5 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.507 -0.746 . . . . 0.0 110.574 173.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.94 128.2 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -91.6 136.95 32.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.698 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 -27.19 3.36 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.494 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.672 ' HB3' HD23 ' A' ' 74' ' ' LEU . 66.2 m -105.32 155.36 19.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.624 0.249 . . . . 0.0 110.374 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -84.15 12.23 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.234 0.54 . . . . 0.0 110.374 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' A' ' 72' ' ' SER . 3.9 mm? -78.35 170.83 15.99 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.002 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -158.93 117.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -171.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG12 HG11 ' A' ' 63' ' ' VAL . 86.5 t -91.73 95.92 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.599 0.714 . . . . 0.0 110.564 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.24 145.8 33.77 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.038 -0.414 . . . . 0.0 111.17 -176.048 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -47.63 98.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 124.074 0.858 . . . . 0.0 111.392 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.07 7.14 3.76 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.262 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.0 m -63.07 104.19 0.54 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.759 0.79 . . . . 0.0 110.032 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.92 114.59 27.19 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.098 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.679 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.4 t -131.37 121.06 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.662 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 56.8 pttt -107.9 166.99 10.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.731 0.777 . . . . 0.0 112.959 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.522 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER 71.1 36.7 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.203 172.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.3 pt -66.71 -178.11 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.808 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 0.3 OUTLIER -130.63 131.05 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.895 174.802 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.7 110.83 6.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 88' ' ' VAL . 1.5 t . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.513 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 C--O 1.217 -0.61 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.551 HG12 HG21 ' A' ' 47' ' ' ILE . 69.7 mt -140.62 126.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.694 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.808 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.8 t70 -93.04 126.29 38.06 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.679 ' HB2' HG11 ' A' ' 82' ' ' VAL . 20.1 p -134.58 141.6 46.7 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.009 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 84' ' ' ASN . 11.4 ptpt -98.93 114.73 27.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.49 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.7 mt -116.98 104.94 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.403 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -47.66 130.35 14.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.639 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.2 -73.93 0.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.864 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 102' ' ' GLY . 32.6 pt -80.67 -46.27 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.774 0.321 . . . . 0.0 111.203 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 134.44 -146.33 18.33 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -88.57 155.97 19.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.101 0.45 . . . . 0.0 111.031 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.0 ttp -149.37 164.61 34.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.21 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 72.6 mttt -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.704 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.13 153.86 20.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.116 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 13.5 tptt -83.9 114.22 21.52 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.072 174.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.704 ' HA ' HG22 ' A' ' 111' ' ' VAL . 88.7 p -53.88 -39.54 65.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.132 0.968 . . . . 0.0 109.627 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 50' ' ' SER . 41.1 mt-10 -64.86 -3.39 3.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.539 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.474 ' O ' HD13 ' A' ' 64' ' ' ILE . 35.7 m-85 -117.23 0.74 12.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 171.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.704 HG22 ' HA ' ' A' ' 108' ' ' SER . 19.2 m -121.24 178.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.467 0.651 . . . . 0.0 112.396 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 51' ' ' VAL . 6.9 ttt180 -144.11 133.12 22.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.944 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.649 ' HD2' ' HA ' ' A' ' 55' ' ' LEU . 88.0 tttt -65.87 121.3 14.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.526 173.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.6 -65.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.29 33.01 6.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.804 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.507 -0.759 . . . . 0.0 110.189 -179.825 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.596 0.236 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.7 160.21 46.86 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.643 2.229 . . . . 0.0 111.345 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.56 -166.44 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.0 112.432 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 8.5 t -98.17 121.95 55.62 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.11 6.61 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.681 2.254 . . . . 0.0 112.199 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 50.8 tt0 -119.89 -34.28 3.77 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -112.22 -43.53 3.53 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.816 0.735 . . . . 0.0 110.15 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.7 t30 73.19 2.9 4.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.889 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 23.3 p -65.0 -35.44 81.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.696 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 13' ' ' SER . 2.4 mt-10 85.74 25.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.13 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -70.92 2.25 4.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.788 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 23' ' ' LEU . 1.4 m -58.42 145.73 37.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.807 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 46.3 p90 -153.27 174.82 13.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.85 111.36 23.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.104 0.478 . . . . 0.0 111.26 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.505 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.9 t0 -108.49 74.16 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.39 -112.82 4.56 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.828 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.69 16.96 23.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -172.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -156.01 -174.45 4.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.415 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' HG22 ' A' ' 16' ' ' THR . 22.6 mt -110.51 134.23 52.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 31' ' ' GLU . 85.9 t -118.66 132.45 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 122.114 -0.366 . . . . 0.0 110.208 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -99.45 109.88 56.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.44 -3.09 12.32 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.815 2.343 . . . . 0.0 112.109 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.82 -61.07 1.77 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.26 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -93.05 12.04 25.49 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 121.748 -0.595 . . . . 0.0 112.524 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.92 31.76 18.06 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -138.96 131.95 29.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.792 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HG3' HG13 ' A' ' 24' ' ' VAL . 1.1 mp0 -91.6 171.0 9.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.516 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -167.36 161.5 14.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.9 m -124.81 125.23 25.47 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 C--O 1.234 0.313 0 C-N-CA 122.905 2.404 . . . . 0.0 112.869 -172.887 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.447 HG21 HG13 ' A' ' 94' ' ' ILE . 16.3 mm -78.58 132.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.424 -172.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.1 ttmt -122.47 135.67 54.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.063 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.5 ' CG ' HG23 ' A' ' 111' ' ' VAL . 84.0 m-20 -99.17 -178.99 4.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 23.1 t -74.06 -5.31 40.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.786 0.803 . . . . 0.0 110.971 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 4.4 t -87.71 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.487 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.11 -8.86 63.17 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.448 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -80.32 148.68 30.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.781 0.801 . . . . 0.0 112.07 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' A' ' 48' ' ' LYS . 3.7 t -102.88 137.26 31.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.044 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.826 ' HG ' ' HG3' ' A' ' 113' ' ' LYS . 7.3 mp -95.84 174.0 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.469 0.652 . . . . 0.0 111.925 -169.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.1 tp-100 -122.32 139.08 54.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.406 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 22.7 t70 -66.56 102.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' ASN . . . 116.34 -2.52 20.51 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.574 -176.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 1.3 t70 -77.18 175.21 9.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.695 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 10.3 m -103.67 139.07 39.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.99 166.73 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -149.04 117.04 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.767 0.317 . . . . 0.0 110.474 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.54 124.86 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -96.46 13.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.565 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.62 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -134.74 159.1 42.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.188 0.518 . . . . 0.0 109.742 -172.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.05 103.43 7.98 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.66 0.743 . . . . 0.0 111.544 170.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 65' ' ' LYS . 2.2 mm? -115.68 128.91 56.26 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.145 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -88.06 174.09 8.48 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 120.911 -1.118 . . . . 0.0 109.573 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.63 123.68 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -79.72 -41.99 25.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.34 -20.45 66.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.558 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.2 m -113.8 173.69 6.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 m -98.28 2.1 47.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.15 0.5 . . . . 0.0 110.363 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.9 141.08 36.43 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.314 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.92 140.8 27.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.163 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.709 HG12 HG11 ' A' ' 63' ' ' VAL . 69.8 t -99.4 119.9 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.2 149.93 36.91 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.829 -175.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -49.39 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.539 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.09 5.14 3.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.635 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.1 m -62.33 105.16 0.57 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.811 0.815 . . . . 0.0 110.224 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -93.53 112.95 24.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.976 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.584 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -124.45 119.35 56.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.374 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 16.8 pttm -106.19 159.45 16.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 19.3 m120 65.4 43.94 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.892 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 45.5 pt -64.89 -179.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.427 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 6.2 tpp180 -125.52 125.38 43.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.281 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.33 118.05 21.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.9 t . . . . . 0 C--N 1.318 -0.779 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 88' ' ' VAL . 53.4 m-20 . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.832 0.825 . . . . 0.0 112.725 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.587 ' CD1' HG21 ' A' ' 111' ' ' VAL . 49.1 mt -115.52 119.93 63.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.475 174.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.28 135.93 36.27 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.584 ' HB2' HG11 ' A' ' 82' ' ' VAL . 22.1 p -143.13 153.68 43.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.775 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -110.56 125.35 53.27 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -126.16 115.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.726 0.298 . . . . 0.0 110.478 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.14 104.49 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.086 0.47 . . . . 0.0 110.54 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.57 -44.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.066 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.1 pt -125.51 -38.55 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.905 0.383 . . . . 0.0 110.496 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.25 -151.38 21.44 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.26 145.24 30.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.4 tpt -136.34 156.63 48.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -108.64 128.5 54.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.713 178.011 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -115.35 140.99 48.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.43 0.633 . . . . 0.0 111.292 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -78.74 113.97 17.26 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.674 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.614 ' HA ' HG22 ' A' ' 111' ' ' VAL . 4.3 p -52.42 -38.81 59.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.77 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 50' ' ' SER . 33.2 mt-10 -60.08 -15.13 20.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.64 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.457 ' CG ' HD21 ' A' ' 67' ' ' LEU . 27.6 m-85 -114.96 4.86 14.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.506 -0.478 . . . . 0.0 112.085 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.3 m -126.1 179.11 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.394 0.616 . . . . 0.0 112.422 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 9.7 ttt180 -145.86 137.82 25.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.826 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 2.0 ttpp -73.3 125.01 26.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.786 173.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.81 -61.26 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.46 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.97 40.34 8.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.7 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.817 -178.161 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.404 HD11 ' CD ' ' A' ' 18' ' ' GLU . 21.3 mt . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 73.3 Cg_endo -73.61 158.24 47.62 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.504 2.136 . . . . 0.0 110.989 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 16.2 Cg_exo -68.28 -166.6 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.369 2.046 . . . . 0.0 112.057 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.0 t -97.93 120.89 59.11 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.508 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 9.24 0.31 Allowed 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.801 2.334 . . . . 0.0 112.141 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.578 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 33.8 mt-30 -117.6 -35.19 4.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.4 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.53 -48.53 3.07 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 121.0 0.429 . . . . 0.0 110.123 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.5 t30 69.9 -3.05 1.83 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.025 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -53.29 -76.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.944 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 173.06 -19.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.718 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 93.3 m-85 -82.5 48.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.051 0.453 . . . . 0.0 111.637 -167.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.4 m -109.23 146.25 34.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.334 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.4 p90 -152.88 178.45 9.65 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -103.58 118.78 37.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.001 0.429 . . . . 0.0 110.762 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.489 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 37.8 t70 -116.78 80.86 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.99 -113.03 4.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.213 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.26 21.45 16.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -172.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD11 ' HG3' ' A' ' 31' ' ' GLU . 2.4 pt? -158.47 -175.01 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.342 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 17.0 mt -107.25 130.29 54.77 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 19' ' ' ASP . 52.9 t -118.0 132.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 O-C-N 122.103 -0.373 . . . . 0.0 110.43 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.0 t -103.35 105.16 45.27 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.718 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 40.1 Cg_endo -68.14 -11.07 30.87 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 111.176 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.616 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.2 tp10 -72.52 -66.49 0.65 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.675 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -95.35 12.54 28.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.91 32.6 20.01 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.109 0.481 . . . . 0.0 111.915 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.463 ' HB3' HE22 ' A' ' 10' ' ' GLN . 40.2 t60 -136.64 133.24 36.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.193 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -105.87 167.47 9.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.798 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -165.57 162.2 18.91 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 t -116.93 136.92 23.39 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.6 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.798 2.332 . . . . 0.0 112.97 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.533 HG12 HD22 ' A' ' 87' ' ' LEU . 1.4 mm -80.45 130.62 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.925 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 3.5 ttmt -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.565 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 14.3 m-20 -106.08 170.48 7.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 9.2 t -82.65 -9.95 59.15 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.096 0.95 . . . . 0.0 110.236 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.517 HG11 ' HG3' ' A' ' 112' ' ' ARG . 2.6 p -89.09 4.13 5.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.403 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.88 80.74 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.552 -1.203 . . . . 0.0 113.511 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.428 ' OD1' HG13 ' A' ' 51' ' ' VAL . 9.9 p30 -103.62 161.96 13.46 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.327 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' HE2' ' A' ' 48' ' ' LYS . 11.6 t -102.4 142.85 15.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.175 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.614 HD22 HG22 ' A' ' 61' ' ' ILE . 17.9 mt -94.48 174.97 6.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 111.319 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.434 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 14.0 tt0 -138.53 159.49 41.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.483 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 10.0 p-10 -69.69 130.47 42.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.416 0.627 . . . . 0.0 109.712 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 91.57 -7.94 79.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.173 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.484 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 1.7 t70 -77.98 167.39 21.55 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.318 -0.519 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.2 m -96.53 140.08 31.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.953 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.614 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -123.86 165.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.082 0.468 . . . . 0.0 110.069 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.8 m -149.72 121.12 7.9 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.746 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.28 127.58 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.096 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.557 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -99.34 17.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.557 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.6 mptm? -140.81 161.46 37.75 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.459 -0.775 . . . . 0.0 109.041 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.537 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.0 p-10 -81.28 115.25 20.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.706 0.765 . . . . 0.0 111.926 172.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 13.7 mt -130.17 144.19 51.22 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.064 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -95.14 178.59 5.49 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.866 -0.521 . . . . 0.0 111.14 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 72' ' ' SER . 47.0 t -127.45 127.63 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.414 ' H ' ' HG2' ' A' ' 70' ' ' LYS . 39.4 pttt -82.26 -45.72 14.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -170.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.4 -26.28 57.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.567 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.821 ' HB3' HD23 ' A' ' 74' ' ' LEU . 58.3 m -110.03 165.73 11.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -86.7 11.99 11.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.785 0.803 . . . . 0.0 109.201 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.12 172.71 12.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.962 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.2 t -159.03 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -166.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.746 HG12 HG11 ' A' ' 63' ' ' VAL . 85.1 t -93.27 96.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.89 0.852 . . . . 0.0 110.611 -173.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.4 pptp? -102.64 146.18 28.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.153 -175.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.537 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.57 97.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.913 0.863 . . . . 0.0 110.774 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.36 3.36 4.3 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.013 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' THR . 94.9 m -62.12 103.81 0.41 Allowed 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 121.868 0.842 . . . . 0.0 109.65 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -90.85 114.74 27.24 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.226 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 96' ' ' CYS . 42.6 t -126.14 113.72 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.6 ptmt -96.59 161.47 13.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.032 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.585 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 86.7 m-20 63.52 44.92 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.839 0.712 . . . . 0.0 111.526 174.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' CG2' ' A' ' 61' ' ' ILE . 34.2 pt -65.7 175.64 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.911 0.862 . . . . 0.0 113.042 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 19.3 tpp180 -130.17 129.89 44.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.378 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.533 HD22 HG12 ' A' ' 47' ' ' ILE . 63.0 mt -81.17 113.07 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 120.967 0.413 . . . . 0.0 110.833 -174.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.8 m-20 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.516 HG13 HG21 ' A' ' 47' ' ' ILE . 3.9 mp -109.0 113.63 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.743 170.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 36.6 t70 -94.69 136.9 34.47 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.488 ' HB2' HG11 ' A' ' 82' ' ' VAL . 17.4 p -138.03 143.46 40.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.505 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.71 121.01 43.83 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.53 107.32 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.62 117.25 6.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.86 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.15 -65.26 0.57 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.477 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.47 HG21 HD21 ' A' ' 74' ' ' LEU . 26.7 pt -95.78 -47.65 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.88 0.371 . . . . 0.0 110.369 178.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.99 -161.18 28.12 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.39 148.33 26.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.702 0.287 . . . . 0.0 111.009 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 43.9 ttm -138.79 158.09 44.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.318 . . . . 0.0 110.58 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.94 134.88 54.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.087 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.2 mt -118.83 142.44 47.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.203 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HB3' ' OE1' ' A' ' 109' ' ' GLU . 30.0 mtpt -74.41 130.86 40.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.966 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.7 t -59.49 -32.98 70.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.478 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.529 ' OE1' ' HB3' ' A' ' 107' ' ' LYS . 3.4 pm0 -85.55 -0.16 54.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 33.3 m-85 -115.8 3.06 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.891 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 28.9 m -111.8 168.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.269 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.517 ' HG3' HG11 ' A' ' 51' ' ' VAL . 25.1 ttt180 -150.64 132.49 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.282 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.2 tttt -65.48 121.08 14.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 174.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.1 t -85.47 -48.76 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.81 85.3 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.867 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.909 -179.369 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.446 HD13 HD22 ' A' ' 23' ' ' LEU . 30.2 mt . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.471 0.177 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 54.3 Cg_endo -69.22 160.0 51.57 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.215 1.943 . . . . 0.0 111.139 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.22 -172.39 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.357 2.038 . . . . 0.0 112.031 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.09 127.03 38.05 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.57 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.69 6.82 1.46 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.541 2.16 . . . . 0.0 111.722 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.616 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 41.8 mt-30 -115.54 -39.21 3.59 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.431 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 m -109.67 -52.01 2.82 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.908 0.385 . . . . 0.0 110.268 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.74 -0.82 3.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.611 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.632 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 45.2 m -60.87 -78.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.994 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.1 pt-20 176.77 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.729 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 23.8 m-85 -82.2 33.58 0.4 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.584 0.629 . . . . 0.0 111.827 -171.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -91.48 135.22 34.0 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.766 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CE1' ' HD3' ' A' ' 26' ' ' PRO . 22.0 p90 -146.04 170.17 17.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 123.85 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.83 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -120.03 79.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.09 -112.9 4.52 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.076 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.03 16.13 25.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.12 -175.5 5.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.725 0.298 . . . . 0.0 110.248 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 19.9 mt -110.05 129.15 55.73 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.881 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -123.59 138.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.037 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.97 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 47.1 t -110.72 104.2 55.66 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.352 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 56.1 Cg_endo -70.78 -9.81 26.49 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.836 2.358 . . . . 0.0 109.913 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.97 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -70.75 -45.13 65.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.206 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.0 p -117.88 15.17 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.08 39.9 28.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.157 0.435 . . . . 0.0 111.874 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.78 127.62 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.85 0.357 . . . . 0.0 111.399 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.881 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 27.1 mt-10 -91.18 156.37 17.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.129 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.39 162.24 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.438 . . . . 0.0 110.726 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -110.44 130.87 22.41 Favored Pre-proline 0 C--N 1.317 -0.845 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.506 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 18.4 Cg_endo . . . . . 0 CA--C 1.529 0.264 0 C-N-CA 122.887 2.391 . . . . 0.0 113.576 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.572 HG23 HD13 ' A' ' 87' ' ' LEU . 7.8 p . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.424 HG21 HG13 ' A' ' 94' ' ' ILE . 4.4 mm -85.75 138.77 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.456 0.17 . . . . 0.0 110.649 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -109.62 155.78 21.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.119 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 5.0 m-20 -98.73 167.19 10.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.682 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.688 ' OG ' HD11 ' A' ' 64' ' ' ILE . 89.8 p -76.68 -10.63 59.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.904 0.859 . . . . 0.0 110.867 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.541 HG11 ' HG3' ' A' ' 112' ' ' ARG . 2.1 p -85.4 1.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.451 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.23 7.15 73.62 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.504 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -108.45 168.39 9.36 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.942 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 48' ' ' LYS . 9.4 t -113.7 142.51 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.931 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 113' ' ' LYS . 13.9 mt -96.64 175.95 6.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.547 0.689 . . . . 0.0 111.204 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.478 ' HB3' ' OD1' ' A' ' 59' ' ' ASP . 16.8 tt0 -131.91 154.21 49.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -67.54 96.46 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.955 0.407 . . . . 0.0 109.944 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.83 -7.11 6.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.974 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 56' ' ' GLN . 32.0 m-20 -71.13 165.27 23.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.112 0.482 . . . . 0.0 111.167 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 2.8 m -99.37 136.09 39.83 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.472 HG22 HD22 ' A' ' 55' ' ' LEU . 1.9 pp -120.76 166.01 15.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.0 m -150.46 118.78 6.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.851 175.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -60.73 126.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.295 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.688 HD11 ' OG ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -99.54 19.01 2.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.525 ' HD2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -143.48 166.41 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.592 -0.692 . . . . 0.0 109.332 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.77 113.96 21.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.894 0.854 . . . . 0.0 111.343 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 ' CG ' ' A' ' 110' ' ' PHE . 7.2 mp -126.0 141.19 52.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.485 175.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.428 ' HE2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -88.52 171.37 10.12 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.31 173.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.502 ' CG2' HG23 ' A' ' 76' ' ' VAL . 47.8 t -120.25 133.55 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -78.57 -57.49 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.78 -17.55 79.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.968 -0.635 . . . . 0.0 113.094 -174.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.471 ' HB2' HG11 ' A' ' 69' ' ' VAL . 55.5 m -115.0 155.13 27.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.746 0.308 . . . . 0.0 110.869 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -79.79 -1.13 37.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.47 HD22 HD13 ' A' ' 101' ' ' ILE . 9.5 mp -78.83 146.61 33.6 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.9 t -107.78 134.3 50.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.318 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 63' ' ' VAL . 63.1 t -84.1 104.25 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 149.87 25.48 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.469 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.73 96.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.99 0.9 . . . . 0.0 111.083 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.64 5.82 3.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.057 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 62' ' ' THR . 90.1 m -62.58 104.07 0.48 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 121.717 0.77 . . . . 0.0 109.87 176.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.25 121.3 33.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.174 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 96' ' ' CYS . 30.6 t -133.88 116.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.627 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 51.9 pttt -100.35 158.88 15.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.726 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.495 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 23.2 m120 63.32 47.49 3.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.8 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -64.88 178.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 122.005 0.907 . . . . 0.0 113.347 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.653 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 11.0 tpp85 -129.96 124.65 33.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.823 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.572 HD13 HG23 ' A' ' 46' ' ' VAL . 34.5 mt -78.92 116.05 18.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.6 t . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.384 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.475 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.556 ' CD1' HG21 ' A' ' 111' ' ' VAL . 36.6 mt -144.34 120.61 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 33.9 t70 -95.53 136.72 35.56 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.167 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.536 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -154.18 163.26 40.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.704 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 87.9 tttt -124.7 147.26 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.976 0.417 . . . . 0.0 110.04 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.32 105.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.57 103.87 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.795 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 144.27 -70.3 0.4 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.215 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.47 HD13 HD22 ' A' ' 74' ' ' LEU . 25.4 pt -84.77 -46.5 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.542 0.21 . . . . 0.0 111.173 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.425 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 146.94 -162.62 28.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.893 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.772 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -86.72 149.91 24.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.829 0.315 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.4 ttt -140.29 156.89 46.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.946 0.403 . . . . 0.0 110.671 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -113.83 139.03 49.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.583 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 53.9 mt -123.08 141.16 52.27 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.669 0.747 . . . . 0.0 111.732 -170.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -84.83 119.61 25.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.973 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -47.82 -39.71 19.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.7 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.77 -11.15 33.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.61 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.45 ' CG ' HD21 ' A' ' 67' ' ' LEU . 86.4 m-85 -112.91 1.8 15.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.556 HG21 ' CD1' ' A' ' 94' ' ' ILE . 13.5 m -113.4 169.51 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.37 -172.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.573 ' HB3' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -155.13 129.77 9.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.07 179.054 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.482 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.7 tttt -59.97 123.25 16.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.786 0.327 . . . . 0.0 110.31 171.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -60.53 -44.8 97.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.429 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.98 -21.13 3.01 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.184 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.236 -0.887 . . . . 0.0 109.47 176.19 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.428 HD22 HD12 ' A' ' 23' ' ' LEU . 16.2 mt . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 72.4 Cg_endo -72.47 155.95 54.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.925 1.75 . . . . 0.0 110.783 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 15.6 Cg_exo -67.84 -175.44 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.31 2.007 . . . . 0.0 111.882 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 4.7 t -97.65 123.0 53.56 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.46 10.94 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.73 2.287 . . . . 0.0 111.919 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.572 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 38.6 mt-30 -118.9 -40.57 2.84 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.147 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.4 m -108.98 -50.86 2.95 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.185 0.516 . . . . 0.0 110.265 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 t30 70.78 2.07 4.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.871 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 4.8 m -58.95 -78.34 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.3 pt-20 175.66 -18.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.516 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.7 m-85 -79.21 31.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.132 -169.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 m -94.17 136.19 34.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.825 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -139.05 169.87 17.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.19 122.03 45.71 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.11 0.481 . . . . 0.0 111.205 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -111.27 71.75 0.75 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.53 -107.99 3.53 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.382 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.9 19.4 19.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -171.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 23' ' ' LEU . 2.6 pt? -155.41 -179.44 8.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.171 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.706 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -109.24 134.03 52.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.796 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 31' ' ' GLU . 57.7 t -115.14 127.15 72.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 49.4 t -103.95 103.91 40.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 53.4 Cg_endo -71.61 -8.88 24.06 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.549 2.166 . . . . 0.0 110.412 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 20.2 tt0 -69.27 -62.59 1.32 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.017 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.2 p -98.47 9.59 42.8 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.71 46.05 12.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.771 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -150.59 135.02 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HB3' HG13 ' A' ' 24' ' ' VAL . 10.1 pt-20 -114.36 163.53 15.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.733 0.301 . . . . 0.0 110.882 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.564 ' NE1' HD23 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -163.11 162.64 25.77 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 t -112.18 139.79 22.86 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' ' CD2' ' A' ' 23' ' ' LEU . 19.7 Cg_endo . . . . . 0 C--N 1.349 0.593 0 C-N-CA 122.403 2.069 . . . . 0.0 112.452 -173.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.615 HG13 HD13 ' A' ' 87' ' ' LEU . 15.8 t . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.686 HG21 HG13 ' A' ' 94' ' ' ILE . 2.5 mm -86.18 135.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.52 177.36 4.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 6.3 m-20 -114.42 169.99 8.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.611 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.468 ' OG ' HD11 ' A' ' 64' ' ' ILE . 90.3 p -70.47 -6.23 34.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.123 0.963 . . . . 0.0 110.51 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.47 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.1 t -86.45 -13.52 10.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.642 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.79 5.68 64.33 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.886 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.47 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -97.1 168.24 10.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.543 0.687 . . . . 0.0 111.561 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 48' ' ' LYS . 16.4 t -113.97 144.64 21.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.787 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.591 HD22 HG22 ' A' ' 61' ' ' ILE . 24.2 mt -101.1 173.2 6.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.647 . . . . 0.0 111.69 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 9.1 tp-100 -124.89 145.71 49.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.483 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 15.1 t70 -71.23 97.1 1.49 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 123.51 -6.5 9.15 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.556 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 42.2 t0 -68.62 166.53 17.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.899 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 34.5 m -104.89 136.51 44.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.591 HG22 HD22 ' A' ' 55' ' ' LEU . 1.8 pp -123.71 171.85 12.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -150.19 123.34 8.87 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 0.0 111.102 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.614 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -65.8 126.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -97.7 14.06 4.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG3' HG12 ' A' ' 64' ' ' ILE . 54.8 mttt -143.64 164.99 28.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.094 0.861 . . . . 0.0 109.634 -176.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.69 117.15 24.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.082 0.944 . . . . 0.0 112.648 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.461 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.6 mp -134.79 150.66 50.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.307 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.32 178.27 5.89 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.703 -0.623 . . . . 0.0 111.502 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' A' ' 74' ' ' LEU . 46.7 t -120.06 129.07 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -56.51 108.36 0.48 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.22 3.88 26.57 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.005 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m -101.0 166.69 10.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.982 0.42 . . . . 0.0 111.122 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 p -84.92 -3.84 58.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.56 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.512 ' HB3' HG21 ' A' ' 69' ' ' VAL . 12.1 tp -81.85 171.66 14.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.661 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.473 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 70.0 t -158.72 120.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -169.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.614 HG12 HG11 ' A' ' 63' ' ' VAL . 64.9 t -89.65 97.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.715 0.769 . . . . 0.0 110.61 -174.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.478 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.21 145.47 34.2 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.329 -176.698 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -48.01 97.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.868 0.842 . . . . 0.0 111.19 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.52 4.09 4.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.251 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -62.53 104.95 0.57 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 122.089 0.947 . . . . 0.0 110.009 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -89.35 120.75 30.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.895 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.693 HG11 ' HB2' ' A' ' 96' ' ' CYS . 22.2 t -131.9 113.41 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.398 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.7 ptmt -100.55 154.04 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.714 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.504 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 19.0 m120 62.76 53.22 2.56 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.038 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 55' ' ' LEU . 32.4 pt -64.56 174.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 121.815 0.817 . . . . 0.0 112.43 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 20.4 tpp180 -129.22 123.01 30.89 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.879 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG13 ' A' ' 46' ' ' VAL . 39.7 mt -78.24 113.39 16.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.658 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.021 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.556 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.3 m-20 . . . . . 0 C--O 1.224 -0.282 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.686 HG13 HG21 ' A' ' 47' ' ' ILE . 2.8 mp -110.41 113.1 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 170.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 15.5 t70 -95.0 138.96 32.03 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.693 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -147.35 156.52 42.98 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.406 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -116.64 130.03 56.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.406 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.46 109.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.87 97.31 1.8 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.287 0.565 . . . . 0.0 110.134 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.93 -40.53 0.42 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 102' ' ' GLY . 43.2 pt -122.62 -37.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.477 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 138.15 -150.99 21.23 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -91.01 149.13 21.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.759 0.314 . . . . 0.0 110.744 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.3 ttt -140.57 159.75 41.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.187 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -116.78 143.23 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.2 mt -125.73 146.91 49.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.294 0.568 . . . . 0.0 111.984 -169.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.632 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 1.7 mptm? -75.26 128.33 35.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.855 174.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.6 t -53.31 -40.8 65.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.632 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 8.6 pt-20 -66.88 -12.29 58.8 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.066 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.473 ' O ' HD13 ' A' ' 64' ' ' ILE . 64.7 m-85 -111.87 4.8 18.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.459 -0.776 . . . . 0.0 112.777 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 24.2 m -114.4 169.84 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.505 -173.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 15.8 ttt180 -147.88 142.59 26.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.639 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.748 ' HB2' ' HZ2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -65.58 140.83 58.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.254 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 116' ' ' SER . 94.0 t -107.84 -57.83 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 170.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.57 -3.51 71.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.744 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 114' ' ' VAL . 31.1 m . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.337 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.454 HD13 HD22 ' A' ' 23' ' ' LEU . 72.8 mt . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.9 Cg_endo -70.65 158.29 56.22 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.155 1.903 . . . . 0.0 111.131 176.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 13.1 Cg_exo -70.18 -171.65 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 10' ' ' GLN . 33.8 t -99.1 122.04 53.64 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.205 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.84 7.49 0.58 Allowed 'Trans proline' 0 C--O 1.23 0.113 0 C-N-CA 122.613 2.208 . . . . 0.0 112.284 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 8' ' ' CYS . 45.2 tt0 -113.94 -39.54 3.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.095 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -126.14 -35.15 2.46 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.553 -0.717 . . . . 0.0 111.468 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t30 72.53 1.84 4.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.92 0.488 . . . . 0.0 111.634 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.584 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 4.8 m -53.93 -78.43 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 171.85 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.164 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.793 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 79.0 m-85 -118.06 24.95 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.296 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.404 HG22 ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -93.54 132.38 37.89 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.389 172.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 38.3 p90 -144.9 171.27 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -100.8 117.54 35.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.884 0.373 . . . . 0.0 110.715 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.57 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 35.1 t70 -115.69 69.99 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.02 -113.44 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.91 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.48 18.91 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.883 0.373 . . . . 0.0 111.645 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.4 pt? -154.96 -174.83 5.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.349 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.577 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 24.1 mt -113.46 137.1 52.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 31' ' ' GLU . 46.1 t -121.27 136.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 122.231 -0.293 . . . . 0.0 110.375 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 48.6 t -102.58 105.14 42.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.349 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.793 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 20.8 Cg_endo -61.64 -25.45 79.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.63 2.22 . . . . 0.0 111.66 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.13 -58.95 3.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.7 m -75.92 -9.13 58.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.7 39.54 24.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 111.466 -173.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -149.17 136.92 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.534 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -103.69 174.76 5.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -178.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -166.94 161.87 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.6 t -106.18 135.11 19.5 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.577 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.9 Cg_endo . . . . . 0 C--N 1.343 0.241 0 C-N-CA 122.868 2.379 . . . . 0.0 112.855 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.599 HG21 HG13 ' A' ' 94' ' ' ILE . 5.1 mm -81.3 139.85 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -114.8 176.25 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.3 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.416 ' OD1' HG23 ' A' ' 111' ' ' VAL . 15.6 m-20 -112.05 172.41 6.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.25 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 64' ' ' ILE . 81.6 p -74.66 -8.33 56.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.039 0.923 . . . . 0.0 110.678 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.449 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -89.24 -11.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.406 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.65 -2.63 64.85 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.773 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.449 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -91.52 166.39 12.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.775 0.798 . . . . 0.0 111.584 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' HG3' ' A' ' 48' ' ' LYS . 11.3 t -117.05 139.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.923 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD22 HG22 ' A' ' 61' ' ' ILE . 17.8 mt -94.9 172.98 7.82 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.238 0.542 . . . . 0.0 110.564 -173.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -129.36 150.48 50.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -69.71 96.02 0.93 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 0.0 109.929 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 124.67 -7.83 8.31 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.045 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.468 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 2.1 t0 -72.16 175.81 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 25.3 m -105.46 137.19 43.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.603 HG22 HD22 ' A' ' 55' ' ' LEU . 1.5 pp -123.35 164.49 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.772 0.32 . . . . 0.0 110.279 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -148.53 124.88 10.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 174.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.712 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -66.71 124.79 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.134 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.76 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -96.13 17.19 2.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.904 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 6.7 mttt -143.5 163.71 32.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.03 0.832 . . . . 0.0 109.643 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.538 ' O ' HD23 ' A' ' 67' ' ' LEU . 2.5 p-10 -83.67 115.89 22.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.087 0.946 . . . . 0.0 111.995 173.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.2 mt -129.17 143.92 51.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.359 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -91.87 178.31 5.93 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.618 -0.676 . . . . 0.0 110.525 173.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 HG23 ' A' ' 76' ' ' VAL . 8.0 t -129.15 130.4 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 13.9 tppt? -78.63 -60.04 2.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -172.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.69 37.62 3.35 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.515 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.424 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 69.6 m -144.73 166.85 24.03 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -95.62 2.88 54.36 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.4 mp -78.6 175.25 10.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.452 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.8 t -158.69 116.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.712 HG12 HG11 ' A' ' 63' ' ' VAL . 88.1 t -87.32 98.56 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-O 121.682 0.753 . . . . 0.0 110.753 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.6 pptp? -105.83 145.01 31.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.41 -175.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -48.65 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.925 0.869 . . . . 0.0 111.228 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.23 5.5 4.67 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.072 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.47 104.39 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.807 0.813 . . . . 0.0 109.555 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -94.79 115.02 26.99 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.431 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 96' ' ' CYS . 68.0 t -132.22 117.31 32.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.8 pttt -107.89 169.67 8.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.682 0.753 . . . . 0.0 112.903 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.524 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 69.62 36.13 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.426 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 55' ' ' LEU . 37.2 pt -60.74 175.83 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.645 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 9.0 tpp85 -131.25 123.08 27.65 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.156 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.1 mt -75.25 109.08 8.46 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.624 HG22 ' HB2' ' A' ' 95' ' ' ASP . 2.6 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -170.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.704 ' CD1' HG21 ' A' ' 111' ' ' VAL . 25.7 mt -110.4 129.69 65.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.435 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.624 ' HB2' HG22 ' A' ' 88' ' ' VAL . 9.9 t70 -96.42 132.81 41.57 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.746 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.6 p -138.27 145.21 41.01 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.832 -168.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.562 ' O ' HG13 ' A' ' 82' ' ' VAL . 96.3 mttt -93.45 107.84 19.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.498 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.6 mt -104.51 155.32 6.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -101.09 130.5 47.14 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.64 -52.42 0.77 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.988 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 102' ' ' GLY . 44.7 pt -95.83 -40.32 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.413 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 126.96 -138.32 10.49 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.791 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -100.34 159.68 14.94 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.11 0.455 . . . . 0.0 111.377 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 38.8 ttm -154.2 165.75 35.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.121 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 80.6 mttt -113.69 126.08 54.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.572 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.44 146.72 39.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.646 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 25.9 ttmt -76.68 125.25 28.93 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.218 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.1 t -47.94 -37.96 15.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.093 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.646 ' HG2' ' HG2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -75.41 -5.33 44.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.904 ' HD1' ' HD3' ' A' ' 65' ' ' LYS . 30.7 m-85 -113.72 7.44 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.531 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.704 HG21 ' CD1' ' A' ' 94' ' ' ILE . 30.3 m -116.62 171.83 5.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -174.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -150.32 133.83 16.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.012 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 87.4 tttt -70.46 120.38 16.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 t -93.86 -70.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.52 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.72 -42.33 1.52 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.769 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.291 -179.351 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.49 HD11 ' HG2' ' A' ' 18' ' ' GLU . 52.7 mt . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.709 0.29 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.1 Cg_endo -73.63 162.49 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.042 2.495 . . . . 0.0 111.714 176.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 6.6 Cg_exo -73.39 -169.45 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 t -98.68 130.68 27.32 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.9 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.96 8.98 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.638 2.225 . . . . 0.0 112.553 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -123.04 -37.08 2.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.393 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.6 m -107.04 -45.94 4.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.24 -9.66 0.86 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 1.4 m -43.86 -75.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.004 0.522 . . . . 0.0 111.974 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.0 pt-20 159.04 -3.49 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.005 0.816 . . . . 0.0 111.569 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.591 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 63.2 m-85 -77.26 34.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.628 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -100.85 141.08 34.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.159 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -151.89 177.15 10.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HG2' HD11 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -110.42 124.61 52.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.418 0.628 . . . . 0.0 111.61 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.66 70.05 0.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.674 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.19 -107.66 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.112 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.8 18.03 21.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -159.96 -174.32 4.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.159 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.92 134.45 53.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -124.97 141.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 50.4 t -104.63 105.81 51.94 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.758 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.7 Cg_endo -66.85 -14.26 43.09 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.658 2.239 . . . . 0.0 110.968 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.483 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 33.2 tt0 -70.29 -58.97 3.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.633 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.34 10.29 39.24 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.5 46.11 12.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -142.91 127.41 17.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.678 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.539 ' HB3' HD11 ' A' ' 22' ' ' LEU . 2.3 mp0 -91.4 157.07 17.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.023 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -159.07 162.08 36.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -115.98 127.76 26.51 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 CA--C 1.528 0.223 0 C-N-CA 122.786 2.324 . . . . 0.0 113.192 -175.396 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.74 HG12 HG22 ' A' ' 54' ' ' VAL . 5.5 t . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.153 0.502 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.707 HG21 HG13 ' A' ' 94' ' ' ILE . 2.1 mm -91.09 131.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.413 -170.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.51 176.58 6.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 111.84 -179.226 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 15.2 m-20 -116.23 178.26 4.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.109 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.498 ' HB3' HD11 ' A' ' 64' ' ' ILE . 9.3 t -77.03 -5.22 47.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.243 1.02 . . . . 0.0 109.968 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.48 HG21 ' CG ' ' A' ' 112' ' ' ARG . 2.5 t -91.03 -8.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.602 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.28 -6.22 78.26 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.714 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.439 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -90.3 165.41 13.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 110.941 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.74 HG22 HG12 ' A' ' 46' ' ' VAL . 2.9 p -119.79 147.63 23.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.917 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.841 ' HA ' ' HD3' ' A' ' 113' ' ' LYS . 1.8 mt -96.54 178.23 5.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.411 -169.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -127.79 147.95 50.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.596 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -69.19 99.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.8 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.77 -6.91 9.58 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.523 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.91 175.44 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.96 0.41 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 41.4 m -103.01 137.47 41.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.595 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.712 HG22 HD22 ' A' ' 55' ' ' LEU . 1.4 pp -121.84 164.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.423 HG23 ' HA2' ' A' ' 79' ' ' GLY . 2.7 m -149.16 117.95 6.65 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.12 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.632 HG11 HG12 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.48 129.45 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.581 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.561 HG12 ' HD3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -102.86 17.19 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.561 ' HD3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -140.7 164.46 30.14 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.76 0.709 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.646 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -82.94 118.44 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.885 0.85 . . . . 0.0 112.656 174.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 66' ' ' ASP . 11.7 mt -135.4 142.29 45.63 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.758 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -92.54 178.32 5.85 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.399 -0.813 . . . . 0.0 111.29 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.76 131.98 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 70' ' ' LYS . 17.0 tptm -93.02 130.2 38.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.82 18.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.083 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.692 ' HB3' HD23 ' A' ' 74' ' ' LEU . 39.5 m -115.37 155.97 26.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.689 0.28 . . . . 0.0 110.816 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -85.18 18.88 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.603 0.716 . . . . 0.0 109.943 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.692 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -79.36 171.87 14.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.258 175.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.3 t -159.29 118.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -169.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.632 HG12 HG11 ' A' ' 63' ' ' VAL . 84.8 t -92.13 95.16 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.069 0.938 . . . . 0.0 109.95 -175.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 146.41 34.44 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.252 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -46.54 97.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.097 0.873 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.423 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.04 2.73 5.07 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.487 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.5 m -61.85 104.51 0.46 Allowed 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.904 0.859 . . . . 0.0 109.732 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -90.77 115.62 27.99 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.034 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 96' ' ' CYS . 77.7 t -131.91 113.45 22.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.213 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 60.1 pttt -107.88 164.05 12.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.329 0.585 . . . . 0.0 112.324 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.577 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 17.6 m120 70.26 42.04 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.892 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.3 pt -65.39 175.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.987 0.899 . . . . 0.0 112.904 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.596 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 7.3 tpp180 -126.66 126.07 42.94 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.212 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.489 HD22 HG12 ' A' ' 47' ' ' ILE . 38.1 mt -81.54 117.5 21.98 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.785 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -176.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.785 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.0 m-20 . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.707 HG13 HG21 ' A' ' 47' ' ' ILE . 9.6 mt -114.44 115.53 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.7 t70 -96.39 134.06 40.01 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.592 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.4 p -129.88 134.91 47.8 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.779 -176.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -101.29 111.66 23.95 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.79 108.5 25.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.956 0.408 . . . . 0.0 110.858 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.81 101.46 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.938 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.31 -39.42 0.76 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.493 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.428 HG21 HD21 ' A' ' 74' ' ' LEU . 23.8 pt -130.35 -39.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.62 -149.02 20.01 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -91.31 148.53 22.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.965 0.412 . . . . 0.0 110.939 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' MET . . . . . 0.48 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 50.7 ttm -136.3 157.24 47.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.194 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.515 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -99.86 141.82 32.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.698 175.614 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 93.7 mt -132.48 138.08 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.172 0.511 . . . . 0.0 111.492 -176.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 110' ' ' PHE . 43.5 mtpt -81.95 125.79 31.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.423 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.3 t -48.07 -42.62 29.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.945 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.17 -7.76 20.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.091 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.498 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 33.6 m-85 -115.93 2.4 13.52 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 94' ' ' ILE . 33.8 m -113.33 170.13 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.48 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.2 ttt-85 -150.87 131.32 13.79 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.819 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.841 ' HD3' ' HA ' ' A' ' 55' ' ' LEU . 35.1 ttpt -75.94 123.64 26.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 110.554 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.6 t -76.21 -41.4 37.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.577 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.46 11.15 80.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.975 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.8 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.889 179.296 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.28 160.92 47.42 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.606 2.204 . . . . 0.0 111.609 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.46 -172.8 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.344 2.03 . . . . 0.0 111.79 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.5 t -97.89 125.93 42.46 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.34 10.87 0.39 Allowed 'Trans proline' 0 N--CA 1.469 0.052 0 C-N-CA 122.547 2.165 . . . . 0.0 111.81 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.508 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 35.3 mt-30 -125.3 -31.11 3.08 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.991 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.8 m -116.07 -40.25 3.32 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.843 -0.536 . . . . 0.0 110.37 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 75.76 -26.83 0.19 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.272 1.029 . . . . 0.0 113.004 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 m -45.7 -77.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 173.59 30.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.594 0.712 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.736 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 64.7 m-85 -96.63 27.8 3.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.125 -172.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 23' ' ' LEU . 1.7 m -101.91 141.42 34.79 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.451 174.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.8 p90 -148.12 175.82 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.17 121.41 45.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.75 0.705 . . . . 0.0 111.487 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.431 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 33.0 t70 -113.52 75.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.269 0.556 . . . . 0.0 109.59 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.18 -108.75 3.63 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.118 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.24 20.38 18.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.471 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.2 pt? -160.49 -174.17 4.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.592 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 25.0 mt -109.06 136.57 48.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.731 174.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.462 HG13 ' HG3' ' A' ' 31' ' ' GLU . 60.2 t -122.19 131.35 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 122.296 -0.253 . . . . 0.0 110.385 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -101.28 108.96 57.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 58.7 Cg_endo -71.7 -8.42 23.09 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.907 2.404 . . . . 0.0 111.216 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.538 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 13.8 tp10 -75.87 -70.49 0.43 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.313 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.12 10.55 23.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.33 41.34 23.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.092 0.472 . . . . 0.0 111.992 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -138.74 128.46 24.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.867 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB3' HD11 ' A' ' 22' ' ' LEU . 2.2 mp0 -91.1 161.31 15.15 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.84 161.52 17.84 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 120.947 0.404 . . . . 0.0 110.41 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 t -115.14 137.91 23.23 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 11.5 Cg_endo . . . . . 0 C--N 1.343 0.264 0 C-N-CA 123.169 2.579 . . . . 0.0 113.219 -173.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.407 HG12 ' CG1' ' A' ' 54' ' ' VAL . 14.5 t . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.417 HG21 HG12 ' A' ' 94' ' ' ILE . 9.6 mm -75.58 137.83 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.627 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.579 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.1 OUTLIER -119.17 156.6 29.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.0 176.496 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 5.9 m-20 -96.92 -179.01 4.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.224 -176.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 30.7 t -80.13 -6.54 57.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.964 0.888 . . . . 0.0 109.538 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.475 HG21 ' HD2' ' A' ' 112' ' ' ARG . 3.7 t -90.95 -17.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.716 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.13 3.14 57.92 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.211 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.31 167.44 16.57 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.036 0.922 . . . . 0.0 110.819 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.54 HG22 ' HG3' ' A' ' 48' ' ' LYS . 24.0 t -117.05 139.28 44.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.887 -1.96 . . . . 0.0 108.255 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.418 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 2.1 mm? -97.33 174.55 6.64 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.37 0.605 . . . . 0.0 110.704 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -125.24 145.67 49.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.717 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 14.9 t70 -67.76 99.51 0.82 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.643 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.62 -7.21 9.63 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.17 174.99 5.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.944 0.402 . . . . 0.0 110.937 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.5 m -106.91 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.67 166.89 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.1 m -150.54 119.1 6.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.851 0.358 . . . . 0.0 111.355 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.717 HG11 HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -63.66 126.65 22.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.19 22.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.627 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -143.24 159.53 42.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.534 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.48 100.53 11.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.952 0.882 . . . . 0.0 112.707 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.629 HD21 ' CD2' ' A' ' 110' ' ' PHE . 6.6 mp -110.63 153.71 24.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.038 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -98.76 179.33 4.69 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.777 0.322 . . . . 0.0 111.385 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.61 HG21 ' HB2' ' A' ' 72' ' ' SER . 33.7 m -119.55 147.2 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.7 ' HG3' ' H ' ' A' ' 71' ' ' GLY . 18.2 ptmt -77.84 -76.81 0.17 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.7 ' H ' ' HG3' ' A' ' 70' ' ' LYS . . . -92.07 47.96 2.69 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.969 -173.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.61 ' HB2' HG21 ' A' ' 69' ' ' VAL . 74.6 m -144.33 176.76 9.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.7 m -104.96 6.43 33.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.604 1.192 . . . . 0.0 108.03 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.578 ' O ' HG22 ' A' ' 69' ' ' VAL . 4.5 mm? -77.91 176.67 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.224 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.1 t -160.02 113.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.717 HG12 HG11 ' A' ' 63' ' ' VAL . 87.2 t -85.68 93.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.56 0.695 . . . . 0.0 109.503 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -106.48 148.15 28.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -171.491 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -48.29 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.92 0.867 . . . . 0.0 111.348 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.59 8.0 3.28 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.107 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 62' ' ' THR . 85.7 m -63.92 103.19 0.55 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 122.153 0.978 . . . . 0.0 109.653 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 81' ' ' LYS . 5.6 ttpm? -92.5 110.48 21.89 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.096 -174.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 96' ' ' CYS . 56.8 t -126.49 117.88 49.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.758 177.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 55.6 pttt -105.1 163.02 12.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.662 . . . . 0.0 112.11 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.643 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.8 OUTLIER 67.81 42.87 1.86 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.298 174.806 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.518 HG22 ' HB3' ' A' ' 96' ' ' CYS . 36.1 pt -65.63 -175.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.717 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 12.2 tpp85 -135.01 122.82 22.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.423 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.41 HD22 HG12 ' A' ' 47' ' ' ILE . 71.0 mt -76.4 118.91 19.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.879 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 121.319 0.58 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 108' ' ' SER . 63.6 mt -142.72 125.66 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.204 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 4.5 t70 -104.98 139.04 40.27 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.518 ' HB3' HG22 ' A' ' 85' ' ' ILE . 27.2 p -155.05 165.56 36.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -112.07 135.77 52.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.517 HG13 HD11 ' A' ' 101' ' ' ILE . 2.2 mm -100.84 98.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.9 105.88 0.14 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.723 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.25 0.68 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.356 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.574 HG21 HD21 ' A' ' 74' ' ' LEU . 34.2 pt -96.07 -42.63 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 145.06 -166.11 27.59 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.0 148.38 24.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.998 0.899 . . . . 0.0 110.874 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.3 ttm -140.02 158.61 43.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -117.05 138.37 51.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.5 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -123.96 147.88 47.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.434 -171.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 13.6 tptm -84.82 122.37 29.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.812 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -50.97 -39.76 56.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.745 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' SER . 10.4 pt-20 -66.02 -9.05 26.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.294 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.629 ' CD2' HD21 ' A' ' 67' ' ' LEU . 42.1 m-85 -110.74 0.62 17.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.165 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 15.4 m -112.5 170.77 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.475 ' HD2' HG21 ' A' ' 51' ' ' VAL . 22.0 ttt180 -145.66 138.28 25.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.457 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 87.8 tttt -68.83 119.13 12.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.612 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.17 -47.36 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.02 48.63 25.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.052 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.427 -178.397 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 72.9 Cg_endo -73.11 156.9 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.223 1.949 . . . . 0.0 111.133 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 8.0 Cg_exo -72.49 -163.3 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.9 2.4 . . . . 0.0 112.603 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.4 t -98.32 130.56 28.03 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.47 5.28 2.03 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.287 . . . . 0.0 112.927 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -121.2 -35.13 3.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.241 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 13' ' ' SER . 58.0 m -104.79 -47.31 4.08 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.49 -0.756 . . . . 0.0 109.511 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.54 -2.35 1.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.08 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 11' ' ' CYS . 15.0 p -48.32 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.095 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 170.03 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.263 0.352 . . . . 0.0 111.681 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.657 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 80.8 m-85 -77.79 39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -171.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -103.28 143.31 32.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.515 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -153.88 176.73 11.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.71 123.47 47.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.838 0.352 . . . . 0.0 111.441 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -121.17 86.43 2.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.43 -116.16 5.01 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.132 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.77 18.23 22.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.902 0.382 . . . . 0.0 111.789 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.4 -173.49 4.52 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 mt -112.86 138.39 49.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.651 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -126.75 142.75 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 51.7 t -104.5 105.48 50.2 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.733 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.7 Cg_endo -65.84 -15.95 51.02 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.816 2.344 . . . . 0.0 111.512 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.1 tt0 -71.21 -61.39 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.93 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -98.82 12.76 34.69 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.95 29.54 17.81 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -135.75 133.92 38.49 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.131 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.651 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.4 mp0 -95.11 171.68 8.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.642 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -166.22 161.83 17.09 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.932 0.396 . . . . 0.0 110.558 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -115.57 113.79 42.65 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--O 1.232 0.189 0 C-N-CA 123.201 2.601 . . . . 0.0 113.195 -168.02 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.662 HG21 HG13 ' A' ' 94' ' ' ILE . 3.0 mm -89.93 135.44 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.079 -172.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.733 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -115.0 145.71 41.99 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' OD2' HD11 ' A' ' 55' ' ' LEU . 70.4 m-20 -104.5 179.43 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.515 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 5.0 t -73.93 -9.22 58.42 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.93 0.872 . . . . 0.0 110.315 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.1 t -84.91 -18.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.657 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.58 12.7 60.66 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.5 -175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 49' ' ' ASP . 3.1 p30 -99.72 153.38 19.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.257 0.551 . . . . 0.0 111.112 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.41 133.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.328 -175.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.557 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.3 mp -96.67 175.17 6.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.25 0.548 . . . . 0.0 111.724 -168.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -124.81 146.98 48.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.687 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 17.8 t70 -70.65 102.21 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 0.0 110.625 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.48 -3.98 13.53 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.27 171.61 10.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.969 -0.615 . . . . 0.0 110.833 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 31.1 m -104.75 137.64 42.25 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -121.16 168.56 13.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.7 m -148.96 118.3 6.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.888 0.375 . . . . 0.0 110.868 175.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 1.1 p -62.91 129.48 26.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.534 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -95.14 10.41 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 64' ' ' ILE . 74.9 mmtt -138.0 171.1 14.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 119.83 1.195 . . . . 0.0 110.255 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.78 112.23 22.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.496 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.9 mp -130.23 143.44 50.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.984 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -90.99 178.76 5.92 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.793 -0.567 . . . . 0.0 110.343 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 74' ' ' LEU . 57.8 t -122.24 115.68 46.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -79.16 117.87 20.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -166.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.9 45.76 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.08 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -110.86 172.86 6.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.343 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -98.01 9.16 43.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.532 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 69' ' ' VAL . 14.8 tp -78.85 170.66 16.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.734 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 72.5 t -158.13 117.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -168.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.528 HG12 HG11 ' A' ' 63' ' ' VAL . 94.3 t -93.48 95.76 5.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.851 0.834 . . . . 0.0 110.544 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.12 151.61 27.04 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.473 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.534 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -52.18 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.824 0.821 . . . . 0.0 110.817 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.16 4.89 3.16 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.174 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.5 m -61.92 104.74 0.49 Allowed 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 122.032 0.92 . . . . 0.0 110.148 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 30.0 ttpt -89.97 112.65 24.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.921 -175.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.1 t -123.67 114.39 41.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 ptmt -104.28 151.29 23.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.642 -175.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 68.88 47.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 124.33 1.019 . . . . 0.0 111.468 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.3 pt -65.89 -179.5 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.058 0.932 . . . . 0.0 113.193 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.687 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 19.4 tpt180 -129.15 122.37 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.636 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.576 HD22 HG12 ' A' ' 47' ' ' ILE . 79.6 mt -83.07 119.64 24.75 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.951 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -175.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 88' ' ' VAL . 6.0 m-20 . . . . . 0 C--O 1.225 -0.224 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.662 HG13 HG21 ' A' ' 47' ' ' ILE . 38.1 mt -120.09 113.69 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.322 174.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 13.4 t70 -95.63 139.79 31.38 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.802 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.488 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.7 p -149.39 159.79 43.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.069 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 14.2 mptt -112.32 135.13 53.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.686 HG13 HD11 ' A' ' 101' ' ' ILE . 1.8 mm -114.07 109.01 26.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.6 102.02 0.13 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.94 -66.48 0.51 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.829 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.686 HD11 HG13 ' A' ' 98' ' ' ILE . 45.7 pt -86.9 -48.82 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.545 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 141.63 -157.72 26.34 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -176.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -77.37 144.03 38.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 117.939 0.869 . . . . 0.0 110.529 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 52.9 ttp -133.69 151.88 51.75 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -112.11 140.67 46.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.1 mt -120.96 139.58 53.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.464 0.649 . . . . 0.0 111.528 -171.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 22.2 tptm -80.83 116.23 20.71 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.824 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.733 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 7.5 p -53.98 -34.52 60.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.602 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 50' ' ' SER . 37.5 mt-10 -68.94 -9.87 54.27 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.47 ' O ' HD13 ' A' ' 64' ' ' ILE . 63.8 m-85 -109.41 -4.46 16.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.049 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.9 m -113.6 173.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.314 0.578 . . . . 0.0 112.12 -174.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.506 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.9 ttt180 -147.07 133.14 19.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.002 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 27.8 tttp -65.1 136.87 57.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.009 176.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.2 -56.56 5.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.588 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.54 49.62 10.98 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.063 -172.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.589 -178.015 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 23' ' ' LEU . 51.0 mt . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 62.8 Cg_endo -70.95 156.85 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.029 1.82 . . . . 0.0 111.344 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -73.91 -163.55 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.843 2.362 . . . . 0.0 112.7 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.9 t -98.29 124.2 47.89 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.406 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.45 11.27 0.63 Allowed 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 122.899 2.399 . . . . 0.0 111.563 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 41.3 mt-30 -120.8 -38.32 2.87 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 -178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m -108.26 -50.29 3.06 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t30 70.0 7.18 6.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.368 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.51 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 5.1 m -54.32 -76.6 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.982 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 13' ' ' SER . 15.5 pt-20 165.66 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.327 0.392 . . . . 0.0 111.977 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.501 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 87.6 m-85 -78.43 33.67 0.2 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -169.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -95.71 139.89 31.29 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.587 0.232 . . . . 0.0 110.563 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 20.9 p90 -147.48 178.09 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.1 122.19 47.26 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.206 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.539 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 24.0 t70 -118.35 89.28 3.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.879 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.46 -106.58 3.43 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.196 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.36 17.34 17.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 31' ' ' GLU . 1.3 pt? -163.91 -175.05 3.88 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.249 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.409 ' CD1' ' HG2' ' A' ' 6' ' ' PRO . 22.4 mt -101.36 135.56 42.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.561 HG13 ' HG3' ' A' ' 31' ' ' GLU . 64.8 t -117.62 130.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 50.4 t -101.6 103.93 31.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 173.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.0 Cg_endo -65.89 -18.65 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.508 2.139 . . . . 0.0 110.969 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.59 -61.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.194 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.4 p -95.44 11.35 33.18 Favored 'General case' 0 C--O 1.23 0.055 0 O-C-N 121.649 -0.657 . . . . 0.0 112.313 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.63 26.0 15.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -125.94 135.83 52.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.506 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.561 ' HG3' HG13 ' A' ' 24' ' ' VAL . 6.2 mp0 -96.54 158.27 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.545 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -158.9 161.32 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -120.15 128.63 25.74 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 174.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.545 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 8.6 Cg_endo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 123.412 2.741 . . . . 0.0 113.215 -170.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.558 HG23 HD13 ' A' ' 87' ' ' LEU . 14.4 p . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.925 0.393 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.433 HG12 ' HB3' ' A' ' 87' ' ' LEU . 6.3 mm -72.84 139.34 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.904 -172.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -126.48 154.44 43.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.11 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 8.3 m-20 -99.95 179.99 4.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.189 0.518 . . . . 0.0 111.467 -174.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 14.7 t -82.8 -13.02 56.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.023 0.916 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.478 HG11 ' HG3' ' A' ' 112' ' ' ARG . 2.0 p -89.24 -0.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.097 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 5.37 68.6 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.277 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.454 ' OD1' HG13 ' A' ' 51' ' ' VAL . 9.7 p30 -108.32 173.16 6.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.536 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.549 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.9 t -115.17 142.31 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.254 -175.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.728 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -98.7 -177.47 3.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 110.251 -177.623 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.445 ' HA ' HD11 ' A' ' 87' ' ' LEU . 14.5 tt0 -136.69 163.41 30.65 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 16.5 t70 -65.26 130.73 44.38 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.83 -6.96 82.71 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.351 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.87 165.24 20.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 61.4 m -103.81 137.2 42.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.575 HG22 HD22 ' A' ' 55' ' ' LEU . 1.6 pp -117.72 164.67 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' THR . 3.8 m -149.92 112.12 4.65 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -59.8 129.23 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.667 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.558 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -99.23 15.2 4.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.801 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.471 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.37 157.79 45.49 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -89.78 109.18 20.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 112.135 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.414 HD21 ' CD2' ' A' ' 110' ' ' PHE . 12.4 mt -124.59 152.44 43.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.25 177.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -95.81 178.52 5.42 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.997 -0.44 . . . . 0.0 111.291 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.11 130.81 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -74.82 128.53 35.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.837 0.351 . . . . 0.0 111.529 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.15 -13.12 3.6 Favored Glycine 0 CA--C 1.517 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.574 173.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.524 ' HB3' HD23 ' A' ' 74' ' ' LEU . 37.3 m -107.58 155.15 20.43 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.643 -0.328 . . . . 0.0 110.877 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -81.5 8.28 9.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.495 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 72' ' ' SER . 3.8 mm? -78.6 170.37 16.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.604 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -159.88 117.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.606 HG12 HG11 ' A' ' 63' ' ' VAL . 86.5 t -93.66 95.69 5.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 110.368 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 150.23 27.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.048 -175.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -49.94 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.948 0.88 . . . . 0.0 110.759 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.72 4.79 4.19 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.475 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.8 m -62.36 105.32 0.6 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.871 0.843 . . . . 0.0 110.059 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -89.27 112.68 23.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.75 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 96' ' ' CYS . 44.7 t -124.59 113.18 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.249 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.3 ptmt -96.12 167.76 11.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.763 -174.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.64 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 1.4 p-10 60.04 39.66 19.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.943 -1.48 . . . . 0.0 112.314 170.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.3 pt -64.18 179.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 -128.69 126.84 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.077 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.558 HD13 HG23 ' A' ' 46' ' ' VAL . 58.2 mt -80.58 120.16 24.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 93' ' ' ASP . 5.3 t . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 121.114 0.483 . . . . 0.0 110.742 -172.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.598 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.5 m-20 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.221 0.534 . . . . 0.0 111.473 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.635 ' CD1' HG21 ' A' ' 111' ' ' VAL . 66.7 mt -116.23 122.35 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.791 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.51 132.4 42.13 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.091 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.458 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -134.18 142.72 47.52 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -105.32 117.02 32.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.5 mt -117.28 113.33 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.167 -171.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.28 110.64 1.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 143.95 -62.19 0.5 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.815 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 -35.85 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 0.0 111.392 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.94 -147.88 19.46 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.66 147.02 23.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 111.065 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 61.2 ttp -144.46 165.87 26.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.881 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.98 148.01 34.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.897 0.38 . . . . 0.0 110.195 177.253 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.0 mt -130.08 140.37 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.912 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.45 ' HG3' ' OE1' ' A' ' 109' ' ' GLU . 9.3 tptp -80.0 115.07 19.37 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.675 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -50.36 -40.19 48.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 50' ' ' SER . 1.6 mp0 -69.6 -10.01 56.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.421 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.425 ' HD1' ' HB3' ' A' ' 107' ' ' LYS . 75.3 m-85 -112.09 -0.12 15.74 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 35.0 m -115.62 174.5 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.259 0.552 . . . . 0.0 112.163 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.478 ' HG3' HG11 ' A' ' 51' ' ' VAL . 19.9 ttt180 -143.22 131.78 22.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.273 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.728 ' HG3' ' HA ' ' A' ' 55' ' ' LEU . 1.9 tmtp? -70.43 119.97 15.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.381 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.25 -48.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.52 ' HA2' ' HE3' ' A' ' 113' ' ' LYS . . . 88.49 44.72 5.17 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.831 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.455 177.014 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.608 HD13 HD22 ' A' ' 23' ' ' LEU . 17.8 mt . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.356 0.122 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 36.6 Cg_endo -63.45 161.63 30.57 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.551 2.167 . . . . 0.0 111.808 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.536 ' HB3' ' HG3' ' A' ' 14' ' ' GLU . 11.5 Cg_exo -70.44 -170.7 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.775 2.316 . . . . 0.0 112.496 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.46 123.68 49.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.08 9.04 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.545 2.163 . . . . 0.0 111.866 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.581 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 48.8 mt-30 -119.42 -36.21 3.4 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.889 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -110.82 -46.99 3.28 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 121.265 0.555 . . . . 0.0 109.727 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.21 5.83 5.13 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.91 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 m -61.41 -27.5 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.043 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 7' ' ' PRO . 4.4 mt-10 78.06 13.54 1.63 Allowed 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 174.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -81.03 47.46 1.0 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.717 0.77 . . . . 0.0 109.039 170.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 m -99.18 147.12 25.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.961 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -148.08 173.92 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.43 116.05 31.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 0.0 110.582 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -96.94 28.27 3.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.049 0.928 . . . . 0.0 109.675 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.82 -99.7 0.41 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.546 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.27 17.64 22.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.916 0.389 . . . . 0.0 111.577 -173.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 31' ' ' GLU . 2.2 pt? -159.83 -176.67 5.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.608 HD22 HD13 ' A' ' 5' ' ' LEU . 3.5 mt -109.98 135.04 51.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -125.76 140.52 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 0.0 109.599 177.425 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 45.9 t -102.36 106.19 47.37 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.475 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 25' ' ' CYS . 33.9 Cg_endo -65.2 -14.66 46.3 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.679 2.253 . . . . 0.0 111.361 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.07 -59.36 2.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.891 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.1 p -99.08 10.14 42.07 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.59 39.85 20.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -139.47 126.72 21.32 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.585 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.47 164.66 11.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.778 177.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -163.99 162.05 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.489 . . . . 0.0 111.026 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.2 t -104.68 123.26 40.79 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 C-N-CA 122.952 2.435 . . . . 0.0 113.112 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.475 HG13 HD13 ' A' ' 87' ' ' LEU . 6.1 t . . . . . 0 C--O 1.231 0.108 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.59 HG21 HG13 ' A' ' 94' ' ' ILE . 2.8 mm -91.66 135.23 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.667 ' O ' ' HB2' ' A' ' 108' ' ' SER . 11.7 ttmt -121.09 155.0 35.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 111' ' ' VAL . 9.0 m-20 -92.98 176.83 6.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.304 0.573 . . . . 0.0 111.449 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 13.5 t -79.0 -7.37 58.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.642 174.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.02 -15.37 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.347 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.98 0.39 60.16 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.45 162.67 20.89 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.901 0.857 . . . . 0.0 110.767 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.494 HG22 ' HE2' ' A' ' 48' ' ' LYS . 2.9 t -118.19 130.64 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.909 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.411 ' HB2' HD21 ' A' ' 87' ' ' LEU . 1.5 mm? -93.76 173.19 7.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.377 0.608 . . . . 0.0 110.645 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.29 150.72 48.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.692 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.583 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 17.7 t70 -67.43 99.14 0.71 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.449 . . . . 0.0 109.891 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 121.72 -7.45 10.27 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.385 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.67 167.96 14.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.698 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.5 m -106.45 131.65 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.795 HG13 HG23 ' A' ' 82' ' ' VAL . 1.9 pp -127.57 169.11 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.721 0.296 . . . . 0.0 110.311 -174.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.8 m -150.6 121.68 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.574 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -61.93 131.04 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 109.867 176.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.537 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -94.98 10.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 64' ' ' ILE . 58.1 mmtt -139.18 167.63 21.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 119.843 1.201 . . . . 0.0 110.034 -176.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.4 109.86 20.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.176 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 mp -123.95 138.54 54.45 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.466 173.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.02 177.7 5.66 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.651 -0.656 . . . . 0.0 110.265 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 72' ' ' SER . 39.0 t -128.83 120.98 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -84.77 -32.77 23.22 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.157 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.559 ' N ' ' HD3' ' A' ' 70' ' ' LYS . . . -86.4 -26.82 32.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.924 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.698 ' HB3' HD23 ' A' ' 74' ' ' LEU . 60.8 m -110.42 163.71 13.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 m -81.37 8.66 8.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.57 0.7 . . . . 0.0 109.96 173.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.93 172.35 13.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.107 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.4 t -159.35 113.81 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -166.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.495 HG12 HG11 ' A' ' 63' ' ' VAL . 94.8 t -90.97 96.78 6.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.828 0.823 . . . . 0.0 110.246 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.459 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.3 pptp? -106.04 148.2 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.54 96.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.974 0.893 . . . . 0.0 110.605 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA2' ' CG2' ' A' ' 62' ' ' THR . . . 133.09 4.76 3.21 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.005 -177.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' THR . 88.7 m -63.53 103.46 0.53 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.959 0.885 . . . . 0.0 109.956 176.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -92.29 115.3 27.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.654 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.795 HG23 HG13 ' A' ' 61' ' ' ILE . 2.6 m -120.04 119.87 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.808 0.813 . . . . 0.0 110.519 171.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.0 pttp -103.82 148.8 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.465 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.58 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 5.4 m-20 71.54 43.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.127 0.892 . . . . 0.0 111.284 176.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.31 -178.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 122.098 0.951 . . . . 0.0 113.016 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -129.74 124.69 34.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.867 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.475 HD13 HG13 ' A' ' 46' ' ' VAL . 71.3 mt -82.63 117.51 22.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.9 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--N 1.318 -0.8 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.12 -173.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.9 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 4.6 m-20 . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.59 HG13 HG21 ' A' ' 47' ' ' ILE . 30.5 mt -120.94 111.06 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.557 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 24.7 t70 -94.47 135.31 36.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 p -134.42 142.07 47.02 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.955 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -104.89 119.29 38.65 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.7 mt -118.72 108.81 25.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.292 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -54.66 126.17 22.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.382 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.87 -53.45 0.78 Allowed Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 102' ' ' GLY . 40.6 pt -112.18 -39.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.782 0.325 . . . . 0.0 110.961 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 135.3 -149.21 19.89 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.98 155.01 19.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.015 0.407 . . . . 0.0 110.863 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -147.21 161.93 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.431 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -107.69 146.89 31.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.26 142.18 50.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.398 0.618 . . . . 0.0 111.452 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -78.05 120.05 22.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.671 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.667 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.9 p -57.11 -34.57 68.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.988 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 50' ' ' SER . 4.8 pm0 -70.23 -7.22 40.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.421 ' O ' HD13 ' A' ' 64' ' ' ILE . 55.0 m-85 -112.75 3.63 16.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 49' ' ' ASP . 29.1 m -110.48 166.53 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.422 0.63 . . . . 0.0 112.531 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -141.3 133.51 27.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.356 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.491 ' HE3' ' CA ' ' A' ' 115' ' ' GLY . 33.0 tttp -65.95 139.49 58.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.22 -42.78 8.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.491 ' CA ' ' HE3' ' A' ' 113' ' ' LYS . . . 79.54 29.56 48.24 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.143 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.85 176.816 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 21.9 mt . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 63.2 Cg_endo -68.88 154.61 70.68 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 121.552 1.501 . . . . 0.0 110.741 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 7.7 Cg_exo -71.77 -165.78 0.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.669 2.246 . . . . 0.0 112.294 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.7 t -97.75 123.26 52.41 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.046 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.39 11.21 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.895 2.397 . . . . 0.0 111.739 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 46.6 mt-30 -122.22 -37.68 2.79 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.891 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -107.09 -49.12 3.34 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.247 0.546 . . . . 0.0 109.721 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 70.51 -3.73 1.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.249 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 8.3 t -54.68 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.371 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 13' ' ' SER . 11.3 pt-20 171.68 -8.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 96.7 m-85 -78.8 35.42 0.24 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 112.017 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -97.82 134.98 40.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.307 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 27.5 p90 -145.52 171.66 14.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.12 123.22 46.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.067 0.46 . . . . 0.0 110.916 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.69 84.08 2.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.02 -114.03 4.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.225 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.93 20.66 18.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -171.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.72 -174.82 4.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.495 HD22 HD13 ' A' ' 5' ' ' LEU . 35.0 mt -110.58 135.61 50.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -126.31 140.65 48.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.792 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -107.49 106.22 57.88 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.176 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.3 Cg_endo -68.46 -14.31 39.58 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.704 2.27 . . . . 0.0 110.79 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.601 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 32.6 tt0 -66.09 -58.78 4.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.076 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.18 8.74 36.31 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.46 49.36 13.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.429 0.559 . . . . 0.0 112.112 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -147.72 128.09 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.01 171.62 8.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -168.75 162.16 11.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 m -119.81 116.31 33.08 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 C--N 1.344 0.298 0 C-N-CA 123.319 2.68 . . . . 0.0 113.106 -170.675 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.501 HG13 HD13 ' A' ' 87' ' ' LEU . 2.6 t . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.045 0.45 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 93' ' ' ASP . 2.5 mm -105.32 141.22 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.058 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -105.03 165.79 10.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.0 111.739 -178.102 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.9 m-20 -109.97 172.7 6.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.784 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 64' ' ' ILE . 36.1 t -77.22 -7.46 55.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.441 HG11 ' HG3' ' A' ' 112' ' ' ARG . 2.4 p -93.2 0.31 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.257 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 4.08 69.86 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.285 171.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.435 ' OD1' HG13 ' A' ' 51' ' ' VAL . 8.6 p30 -105.02 168.25 9.17 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.829 -0.748 . . . . 0.0 112.14 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 46' ' ' VAL . 2.4 t -113.66 137.08 48.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.847 -174.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 61' ' ' ILE . 9.2 mt -89.88 172.84 8.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.581 0.705 . . . . 0.0 112.097 -171.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -121.84 142.63 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.571 173.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.635 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 6.4 t70 -67.03 105.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.041 0.448 . . . . 0.0 110.375 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.424 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 114.49 -0.84 23.55 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -80.2 174.25 11.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.306 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 26.9 m -102.56 139.18 38.49 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.6 HG22 HD22 ' A' ' 55' ' ' LEU . 2.1 pp -118.66 165.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 m -147.97 118.39 7.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.835 0.35 . . . . 0.0 110.084 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.662 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.22 127.51 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.793 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.42 19.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.793 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.1 mptp? -135.62 163.93 29.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.436 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.6 p-10 -86.83 113.39 22.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.933 0.873 . . . . 0.0 111.72 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 66' ' ' ASP . 18.3 mt -125.4 148.05 48.94 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.98 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -98.31 177.12 5.47 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.8 170.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 72' ' ' SER . 57.3 t -125.15 131.42 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -83.1 -38.96 21.75 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.48 -25.03 59.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.254 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 69' ' ' VAL . 71.8 m -115.11 171.6 7.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.234 0.54 . . . . 0.0 111.774 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.0 t -92.07 1.9 56.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.398 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 101' ' ' ILE . 10.7 mp -79.68 136.49 36.81 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.464 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.03 133.69 43.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.006 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.662 HG12 HG11 ' A' ' 63' ' ' VAL . 53.5 t -89.03 100.56 10.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.615 0.722 . . . . 0.0 109.925 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -105.18 150.44 25.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.721 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -51.31 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.848 0.832 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.13 4.82 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.16 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.0 m -61.29 105.45 0.5 Allowed 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 122.147 0.975 . . . . 0.0 110.129 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 36.3 ttpt -90.84 114.24 26.61 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.206 -173.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 96' ' ' CYS . 21.5 t -123.72 117.26 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.027 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 11.3 ptmm? -99.92 154.03 18.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.558 -173.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.424 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 16.2 m-80 64.25 50.01 2.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.685 175.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.8 pt -65.66 177.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.826 0.822 . . . . 0.0 112.725 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.635 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 10.3 tpt180 -131.69 125.52 32.3 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.076 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD13 HG13 ' A' ' 46' ' ' VAL . 36.3 mt -84.25 118.33 24.1 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.542 ' O ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.953 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.48 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.3 m-20 . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.596 ' CD1' HG21 ' A' ' 111' ' ' VAL . 50.5 mt -121.22 116.49 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.388 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 30.8 t70 -93.96 128.42 40.27 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.77 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.823 ' HB2' HG11 ' A' ' 82' ' ' VAL . 25.3 p -130.86 137.12 49.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.071 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -107.72 118.85 37.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.84 108.27 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 -171.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -63.93 107.61 1.28 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.434 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.27 -45.04 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.394 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.45 HD13 HD22 ' A' ' 74' ' ' LEU . 15.6 pt -120.29 -37.54 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.87 0.366 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.27 -153.33 21.85 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.26 151.92 21.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.092 0.446 . . . . 0.0 110.503 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.8 ttp -143.15 164.17 30.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.95 147.92 37.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 0.0 110.379 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 90.1 mt -129.52 144.01 51.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.791 -171.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -81.5 120.44 25.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.279 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.71 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 2.5 m -50.89 -36.91 40.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.328 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' SER . 42.8 mt-10 -71.32 -5.4 32.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.435 ' CG ' HD11 ' A' ' 67' ' ' LEU . 55.0 m-85 -114.36 -2.75 13.2 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.857 -0.737 . . . . 0.0 112.749 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 94' ' ' ILE . 34.8 m -113.72 172.7 3.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 25.0 ttt180 -151.74 133.94 15.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.582 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.408 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.4 tttt -65.28 123.16 18.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.19 174.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.47 -51.91 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.871 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.16 39.06 16.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.318 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.389 179.172 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.412 HD11 ' CD ' ' A' ' 18' ' ' GLU . 55.2 mt . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.2 Cg_endo -71.49 157.45 56.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.1 1.867 . . . . 0.0 110.688 174.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 19.0 Cg_exo -66.6 -174.64 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.093 . . . . 0.0 113.258 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.764 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 34.3 t -99.6 123.22 48.76 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HG2' ' OE1' ' A' ' 10' ' ' GLN . 39.2 Cg_endo -70.01 7.27 1.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 121.887 1.725 . . . . 0.0 112.059 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.764 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 1.2 mp0 -103.0 -54.26 2.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.307 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.414 ' C ' ' H ' ' A' ' 13' ' ' SER . 28.4 p -117.77 -28.29 6.01 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.0 t30 75.88 -28.55 0.18 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.287 0.635 . . . . 0.0 112.287 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 63.5 p -32.5 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.574 1.171 . . . . 0.0 113.401 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.0 pt-20 169.35 -4.93 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.533 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.6 m-85 -81.16 42.41 0.65 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.27 0.557 . . . . 0.0 111.747 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -109.26 148.56 30.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.853 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -150.09 174.1 13.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.2 pm0 -102.77 115.61 30.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.377 0.608 . . . . 0.0 111.268 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.514 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 10.7 t70 -122.86 83.65 2.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.824 174.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.97 -126.38 8.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.336 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.47 17.61 23.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.962 0.41 . . . . 0.0 111.372 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.7 -174.07 4.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.1 mt -120.23 136.82 54.52 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.808 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -125.12 143.58 38.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.259 -179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.1 t -104.22 104.21 42.84 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 23.0 Cg_endo -61.49 -22.1 73.64 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.843 2.362 . . . . 0.0 111.179 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 17.0 tp10 -74.15 -59.7 2.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.7 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.2 m -74.48 -9.91 59.05 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.72 44.83 25.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.314 0.578 . . . . 0.0 110.433 -170.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -145.1 122.94 11.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.808 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.6 mp0 -91.62 157.92 16.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.787 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -158.3 163.13 37.67 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.6 t -125.5 124.41 25.05 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo . . . . . 0 C--N 1.343 0.242 0 C-N-CA 123.075 2.517 . . . . 0.0 113.023 -173.392 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 87' ' ' LEU . 12.2 p . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 120.682 0.277 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.442 HG22 ' HB3' ' A' ' 108' ' ' SER . 2.0 mm -78.79 117.01 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.429 -173.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 108' ' ' SER . 1.2 mtmt -100.01 150.11 22.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.092 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.573 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 9.2 m-20 -90.5 176.64 6.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.516 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.6 t -77.09 -7.97 56.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.722 0.772 . . . . 0.0 110.761 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.492 HG11 ' HG3' ' A' ' 112' ' ' ARG . 2.1 p -97.3 -2.25 10.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.18 0.99 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.01 3.92 79.06 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.976 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.448 ' OD1' HG13 ' A' ' 51' ' ' VAL . 3.0 p30 -92.91 154.76 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.685 0.743 . . . . 0.0 111.017 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.3 109.94 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.612 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 113' ' ' LYS . 94.2 mt -58.76 145.7 39.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.383 175.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -120.51 148.94 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.709 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 1.2 t70 -63.94 126.36 27.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 88.66 2.01 79.63 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.816 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 173.64 12.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.967 0.383 . . . . 0.0 110.473 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 11.4 m -101.59 139.82 36.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.569 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.45 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -124.47 165.39 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.448 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.7 m -150.61 115.6 5.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.438 175.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.679 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.07 129.97 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.086 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.543 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -103.06 17.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.468 178.409 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.444 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.26 161.44 34.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.5 p-10 -85.55 111.31 19.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.938 0.875 . . . . 0.0 111.156 169.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.475 HD11 ' CB ' ' A' ' 110' ' ' PHE . 20.1 mt -124.43 133.88 53.25 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.145 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -88.28 173.2 8.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.749 -0.594 . . . . 0.0 109.963 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 72' ' ' SER . 21.7 t -128.92 120.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -93.36 -2.83 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.475 -170.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.14 26.31 6.45 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' SER . . . . . 0.485 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 58.2 m -146.49 -177.69 5.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -177.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -100.87 -12.12 19.25 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 101' ' ' ILE . 9.8 mp -79.22 142.45 36.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.786 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.98 126.64 67.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.359 167.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.679 HG12 HG11 ' A' ' 63' ' ' VAL . 76.0 t -77.73 104.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.44 150.39 26.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.448 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.543 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -52.34 96.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 121.776 0.798 . . . . 0.0 110.501 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.32 4.13 3.68 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.23 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' THR . 89.8 m -62.76 105.1 0.61 Allowed 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.478 0.656 . . . . 0.0 110.67 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -91.07 120.53 32.11 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.551 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 96' ' ' CYS . 59.8 t -129.7 116.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.745 174.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.8 pttm -102.92 159.51 15.43 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.253 -175.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.589 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 19.3 m120 65.25 48.53 2.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.453 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.9 pt -67.94 -178.95 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 11.1 tpp85 -136.44 124.39 22.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.602 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HB3' HG12 ' A' ' 47' ' ' ILE . 36.9 mt -79.83 125.38 29.63 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.042 -0.411 . . . . 0.0 110.086 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.107 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.3 m-20 . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.533 ' CD1' HG21 ' A' ' 111' ' ' VAL . 27.7 mt -139.36 115.17 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.07 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 20.5 t70 -92.73 133.99 35.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.313 0.578 . . . . 0.0 110.349 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.553 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -142.8 154.31 44.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.602 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 96.1 mttt -125.46 132.22 52.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mt -122.38 113.63 39.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.705 -167.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.75 100.69 0.95 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.215 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.75 -62.91 0.42 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.558 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 74' ' ' LEU . 20.0 pt -95.9 -46.19 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.986 0.422 . . . . 0.0 110.483 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 141.76 -155.82 25.56 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.607 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -81.85 144.75 30.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.757 0.279 . . . . 0.0 110.801 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.3 ttt -138.52 158.83 43.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 110.827 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.2 OUTLIER -111.16 137.17 49.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.816 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 86.3 mt -123.85 142.01 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.493 0.664 . . . . 0.0 111.455 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 6.5 mptt -92.9 121.24 34.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.256 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.3 p -51.88 -37.56 52.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.172 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -72.06 -6.75 44.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.844 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.475 ' CB ' HD11 ' A' ' 67' ' ' LEU . 60.5 m-85 -111.71 -4.13 14.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.891 -0.506 . . . . 0.0 111.995 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 34.8 m -114.88 175.36 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.492 ' HG3' HG11 ' A' ' 51' ' ' VAL . 26.7 ttt180 -151.46 130.98 12.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.423 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.479 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.1 tttt -66.63 122.21 17.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.338 175.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.44 -44.28 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.271 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.87 9.81 85.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.298 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.85 -178.51 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 121.39 0.614 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.4 p -104.52 151.93 6.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.563 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -83.74 134.13 34.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.058 0.456 . . . . 0.0 111.163 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 t -94.05 17.22 12.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.331 1.062 . . . . 0.0 108.705 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD13 HD22 ' A' ' 23' ' ' LEU . 11.2 mt -87.2 160.75 48.13 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.742 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 41.8 Cg_endo -64.89 160.01 43.19 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.319 2.013 . . . . 0.0 111.423 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.78 -169.69 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.079 1.853 . . . . 0.0 112.161 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 8.4 t -97.35 123.61 52.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.19 11.31 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.961 2.441 . . . . 0.0 111.806 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.491 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 39.7 mt-30 -122.73 -34.7 3.18 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.9 m -112.68 -45.13 3.25 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.785 -0.572 . . . . 0.0 110.489 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 12.91 7.49 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.02 0.914 . . . . 0.0 110.511 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.602 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 20.9 p -67.12 -32.19 73.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.926 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 84.85 5.76 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.011 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.602 ' HD1' ' HB2' ' A' ' 13' ' ' SER . 83.7 m-85 -82.7 47.32 1.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.689 0.757 . . . . 0.0 109.804 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -102.65 150.23 23.65 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.121 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.4 p90 -142.0 169.11 18.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.68 117.78 35.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.178 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.532 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 t70 -110.04 74.76 0.9 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.99 -102.8 2.72 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.208 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.85 18.69 15.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.08 -175.42 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 5' ' ' LEU . 5.8 mt -108.93 133.99 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 31' ' ' GLU . 49.9 t -118.66 128.04 75.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 52.3 t -97.9 108.34 45.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.33 -7.21 20.84 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.596 2.197 . . . . 0.0 111.387 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.4 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 48.2 tt0 -79.22 -67.48 0.75 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.65 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.05 9.19 29.0 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.297 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.14 46.79 12.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 112.007 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -144.18 125.91 15.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.415 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -93.44 149.03 21.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.553 176.287 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -153.27 161.84 41.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.558 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 8.7 t -119.58 129.94 25.1 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.484 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 12.0 Cg_endo -54.33 -54.98 3.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.893 2.396 . . . . 0.0 112.826 -170.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.99 -35.12 10.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.516 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 37.0 tt0 -69.06 -15.06 63.36 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.305 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.84 -30.55 71.63 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.815 0.341 . . . . 0.0 110.379 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.23 -40.75 58.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 m 70.41 150.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.788 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.15 162.7 39.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.437 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 m -81.17 96.19 7.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.846 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -99.52 172.73 7.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 58.19 37.02 26.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.64 26.42 22.62 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.568 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -96.57 5.27 51.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.51 0.672 . . . . 0.0 109.694 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.59 HG13 HD13 ' A' ' 87' ' ' LEU . 6.2 t -63.65 142.09 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.115 172.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -69.69 119.37 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.191 0.307 . . . . 0.0 110.655 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.7 OUTLIER -106.78 146.35 30.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.524 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.47 ' OD1' HG23 ' A' ' 111' ' ' VAL . 12.8 m-20 -90.0 175.51 7.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.621 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 7.0 t -74.37 -4.0 33.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.094 0.95 . . . . 0.0 110.12 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.483 HG21 ' HD2' ' A' ' 112' ' ' ARG . 3.5 t -87.88 -14.42 9.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.0 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.77 7.97 68.03 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.823 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -104.48 164.54 11.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.678 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.443 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.7 t -109.65 140.14 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.045 -173.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD22 HG22 ' A' ' 61' ' ' ILE . 24.9 mt -95.73 172.73 7.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.332 0.587 . . . . 0.0 111.136 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.436 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 53.7 tt0 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.712 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.497 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 13.6 t70 -69.13 94.96 0.71 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.193 0.52 . . . . 0.0 109.617 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.65 -11.0 6.72 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.2 t70 -72.04 169.51 15.82 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.304 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 83' ' ' LYS . 3.0 m -100.49 135.43 41.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.598 HG22 HD22 ' A' ' 55' ' ' LEU . 1.8 pp -121.42 163.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.0 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -150.27 119.91 7.0 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.172 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.875 HG11 HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -60.76 128.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.747 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.55 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -98.92 17.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 4.3 mptp? -142.09 166.57 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.547 -0.721 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -77.12 105.89 8.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.102 0.953 . . . . 0.0 111.101 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 2.4 mm? -114.84 126.44 54.82 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.675 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.87 171.7 14.18 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.407 HG11 ' HB2' ' A' ' 72' ' ' SER . 40.2 t -126.78 120.56 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.51 -45.0 69.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.64 -10.39 57.95 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.932 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.407 ' HB2' HG11 ' A' ' 69' ' ' VAL . 26.1 m -111.93 153.65 26.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.951 0.405 . . . . 0.0 111.144 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -71.04 -12.01 61.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.9 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mp -79.44 137.92 37.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.213 0.53 . . . . 0.0 111.121 -174.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.13 127.21 66.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.193 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.875 HG12 HG11 ' A' ' 63' ' ' VAL . 69.7 t -81.97 116.42 26.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.479 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -109.07 149.2 29.64 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.516 -176.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -50.04 97.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.838 0.828 . . . . 0.0 110.266 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.69 3.43 5.05 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.081 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 m -62.57 105.76 0.68 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 122.071 0.938 . . . . 0.0 110.163 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -88.36 116.85 26.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 -174.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 61' ' ' ILE . 93.5 t -129.09 110.16 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.781 ' HB3' HG23 ' A' ' 60' ' ' THR . 26.2 pttm -102.07 165.77 10.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.908 0.385 . . . . 0.0 111.624 -174.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.555 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 4.3 m-20 63.57 44.06 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.739 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 55' ' ' LEU . 39.6 pt -65.83 174.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.048 0.928 . . . . 0.0 113.064 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 2.2 tpp180 -122.56 123.93 42.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.941 -1.482 . . . . 0.0 108.236 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 HG13 ' A' ' 46' ' ' VAL . 42.5 mt -83.0 119.39 24.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -86.87 179.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.562 ' H ' HG12 ' A' ' 88' ' ' VAL . 15.3 t70 -60.13 -49.15 78.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.844 0.354 . . . . 0.0 111.521 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . -82.3 138.59 18.68 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.677 -177.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.98 -18.33 44.99 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.475 0.655 . . . . 0.0 111.876 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.448 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 1.0 OUTLIER -100.64 51.56 0.87 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.525 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 88' ' ' VAL . 9.4 m-20 -161.53 102.15 1.2 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -166.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.822 HG13 HG21 ' A' ' 47' ' ' ILE . 3.9 mp -110.55 116.6 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 170.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 28.1 t70 -94.1 130.36 40.3 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.47 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -144.22 154.58 43.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.567 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 98.7 mttt -121.18 129.5 53.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.0 mt -121.37 118.93 57.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.419 -170.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.11 120.91 8.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.743 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.35 -80.77 0.31 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 102' ' ' GLY . 26.1 pt -74.93 -46.03 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.733 0.301 . . . . 0.0 111.476 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 137.27 -150.84 20.86 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.89 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.86 146.82 24.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.656 0.265 . . . . 0.0 110.85 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.9 ttt -142.31 163.39 32.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.236 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.25 140.03 49.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.6 mt -120.04 144.1 47.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.121 0.486 . . . . 0.0 111.419 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 16.9 ttmt -80.89 118.76 22.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.977 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.689 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 3.3 m -49.08 -37.59 21.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.48 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 50' ' ' SER . 27.7 mt-10 -72.08 -8.62 55.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.279 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.454 ' CG ' HD21 ' A' ' 67' ' ' LEU . 33.9 m-85 -113.46 -0.62 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.174 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 21.9 m -113.51 171.69 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.798 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.483 ' HD2' HG21 ' A' ' 51' ' ' VAL . 13.5 ttt180 -150.29 138.21 20.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.641 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 113' ' ' LYS . 26.5 ttpt -62.88 117.11 5.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.857 165.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -55.59 -56.05 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.14 -0.05 13.03 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.325 176.431 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.966 0.413 . . . . 0.0 111.823 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.29 127.03 39.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.022 0.439 . . . . 0.0 110.659 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 m -71.24 147.08 48.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.336 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.1 p -101.05 34.99 2.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 110.627 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.572 HD13 HD22 ' A' ' 23' ' ' LEU . 31.9 mt -89.1 168.58 15.06 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.56 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 61.1 Cg_endo -69.43 158.35 57.72 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.868 1.712 . . . . 0.0 110.742 171.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 6.5 Cg_exo -73.06 -167.51 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.461 2.107 . . . . 0.0 112.4 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.4 t -98.36 125.68 42.34 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.522 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.44 7.76 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.804 2.336 . . . . 0.0 112.314 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.447 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 41.1 mt-30 -119.36 -38.44 3.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.8 m -107.23 -46.95 3.77 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.311 0.577 . . . . 0.0 109.917 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.36 0.81 2.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.414 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 m -57.88 -77.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.354 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 171.15 -21.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 73.2 m-85 -78.87 36.99 0.29 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -167.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -101.01 144.34 30.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.263 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -146.12 173.41 12.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.453 ' CD ' HD11 ' A' ' 5' ' ' LEU . 1.2 pm0 -101.7 119.42 38.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.575 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 15.7 t70 -120.18 75.42 1.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.12 -119.64 6.58 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.903 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.64 16.46 25.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.723 0.297 . . . . 0.0 111.72 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.6 pt? -152.24 -176.54 5.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.737 0.303 . . . . 0.0 110.293 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 5' ' ' LEU . 17.0 mt -111.69 130.7 55.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.17 127.94 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.2 t -102.6 103.98 35.56 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -70.07 -9.86 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.836 2.357 . . . . 0.0 110.65 176.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.624 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 74.0 tt0 -70.08 -65.02 0.78 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.991 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -95.12 11.41 32.31 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 43.69 19.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 111.824 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -150.1 136.33 18.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.928 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -107.63 166.77 10.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -162.3 161.85 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.9 t -112.93 124.73 31.06 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.57 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.5 Cg_endo -57.72 -45.48 32.98 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.304 2.669 . . . . 0.0 113.815 -168.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -105.18 -32.84 8.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.911 0.386 . . . . 0.0 110.961 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 36.0 tt0 -65.42 -32.79 74.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.955 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.77 -34.61 77.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 110.738 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.09 -41.74 18.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.455 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.9 m 69.54 -67.55 0.22 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.766 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.03 135.13 43.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.929 0.395 . . . . 0.0 111.054 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 m -101.13 28.67 5.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.164 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 68.65 153.51 0.1 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.764 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -82.15 -47.0 13.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.378 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.84 106.58 0.31 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.993 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.787 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 7.4 mmpt? -89.73 -3.35 58.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.638 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 87' ' ' LEU . 2.8 t -121.88 148.38 25.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.697 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.61 HD11 ' O ' ' A' ' 88' ' ' VAL . 3.1 mm -91.17 138.1 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.5 ttmt -121.06 149.49 42.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.316 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.588 ' OD1' HG23 ' A' ' 111' ' ' VAL . 6.8 m-20 -90.05 -179.79 5.77 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.273 0.559 . . . . 0.0 111.542 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 28.4 t -83.85 -3.21 57.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.014 0.911 . . . . 0.0 110.005 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG21 ' HB2' ' A' ' 112' ' ' ARG . 4.6 t -92.39 -14.42 8.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.819 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.62 3.28 59.67 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.688 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -87.68 163.39 16.57 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.933 0.873 . . . . 0.0 111.423 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 48' ' ' LYS . 2.6 t -117.69 135.18 58.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.663 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 87' ' ' LEU . 1.4 mm? -95.79 -157.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 111.278 -172.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 44.4 tt0 -159.56 146.34 16.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -70.59 97.85 1.39 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.811 0.815 . . . . 0.0 110.012 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 125.34 -6.6 8.09 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.941 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.592 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 40.9 t0 -73.87 167.8 20.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.719 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.2 m -110.88 134.2 52.74 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.47 171.86 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 6.0 m -150.12 119.34 6.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.789 0.328 . . . . 0.0 111.56 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.651 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -59.82 132.16 24.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 122.886 0.474 . . . . 0.0 110.155 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.727 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -104.68 19.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.727 ' HD2' HG12 ' A' ' 64' ' ' ILE . 4.9 mptp? -138.26 161.88 35.76 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -84.83 101.4 12.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.294 171.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD21 ' CG ' ' A' ' 110' ' ' PHE . 6.3 mp -112.96 145.66 40.41 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.86 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.37 173.97 8.42 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.876 0.369 . . . . 0.0 111.238 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 60.7 t -126.68 137.78 56.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -104.03 138.51 40.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.97 -37.45 3.5 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.36 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -110.56 155.62 22.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -80.35 -0.96 39.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 2.2 mm? -80.91 141.64 34.36 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.195 0.521 . . . . 0.0 111.409 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.2 t -112.71 134.83 54.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.466 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.651 HG12 HG11 ' A' ' 63' ' ' VAL . 78.6 t -83.68 99.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.028 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.15 148.64 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.265 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.98 96.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 122.038 0.923 . . . . 0.0 111.063 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.93 3.95 3.47 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.123 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.1 m -62.17 104.5 0.49 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.522 0.677 . . . . 0.0 110.294 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -87.17 116.2 25.08 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.651 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG11 ' HB2' ' A' ' 96' ' ' CYS . 18.2 t -125.31 116.58 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 pttm -104.71 162.51 13.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.564 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 74.6 m-20 66.81 38.65 3.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.341 170.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.5 pt -67.58 -178.72 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 122.168 0.985 . . . . 0.0 113.486 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 16.5 tpp180 -130.05 129.63 43.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.611 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.505 HD13 HG13 ' A' ' 46' ' ' VAL . 82.3 mt -84.88 123.74 30.82 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.765 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -93.33 163.98 2.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.46 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.14 102.63 5.82 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.85 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 164.09 -168.27 38.47 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.951 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -102.24 -45.4 5.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.289 0.566 . . . . 0.0 111.606 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.446 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 30.7 m80 -106.91 54.17 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.502 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.765 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.4 m-20 -135.26 93.98 3.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -161.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 106' ' ' LEU . 51.6 mt -125.96 117.41 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.328 0.585 . . . . 0.0 111.334 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 26.2 t70 -94.57 131.97 39.76 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.544 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.594 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.8 p -134.16 138.83 45.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.857 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -112.58 127.13 56.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.11 109.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.893 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.58 94.98 2.23 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.42 -56.39 0.31 Allowed Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.207 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.465 HG21 HD21 ' A' ' 74' ' ' LEU . 48.1 pt -104.39 -42.28 7.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.339 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 143.09 -158.87 27.35 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.024 -0.607 . . . . 0.0 111.698 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.2 144.42 26.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.728 0.299 . . . . 0.0 110.629 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.3 tpt -134.64 155.58 50.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.856 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.45 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -101.41 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.915 177.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 99.0 mt -130.85 136.6 48.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.674 0.75 . . . . 0.0 111.504 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.61 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 30.9 mttm -84.82 114.68 22.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.463 175.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.723 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.7 p -53.5 -35.76 60.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.137 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.61 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 5.9 pt-20 -61.31 -14.73 29.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.497 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.453 ' O ' HD13 ' A' ' 64' ' ' ILE . 56.6 m-85 -112.72 2.3 16.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.969 -0.457 . . . . 0.0 112.224 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.686 HG22 ' HA ' ' A' ' 108' ' ' SER . 17.8 m -114.14 170.3 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.38 0.609 . . . . 0.0 112.297 -173.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.495 ' HB2' HG21 ' A' ' 51' ' ' VAL . 7.5 ttt180 -142.09 141.22 32.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.291 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -71.03 140.76 50.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.369 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.0 t -105.03 -49.41 9.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.285 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.78 31.45 73.07 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.814 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.992 179.812 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.422 ' HE3' ' HB2' ' A' ' 1' ' ' MET . 19.4 ptm . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t 50.24 40.52 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 122.085 0.945 . . . . 0.0 109.046 -172.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.558 ' HB3' ' HG ' ' A' ' 5' ' ' LEU . 16.3 m -103.32 139.54 38.61 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.362 -172.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.1 p -107.19 30.78 5.9 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.283 0.563 . . . . 0.0 110.279 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.558 ' HG ' ' HB3' ' A' ' 3' ' ' SER . 12.4 mt -63.7 146.04 97.09 Favored Pre-proline 0 CA--C 1.518 -0.275 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.277 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.78 161.48 45.28 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.501 2.134 . . . . 0.0 111.201 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.28 -167.03 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.354 2.036 . . . . 0.0 111.769 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 10.7 t -98.47 129.2 30.89 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.628 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.98 8.47 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.581 2.188 . . . . 0.0 111.34 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.633 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 46.0 mt-30 -119.36 -38.45 3.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.555 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.4 m -108.63 -52.89 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.589 0.709 . . . . 0.0 109.53 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 71.76 3.22 4.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.474 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.684 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 14.8 m -59.5 -77.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.615 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 13' ' ' SER . 16.3 pt-20 176.91 -15.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.518 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 25.8 m-85 -81.81 32.74 0.37 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.386 0.539 . . . . 0.0 112.007 -169.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -91.9 135.72 33.71 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.0 p90 -143.62 170.07 16.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -98.66 118.92 36.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.722 0.296 . . . . 0.0 111.296 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.536 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 32.9 t70 -123.3 86.15 2.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 171.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.61 -111.79 3.99 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.406 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.1 18.86 18.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.7 -175.08 5.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 110.39 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 32' ' ' TRP . 43.9 mt -110.1 131.24 55.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.633 174.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG13 ' HG3' ' A' ' 31' ' ' GLU . 57.6 t -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.949 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 41.7 t -104.24 103.16 37.09 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.2 Cg_endo -69.73 -15.43 37.18 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.366 2.044 . . . . 0.0 109.645 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.949 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 28.2 tt0 -64.16 -44.46 92.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.657 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 22.4 p -118.06 11.83 13.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 171.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.21 47.19 14.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -143.61 131.49 21.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.493 178.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HG3' HG13 ' A' ' 24' ' ' VAL . 2.0 mp0 -91.73 145.34 24.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.446 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.445 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -150.16 160.99 43.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.222 0.534 . . . . 0.0 110.933 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 30.8 t -118.15 124.51 28.61 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 18.3 Cg_endo -57.95 -23.24 58.84 Favored 'Trans proline' 0 C--N 1.34 0.106 0 C-N-CA 122.672 2.248 . . . . 0.0 111.745 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -100.92 -56.64 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.89 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 39' ' ' THR . 34.0 tt0 -67.81 -19.07 65.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.069 -171.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.58 -56.14 20.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.015 0.436 . . . . 0.0 110.691 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.48 -46.32 10.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.235 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 11.1 m -114.16 155.53 25.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.851 -172.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.69 146.03 38.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.759 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.7 m -81.77 12.45 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.096 0.474 . . . . 0.0 111.416 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -106.73 141.78 37.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.956 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.581 ' OD1' ' HE2' ' A' ' 45' ' ' LYS . 9.9 t70 -156.94 -78.17 0.08 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.32 -31.63 4.38 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.58 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.581 ' HE2' ' OD1' ' A' ' 43' ' ' ASP . 33.7 mtmt -85.37 115.44 23.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.943 0.401 . . . . 0.0 110.438 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.577 HG13 HD13 ' A' ' 87' ' ' LEU . 10.3 t -131.47 149.39 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.91 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.512 HD11 ' O ' ' A' ' 88' ' ' VAL . 2.2 mm -101.34 140.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -107.13 179.71 4.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.886 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.792 ' OD2' HD11 ' A' ' 55' ' ' LEU . 84.0 m-20 -120.35 -179.65 4.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.26 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 8.6 t -75.44 -6.44 50.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.257 1.027 . . . . 0.0 109.161 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.53 HG21 ' HD2' ' A' ' 112' ' ' ARG . 4.2 t -92.53 -15.55 8.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.884 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.38 -1.4 76.32 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.2 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.54 161.04 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.237 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 48' ' ' LYS . 16.6 t -115.04 135.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.48 -173.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.792 HD11 ' OD2' ' A' ' 49' ' ' ASP . 3.1 mp -103.18 -178.19 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 110.853 -168.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.533 ' HA ' HD11 ' A' ' 87' ' ' LEU . 8.5 tt0 -132.07 157.82 43.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.425 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.401 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 16.7 p-10 -73.87 133.85 43.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 172.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 90.07 -9.47 77.25 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.573 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.06 169.2 18.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.709 0.29 . . . . 0.0 110.909 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 4.6 m -105.02 135.98 45.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CG2' HD13 ' A' ' 85' ' ' ILE . 1.8 pp -124.04 168.96 15.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.8 m -150.14 117.92 6.22 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.48 0.312 . . . . 0.0 110.675 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.715 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.01 131.24 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 176.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.523 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -100.11 16.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -135.73 158.15 45.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -85.94 104.83 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.983 0.897 . . . . 0.0 111.361 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD11 ' CB ' ' A' ' 110' ' ' PHE . 18.5 mt -119.98 146.44 45.84 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.474 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -85.62 175.13 8.94 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.378 0.608 . . . . 0.0 111.415 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 76' ' ' VAL . 85.3 t -120.99 128.82 76.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -92.08 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.314 0.506 . . . . 0.0 110.635 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.35 -21.22 22.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.588 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -115.95 157.94 23.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -87.59 5.47 39.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.039 0.447 . . . . 0.0 110.867 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.73 136.6 34.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.565 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.32 134.79 44.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.166 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.715 HG12 HG11 ' A' ' 63' ' ' VAL . 59.2 t -85.92 101.71 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.536 0.684 . . . . 0.0 109.665 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.65 148.46 25.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.438 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.92 96.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.874 0.845 . . . . 0.0 110.647 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.415 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.04 6.22 4.06 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.9 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.0 m -62.19 103.97 0.43 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.695 0.76 . . . . 0.0 109.669 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.75 111.85 23.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 96' ' ' CYS . 46.2 t -117.62 115.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 50.1 pttt -101.8 149.87 23.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.779 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 46.7 m-80 68.91 48.05 0.75 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.098 0.874 . . . . 0.0 111.245 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.605 HG22 ' SG ' ' A' ' 96' ' ' CYS . 44.5 pt -66.58 -175.53 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 122.064 0.935 . . . . 0.0 112.085 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -136.24 129.21 31.22 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.276 173.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.577 HD13 HG13 ' A' ' 46' ' ' VAL . 60.9 mt -83.06 122.55 28.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.512 ' O ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -101.7 178.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.355 -176.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -79.92 91.94 5.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.761 0.791 . . . . 0.0 112.496 -174.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.35 -173.82 42.5 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.395 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -102.33 -29.21 11.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.515 0.658 . . . . 0.0 110.736 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 52.0 m80 -108.33 52.16 0.72 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.122 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.467 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.9 m-20 -142.53 93.18 2.49 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -158.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.634 ' CD1' HG21 ' A' ' 111' ' ' VAL . 42.5 mt -124.31 112.43 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.617 0.722 . . . . 0.0 112.004 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.18 133.77 40.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.662 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.605 ' SG ' HG22 ' A' ' 85' ' ' ILE . 16.1 m -143.75 146.37 33.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.339 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -106.12 129.63 54.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.707 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 mt -130.24 107.35 14.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -76.18 96.07 3.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.03 -63.64 0.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.168 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 pt -98.56 -42.25 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.65 27.49 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.76 145.75 32.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.5 ttp -135.2 155.37 50.77 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.18 142.6 43.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.892 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 85.1 mt -124.74 139.42 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.732 0.777 . . . . 0.0 111.872 -172.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -76.8 116.4 17.43 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.892 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.491 ' HB3' ' HA ' ' A' ' 92' ' ' HIS . 2.8 t -46.89 -42.7 17.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.961 175.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 50' ' ' SER . 9.5 mt-10 -67.87 -13.34 62.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.778 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.446 ' CB ' HD11 ' A' ' 67' ' ' LEU . 42.0 m-85 -113.03 3.16 16.02 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.634 HG21 ' CD1' ' A' ' 94' ' ' ILE . 32.9 m -114.24 168.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.294 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.53 ' HD2' HG21 ' A' ' 51' ' ' VAL . 18.4 ttt180 -149.24 128.44 12.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.53 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 9.9 tttp -59.5 132.78 55.03 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.478 173.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.7 -56.08 10.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.75 -8.09 19.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.417 177.405 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.969 0.414 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.19 134.99 54.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.666 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.6 m -67.72 145.37 54.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.88 0.371 . . . . 0.0 110.849 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 t -83.54 33.04 0.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.607 0.718 . . . . 0.0 110.741 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 23' ' ' LEU . 20.5 mt -109.22 167.76 8.67 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.528 -174.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 72.6 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.378 2.052 . . . . 0.0 111.033 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.5 -163.93 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.578 2.185 . . . . 0.0 112.709 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 5.0 t -98.88 128.24 32.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.1 8.55 1.04 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.789 2.326 . . . . 0.0 112.464 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.444 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 50.0 mt-30 -119.18 -37.84 3.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.9 m -110.03 -45.99 3.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.984 0.421 . . . . 0.0 109.886 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.86 2.23 3.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.592 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -48.47 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 169.86 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HE1' ' HB2' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -87.57 57.42 4.39 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.867 0.841 . . . . 0.0 110.765 -168.651 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -105.84 140.47 38.82 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.305 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 37.5 p90 -141.16 171.18 14.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HB3' HD11 ' A' ' 5' ' ' LEU . 1.3 pm0 -100.94 114.56 28.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.928 0.394 . . . . 0.0 110.755 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.56 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 26.7 t70 -113.38 83.03 1.77 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.08 -108.35 3.65 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.339 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.87 19.65 16.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -170.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.551 HD11 ' HB3' ' A' ' 31' ' ' GLU . 1.4 pt? -162.3 -174.68 4.17 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 5' ' ' LEU . 8.3 mt -106.39 132.58 52.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 31' ' ' GLU . 58.0 t -117.76 129.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 53.0 t -100.71 109.97 59.23 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 38.3 Cg_endo -67.64 -16.31 46.44 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.703 2.268 . . . . 0.0 111.193 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.624 ' HB2' ' HE1' ' A' ' 15' ' ' TYR . 9.9 tp10 -69.36 -73.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.558 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -88.12 10.35 19.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 45.47 16.48 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -144.61 129.45 18.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.85 0.357 . . . . 0.0 110.23 177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' HB3' HD11 ' A' ' 22' ' ' LEU . 1.9 mp0 -90.42 152.68 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.441 ' NE1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -155.26 161.31 41.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.556 ' HB3' ' OE1' ' A' ' 36' ' ' GLU . 59.3 m -121.66 130.42 24.78 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 14.3 Cg_endo -55.53 -38.55 93.97 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.412 2.741 . . . . 0.0 113.295 -169.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.29 -36.76 3.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.5 0.667 . . . . 0.0 109.783 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 36' ' ' GLU . 17.2 mp0 -67.09 -22.71 65.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.15 -169.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.91 -33.38 75.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 110.297 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.84 -62.25 1.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.092 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 t -179.1 178.62 0.71 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.141 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.68 95.25 3.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.908 0.385 . . . . 0.0 110.573 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.5 m -100.47 14.3 31.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.455 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -130.7 141.63 50.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.113 0.483 . . . . 0.0 110.542 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -127.24 -1.45 6.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.957 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.4 41.36 2.48 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.114 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.74 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -111.74 -41.29 4.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.871 0.367 . . . . 0.0 110.414 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 87' ' ' LEU . 7.3 t -127.39 155.4 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.087 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.492 HG21 HG13 ' A' ' 94' ' ' ILE . 6.9 mm -93.35 138.75 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.4 ttmt -127.75 142.65 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.719 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.498 ' CG ' HG23 ' A' ' 111' ' ' VAL . 71.4 m-20 -100.28 -179.42 4.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 21.2 t -77.29 -5.65 50.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.867 0.842 . . . . 0.0 110.533 -174.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.9 t -88.57 -16.1 8.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.727 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.8 -3.23 67.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.171 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -87.07 149.37 24.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.643 0.735 . . . . 0.0 111.859 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.551 HG22 ' HG3' ' A' ' 48' ' ' LYS . 3.6 t -104.7 136.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.345 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.1 mp -100.35 179.74 4.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.449 -169.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.449 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 12.4 tt0 -132.0 156.17 46.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.251 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -69.74 138.34 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 82.21 -4.91 74.52 Favored Glycine 0 C--N 1.316 -0.562 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.538 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -72.78 171.53 12.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.727 0.299 . . . . 0.0 110.337 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 91.9 m -109.27 137.15 47.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.9 169.54 12.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' THR . 3.0 m -149.4 117.17 6.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.942 0.401 . . . . 0.0 110.859 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -62.15 128.9 24.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.596 HG12 ' CD ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -100.51 15.56 4.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.596 ' CD ' HG12 ' A' ' 64' ' ' ILE . 2.4 mptm? -135.79 165.1 26.4 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.588 -0.695 . . . . 0.0 109.168 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.85 116.05 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.802 0.811 . . . . 0.0 111.51 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 110' ' ' PHE . 5.1 mp -130.08 147.6 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.281 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.28 175.32 6.89 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.117 -0.364 . . . . 0.0 110.343 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.49 134.49 61.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 2.2 mmmp? -43.14 -88.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.46 21.78 42.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.383 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 m -122.67 153.62 39.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.898 0.38 . . . . 0.0 110.627 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -83.31 6.57 19.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.1 131.23 34.76 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 120.865 0.364 . . . . 0.0 110.052 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.7 t -100.67 133.53 43.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.454 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.579 HG12 HG11 ' A' ' 63' ' ' VAL . 53.8 t -85.85 99.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.38 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.11 152.09 25.0 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.684 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -52.12 97.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.918 0.866 . . . . 0.0 110.991 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.65 4.73 3.81 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.491 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.0 m -62.38 105.68 0.65 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.672 0.748 . . . . 0.0 110.627 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.31 113.34 24.6 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.052 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 96' ' ' CYS . 43.0 t -122.02 117.01 50.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 13.4 ptmm? -106.23 153.68 21.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.199 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.497 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 4.4 m-20 71.95 42.38 0.61 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.337 173.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 94' ' ' ILE . 42.6 pt -67.27 -177.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 122.25 1.024 . . . . 0.0 113.602 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -128.9 126.21 39.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.765 -1.561 . . . . 0.0 108.429 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD13 HG13 ' A' ' 46' ' ' VAL . 81.8 mt -80.26 122.87 27.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 93' ' ' ASP . 2.6 t -76.32 132.92 32.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.488 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.14 78.68 2.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.17 -169.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.56 -65.58 0.54 Allowed Glycine 0 C--N 1.297 -1.631 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.2 169.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -79.59 151.15 30.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -84.34 45.98 1.17 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -168.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 88' ' ' VAL . 10.7 m-20 -98.26 165.78 11.71 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.191 0.905 . . . . 0.0 111.543 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.591 ' CD1' HG21 ' A' ' 111' ' ' VAL . 63.4 mt -114.33 116.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.146 171.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -94.69 133.27 38.54 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.357 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.479 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.1 p -145.46 159.86 42.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.621 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -118.36 134.57 54.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.006 176.4 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.0 mt -120.57 107.16 20.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.934 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -63.35 107.17 1.03 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.94 -46.34 0.86 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.937 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.3 pt -117.98 -38.83 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.69 0.281 . . . . 0.0 110.826 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.85 -157.09 24.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.378 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.8 149.62 23.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.969 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -153.99 171.54 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.466 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 19.0 ptmt -120.74 151.27 39.76 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.717 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.1 mt -127.32 140.32 52.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.27 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' A' ' 110' ' ' PHE . 76.5 tttt -82.31 117.61 22.52 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.132 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.635 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 1.4 p -50.86 -37.06 41.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.625 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 50' ' ' SER . 31.2 mt-10 -69.5 -7.33 37.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.309 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 64' ' ' ILE . 66.6 m-85 -113.46 -2.87 13.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.761 -0.587 . . . . 0.0 112.001 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 m -116.94 173.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 112.38 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.479 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.8 ttt180 -143.22 137.19 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.023 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 14.3 tttp -70.55 135.81 48.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.695 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.77 -58.56 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.905 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.75 34.93 3.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.235 178.915 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.88 0.371 . . . . 0.0 111.657 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.92 3.52 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.558 0.694 . . . . 0.0 110.92 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 m -66.01 138.02 57.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.909 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.3 t -103.56 16.52 26.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.558 0.694 . . . . 0.0 109.754 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.15 150.86 85.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.164 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.69 161.83 42.88 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.863 2.375 . . . . 0.0 111.748 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.441 ' HB2' ' HA ' ' A' ' 12' ' ' ASN . 19.8 Cg_endo -64.57 -169.43 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.353 2.036 . . . . 0.0 112.385 174.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -98.81 129.13 30.57 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.969 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HG3' ' CE3' ' A' ' 32' ' ' TRP . 55.8 Cg_endo -69.11 7.25 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.692 2.261 . . . . 0.0 112.214 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.524 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 47.9 mt-30 -117.7 -39.32 3.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.479 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.7 m -106.2 -45.83 4.21 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 7' ' ' PRO . 64.5 t30 70.44 -3.3 1.91 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.851 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.7 m -55.34 -77.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.711 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.2 pt-20 164.31 -7.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.69 0.618 . . . . 0.0 112.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.662 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 61.1 m-85 -80.64 41.56 0.56 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 111.406 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -104.24 148.1 26.72 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.453 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 41.2 p90 -148.9 174.79 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.92 117.76 34.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.808 0.337 . . . . 0.0 111.108 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.537 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 14.7 t70 -115.75 79.07 1.24 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.97 -107.97 3.59 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.319 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.19 17.71 19.27 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.3 pt? -157.75 -175.46 5.39 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 16.2 mt -107.92 130.06 55.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 31' ' ' GLU . 52.2 t -116.9 127.39 74.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.2 t -102.7 105.41 44.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 44.8 Cg_endo -69.76 -12.5 33.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.565 2.177 . . . . 0.0 110.785 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 36.0 tt0 -68.7 -59.06 3.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.081 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.09 14.52 31.7 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.6 27.77 16.35 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -140.66 142.25 34.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -98.15 177.38 5.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.505 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -172.28 161.88 5.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.605 ' HB3' ' HB2' ' A' ' 36' ' ' GLU . 1.8 t -119.07 129.85 25.17 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.505 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 12.2 Cg_endo -54.82 -47.79 24.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.274 2.649 . . . . 0.0 113.338 -170.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -104.91 -31.37 9.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.389 0.614 . . . . 0.0 110.811 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 16.8 mp0 -77.88 -3.07 39.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.542 -175.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.15 -49.78 63.58 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.68 -32.75 31.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 109.92 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 40' ' ' ALA . 3.7 m 67.4 -85.17 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.58 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.415 ' H ' ' HB ' ' A' ' 39' ' ' THR . . . 175.1 50.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -174.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 p -69.03 88.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.989 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 t70 68.11 177.99 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.847 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 45' ' ' LYS . 15.5 m-20 -109.49 -18.35 13.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.622 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.58 57.16 2.5 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.879 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.565 ' HD2' ' HB2' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -82.65 -37.36 24.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.0 110.331 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.7 p -87.91 125.98 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.604 HG21 HG13 ' A' ' 94' ' ' ILE . 5.3 mm -76.97 137.38 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.823 -170.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 54' ' ' VAL . 1.6 ttmt -124.86 177.37 6.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.661 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.477 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 19.2 m-20 -113.16 179.26 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 44.8 t -82.16 -8.29 59.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.015 171.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.421 HG21 ' CG ' ' A' ' 112' ' ' ARG . 2.9 t -91.07 -17.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.141 -1.39 . . . . 0.0 109.347 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.68 -0.8 52.57 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.235 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.46 167.33 17.55 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.022 0.915 . . . . 0.0 111.283 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 48' ' ' LYS . 10.0 t -116.84 136.53 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.775 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 87' ' ' LEU . 2.1 mm? -97.04 175.83 6.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.342 0.591 . . . . 0.0 110.64 -172.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -131.4 151.12 51.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.024 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 15.6 t70 -72.62 91.92 1.48 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 133.69 -14.29 4.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.75 169.11 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.7 0.286 . . . . 0.0 111.013 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 22.2 m -100.12 137.27 38.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 85' ' ' ILE . 1.5 pp -125.81 165.43 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.4 m -147.31 125.39 12.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.052 0.453 . . . . 0.0 111.894 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -67.77 129.57 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.611 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.648 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.72 19.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.648 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.2 mptm? -138.69 160.81 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.964 0.802 . . . . 0.0 108.876 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -87.67 114.07 23.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.141 0.972 . . . . 0.0 112.433 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 3.8 mp -124.88 149.74 47.21 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.308 170.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -89.41 179.07 6.16 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.778 -0.576 . . . . 0.0 111.153 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 76' ' ' VAL . 9.6 t -132.05 130.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 141.15 33.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.32 -16.35 3.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.881 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.9 p -106.7 172.79 6.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.136 0.493 . . . . 0.0 111.158 -175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -97.12 16.79 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mp -91.75 171.79 8.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -159.27 117.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.635 HG23 HG22 ' A' ' 69' ' ' VAL . 93.9 t -82.01 94.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.785 0.802 . . . . 0.0 109.497 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 146.78 32.93 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -47.98 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.937 0.875 . . . . 0.0 110.896 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.09 7.74 3.96 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.179 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.4 m -62.7 104.21 0.51 Allowed 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 121.694 0.759 . . . . 0.0 109.52 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.2 113.93 26.34 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.346 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -132.02 118.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 61.9 pttt -110.04 170.39 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.57 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 89.9 m-20 66.82 34.17 5.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.216 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 61' ' ' ILE . 23.2 pt -64.57 175.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 122.195 0.997 . . . . 0.0 113.513 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -119.16 122.18 41.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.232 174.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 55' ' ' LEU . 89.7 mt -74.83 118.92 18.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 93' ' ' ASP . 5.3 t -74.45 136.67 24.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-O 121.633 0.73 . . . . 0.0 111.637 -171.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.33 33.05 0.82 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.625 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.52 -88.86 0.13 Allowed Glycine 0 C--N 1.303 -1.273 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.999 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -94.6 -179.05 4.75 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 108' ' ' SER . 23.1 p80 -89.09 46.58 1.4 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.763 0.316 . . . . 0.0 111.577 -175.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.6 m-20 -100.49 162.89 12.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.377 0.608 . . . . 0.0 111.944 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.604 HG13 HG21 ' A' ' 47' ' ' ILE . 4.9 mp -105.44 119.91 55.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.464 172.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.3 t70 -94.31 130.78 40.47 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.887 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.76 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.1 p -140.37 151.4 44.94 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.284 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -105.43 122.13 45.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.432 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.0 mt -122.63 107.78 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.255 0.55 . . . . 0.0 110.585 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -69.34 105.72 2.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.522 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.3 -37.96 0.79 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.234 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 pt -132.28 -38.49 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.863 0.363 . . . . 0.0 110.688 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.89 -153.67 23.92 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.734 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.57 24.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.722 0.261 . . . . 0.0 110.698 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.462 ' HG2' ' N ' ' A' ' 105' ' ' LYS . 49.4 ttm -142.0 164.05 31.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.143 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -117.57 139.08 51.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.05 138.76 52.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.499 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 14.6 tptm -72.25 125.03 26.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.884 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' ' 92' ' ' HIS . 28.8 t -52.1 -27.63 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.179 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 107' ' ' LYS . 10.9 pt-20 -87.1 -5.27 59.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.997 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.403 ' HD2' ' HB3' ' A' ' 107' ' ' LYS . 35.5 m-85 -116.59 7.69 13.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.341 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 94' ' ' ILE . 34.0 m -111.91 162.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.421 ' CG ' HG21 ' A' ' 51' ' ' VAL . 28.2 ttt180 -141.25 135.26 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.97 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -67.46 140.88 57.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.178 0.513 . . . . 0.0 110.914 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.99 -69.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.816 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.99 51.14 9.34 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.838 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.0 m . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.071 178.866 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.695 0.283 . . . . 0.0 110.278 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.0 t -102.35 125.25 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.685 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 t -165.15 176.28 8.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.693 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -117.24 15.16 14.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.412 0.625 . . . . 0.0 110.231 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.466 HD13 HD22 ' A' ' 23' ' ' LEU . 60.9 mt -90.15 163.17 32.72 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.143 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 68.5 Cg_endo -71.2 159.99 50.33 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.264 1.976 . . . . 0.0 111.264 175.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.73 -163.67 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.649 2.233 . . . . 0.0 112.376 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 7.9 t -98.49 127.64 35.4 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.693 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 7.89 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.329 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.456 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 56.5 tt0 -122.05 -32.84 3.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.278 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.14 -45.25 3.62 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.667 -0.645 . . . . 0.0 109.984 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t30 69.95 -2.81 1.92 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.698 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.9 p -45.27 -77.06 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 13' ' ' SER . 10.7 pt-20 161.85 -15.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.808 0.693 . . . . 0.0 111.06 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.605 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m-85 -81.97 45.57 0.93 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.374 0.606 . . . . 0.0 111.043 -171.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -104.85 143.2 33.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.693 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.74 176.6 10.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.31 126.77 53.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.382 0.611 . . . . 0.0 110.819 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.27 82.07 1.75 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.112 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -112.58 4.33 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.39 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.79 17.32 22.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -154.0 -174.57 5.01 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.554 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 15.9 mt -114.5 136.46 52.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.741 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -127.87 142.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.861 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 46.6 t -104.62 106.99 56.9 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.8 Cg_endo -66.88 -14.0 42.09 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.763 2.309 . . . . 0.0 111.423 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 29.8 tt0 -73.15 -61.32 1.86 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.02 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.9 p -97.81 10.9 38.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.33 45.41 20.16 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -135.88 124.12 23.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.729 0.299 . . . . 0.0 110.516 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.741 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 34.6 mt-10 -93.3 143.57 26.14 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.11 161.99 41.79 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 120.807 0.337 . . . . 0.0 110.121 -176.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.3 p -112.05 132.76 21.88 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.554 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 9.9 Cg_endo -52.95 -44.48 48.27 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.336 2.69 . . . . 0.0 113.284 -169.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 m-20 -124.61 -27.58 3.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.254 0.549 . . . . 0.0 110.757 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 2.4 mp0 -67.12 -24.41 65.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.372 -176.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.48 -37.35 86.59 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.992 0.425 . . . . 0.0 110.574 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.07 -36.44 35.59 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 m 70.24 151.22 0.09 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.281 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.92 99.88 12.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.771 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.2 t -77.09 100.36 5.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.84 162.14 35.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.594 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.56 -12.88 38.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.647 0.261 . . . . 0.0 111.062 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.638 ' HA3' ' HA2' ' A' ' 90' ' ' GLY . . . 90.92 58.37 1.5 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -174.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -86.92 -28.2 22.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.741 0.305 . . . . 0.0 111.225 -174.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 87' ' ' LEU . 13.7 p -136.59 148.12 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.936 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.681 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.144 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.516 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -107.27 177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 0.0 111.202 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 6.6 m-20 -118.22 174.45 6.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.867 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 64' ' ' ILE . 27.5 t -70.62 -7.11 41.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.836 0.827 . . . . 0.0 110.696 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.454 HG21 ' HD2' ' A' ' 112' ' ' ARG . 3.0 t -88.93 -16.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.854 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 2.22 65.35 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.668 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -93.66 162.82 13.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.332 0.587 . . . . 0.0 111.477 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 t -114.46 136.25 51.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.454 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.628 HD22 HG22 ' A' ' 61' ' ' ILE . 13.1 mt -93.57 174.96 6.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.398 0.618 . . . . 0.0 112.002 -170.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.3 tt0 -125.64 147.18 49.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.581 175.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.4 105.68 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.045 0.926 . . . . 0.0 109.436 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 114.14 -2.46 23.99 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.0 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.8 t70 -76.59 169.31 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.6 m -105.53 137.03 44.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.628 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -120.7 166.4 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -148.08 119.84 8.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.929 0.395 . . . . 0.0 110.773 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.623 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -62.39 126.34 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.107 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.624 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -100.12 17.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.227 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.575 ' HD3' HG12 ' A' ' 64' ' ' ILE . 1.8 mppt? -141.77 165.18 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.75 -0.594 . . . . 0.0 109.517 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.514 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.0 p-10 -83.21 113.94 21.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.596 0.713 . . . . 0.0 111.484 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.551 HD21 ' CD1' ' A' ' 110' ' ' PHE . 23.9 mt -126.53 140.44 52.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.694 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -91.22 174.16 7.54 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.225 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 72' ' ' SER . 38.7 t -124.91 126.37 71.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -88.49 -36.19 16.59 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.14 -32.37 52.63 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.125 -1.035 . . . . 0.0 111.575 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 69' ' ' VAL . 37.2 m -107.04 175.74 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.343 -0.429 . . . . 0.0 111.145 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -98.19 -4.78 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.058 0.456 . . . . 0.0 110.561 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mp -77.3 143.25 38.97 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.829 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.64 125.73 66.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.284 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.623 HG12 HG11 ' A' ' 63' ' ' VAL . 69.5 t -78.72 116.7 22.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.557 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -111.76 147.45 35.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.41 -175.096 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.31 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.924 0.868 . . . . 0.0 110.654 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.28 7.51 3.96 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.716 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -62.84 104.64 0.57 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.536 0.684 . . . . 0.0 109.657 174.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -89.67 115.83 27.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.847 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 96' ' ' CYS . 38.5 t -125.01 115.16 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 21.4 ptmt -99.87 157.15 16.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.382 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.589 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 15.8 m120 66.27 45.17 2.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.659 173.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.41 HD11 ' HB3' ' A' ' 55' ' ' LEU . 31.1 pt -65.57 176.22 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 122.0 0.905 . . . . 0.0 113.38 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 21.8 tpp180 -130.26 131.95 45.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.831 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.519 HD13 HG23 ' A' ' 46' ' ' VAL . 15.8 mt -79.18 114.7 18.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.571 HG23 ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -115.52 126.02 72.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.344 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.88 29.05 5.6 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 154.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.638 ' HA2' ' HA3' ' A' ' 44' ' ' GLY . . . 139.42 -137.86 8.86 Favored Glycine 0 C--N 1.304 -1.2 0 C-N-CA 119.215 -1.469 . . . . 0.0 115.885 171.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -104.19 -34.62 8.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.111 -0.544 . . . . 0.0 112.079 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -105.53 55.16 0.69 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.273 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -163.98 98.22 0.85 Allowed 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -167.21 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.681 HG13 HG21 ' A' ' 47' ' ' ILE . 3.7 mp -112.15 117.21 54.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.98 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.2 t70 -93.78 131.68 38.91 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.621 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.579 ' HB2' HG11 ' A' ' 82' ' ' VAL . 18.3 p -144.74 156.15 43.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.91 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 131.39 55.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.893 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.44 110.5 27.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.944 0.402 . . . . 0.0 110.028 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.16 102.94 1.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.299 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.09 -42.86 0.8 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.634 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.31 -42.19 2.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.06 0.457 . . . . 0.0 110.398 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.05 -154.17 23.75 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.86 149.44 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.312 0.556 . . . . 0.0 110.453 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.1 ttp -146.45 165.08 30.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.049 0.452 . . . . 0.0 110.95 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -114.03 138.65 50.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.866 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 81.0 mt -119.15 142.11 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.311 0.577 . . . . 0.0 111.437 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 66.1 mmtt -80.65 124.72 29.24 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.042 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.4 t -48.96 -43.66 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.981 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.452 ' C ' ' HB2' ' A' ' 50' ' ' SER . 1.5 pm0 -74.71 0.44 15.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.576 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.551 ' CD1' HD21 ' A' ' 67' ' ' LEU . 76.8 m-85 -119.72 2.64 11.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.45 -0.781 . . . . 0.0 112.993 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.59 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 34.1 m -114.04 172.93 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.193 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.454 ' HD2' HG21 ' A' ' 51' ' ' VAL . 10.9 ttt-85 -149.83 138.1 20.53 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.58 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -73.97 120.44 19.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.15 -46.55 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.907 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.49 11.35 82.11 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.177 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.228 -179.304 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.5 ttp . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.04 144.87 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -67.46 130.84 44.34 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 t -147.34 10.41 0.98 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.415 0.626 . . . . 0.0 110.632 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 84.9 mt -102.0 157.21 34.13 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -67.75 155.12 71.2 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 121.81 1.673 . . . . 0.0 111.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.58 -170.85 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.71 2.273 . . . . 0.0 112.371 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -97.94 123.41 51.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.767 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.16 6.96 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.814 2.343 . . . . 0.0 112.269 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 49.2 mt-30 -115.36 -38.7 3.74 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.388 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -109.42 -48.19 3.28 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 72.03 -1.97 2.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.81 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 23.5 p -48.73 -76.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.53 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.5 pt-20 164.98 -13.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.584 0.553 . . . . 0.0 111.589 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 56.6 m-85 -78.7 35.32 0.24 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.083 0.468 . . . . 0.0 111.541 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -97.83 138.94 34.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.047 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -147.26 174.8 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.06 130.84 55.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.254 0.55 . . . . 0.0 110.97 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -122.87 84.47 2.27 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.535 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.91 -110.27 3.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.363 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.09 19.92 17.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.872 -171.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.59 -173.82 4.57 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.577 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 23.7 mt -114.21 137.42 51.79 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -127.83 142.41 43.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.071 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.0 t -106.3 106.7 58.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.908 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 39.0 Cg_endo -67.84 -10.16 27.93 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.804 2.336 . . . . 0.0 111.212 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.499 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 31.6 tt0 -75.74 -61.41 1.93 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.679 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.58 9.78 42.47 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.37 26.55 15.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HB3' HE22 ' A' ' 10' ' ' GLN . 47.3 m-70 -123.12 133.68 54.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.113 0.482 . . . . 0.0 111.214 175.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -91.28 162.6 14.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.607 176.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -162.09 162.54 28.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.469 ' H ' ' HB2' ' A' ' 37' ' ' ALA . 31.0 t -109.65 134.84 20.46 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.577 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.2 Cg_endo -60.49 -23.85 76.38 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.489 2.126 . . . . 0.0 112.533 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -131.2 -41.79 1.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 111.524 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -80.08 -0.9 37.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.04 0.447 . . . . 0.0 111.28 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' HB2' ' H ' ' A' ' 33' ' ' SER . . . -72.83 -5.5 38.56 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.129 -0.357 . . . . 0.0 111.042 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.15 -20.28 64.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.571 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 m -67.08 153.49 43.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.465 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.97 111.09 11.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.811 0.339 . . . . 0.0 110.636 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.7 m -81.71 100.31 9.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.042 0.449 . . . . 0.0 109.993 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.424 ' HA ' ' NZ ' ' A' ' 45' ' ' LYS . 37.0 t70 -144.68 147.99 33.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.301 0.572 . . . . 0.0 111.801 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -129.35 -41.61 1.38 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.966 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.7 39.99 0.47 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.17 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' NZ ' ' HA ' ' A' ' 42' ' ' ASP . 29.2 mtmm -110.88 -31.65 7.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.332 0.587 . . . . 0.0 109.666 174.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.579 HG13 HD13 ' A' ' 87' ' ' LEU . 20.3 t -105.33 146.78 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.211 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.511 HG21 ' CG1' ' A' ' 94' ' ' ILE . 5.9 mm -85.22 134.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.807 0.337 . . . . 0.0 110.987 -174.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -112.18 149.36 32.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.211 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.6 m-20 -94.97 177.88 5.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.797 0.332 . . . . 0.0 110.633 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 32.8 t -72.57 -7.44 50.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.965 0.888 . . . . 0.0 110.536 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.469 HG21 ' CG ' ' A' ' 112' ' ' ARG . 3.0 t -88.23 -14.42 9.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.944 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.58 1.74 68.22 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.631 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -94.5 159.2 15.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.371 0.605 . . . . 0.0 111.6 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.8 t -108.75 135.14 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.053 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.58 HD22 HG22 ' A' ' 61' ' ' ILE . 12.7 mt -92.14 178.96 5.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.053 0.454 . . . . 0.0 110.715 -175.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.946 ' HG2' ' HB2' ' A' ' 59' ' ' ASP . 9.1 pt20 -126.03 154.77 42.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.488 ' OD1' ' HD3' ' A' ' 86' ' ' ARG . 19.4 t70 -66.59 104.4 1.27 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 112.71 -0.28 26.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.787 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.946 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 2.7 t0 -78.96 171.59 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 33.0 m -106.22 137.52 44.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.58 HG22 HD22 ' A' ' 55' ' ' LEU . 2.1 pp -120.82 167.71 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.6 m -149.38 117.17 6.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.824 0.345 . . . . 0.0 110.382 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.752 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -59.69 128.89 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.439 176.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -100.65 17.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -137.38 161.91 35.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.678 -0.639 . . . . 0.0 109.321 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.2 p-10 -84.13 109.77 17.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.744 0.783 . . . . 0.0 111.467 170.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 66' ' ' ASP . 21.7 mt -127.05 145.93 50.55 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.616 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -90.51 174.75 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.948 -0.47 . . . . 0.0 111.382 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.46 ' CG2' HG23 ' A' ' 76' ' ' VAL . 49.7 t -123.25 130.21 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -73.76 -63.31 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.165 0.439 . . . . 0.0 112.016 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.57 -23.01 76.81 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.37 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.444 ' HB2' HG11 ' A' ' 69' ' ' VAL . 66.9 m -112.59 151.02 30.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -74.47 -0.22 16.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.17 0.51 . . . . 0.0 110.959 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.475 ' CD2' HG21 ' A' ' 101' ' ' ILE . 3.1 mm? -78.55 143.39 36.56 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.474 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -107.55 134.61 48.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.804 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.752 HG12 HG11 ' A' ' 63' ' ' VAL . 75.5 t -89.2 101.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.6 147.89 27.13 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.593 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.3 p -51.45 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.855 0.836 . . . . 0.0 110.935 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.84 4.52 4.21 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.914 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.5 105.02 0.57 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 110.368 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -91.47 114.16 26.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 96' ' ' CYS . 43.2 t -122.08 118.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.861 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.1 ptmt -98.53 156.22 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.435 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.468 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 12.0 m120 63.08 49.91 3.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.325 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.8 pt -64.86 176.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 11.7 tpp180 -131.59 121.89 25.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.269 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.579 HD13 HG13 ' A' ' 46' ' ' VAL . 22.8 mt -85.96 126.24 33.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.091 0.405 . . . . 0.0 109.919 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -103.42 -179.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.763 -178.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.49 -42.62 99.62 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -171.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . -82.72 162.12 40.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.572 -176.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -72.07 -31.47 66.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.52 0.676 . . . . 0.0 110.017 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -89.8 46.25 1.35 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.788 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.671 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 5.0 m-20 -145.57 88.02 1.82 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -164.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 106' ' ' LEU . 30.9 mt -119.96 108.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.217 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 16.6 t70 -95.72 103.77 15.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.53 0.681 . . . . 0.0 109.263 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.578 ' HB2' HG11 ' A' ' 82' ' ' VAL . 28.6 p -107.35 157.79 17.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.344 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 21.6 pttp -118.03 138.47 52.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.505 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.2 104.92 14.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.86 100.54 0.21 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.176 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.16 -64.86 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.647 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.475 HG21 ' CD2' ' A' ' 74' ' ' LEU . 40.5 pt -89.88 -46.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.383 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.15 -162.21 27.86 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 176.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -83.61 149.66 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.025 0.441 . . . . 0.0 110.985 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.9 ttp -136.82 153.51 50.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -98.84 146.44 25.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 95.5 mt -129.75 134.31 47.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.502 0.668 . . . . 0.0 111.765 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -81.28 114.73 20.27 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.596 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.4 p -52.69 -37.46 58.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.421 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' SER . 39.1 mt-10 -71.37 -3.84 22.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.863 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.444 ' HB3' HD11 ' A' ' 67' ' ' LEU . 66.6 m-85 -118.58 4.5 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.4 m -117.24 175.28 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.935 0.398 . . . . 0.0 112.064 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.469 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.4 ttt180 -147.7 141.59 25.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.562 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -72.52 121.9 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.995 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.08 -54.59 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.031 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.71 -9.34 55.38 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.571 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.344 179.004 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 121.342 0.591 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.69 126.34 47.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.57 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -88.6 70.07 8.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.181 0.515 . . . . 0.0 110.816 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.3 p -126.9 117.75 23.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.7 mt -110.1 152.3 43.03 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.825 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.22 157.76 56.4 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.276 1.984 . . . . 0.0 111.243 176.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -66.3 -168.01 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 44.5 t -99.55 123.87 46.49 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.713 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.26 5.53 1.85 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.32 2.013 . . . . 0.0 111.724 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.661 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 42.2 mt-30 -105.44 -47.19 4.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.48 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -124.32 -33.42 3.05 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.891 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.416 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 8.3 t-20 70.81 11.84 7.15 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.402 0.62 . . . . 0.0 111.026 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 38.7 m -58.0 -25.76 61.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.285 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 13' ' ' SER . 89.2 mt-10 86.39 10.42 0.21 Allowed 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 111.504 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.435 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 85.5 m-85 -89.11 52.1 2.31 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.558 0.694 . . . . 0.0 109.387 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 m -105.24 149.8 25.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.713 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 48.3 p90 -150.52 177.1 10.34 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.83 128.24 52.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.794 0.33 . . . . 0.0 110.175 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -113.78 25.68 11.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.75 -114.82 0.85 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.388 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.88 14.38 29.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.645 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.2 pt? -150.0 -175.69 5.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.042 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mt -118.23 141.07 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.88 147.02 33.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.792 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 43.6 t -101.74 111.48 64.05 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' A' ' 17' ' ' TYR . 23.6 Cg_endo -62.01 -22.64 74.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.882 2.388 . . . . 0.0 111.454 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 22.4 tt0 -76.79 -59.61 2.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.022 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.9 m -76.86 -4.85 45.82 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.63 37.32 28.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -141.25 135.22 30.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.011 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HB3' HD11 ' A' ' 22' ' ' LEU . 21.6 mp0 -91.87 160.88 15.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.013 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -159.55 162.0 35.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.368 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -117.53 134.18 23.19 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -63.93 -26.92 66.69 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.607 2.205 . . . . 0.0 113.352 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -133.63 -44.74 0.82 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.76 0.314 . . . . 0.0 111.597 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.1 -17.85 63.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.065 -174.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.69 -19.73 65.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.482 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.3 -49.31 50.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.246 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.6 p -127.94 111.6 13.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.899 0.381 . . . . 0.0 111.524 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.67 16.56 5.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.304 0.573 . . . . 0.0 110.203 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.1 m -94.83 16.71 15.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.16 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -143.03 152.97 42.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 45' ' ' LYS . 25.5 t70 -101.87 -19.25 15.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.323 0.582 . . . . 0.0 110.675 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.72 27.7 60.43 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.695 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 57.2 pttt -97.33 -21.27 17.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.641 0.257 . . . . 0.0 111.271 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.52 134.75 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.218 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.551 HG21 HG12 ' A' ' 94' ' ' ILE . 32.3 mm -73.54 122.02 25.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.404 -174.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 6.1 ttmt -119.03 137.39 53.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.613 -177.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.548 ' OD2' HD11 ' A' ' 55' ' ' LEU . 80.8 m-20 -92.88 -175.84 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.345 -169.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 16.7 t -77.1 -5.9 50.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.219 1.009 . . . . 0.0 110.269 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 112' ' ' ARG . 6.5 t -89.02 -21.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.18 -6.46 68.86 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.821 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.434 ' OD1' ' HB2' ' A' ' 49' ' ' ASP . 6.2 p30 -79.13 146.35 33.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.539 0.685 . . . . 0.0 111.179 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.3 t -102.94 134.74 43.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.522 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.649 ' HA ' ' HD2' ' A' ' 113' ' ' LYS . 7.1 mp -96.42 173.61 7.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.28 -169.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.435 ' O ' ' HB2' ' A' ' 59' ' ' ASP . 8.7 tp-100 -126.04 149.26 48.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.373 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.486 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 13.4 t70 -65.15 130.16 42.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.27 -4.55 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.231 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 56' ' ' GLN . 1.1 t70 -73.52 175.73 6.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.129 0.465 . . . . 0.0 110.911 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.0 m -106.31 138.69 42.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.73 166.14 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -150.47 113.84 4.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.717 0.294 . . . . 0.0 110.512 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -61.05 125.82 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -97.43 14.35 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.506 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 2.4 mptm? -137.81 160.71 38.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.16 116.17 24.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.547 0.689 . . . . 0.0 111.848 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 5.1 mp -129.63 146.51 51.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.973 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . 18.1 ptmt -92.76 179.38 5.5 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.507 -0.746 . . . . 0.0 110.574 173.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.94 128.2 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -91.6 136.95 32.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.698 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 -27.19 3.36 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.494 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.672 ' HB3' HD23 ' A' ' 74' ' ' LEU . 66.2 m -105.32 155.36 19.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.624 0.249 . . . . 0.0 110.374 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -84.15 12.23 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.234 0.54 . . . . 0.0 110.374 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' A' ' 72' ' ' SER . 3.9 mm? -78.35 170.83 15.99 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.002 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -158.93 117.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -171.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG12 HG11 ' A' ' 63' ' ' VAL . 86.5 t -91.73 95.92 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.599 0.714 . . . . 0.0 110.564 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.24 145.8 33.77 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.038 -0.414 . . . . 0.0 111.17 -176.048 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -47.63 98.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 124.074 0.858 . . . . 0.0 111.392 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.07 7.14 3.76 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.262 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.0 m -63.07 104.19 0.54 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.759 0.79 . . . . 0.0 110.032 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.92 114.59 27.19 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.098 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.679 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.4 t -131.37 121.06 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.662 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 56.8 pttt -107.9 166.99 10.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.731 0.777 . . . . 0.0 112.959 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.522 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER 71.1 36.7 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.203 172.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.3 pt -66.71 -178.11 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.808 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 0.3 OUTLIER -130.63 131.05 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.895 174.802 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.7 110.83 6.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 90' ' ' GLY . 1.5 t -77.5 148.28 6.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.513 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -78.12 -20.36 52.28 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.631 ' H ' HG12 ' A' ' 88' ' ' VAL . . . -59.29 137.01 50.48 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.571 170.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -24.23 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -166.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.509 ' O ' HG23 ' A' ' 47' ' ' ILE . 54.6 m170 -109.92 2.67 19.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -86.49 -169.72 2.76 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -160.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.551 HG12 HG21 ' A' ' 47' ' ' ILE . 69.7 mt -140.62 126.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.694 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.808 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.8 t70 -93.04 126.29 38.06 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.679 ' HB2' HG11 ' A' ' 82' ' ' VAL . 20.1 p -134.58 141.6 46.7 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.009 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 84' ' ' ASN . 11.4 ptpt -98.93 114.73 27.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.49 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.7 mt -116.98 104.94 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.403 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -47.66 130.35 14.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.639 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.2 -73.93 0.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.864 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 102' ' ' GLY . 32.6 pt -80.67 -46.27 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.774 0.321 . . . . 0.0 111.203 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 134.44 -146.33 18.33 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -88.57 155.97 19.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.101 0.45 . . . . 0.0 111.031 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.0 ttp -149.37 164.61 34.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.21 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 72.6 mttt -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.704 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.13 153.86 20.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.116 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 13.5 tptt -83.9 114.22 21.52 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.072 174.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.704 ' HA ' HG22 ' A' ' 111' ' ' VAL . 88.7 p -53.88 -39.54 65.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.132 0.968 . . . . 0.0 109.627 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 50' ' ' SER . 41.1 mt-10 -64.86 -3.39 3.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.539 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.474 ' O ' HD13 ' A' ' 64' ' ' ILE . 35.7 m-85 -117.23 0.74 12.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 171.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.704 HG22 ' HA ' ' A' ' 108' ' ' SER . 19.2 m -121.24 178.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.467 0.651 . . . . 0.0 112.396 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 51' ' ' VAL . 6.9 ttt180 -144.11 133.12 22.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.944 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.649 ' HD2' ' HA ' ' A' ' 55' ' ' LEU . 88.0 tttt -65.87 121.3 14.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.526 173.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.6 -65.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.29 33.01 6.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.804 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.507 -0.759 . . . . 0.0 110.189 -179.825 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.826 0.346 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.65 135.53 13.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.929 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -73.65 120.33 19.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.521 . . . . 0.0 111.422 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -102.94 107.81 18.76 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 170.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.9 mt -101.02 151.49 37.64 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.382 -174.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.7 160.21 46.86 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.643 2.229 . . . . 0.0 111.345 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.56 -166.44 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.0 112.432 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 8.5 t -98.17 121.95 55.62 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.11 6.61 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.681 2.254 . . . . 0.0 112.199 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 50.8 tt0 -119.89 -34.28 3.77 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -112.22 -43.53 3.53 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.816 0.735 . . . . 0.0 110.15 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.7 t30 73.19 2.9 4.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.889 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 23.3 p -65.0 -35.44 81.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.696 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 13' ' ' SER . 2.4 mt-10 85.74 25.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.13 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -70.92 2.25 4.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.788 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 23' ' ' LEU . 1.4 m -58.42 145.73 37.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.807 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 46.3 p90 -153.27 174.82 13.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.85 111.36 23.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.104 0.478 . . . . 0.0 111.26 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.505 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.9 t0 -108.49 74.16 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.39 -112.82 4.56 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.828 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.69 16.96 23.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -172.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -156.01 -174.45 4.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.415 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' HG22 ' A' ' 16' ' ' THR . 22.6 mt -110.51 134.23 52.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 31' ' ' GLU . 85.9 t -118.66 132.45 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 122.114 -0.366 . . . . 0.0 110.208 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -99.45 109.88 56.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.44 -3.09 12.32 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.815 2.343 . . . . 0.0 112.109 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.82 -61.07 1.77 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.26 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -93.05 12.04 25.49 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 121.748 -0.595 . . . . 0.0 112.524 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.92 31.76 18.06 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -138.96 131.95 29.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.792 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HG3' HG13 ' A' ' 24' ' ' VAL . 1.1 mp0 -91.6 171.0 9.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.516 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -167.36 161.5 14.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.9 m -124.81 125.23 25.47 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.5 -36.71 97.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.905 2.404 . . . . 0.0 112.869 -172.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -124.45 -44.7 1.98 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.514 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.56 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 9.9 tp10 -60.55 -25.47 66.18 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.17 -14.34 24.45 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.987 -0.445 . . . . 0.0 111.563 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.87 -21.53 43.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.56 ' HB ' ' OE1' ' A' ' 36' ' ' GLU . 16.1 m -115.32 -70.75 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 36' ' ' GLU . . . -144.09 -160.72 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.788 0.328 . . . . 0.0 111.038 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -102.19 15.99 27.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.05 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 67.14 127.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.129 0.966 . . . . 0.0 111.525 -172.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -133.1 -34.63 1.08 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.528 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.41 16.72 1.31 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.979 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 45.1 mtpt -78.22 -29.52 48.34 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.8 t -86.97 139.69 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.447 HG21 HG13 ' A' ' 94' ' ' ILE . 16.3 mm -78.58 132.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.424 -172.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.1 ttmt -122.47 135.67 54.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.063 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.5 ' CG ' HG23 ' A' ' 111' ' ' VAL . 84.0 m-20 -99.17 -178.99 4.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 23.1 t -74.06 -5.31 40.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.786 0.803 . . . . 0.0 110.971 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 4.4 t -87.71 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.487 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.11 -8.86 63.17 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.448 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -80.32 148.68 30.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.781 0.801 . . . . 0.0 112.07 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' A' ' 48' ' ' LYS . 3.7 t -102.88 137.26 31.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.044 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.826 ' HG ' ' HG3' ' A' ' 113' ' ' LYS . 7.3 mp -95.84 174.0 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.469 0.652 . . . . 0.0 111.925 -169.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.1 tp-100 -122.32 139.08 54.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.406 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 22.7 t70 -66.56 102.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' ASN . . . 116.34 -2.52 20.51 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.574 -176.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 1.3 t70 -77.18 175.21 9.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.695 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 10.3 m -103.67 139.07 39.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.99 166.73 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -149.04 117.04 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.767 0.317 . . . . 0.0 110.474 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.54 124.86 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -96.46 13.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.565 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.62 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -134.74 159.1 42.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.188 0.518 . . . . 0.0 109.742 -172.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.05 103.43 7.98 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.66 0.743 . . . . 0.0 111.544 170.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 65' ' ' LYS . 2.2 mm? -115.68 128.91 56.26 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.145 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -88.06 174.09 8.48 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 120.911 -1.118 . . . . 0.0 109.573 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.63 123.68 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -79.72 -41.99 25.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.34 -20.45 66.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.558 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.2 m -113.8 173.69 6.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 m -98.28 2.1 47.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.15 0.5 . . . . 0.0 110.363 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.9 141.08 36.43 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.314 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.92 140.8 27.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.163 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.709 HG12 HG11 ' A' ' 63' ' ' VAL . 69.8 t -99.4 119.9 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.2 149.93 36.91 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.829 -175.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -49.39 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.539 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.09 5.14 3.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.635 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.1 m -62.33 105.16 0.57 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.811 0.815 . . . . 0.0 110.224 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -93.53 112.95 24.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.976 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.584 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -124.45 119.35 56.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.374 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 16.8 pttm -106.19 159.45 16.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 19.3 m120 65.4 43.94 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.892 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 45.5 pt -64.89 -179.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.427 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 6.2 tpp180 -125.52 125.38 43.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.281 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.33 118.05 21.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.9 t -79.7 128.14 38.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -102.55 80.22 1.9 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 123.37 1.557 . . . . 0.0 112.954 -172.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.57 -76.55 0.04 OUTLIER Glycine 0 C--N 1.296 -1.677 0 CA-C-N 112.812 -1.995 . . . . 0.0 110.3 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 92' ' ' HIS . 14.5 t70 -87.85 -167.01 1.74 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 168.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.409 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 53.5 m80 -105.66 46.66 0.91 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.718 -175.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 88' ' ' VAL . 53.4 m-20 -97.1 165.7 11.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.418 1.008 . . . . 0.0 112.725 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.587 ' CD1' HG21 ' A' ' 111' ' ' VAL . 49.1 mt -115.52 119.93 63.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.475 174.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.28 135.93 36.27 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.584 ' HB2' HG11 ' A' ' 82' ' ' VAL . 22.1 p -143.13 153.68 43.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.775 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -110.56 125.35 53.27 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -126.16 115.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.726 0.298 . . . . 0.0 110.478 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.14 104.49 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.086 0.47 . . . . 0.0 110.54 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.57 -44.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.066 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.1 pt -125.51 -38.55 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.905 0.383 . . . . 0.0 110.496 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.25 -151.38 21.44 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.26 145.24 30.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.4 tpt -136.34 156.63 48.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -108.64 128.5 54.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.713 178.011 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -115.35 140.99 48.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.43 0.633 . . . . 0.0 111.292 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -78.74 113.97 17.26 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.674 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.614 ' HA ' HG22 ' A' ' 111' ' ' VAL . 4.3 p -52.42 -38.81 59.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.77 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 50' ' ' SER . 33.2 mt-10 -60.08 -15.13 20.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.64 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.457 ' CG ' HD21 ' A' ' 67' ' ' LEU . 27.6 m-85 -114.96 4.86 14.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.506 -0.478 . . . . 0.0 112.085 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.3 m -126.1 179.11 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.394 0.616 . . . . 0.0 112.422 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 9.7 ttt180 -145.86 137.82 25.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.826 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 2.0 ttpp -73.3 125.01 26.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.786 173.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.81 -61.26 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.46 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.97 40.34 8.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.7 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.817 -178.161 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.13 124.91 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.197 0.522 . . . . 0.0 111.137 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -148.65 86.61 1.53 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.83 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 p -117.58 -54.03 2.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.127 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.404 HD11 ' CD ' ' A' ' 18' ' ' GLU . 21.3 mt -83.57 151.06 61.19 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.086 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 73.3 Cg_endo -73.61 158.24 47.62 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.504 2.136 . . . . 0.0 110.989 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 16.2 Cg_exo -68.28 -166.6 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.369 2.046 . . . . 0.0 112.057 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.0 t -97.93 120.89 59.11 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.508 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 9.24 0.31 Allowed 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.801 2.334 . . . . 0.0 112.141 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.578 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 33.8 mt-30 -117.6 -35.19 4.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.4 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.53 -48.53 3.07 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 121.0 0.429 . . . . 0.0 110.123 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.5 t30 69.9 -3.05 1.83 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.025 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -53.29 -76.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.944 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 173.06 -19.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.718 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 93.3 m-85 -82.5 48.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.051 0.453 . . . . 0.0 111.637 -167.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.4 m -109.23 146.25 34.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.334 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.4 p90 -152.88 178.45 9.65 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -103.58 118.78 37.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.001 0.429 . . . . 0.0 110.762 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.489 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 37.8 t70 -116.78 80.86 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.99 -113.03 4.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.213 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.26 21.45 16.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -172.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD11 ' HG3' ' A' ' 31' ' ' GLU . 2.4 pt? -158.47 -175.01 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.342 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 17.0 mt -107.25 130.29 54.77 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 19' ' ' ASP . 52.9 t -118.0 132.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 O-C-N 122.103 -0.373 . . . . 0.0 110.43 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.0 t -103.35 105.16 45.27 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.718 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 40.1 Cg_endo -68.14 -11.07 30.87 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 111.176 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.616 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.2 tp10 -72.52 -66.49 0.65 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.675 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -95.35 12.54 28.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.91 32.6 20.01 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.109 0.481 . . . . 0.0 111.915 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.463 ' HB3' HE22 ' A' ' 10' ' ' GLN . 40.2 t60 -136.64 133.24 36.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.193 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -105.87 167.47 9.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.798 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -165.57 162.2 18.91 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 31.3 t -116.93 136.92 23.39 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.6 Cg_endo -59.46 -22.8 67.83 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.798 2.332 . . . . 0.0 112.97 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -124.19 -40.42 2.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.603 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 35.2 tt0 -67.91 -21.88 65.1 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.323 -175.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.95 -32.34 71.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.772 0.32 . . . . 0.0 110.49 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.1 -43.51 52.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.977 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t 49.25 -165.67 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 O-C-N 124.345 1.028 . . . . 0.0 112.34 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.25 41.98 22.58 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.332 0.586 . . . . 0.0 111.064 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.9 m -98.38 33.23 2.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.567 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -153.98 164.21 38.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.615 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -79.23 -30.38 43.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.946 0.403 . . . . 0.0 110.304 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.88 -28.37 16.29 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.457 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 89' ' ' ASP . 44.7 mtpt -84.25 8.78 14.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 111.849 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t -93.66 105.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.533 HG12 HD22 ' A' ' 87' ' ' LEU . 1.4 mm -80.45 130.62 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.925 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 3.5 ttmt -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.565 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 14.3 m-20 -106.08 170.48 7.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 9.2 t -82.65 -9.95 59.15 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.096 0.95 . . . . 0.0 110.236 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.517 HG11 ' HG3' ' A' ' 112' ' ' ARG . 2.6 p -89.09 4.13 5.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.403 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.88 80.74 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.552 -1.203 . . . . 0.0 113.511 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.428 ' OD1' HG13 ' A' ' 51' ' ' VAL . 9.9 p30 -103.62 161.96 13.46 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.327 -178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' HE2' ' A' ' 48' ' ' LYS . 11.6 t -102.4 142.85 15.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.175 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.614 HD22 HG22 ' A' ' 61' ' ' ILE . 17.9 mt -94.48 174.97 6.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 111.319 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.434 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 14.0 tt0 -138.53 159.49 41.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.483 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 10.0 p-10 -69.69 130.47 42.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.416 0.627 . . . . 0.0 109.712 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 91.57 -7.94 79.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.173 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.484 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 1.7 t70 -77.98 167.39 21.55 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.318 -0.519 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.2 m -96.53 140.08 31.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.953 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.614 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -123.86 165.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.082 0.468 . . . . 0.0 110.069 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.8 m -149.72 121.12 7.9 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.746 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.28 127.58 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.557 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -99.34 17.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.557 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.6 mptm? -140.81 161.46 37.75 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.459 -0.775 . . . . 0.0 109.041 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.537 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.0 p-10 -81.28 115.25 20.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.706 0.765 . . . . 0.0 111.926 172.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 13.7 mt -130.17 144.19 51.22 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.064 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -95.14 178.59 5.49 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.866 -0.521 . . . . 0.0 111.14 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 72' ' ' SER . 47.0 t -127.45 127.63 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' H ' ' HG2' ' A' ' 70' ' ' LYS . 39.4 pttt -82.26 -45.72 14.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -170.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.4 -26.28 57.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.567 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.821 ' HB3' HD23 ' A' ' 74' ' ' LEU . 58.3 m -110.03 165.73 11.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -86.7 11.99 11.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.785 0.803 . . . . 0.0 109.201 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.12 172.71 12.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.962 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.2 t -159.03 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -166.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.746 HG12 HG11 ' A' ' 63' ' ' VAL . 85.1 t -93.27 96.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.89 0.852 . . . . 0.0 110.611 -173.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.4 pptp? -102.64 146.18 28.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.153 -175.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.537 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.57 97.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.913 0.863 . . . . 0.0 110.774 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.36 3.36 4.3 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.013 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' THR . 94.9 m -62.12 103.81 0.41 Allowed 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 121.868 0.842 . . . . 0.0 109.65 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -90.85 114.74 27.24 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.226 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 96' ' ' CYS . 42.6 t -126.14 113.72 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.6 ptmt -96.59 161.47 13.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.032 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.585 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 86.7 m-20 63.52 44.92 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.839 0.712 . . . . 0.0 111.526 174.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' CG2' ' A' ' 61' ' ' ILE . 34.2 pt -65.7 175.64 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.911 0.862 . . . . 0.0 113.042 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 19.3 tpp180 -130.17 129.89 44.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.378 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.533 HD22 HG12 ' A' ' 47' ' ' ILE . 63.0 mt -81.17 113.07 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -88.63 178.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.967 0.413 . . . . 0.0 110.833 -174.408 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.537 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 5.5 m-20 -81.18 80.38 7.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.247 0.546 . . . . 0.0 110.767 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . 172.21 -175.1 45.52 Favored Glycine 0 C--N 1.304 -1.209 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -101.15 -29.62 12.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.452 0.644 . . . . 0.0 110.7 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 108' ' ' SER . 42.5 p-80 -107.03 51.69 0.73 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.287 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.8 m-20 -149.67 91.79 1.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -159.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.516 HG13 HG21 ' A' ' 47' ' ' ILE . 3.9 mp -109.0 113.63 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.743 170.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 36.6 t70 -94.69 136.9 34.47 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.488 ' HB2' HG11 ' A' ' 82' ' ' VAL . 17.4 p -138.03 143.46 40.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.505 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.71 121.01 43.83 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.53 107.32 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.62 117.25 6.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.86 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.15 -65.26 0.57 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.477 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.47 HG21 HD21 ' A' ' 74' ' ' LEU . 26.7 pt -95.78 -47.65 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.88 0.371 . . . . 0.0 110.369 178.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.99 -161.18 28.12 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.39 148.33 26.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.702 0.287 . . . . 0.0 111.009 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 43.9 ttm -138.79 158.09 44.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.318 . . . . 0.0 110.58 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.94 134.88 54.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.087 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.2 mt -118.83 142.44 47.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.203 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HB3' ' OE1' ' A' ' 109' ' ' GLU . 30.0 mtpt -74.41 130.86 40.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.966 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 92' ' ' HIS . 28.7 t -59.49 -32.98 70.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.478 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.529 ' OE1' ' HB3' ' A' ' 107' ' ' LYS . 3.4 pm0 -85.55 -0.16 54.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 33.3 m-85 -115.8 3.06 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.891 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 28.9 m -111.8 168.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.269 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.517 ' HG3' HG11 ' A' ' 51' ' ' VAL . 25.1 ttt180 -150.64 132.49 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.282 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.2 tttt -65.48 121.08 14.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 174.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.1 t -85.47 -48.76 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.81 85.3 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.867 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.909 -179.369 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p 178.26 138.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -73.9 95.02 2.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.987 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.1 p -116.48 95.49 5.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.423 0.63 . . . . 0.0 109.896 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.446 HD13 HD22 ' A' ' 23' ' ' LEU . 30.2 mt -96.59 161.96 24.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.039 -171.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 54.3 Cg_endo -69.22 160.0 51.57 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.215 1.943 . . . . 0.0 111.139 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.22 -172.39 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.357 2.038 . . . . 0.0 112.031 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.09 127.03 38.05 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.57 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.69 6.82 1.46 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.541 2.16 . . . . 0.0 111.722 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.616 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 41.8 mt-30 -115.54 -39.21 3.59 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.431 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 m -109.67 -52.01 2.82 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.908 0.385 . . . . 0.0 110.268 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.74 -0.82 3.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.611 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.632 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 45.2 m -60.87 -78.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.994 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.1 pt-20 176.77 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.729 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 23.8 m-85 -82.2 33.58 0.4 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.584 0.629 . . . . 0.0 111.827 -171.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -91.48 135.22 34.0 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.766 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CE1' ' HD3' ' A' ' 26' ' ' PRO . 22.0 p90 -146.04 170.17 17.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 123.85 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.83 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -120.03 79.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.09 -112.9 4.52 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.076 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.03 16.13 25.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.12 -175.5 5.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.725 0.298 . . . . 0.0 110.248 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 19.9 mt -110.05 129.15 55.73 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.881 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -123.59 138.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.037 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.97 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 47.1 t -110.72 104.2 55.66 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.352 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 56.1 Cg_endo -70.78 -9.81 26.49 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.836 2.358 . . . . 0.0 109.913 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.97 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -70.75 -45.13 65.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.206 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.0 p -117.88 15.17 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.08 39.9 28.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.157 0.435 . . . . 0.0 111.874 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.78 127.62 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.85 0.357 . . . . 0.0 111.399 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.881 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 27.1 mt-10 -91.18 156.37 17.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.129 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.39 162.24 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.438 . . . . 0.0 110.726 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -110.44 130.87 22.41 Favored Pre-proline 0 C--N 1.317 -0.845 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.506 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 18.4 Cg_endo -59.65 -34.32 96.46 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.887 2.391 . . . . 0.0 113.576 -171.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -119.43 -42.92 2.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.962 0.411 . . . . 0.0 111.113 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -63.62 -18.24 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.546 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.15 61.22 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.595 0.236 . . . . 0.0 111.397 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.77 -30.86 71.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.51 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 m 69.23 163.19 0.23 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.074 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.25 -179.85 3.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.862 0.363 . . . . 0.0 110.769 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.8 m -91.45 -177.67 4.89 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.359 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -150.87 156.56 41.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -69.02 -29.56 67.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 0.0 111.434 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.66 95.21 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.922 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.694 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.8 mmpt? -90.97 -53.19 4.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.47 0.652 . . . . 0.0 109.396 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.572 HG23 HD13 ' A' ' 87' ' ' LEU . 7.8 p -142.34 146.94 21.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.83 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.424 HG21 HG13 ' A' ' 94' ' ' ILE . 4.4 mm -85.75 138.77 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.456 0.17 . . . . 0.0 110.649 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -109.62 155.78 21.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.119 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 5.0 m-20 -98.73 167.19 10.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.682 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.688 ' OG ' HD11 ' A' ' 64' ' ' ILE . 89.8 p -76.68 -10.63 59.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.904 0.859 . . . . 0.0 110.867 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.541 HG11 ' HG3' ' A' ' 112' ' ' ARG . 2.1 p -85.4 1.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.451 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.23 7.15 73.62 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.504 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -108.45 168.39 9.36 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.942 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 48' ' ' LYS . 9.4 t -113.7 142.51 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.931 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 113' ' ' LYS . 13.9 mt -96.64 175.95 6.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.547 0.689 . . . . 0.0 111.204 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.478 ' HB3' ' OD1' ' A' ' 59' ' ' ASP . 16.8 tt0 -131.91 154.21 49.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -67.54 96.46 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.955 0.407 . . . . 0.0 109.944 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.83 -7.11 6.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.974 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 56' ' ' GLN . 32.0 m-20 -71.13 165.27 23.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.112 0.482 . . . . 0.0 111.167 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 2.8 m -99.37 136.09 39.83 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.472 HG22 HD22 ' A' ' 55' ' ' LEU . 1.9 pp -120.76 166.01 15.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.0 m -150.46 118.78 6.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.851 175.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -60.73 126.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.295 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.688 HD11 ' OG ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -99.54 19.01 2.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' HD2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -143.48 166.41 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.592 -0.692 . . . . 0.0 109.332 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.77 113.96 21.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.894 0.854 . . . . 0.0 111.343 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 ' CG ' ' A' ' 110' ' ' PHE . 7.2 mp -126.0 141.19 52.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.485 175.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.428 ' HE2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -88.52 171.37 10.12 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.31 173.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.502 ' CG2' HG23 ' A' ' 76' ' ' VAL . 47.8 t -120.25 133.55 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -78.57 -57.49 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.78 -17.55 79.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.968 -0.635 . . . . 0.0 113.094 -174.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.471 ' HB2' HG11 ' A' ' 69' ' ' VAL . 55.5 m -115.0 155.13 27.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.746 0.308 . . . . 0.0 110.869 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -79.79 -1.13 37.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.47 HD22 HD13 ' A' ' 101' ' ' ILE . 9.5 mp -78.83 146.61 33.6 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.9 t -107.78 134.3 50.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.318 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 63' ' ' VAL . 63.1 t -84.1 104.25 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 149.87 25.48 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.469 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.73 96.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.99 0.9 . . . . 0.0 111.083 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.64 5.82 3.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.057 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 62' ' ' THR . 90.1 m -62.58 104.07 0.48 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 121.717 0.77 . . . . 0.0 109.87 176.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.25 121.3 33.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.174 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 96' ' ' CYS . 30.6 t -133.88 116.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.627 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 51.9 pttt -100.35 158.88 15.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.726 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.495 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 23.2 m120 63.32 47.49 3.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.8 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -64.88 178.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 122.005 0.907 . . . . 0.0 113.347 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.653 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 11.0 tpp85 -129.96 124.65 33.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.823 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.572 HD13 HG23 ' A' ' 46' ' ' VAL . 34.5 mt -78.92 116.05 18.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.6 t -82.12 163.02 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.384 -176.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -76.44 89.93 3.24 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.539 0.685 . . . . 0.0 109.928 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.38 126.56 2.02 Favored Glycine 0 C--N 1.306 -1.138 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.63 -13.72 10.73 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.249 0.547 . . . . 0.0 112.237 -170.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -106.43 51.34 0.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -173.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.475 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -174.49 143.02 0.79 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 118.732 -1.187 . . . . 0.0 114.082 -170.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.556 ' CD1' HG21 ' A' ' 111' ' ' VAL . 36.6 mt -144.34 120.61 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 33.9 t70 -95.53 136.72 35.56 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.167 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.536 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -154.18 163.26 40.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.704 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 87.9 tttt -124.7 147.26 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.976 0.417 . . . . 0.0 110.04 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.32 105.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.57 103.87 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.795 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 144.27 -70.3 0.4 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.215 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.47 HD13 HD22 ' A' ' 74' ' ' LEU . 25.4 pt -84.77 -46.5 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.542 0.21 . . . . 0.0 111.173 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.425 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 146.94 -162.62 28.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.893 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.772 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -86.72 149.91 24.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.829 0.315 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.4 ttt -140.29 156.89 46.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.946 0.403 . . . . 0.0 110.671 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -113.83 139.03 49.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.583 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 53.9 mt -123.08 141.16 52.27 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.669 0.747 . . . . 0.0 111.732 -170.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -84.83 119.61 25.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.973 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -47.82 -39.71 19.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.7 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.77 -11.15 33.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.61 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.45 ' CG ' HD21 ' A' ' 67' ' ' LEU . 86.4 m-85 -112.91 1.8 15.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.556 HG21 ' CD1' ' A' ' 94' ' ' ILE . 13.5 m -113.4 169.51 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.37 -172.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.573 ' HB3' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -155.13 129.77 9.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.07 179.054 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.482 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.7 tttt -59.97 123.25 16.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.786 0.327 . . . . 0.0 110.31 171.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -60.53 -44.8 97.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.429 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.98 -21.13 3.01 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.184 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.236 -0.887 . . . . 0.0 109.47 176.19 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.812 0.339 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.23 -17.68 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.622 0.725 . . . . 0.0 110.884 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -103.27 97.02 7.16 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.697 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 p -126.25 25.27 6.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.564 0.697 . . . . 0.0 110.331 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.428 HD22 HD12 ' A' ' 23' ' ' LEU . 16.2 mt -78.48 157.79 77.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.406 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 72.4 Cg_endo -72.47 155.95 54.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.925 1.75 . . . . 0.0 110.783 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 15.6 Cg_exo -67.84 -175.44 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.31 2.007 . . . . 0.0 111.882 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 4.7 t -97.65 123.0 53.56 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.46 10.94 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.73 2.287 . . . . 0.0 111.919 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.572 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 38.6 mt-30 -118.9 -40.57 2.84 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.147 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.4 m -108.98 -50.86 2.95 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.185 0.516 . . . . 0.0 110.265 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 t30 70.78 2.07 4.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.871 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 4.8 m -58.95 -78.34 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.3 pt-20 175.66 -18.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.516 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.7 m-85 -79.21 31.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.132 -169.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 m -94.17 136.19 34.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.825 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -139.05 169.87 17.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.19 122.03 45.71 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.11 0.481 . . . . 0.0 111.205 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -111.27 71.75 0.75 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.53 -107.99 3.53 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.382 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.9 19.4 19.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -171.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 23' ' ' LEU . 2.6 pt? -155.41 -179.44 8.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.171 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.706 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -109.24 134.03 52.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 31' ' ' GLU . 57.7 t -115.14 127.15 72.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 49.4 t -103.95 103.91 40.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 53.4 Cg_endo -71.61 -8.88 24.06 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.549 2.166 . . . . 0.0 110.412 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 20.2 tt0 -69.27 -62.59 1.32 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.017 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.2 p -98.47 9.59 42.8 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.71 46.05 12.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.771 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -150.59 135.02 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HB3' HG13 ' A' ' 24' ' ' VAL . 10.1 pt-20 -114.36 163.53 15.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.733 0.301 . . . . 0.0 110.882 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.564 ' NE1' HD23 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -163.11 162.64 25.77 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 36' ' ' GLU . 32.7 t -112.18 139.79 22.86 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' ' CD2' ' A' ' 23' ' ' LEU . 19.7 Cg_endo -58.19 -48.87 14.18 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.403 2.069 . . . . 0.0 112.452 -173.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -101.32 -37.88 8.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.48 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.535 ' HA ' ' OG1' ' A' ' 39' ' ' THR . 15.0 mm-40 -69.1 -12.28 61.54 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -174.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.35 -34.66 74.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.09 0.471 . . . . 0.0 109.951 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.22 -45.67 11.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.316 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 36' ' ' GLU . 2.7 p -76.1 -35.82 59.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 70.26 112.12 0.05 Allowed 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.816 0.697 . . . . 0.0 111.009 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -60.6 111.57 1.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.455 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 43' ' ' ASP . 12.0 t70 -149.1 -154.22 0.54 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.431 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 33.7 t70 -59.89 -39.3 84.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 0.0 110.958 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.47 45.55 1.05 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.349 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 45' ' ' LYS . 30.5 mmmt -76.58 94.29 3.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.346 0.593 . . . . 0.0 110.632 176.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.615 HG13 HD13 ' A' ' 87' ' ' LEU . 15.8 t -130.84 155.75 42.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.637 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.686 HG21 HG13 ' A' ' 94' ' ' ILE . 2.5 mm -86.18 135.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.52 177.36 4.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 6.3 m-20 -114.42 169.99 8.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.611 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.468 ' OG ' HD11 ' A' ' 64' ' ' ILE . 90.3 p -70.47 -6.23 34.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.123 0.963 . . . . 0.0 110.51 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.47 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.1 t -86.45 -13.52 10.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.642 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.79 5.68 64.33 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.886 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.47 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -97.1 168.24 10.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.543 0.687 . . . . 0.0 111.561 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 48' ' ' LYS . 16.4 t -113.97 144.64 21.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.787 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.591 HD22 HG22 ' A' ' 61' ' ' ILE . 24.2 mt -101.1 173.2 6.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.647 . . . . 0.0 111.69 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 9.1 tp-100 -124.89 145.71 49.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.483 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 15.1 t70 -71.23 97.1 1.49 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 123.51 -6.5 9.15 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.556 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 42.2 t0 -68.62 166.53 17.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.899 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 34.5 m -104.89 136.51 44.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.591 HG22 HD22 ' A' ' 55' ' ' LEU . 1.8 pp -123.71 171.85 12.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -150.19 123.34 8.87 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 0.0 111.102 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.614 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -65.8 126.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -97.7 14.06 4.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG3' HG12 ' A' ' 64' ' ' ILE . 54.8 mttt -143.64 164.99 28.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.094 0.861 . . . . 0.0 109.634 -176.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.69 117.15 24.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.082 0.944 . . . . 0.0 112.648 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.461 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.6 mp -134.79 150.66 50.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.307 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.32 178.27 5.89 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.703 -0.623 . . . . 0.0 111.502 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' A' ' 74' ' ' LEU . 46.7 t -120.06 129.07 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -56.51 108.36 0.48 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.22 3.88 26.57 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.005 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m -101.0 166.69 10.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.982 0.42 . . . . 0.0 111.122 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 p -84.92 -3.84 58.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.56 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.512 ' HB3' HG21 ' A' ' 69' ' ' VAL . 12.1 tp -81.85 171.66 14.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.661 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.473 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 70.0 t -158.72 120.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -169.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.614 HG12 HG11 ' A' ' 63' ' ' VAL . 64.9 t -89.65 97.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.715 0.769 . . . . 0.0 110.61 -174.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.478 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.21 145.47 34.2 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.329 -176.698 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -48.01 97.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.868 0.842 . . . . 0.0 111.19 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.52 4.09 4.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.251 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -62.53 104.95 0.57 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 122.089 0.947 . . . . 0.0 110.009 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -89.35 120.75 30.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.895 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.693 HG11 ' HB2' ' A' ' 96' ' ' CYS . 22.2 t -131.9 113.41 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.398 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.7 ptmt -100.55 154.04 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.714 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.504 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 19.0 m120 62.76 53.22 2.56 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.038 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 55' ' ' LEU . 32.4 pt -64.56 174.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 121.815 0.817 . . . . 0.0 112.43 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 20.4 tpp180 -129.22 123.01 30.89 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.879 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG13 ' A' ' 46' ' ' VAL . 39.7 mt -78.24 113.39 16.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -91.05 176.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.021 -178.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -85.09 86.2 7.41 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.121 0.962 . . . . 0.0 111.407 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.14 -172.11 45.07 Favored Glycine 0 C--N 1.293 -1.806 0 CA-C-N 113.593 -1.639 . . . . 0.0 109.68 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.66 -20.59 14.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 118.056 0.928 . . . . 0.0 110.173 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -107.08 50.39 0.77 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.792 -175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.556 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.3 m-20 -150.8 89.78 1.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -160.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.686 HG13 HG21 ' A' ' 47' ' ' ILE . 2.8 mp -110.41 113.1 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 170.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 15.5 t70 -95.0 138.96 32.03 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.693 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -147.35 156.52 42.98 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.406 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -116.64 130.03 56.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.406 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.46 109.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.87 97.31 1.8 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.287 0.565 . . . . 0.0 110.134 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.93 -40.53 0.42 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 102' ' ' GLY . 43.2 pt -122.62 -37.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.477 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 138.15 -150.99 21.23 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -91.01 149.13 21.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.759 0.314 . . . . 0.0 110.744 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.3 ttt -140.57 159.75 41.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.187 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -116.78 143.23 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.2 mt -125.73 146.91 49.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.294 0.568 . . . . 0.0 111.984 -169.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.632 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 1.7 mptm? -75.26 128.33 35.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.855 174.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.6 t -53.31 -40.8 65.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.632 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 8.6 pt-20 -66.88 -12.29 58.8 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.066 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.473 ' O ' HD13 ' A' ' 64' ' ' ILE . 64.7 m-85 -111.87 4.8 18.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.459 -0.776 . . . . 0.0 112.777 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 24.2 m -114.4 169.84 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.505 -173.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 15.8 ttt180 -147.88 142.59 26.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.639 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.748 ' HB2' ' HZ2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -65.58 140.83 58.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.254 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 116' ' ' SER . 94.0 t -107.84 -57.83 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 170.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.57 -3.51 71.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.744 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 114' ' ' VAL . 31.1 m . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.337 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.7 -15.03 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.79 0.805 . . . . 0.0 110.522 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m -84.85 83.04 8.18 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.865 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -107.89 -12.98 15.08 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.433 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.454 HD13 HD22 ' A' ' 23' ' ' LEU . 72.8 mt -110.02 157.01 39.03 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.574 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.9 Cg_endo -70.65 158.29 56.22 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.155 1.903 . . . . 0.0 111.131 176.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 13.1 Cg_exo -70.18 -171.65 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 10' ' ' GLN . 33.8 t -99.1 122.04 53.64 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.205 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.84 7.49 0.58 Allowed 'Trans proline' 0 C--O 1.23 0.113 0 C-N-CA 122.613 2.208 . . . . 0.0 112.284 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 8' ' ' CYS . 45.2 tt0 -113.94 -39.54 3.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.095 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -126.14 -35.15 2.46 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.553 -0.717 . . . . 0.0 111.468 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t30 72.53 1.84 4.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.92 0.488 . . . . 0.0 111.634 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.584 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 4.8 m -53.93 -78.43 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 171.85 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.164 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.793 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 79.0 m-85 -118.06 24.95 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.296 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.404 HG22 ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -93.54 132.38 37.89 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.389 172.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 38.3 p90 -144.9 171.27 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -100.8 117.54 35.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.884 0.373 . . . . 0.0 110.715 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.57 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 35.1 t70 -115.69 69.99 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.02 -113.44 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.91 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.48 18.91 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.883 0.373 . . . . 0.0 111.645 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.4 pt? -154.96 -174.83 5.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.349 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.577 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 24.1 mt -113.46 137.1 52.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 31' ' ' GLU . 46.1 t -121.27 136.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 122.231 -0.293 . . . . 0.0 110.375 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 48.6 t -102.58 105.14 42.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.349 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.793 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 20.8 Cg_endo -61.64 -25.45 79.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.63 2.22 . . . . 0.0 111.66 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.13 -58.95 3.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.7 m -75.92 -9.13 58.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.7 39.54 24.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 111.466 -173.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -149.17 136.92 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.534 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -103.69 174.76 5.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -178.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -166.94 161.87 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' A' ' 36' ' ' GLU . 20.6 t -106.18 135.11 19.5 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.577 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.9 Cg_endo -58.52 -52.23 5.86 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.868 2.379 . . . . 0.0 112.855 -173.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -121.98 -20.56 6.28 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.779 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.491 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 21.1 mm-40 -81.38 -14.09 57.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.585 0.231 . . . . 0.0 111.08 -175.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.89 -54.47 46.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.543 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.22 -56.78 7.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.08 121.13 12.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.212 0.53 . . . . 0.0 111.56 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . . . -137.34 32.92 2.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.471 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.5 m -70.49 103.94 2.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.654 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -121.15 4.21 10.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.98 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.443 ' OD1' HG23 ' A' ' 46' ' ' VAL . 10.9 t0 64.98 93.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.615 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 91' ' ' ASP . . . -98.03 -5.96 57.13 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.375 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -74.41 -21.04 59.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.607 0.241 . . . . 0.0 111.304 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.443 HG23 ' OD1' ' A' ' 43' ' ' ASP . 61.7 t -85.18 122.71 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.124 0.488 . . . . 0.0 109.808 175.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.599 HG21 HG13 ' A' ' 94' ' ' ILE . 5.1 mm -81.3 139.85 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -114.8 176.25 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.3 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.416 ' OD1' HG23 ' A' ' 111' ' ' VAL . 15.6 m-20 -112.05 172.41 6.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.25 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 64' ' ' ILE . 81.6 p -74.66 -8.33 56.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.039 0.923 . . . . 0.0 110.678 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.449 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -89.24 -11.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.406 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.65 -2.63 64.85 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.773 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.449 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -91.52 166.39 12.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.775 0.798 . . . . 0.0 111.584 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' HG3' ' A' ' 48' ' ' LYS . 11.3 t -117.05 139.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.923 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD22 HG22 ' A' ' 61' ' ' ILE . 17.8 mt -94.9 172.98 7.82 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.238 0.542 . . . . 0.0 110.564 -173.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -129.36 150.48 50.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -69.71 96.02 0.93 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 0.0 109.929 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 124.67 -7.83 8.31 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.045 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.468 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 2.1 t0 -72.16 175.81 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 25.3 m -105.46 137.19 43.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.603 HG22 HD22 ' A' ' 55' ' ' LEU . 1.5 pp -123.35 164.49 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.772 0.32 . . . . 0.0 110.279 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -148.53 124.88 10.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 174.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.712 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -66.71 124.79 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.134 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.76 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -96.13 17.19 2.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.904 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 6.7 mttt -143.5 163.71 32.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.03 0.832 . . . . 0.0 109.643 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.538 ' O ' HD23 ' A' ' 67' ' ' LEU . 2.5 p-10 -83.67 115.89 22.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.087 0.946 . . . . 0.0 111.995 173.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.2 mt -129.17 143.92 51.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.359 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -91.87 178.31 5.93 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.618 -0.676 . . . . 0.0 110.525 173.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 HG23 ' A' ' 76' ' ' VAL . 8.0 t -129.15 130.4 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 13.9 tppt? -78.63 -60.04 2.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -172.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.69 37.62 3.35 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.515 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.424 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 69.6 m -144.73 166.85 24.03 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -95.62 2.88 54.36 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.4 mp -78.6 175.25 10.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.452 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.8 t -158.69 116.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.712 HG12 HG11 ' A' ' 63' ' ' VAL . 88.1 t -87.32 98.56 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-O 121.682 0.753 . . . . 0.0 110.753 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.6 pptp? -105.83 145.01 31.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.41 -175.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -48.65 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.925 0.869 . . . . 0.0 111.228 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.23 5.5 4.67 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.072 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.47 104.39 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.807 0.813 . . . . 0.0 109.555 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -94.79 115.02 26.99 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.431 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 96' ' ' CYS . 68.0 t -132.22 117.31 32.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.8 pttt -107.89 169.67 8.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.682 0.753 . . . . 0.0 112.903 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.524 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 69.62 36.13 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.426 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 55' ' ' LEU . 37.2 pt -60.74 175.83 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.645 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 9.0 tpp85 -131.25 123.08 27.65 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.156 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.1 mt -75.25 109.08 8.46 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.624 HG22 ' HB2' ' A' ' 95' ' ' ASP . 2.6 t -74.32 161.44 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -170.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.76 35.01 0.19 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.868 0.842 . . . . 0.0 110.649 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -137.62 132.79 6.07 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 6.1 p-10 -66.86 -6.23 15.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -168.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -108.78 -46.0 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -91.46 153.3 19.92 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -158.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.704 ' CD1' HG21 ' A' ' 111' ' ' VAL . 25.7 mt -110.4 129.69 65.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.435 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.624 ' HB2' HG22 ' A' ' 88' ' ' VAL . 9.9 t70 -96.42 132.81 41.57 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.746 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.6 p -138.27 145.21 41.01 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.832 -168.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.562 ' O ' HG13 ' A' ' 82' ' ' VAL . 96.3 mttt -93.45 107.84 19.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.498 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.6 mt -104.51 155.32 6.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -101.09 130.5 47.14 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.64 -52.42 0.77 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.988 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 102' ' ' GLY . 44.7 pt -95.83 -40.32 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.413 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 126.96 -138.32 10.49 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.791 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -100.34 159.68 14.94 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.11 0.455 . . . . 0.0 111.377 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 38.8 ttm -154.2 165.75 35.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.121 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 80.6 mttt -113.69 126.08 54.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.572 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.44 146.72 39.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.646 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 25.9 ttmt -76.68 125.25 28.93 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.218 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.1 t -47.94 -37.96 15.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.093 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.646 ' HG2' ' HG2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -75.41 -5.33 44.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.904 ' HD1' ' HD3' ' A' ' 65' ' ' LYS . 30.7 m-85 -113.72 7.44 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.531 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.704 HG21 ' CD1' ' A' ' 94' ' ' ILE . 30.3 m -116.62 171.83 5.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -174.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -150.32 133.83 16.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.012 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 87.4 tttt -70.46 120.38 16.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 t -93.86 -70.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.52 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.72 -42.33 1.52 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.769 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.291 -179.351 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.964 0.411 . . . . 0.0 111.487 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.5 p -155.92 153.07 7.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.56 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.6 m 69.31 43.13 1.1 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.207 0.527 . . . . 0.0 111.349 175.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 t -153.24 136.76 15.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.925 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.49 HD11 ' HG2' ' A' ' 18' ' ' GLU . 52.7 mt -110.44 148.96 39.52 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.709 0.29 . . . . 0.0 110.766 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.1 Cg_endo -73.63 162.49 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.042 2.495 . . . . 0.0 111.714 176.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 6.6 Cg_exo -73.39 -169.45 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 t -98.68 130.68 27.32 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.9 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.96 8.98 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.638 2.225 . . . . 0.0 112.553 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -123.04 -37.08 2.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.393 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.6 m -107.04 -45.94 4.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.24 -9.66 0.86 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 1.4 m -43.86 -75.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.004 0.522 . . . . 0.0 111.974 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.0 pt-20 159.04 -3.49 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.005 0.816 . . . . 0.0 111.569 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.591 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 63.2 m-85 -77.26 34.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.628 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -100.85 141.08 34.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.159 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -151.89 177.15 10.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HG2' HD11 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -110.42 124.61 52.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.418 0.628 . . . . 0.0 111.61 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.66 70.05 0.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.674 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.19 -107.66 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.112 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.8 18.03 21.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -159.96 -174.32 4.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.159 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.92 134.45 53.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -124.97 141.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 50.4 t -104.63 105.81 51.94 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.758 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.7 Cg_endo -66.85 -14.26 43.09 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.658 2.239 . . . . 0.0 110.968 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.483 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 33.2 tt0 -70.29 -58.97 3.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.633 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.34 10.29 39.24 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.5 46.11 12.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -142.91 127.41 17.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.678 175.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.539 ' HB3' HD11 ' A' ' 22' ' ' LEU . 2.3 mp0 -91.4 157.07 17.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.023 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -159.07 162.08 36.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.508 ' OG ' ' HB3' ' A' ' 36' ' ' GLU . 14.9 t -115.98 127.76 26.51 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.87 -47.79 12.17 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.786 2.324 . . . . 0.0 113.192 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -116.3 -34.64 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.508 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 26.2 tt0 -67.26 -27.14 66.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.649 0.262 . . . . 0.0 111.459 -176.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.42 -30.76 71.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.109 0.48 . . . . 0.0 110.201 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.02 -62.15 1.6 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.425 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.9 p -99.72 112.6 24.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.586 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.31 174.78 10.17 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.53 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.9 m -99.03 122.83 42.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.91 126.34 37.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.632 0.729 . . . . 0.0 111.417 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 178.66 96.07 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.514 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.2 39.44 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.346 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -99.78 -35.9 9.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.993 0.425 . . . . 0.0 110.26 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.74 HG12 HG22 ' A' ' 54' ' ' VAL . 5.5 t -108.11 125.68 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.879 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.707 HG21 HG13 ' A' ' 94' ' ' ILE . 2.1 mm -91.09 131.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.413 -170.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.51 176.58 6.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 111.84 -179.226 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 15.2 m-20 -116.23 178.26 4.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.109 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.498 ' HB3' HD11 ' A' ' 64' ' ' ILE . 9.3 t -77.03 -5.22 47.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.243 1.02 . . . . 0.0 109.968 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.48 HG21 ' CG ' ' A' ' 112' ' ' ARG . 2.5 t -91.03 -8.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.602 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.28 -6.22 78.26 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.714 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.439 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -90.3 165.41 13.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 110.941 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.74 HG22 HG12 ' A' ' 46' ' ' VAL . 2.9 p -119.79 147.63 23.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.917 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.841 ' HA ' ' HD3' ' A' ' 113' ' ' LYS . 1.8 mt -96.54 178.23 5.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.411 -169.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -127.79 147.95 50.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.596 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -69.19 99.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.8 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.77 -6.91 9.58 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.523 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.91 175.44 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.96 0.41 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 41.4 m -103.01 137.47 41.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.595 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.712 HG22 HD22 ' A' ' 55' ' ' LEU . 1.4 pp -121.84 164.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.423 HG23 ' HA2' ' A' ' 79' ' ' GLY . 2.7 m -149.16 117.95 6.65 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.12 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.632 HG11 HG12 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.48 129.45 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.581 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.561 HG12 ' HD3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -102.86 17.19 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.561 ' HD3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -140.7 164.46 30.14 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.76 0.709 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.646 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -82.94 118.44 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.885 0.85 . . . . 0.0 112.656 174.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 66' ' ' ASP . 11.7 mt -135.4 142.29 45.63 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.758 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -92.54 178.32 5.85 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.399 -0.813 . . . . 0.0 111.29 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.76 131.98 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 70' ' ' LYS . 17.0 tptm -93.02 130.2 38.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.82 18.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.083 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.692 ' HB3' HD23 ' A' ' 74' ' ' LEU . 39.5 m -115.37 155.97 26.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.689 0.28 . . . . 0.0 110.816 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -85.18 18.88 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.603 0.716 . . . . 0.0 109.943 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.692 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -79.36 171.87 14.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.258 175.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.3 t -159.29 118.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -169.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.632 HG12 HG11 ' A' ' 63' ' ' VAL . 84.8 t -92.13 95.16 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.069 0.938 . . . . 0.0 109.95 -175.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 146.41 34.44 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.252 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -46.54 97.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.097 0.873 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.423 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.04 2.73 5.07 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.487 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.5 m -61.85 104.51 0.46 Allowed 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.904 0.859 . . . . 0.0 109.732 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -90.77 115.62 27.99 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.034 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 96' ' ' CYS . 77.7 t -131.91 113.45 22.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.213 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 60.1 pttt -107.88 164.05 12.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.329 0.585 . . . . 0.0 112.324 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.577 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 17.6 m120 70.26 42.04 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.892 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.3 pt -65.39 175.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.987 0.899 . . . . 0.0 112.904 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.596 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 7.3 tpp180 -126.66 126.07 42.94 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.212 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.489 HD22 HG12 ' A' ' 47' ' ' ILE . 38.1 mt -81.54 117.5 21.98 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.785 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -85.51 177.89 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -176.421 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.531 ' H ' HG12 ' A' ' 88' ' ' VAL . 30.0 t70 -89.82 84.58 6.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.408 1.099 . . . . 0.0 110.087 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 47' ' ' ILE . . . 159.33 141.46 3.14 Favored Glycine 0 C--N 1.294 -1.777 0 CA-C-N 113.296 -1.774 . . . . 0.0 110.431 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.25 -19.61 61.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.611 0.706 . . . . 0.0 110.944 -171.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -106.29 50.65 0.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.509 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.785 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.0 m-20 -149.5 93.24 2.03 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -163.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.707 HG13 HG21 ' A' ' 47' ' ' ILE . 9.6 mt -114.44 115.53 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.7 t70 -96.39 134.06 40.01 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.592 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.4 p -129.88 134.91 47.8 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.779 -176.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -101.29 111.66 23.95 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.79 108.5 25.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.956 0.408 . . . . 0.0 110.858 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.81 101.46 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.938 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.31 -39.42 0.76 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.493 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.428 HG21 HD21 ' A' ' 74' ' ' LEU . 23.8 pt -130.35 -39.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.62 -149.02 20.01 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -91.31 148.53 22.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.965 0.412 . . . . 0.0 110.939 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . 0.48 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 50.7 ttm -136.3 157.24 47.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.194 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.515 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -99.86 141.82 32.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.698 175.614 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 93.7 mt -132.48 138.08 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.172 0.511 . . . . 0.0 111.492 -176.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 110' ' ' PHE . 43.5 mtpt -81.95 125.79 31.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.423 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.3 t -48.07 -42.62 29.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.945 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.17 -7.76 20.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.091 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.498 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 33.6 m-85 -115.93 2.4 13.52 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 94' ' ' ILE . 33.8 m -113.33 170.13 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.48 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.2 ttt-85 -150.87 131.32 13.79 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.819 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.841 ' HD3' ' HA ' ' A' ' 55' ' ' LEU . 35.1 ttpt -75.94 123.64 26.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 110.554 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.6 t -76.21 -41.4 37.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.577 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.46 11.15 80.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.975 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.8 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.889 179.296 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.825 0.345 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG22 HG23 ' A' ' 4' ' ' THR . 14.1 p -63.17 127.61 23.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.317 0.58 . . . . 0.0 110.721 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 m -95.06 60.7 2.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.283 0.563 . . . . 0.0 110.95 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.5 HG23 HG22 ' A' ' 2' ' ' VAL . 16.7 p -108.17 -1.99 19.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.945 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.73 148.17 36.81 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.618 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.28 160.92 47.42 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.606 2.204 . . . . 0.0 111.609 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.46 -172.8 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.344 2.03 . . . . 0.0 111.79 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.5 t -97.89 125.93 42.46 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.34 10.87 0.39 Allowed 'Trans proline' 0 N--CA 1.469 0.052 0 C-N-CA 122.547 2.165 . . . . 0.0 111.81 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.508 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 35.3 mt-30 -125.3 -31.11 3.08 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.991 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.8 m -116.07 -40.25 3.32 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.843 -0.536 . . . . 0.0 110.37 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 75.76 -26.83 0.19 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.272 1.029 . . . . 0.0 113.004 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 m -45.7 -77.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 173.59 30.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.594 0.712 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.736 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 64.7 m-85 -96.63 27.8 3.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.125 -172.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 23' ' ' LEU . 1.7 m -101.91 141.42 34.79 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.451 174.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.8 p90 -148.12 175.82 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.17 121.41 45.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.75 0.705 . . . . 0.0 111.487 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.431 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 33.0 t70 -113.52 75.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.269 0.556 . . . . 0.0 109.59 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.18 -108.75 3.63 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.118 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.24 20.38 18.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.471 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.2 pt? -160.49 -174.17 4.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.592 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 25.0 mt -109.06 136.57 48.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.731 174.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.462 HG13 ' HG3' ' A' ' 31' ' ' GLU . 60.2 t -122.19 131.35 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 122.296 -0.253 . . . . 0.0 110.385 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -101.28 108.96 57.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 58.7 Cg_endo -71.7 -8.42 23.09 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.907 2.404 . . . . 0.0 111.216 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.538 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 13.8 tp10 -75.87 -70.49 0.43 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.313 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.12 10.55 23.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.33 41.34 23.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.092 0.472 . . . . 0.0 111.992 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -138.74 128.46 24.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.867 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB3' HD11 ' A' ' 22' ' ' LEU . 2.2 mp0 -91.1 161.31 15.15 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.84 161.52 17.84 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 120.947 0.404 . . . . 0.0 110.41 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 36' ' ' GLU . 32.7 t -115.14 137.91 23.23 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 11.5 Cg_endo -56.47 -33.14 91.58 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.169 2.579 . . . . 0.0 113.219 -173.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -136.98 -45.31 0.57 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.519 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.543 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -52.05 -39.67 59.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.78 -179.005 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.473 ' H ' ' HB3' ' A' ' 33' ' ' SER . . . -64.88 -25.92 68.1 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -177.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.99 -9.71 59.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.6 m -116.25 -65.93 1.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.717 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -176.26 124.74 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.295 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.0 m -72.11 97.16 1.88 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.049 0.452 . . . . 0.0 110.612 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -147.84 173.52 12.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.77 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.57 -23.98 60.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.27 0.557 . . . . 0.0 109.911 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.83 25.65 26.73 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -173.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -83.47 6.16 21.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.871 -0.665 . . . . 0.0 111.483 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.407 HG12 ' CG1' ' A' ' 54' ' ' VAL . 14.5 t -96.41 102.53 13.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.506 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 91' ' ' ASP . 9.6 mm -75.58 137.83 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.627 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.579 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.1 OUTLIER -119.17 156.6 29.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.0 176.496 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 5.9 m-20 -96.92 -179.01 4.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.224 -176.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 30.7 t -80.13 -6.54 57.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.964 0.888 . . . . 0.0 109.538 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.475 HG21 ' HD2' ' A' ' 112' ' ' ARG . 3.7 t -90.95 -17.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.716 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.13 3.14 57.92 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.211 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -84.31 167.44 16.57 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.036 0.922 . . . . 0.0 110.819 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.54 HG22 ' HG3' ' A' ' 48' ' ' LYS . 24.0 t -117.05 139.28 44.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.887 -1.96 . . . . 0.0 108.255 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.418 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 2.1 mm? -97.33 174.55 6.64 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.37 0.605 . . . . 0.0 110.704 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -125.24 145.67 49.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.717 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 14.9 t70 -67.76 99.51 0.82 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.643 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.62 -7.21 9.63 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.17 174.99 5.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.944 0.402 . . . . 0.0 110.937 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.5 m -106.91 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.67 166.89 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.1 m -150.54 119.1 6.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.851 0.358 . . . . 0.0 111.355 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.717 HG11 HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -63.66 126.65 22.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.19 22.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.627 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -143.24 159.53 42.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.534 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.48 100.53 11.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.952 0.882 . . . . 0.0 112.707 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.629 HD21 ' CD2' ' A' ' 110' ' ' PHE . 6.6 mp -110.63 153.71 24.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.038 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -98.76 179.33 4.69 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.777 0.322 . . . . 0.0 111.385 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.61 HG21 ' HB2' ' A' ' 72' ' ' SER . 33.7 m -119.55 147.2 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.7 ' HG3' ' H ' ' A' ' 71' ' ' GLY . 18.2 ptmt -77.84 -76.81 0.17 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.7 ' H ' ' HG3' ' A' ' 70' ' ' LYS . . . -92.07 47.96 2.69 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.969 -173.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.61 ' HB2' HG21 ' A' ' 69' ' ' VAL . 74.6 m -144.33 176.76 9.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.7 m -104.96 6.43 33.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.604 1.192 . . . . 0.0 108.03 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.578 ' O ' HG22 ' A' ' 69' ' ' VAL . 4.5 mm? -77.91 176.67 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.224 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.1 t -160.02 113.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.717 HG12 HG11 ' A' ' 63' ' ' VAL . 87.2 t -85.68 93.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.56 0.695 . . . . 0.0 109.503 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -106.48 148.15 28.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -171.491 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -48.29 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.92 0.867 . . . . 0.0 111.348 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.59 8.0 3.28 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.107 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 62' ' ' THR . 85.7 m -63.92 103.19 0.55 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 122.153 0.978 . . . . 0.0 109.653 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 81' ' ' LYS . 5.6 ttpm? -92.5 110.48 21.89 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.096 -174.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 96' ' ' CYS . 56.8 t -126.49 117.88 49.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.758 177.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 55.6 pttt -105.1 163.02 12.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.662 . . . . 0.0 112.11 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.643 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.8 OUTLIER 67.81 42.87 1.86 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.298 174.806 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.518 HG22 ' HB3' ' A' ' 96' ' ' CYS . 36.1 pt -65.63 -175.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.717 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 12.2 tpp85 -135.01 122.82 22.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.423 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.41 HD22 HG12 ' A' ' 47' ' ' ILE . 71.0 mt -76.4 118.91 19.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.1 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.879 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.41 -44.72 95.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.826 0.346 . . . . 0.0 111.557 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.15 132.98 11.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.274 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 47' ' ' ILE . 15.8 t70 -57.43 -31.77 66.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.286 0.565 . . . . 0.0 110.803 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -81.23 52.1 1.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.081 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.27 138.12 3.05 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 121.319 0.58 . . . . 0.0 112.059 -169.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 108' ' ' SER . 63.6 mt -142.72 125.66 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.204 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 4.5 t70 -104.98 139.04 40.27 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.518 ' HB3' HG22 ' A' ' 85' ' ' ILE . 27.2 p -155.05 165.56 36.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -112.07 135.77 52.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.517 HG13 HD11 ' A' ' 101' ' ' ILE . 2.2 mm -100.84 98.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.9 105.88 0.14 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.723 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.25 0.68 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.356 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.574 HG21 HD21 ' A' ' 74' ' ' LEU . 34.2 pt -96.07 -42.63 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 145.06 -166.11 27.59 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.0 148.38 24.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.998 0.899 . . . . 0.0 110.874 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.3 ttm -140.02 158.61 43.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -117.05 138.37 51.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.5 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -123.96 147.88 47.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.434 -171.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 13.6 tptm -84.82 122.37 29.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.812 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -50.97 -39.76 56.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.745 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' SER . 10.4 pt-20 -66.02 -9.05 26.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.294 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.629 ' CD2' HD21 ' A' ' 67' ' ' LEU . 42.1 m-85 -110.74 0.62 17.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.165 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 15.4 m -112.5 170.77 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.475 ' HD2' HG21 ' A' ' 51' ' ' VAL . 22.0 ttt180 -145.66 138.28 25.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.457 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 87.8 tttt -68.83 119.13 12.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.612 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.17 -47.36 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.02 48.63 25.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.052 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.427 -178.397 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 121.165 0.507 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 p -90.51 130.13 40.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.508 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.9 m 58.49 31.8 21.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.38 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.1 p -85.18 -39.99 17.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.128 0.49 . . . . 0.0 110.476 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt -92.61 150.68 40.18 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 72.9 Cg_endo -73.11 156.9 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.223 1.949 . . . . 0.0 111.133 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 8.0 Cg_exo -72.49 -163.3 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.9 2.4 . . . . 0.0 112.603 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.4 t -98.32 130.56 28.03 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.47 5.28 2.03 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.287 . . . . 0.0 112.927 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -121.2 -35.13 3.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.241 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 13' ' ' SER . 58.0 m -104.79 -47.31 4.08 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.49 -0.756 . . . . 0.0 109.511 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.54 -2.35 1.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.08 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 11' ' ' CYS . 15.0 p -48.32 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.095 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 170.03 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.263 0.352 . . . . 0.0 111.681 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.657 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 80.8 m-85 -77.79 39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -171.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -103.28 143.31 32.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.515 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -153.88 176.73 11.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.71 123.47 47.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.838 0.352 . . . . 0.0 111.441 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -121.17 86.43 2.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.43 -116.16 5.01 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.132 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.77 18.23 22.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.902 0.382 . . . . 0.0 111.789 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.4 -173.49 4.52 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 mt -112.86 138.39 49.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.651 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -126.75 142.75 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 51.7 t -104.5 105.48 50.2 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.733 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.7 Cg_endo -65.84 -15.95 51.02 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.816 2.344 . . . . 0.0 111.512 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.1 tt0 -71.21 -61.39 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.93 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -98.82 12.76 34.69 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.95 29.54 17.81 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -135.75 133.92 38.49 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.131 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.651 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.4 mp0 -95.11 171.68 8.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.642 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -166.22 161.83 17.09 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.932 0.396 . . . . 0.0 110.558 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -115.57 113.79 42.65 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.59 -56.79 2.52 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.201 2.601 . . . . 0.0 113.195 -168.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -85.79 -28.14 24.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.597 -173.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -76.43 -31.29 57.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.842 0.354 . . . . 0.0 110.482 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.212 174.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.92 -32.44 51.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.262 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 m 66.04 -84.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.027 175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.78 15.94 2.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.162 0.506 . . . . 0.0 110.95 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -100.23 12.0 38.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.663 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 43' ' ' ASP . 12.9 t70 60.74 -170.75 0.15 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.937 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.424 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 35.0 t70 -144.14 89.46 2.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.352 0.596 . . . . 0.0 110.397 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.03 -60.06 0.66 Allowed Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.434 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.882 ' HD3' ' HA ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -101.65 111.7 24.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.774 0.797 . . . . 0.0 111.801 -174.536 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t -142.37 143.34 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.662 HG21 HG13 ' A' ' 94' ' ' ILE . 3.0 mm -89.93 135.44 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.079 -172.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.733 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -115.0 145.71 41.99 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.465 ' OD2' HD11 ' A' ' 55' ' ' LEU . 70.4 m-20 -104.5 179.43 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.515 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 5.0 t -73.93 -9.22 58.42 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.93 0.872 . . . . 0.0 110.315 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.1 t -84.91 -18.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.657 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.58 12.7 60.66 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.5 -175.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 49' ' ' ASP . 3.1 p30 -99.72 153.38 19.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.257 0.551 . . . . 0.0 111.112 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.41 133.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.328 -175.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.3 mp -96.67 175.17 6.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.25 0.548 . . . . 0.0 111.724 -168.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -124.81 146.98 48.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.687 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 17.8 t70 -70.65 102.21 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 0.0 110.625 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.48 -3.98 13.53 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.27 171.61 10.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.969 -0.615 . . . . 0.0 110.833 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 31.1 m -104.75 137.64 42.25 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -121.16 168.56 13.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.7 m -148.96 118.3 6.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.888 0.375 . . . . 0.0 110.868 175.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 1.1 p -62.91 129.48 26.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.534 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -95.14 10.41 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 64' ' ' ILE . 74.9 mmtt -138.0 171.1 14.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 119.83 1.195 . . . . 0.0 110.255 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.78 112.23 22.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.496 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.9 mp -130.23 143.44 50.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.984 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -90.99 178.76 5.92 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.793 -0.567 . . . . 0.0 110.343 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 74' ' ' LEU . 57.8 t -122.24 115.68 46.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -79.16 117.87 20.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -166.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.9 45.76 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.08 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -110.86 172.86 6.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.343 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -98.01 9.16 43.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.532 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 69' ' ' VAL . 14.8 tp -78.85 170.66 16.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.734 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 72.5 t -158.13 117.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -168.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.528 HG12 HG11 ' A' ' 63' ' ' VAL . 94.3 t -93.48 95.76 5.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.851 0.834 . . . . 0.0 110.544 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.12 151.61 27.04 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.473 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.534 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -52.18 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.824 0.821 . . . . 0.0 110.817 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.16 4.89 3.16 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.174 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.5 m -61.92 104.74 0.49 Allowed 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 122.032 0.92 . . . . 0.0 110.148 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 30.0 ttpt -89.97 112.65 24.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.921 -175.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.1 t -123.67 114.39 41.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 ptmt -104.28 151.29 23.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.642 -175.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 68.88 47.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 124.33 1.019 . . . . 0.0 111.468 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.3 pt -65.89 -179.5 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.058 0.932 . . . . 0.0 113.193 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.687 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 19.4 tpt180 -129.15 122.37 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.636 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.576 HD22 HG12 ' A' ' 47' ' ' ILE . 79.6 mt -83.07 119.64 24.75 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -96.01 169.26 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -175.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.882 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 1.3 m-20 -75.13 92.73 2.7 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.657 0.741 . . . . 0.0 111.501 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.431 ' HA3' ' OD1' ' A' ' 93' ' ' ASP . . . 171.23 -174.07 44.85 Favored Glycine 0 C--N 1.303 -1.277 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.04 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -103.09 -25.57 13.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.623 0.725 . . . . 0.0 110.101 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.455 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 13.8 p-80 -108.35 50.86 0.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.931 -176.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 88' ' ' VAL . 6.0 m-20 -143.94 89.65 2.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -160.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.662 HG13 HG21 ' A' ' 47' ' ' ILE . 38.1 mt -120.09 113.69 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.322 174.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 13.4 t70 -95.63 139.79 31.38 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.802 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.488 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.7 p -149.39 159.79 43.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.069 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 14.2 mptt -112.32 135.13 53.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.686 HG13 HD11 ' A' ' 101' ' ' ILE . 1.8 mm -114.07 109.01 26.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.6 102.02 0.13 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.94 -66.48 0.51 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.829 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.686 HD11 HG13 ' A' ' 98' ' ' ILE . 45.7 pt -86.9 -48.82 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.545 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 141.63 -157.72 26.34 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -176.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -77.37 144.03 38.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 117.939 0.869 . . . . 0.0 110.529 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 52.9 ttp -133.69 151.88 51.75 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -112.11 140.67 46.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.1 mt -120.96 139.58 53.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.464 0.649 . . . . 0.0 111.528 -171.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 22.2 tptm -80.83 116.23 20.71 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.824 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.733 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 7.5 p -53.98 -34.52 60.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.602 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 50' ' ' SER . 37.5 mt-10 -68.94 -9.87 54.27 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.47 ' O ' HD13 ' A' ' 64' ' ' ILE . 63.8 m-85 -109.41 -4.46 16.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.049 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.9 m -113.6 173.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.314 0.578 . . . . 0.0 112.12 -174.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.506 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.9 ttt180 -147.07 133.14 19.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.002 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 27.8 tttp -65.1 136.87 57.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.009 176.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.2 -56.56 5.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.588 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.54 49.62 10.98 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.063 -172.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.589 -178.015 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.143 0.497 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.61 153.57 19.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.825 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -148.68 101.85 3.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.017 0.437 . . . . 0.0 110.489 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.5 p -124.79 -55.17 1.62 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.016 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 23' ' ' LEU . 51.0 mt -79.38 154.38 76.71 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.242 173.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 62.8 Cg_endo -70.95 156.85 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.029 1.82 . . . . 0.0 111.344 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -73.91 -163.55 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.843 2.362 . . . . 0.0 112.7 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.9 t -98.29 124.2 47.89 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.406 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.45 11.27 0.63 Allowed 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 122.899 2.399 . . . . 0.0 111.563 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 41.3 mt-30 -120.8 -38.32 2.87 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 -178.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m -108.26 -50.29 3.06 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t30 70.0 7.18 6.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.368 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.51 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 5.1 m -54.32 -76.6 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.982 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 13' ' ' SER . 15.5 pt-20 165.66 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.327 0.392 . . . . 0.0 111.977 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.501 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 87.6 m-85 -78.43 33.67 0.2 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -169.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -95.71 139.89 31.29 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.587 0.232 . . . . 0.0 110.563 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 20.9 p90 -147.48 178.09 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.1 122.19 47.26 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.206 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.539 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 24.0 t70 -118.35 89.28 3.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.879 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.46 -106.58 3.43 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.196 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.36 17.34 17.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 31' ' ' GLU . 1.3 pt? -163.91 -175.05 3.88 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.249 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.409 ' CD1' ' HG2' ' A' ' 6' ' ' PRO . 22.4 mt -101.36 135.56 42.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.561 HG13 ' HG3' ' A' ' 31' ' ' GLU . 64.8 t -117.62 130.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 50.4 t -101.6 103.93 31.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 173.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.0 Cg_endo -65.89 -18.65 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.508 2.139 . . . . 0.0 110.969 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.59 -61.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.194 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.4 p -95.44 11.35 33.18 Favored 'General case' 0 C--O 1.23 0.055 0 O-C-N 121.649 -0.657 . . . . 0.0 112.313 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.63 26.0 15.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -125.94 135.83 52.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.506 178.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.561 ' HG3' HG13 ' A' ' 24' ' ' VAL . 6.2 mp0 -96.54 158.27 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.545 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -158.9 161.32 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 1.9 p -120.15 128.63 25.74 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.545 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 8.6 Cg_endo -52.26 -47.0 29.14 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.412 2.741 . . . . 0.0 113.215 -170.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -125.62 -26.79 3.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 39' ' ' THR . 2.3 mp0 -68.96 -17.3 63.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.571 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.19 67.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.022 0.439 . . . . 0.0 110.526 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.69 -37.89 20.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.096 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -141.65 136.79 31.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.157 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.19 9.57 14.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.327 0.584 . . . . 0.0 110.5 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -82.07 115.67 21.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.071 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 t70 60.27 -150.66 0.42 Allowed 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.753 0.658 . . . . 0.0 109.226 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.69 -28.57 68.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.984 0.421 . . . . 0.0 111.067 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.27 10.87 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.609 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -64.22 -27.32 68.98 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.121 0.568 . . . . 0.0 112.053 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.558 HG23 HD13 ' A' ' 87' ' ' LEU . 14.4 p -61.47 138.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.034 -172.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.444 HD12 ' C ' ' A' ' 92' ' ' HIS . 6.3 mm -72.84 139.34 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.904 -172.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -126.48 154.44 43.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.11 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 8.3 m-20 -99.95 179.99 4.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.189 0.518 . . . . 0.0 111.467 -174.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 14.7 t -82.8 -13.02 56.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.023 0.916 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.478 HG11 ' HG3' ' A' ' 112' ' ' ARG . 2.0 p -89.24 -0.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.097 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 5.37 68.6 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.277 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.454 ' OD1' HG13 ' A' ' 51' ' ' VAL . 9.7 p30 -108.32 173.16 6.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.536 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.549 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.9 t -115.17 142.31 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.254 -175.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.728 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -98.7 -177.47 3.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 110.251 -177.623 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.445 ' HA ' HD11 ' A' ' 87' ' ' LEU . 14.5 tt0 -136.69 163.41 30.65 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 16.5 t70 -65.26 130.73 44.38 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.83 -6.96 82.71 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.351 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.87 165.24 20.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 61.4 m -103.81 137.2 42.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.575 HG22 HD22 ' A' ' 55' ' ' LEU . 1.6 pp -117.72 164.67 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' THR . 3.8 m -149.92 112.12 4.65 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -59.8 129.23 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.667 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.558 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -99.23 15.2 4.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.801 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.471 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.37 157.79 45.49 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -89.78 109.18 20.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 112.135 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.414 HD21 ' CD2' ' A' ' 110' ' ' PHE . 12.4 mt -124.59 152.44 43.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.25 177.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -95.81 178.52 5.42 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.997 -0.44 . . . . 0.0 111.291 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.11 130.81 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -74.82 128.53 35.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.837 0.351 . . . . 0.0 111.529 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.15 -13.12 3.6 Favored Glycine 0 CA--C 1.517 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.574 173.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.524 ' HB3' HD23 ' A' ' 74' ' ' LEU . 37.3 m -107.58 155.15 20.43 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.643 -0.328 . . . . 0.0 110.877 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -81.5 8.28 9.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.495 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 72' ' ' SER . 3.8 mm? -78.6 170.37 16.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.604 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -159.88 117.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.606 HG12 HG11 ' A' ' 63' ' ' VAL . 86.5 t -93.66 95.69 5.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 110.368 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 150.23 27.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.048 -175.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -49.94 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.948 0.88 . . . . 0.0 110.759 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.72 4.79 4.19 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.475 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.8 m -62.36 105.32 0.6 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.871 0.843 . . . . 0.0 110.059 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -89.27 112.68 23.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.75 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 96' ' ' CYS . 44.7 t -124.59 113.18 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.249 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.3 ptmt -96.12 167.76 11.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.763 -174.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.64 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 1.4 p-10 60.04 39.66 19.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.943 -1.48 . . . . 0.0 112.314 170.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.3 pt -64.18 179.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 -128.69 126.84 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.077 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.558 HD13 HG23 ' A' ' 46' ' ' VAL . 58.2 mt -80.58 120.16 24.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 93' ' ' ASP . 5.3 t -76.2 134.81 28.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.114 0.483 . . . . 0.0 110.742 -172.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.22 -58.9 6.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.371 -172.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.3 -46.35 2.82 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.319 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.535 ' O ' ' HB ' ' A' ' 88' ' ' VAL . 12.3 m-20 -75.65 132.29 40.49 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.444 ' C ' HD12 ' A' ' 47' ' ' ILE . 14.2 m-70 -80.74 47.91 1.02 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.466 0.65 . . . . 0.0 110.175 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.598 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.5 m-20 -120.6 178.87 4.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.473 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.635 ' CD1' HG21 ' A' ' 111' ' ' VAL . 66.7 mt -116.23 122.35 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.791 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.51 132.4 42.13 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.091 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.458 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -134.18 142.72 47.52 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -105.32 117.02 32.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.5 mt -117.28 113.33 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.167 -171.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.28 110.64 1.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 143.95 -62.19 0.5 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.815 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 -35.85 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 0.0 111.392 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.94 -147.88 19.46 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.66 147.02 23.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 111.065 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 61.2 ttp -144.46 165.87 26.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.881 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.98 148.01 34.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.897 0.38 . . . . 0.0 110.195 177.253 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.0 mt -130.08 140.37 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.912 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.45 ' HG3' ' OE1' ' A' ' 109' ' ' GLU . 9.3 tptp -80.0 115.07 19.37 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.675 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -50.36 -40.19 48.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 50' ' ' SER . 1.6 mp0 -69.6 -10.01 56.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.421 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.425 ' HD1' ' HB3' ' A' ' 107' ' ' LYS . 75.3 m-85 -112.09 -0.12 15.74 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 35.0 m -115.62 174.5 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.259 0.552 . . . . 0.0 112.163 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.478 ' HG3' HG11 ' A' ' 51' ' ' VAL . 19.9 ttt180 -143.22 131.78 22.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.273 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.728 ' HG3' ' HA ' ' A' ' 55' ' ' LEU . 1.9 tmtp? -70.43 119.97 15.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.381 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.25 -48.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.52 ' HA2' ' HE3' ' A' ' 113' ' ' LYS . . . 88.49 44.72 5.17 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.831 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.455 177.014 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HG3' HG23 ' A' ' 2' ' ' VAL . 11.7 ptm . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 121.745 0.783 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.48 HG23 ' HG3' ' A' ' 1' ' ' MET . 14.2 t -86.88 60.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 172.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -128.28 142.34 51.18 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.051 -168.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 t -132.6 30.39 4.11 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.608 HD13 HD22 ' A' ' 23' ' ' LEU . 17.8 mt -73.39 161.02 81.02 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.297 -1.319 . . . . 0.0 110.896 -174.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 36.6 Cg_endo -63.45 161.63 30.57 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.551 2.167 . . . . 0.0 111.808 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.536 ' HB3' ' HG3' ' A' ' 14' ' ' GLU . 11.5 Cg_exo -70.44 -170.7 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.775 2.316 . . . . 0.0 112.496 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.46 123.68 49.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.08 9.04 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.545 2.163 . . . . 0.0 111.866 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.581 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 48.8 mt-30 -119.42 -36.21 3.4 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.889 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -110.82 -46.99 3.28 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 121.265 0.555 . . . . 0.0 109.727 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.21 5.83 5.13 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.91 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 m -61.41 -27.5 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.043 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 7' ' ' PRO . 4.4 mt-10 78.06 13.54 1.63 Allowed 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 174.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -81.03 47.46 1.0 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.717 0.77 . . . . 0.0 109.039 170.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 m -99.18 147.12 25.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.961 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -148.08 173.92 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.43 116.05 31.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 0.0 110.582 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -96.94 28.27 3.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.049 0.928 . . . . 0.0 109.675 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.82 -99.7 0.41 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.546 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.27 17.64 22.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.916 0.389 . . . . 0.0 111.577 -173.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 31' ' ' GLU . 2.2 pt? -159.83 -176.67 5.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.608 HD22 HD13 ' A' ' 5' ' ' LEU . 3.5 mt -109.98 135.04 51.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -125.76 140.52 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 0.0 109.599 177.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 45.9 t -102.36 106.19 47.37 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.475 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 25' ' ' CYS . 33.9 Cg_endo -65.2 -14.66 46.3 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.679 2.253 . . . . 0.0 111.361 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.07 -59.36 2.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.891 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.1 p -99.08 10.14 42.07 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.59 39.85 20.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -139.47 126.72 21.32 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.585 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.47 164.66 11.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.778 177.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -163.99 162.05 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.489 . . . . 0.0 111.026 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 48.2 t -104.68 123.26 40.79 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.8 Cg_endo -56.82 -36.52 98.77 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.952 2.435 . . . . 0.0 113.112 -171.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -104.41 -43.89 5.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.225 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 42.0 tt0 -64.74 -27.38 68.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.355 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.75 -39.06 90.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.428 . . . . 0.0 110.602 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.53 -52.82 12.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.198 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 41' ' ' SER . 5.2 m -152.84 147.2 25.74 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.081 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . . . -135.08 7.69 3.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.658 0.742 . . . . 0.0 109.729 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.611 ' H ' HG22 ' A' ' 39' ' ' THR . 38.5 t -100.49 2.24 41.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.007 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -105.28 165.54 11.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.741 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.595 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 11.4 t70 -114.11 -47.68 2.93 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.11 -45.13 1.96 Allowed Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.767 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.661 ' HG3' HG23 ' A' ' 46' ' ' VAL . 20.1 pttm -100.28 -28.75 12.82 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.772 -0.252 . . . . 0.0 111.332 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.661 HG23 ' HG3' ' A' ' 45' ' ' LYS . 6.1 t -121.56 153.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.59 HG21 HG13 ' A' ' 94' ' ' ILE . 2.8 mm -91.66 135.23 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.667 ' O ' ' HB2' ' A' ' 108' ' ' SER . 11.7 ttmt -121.09 155.0 35.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 111' ' ' VAL . 9.0 m-20 -92.98 176.83 6.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.304 0.573 . . . . 0.0 111.449 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 13.5 t -79.0 -7.37 58.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.642 174.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.02 -15.37 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.347 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.98 0.39 60.16 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -83.45 162.67 20.89 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.901 0.857 . . . . 0.0 110.767 178.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.494 HG22 ' HE2' ' A' ' 48' ' ' LYS . 2.9 t -118.19 130.64 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.909 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.411 ' HB2' HD21 ' A' ' 87' ' ' LEU . 1.5 mm? -93.76 173.19 7.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.377 0.608 . . . . 0.0 110.645 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.29 150.72 48.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.692 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.583 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 17.7 t70 -67.43 99.14 0.71 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.449 . . . . 0.0 109.891 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 121.72 -7.45 10.27 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.385 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.67 167.96 14.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.698 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.5 m -106.45 131.65 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.795 HG13 HG23 ' A' ' 82' ' ' VAL . 1.9 pp -127.57 169.11 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.721 0.296 . . . . 0.0 110.311 -174.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.8 m -150.6 121.68 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.574 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -61.93 131.04 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 109.867 176.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.537 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -94.98 10.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 64' ' ' ILE . 58.1 mmtt -139.18 167.63 21.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 119.843 1.201 . . . . 0.0 110.034 -176.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.4 109.86 20.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.176 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 mp -123.95 138.54 54.45 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.466 173.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.02 177.7 5.66 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.651 -0.656 . . . . 0.0 110.265 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 72' ' ' SER . 39.0 t -128.83 120.98 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -84.77 -32.77 23.22 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.157 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.559 ' N ' ' HD3' ' A' ' 70' ' ' LYS . . . -86.4 -26.82 32.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.924 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.698 ' HB3' HD23 ' A' ' 74' ' ' LEU . 60.8 m -110.42 163.71 13.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 m -81.37 8.66 8.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.57 0.7 . . . . 0.0 109.96 173.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.93 172.35 13.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.107 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.4 t -159.35 113.81 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -166.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.495 HG12 HG11 ' A' ' 63' ' ' VAL . 94.8 t -90.97 96.78 6.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.828 0.823 . . . . 0.0 110.246 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.459 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.3 pptp? -106.04 148.2 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.54 96.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.974 0.893 . . . . 0.0 110.605 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA2' ' CG2' ' A' ' 62' ' ' THR . . . 133.09 4.76 3.21 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.005 -177.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' THR . 88.7 m -63.53 103.46 0.53 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.959 0.885 . . . . 0.0 109.956 176.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -92.29 115.3 27.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.654 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.795 HG23 HG13 ' A' ' 61' ' ' ILE . 2.6 m -120.04 119.87 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.808 0.813 . . . . 0.0 110.519 171.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.0 pttp -103.82 148.8 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.465 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.58 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 5.4 m-20 71.54 43.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.127 0.892 . . . . 0.0 111.284 176.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.31 -178.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 122.098 0.951 . . . . 0.0 113.016 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -129.74 124.69 34.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.867 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.475 HD13 HG13 ' A' ' 46' ' ' VAL . 71.3 mt -82.63 117.51 22.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.9 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -88.97 167.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.12 -173.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -79.25 70.76 5.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.687 1.232 . . . . 0.0 110.717 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.418 ' HA3' ' OD1' ' A' ' 93' ' ' ASP . . . -163.95 -167.53 24.58 Favored Glycine 0 C--N 1.296 -1.644 0 CA-C-N 113.22 -1.809 . . . . 0.0 112.773 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -102.66 -42.85 5.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.503 0.668 . . . . 0.0 110.903 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.412 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 83.3 m-70 -104.24 55.06 0.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.803 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.9 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 4.6 m-20 -137.8 88.67 2.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -160.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.59 HG13 HG21 ' A' ' 47' ' ' ILE . 30.5 mt -120.94 111.06 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.557 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 24.7 t70 -94.47 135.31 36.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 p -134.42 142.07 47.02 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.955 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -104.89 119.29 38.65 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.7 mt -118.72 108.81 25.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.292 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -54.66 126.17 22.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.382 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.87 -53.45 0.78 Allowed Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 102' ' ' GLY . 40.6 pt -112.18 -39.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.782 0.325 . . . . 0.0 110.961 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 135.3 -149.21 19.89 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.98 155.01 19.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.015 0.407 . . . . 0.0 110.863 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -147.21 161.93 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.431 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -107.69 146.89 31.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.26 142.18 50.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.398 0.618 . . . . 0.0 111.452 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -78.05 120.05 22.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.671 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.667 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.9 p -57.11 -34.57 68.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.988 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 50' ' ' SER . 4.8 pm0 -70.23 -7.22 40.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.421 ' O ' HD13 ' A' ' 64' ' ' ILE . 55.0 m-85 -112.75 3.63 16.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 49' ' ' ASP . 29.1 m -110.48 166.53 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.422 0.63 . . . . 0.0 112.531 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -141.3 133.51 27.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.356 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.491 ' HE3' ' CA ' ' A' ' 115' ' ' GLY . 33.0 tttp -65.95 139.49 58.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.22 -42.78 8.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.491 ' CA ' ' HE3' ' A' ' 113' ' ' LYS . . . 79.54 29.56 48.24 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.143 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.85 176.816 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptm . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.176 0.512 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.2 t -76.53 115.02 17.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.512 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -150.73 116.68 5.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.135 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.631 HG23 ' HG ' ' A' ' 5' ' ' LEU . 1.7 t -79.65 -36.11 38.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.543 0.687 . . . . 0.0 109.989 175.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.631 ' HG ' HG23 ' A' ' 4' ' ' THR . 21.9 mt -82.94 168.7 21.2 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.59 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 63.2 Cg_endo -68.88 154.61 70.68 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 121.552 1.501 . . . . 0.0 110.741 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 7.7 Cg_exo -71.77 -165.78 0.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.669 2.246 . . . . 0.0 112.294 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.7 t -97.75 123.26 52.41 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.046 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.39 11.21 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.895 2.397 . . . . 0.0 111.739 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 46.6 mt-30 -122.22 -37.68 2.79 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.891 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -107.09 -49.12 3.34 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.247 0.546 . . . . 0.0 109.721 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 70.51 -3.73 1.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.249 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 8.3 t -54.68 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.371 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 13' ' ' SER . 11.3 pt-20 171.68 -8.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 96.7 m-85 -78.8 35.42 0.24 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 112.017 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -97.82 134.98 40.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.307 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 27.5 p90 -145.52 171.66 14.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.12 123.22 46.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.067 0.46 . . . . 0.0 110.916 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.69 84.08 2.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.02 -114.03 4.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.225 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.93 20.66 18.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -171.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.72 -174.82 4.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.495 HD22 HD13 ' A' ' 5' ' ' LEU . 35.0 mt -110.58 135.61 50.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -126.31 140.65 48.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.792 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -107.49 106.22 57.88 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.176 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.3 Cg_endo -68.46 -14.31 39.58 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.704 2.27 . . . . 0.0 110.79 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.601 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 32.6 tt0 -66.09 -58.78 4.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.076 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.18 8.74 36.31 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.46 49.36 13.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.429 0.559 . . . . 0.0 112.112 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -147.72 128.09 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 175.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.01 171.62 8.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -168.75 162.16 11.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.452 ' CB ' ' HB2' ' A' ' 36' ' ' GLU . 5.9 m -119.81 116.31 33.08 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.63 -37.19 98.15 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.319 2.68 . . . . 0.0 113.106 -170.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -112.51 -37.85 4.82 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.657 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.452 ' HB2' ' CB ' ' A' ' 33' ' ' SER . 20.7 mp0 -70.0 -15.47 63.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.66 -171.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.34 -49.98 8.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.088 0.471 . . . . 0.0 110.8 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.11 -37.14 46.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.33 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 40' ' ' ALA . 2.0 m -103.74 173.71 6.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.549 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' H ' HG22 ' A' ' 39' ' ' THR . . . -58.33 143.19 45.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.4 m -84.8 7.86 19.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.145 0.498 . . . . 0.0 111.307 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.59 155.39 22.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.441 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.5 t70 179.38 -37.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.686 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.96 47.56 0.28 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.314 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 3.3 mmpt? -97.05 -9.37 28.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.808 0.337 . . . . 0.0 110.846 -175.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.501 HG13 HD13 ' A' ' 87' ' ' LEU . 2.6 t -121.87 136.49 58.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.045 0.45 . . . . 0.0 110.96 -174.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 93' ' ' ASP . 2.5 mm -105.32 141.22 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.058 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -105.03 165.79 10.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.0 111.739 -178.102 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.9 m-20 -109.97 172.7 6.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.784 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 64' ' ' ILE . 36.1 t -77.22 -7.46 55.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.441 HG11 ' HG3' ' A' ' 112' ' ' ARG . 2.4 p -93.2 0.31 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.257 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 4.08 69.86 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.285 171.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.435 ' OD1' HG13 ' A' ' 51' ' ' VAL . 8.6 p30 -105.02 168.25 9.17 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.829 -0.748 . . . . 0.0 112.14 -178.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 46' ' ' VAL . 2.4 t -113.66 137.08 48.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.847 -174.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 61' ' ' ILE . 9.2 mt -89.88 172.84 8.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.581 0.705 . . . . 0.0 112.097 -171.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -121.84 142.63 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.571 173.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.635 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 6.4 t70 -67.03 105.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.041 0.448 . . . . 0.0 110.375 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.424 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 114.49 -0.84 23.55 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -80.2 174.25 11.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.306 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 26.9 m -102.56 139.18 38.49 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.6 HG22 HD22 ' A' ' 55' ' ' LEU . 2.1 pp -118.66 165.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 m -147.97 118.39 7.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.835 0.35 . . . . 0.0 110.084 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.662 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.22 127.51 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.793 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.42 19.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.793 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.1 mptp? -135.62 163.93 29.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.436 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.6 p-10 -86.83 113.39 22.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.933 0.873 . . . . 0.0 111.72 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 66' ' ' ASP . 18.3 mt -125.4 148.05 48.94 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.98 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -98.31 177.12 5.47 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.8 170.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 72' ' ' SER . 57.3 t -125.15 131.42 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -83.1 -38.96 21.75 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.48 -25.03 59.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.254 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 69' ' ' VAL . 71.8 m -115.11 171.6 7.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.234 0.54 . . . . 0.0 111.774 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.0 t -92.07 1.9 56.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.398 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 101' ' ' ILE . 10.7 mp -79.68 136.49 36.81 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.464 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.03 133.69 43.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.006 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.662 HG12 HG11 ' A' ' 63' ' ' VAL . 53.5 t -89.03 100.56 10.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.615 0.722 . . . . 0.0 109.925 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -105.18 150.44 25.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.721 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -51.31 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.848 0.832 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.13 4.82 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.16 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.0 m -61.29 105.45 0.5 Allowed 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 122.147 0.975 . . . . 0.0 110.129 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 36.3 ttpt -90.84 114.24 26.61 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.206 -173.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 96' ' ' CYS . 21.5 t -123.72 117.26 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.027 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 11.3 ptmm? -99.92 154.03 18.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.558 -173.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.424 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 16.2 m-80 64.25 50.01 2.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.685 175.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.8 pt -65.66 177.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.826 0.822 . . . . 0.0 112.725 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.635 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 10.3 tpt180 -131.69 125.52 32.3 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.076 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD13 HG13 ' A' ' 46' ' ' VAL . 36.3 mt -84.25 118.33 24.1 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.542 ' O ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -100.06 179.16 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.48 -175.208 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.14 93.91 7.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.15 0.976 . . . . 0.0 111.915 -171.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.52 -174.43 37.21 Favored Glycine 0 C--N 1.298 -1.547 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.403 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.12 -20.51 14.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.782 0.791 . . . . 0.0 110.578 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -106.61 47.86 0.86 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.031 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.3 m-20 -142.0 89.81 2.21 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -160.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.596 ' CD1' HG21 ' A' ' 111' ' ' VAL . 50.5 mt -121.22 116.49 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.388 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 30.8 t70 -93.96 128.42 40.27 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.77 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.823 ' HB2' HG11 ' A' ' 82' ' ' VAL . 25.3 p -130.86 137.12 49.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.071 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -107.72 118.85 37.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.84 108.27 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 -171.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -63.93 107.61 1.28 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.434 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.27 -45.04 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.394 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.45 HD13 HD22 ' A' ' 74' ' ' LEU . 15.6 pt -120.29 -37.54 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.87 0.366 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.27 -153.33 21.85 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.26 151.92 21.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.092 0.446 . . . . 0.0 110.503 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.8 ttp -143.15 164.17 30.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.95 147.92 37.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 0.0 110.379 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 90.1 mt -129.52 144.01 51.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.791 -171.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -81.5 120.44 25.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.279 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.71 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 2.5 m -50.89 -36.91 40.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.328 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' SER . 42.8 mt-10 -71.32 -5.4 32.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.435 ' CG ' HD11 ' A' ' 67' ' ' LEU . 55.0 m-85 -114.36 -2.75 13.2 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.857 -0.737 . . . . 0.0 112.749 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 94' ' ' ILE . 34.8 m -113.72 172.7 3.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 25.0 ttt180 -151.74 133.94 15.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.582 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.408 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.4 tttt -65.28 123.16 18.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.19 174.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.47 -51.91 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.871 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.16 39.06 16.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.318 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.389 179.172 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.927 0.394 . . . . 0.0 111.698 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 p -118.48 111.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.383 0.611 . . . . 0.0 110.569 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.6 m -75.69 142.34 42.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.903 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.2 p -97.84 0.64 47.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.349 -175.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.412 HD11 ' CD ' ' A' ' 18' ' ' GLU . 55.2 mt -110.29 158.77 34.33 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.97 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.2 Cg_endo -71.49 157.45 56.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.1 1.867 . . . . 0.0 110.688 174.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 19.0 Cg_exo -66.6 -174.64 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.093 . . . . 0.0 113.258 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.764 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 34.3 t -99.6 123.22 48.76 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HG2' ' OE1' ' A' ' 10' ' ' GLN . 39.2 Cg_endo -70.01 7.27 1.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 121.887 1.725 . . . . 0.0 112.059 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.764 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 1.2 mp0 -103.0 -54.26 2.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.307 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.414 ' C ' ' H ' ' A' ' 13' ' ' SER . 28.4 p -117.77 -28.29 6.01 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.0 t30 75.88 -28.55 0.18 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.287 0.635 . . . . 0.0 112.287 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 63.5 p -32.5 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.574 1.171 . . . . 0.0 113.401 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.0 pt-20 169.35 -4.93 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.533 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.6 m-85 -81.16 42.41 0.65 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.27 0.557 . . . . 0.0 111.747 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -109.26 148.56 30.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.853 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -150.09 174.1 13.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.2 pm0 -102.77 115.61 30.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.377 0.608 . . . . 0.0 111.268 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.514 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 10.7 t70 -122.86 83.65 2.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.824 174.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.97 -126.38 8.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.336 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.47 17.61 23.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.962 0.41 . . . . 0.0 111.372 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.7 -174.07 4.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.1 mt -120.23 136.82 54.52 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.808 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -125.12 143.58 38.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.259 -179.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.1 t -104.22 104.21 42.84 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 23.0 Cg_endo -61.49 -22.1 73.64 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.843 2.362 . . . . 0.0 111.179 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 17.0 tp10 -74.15 -59.7 2.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.7 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.2 m -74.48 -9.91 59.05 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.72 44.83 25.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.314 0.578 . . . . 0.0 110.433 -170.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -145.1 122.94 11.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.808 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.6 mp0 -91.62 157.92 16.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.787 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -158.3 163.13 37.67 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.534 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 22.6 t -125.5 124.41 25.05 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.57 -30.96 90.36 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.075 2.517 . . . . 0.0 113.023 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -111.86 -29.89 7.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.626 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 28.3 tt0 -90.04 -4.62 57.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.474 -173.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.22 -32.91 74.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 111.074 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.11 70.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.794 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 m 69.96 -73.85 0.09 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.226 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.86 113.49 3.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.225 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.1 m -82.59 90.17 6.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.337 0.589 . . . . 0.0 110.237 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.56 150.52 47.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.455 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -118.98 81.46 1.7 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.449 0.642 . . . . 0.0 110.513 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.28 41.88 2.04 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.447 170.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -104.26 -20.23 13.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.716 0.294 . . . . 0.0 110.985 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 87' ' ' LEU . 12.2 p -146.01 139.83 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.63 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.499 HD13 ' C ' ' A' ' 90' ' ' GLY . 2.0 mm -78.79 117.01 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.429 -173.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 108' ' ' SER . 1.2 mtmt -100.01 150.11 22.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.092 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.573 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 9.2 m-20 -90.5 176.64 6.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.516 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.6 t -77.09 -7.97 56.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.722 0.772 . . . . 0.0 110.761 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.492 HG11 ' HG3' ' A' ' 112' ' ' ARG . 2.1 p -97.3 -2.25 10.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.18 0.99 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.01 3.92 79.06 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.976 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.448 ' OD1' HG13 ' A' ' 51' ' ' VAL . 3.0 p30 -92.91 154.76 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.685 0.743 . . . . 0.0 111.017 177.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.3 109.94 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.612 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 113' ' ' LYS . 94.2 mt -58.76 145.7 39.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.383 175.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -120.51 148.94 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.709 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 1.2 t70 -63.94 126.36 27.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 88.66 2.01 79.63 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.816 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 173.64 12.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.967 0.383 . . . . 0.0 110.473 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 11.4 m -101.59 139.82 36.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.569 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.45 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -124.47 165.39 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.448 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.7 m -150.61 115.6 5.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.438 175.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.679 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.07 129.97 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.086 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.543 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -103.06 17.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.468 178.409 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.444 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.26 161.44 34.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.5 p-10 -85.55 111.31 19.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.938 0.875 . . . . 0.0 111.156 169.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.475 HD11 ' CB ' ' A' ' 110' ' ' PHE . 20.1 mt -124.43 133.88 53.25 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.145 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -88.28 173.2 8.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.749 -0.594 . . . . 0.0 109.963 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 72' ' ' SER . 21.7 t -128.92 120.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -93.36 -2.83 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.475 -170.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.14 26.31 6.45 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.485 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 58.2 m -146.49 -177.69 5.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -177.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -100.87 -12.12 19.25 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 101' ' ' ILE . 9.8 mp -79.22 142.45 36.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.786 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.98 126.64 67.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.359 167.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.679 HG12 HG11 ' A' ' 63' ' ' VAL . 76.0 t -77.73 104.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.44 150.39 26.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.448 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.543 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -52.34 96.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 121.776 0.798 . . . . 0.0 110.501 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.32 4.13 3.68 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.23 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' THR . 89.8 m -62.76 105.1 0.61 Allowed 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.478 0.656 . . . . 0.0 110.67 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -91.07 120.53 32.11 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.551 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 96' ' ' CYS . 59.8 t -129.7 116.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.745 174.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.8 pttm -102.92 159.51 15.43 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.253 -175.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.589 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 19.3 m120 65.25 48.53 2.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.453 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.9 pt -67.94 -178.95 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 11.1 tpp85 -136.44 124.39 22.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.602 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HB3' HG12 ' A' ' 47' ' ' ILE . 36.9 mt -79.83 125.38 29.63 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.042 -0.411 . . . . 0.0 110.086 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -105.74 121.68 58.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.107 -177.398 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 69.51 -0.76 2.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.594 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.499 ' C ' HD13 ' A' ' 47' ' ' ILE . . . 57.99 0.98 0.53 Allowed Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.178 -169.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 92' ' ' HIS . 31.2 t70 -104.16 -98.32 0.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.493 ' HB2' ' OD2' ' A' ' 91' ' ' ASP . 1.5 t60 -109.67 53.6 0.68 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -166.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.3 m-20 -173.28 143.17 1.07 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -165.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.533 ' CD1' HG21 ' A' ' 111' ' ' VAL . 27.7 mt -139.36 115.17 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.07 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 20.5 t70 -92.73 133.99 35.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.313 0.578 . . . . 0.0 110.349 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.553 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -142.8 154.31 44.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.602 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 96.1 mttt -125.46 132.22 52.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mt -122.38 113.63 39.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.705 -167.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.75 100.69 0.95 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.215 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.75 -62.91 0.42 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.558 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 74' ' ' LEU . 20.0 pt -95.9 -46.19 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.986 0.422 . . . . 0.0 110.483 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 141.76 -155.82 25.56 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.607 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -81.85 144.75 30.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.757 0.279 . . . . 0.0 110.801 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.3 ttt -138.52 158.83 43.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 110.827 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.2 OUTLIER -111.16 137.17 49.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.816 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 86.3 mt -123.85 142.01 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.493 0.664 . . . . 0.0 111.455 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 6.5 mptt -92.9 121.24 34.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.256 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.3 p -51.88 -37.56 52.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.172 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -72.06 -6.75 44.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.844 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.475 ' CB ' HD11 ' A' ' 67' ' ' LEU . 60.5 m-85 -111.71 -4.13 14.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.891 -0.506 . . . . 0.0 111.995 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 34.8 m -114.88 175.36 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.492 ' HG3' HG11 ' A' ' 51' ' ' VAL . 26.7 ttt180 -151.46 130.98 12.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.423 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.479 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.1 tttt -66.63 122.21 17.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.338 175.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.44 -44.28 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.271 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.87 9.81 85.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.298 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.85 -178.51 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.562 HD13 HD22 ' A' ' 23' ' ' LEU . 11.2 mt . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 41.8 Cg_endo -64.89 160.01 43.19 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.319 2.013 . . . . 0.0 111.423 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.78 -169.69 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.079 1.853 . . . . 0.0 112.161 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 8.4 t -97.35 123.61 52.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.19 11.31 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.961 2.441 . . . . 0.0 111.806 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.491 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 37.8 mt-30 -122.73 -34.7 3.18 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.9 m -112.68 -45.13 3.25 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.785 -0.572 . . . . 0.0 110.489 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 12.91 7.49 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.02 0.914 . . . . 0.0 110.511 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.602 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 20.9 p -67.12 -32.19 73.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.926 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 84.85 5.76 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.011 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.602 ' HD1' ' HB2' ' A' ' 13' ' ' SER . 83.7 m-85 -82.7 47.32 1.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.689 0.757 . . . . 0.0 109.804 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -102.65 150.23 23.65 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.121 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.4 p90 -142.0 169.11 18.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.68 117.78 35.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.178 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.532 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 t70 -110.04 74.76 0.9 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.99 -102.8 2.72 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.208 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.85 18.69 15.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.08 -175.42 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 5' ' ' LEU . 5.8 mt -108.93 133.99 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 31' ' ' GLU . 49.9 t -118.66 128.04 75.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 52.3 t -97.9 108.34 45.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.33 -7.21 20.84 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.596 2.197 . . . . 0.0 111.387 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.4 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 48.2 tt0 -79.22 -67.48 0.75 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.65 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.05 9.19 29.0 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.297 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.14 46.79 12.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 112.007 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.428 ' HB3' HE22 ' A' ' 10' ' ' GLN . 2.2 t-160 -144.18 125.91 15.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.415 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.484 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -93.44 149.03 21.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.553 176.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -153.27 161.84 41.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -119.58 129.94 25.1 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.484 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 12.0 Cg_endo . . . . . 0 C--N 1.344 0.305 0 C-N-CA 122.893 2.396 . . . . 0.0 112.826 -170.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.59 HG13 HD13 ' A' ' 87' ' ' LEU . 6.2 t . . . . . 0 N--CA 1.456 -0.172 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -69.69 119.37 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.191 0.307 . . . . 0.0 110.655 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.7 OUTLIER -106.78 146.35 30.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.524 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.47 ' OD1' HG23 ' A' ' 111' ' ' VAL . 12.8 m-20 -90.0 175.51 7.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.621 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 7.0 t -74.37 -4.0 33.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.094 0.95 . . . . 0.0 110.12 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.493 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.5 t -87.88 -14.42 9.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.0 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.77 7.97 68.03 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.823 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.493 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -104.48 164.54 11.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.678 178.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.443 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.7 t -109.65 140.14 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.045 -173.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.598 HD22 HG22 ' A' ' 61' ' ' ILE . 24.9 mt -95.73 172.73 7.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.332 0.587 . . . . 0.0 111.136 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.436 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.3 tt0 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.712 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.497 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 13.6 t70 -69.13 94.96 0.71 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.193 0.52 . . . . 0.0 109.617 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.65 -11.0 6.72 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.2 t70 -72.04 169.51 15.82 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.304 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 83' ' ' LYS . 3.0 m -100.49 135.43 41.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.598 HG22 HD22 ' A' ' 55' ' ' LEU . 1.8 pp -121.42 163.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.0 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -150.27 119.91 7.0 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.172 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.875 HG11 HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -60.76 128.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.55 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -98.92 17.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 4.3 mptp? -142.09 166.57 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.547 -0.721 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -77.12 105.89 8.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.102 0.953 . . . . 0.0 111.101 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 2.4 mm? -114.84 126.44 54.82 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.675 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.87 171.7 14.18 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.407 HG11 ' HB2' ' A' ' 72' ' ' SER . 40.2 t -126.78 120.56 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.51 -45.0 69.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.64 -10.39 57.95 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.932 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.407 ' HB2' HG11 ' A' ' 69' ' ' VAL . 26.1 m -111.93 153.65 26.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.951 0.405 . . . . 0.0 111.144 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -71.04 -12.01 61.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.9 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mp -79.44 137.92 37.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.213 0.53 . . . . 0.0 111.121 -174.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.13 127.21 66.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.193 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.875 HG12 HG11 ' A' ' 63' ' ' VAL . 69.7 t -81.97 116.42 26.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.479 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -109.07 149.2 29.64 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.516 -176.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -50.04 97.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.838 0.828 . . . . 0.0 110.266 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.69 3.43 5.05 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.081 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 m -62.57 105.76 0.68 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 122.071 0.938 . . . . 0.0 110.163 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -88.36 116.85 26.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 -174.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 61' ' ' ILE . 93.5 t -129.09 110.16 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.781 ' HB3' HG23 ' A' ' 60' ' ' THR . 26.2 pttm -102.07 165.77 10.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.908 0.385 . . . . 0.0 111.624 -174.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.555 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 63.57 44.06 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.739 175.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 55' ' ' LEU . 39.6 pt -65.83 174.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.048 0.928 . . . . 0.0 113.064 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 2.2 tpp180 -122.56 123.93 42.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.941 -1.482 . . . . 0.0 108.236 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 HG13 ' A' ' 46' ' ' VAL . 42.5 mt -83.0 119.39 24.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--N 1.319 -0.726 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 88' ' ' VAL . 9.4 m-20 . . . . . 0 N--CA 1.464 0.26 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.822 HG13 HG21 ' A' ' 47' ' ' ILE . 3.9 mp -110.55 116.6 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 170.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 28.1 t70 -94.1 130.36 40.3 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.47 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -144.22 154.58 43.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.567 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 98.7 mttt -121.18 129.5 53.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.0 mt -121.37 118.93 57.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.419 -170.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.11 120.91 8.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.743 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.35 -80.77 0.31 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 102' ' ' GLY . 26.1 pt -74.93 -46.03 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.733 0.301 . . . . 0.0 111.476 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 137.27 -150.84 20.86 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.89 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.86 146.82 24.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.656 0.265 . . . . 0.0 110.85 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.9 ttt -142.31 163.39 32.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.236 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.25 140.03 49.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.6 mt -120.04 144.1 47.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.121 0.486 . . . . 0.0 111.419 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 16.9 ttmt -80.89 118.76 22.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.977 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.689 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 3.3 m -49.08 -37.59 21.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.48 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 50' ' ' SER . 27.7 mt-10 -72.08 -8.62 55.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.279 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.454 ' CG ' HD21 ' A' ' 67' ' ' LEU . 33.9 m-85 -113.46 -0.62 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.174 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 21.9 m -113.51 171.69 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.798 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.483 ' HD2' HG21 ' A' ' 51' ' ' VAL . 13.5 ttt180 -150.29 138.21 20.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.641 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 113' ' ' LYS . 26.5 ttpt -62.88 117.11 5.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.857 165.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -55.59 -56.05 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.14 -0.05 13.03 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.325 176.431 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.572 HD13 HD22 ' A' ' 23' ' ' LEU . 31.9 mt . . . . . 0 C--O 1.233 0.202 0 N-CA-C 110.56 -0.163 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 61.1 Cg_endo -69.43 158.35 57.72 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.868 1.712 . . . . 0.0 110.742 171.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 6.5 Cg_exo -73.06 -167.51 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.461 2.107 . . . . 0.0 112.4 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.4 t -98.36 125.68 42.34 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.522 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.44 7.76 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.804 2.336 . . . . 0.0 112.314 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.452 HE22 ' HB3' ' A' ' 30' ' ' HIS . 36.9 mt-30 -119.36 -38.44 3.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.8 m -107.23 -46.95 3.77 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.311 0.577 . . . . 0.0 109.917 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.36 0.81 2.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.414 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 m -57.88 -77.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.354 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 171.15 -21.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 73.2 m-85 -78.87 36.99 0.29 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -167.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -101.01 144.34 30.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.263 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -146.12 173.41 12.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.453 ' CD ' HD11 ' A' ' 5' ' ' LEU . 1.2 pm0 -101.7 119.42 38.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.575 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 15.7 t70 -120.18 75.42 1.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.12 -119.64 6.58 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.903 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.64 16.46 25.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.723 0.297 . . . . 0.0 111.72 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.6 pt? -152.24 -176.54 5.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.737 0.303 . . . . 0.0 110.293 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 5' ' ' LEU . 17.0 mt -111.69 130.7 55.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.17 127.94 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.2 t -102.6 103.98 35.56 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -70.07 -9.86 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.836 2.357 . . . . 0.0 110.65 176.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.624 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 74.0 tt0 -70.08 -65.02 0.78 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.991 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -95.12 11.41 32.31 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 43.69 19.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 111.824 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.452 ' HB3' HE22 ' A' ' 10' ' ' GLN . 54.3 t60 -150.1 136.33 18.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.928 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -107.63 166.77 10.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -162.3 161.85 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.9 t -112.93 124.73 31.06 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.57 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.5 Cg_endo . . . . . 0 C--N 1.345 0.39 0 C-N-CA 123.304 2.669 . . . . 0.0 113.815 -168.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 87' ' ' LEU . 2.8 t . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.61 HD11 ' O ' ' A' ' 88' ' ' VAL . 3.1 mm -91.17 138.1 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.5 ttmt -121.06 149.49 42.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.316 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.588 ' OD1' HG23 ' A' ' 111' ' ' VAL . 6.8 m-20 -90.05 -179.79 5.77 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.273 0.559 . . . . 0.0 111.542 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 28.4 t -83.85 -3.21 57.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.014 0.911 . . . . 0.0 110.005 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.503 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 4.6 t -92.39 -14.42 8.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.819 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.62 3.28 59.67 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.688 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.594 ' ND2' ' H ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -87.68 163.39 16.57 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.933 0.873 . . . . 0.0 111.423 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 48' ' ' LYS . 2.6 t -117.69 135.18 58.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.663 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 87' ' ' LEU . 1.4 mm? -95.79 -157.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 111.278 -172.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 5.9 tt0 -159.56 146.34 16.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -70.59 97.85 1.39 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.811 0.815 . . . . 0.0 110.012 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 125.34 -6.6 8.09 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.941 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.592 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 40.9 t0 -73.87 167.8 20.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.719 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.2 m -110.88 134.2 52.74 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.47 171.86 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 6.0 m -150.12 119.34 6.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.789 0.328 . . . . 0.0 111.56 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.651 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -59.82 132.16 24.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 122.886 0.474 . . . . 0.0 110.155 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.727 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -104.68 19.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.727 ' HD2' HG12 ' A' ' 64' ' ' ILE . 4.9 mptp? -138.26 161.88 35.76 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -84.83 101.4 12.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.294 171.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.434 HD21 ' CG ' ' A' ' 110' ' ' PHE . 6.3 mp -112.96 145.66 40.41 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.86 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.37 173.97 8.42 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.876 0.369 . . . . 0.0 111.238 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 60.7 t -126.68 137.78 56.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -104.03 138.51 40.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.97 -37.45 3.5 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.36 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -110.56 155.62 22.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -80.35 -0.96 39.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 2.2 mm? -80.91 141.64 34.36 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.195 0.521 . . . . 0.0 111.409 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.2 t -112.71 134.83 54.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.466 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.651 HG12 HG11 ' A' ' 63' ' ' VAL . 78.6 t -83.68 99.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.028 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.15 148.64 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.265 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.98 96.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 122.038 0.923 . . . . 0.0 111.063 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.93 3.95 3.47 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.123 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.1 m -62.17 104.5 0.49 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.522 0.677 . . . . 0.0 110.294 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -87.17 116.2 25.08 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.651 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.594 HG11 ' HB2' ' A' ' 96' ' ' CYS . 18.2 t -125.31 116.58 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 pttm -104.71 162.51 13.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.564 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 74.6 m-20 66.81 38.65 3.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.341 170.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.5 pt -67.58 -178.72 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 122.168 0.985 . . . . 0.0 113.486 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 16.5 tpp180 -130.05 129.63 43.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.611 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.505 HD13 HG13 ' A' ' 46' ' ' VAL . 82.3 mt -84.88 123.74 30.82 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.765 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.318 -0.798 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.765 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.4 m-20 . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 106' ' ' LEU . 51.6 mt -125.96 117.41 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.328 0.585 . . . . 0.0 111.334 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 26.2 t70 -94.57 131.97 39.76 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.544 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.594 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.8 p -134.16 138.83 45.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.857 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -112.58 127.13 56.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.11 109.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.893 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.58 94.98 2.23 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.42 -56.39 0.31 Allowed Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.207 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.465 HG21 HD21 ' A' ' 74' ' ' LEU . 48.1 pt -104.39 -42.28 7.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.339 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 143.09 -158.87 27.35 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.024 -0.607 . . . . 0.0 111.698 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.2 144.42 26.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.728 0.299 . . . . 0.0 110.629 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.3 tpt -134.64 155.58 50.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.856 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.45 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -101.41 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.915 177.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 99.0 mt -130.85 136.6 48.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.674 0.75 . . . . 0.0 111.504 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.61 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 30.9 mttm -84.82 114.68 22.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.463 175.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.723 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.7 p -53.5 -35.76 60.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.137 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.61 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 5.9 pt-20 -61.31 -14.73 29.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.497 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.453 ' O ' HD13 ' A' ' 64' ' ' ILE . 56.6 m-85 -112.72 2.3 16.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.969 -0.457 . . . . 0.0 112.224 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.686 HG22 ' HA ' ' A' ' 108' ' ' SER . 17.8 m -114.14 170.3 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.38 0.609 . . . . 0.0 112.297 -173.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.495 ' HB2' HG21 ' A' ' 51' ' ' VAL . 7.5 ttt180 -142.09 141.22 32.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.291 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.594 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 36.1 tttp -71.03 140.76 50.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.369 176.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.0 t -105.03 -49.41 9.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.285 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.78 31.45 73.07 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.814 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.992 179.812 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.684 0.278 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.78 161.48 45.28 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.501 2.134 . . . . 0.0 111.201 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.28 -167.03 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.354 2.036 . . . . 0.0 111.769 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 10.7 t -98.47 129.2 30.89 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.628 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.98 8.47 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.581 2.188 . . . . 0.0 111.34 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.633 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 13.3 mt-30 -119.36 -38.45 3.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.555 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.4 m -108.63 -52.89 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.589 0.709 . . . . 0.0 109.53 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 71.76 3.22 4.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.474 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.684 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 14.8 m -59.5 -77.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.615 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 13' ' ' SER . 16.3 pt-20 176.91 -15.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.518 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 25.8 m-85 -81.81 32.74 0.37 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.386 0.539 . . . . 0.0 112.007 -169.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -91.9 135.72 33.71 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.0 p90 -143.62 170.07 16.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -98.66 118.92 36.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.722 0.296 . . . . 0.0 111.296 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.536 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 32.9 t70 -123.3 86.15 2.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 171.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.61 -111.79 3.99 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.406 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.1 18.86 18.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.7 -175.08 5.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 110.39 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 32' ' ' TRP . 43.9 mt -110.1 131.24 55.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.633 174.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG13 ' HG3' ' A' ' 31' ' ' GLU . 57.6 t -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.949 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 41.7 t -104.24 103.16 37.09 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.2 Cg_endo -69.73 -15.43 37.18 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.366 2.044 . . . . 0.0 109.645 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.949 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 28.2 tt0 -64.16 -44.46 92.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.657 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.414 ' SG ' ' NE2' ' A' ' 10' ' ' GLN . 22.4 p -118.06 11.83 13.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 171.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.21 47.19 14.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.438 ' HB3' HE22 ' A' ' 10' ' ' GLN . 38.0 t-80 -143.61 131.49 21.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.493 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HG3' HG13 ' A' ' 24' ' ' VAL . 2.0 mp0 -91.73 145.34 24.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.446 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.445 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -150.16 160.99 43.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.222 0.534 . . . . 0.0 110.933 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.8 t -118.15 124.51 28.61 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 18.3 Cg_endo . . . . . 0 C--N 1.34 0.106 0 C-N-CA 122.672 2.248 . . . . 0.0 111.745 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.577 HG13 HD13 ' A' ' 87' ' ' LEU . 10.3 t . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.512 HD11 ' O ' ' A' ' 88' ' ' VAL . 2.2 mm -101.34 140.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -107.13 179.71 4.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.886 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.792 ' OD2' HD11 ' A' ' 55' ' ' LEU . 84.0 m-20 -120.35 -179.65 4.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.26 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 8.6 t -75.44 -6.44 50.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.257 1.027 . . . . 0.0 109.161 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.53 HG21 ' HD2' ' A' ' 112' ' ' ARG . 4.2 t -92.53 -15.55 8.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.884 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.38 -1.4 76.32 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.2 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.518 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -88.54 161.04 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.237 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 48' ' ' LYS . 16.6 t -115.04 135.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.48 -173.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.792 HD11 ' OD2' ' A' ' 49' ' ' ASP . 3.1 mp -103.18 -178.19 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 110.853 -168.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.533 ' HA ' HD11 ' A' ' 87' ' ' LEU . 8.5 tt0 -132.07 157.82 43.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.425 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.401 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 16.7 p-10 -73.87 133.85 43.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 172.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 90.07 -9.47 77.25 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.573 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.06 169.2 18.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.709 0.29 . . . . 0.0 110.909 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 4.6 m -105.02 135.98 45.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CG2' HD13 ' A' ' 85' ' ' ILE . 1.8 pp -124.04 168.96 15.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.8 m -150.14 117.92 6.22 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.48 0.312 . . . . 0.0 110.675 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.715 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.01 131.24 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 176.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.523 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -100.11 16.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -135.73 158.15 45.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -85.94 104.83 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.983 0.897 . . . . 0.0 111.361 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD11 ' CB ' ' A' ' 110' ' ' PHE . 18.5 mt -119.98 146.44 45.84 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.474 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -85.62 175.13 8.94 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.378 0.608 . . . . 0.0 111.415 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 76' ' ' VAL . 85.3 t -120.99 128.82 76.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -92.08 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.314 0.506 . . . . 0.0 110.635 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.35 -21.22 22.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.588 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -115.95 157.94 23.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -87.59 5.47 39.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.039 0.447 . . . . 0.0 110.867 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.73 136.6 34.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.565 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.32 134.79 44.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.166 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.715 HG12 HG11 ' A' ' 63' ' ' VAL . 59.2 t -85.92 101.71 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.536 0.684 . . . . 0.0 109.665 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.65 148.46 25.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.438 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.92 96.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.874 0.845 . . . . 0.0 110.647 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.415 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.04 6.22 4.06 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.9 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.0 m -62.19 103.97 0.43 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.695 0.76 . . . . 0.0 109.669 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.75 111.85 23.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 96' ' ' CYS . 46.2 t -117.62 115.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 50.1 pttt -101.8 149.87 23.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.779 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 46.7 m-80 68.91 48.05 0.75 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.098 0.874 . . . . 0.0 111.245 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.605 HG22 ' SG ' ' A' ' 96' ' ' CYS . 44.5 pt -66.58 -175.53 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 122.064 0.935 . . . . 0.0 112.085 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -136.24 129.21 31.22 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.276 173.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.577 HD13 HG13 ' A' ' 46' ' ' VAL . 60.9 mt -83.06 122.55 28.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.512 ' O ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.311 -1.082 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.355 -176.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.467 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.9 m-20 . . . . . 0 C--O 1.222 -0.38 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.634 ' CD1' HG21 ' A' ' 111' ' ' VAL . 42.5 mt -124.31 112.43 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.617 0.722 . . . . 0.0 112.004 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.18 133.77 40.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.662 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.605 ' SG ' HG22 ' A' ' 85' ' ' ILE . 16.1 m -143.75 146.37 33.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.339 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -106.12 129.63 54.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.707 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 mt -130.24 107.35 14.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -76.18 96.07 3.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.03 -63.64 0.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.168 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 pt -98.56 -42.25 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.65 27.49 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.76 145.75 32.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.5 ttp -135.2 155.37 50.77 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.18 142.6 43.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.892 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 85.1 mt -124.74 139.42 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.732 0.777 . . . . 0.0 111.872 -172.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -76.8 116.4 17.43 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.892 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.8 t -46.89 -42.7 17.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.961 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 50' ' ' SER . 9.5 mt-10 -67.87 -13.34 62.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.778 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.446 ' CB ' HD11 ' A' ' 67' ' ' LEU . 42.0 m-85 -113.03 3.16 16.02 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.634 HG21 ' CD1' ' A' ' 94' ' ' ILE . 32.9 m -114.24 168.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.294 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.53 ' HD2' HG21 ' A' ' 51' ' ' VAL . 18.4 ttt180 -149.24 128.44 12.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.53 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 9.9 tttp -59.5 132.78 55.03 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.478 173.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.7 -56.08 10.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.75 -8.09 19.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.417 177.405 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 23' ' ' LEU . 20.5 mt . . . . . 0 N--CA 1.454 -0.25 0 N-CA-C 110.528 -0.175 . . . . 0.0 110.528 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 72.6 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.378 2.052 . . . . 0.0 111.033 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.5 -163.93 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.578 2.185 . . . . 0.0 112.709 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 5.0 t -98.88 128.24 32.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.1 8.55 1.04 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.789 2.326 . . . . 0.0 112.464 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.446 HE22 ' HB3' ' A' ' 30' ' ' HIS . 44.7 mt-30 -119.18 -37.84 3.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.9 m -110.03 -45.99 3.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.984 0.421 . . . . 0.0 109.886 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.86 2.23 3.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.592 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -48.47 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 169.86 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HE1' ' HB2' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -87.57 57.42 4.39 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.867 0.841 . . . . 0.0 110.765 -168.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -105.84 140.47 38.82 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.305 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 37.5 p90 -141.16 171.18 14.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HB3' HD11 ' A' ' 5' ' ' LEU . 1.3 pm0 -100.94 114.56 28.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.928 0.394 . . . . 0.0 110.755 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.56 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 26.7 t70 -113.38 83.03 1.77 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.08 -108.35 3.65 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.339 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.87 19.65 16.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -170.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.551 HD11 ' HB3' ' A' ' 31' ' ' GLU . 1.4 pt? -162.3 -174.68 4.17 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 5' ' ' LEU . 8.3 mt -106.39 132.58 52.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 31' ' ' GLU . 58.0 t -117.76 129.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 53.0 t -100.71 109.97 59.23 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 38.3 Cg_endo -67.64 -16.31 46.44 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.703 2.268 . . . . 0.0 111.193 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.624 ' HB2' ' HE1' ' A' ' 15' ' ' TYR . 9.9 tp10 -69.36 -73.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.558 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -88.12 10.35 19.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 45.47 16.48 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.446 ' HB3' HE22 ' A' ' 10' ' ' GLN . 38.9 t-80 -144.61 129.45 18.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.85 0.357 . . . . 0.0 110.23 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' HB3' HD11 ' A' ' 22' ' ' LEU . 1.9 mp0 -90.42 152.68 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.441 ' NE1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -155.26 161.31 41.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 59.3 m -121.66 130.42 24.78 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 14.3 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 123.412 2.741 . . . . 0.0 113.295 -169.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 87' ' ' LEU . 7.3 t . . . . . 0 CA--C 1.53 0.19 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.492 HG21 HG13 ' A' ' 94' ' ' ILE . 6.9 mm -93.35 138.75 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.4 ttmt -127.75 142.65 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.719 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 71.4 m-20 -100.28 -179.42 4.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 21.2 t -77.29 -5.65 50.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.867 0.842 . . . . 0.0 110.533 -174.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.9 t -88.57 -16.1 8.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.727 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.8 -3.23 67.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.171 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -87.07 149.37 24.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.643 0.735 . . . . 0.0 111.859 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.551 HG22 ' HG3' ' A' ' 48' ' ' LYS . 3.6 t -104.7 136.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.345 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.1 mp -100.35 179.74 4.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.449 -169.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.449 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 12.4 tt0 -132.0 156.17 46.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.251 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -69.74 138.34 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 82.21 -4.91 74.52 Favored Glycine 0 C--N 1.316 -0.562 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.538 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -72.78 171.53 12.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.727 0.299 . . . . 0.0 110.337 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 91.9 m -109.27 137.15 47.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.9 169.54 12.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' THR . 3.0 m -149.4 117.17 6.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.942 0.401 . . . . 0.0 110.859 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -62.15 128.9 24.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.596 HG12 ' CD ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -100.51 15.56 4.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.596 ' CD ' HG12 ' A' ' 64' ' ' ILE . 2.4 mptm? -135.79 165.1 26.4 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.588 -0.695 . . . . 0.0 109.168 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.85 116.05 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.802 0.811 . . . . 0.0 111.51 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 110' ' ' PHE . 5.1 mp -130.08 147.6 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.281 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.28 175.32 6.89 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.117 -0.364 . . . . 0.0 110.343 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.49 134.49 61.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 2.2 mmmp? -43.14 -88.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.46 21.78 42.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.383 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 m -122.67 153.62 39.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.898 0.38 . . . . 0.0 110.627 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -83.31 6.57 19.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.1 131.23 34.76 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 120.865 0.364 . . . . 0.0 110.052 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.7 t -100.67 133.53 43.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.454 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.579 HG12 HG11 ' A' ' 63' ' ' VAL . 53.8 t -85.85 99.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.38 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.11 152.09 25.0 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.684 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -52.12 97.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.918 0.866 . . . . 0.0 110.991 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.65 4.73 3.81 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.491 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.0 m -62.38 105.68 0.65 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.672 0.748 . . . . 0.0 110.627 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.31 113.34 24.6 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.052 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 96' ' ' CYS . 43.0 t -122.02 117.01 50.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 13.4 ptmm? -106.23 153.68 21.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.199 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.497 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 71.95 42.38 0.61 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.337 173.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 94' ' ' ILE . 42.6 pt -67.27 -177.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 122.25 1.024 . . . . 0.0 113.602 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -128.9 126.21 39.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.765 -1.561 . . . . 0.0 108.429 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.444 HD13 HG13 ' A' ' 46' ' ' VAL . 81.8 mt -80.26 122.87 27.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 93' ' ' ASP . 2.6 t . . . . . 0 C--N 1.316 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.488 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 88' ' ' VAL . 10.7 m-20 . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 121.445 0.64 . . . . 0.0 111.543 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.591 ' CD1' HG21 ' A' ' 111' ' ' VAL . 63.4 mt -114.33 116.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.146 171.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -94.69 133.27 38.54 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.357 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.479 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.1 p -145.46 159.86 42.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.621 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -118.36 134.57 54.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.006 176.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.0 mt -120.57 107.16 20.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.934 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -63.35 107.17 1.03 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.94 -46.34 0.86 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.937 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.3 pt -117.98 -38.83 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.69 0.281 . . . . 0.0 110.826 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.85 -157.09 24.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.378 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.8 149.62 23.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.969 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -153.99 171.54 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.466 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 19.0 ptmt -120.74 151.27 39.76 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.717 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.1 mt -127.32 140.32 52.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.27 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' A' ' 110' ' ' PHE . 76.5 tttt -82.31 117.61 22.52 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.132 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.635 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 1.4 p -50.86 -37.06 41.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.625 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 50' ' ' SER . 31.2 mt-10 -69.5 -7.33 37.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.309 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 64' ' ' ILE . 66.6 m-85 -113.46 -2.87 13.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.761 -0.587 . . . . 0.0 112.001 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 m -116.94 173.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 112.38 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.479 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.8 ttt180 -143.22 137.19 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.023 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 14.3 tttp -70.55 135.81 48.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.695 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.77 -58.56 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.905 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.75 34.93 3.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.235 178.915 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.777 0.323 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.69 161.83 42.88 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.863 2.375 . . . . 0.0 111.748 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.441 ' HB2' ' HA ' ' A' ' 12' ' ' ASN . 19.8 Cg_endo -64.57 -169.43 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.353 2.036 . . . . 0.0 112.385 174.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -98.81 129.13 30.57 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.969 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HG3' ' CE3' ' A' ' 32' ' ' TRP . 55.8 Cg_endo -69.11 7.25 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.692 2.261 . . . . 0.0 112.214 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.524 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 44.5 mt-30 -117.7 -39.32 3.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.479 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.7 m -106.2 -45.83 4.21 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 7' ' ' PRO . 64.5 t30 70.44 -3.3 1.91 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.851 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.7 m -55.34 -77.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.711 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.2 pt-20 164.31 -7.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.69 0.618 . . . . 0.0 112.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.662 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 61.1 m-85 -80.64 41.56 0.56 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 111.406 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -104.24 148.1 26.72 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.453 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 41.2 p90 -148.9 174.79 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.92 117.76 34.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.808 0.337 . . . . 0.0 111.108 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.537 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 14.7 t70 -115.75 79.07 1.24 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.97 -107.97 3.59 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.319 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.19 17.71 19.27 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.3 pt? -157.75 -175.46 5.39 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 16.2 mt -107.92 130.06 55.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 31' ' ' GLU . 52.2 t -116.9 127.39 74.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.2 t -102.7 105.41 44.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 44.8 Cg_endo -69.76 -12.5 33.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.565 2.177 . . . . 0.0 110.785 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 36.0 tt0 -68.7 -59.06 3.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.081 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.09 14.52 31.7 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.6 27.77 16.35 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.446 ' HB3' HE22 ' A' ' 10' ' ' GLN . 29.1 t-80 -140.66 142.25 34.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -98.15 177.38 5.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.505 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -172.28 161.88 5.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -119.07 129.85 25.17 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.505 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 12.2 Cg_endo . . . . . 0 C--N 1.342 0.197 0 C-N-CA 123.274 2.649 . . . . 0.0 113.338 -170.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.604 HG21 HG13 ' A' ' 94' ' ' ILE . 5.3 mm -76.97 137.38 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.823 -170.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 54' ' ' VAL . 1.6 ttmt -124.86 177.37 6.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.661 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' CG ' HD22 ' A' ' 53' ' ' ASN . 19.2 m-20 -113.16 179.26 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 44.8 t -82.16 -8.29 59.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.015 171.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.518 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 2.9 t -91.07 -17.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.141 -1.39 . . . . 0.0 109.347 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.68 -0.8 52.57 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.235 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.518 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -83.46 167.33 17.55 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.022 0.915 . . . . 0.0 111.283 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 48' ' ' LYS . 10.0 t -116.84 136.53 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.775 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 87' ' ' LEU . 2.1 mm? -97.04 175.83 6.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.342 0.591 . . . . 0.0 110.64 -172.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -131.4 151.12 51.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.024 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 15.6 t70 -72.62 91.92 1.48 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 133.69 -14.29 4.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.75 169.11 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.7 0.286 . . . . 0.0 111.013 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 22.2 m -100.12 137.27 38.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 85' ' ' ILE . 1.5 pp -125.81 165.43 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.4 m -147.31 125.39 12.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.052 0.453 . . . . 0.0 111.894 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -67.77 129.57 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.648 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.72 19.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.648 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.2 mptm? -138.69 160.81 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.964 0.802 . . . . 0.0 108.876 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -87.67 114.07 23.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.141 0.972 . . . . 0.0 112.433 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 3.8 mp -124.88 149.74 47.21 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.308 170.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -89.41 179.07 6.16 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.778 -0.576 . . . . 0.0 111.153 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 76' ' ' VAL . 9.6 t -132.05 130.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 141.15 33.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.32 -16.35 3.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.881 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.9 p -106.7 172.79 6.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.136 0.493 . . . . 0.0 111.158 -175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -97.12 16.79 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mp -91.75 171.79 8.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -159.27 117.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.635 HG23 HG22 ' A' ' 69' ' ' VAL . 93.9 t -82.01 94.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.785 0.802 . . . . 0.0 109.497 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 146.78 32.93 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -47.98 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.937 0.875 . . . . 0.0 110.896 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.09 7.74 3.96 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.179 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.4 m -62.7 104.21 0.51 Allowed 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 121.694 0.759 . . . . 0.0 109.52 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.2 113.93 26.34 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.346 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -132.02 118.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 61.9 pttt -110.04 170.39 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.57 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 89.9 m-20 66.82 34.17 5.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.216 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 61' ' ' ILE . 23.2 pt -64.57 175.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 122.195 0.997 . . . . 0.0 113.513 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -119.16 122.18 41.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.232 174.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 55' ' ' LEU . 89.7 mt -74.83 118.92 18.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 93' ' ' ASP . 5.3 t . . . . . 0 C--N 1.319 -0.717 0 CA-C-O 121.633 0.73 . . . . 0.0 111.637 -171.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.6 m-20 . . . . . 0 C--O 1.224 -0.241 0 CA-C-O 121.377 0.608 . . . . 0.0 111.944 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.604 HG13 HG21 ' A' ' 47' ' ' ILE . 4.9 mp -105.44 119.91 55.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.464 172.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.3 t70 -94.31 130.78 40.47 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.887 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.76 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.1 p -140.37 151.4 44.94 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.284 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -105.43 122.13 45.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.432 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.0 mt -122.63 107.78 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.255 0.55 . . . . 0.0 110.585 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -69.34 105.72 2.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.522 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.3 -37.96 0.79 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.234 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 pt -132.28 -38.49 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.863 0.363 . . . . 0.0 110.688 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.89 -153.67 23.92 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.734 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.57 24.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.722 0.261 . . . . 0.0 110.698 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.462 ' HG2' ' N ' ' A' ' 105' ' ' LYS . 49.4 ttm -142.0 164.05 31.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.143 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -117.57 139.08 51.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.05 138.76 52.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.499 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 14.6 tptm -72.25 125.03 26.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.884 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -52.1 -27.63 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.179 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 107' ' ' LYS . 10.9 pt-20 -87.1 -5.27 59.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.997 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.403 ' HD2' ' HB3' ' A' ' 107' ' ' LYS . 35.5 m-85 -116.59 7.69 13.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.341 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 94' ' ' ILE . 34.0 m -111.91 162.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.421 ' CG ' HG21 ' A' ' 51' ' ' VAL . 28.2 ttt180 -141.25 135.26 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.97 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -67.46 140.88 57.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.178 0.513 . . . . 0.0 110.914 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.99 -69.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.816 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.99 51.14 9.34 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.838 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.0 m . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.071 178.866 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.466 HD13 HD22 ' A' ' 23' ' ' LEU . 60.9 mt . . . . . 0 C--O 1.234 0.262 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 68.5 Cg_endo -71.2 159.99 50.33 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.264 1.976 . . . . 0.0 111.264 175.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.73 -163.67 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.649 2.233 . . . . 0.0 112.376 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 7.9 t -98.49 127.64 35.4 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.693 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 7.89 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.329 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.456 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 9.7 tt0 -122.05 -32.84 3.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.278 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.14 -45.25 3.62 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.667 -0.645 . . . . 0.0 109.984 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t30 69.95 -2.81 1.92 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.698 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.9 p -45.27 -77.06 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 13' ' ' SER . 10.7 pt-20 161.85 -15.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.808 0.693 . . . . 0.0 111.06 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.605 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m-85 -81.97 45.57 0.93 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.374 0.606 . . . . 0.0 111.043 -171.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -104.85 143.2 33.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.693 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.74 176.6 10.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.31 126.77 53.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.382 0.611 . . . . 0.0 110.819 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.27 82.07 1.75 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.112 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -112.58 4.33 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.39 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.79 17.32 22.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -154.0 -174.57 5.01 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.554 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 15.9 mt -114.5 136.46 52.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.741 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -127.87 142.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.861 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 46.6 t -104.62 106.99 56.9 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.8 Cg_endo -66.88 -14.0 42.09 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.763 2.309 . . . . 0.0 111.423 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 29.8 tt0 -73.15 -61.32 1.86 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.02 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.9 p -97.81 10.9 38.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.33 45.41 20.16 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -135.88 124.12 23.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.729 0.299 . . . . 0.0 110.516 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.741 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 34.6 mt-10 -93.3 143.57 26.14 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.11 161.99 41.79 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 120.807 0.337 . . . . 0.0 110.121 -176.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 p -112.05 132.76 21.88 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.554 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 9.9 Cg_endo . . . . . 0 C--N 1.345 0.368 0 C-N-CA 123.336 2.69 . . . . 0.0 113.284 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 87' ' ' LEU . 13.7 p . . . . . 0 N--CA 1.452 -0.334 0 CA-C-O 120.734 0.302 . . . . 0.0 110.936 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.681 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.144 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.516 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -107.27 177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 0.0 111.202 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 6.6 m-20 -118.22 174.45 6.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.867 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 64' ' ' ILE . 27.5 t -70.62 -7.11 41.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.836 0.827 . . . . 0.0 110.696 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.478 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.0 t -88.93 -16.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.854 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 2.22 65.35 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.668 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -93.66 162.82 13.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.332 0.587 . . . . 0.0 111.477 178.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 t -114.46 136.25 51.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.454 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.628 HD22 HG22 ' A' ' 61' ' ' ILE . 13.1 mt -93.57 174.96 6.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.398 0.618 . . . . 0.0 112.002 -170.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.3 tt0 -125.64 147.18 49.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.581 175.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.4 105.68 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.045 0.926 . . . . 0.0 109.436 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 114.14 -2.46 23.99 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.0 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.8 t70 -76.59 169.31 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.6 m -105.53 137.03 44.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.628 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -120.7 166.4 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -148.08 119.84 8.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.929 0.395 . . . . 0.0 110.773 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.623 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -62.39 126.34 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.624 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -100.12 17.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.575 ' HD3' HG12 ' A' ' 64' ' ' ILE . 1.8 mppt? -141.77 165.18 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.75 -0.594 . . . . 0.0 109.517 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.514 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.0 p-10 -83.21 113.94 21.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.596 0.713 . . . . 0.0 111.484 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.551 HD21 ' CD1' ' A' ' 110' ' ' PHE . 23.9 mt -126.53 140.44 52.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.694 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -91.22 174.16 7.54 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.225 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 72' ' ' SER . 38.7 t -124.91 126.37 71.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -88.49 -36.19 16.59 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.14 -32.37 52.63 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.125 -1.035 . . . . 0.0 111.575 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 69' ' ' VAL . 37.2 m -107.04 175.74 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.343 -0.429 . . . . 0.0 111.145 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -98.19 -4.78 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.058 0.456 . . . . 0.0 110.561 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mp -77.3 143.25 38.97 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.829 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.64 125.73 66.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.284 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.623 HG12 HG11 ' A' ' 63' ' ' VAL . 69.5 t -78.72 116.7 22.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.557 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -111.76 147.45 35.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.41 -175.096 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.31 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.924 0.868 . . . . 0.0 110.654 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.28 7.51 3.96 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.716 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -62.84 104.64 0.57 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.536 0.684 . . . . 0.0 109.657 174.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -89.67 115.83 27.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.847 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 96' ' ' CYS . 38.5 t -125.01 115.16 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 21.4 ptmt -99.87 157.15 16.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.382 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.589 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 93.6 m-20 66.27 45.17 2.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.659 173.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.41 HD11 ' HB3' ' A' ' 55' ' ' LEU . 31.1 pt -65.57 176.22 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 122.0 0.905 . . . . 0.0 113.38 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 21.8 tpp180 -130.26 131.95 45.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.831 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.519 HD13 HG23 ' A' ' 46' ' ' VAL . 15.8 mt -79.18 114.7 18.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.571 HG23 ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.219 -0.54 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.222 -0.386 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.681 HG13 HG21 ' A' ' 47' ' ' ILE . 3.7 mp -112.15 117.21 54.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.98 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.2 t70 -93.78 131.68 38.91 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.621 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.579 ' HB2' HG11 ' A' ' 82' ' ' VAL . 18.3 p -144.74 156.15 43.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.91 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 131.39 55.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.893 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.44 110.5 27.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.944 0.402 . . . . 0.0 110.028 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.16 102.94 1.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.299 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.09 -42.86 0.8 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.634 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.31 -42.19 2.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.06 0.457 . . . . 0.0 110.398 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.05 -154.17 23.75 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.86 149.44 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.312 0.556 . . . . 0.0 110.453 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.1 ttp -146.45 165.08 30.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.049 0.452 . . . . 0.0 110.95 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -114.03 138.65 50.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.866 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 81.0 mt -119.15 142.11 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.311 0.577 . . . . 0.0 111.437 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 66.1 mmtt -80.65 124.72 29.24 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.042 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.4 t -48.96 -43.66 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.981 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.452 ' C ' ' HB2' ' A' ' 50' ' ' SER . 1.5 pm0 -74.71 0.44 15.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.576 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.551 ' CD1' HD21 ' A' ' 67' ' ' LEU . 76.8 m-85 -119.72 2.64 11.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.45 -0.781 . . . . 0.0 112.993 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.59 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 34.1 m -114.04 172.93 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.193 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.454 ' HD2' HG21 ' A' ' 51' ' ' VAL . 10.9 ttt-85 -149.83 138.1 20.53 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.58 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -73.97 120.44 19.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.15 -46.55 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.907 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.49 11.35 82.11 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.177 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.228 -179.304 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 84.9 mt . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -67.75 155.12 71.2 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 121.81 1.673 . . . . 0.0 111.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.58 -170.85 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.71 2.273 . . . . 0.0 112.371 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -97.94 123.41 51.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.767 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.16 6.96 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.814 2.343 . . . . 0.0 112.269 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 49.2 mt-30 -115.36 -38.7 3.74 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.388 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -109.42 -48.19 3.28 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 72.03 -1.97 2.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.81 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 23.5 p -48.73 -76.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.53 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.5 pt-20 164.98 -13.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.584 0.553 . . . . 0.0 111.589 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 56.6 m-85 -78.7 35.32 0.24 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.083 0.468 . . . . 0.0 111.541 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -97.83 138.94 34.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.047 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -147.26 174.8 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.06 130.84 55.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.254 0.55 . . . . 0.0 110.97 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -122.87 84.47 2.27 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.535 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.91 -110.27 3.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.363 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.09 19.92 17.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.872 -171.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.59 -173.82 4.57 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.577 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 23.7 mt -114.21 137.42 51.79 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -127.83 142.41 43.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.071 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.0 t -106.3 106.7 58.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.908 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 39.0 Cg_endo -67.84 -10.16 27.93 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.804 2.336 . . . . 0.0 111.212 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.499 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 31.6 tt0 -75.74 -61.41 1.93 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.679 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.58 9.78 42.47 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.37 26.55 15.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HB3' HE22 ' A' ' 10' ' ' GLN . 47.3 m-70 -123.12 133.68 54.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.113 0.482 . . . . 0.0 111.214 175.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -91.28 162.6 14.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.607 176.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -162.09 162.54 28.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.0 t -109.65 134.84 20.46 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.577 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.2 Cg_endo . . . . . 0 CA--C 1.528 0.196 0 C-N-CA 122.489 2.126 . . . . 0.0 112.533 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.579 HG13 HD13 ' A' ' 87' ' ' LEU . 20.3 t . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.511 HG21 ' CG1' ' A' ' 94' ' ' ILE . 5.9 mm -85.22 134.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.807 0.337 . . . . 0.0 110.987 -174.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -112.18 149.36 32.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.211 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.6 m-20 -94.97 177.88 5.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.797 0.332 . . . . 0.0 110.633 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 32.8 t -72.57 -7.44 50.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.965 0.888 . . . . 0.0 110.536 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.469 HG21 ' CG ' ' A' ' 112' ' ' ARG . 3.0 t -88.23 -14.42 9.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.944 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.58 1.74 68.22 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.631 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -94.5 159.2 15.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.371 0.605 . . . . 0.0 111.6 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.473 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.8 t -108.75 135.14 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.053 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.58 HD22 HG22 ' A' ' 61' ' ' ILE . 12.7 mt -92.14 178.96 5.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.053 0.454 . . . . 0.0 110.715 -175.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.946 ' HG2' ' HB2' ' A' ' 59' ' ' ASP . 9.1 pt20 -126.03 154.77 42.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.488 ' OD1' ' HD3' ' A' ' 86' ' ' ARG . 19.4 t70 -66.59 104.4 1.27 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 112.71 -0.28 26.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.787 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.946 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 2.7 t0 -78.96 171.59 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 33.0 m -106.22 137.52 44.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.58 HG22 HD22 ' A' ' 55' ' ' LEU . 2.1 pp -120.82 167.71 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.6 m -149.38 117.17 6.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.824 0.345 . . . . 0.0 110.382 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.752 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -59.69 128.89 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.439 176.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -100.65 17.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -137.38 161.91 35.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.678 -0.639 . . . . 0.0 109.321 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.2 p-10 -84.13 109.77 17.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.744 0.783 . . . . 0.0 111.467 170.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 66' ' ' ASP . 21.7 mt -127.05 145.93 50.55 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.616 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -90.51 174.75 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.948 -0.47 . . . . 0.0 111.382 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.46 ' CG2' HG23 ' A' ' 76' ' ' VAL . 49.7 t -123.25 130.21 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -73.76 -63.31 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.165 0.439 . . . . 0.0 112.016 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.57 -23.01 76.81 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.37 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.444 ' HB2' HG11 ' A' ' 69' ' ' VAL . 66.9 m -112.59 151.02 30.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -74.47 -0.22 16.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.17 0.51 . . . . 0.0 110.959 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.475 ' CD2' HG21 ' A' ' 101' ' ' ILE . 3.1 mm? -78.55 143.39 36.56 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.474 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -107.55 134.61 48.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.804 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.752 HG12 HG11 ' A' ' 63' ' ' VAL . 75.5 t -89.2 101.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.6 147.89 27.13 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.593 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.3 p -51.45 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.855 0.836 . . . . 0.0 110.935 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.84 4.52 4.21 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.914 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.5 105.02 0.57 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 110.368 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -91.47 114.16 26.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 96' ' ' CYS . 43.2 t -122.08 118.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.861 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.1 ptmt -98.53 156.22 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.435 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.468 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 85.3 m-20 63.08 49.91 3.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.325 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.8 pt -64.86 176.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 11.7 tpp180 -131.59 121.89 25.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.269 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.579 HD13 HG13 ' A' ' 46' ' ' VAL . 22.8 mt -85.96 126.24 33.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.091 0.405 . . . . 0.0 109.919 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.654 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.763 -178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.671 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 5.0 m-20 . . . . . 0 N--CA 1.446 -0.644 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 106' ' ' LEU . 30.9 mt -119.96 108.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.217 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 16.6 t70 -95.72 103.77 15.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.53 0.681 . . . . 0.0 109.263 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.578 ' HB2' HG11 ' A' ' 82' ' ' VAL . 28.6 p -107.35 157.79 17.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.344 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 21.6 pttp -118.03 138.47 52.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.505 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.2 104.92 14.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.86 100.54 0.21 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.176 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.16 -64.86 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.647 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.475 HG21 ' CD2' ' A' ' 74' ' ' LEU . 40.5 pt -89.88 -46.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.383 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.15 -162.21 27.86 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 176.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -83.61 149.66 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.025 0.441 . . . . 0.0 110.985 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.9 ttp -136.82 153.51 50.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -98.84 146.44 25.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 95.5 mt -129.75 134.31 47.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.502 0.668 . . . . 0.0 111.765 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -81.28 114.73 20.27 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.596 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.4 p -52.69 -37.46 58.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.421 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' SER . 39.1 mt-10 -71.37 -3.84 22.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.863 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.444 ' HB3' HD11 ' A' ' 67' ' ' LEU . 66.6 m-85 -118.58 4.5 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.4 m -117.24 175.28 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.935 0.398 . . . . 0.0 112.064 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.469 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.4 ttt180 -147.7 141.59 25.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.562 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -72.52 121.9 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.995 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.08 -54.59 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.031 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.71 -9.34 55.38 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.571 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.344 179.004 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.7 mt . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.22 157.76 56.4 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.276 1.984 . . . . 0.0 111.243 176.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -66.3 -168.01 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 44.5 t -99.55 123.87 46.49 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.713 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.26 5.53 1.85 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.32 2.013 . . . . 0.0 111.724 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.661 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 42.2 mt-30 -105.44 -47.19 4.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.48 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -124.32 -33.42 3.05 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.891 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.416 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 8.3 t-20 70.81 11.84 7.15 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.402 0.62 . . . . 0.0 111.026 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 38.7 m -58.0 -25.76 61.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.285 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 13' ' ' SER . 89.2 mt-10 86.39 10.42 0.21 Allowed 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 111.504 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.435 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 85.5 m-85 -89.11 52.1 2.31 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.558 0.694 . . . . 0.0 109.387 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 m -105.24 149.8 25.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.713 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 48.3 p90 -150.52 177.1 10.34 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.83 128.24 52.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.794 0.33 . . . . 0.0 110.175 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -113.78 25.68 11.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.75 -114.82 0.85 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.388 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.88 14.38 29.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.645 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.2 pt? -150.0 -175.69 5.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.042 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mt -118.23 141.07 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.88 147.02 33.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.792 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 43.6 t -101.74 111.48 64.05 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' A' ' 17' ' ' TYR . 23.6 Cg_endo -62.01 -22.64 74.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.882 2.388 . . . . 0.0 111.454 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 22.4 tt0 -76.79 -59.61 2.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.022 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.9 m -76.86 -4.85 45.82 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.63 37.32 28.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -141.25 135.22 30.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.011 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HB3' HD11 ' A' ' 22' ' ' LEU . 21.6 mp0 -91.87 160.88 15.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.013 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -159.55 162.0 35.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.368 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -117.53 134.18 23.19 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo . . . . . 0 CA--C 1.531 0.342 0 C-N-CA 122.607 2.205 . . . . 0.0 113.352 -176.226 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.451 -0.409 0 CA-C-O 120.937 0.398 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.551 HG21 HG12 ' A' ' 94' ' ' ILE . 32.3 mm -73.54 122.02 25.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.404 -174.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 6.1 ttmt -119.03 137.39 53.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.613 -177.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.595 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 80.8 m-20 -92.88 -175.84 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.345 -169.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 16.7 t -77.1 -5.9 50.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.219 1.009 . . . . 0.0 110.269 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 112' ' ' ARG . 6.5 t -89.02 -21.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.18 -6.46 68.86 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.821 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.595 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -79.13 146.35 33.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.539 0.685 . . . . 0.0 111.179 178.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.3 t -102.94 134.74 43.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.522 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.649 ' HA ' ' HD2' ' A' ' 113' ' ' LYS . 7.1 mp -96.42 173.61 7.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.28 -169.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.595 HE21 ' H ' ' A' ' 57' ' ' ASP . 29.9 tp60 -126.04 149.26 48.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.373 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.595 ' H ' HE21 ' A' ' 56' ' ' GLN . 13.4 t70 -65.15 130.16 42.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.27 -4.55 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.231 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 56' ' ' GLN . 1.1 t70 -73.52 175.73 6.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.129 0.465 . . . . 0.0 110.911 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.0 m -106.31 138.69 42.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.73 166.14 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -150.47 113.84 4.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.717 0.294 . . . . 0.0 110.512 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -61.05 125.82 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -97.43 14.35 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.506 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 2.4 mptm? -137.81 160.71 38.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.16 116.17 24.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.547 0.689 . . . . 0.0 111.848 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 5.1 mp -129.63 146.51 51.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.973 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . 18.1 ptmt -92.76 179.38 5.5 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.507 -0.746 . . . . 0.0 110.574 173.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.94 128.2 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -91.6 136.95 32.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.698 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 -27.19 3.36 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.494 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.672 ' HB3' HD23 ' A' ' 74' ' ' LEU . 66.2 m -105.32 155.36 19.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.624 0.249 . . . . 0.0 110.374 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -84.15 12.23 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.234 0.54 . . . . 0.0 110.374 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' A' ' 72' ' ' SER . 3.9 mm? -78.35 170.83 15.99 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.002 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -158.93 117.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -171.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.548 HG12 HG11 ' A' ' 63' ' ' VAL . 86.5 t -91.73 95.92 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.599 0.714 . . . . 0.0 110.564 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.24 145.8 33.77 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.038 -0.414 . . . . 0.0 111.17 -176.048 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -47.63 98.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 124.074 0.858 . . . . 0.0 111.392 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.07 7.14 3.76 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.262 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.0 m -63.07 104.19 0.54 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.759 0.79 . . . . 0.0 110.032 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.92 114.59 27.19 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.098 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.679 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.4 t -131.37 121.06 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.662 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 56.8 pttt -107.9 166.99 10.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.731 0.777 . . . . 0.0 112.959 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.522 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER 71.1 36.7 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.203 172.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.3 pt -66.71 -178.11 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.808 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 0.3 OUTLIER -130.63 131.05 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.895 174.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.7 110.83 6.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 88' ' ' VAL . 1.5 t . . . . . 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.513 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 . . . . . 0 C--O 1.217 -0.61 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.551 HG12 HG21 ' A' ' 47' ' ' ILE . 69.7 mt -140.62 126.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.694 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.808 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.8 t70 -93.04 126.29 38.06 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.679 ' HB2' HG11 ' A' ' 82' ' ' VAL . 20.1 p -134.58 141.6 46.7 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.009 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 84' ' ' ASN . 11.4 ptpt -98.93 114.73 27.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.49 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.7 mt -116.98 104.94 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.403 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -47.66 130.35 14.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.639 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.2 -73.93 0.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.864 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 102' ' ' GLY . 32.6 pt -80.67 -46.27 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.774 0.321 . . . . 0.0 111.203 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 134.44 -146.33 18.33 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -88.57 155.97 19.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.101 0.45 . . . . 0.0 111.031 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.0 ttp -149.37 164.61 34.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.21 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 72.6 mttt -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.704 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.13 153.86 20.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.116 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 13.5 tptt -83.9 114.22 21.52 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.072 174.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.704 ' HA ' HG22 ' A' ' 111' ' ' VAL . 88.7 p -53.88 -39.54 65.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.132 0.968 . . . . 0.0 109.627 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 50' ' ' SER . 41.1 mt-10 -64.86 -3.39 3.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.539 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.474 ' O ' HD13 ' A' ' 64' ' ' ILE . 35.7 m-85 -117.23 0.74 12.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 171.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.704 HG22 ' HA ' ' A' ' 108' ' ' SER . 19.2 m -121.24 178.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.467 0.651 . . . . 0.0 112.396 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 51' ' ' VAL . 6.9 ttt180 -144.11 133.12 22.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.944 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.649 ' HD2' ' HA ' ' A' ' 55' ' ' LEU . 88.0 tttt -65.87 121.3 14.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.526 173.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.6 -65.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.29 33.01 6.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.804 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.507 -0.759 . . . . 0.0 110.189 -179.825 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.596 0.236 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.7 160.21 46.86 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.643 2.229 . . . . 0.0 111.345 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.56 -166.44 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.0 112.432 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 8.5 t -98.17 121.95 55.62 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.11 6.61 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.681 2.254 . . . . 0.0 112.199 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 9.1 tt0 -119.89 -34.28 3.77 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -112.22 -43.53 3.53 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.816 0.735 . . . . 0.0 110.15 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.7 t30 73.19 2.9 4.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.889 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 23.3 p -65.0 -35.44 81.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.696 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 13' ' ' SER . 2.4 mt-10 85.74 25.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.13 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -70.92 2.25 4.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.788 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 23' ' ' LEU . 1.4 m -58.42 145.73 37.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.807 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 46.3 p90 -153.27 174.82 13.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.85 111.36 23.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.104 0.478 . . . . 0.0 111.26 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.505 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.9 t0 -108.49 74.16 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.39 -112.82 4.56 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.828 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.69 16.96 23.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -172.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -156.01 -174.45 4.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.415 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' HG22 ' A' ' 16' ' ' THR . 22.6 mt -110.51 134.23 52.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 31' ' ' GLU . 85.9 t -118.66 132.45 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 122.114 -0.366 . . . . 0.0 110.208 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -99.45 109.88 56.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.44 -3.09 12.32 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.815 2.343 . . . . 0.0 112.109 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.82 -61.07 1.77 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.26 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -93.05 12.04 25.49 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 121.748 -0.595 . . . . 0.0 112.524 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.92 31.76 18.06 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -138.96 131.95 29.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.792 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HG3' HG13 ' A' ' 24' ' ' VAL . 1.1 mp0 -91.6 171.0 9.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.516 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -167.36 161.5 14.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.9 m -124.81 125.23 25.47 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo . . . . . 0 C--O 1.234 0.313 0 C-N-CA 122.905 2.404 . . . . 0.0 112.869 -172.887 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.448 -0.553 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.447 HG21 HG13 ' A' ' 94' ' ' ILE . 16.3 mm -78.58 132.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.424 -172.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.1 ttmt -122.47 135.67 54.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.063 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 84.0 m-20 -99.17 -178.99 4.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 23.1 t -74.06 -5.31 40.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.786 0.803 . . . . 0.0 110.971 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 4.4 t -87.71 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.487 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.11 -8.86 63.17 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.448 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -80.32 148.68 30.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.781 0.801 . . . . 0.0 112.07 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' A' ' 48' ' ' LYS . 3.7 t -102.88 137.26 31.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.044 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.826 ' HG ' ' HG3' ' A' ' 113' ' ' LYS . 7.3 mp -95.84 174.0 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.469 0.652 . . . . 0.0 111.925 -169.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.496 HE21 ' N ' ' A' ' 57' ' ' ASP . 30.1 tp60 -122.32 139.08 54.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.406 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' N ' HE21 ' A' ' 56' ' ' GLN . 22.7 t70 -66.56 102.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' ASN . . . 116.34 -2.52 20.51 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.574 -176.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 1.3 t70 -77.18 175.21 9.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.695 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 10.3 m -103.67 139.07 39.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.99 166.73 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -149.04 117.04 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.767 0.317 . . . . 0.0 110.474 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.54 124.86 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -96.46 13.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.565 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.62 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -134.74 159.1 42.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.188 0.518 . . . . 0.0 109.742 -172.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.05 103.43 7.98 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.66 0.743 . . . . 0.0 111.544 170.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 65' ' ' LYS . 2.2 mm? -115.68 128.91 56.26 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.145 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -88.06 174.09 8.48 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 120.911 -1.118 . . . . 0.0 109.573 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.63 123.68 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -79.72 -41.99 25.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.34 -20.45 66.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.558 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.2 m -113.8 173.69 6.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 m -98.28 2.1 47.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.15 0.5 . . . . 0.0 110.363 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.9 141.08 36.43 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.314 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.92 140.8 27.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.163 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.709 HG12 HG11 ' A' ' 63' ' ' VAL . 69.8 t -99.4 119.9 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.2 149.93 36.91 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.829 -175.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -49.39 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.539 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.09 5.14 3.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.635 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.1 m -62.33 105.16 0.57 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.811 0.815 . . . . 0.0 110.224 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -93.53 112.95 24.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.976 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.584 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -124.45 119.35 56.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.374 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 16.8 pttm -106.19 159.45 16.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 45.1 m-80 65.4 43.94 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.892 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 45.5 pt -64.89 -179.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.427 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 6.2 tpp180 -125.52 125.38 43.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.281 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.33 118.05 21.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.9 t . . . . . 0 C--N 1.318 -0.779 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 88' ' ' VAL . 53.4 m-20 . . . . . 0 CA--C 1.517 -0.291 0 CA-C-O 121.832 0.825 . . . . 0.0 112.725 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.587 ' CD1' HG21 ' A' ' 111' ' ' VAL . 49.1 mt -115.52 119.93 63.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.475 174.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.28 135.93 36.27 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.584 ' HB2' HG11 ' A' ' 82' ' ' VAL . 22.1 p -143.13 153.68 43.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.775 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -110.56 125.35 53.27 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -126.16 115.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.726 0.298 . . . . 0.0 110.478 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.14 104.49 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.086 0.47 . . . . 0.0 110.54 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.57 -44.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.066 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.1 pt -125.51 -38.55 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.905 0.383 . . . . 0.0 110.496 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.25 -151.38 21.44 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.26 145.24 30.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.4 tpt -136.34 156.63 48.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -108.64 128.5 54.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.713 178.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -115.35 140.99 48.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.43 0.633 . . . . 0.0 111.292 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -78.74 113.97 17.26 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.674 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.614 ' HA ' HG22 ' A' ' 111' ' ' VAL . 4.3 p -52.42 -38.81 59.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.77 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 50' ' ' SER . 33.2 mt-10 -60.08 -15.13 20.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.64 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.457 ' CG ' HD21 ' A' ' 67' ' ' LEU . 27.6 m-85 -114.96 4.86 14.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.506 -0.478 . . . . 0.0 112.085 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.3 m -126.1 179.11 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.394 0.616 . . . . 0.0 112.422 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 9.7 ttt180 -145.86 137.82 25.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.826 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 2.0 ttpp -73.3 125.01 26.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.786 173.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.81 -61.26 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.46 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.97 40.34 8.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.7 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.817 -178.161 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.404 HD11 ' CD ' ' A' ' 18' ' ' GLU . 21.3 mt . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 73.3 Cg_endo -73.61 158.24 47.62 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.504 2.136 . . . . 0.0 110.989 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 16.2 Cg_exo -68.28 -166.6 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.369 2.046 . . . . 0.0 112.057 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.0 t -97.93 120.89 59.11 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.508 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 9.24 0.31 Allowed 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.801 2.334 . . . . 0.0 112.141 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.578 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 33.8 mt-30 -117.6 -35.19 4.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.4 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.53 -48.53 3.07 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 121.0 0.429 . . . . 0.0 110.123 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.5 t30 69.9 -3.05 1.83 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.025 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -53.29 -76.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.944 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 173.06 -19.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.718 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 93.3 m-85 -82.5 48.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.051 0.453 . . . . 0.0 111.637 -167.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.4 m -109.23 146.25 34.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.334 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.4 p90 -152.88 178.45 9.65 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -103.58 118.78 37.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.001 0.429 . . . . 0.0 110.762 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.489 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 37.8 t70 -116.78 80.86 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.99 -113.03 4.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.213 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.26 21.45 16.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -172.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD11 ' HG3' ' A' ' 31' ' ' GLU . 2.4 pt? -158.47 -175.01 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.342 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 17.0 mt -107.25 130.29 54.77 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 19' ' ' ASP . 52.9 t -118.0 132.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 O-C-N 122.103 -0.373 . . . . 0.0 110.43 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.0 t -103.35 105.16 45.27 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.718 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 40.1 Cg_endo -68.14 -11.07 30.87 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 111.176 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.616 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.2 tp10 -72.52 -66.49 0.65 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.675 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -95.35 12.54 28.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.91 32.6 20.01 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.109 0.481 . . . . 0.0 111.915 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.463 ' HB3' HE22 ' A' ' 10' ' ' GLN . 40.2 t60 -136.64 133.24 36.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.193 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -105.87 167.47 9.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.798 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -165.57 162.2 18.91 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.3 t -116.93 136.92 23.39 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.6 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.798 2.332 . . . . 0.0 112.97 -176.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.447 -0.594 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.533 HG12 HD22 ' A' ' 87' ' ' LEU . 1.4 mm -80.45 130.62 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.925 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 3.5 ttmt -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.565 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 14.3 m-20 -106.08 170.48 7.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 9.2 t -82.65 -9.95 59.15 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.096 0.95 . . . . 0.0 110.236 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.566 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.6 p -89.09 4.13 5.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.403 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.88 80.74 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.552 -1.203 . . . . 0.0 113.511 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.566 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -103.62 161.96 13.46 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.327 -178.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' HE2' ' A' ' 48' ' ' LYS . 11.6 t -102.4 142.85 15.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.175 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.614 HD22 HG22 ' A' ' 61' ' ' ILE . 17.9 mt -94.48 174.97 6.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 111.319 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.434 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 14.0 tt0 -138.53 159.49 41.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.483 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 10.0 p-10 -69.69 130.47 42.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.416 0.627 . . . . 0.0 109.712 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 91.57 -7.94 79.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.173 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.484 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 1.7 t70 -77.98 167.39 21.55 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.318 -0.519 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.2 m -96.53 140.08 31.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.953 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.614 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -123.86 165.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.082 0.468 . . . . 0.0 110.069 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.8 m -149.72 121.12 7.9 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.746 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.28 127.58 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.557 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -99.34 17.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.557 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.6 mptm? -140.81 161.46 37.75 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.459 -0.775 . . . . 0.0 109.041 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.537 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.0 p-10 -81.28 115.25 20.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.706 0.765 . . . . 0.0 111.926 172.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 13.7 mt -130.17 144.19 51.22 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.064 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -95.14 178.59 5.49 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.866 -0.521 . . . . 0.0 111.14 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 72' ' ' SER . 47.0 t -127.45 127.63 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.414 ' H ' ' HG2' ' A' ' 70' ' ' LYS . 39.4 pttt -82.26 -45.72 14.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -170.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.4 -26.28 57.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.567 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.821 ' HB3' HD23 ' A' ' 74' ' ' LEU . 58.3 m -110.03 165.73 11.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -86.7 11.99 11.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.785 0.803 . . . . 0.0 109.201 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.12 172.71 12.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.962 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.2 t -159.03 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -166.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.746 HG12 HG11 ' A' ' 63' ' ' VAL . 85.1 t -93.27 96.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.89 0.852 . . . . 0.0 110.611 -173.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.4 pptp? -102.64 146.18 28.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.153 -175.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.537 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.57 97.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.913 0.863 . . . . 0.0 110.774 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.36 3.36 4.3 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.013 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' THR . 94.9 m -62.12 103.81 0.41 Allowed 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 121.868 0.842 . . . . 0.0 109.65 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -90.85 114.74 27.24 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.226 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 96' ' ' CYS . 42.6 t -126.14 113.72 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.6 ptmt -96.59 161.47 13.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.032 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.585 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 86.7 m-20 63.52 44.92 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.839 0.712 . . . . 0.0 111.526 174.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' CG2' ' A' ' 61' ' ' ILE . 34.2 pt -65.7 175.64 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.911 0.862 . . . . 0.0 113.042 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 19.3 tpp180 -130.17 129.89 44.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.378 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.533 HD22 HG12 ' A' ' 47' ' ' ILE . 63.0 mt -81.17 113.07 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 120.967 0.413 . . . . 0.0 110.833 -174.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.8 m-20 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.516 HG13 HG21 ' A' ' 47' ' ' ILE . 3.9 mp -109.0 113.63 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.743 170.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 36.6 t70 -94.69 136.9 34.47 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.488 ' HB2' HG11 ' A' ' 82' ' ' VAL . 17.4 p -138.03 143.46 40.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.505 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.71 121.01 43.83 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.53 107.32 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.62 117.25 6.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.86 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.15 -65.26 0.57 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.477 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.47 HG21 HD21 ' A' ' 74' ' ' LEU . 26.7 pt -95.78 -47.65 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.88 0.371 . . . . 0.0 110.369 178.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.99 -161.18 28.12 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.39 148.33 26.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.702 0.287 . . . . 0.0 111.009 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 43.9 ttm -138.79 158.09 44.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.318 . . . . 0.0 110.58 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.94 134.88 54.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.087 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.2 mt -118.83 142.44 47.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.203 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HB3' ' OE1' ' A' ' 109' ' ' GLU . 30.0 mtpt -74.41 130.86 40.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.966 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.7 t -59.49 -32.98 70.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.478 -176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.529 ' OE1' ' HB3' ' A' ' 107' ' ' LYS . 3.4 pm0 -85.55 -0.16 54.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 33.3 m-85 -115.8 3.06 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.891 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 28.9 m -111.8 168.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.269 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.517 ' HG3' HG11 ' A' ' 51' ' ' VAL . 25.1 ttt180 -150.64 132.49 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.282 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.2 tttt -65.48 121.08 14.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 174.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.1 t -85.47 -48.76 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.81 85.3 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.867 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.909 -179.369 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.446 HD13 HD22 ' A' ' 23' ' ' LEU . 30.2 mt . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.471 0.177 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 54.3 Cg_endo -69.22 160.0 51.57 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.215 1.943 . . . . 0.0 111.139 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.22 -172.39 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.357 2.038 . . . . 0.0 112.031 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.09 127.03 38.05 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.57 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.69 6.82 1.46 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.541 2.16 . . . . 0.0 111.722 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.616 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 40.0 mt-30 -115.54 -39.21 3.59 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.431 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 m -109.67 -52.01 2.82 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.908 0.385 . . . . 0.0 110.268 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.74 -0.82 3.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.611 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.632 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 45.2 m -60.87 -78.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.994 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.1 pt-20 176.77 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.729 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 23.8 m-85 -82.2 33.58 0.4 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.584 0.629 . . . . 0.0 111.827 -171.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -91.48 135.22 34.0 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.766 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CE1' ' HD3' ' A' ' 26' ' ' PRO . 22.0 p90 -146.04 170.17 17.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 123.85 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.83 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -120.03 79.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.09 -112.9 4.52 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.076 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.03 16.13 25.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.12 -175.5 5.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.725 0.298 . . . . 0.0 110.248 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 19.9 mt -110.05 129.15 55.73 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.881 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -123.59 138.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.97 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 47.1 t -110.72 104.2 55.66 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.352 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 56.1 Cg_endo -70.78 -9.81 26.49 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.836 2.358 . . . . 0.0 109.913 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.97 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -70.75 -45.13 65.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.206 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.0 p -117.88 15.17 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.08 39.9 28.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.157 0.435 . . . . 0.0 111.874 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.78 127.62 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.85 0.357 . . . . 0.0 111.399 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.881 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 27.1 mt-10 -91.18 156.37 17.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.129 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.39 162.24 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.438 . . . . 0.0 110.726 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -110.44 130.87 22.41 Favored Pre-proline 0 C--N 1.317 -0.845 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.506 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 18.4 Cg_endo . . . . . 0 CA--C 1.529 0.264 0 C-N-CA 122.887 2.391 . . . . 0.0 113.576 -171.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.572 HG23 HD13 ' A' ' 87' ' ' LEU . 7.8 p . . . . . 0 N--CA 1.444 -0.73 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.424 HG21 HG13 ' A' ' 94' ' ' ILE . 4.4 mm -85.75 138.77 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.456 0.17 . . . . 0.0 110.649 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -109.62 155.78 21.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.119 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 5.0 m-20 -98.73 167.19 10.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.682 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.688 ' OG ' HD11 ' A' ' 64' ' ' ILE . 89.8 p -76.68 -10.63 59.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.904 0.859 . . . . 0.0 110.867 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.55 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.1 p -85.4 1.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.451 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.23 7.15 73.62 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.504 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.55 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -108.45 168.39 9.36 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.942 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 48' ' ' LYS . 9.4 t -113.7 142.51 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.931 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 113' ' ' LYS . 13.9 mt -96.64 175.95 6.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.547 0.689 . . . . 0.0 111.204 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.478 ' HB3' ' OD1' ' A' ' 59' ' ' ASP . 16.8 tt0 -131.91 154.21 49.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -67.54 96.46 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.955 0.407 . . . . 0.0 109.944 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.83 -7.11 6.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.974 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 56' ' ' GLN . 32.0 m-20 -71.13 165.27 23.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.112 0.482 . . . . 0.0 111.167 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 2.8 m -99.37 136.09 39.83 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.472 HG22 HD22 ' A' ' 55' ' ' LEU . 1.9 pp -120.76 166.01 15.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.0 m -150.46 118.78 6.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.851 175.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -60.73 126.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.295 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.688 HD11 ' OG ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -99.54 19.01 2.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.525 ' HD2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -143.48 166.41 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.592 -0.692 . . . . 0.0 109.332 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.77 113.96 21.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.894 0.854 . . . . 0.0 111.343 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 ' CG ' ' A' ' 110' ' ' PHE . 7.2 mp -126.0 141.19 52.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.485 175.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.428 ' HE2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -88.52 171.37 10.12 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.31 173.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.502 ' CG2' HG23 ' A' ' 76' ' ' VAL . 47.8 t -120.25 133.55 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -78.57 -57.49 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.78 -17.55 79.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.968 -0.635 . . . . 0.0 113.094 -174.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.471 ' HB2' HG11 ' A' ' 69' ' ' VAL . 55.5 m -115.0 155.13 27.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.746 0.308 . . . . 0.0 110.869 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -79.79 -1.13 37.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.47 HD22 HD13 ' A' ' 101' ' ' ILE . 9.5 mp -78.83 146.61 33.6 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.9 t -107.78 134.3 50.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.318 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 63' ' ' VAL . 63.1 t -84.1 104.25 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 149.87 25.48 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.469 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.73 96.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.99 0.9 . . . . 0.0 111.083 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.64 5.82 3.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.057 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 62' ' ' THR . 90.1 m -62.58 104.07 0.48 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 121.717 0.77 . . . . 0.0 109.87 176.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.25 121.3 33.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.174 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 96' ' ' CYS . 30.6 t -133.88 116.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.627 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 51.9 pttt -100.35 158.88 15.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.726 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.495 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 56.0 m-80 63.32 47.49 3.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.8 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -64.88 178.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 122.005 0.907 . . . . 0.0 113.347 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.653 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 11.0 tpp85 -129.96 124.65 33.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.823 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.572 HD13 HG23 ' A' ' 46' ' ' VAL . 34.5 mt -78.92 116.05 18.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.6 t . . . . . 0 C--N 1.32 -0.707 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.384 -176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.475 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.556 ' CD1' HG21 ' A' ' 111' ' ' VAL . 36.6 mt -144.34 120.61 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 33.9 t70 -95.53 136.72 35.56 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.167 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.536 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -154.18 163.26 40.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.704 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 87.9 tttt -124.7 147.26 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.976 0.417 . . . . 0.0 110.04 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.32 105.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.57 103.87 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.795 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 144.27 -70.3 0.4 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.215 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.47 HD13 HD22 ' A' ' 74' ' ' LEU . 25.4 pt -84.77 -46.5 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.542 0.21 . . . . 0.0 111.173 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.425 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 146.94 -162.62 28.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.893 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.772 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -86.72 149.91 24.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.829 0.315 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.4 ttt -140.29 156.89 46.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.946 0.403 . . . . 0.0 110.671 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -113.83 139.03 49.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.583 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 53.9 mt -123.08 141.16 52.27 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.669 0.747 . . . . 0.0 111.732 -170.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -84.83 119.61 25.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.973 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -47.82 -39.71 19.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.7 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.77 -11.15 33.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.61 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.45 ' CG ' HD21 ' A' ' 67' ' ' LEU . 86.4 m-85 -112.91 1.8 15.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.556 HG21 ' CD1' ' A' ' 94' ' ' ILE . 13.5 m -113.4 169.51 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.37 -172.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.573 ' HB3' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -155.13 129.77 9.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.07 179.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.482 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.7 tttt -59.97 123.25 16.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.786 0.327 . . . . 0.0 110.31 171.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -60.53 -44.8 97.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.429 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.98 -21.13 3.01 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.184 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.236 -0.887 . . . . 0.0 109.47 176.19 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.428 HD22 HD12 ' A' ' 23' ' ' LEU . 16.2 mt . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 72.4 Cg_endo -72.47 155.95 54.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.925 1.75 . . . . 0.0 110.783 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 15.6 Cg_exo -67.84 -175.44 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.31 2.007 . . . . 0.0 111.882 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 4.7 t -97.65 123.0 53.56 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.46 10.94 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.73 2.287 . . . . 0.0 111.919 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.572 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 36.5 mt-30 -118.9 -40.57 2.84 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.147 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.4 m -108.98 -50.86 2.95 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.185 0.516 . . . . 0.0 110.265 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 t30 70.78 2.07 4.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.871 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 4.8 m -58.95 -78.34 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.3 pt-20 175.66 -18.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.516 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.7 m-85 -79.21 31.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.132 -169.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 m -94.17 136.19 34.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.825 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -139.05 169.87 17.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.19 122.03 45.71 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.11 0.481 . . . . 0.0 111.205 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -111.27 71.75 0.75 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.53 -107.99 3.53 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.382 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.9 19.4 19.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -171.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 23' ' ' LEU . 2.6 pt? -155.41 -179.44 8.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.171 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.706 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -109.24 134.03 52.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 31' ' ' GLU . 57.7 t -115.14 127.15 72.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 49.4 t -103.95 103.91 40.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 53.4 Cg_endo -71.61 -8.88 24.06 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.549 2.166 . . . . 0.0 110.412 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 20.2 tt0 -69.27 -62.59 1.32 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.017 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.2 p -98.47 9.59 42.8 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.71 46.05 12.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.771 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.494 ' HB3' HE22 ' A' ' 10' ' ' GLN . 3.6 t-80 -150.59 135.02 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HB3' HG13 ' A' ' 24' ' ' VAL . 10.1 pt-20 -114.36 163.53 15.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.733 0.301 . . . . 0.0 110.882 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.564 ' NE1' HD23 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -163.11 162.64 25.77 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 t -112.18 139.79 22.86 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' ' CD2' ' A' ' 23' ' ' LEU . 19.7 Cg_endo . . . . . 0 C--N 1.349 0.593 0 C-N-CA 122.403 2.069 . . . . 0.0 112.452 -173.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.615 HG13 HD13 ' A' ' 87' ' ' LEU . 15.8 t . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.686 HG21 HG13 ' A' ' 94' ' ' ILE . 2.5 mm -86.18 135.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.52 177.36 4.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 6.3 m-20 -114.42 169.99 8.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.611 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.468 ' OG ' HD11 ' A' ' 64' ' ' ILE . 90.3 p -70.47 -6.23 34.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.123 0.963 . . . . 0.0 110.51 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.47 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.1 t -86.45 -13.52 10.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.642 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.79 5.68 64.33 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.886 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.47 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -97.1 168.24 10.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.543 0.687 . . . . 0.0 111.561 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 48' ' ' LYS . 16.4 t -113.97 144.64 21.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.787 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.591 HD22 HG22 ' A' ' 61' ' ' ILE . 24.2 mt -101.1 173.2 6.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.647 . . . . 0.0 111.69 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 33.7 tp60 -124.89 145.71 49.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.501 ' H ' HE21 ' A' ' 56' ' ' GLN . 15.1 t70 -71.23 97.1 1.49 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 123.51 -6.5 9.15 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.556 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 42.2 t0 -68.62 166.53 17.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.899 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 34.5 m -104.89 136.51 44.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.591 HG22 HD22 ' A' ' 55' ' ' LEU . 1.8 pp -123.71 171.85 12.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -150.19 123.34 8.87 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 0.0 111.102 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.614 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -65.8 126.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -97.7 14.06 4.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG3' HG12 ' A' ' 64' ' ' ILE . 54.8 mttt -143.64 164.99 28.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.094 0.861 . . . . 0.0 109.634 -176.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.69 117.15 24.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.082 0.944 . . . . 0.0 112.648 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.461 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.6 mp -134.79 150.66 50.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.307 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.32 178.27 5.89 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.703 -0.623 . . . . 0.0 111.502 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' A' ' 74' ' ' LEU . 46.7 t -120.06 129.07 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -56.51 108.36 0.48 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.22 3.88 26.57 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.005 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m -101.0 166.69 10.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.982 0.42 . . . . 0.0 111.122 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 p -84.92 -3.84 58.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.56 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.512 ' HB3' HG21 ' A' ' 69' ' ' VAL . 12.1 tp -81.85 171.66 14.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.661 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.473 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 70.0 t -158.72 120.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -169.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.614 HG12 HG11 ' A' ' 63' ' ' VAL . 64.9 t -89.65 97.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.715 0.769 . . . . 0.0 110.61 -174.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.478 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.21 145.47 34.2 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.329 -176.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -48.01 97.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.868 0.842 . . . . 0.0 111.19 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.52 4.09 4.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.251 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -62.53 104.95 0.57 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 122.089 0.947 . . . . 0.0 110.009 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -89.35 120.75 30.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.895 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.693 HG11 ' HB2' ' A' ' 96' ' ' CYS . 22.2 t -131.9 113.41 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.398 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.7 ptmt -100.55 154.04 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.714 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.504 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 50.6 m-80 62.76 53.22 2.56 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.038 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 55' ' ' LEU . 32.4 pt -64.56 174.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 121.815 0.817 . . . . 0.0 112.43 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 20.4 tpp180 -129.22 123.01 30.89 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.879 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG13 ' A' ' 46' ' ' VAL . 39.7 mt -78.24 113.39 16.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.658 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.021 -178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.556 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.3 m-20 . . . . . 0 C--O 1.224 -0.282 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.686 HG13 HG21 ' A' ' 47' ' ' ILE . 2.8 mp -110.41 113.1 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 170.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 15.5 t70 -95.0 138.96 32.03 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.693 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -147.35 156.52 42.98 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.406 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -116.64 130.03 56.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.406 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.46 109.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.87 97.31 1.8 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.287 0.565 . . . . 0.0 110.134 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.93 -40.53 0.42 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 102' ' ' GLY . 43.2 pt -122.62 -37.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.477 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 138.15 -150.99 21.23 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -91.01 149.13 21.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.759 0.314 . . . . 0.0 110.744 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.3 ttt -140.57 159.75 41.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.187 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -116.78 143.23 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.2 mt -125.73 146.91 49.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.294 0.568 . . . . 0.0 111.984 -169.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.632 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 1.7 mptm? -75.26 128.33 35.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.855 174.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.6 t -53.31 -40.8 65.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.632 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 8.6 pt-20 -66.88 -12.29 58.8 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.066 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.473 ' O ' HD13 ' A' ' 64' ' ' ILE . 64.7 m-85 -111.87 4.8 18.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.459 -0.776 . . . . 0.0 112.777 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 24.2 m -114.4 169.84 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.505 -173.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 15.8 ttt180 -147.88 142.59 26.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.639 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.748 ' HB2' ' HZ2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -65.58 140.83 58.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.254 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 116' ' ' SER . 94.0 t -107.84 -57.83 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 170.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.57 -3.51 71.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.744 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 114' ' ' VAL . 31.1 m . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.337 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.454 HD13 HD22 ' A' ' 23' ' ' LEU . 72.8 mt . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.9 Cg_endo -70.65 158.29 56.22 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.155 1.903 . . . . 0.0 111.131 176.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 13.1 Cg_exo -70.18 -171.65 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 10' ' ' GLN . 33.8 t -99.1 122.04 53.64 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.205 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.84 7.49 0.58 Allowed 'Trans proline' 0 C--O 1.23 0.113 0 C-N-CA 122.613 2.208 . . . . 0.0 112.284 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 8' ' ' CYS . 8.4 tt0 -113.94 -39.54 3.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.095 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -126.14 -35.15 2.46 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.553 -0.717 . . . . 0.0 111.468 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t30 72.53 1.84 4.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.92 0.488 . . . . 0.0 111.634 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.584 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 4.8 m -53.93 -78.43 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 171.85 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.164 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.793 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 79.0 m-85 -118.06 24.95 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.296 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.404 HG22 ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -93.54 132.38 37.89 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.389 172.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 38.3 p90 -144.9 171.27 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -100.8 117.54 35.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.884 0.373 . . . . 0.0 110.715 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.57 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 35.1 t70 -115.69 69.99 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.02 -113.44 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.91 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.48 18.91 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.883 0.373 . . . . 0.0 111.645 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.4 pt? -154.96 -174.83 5.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.349 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.577 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 24.1 mt -113.46 137.1 52.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 31' ' ' GLU . 46.1 t -121.27 136.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 122.231 -0.293 . . . . 0.0 110.375 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 48.6 t -102.58 105.14 42.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.349 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.793 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 20.8 Cg_endo -61.64 -25.45 79.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.63 2.22 . . . . 0.0 111.66 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.13 -58.95 3.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.7 m -75.92 -9.13 58.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.7 39.54 24.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 111.466 -173.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -149.17 136.92 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.534 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -103.69 174.76 5.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -178.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -166.94 161.87 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.6 t -106.18 135.11 19.5 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.577 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.9 Cg_endo . . . . . 0 C--N 1.343 0.241 0 C-N-CA 122.868 2.379 . . . . 0.0 112.855 -173.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.7 t . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 109.808 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.599 HG21 HG13 ' A' ' 94' ' ' ILE . 5.1 mm -81.3 139.85 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -114.8 176.25 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.3 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.416 ' OD1' HG23 ' A' ' 111' ' ' VAL . 15.6 m-20 -112.05 172.41 6.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.25 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 64' ' ' ILE . 81.6 p -74.66 -8.33 56.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.039 0.923 . . . . 0.0 110.678 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.449 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -89.24 -11.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.406 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.65 -2.63 64.85 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.773 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.449 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -91.52 166.39 12.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.775 0.798 . . . . 0.0 111.584 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' HG3' ' A' ' 48' ' ' LYS . 11.3 t -117.05 139.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.923 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD22 HG22 ' A' ' 61' ' ' ILE . 17.8 mt -94.9 172.98 7.82 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.238 0.542 . . . . 0.0 110.564 -173.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -129.36 150.48 50.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -69.71 96.02 0.93 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 0.0 109.929 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 124.67 -7.83 8.31 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.045 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.468 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 2.1 t0 -72.16 175.81 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 25.3 m -105.46 137.19 43.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.603 HG22 HD22 ' A' ' 55' ' ' LEU . 1.5 pp -123.35 164.49 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.772 0.32 . . . . 0.0 110.279 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -148.53 124.88 10.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 174.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.712 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -66.71 124.79 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.76 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -96.13 17.19 2.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.904 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 6.7 mttt -143.5 163.71 32.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.03 0.832 . . . . 0.0 109.643 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.538 ' O ' HD23 ' A' ' 67' ' ' LEU . 2.5 p-10 -83.67 115.89 22.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.087 0.946 . . . . 0.0 111.995 173.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.2 mt -129.17 143.92 51.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.359 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -91.87 178.31 5.93 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.618 -0.676 . . . . 0.0 110.525 173.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 HG23 ' A' ' 76' ' ' VAL . 8.0 t -129.15 130.4 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 13.9 tppt? -78.63 -60.04 2.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -172.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.69 37.62 3.35 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.515 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.424 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 69.6 m -144.73 166.85 24.03 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -95.62 2.88 54.36 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.4 mp -78.6 175.25 10.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.452 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.8 t -158.69 116.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.712 HG12 HG11 ' A' ' 63' ' ' VAL . 88.1 t -87.32 98.56 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-O 121.682 0.753 . . . . 0.0 110.753 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.6 pptp? -105.83 145.01 31.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.41 -175.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -48.65 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.925 0.869 . . . . 0.0 111.228 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.23 5.5 4.67 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.072 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.47 104.39 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.807 0.813 . . . . 0.0 109.555 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -94.79 115.02 26.99 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.431 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 96' ' ' CYS . 68.0 t -132.22 117.31 32.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.8 pttt -107.89 169.67 8.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.682 0.753 . . . . 0.0 112.903 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.524 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 69.62 36.13 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.426 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 55' ' ' LEU . 37.2 pt -60.74 175.83 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.645 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 9.0 tpp85 -131.25 123.08 27.65 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.156 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.1 mt -75.25 109.08 8.46 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.624 HG22 ' HB2' ' A' ' 95' ' ' ASP . 2.6 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -170.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.704 ' CD1' HG21 ' A' ' 111' ' ' VAL . 25.7 mt -110.4 129.69 65.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.435 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.624 ' HB2' HG22 ' A' ' 88' ' ' VAL . 9.9 t70 -96.42 132.81 41.57 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.746 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.6 p -138.27 145.21 41.01 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.832 -168.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.562 ' O ' HG13 ' A' ' 82' ' ' VAL . 96.3 mttt -93.45 107.84 19.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.498 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.6 mt -104.51 155.32 6.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -101.09 130.5 47.14 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.64 -52.42 0.77 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.988 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 102' ' ' GLY . 44.7 pt -95.83 -40.32 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.413 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 126.96 -138.32 10.49 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.791 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -100.34 159.68 14.94 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.11 0.455 . . . . 0.0 111.377 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 38.8 ttm -154.2 165.75 35.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.121 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 80.6 mttt -113.69 126.08 54.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.572 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.44 146.72 39.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.646 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 25.9 ttmt -76.68 125.25 28.93 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.218 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.1 t -47.94 -37.96 15.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.093 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.646 ' HG2' ' HG2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -75.41 -5.33 44.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.904 ' HD1' ' HD3' ' A' ' 65' ' ' LYS . 30.7 m-85 -113.72 7.44 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.531 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.704 HG21 ' CD1' ' A' ' 94' ' ' ILE . 30.3 m -116.62 171.83 5.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -174.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -150.32 133.83 16.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.012 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 87.4 tttt -70.46 120.38 16.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 t -93.86 -70.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.52 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.72 -42.33 1.52 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.769 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.291 -179.351 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.49 HD11 ' HG2' ' A' ' 18' ' ' GLU . 52.7 mt . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.709 0.29 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.1 Cg_endo -73.63 162.49 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.042 2.495 . . . . 0.0 111.714 176.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 6.6 Cg_exo -73.39 -169.45 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 t -98.68 130.68 27.32 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.9 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.96 8.98 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.638 2.225 . . . . 0.0 112.553 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.46 HE22 ' HB3' ' A' ' 30' ' ' HIS . 44.2 mt-30 -123.04 -37.08 2.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.393 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.6 m -107.04 -45.94 4.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.24 -9.66 0.86 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 1.4 m -43.86 -75.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.004 0.522 . . . . 0.0 111.974 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.0 pt-20 159.04 -3.49 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.005 0.816 . . . . 0.0 111.569 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.591 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 63.2 m-85 -77.26 34.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.628 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -100.85 141.08 34.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.159 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -151.89 177.15 10.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HG2' HD11 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -110.42 124.61 52.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.418 0.628 . . . . 0.0 111.61 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.66 70.05 0.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.674 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.19 -107.66 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.112 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.8 18.03 21.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -159.96 -174.32 4.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.159 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.92 134.45 53.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -124.97 141.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 50.4 t -104.63 105.81 51.94 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.758 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.7 Cg_endo -66.85 -14.26 43.09 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.658 2.239 . . . . 0.0 110.968 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.483 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 33.2 tt0 -70.29 -58.97 3.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.633 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.34 10.29 39.24 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.5 46.11 12.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.46 ' HB3' HE22 ' A' ' 10' ' ' GLN . 24.8 t-80 -142.91 127.41 17.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.678 175.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.539 ' HB3' HD11 ' A' ' 22' ' ' LEU . 2.3 mp0 -91.4 157.07 17.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.023 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -159.07 162.08 36.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 t -115.98 127.76 26.51 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo . . . . . 0 CA--C 1.528 0.223 0 C-N-CA 122.786 2.324 . . . . 0.0 113.192 -175.396 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.74 HG12 HG22 ' A' ' 54' ' ' VAL . 5.5 t . . . . . 0 N--CA 1.45 -0.474 0 CA-C-O 121.153 0.502 . . . . 0.0 109.879 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.707 HG21 HG13 ' A' ' 94' ' ' ILE . 2.1 mm -91.09 131.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.413 -170.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.51 176.58 6.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 111.84 -179.226 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 15.2 m-20 -116.23 178.26 4.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.109 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.498 ' HB3' HD11 ' A' ' 64' ' ' ILE . 9.3 t -77.03 -5.22 47.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.243 1.02 . . . . 0.0 109.968 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.48 HG21 ' CG ' ' A' ' 112' ' ' ARG . 2.5 t -91.03 -8.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.602 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.28 -6.22 78.26 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.714 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.439 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -90.3 165.41 13.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 110.941 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.74 HG22 HG12 ' A' ' 46' ' ' VAL . 2.9 p -119.79 147.63 23.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.917 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.841 ' HA ' ' HD3' ' A' ' 113' ' ' LYS . 1.8 mt -96.54 178.23 5.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.411 -169.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -127.79 147.95 50.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.596 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -69.19 99.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.8 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.77 -6.91 9.58 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.523 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.91 175.44 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.96 0.41 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 41.4 m -103.01 137.47 41.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.595 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.712 HG22 HD22 ' A' ' 55' ' ' LEU . 1.4 pp -121.84 164.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.423 HG23 ' HA2' ' A' ' 79' ' ' GLY . 2.7 m -149.16 117.95 6.65 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.12 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.632 HG11 HG12 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.48 129.45 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.561 HG12 ' HD3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -102.86 17.19 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.561 ' HD3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -140.7 164.46 30.14 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.76 0.709 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.646 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -82.94 118.44 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.885 0.85 . . . . 0.0 112.656 174.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 66' ' ' ASP . 11.7 mt -135.4 142.29 45.63 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.758 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -92.54 178.32 5.85 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.399 -0.813 . . . . 0.0 111.29 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.76 131.98 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 70' ' ' LYS . 17.0 tptm -93.02 130.2 38.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.82 18.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.083 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.692 ' HB3' HD23 ' A' ' 74' ' ' LEU . 39.5 m -115.37 155.97 26.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.689 0.28 . . . . 0.0 110.816 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -85.18 18.88 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.603 0.716 . . . . 0.0 109.943 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.692 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -79.36 171.87 14.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.258 175.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.3 t -159.29 118.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -169.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.632 HG12 HG11 ' A' ' 63' ' ' VAL . 84.8 t -92.13 95.16 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.069 0.938 . . . . 0.0 109.95 -175.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 146.41 34.44 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.252 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -46.54 97.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.097 0.873 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.423 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.04 2.73 5.07 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.487 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.5 m -61.85 104.51 0.46 Allowed 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.904 0.859 . . . . 0.0 109.732 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -90.77 115.62 27.99 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.034 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 96' ' ' CYS . 77.7 t -131.91 113.45 22.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.213 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 60.1 pttt -107.88 164.05 12.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.329 0.585 . . . . 0.0 112.324 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.577 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 47.3 m-80 70.26 42.04 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.892 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.3 pt -65.39 175.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.987 0.899 . . . . 0.0 112.904 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.596 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 7.3 tpp180 -126.66 126.07 42.94 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.212 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.489 HD22 HG12 ' A' ' 47' ' ' ILE . 38.1 mt -81.54 117.5 21.98 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.785 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.0 OUTLIER . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -176.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.785 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.0 m-20 . . . . . 0 CA--C 1.516 -0.334 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.707 HG13 HG21 ' A' ' 47' ' ' ILE . 9.6 mt -114.44 115.53 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.7 t70 -96.39 134.06 40.01 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.592 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.4 p -129.88 134.91 47.8 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.779 -176.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -101.29 111.66 23.95 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.79 108.5 25.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.956 0.408 . . . . 0.0 110.858 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.81 101.46 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.938 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.31 -39.42 0.76 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.493 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.428 HG21 HD21 ' A' ' 74' ' ' LEU . 23.8 pt -130.35 -39.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.62 -149.02 20.01 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -91.31 148.53 22.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.965 0.412 . . . . 0.0 110.939 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . 0.48 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 50.7 ttm -136.3 157.24 47.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.194 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.515 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -99.86 141.82 32.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.698 175.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 93.7 mt -132.48 138.08 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.172 0.511 . . . . 0.0 111.492 -176.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 110' ' ' PHE . 43.5 mtpt -81.95 125.79 31.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.423 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.3 t -48.07 -42.62 29.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.945 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.17 -7.76 20.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.091 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.498 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 33.6 m-85 -115.93 2.4 13.52 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 94' ' ' ILE . 33.8 m -113.33 170.13 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.48 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.2 ttt-85 -150.87 131.32 13.79 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.819 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.841 ' HD3' ' HA ' ' A' ' 55' ' ' LEU . 35.1 ttpt -75.94 123.64 26.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 110.554 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.6 t -76.21 -41.4 37.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.577 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.46 11.15 80.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.975 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.8 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.889 179.296 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.451 -0.405 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.28 160.92 47.42 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.606 2.204 . . . . 0.0 111.609 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.46 -172.8 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.344 2.03 . . . . 0.0 111.79 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.5 t -97.89 125.93 42.46 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.34 10.87 0.39 Allowed 'Trans proline' 0 N--CA 1.469 0.052 0 C-N-CA 122.547 2.165 . . . . 0.0 111.81 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.508 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 34.9 mt-30 -125.3 -31.11 3.08 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.991 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.8 m -116.07 -40.25 3.32 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.843 -0.536 . . . . 0.0 110.37 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 75.76 -26.83 0.19 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.272 1.029 . . . . 0.0 113.004 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 m -45.7 -77.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 173.59 30.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.594 0.712 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.736 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 64.7 m-85 -96.63 27.8 3.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.125 -172.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 23' ' ' LEU . 1.7 m -101.91 141.42 34.79 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.451 174.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.8 p90 -148.12 175.82 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.17 121.41 45.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.75 0.705 . . . . 0.0 111.487 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.431 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 33.0 t70 -113.52 75.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.269 0.556 . . . . 0.0 109.59 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.18 -108.75 3.63 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.118 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.24 20.38 18.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.471 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.2 pt? -160.49 -174.17 4.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.592 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 25.0 mt -109.06 136.57 48.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.731 174.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.462 HG13 ' HG3' ' A' ' 31' ' ' GLU . 60.2 t -122.19 131.35 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 122.296 -0.253 . . . . 0.0 110.385 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -101.28 108.96 57.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 58.7 Cg_endo -71.7 -8.42 23.09 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.907 2.404 . . . . 0.0 111.216 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.538 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 13.8 tp10 -75.87 -70.49 0.43 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.313 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.12 10.55 23.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.33 41.34 23.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.092 0.472 . . . . 0.0 111.992 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.439 ' HB3' HE22 ' A' ' 10' ' ' GLN . 17.8 t-160 -138.74 128.46 24.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.867 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB3' HD11 ' A' ' 22' ' ' LEU . 2.2 mp0 -91.1 161.31 15.15 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.84 161.52 17.84 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 120.947 0.404 . . . . 0.0 110.41 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.7 t -115.14 137.91 23.23 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 11.5 Cg_endo . . . . . 0 C--N 1.343 0.264 0 C-N-CA 123.169 2.579 . . . . 0.0 113.219 -173.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.407 HG12 ' CG1' ' A' ' 54' ' ' VAL . 14.5 t . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.417 HG21 HG12 ' A' ' 94' ' ' ILE . 9.6 mm -75.58 137.83 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.627 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.579 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.1 OUTLIER -119.17 156.6 29.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.0 176.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 5.9 m-20 -96.92 -179.01 4.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.224 -176.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 30.7 t -80.13 -6.54 57.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.964 0.888 . . . . 0.0 109.538 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.7 t -90.95 -17.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.716 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.13 3.14 57.92 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.211 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.508 HD22 ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -84.31 167.44 16.57 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.036 0.922 . . . . 0.0 110.819 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.54 HG22 ' HG3' ' A' ' 48' ' ' LYS . 24.0 t -117.05 139.28 44.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.887 -1.96 . . . . 0.0 108.255 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.418 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 2.1 mm? -97.33 174.55 6.64 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.37 0.605 . . . . 0.0 110.704 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 57' ' ' ASP . 30.4 tp60 -125.24 145.67 49.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.717 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 14.9 t70 -67.76 99.51 0.82 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.643 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.62 -7.21 9.63 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.17 174.99 5.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.944 0.402 . . . . 0.0 110.937 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.5 m -106.91 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.67 166.89 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.1 m -150.54 119.1 6.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.851 0.358 . . . . 0.0 111.355 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.717 HG11 HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -63.66 126.65 22.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.19 22.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.627 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -143.24 159.53 42.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.48 100.53 11.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.952 0.882 . . . . 0.0 112.707 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.629 HD21 ' CD2' ' A' ' 110' ' ' PHE . 6.6 mp -110.63 153.71 24.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.038 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -98.76 179.33 4.69 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.777 0.322 . . . . 0.0 111.385 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.61 HG21 ' HB2' ' A' ' 72' ' ' SER . 33.7 m -119.55 147.2 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.7 ' HG3' ' H ' ' A' ' 71' ' ' GLY . 18.2 ptmt -77.84 -76.81 0.17 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.7 ' H ' ' HG3' ' A' ' 70' ' ' LYS . . . -92.07 47.96 2.69 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.969 -173.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.61 ' HB2' HG21 ' A' ' 69' ' ' VAL . 74.6 m -144.33 176.76 9.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.7 m -104.96 6.43 33.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.604 1.192 . . . . 0.0 108.03 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.578 ' O ' HG22 ' A' ' 69' ' ' VAL . 4.5 mm? -77.91 176.67 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.224 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.1 t -160.02 113.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.717 HG12 HG11 ' A' ' 63' ' ' VAL . 87.2 t -85.68 93.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.56 0.695 . . . . 0.0 109.503 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -106.48 148.15 28.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -171.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -48.29 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.92 0.867 . . . . 0.0 111.348 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.59 8.0 3.28 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.107 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 62' ' ' THR . 85.7 m -63.92 103.19 0.55 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 122.153 0.978 . . . . 0.0 109.653 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 81' ' ' LYS . 5.6 ttpm? -92.5 110.48 21.89 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.096 -174.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 96' ' ' CYS . 56.8 t -126.49 117.88 49.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.758 177.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 55.6 pttt -105.1 163.02 12.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.662 . . . . 0.0 112.11 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.643 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.8 OUTLIER 67.81 42.87 1.86 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.298 174.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.518 HG22 ' HB3' ' A' ' 96' ' ' CYS . 36.1 pt -65.63 -175.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.717 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 12.2 tpp85 -135.01 122.82 22.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.423 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.41 HD22 HG12 ' A' ' 47' ' ' ILE . 71.0 mt -76.4 118.91 19.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.321 -0.634 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.879 -176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.413 0 CA-C-O 121.319 0.58 . . . . 0.0 112.059 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 108' ' ' SER . 63.6 mt -142.72 125.66 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.204 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 4.5 t70 -104.98 139.04 40.27 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.518 ' HB3' HG22 ' A' ' 85' ' ' ILE . 27.2 p -155.05 165.56 36.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -112.07 135.77 52.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.517 HG13 HD11 ' A' ' 101' ' ' ILE . 2.2 mm -100.84 98.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.9 105.88 0.14 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.723 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.25 0.68 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.356 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.574 HG21 HD21 ' A' ' 74' ' ' LEU . 34.2 pt -96.07 -42.63 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 145.06 -166.11 27.59 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.0 148.38 24.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.998 0.899 . . . . 0.0 110.874 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.3 ttm -140.02 158.61 43.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -117.05 138.37 51.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.5 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -123.96 147.88 47.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.434 -171.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 13.6 tptm -84.82 122.37 29.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.812 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -50.97 -39.76 56.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.745 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' SER . 10.4 pt-20 -66.02 -9.05 26.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.294 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.629 ' CD2' HD21 ' A' ' 67' ' ' LEU . 42.1 m-85 -110.74 0.62 17.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.165 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 15.4 m -112.5 170.77 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.475 ' HD2' HG21 ' A' ' 51' ' ' VAL . 22.0 ttt180 -145.66 138.28 25.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.457 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 87.8 tttt -68.83 119.13 12.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.612 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.17 -47.36 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.02 48.63 25.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.052 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.427 -178.397 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 72.9 Cg_endo -73.11 156.9 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.223 1.949 . . . . 0.0 111.133 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 8.0 Cg_exo -72.49 -163.3 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.9 2.4 . . . . 0.0 112.603 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.4 t -98.32 130.56 28.03 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.47 5.28 2.03 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.287 . . . . 0.0 112.927 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -121.2 -35.13 3.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.241 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 13' ' ' SER . 58.0 m -104.79 -47.31 4.08 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.49 -0.756 . . . . 0.0 109.511 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.54 -2.35 1.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.08 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 11' ' ' CYS . 15.0 p -48.32 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.095 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 170.03 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.263 0.352 . . . . 0.0 111.681 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.657 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 80.8 m-85 -77.79 39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -171.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -103.28 143.31 32.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.515 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -153.88 176.73 11.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.71 123.47 47.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.838 0.352 . . . . 0.0 111.441 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -121.17 86.43 2.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.43 -116.16 5.01 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.132 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.77 18.23 22.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.902 0.382 . . . . 0.0 111.789 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.4 -173.49 4.52 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 mt -112.86 138.39 49.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.651 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -126.75 142.75 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 51.7 t -104.5 105.48 50.2 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.733 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.7 Cg_endo -65.84 -15.95 51.02 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.816 2.344 . . . . 0.0 111.512 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.1 tt0 -71.21 -61.39 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.93 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -98.82 12.76 34.69 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.95 29.54 17.81 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -135.75 133.92 38.49 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.131 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.651 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.4 mp0 -95.11 171.68 8.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.642 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -166.22 161.83 17.09 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.932 0.396 . . . . 0.0 110.558 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -115.57 113.79 42.65 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo . . . . . 0 C--O 1.232 0.189 0 C-N-CA 123.201 2.601 . . . . 0.0 113.195 -168.02 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.662 HG21 HG13 ' A' ' 94' ' ' ILE . 3.0 mm -89.93 135.44 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.079 -172.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.733 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -115.0 145.71 41.99 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.602 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 70.4 m-20 -104.5 179.43 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.515 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 5.0 t -73.93 -9.22 58.42 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.93 0.872 . . . . 0.0 110.315 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.1 t -84.91 -18.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.657 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.58 12.7 60.66 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.5 -175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.602 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -99.72 153.38 19.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.257 0.551 . . . . 0.0 111.112 178.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.41 133.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.328 -175.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.557 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.3 mp -96.67 175.17 6.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.25 0.548 . . . . 0.0 111.724 -168.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -124.81 146.98 48.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.687 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 17.8 t70 -70.65 102.21 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 0.0 110.625 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.48 -3.98 13.53 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.27 171.61 10.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.969 -0.615 . . . . 0.0 110.833 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 31.1 m -104.75 137.64 42.25 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -121.16 168.56 13.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.7 m -148.96 118.3 6.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.888 0.375 . . . . 0.0 110.868 175.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 1.1 p -62.91 129.48 26.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.534 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -95.14 10.41 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 64' ' ' ILE . 74.9 mmtt -138.0 171.1 14.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 119.83 1.195 . . . . 0.0 110.255 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.78 112.23 22.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.496 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.9 mp -130.23 143.44 50.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.984 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -90.99 178.76 5.92 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.793 -0.567 . . . . 0.0 110.343 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 74' ' ' LEU . 57.8 t -122.24 115.68 46.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -79.16 117.87 20.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -166.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.9 45.76 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.08 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -110.86 172.86 6.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.343 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -98.01 9.16 43.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.532 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 69' ' ' VAL . 14.8 tp -78.85 170.66 16.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.734 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.416 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 72.5 t -158.13 117.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -168.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.528 HG12 HG11 ' A' ' 63' ' ' VAL . 94.3 t -93.48 95.76 5.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.851 0.834 . . . . 0.0 110.544 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.12 151.61 27.04 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.473 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.534 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -52.18 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.824 0.821 . . . . 0.0 110.817 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.16 4.89 3.16 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.174 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.5 m -61.92 104.74 0.49 Allowed 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 122.032 0.92 . . . . 0.0 110.148 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 30.0 ttpt -89.97 112.65 24.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.921 -175.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.1 t -123.67 114.39 41.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 ptmt -104.28 151.29 23.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.642 -175.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 68.88 47.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 124.33 1.019 . . . . 0.0 111.468 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.3 pt -65.89 -179.5 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.058 0.932 . . . . 0.0 113.193 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.687 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 19.4 tpt180 -129.15 122.37 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.636 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.576 HD22 HG12 ' A' ' 47' ' ' ILE . 79.6 mt -83.07 119.64 24.75 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.314 -0.951 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -175.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 88' ' ' VAL . 6.0 m-20 . . . . . 0 C--O 1.225 -0.224 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.662 HG13 HG21 ' A' ' 47' ' ' ILE . 38.1 mt -120.09 113.69 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.322 174.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 13.4 t70 -95.63 139.79 31.38 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.802 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.488 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.7 p -149.39 159.79 43.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.069 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 14.2 mptt -112.32 135.13 53.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.686 HG13 HD11 ' A' ' 101' ' ' ILE . 1.8 mm -114.07 109.01 26.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.6 102.02 0.13 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.94 -66.48 0.51 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.829 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.686 HD11 HG13 ' A' ' 98' ' ' ILE . 45.7 pt -86.9 -48.82 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.545 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 141.63 -157.72 26.34 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -176.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -77.37 144.03 38.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 117.939 0.869 . . . . 0.0 110.529 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 52.9 ttp -133.69 151.88 51.75 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -112.11 140.67 46.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.1 mt -120.96 139.58 53.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.464 0.649 . . . . 0.0 111.528 -171.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 22.2 tptm -80.83 116.23 20.71 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.824 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.733 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 7.5 p -53.98 -34.52 60.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.602 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 50' ' ' SER . 37.5 mt-10 -68.94 -9.87 54.27 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.47 ' O ' HD13 ' A' ' 64' ' ' ILE . 63.8 m-85 -109.41 -4.46 16.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.049 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.9 m -113.6 173.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.314 0.578 . . . . 0.0 112.12 -174.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.506 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.9 ttt180 -147.07 133.14 19.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.002 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 27.8 tttp -65.1 136.87 57.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.009 176.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.2 -56.56 5.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.588 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.54 49.62 10.98 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.063 -172.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.589 -178.015 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 23' ' ' LEU . 51.0 mt . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 62.8 Cg_endo -70.95 156.85 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.029 1.82 . . . . 0.0 111.344 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -73.91 -163.55 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.843 2.362 . . . . 0.0 112.7 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.9 t -98.29 124.2 47.89 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.406 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.45 11.27 0.63 Allowed 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 122.899 2.399 . . . . 0.0 111.563 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 12.1 mt-30 -120.8 -38.32 2.87 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 -178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m -108.26 -50.29 3.06 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t30 70.0 7.18 6.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.368 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.51 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 5.1 m -54.32 -76.6 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.982 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 13' ' ' SER . 15.5 pt-20 165.66 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.327 0.392 . . . . 0.0 111.977 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.501 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 87.6 m-85 -78.43 33.67 0.2 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -169.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -95.71 139.89 31.29 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.587 0.232 . . . . 0.0 110.563 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 20.9 p90 -147.48 178.09 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.1 122.19 47.26 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.206 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.539 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 24.0 t70 -118.35 89.28 3.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.879 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.46 -106.58 3.43 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.196 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.36 17.34 17.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 31' ' ' GLU . 1.3 pt? -163.91 -175.05 3.88 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.249 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.409 ' CD1' ' HG2' ' A' ' 6' ' ' PRO . 22.4 mt -101.36 135.56 42.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.561 HG13 ' HG3' ' A' ' 31' ' ' GLU . 64.8 t -117.62 130.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 50.4 t -101.6 103.93 31.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 173.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.0 Cg_endo -65.89 -18.65 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.508 2.139 . . . . 0.0 110.969 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.59 -61.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.194 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.401 ' SG ' ' NE2' ' A' ' 10' ' ' GLN . 28.4 p -95.44 11.35 33.18 Favored 'General case' 0 C--O 1.23 0.055 0 O-C-N 121.649 -0.657 . . . . 0.0 112.313 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.63 26.0 15.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.421 ' HB3' HE22 ' A' ' 10' ' ' GLN . 17.0 t-80 -125.94 135.83 52.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.506 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.561 ' HG3' HG13 ' A' ' 24' ' ' VAL . 6.2 mp0 -96.54 158.27 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.545 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -158.9 161.32 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.9 p -120.15 128.63 25.74 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 174.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.545 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 8.6 Cg_endo . . . . . 0 C--N 1.344 0.311 0 C-N-CA 123.412 2.741 . . . . 0.0 113.215 -170.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.558 HG23 HD13 ' A' ' 87' ' ' LEU . 14.4 p . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.925 0.393 . . . . 0.0 111.034 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.433 HG12 ' HB3' ' A' ' 87' ' ' LEU . 6.3 mm -72.84 139.34 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.904 -172.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -126.48 154.44 43.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.11 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 8.3 m-20 -99.95 179.99 4.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.189 0.518 . . . . 0.0 111.467 -174.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 14.7 t -82.8 -13.02 56.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.023 0.916 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.604 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.0 p -89.24 -0.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.097 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 5.37 68.6 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.277 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.604 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -108.32 173.16 6.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.536 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.549 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.9 t -115.17 142.31 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.254 -175.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.728 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -98.7 -177.47 3.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 110.251 -177.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.445 ' HA ' HD11 ' A' ' 87' ' ' LEU . 14.5 tt0 -136.69 163.41 30.65 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 16.5 t70 -65.26 130.73 44.38 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.83 -6.96 82.71 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.351 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.87 165.24 20.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 61.4 m -103.81 137.2 42.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.575 HG22 HD22 ' A' ' 55' ' ' LEU . 1.6 pp -117.72 164.67 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' THR . 3.8 m -149.92 112.12 4.65 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -59.8 129.23 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.667 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.558 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -99.23 15.2 4.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.801 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.471 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.37 157.79 45.49 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -89.78 109.18 20.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 112.135 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.414 HD21 ' CD2' ' A' ' 110' ' ' PHE . 12.4 mt -124.59 152.44 43.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.25 177.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -95.81 178.52 5.42 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.997 -0.44 . . . . 0.0 111.291 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.11 130.81 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -74.82 128.53 35.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.837 0.351 . . . . 0.0 111.529 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.15 -13.12 3.6 Favored Glycine 0 CA--C 1.517 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.574 173.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.524 ' HB3' HD23 ' A' ' 74' ' ' LEU . 37.3 m -107.58 155.15 20.43 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.643 -0.328 . . . . 0.0 110.877 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -81.5 8.28 9.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.495 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 72' ' ' SER . 3.8 mm? -78.6 170.37 16.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.604 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -159.88 117.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.606 HG12 HG11 ' A' ' 63' ' ' VAL . 86.5 t -93.66 95.69 5.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 110.368 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 150.23 27.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.048 -175.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -49.94 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.948 0.88 . . . . 0.0 110.759 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.72 4.79 4.19 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.475 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.8 m -62.36 105.32 0.6 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.871 0.843 . . . . 0.0 110.059 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -89.27 112.68 23.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.75 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 96' ' ' CYS . 44.7 t -124.59 113.18 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.3 ptmt -96.12 167.76 11.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.763 -174.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.64 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 9.1 p30 60.04 39.66 19.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.943 -1.48 . . . . 0.0 112.314 170.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.3 pt -64.18 179.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 -128.69 126.84 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.077 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.558 HD13 HG23 ' A' ' 46' ' ' VAL . 58.2 mt -80.58 120.16 24.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 93' ' ' ASP . 5.3 t . . . . . 0 C--N 1.316 -0.852 0 CA-C-O 121.114 0.483 . . . . 0.0 110.742 -172.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.598 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.5 m-20 . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.221 0.534 . . . . 0.0 111.473 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.635 ' CD1' HG21 ' A' ' 111' ' ' VAL . 66.7 mt -116.23 122.35 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.791 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.51 132.4 42.13 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.091 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.458 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -134.18 142.72 47.52 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -105.32 117.02 32.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.5 mt -117.28 113.33 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.167 -171.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.28 110.64 1.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 143.95 -62.19 0.5 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.815 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 -35.85 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 0.0 111.392 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.94 -147.88 19.46 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.66 147.02 23.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 111.065 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 61.2 ttp -144.46 165.87 26.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.881 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.98 148.01 34.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.897 0.38 . . . . 0.0 110.195 177.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.0 mt -130.08 140.37 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.912 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.45 ' HG3' ' OE1' ' A' ' 109' ' ' GLU . 9.3 tptp -80.0 115.07 19.37 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.675 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -50.36 -40.19 48.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 50' ' ' SER . 1.6 mp0 -69.6 -10.01 56.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.421 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.425 ' HD1' ' HB3' ' A' ' 107' ' ' LYS . 75.3 m-85 -112.09 -0.12 15.74 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 35.0 m -115.62 174.5 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.259 0.552 . . . . 0.0 112.163 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.478 ' HG3' HG11 ' A' ' 51' ' ' VAL . 19.9 ttt180 -143.22 131.78 22.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.273 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.728 ' HG3' ' HA ' ' A' ' 55' ' ' LEU . 1.9 tmtp? -70.43 119.97 15.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.381 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.25 -48.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.52 ' HA2' ' HE3' ' A' ' 113' ' ' LYS . . . 88.49 44.72 5.17 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.831 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.455 177.014 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.608 HD13 HD22 ' A' ' 23' ' ' LEU . 17.8 mt . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 120.356 0.122 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 36.6 Cg_endo -63.45 161.63 30.57 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.551 2.167 . . . . 0.0 111.808 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.536 ' HB3' ' HG3' ' A' ' 14' ' ' GLU . 11.5 Cg_exo -70.44 -170.7 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.775 2.316 . . . . 0.0 112.496 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.46 123.68 49.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.08 9.04 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.545 2.163 . . . . 0.0 111.866 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.581 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 14.5 mt-30 -119.42 -36.21 3.4 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.889 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -110.82 -46.99 3.28 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 121.265 0.555 . . . . 0.0 109.727 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.21 5.83 5.13 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.91 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 m -61.41 -27.5 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.043 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 7' ' ' PRO . 4.4 mt-10 78.06 13.54 1.63 Allowed 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 174.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -81.03 47.46 1.0 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.717 0.77 . . . . 0.0 109.039 170.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 m -99.18 147.12 25.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.961 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -148.08 173.92 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.43 116.05 31.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 0.0 110.582 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -96.94 28.27 3.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.049 0.928 . . . . 0.0 109.675 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.82 -99.7 0.41 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.546 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.27 17.64 22.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.916 0.389 . . . . 0.0 111.577 -173.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 31' ' ' GLU . 2.2 pt? -159.83 -176.67 5.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.608 HD22 HD13 ' A' ' 5' ' ' LEU . 3.5 mt -109.98 135.04 51.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -125.76 140.52 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 0.0 109.599 177.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 45.9 t -102.36 106.19 47.37 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.475 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 25' ' ' CYS . 33.9 Cg_endo -65.2 -14.66 46.3 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.679 2.253 . . . . 0.0 111.361 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.07 -59.36 2.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.891 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.1 p -99.08 10.14 42.07 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.59 39.85 20.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.406 ' HB3' HE22 ' A' ' 10' ' ' GLN . 20.8 t60 -139.47 126.72 21.32 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.585 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.47 164.66 11.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.778 177.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -163.99 162.05 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.489 . . . . 0.0 111.026 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.2 t -104.68 123.26 40.79 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 C-N-CA 122.952 2.435 . . . . 0.0 113.112 -171.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.475 HG13 HD13 ' A' ' 87' ' ' LEU . 6.1 t . . . . . 0 C--O 1.231 0.108 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.59 HG21 HG13 ' A' ' 94' ' ' ILE . 2.8 mm -91.66 135.23 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.667 ' O ' ' HB2' ' A' ' 108' ' ' SER . 11.7 ttmt -121.09 155.0 35.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 111' ' ' VAL . 9.0 m-20 -92.98 176.83 6.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.304 0.573 . . . . 0.0 111.449 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 13.5 t -79.0 -7.37 58.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.642 174.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.52 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.0 t -91.02 -15.37 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.347 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.98 0.39 60.16 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.52 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -83.45 162.67 20.89 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.901 0.857 . . . . 0.0 110.767 178.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.494 HG22 ' HE2' ' A' ' 48' ' ' LYS . 2.9 t -118.19 130.64 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.909 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.411 ' HB2' HD21 ' A' ' 87' ' ' LEU . 1.5 mm? -93.76 173.19 7.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.377 0.608 . . . . 0.0 110.645 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.29 150.72 48.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.692 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.583 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 17.7 t70 -67.43 99.14 0.71 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.449 . . . . 0.0 109.891 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 121.72 -7.45 10.27 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.385 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.67 167.96 14.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.698 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.5 m -106.45 131.65 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.795 HG13 HG23 ' A' ' 82' ' ' VAL . 1.9 pp -127.57 169.11 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.721 0.296 . . . . 0.0 110.311 -174.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.8 m -150.6 121.68 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.574 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -61.93 131.04 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 109.867 176.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.537 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -94.98 10.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 64' ' ' ILE . 58.1 mmtt -139.18 167.63 21.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 119.843 1.201 . . . . 0.0 110.034 -176.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.4 109.86 20.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.176 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 mp -123.95 138.54 54.45 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.466 173.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.02 177.7 5.66 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.651 -0.656 . . . . 0.0 110.265 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 72' ' ' SER . 39.0 t -128.83 120.98 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -84.77 -32.77 23.22 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.559 ' N ' ' HD3' ' A' ' 70' ' ' LYS . . . -86.4 -26.82 32.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.924 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.698 ' HB3' HD23 ' A' ' 74' ' ' LEU . 60.8 m -110.42 163.71 13.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 m -81.37 8.66 8.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.57 0.7 . . . . 0.0 109.96 173.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.93 172.35 13.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.107 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.4 t -159.35 113.81 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -166.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.495 HG12 HG11 ' A' ' 63' ' ' VAL . 94.8 t -90.97 96.78 6.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.828 0.823 . . . . 0.0 110.246 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.459 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.3 pptp? -106.04 148.2 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.54 96.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.974 0.893 . . . . 0.0 110.605 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA2' ' CG2' ' A' ' 62' ' ' THR . . . 133.09 4.76 3.21 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.005 -177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' THR . 88.7 m -63.53 103.46 0.53 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.959 0.885 . . . . 0.0 109.956 176.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -92.29 115.3 27.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.654 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.795 HG23 HG13 ' A' ' 61' ' ' ILE . 2.6 m -120.04 119.87 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.808 0.813 . . . . 0.0 110.519 171.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.0 pttp -103.82 148.8 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.465 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.58 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 71.54 43.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.127 0.892 . . . . 0.0 111.284 176.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.31 -178.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 122.098 0.951 . . . . 0.0 113.016 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -129.74 124.69 34.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.867 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.475 HD13 HG13 ' A' ' 46' ' ' VAL . 71.3 mt -82.63 117.51 22.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.9 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.9 OUTLIER . . . . . 0 C--N 1.318 -0.8 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.12 -173.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.9 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 4.6 m-20 . . . . . 0 N--CA 1.448 -0.533 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.59 HG13 HG21 ' A' ' 47' ' ' ILE . 30.5 mt -120.94 111.06 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.557 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 24.7 t70 -94.47 135.31 36.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 p -134.42 142.07 47.02 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.955 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -104.89 119.29 38.65 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.7 mt -118.72 108.81 25.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.292 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -54.66 126.17 22.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.382 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.87 -53.45 0.78 Allowed Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 102' ' ' GLY . 40.6 pt -112.18 -39.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.782 0.325 . . . . 0.0 110.961 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.422 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 135.3 -149.21 19.89 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.98 155.01 19.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.015 0.407 . . . . 0.0 110.863 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -147.21 161.93 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.431 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -107.69 146.89 31.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.26 142.18 50.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.398 0.618 . . . . 0.0 111.452 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -78.05 120.05 22.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.671 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.667 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.9 p -57.11 -34.57 68.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.988 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 50' ' ' SER . 4.8 pm0 -70.23 -7.22 40.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.421 ' O ' HD13 ' A' ' 64' ' ' ILE . 55.0 m-85 -112.75 3.63 16.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 49' ' ' ASP . 29.1 m -110.48 166.53 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.422 0.63 . . . . 0.0 112.531 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -141.3 133.51 27.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.356 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.495 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 33.0 tttp -65.95 139.49 58.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.22 -42.78 8.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.491 ' CA ' ' HE3' ' A' ' 113' ' ' LYS . . . 79.54 29.56 48.24 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.143 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.85 176.816 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.546 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 21.9 mt . . . . . 0 N--CA 1.45 -0.435 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 63.2 Cg_endo -68.88 154.61 70.68 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 121.552 1.501 . . . . 0.0 110.741 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 7.7 Cg_exo -71.77 -165.78 0.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.669 2.246 . . . . 0.0 112.294 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.7 t -97.75 123.26 52.41 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.046 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.39 11.21 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.895 2.397 . . . . 0.0 111.739 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 13.7 mt-30 -122.22 -37.68 2.79 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.891 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -107.09 -49.12 3.34 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.247 0.546 . . . . 0.0 109.721 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 70.51 -3.73 1.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.249 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 8.3 t -54.68 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.371 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 13' ' ' SER . 11.3 pt-20 171.68 -8.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 96.7 m-85 -78.8 35.42 0.24 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 112.017 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -97.82 134.98 40.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.307 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 27.5 p90 -145.52 171.66 14.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.12 123.22 46.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.067 0.46 . . . . 0.0 110.916 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.69 84.08 2.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.02 -114.03 4.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.225 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.93 20.66 18.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -171.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.72 -174.82 4.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.495 HD22 HD13 ' A' ' 5' ' ' LEU . 35.0 mt -110.58 135.61 50.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -126.31 140.65 48.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -107.49 106.22 57.88 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.176 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.3 Cg_endo -68.46 -14.31 39.58 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.704 2.27 . . . . 0.0 110.79 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.601 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 32.6 tt0 -66.09 -58.78 4.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.076 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.18 8.74 36.31 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.46 49.36 13.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.429 0.559 . . . . 0.0 112.112 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.435 ' HB3' HE22 ' A' ' 10' ' ' GLN . 13.6 t-80 -147.72 128.09 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.01 171.62 8.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -168.75 162.16 11.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.9 m -119.81 116.31 33.08 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo . . . . . 0 C--N 1.344 0.298 0 C-N-CA 123.319 2.68 . . . . 0.0 113.106 -170.675 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.501 HG13 HD13 ' A' ' 87' ' ' LEU . 2.6 t . . . . . 0 C--O 1.234 0.268 0 CA-C-O 121.045 0.45 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 93' ' ' ASP . 2.5 mm -105.32 141.22 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.058 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -105.03 165.79 10.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.0 111.739 -178.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.9 m-20 -109.97 172.7 6.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.784 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 64' ' ' ILE . 36.1 t -77.22 -7.46 55.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.594 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.4 p -93.2 0.31 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.257 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 4.08 69.86 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.285 171.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.594 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -105.02 168.25 9.17 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.829 -0.748 . . . . 0.0 112.14 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 46' ' ' VAL . 2.4 t -113.66 137.08 48.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.847 -174.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 61' ' ' ILE . 9.2 mt -89.88 172.84 8.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.581 0.705 . . . . 0.0 112.097 -171.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.435 HE21 ' HB3' ' A' ' 56' ' ' GLN . 2.2 tt0 -121.84 142.63 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.571 173.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.635 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 6.4 t70 -67.03 105.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.041 0.448 . . . . 0.0 110.375 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.424 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 114.49 -0.84 23.55 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -80.2 174.25 11.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.306 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 26.9 m -102.56 139.18 38.49 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.6 HG22 HD22 ' A' ' 55' ' ' LEU . 2.1 pp -118.66 165.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 m -147.97 118.39 7.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.835 0.35 . . . . 0.0 110.084 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.662 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.22 127.51 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.793 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.42 19.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.793 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.1 mptp? -135.62 163.93 29.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.436 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.6 p-10 -86.83 113.39 22.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.933 0.873 . . . . 0.0 111.72 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 66' ' ' ASP . 18.3 mt -125.4 148.05 48.94 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.98 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -98.31 177.12 5.47 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.8 170.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 72' ' ' SER . 57.3 t -125.15 131.42 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -83.1 -38.96 21.75 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.48 -25.03 59.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.254 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 69' ' ' VAL . 71.8 m -115.11 171.6 7.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.234 0.54 . . . . 0.0 111.774 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.0 t -92.07 1.9 56.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.398 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 101' ' ' ILE . 10.7 mp -79.68 136.49 36.81 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.464 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.03 133.69 43.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.006 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.662 HG12 HG11 ' A' ' 63' ' ' VAL . 53.5 t -89.03 100.56 10.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.615 0.722 . . . . 0.0 109.925 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -105.18 150.44 25.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.721 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -51.31 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.848 0.832 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.13 4.82 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.16 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.0 m -61.29 105.45 0.5 Allowed 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 122.147 0.975 . . . . 0.0 110.129 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 36.3 ttpt -90.84 114.24 26.61 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.206 -173.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 96' ' ' CYS . 21.5 t -123.72 117.26 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.027 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 11.3 ptmm? -99.92 154.03 18.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.558 -173.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.424 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 16.2 m-80 64.25 50.01 2.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.685 175.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.8 pt -65.66 177.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.826 0.822 . . . . 0.0 112.725 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.635 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 10.3 tpt180 -131.69 125.52 32.3 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.076 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.501 HD13 HG13 ' A' ' 46' ' ' VAL . 36.3 mt -84.25 118.33 24.1 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.542 ' O ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.953 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.48 -175.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.3 m-20 . . . . . 0 CA--C 1.512 -0.496 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.596 ' CD1' HG21 ' A' ' 111' ' ' VAL . 50.5 mt -121.22 116.49 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.388 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 30.8 t70 -93.96 128.42 40.27 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.77 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.823 ' HB2' HG11 ' A' ' 82' ' ' VAL . 25.3 p -130.86 137.12 49.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.071 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -107.72 118.85 37.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.84 108.27 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 -171.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -63.93 107.61 1.28 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.434 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.27 -45.04 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.394 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.45 HD13 HD22 ' A' ' 74' ' ' LEU . 15.6 pt -120.29 -37.54 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.87 0.366 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.27 -153.33 21.85 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.26 151.92 21.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.092 0.446 . . . . 0.0 110.503 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.8 ttp -143.15 164.17 30.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.95 147.92 37.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 0.0 110.379 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 90.1 mt -129.52 144.01 51.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.791 -171.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -81.5 120.44 25.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.279 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.71 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 2.5 m -50.89 -36.91 40.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.328 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' SER . 42.8 mt-10 -71.32 -5.4 32.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.435 ' CG ' HD11 ' A' ' 67' ' ' LEU . 55.0 m-85 -114.36 -2.75 13.2 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.857 -0.737 . . . . 0.0 112.749 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 94' ' ' ILE . 34.8 m -113.72 172.7 3.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 25.0 ttt180 -151.74 133.94 15.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.582 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.408 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.4 tttt -65.28 123.16 18.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.19 174.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.47 -51.91 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.871 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.16 39.06 16.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.318 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.389 179.172 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.412 HD11 ' CD ' ' A' ' 18' ' ' GLU . 55.2 mt . . . . . 0 N--CA 1.451 -0.38 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.2 Cg_endo -71.49 157.45 56.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.1 1.867 . . . . 0.0 110.688 174.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 19.0 Cg_exo -66.6 -174.64 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.093 . . . . 0.0 113.258 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.764 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 34.3 t -99.6 123.22 48.76 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HG2' ' OE1' ' A' ' 10' ' ' GLN . 39.2 Cg_endo -70.01 7.27 1.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 121.887 1.725 . . . . 0.0 112.059 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.764 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 1.2 mp0 -103.0 -54.26 2.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.307 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.414 ' C ' ' H ' ' A' ' 13' ' ' SER . 28.4 p -117.77 -28.29 6.01 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.0 t30 75.88 -28.55 0.18 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.287 0.635 . . . . 0.0 112.287 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 63.5 p -32.5 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.574 1.171 . . . . 0.0 113.401 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.0 pt-20 169.35 -4.93 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.533 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.6 m-85 -81.16 42.41 0.65 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.27 0.557 . . . . 0.0 111.747 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -109.26 148.56 30.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.853 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -150.09 174.1 13.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.2 pm0 -102.77 115.61 30.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.377 0.608 . . . . 0.0 111.268 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.514 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 10.7 t70 -122.86 83.65 2.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.824 174.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.97 -126.38 8.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.336 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.47 17.61 23.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.962 0.41 . . . . 0.0 111.372 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.7 -174.07 4.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.1 mt -120.23 136.82 54.52 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.808 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -125.12 143.58 38.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.259 -179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.1 t -104.22 104.21 42.84 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 23.0 Cg_endo -61.49 -22.1 73.64 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.843 2.362 . . . . 0.0 111.179 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 17.0 tp10 -74.15 -59.7 2.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.7 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.2 m -74.48 -9.91 59.05 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.72 44.83 25.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.314 0.578 . . . . 0.0 110.433 -170.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -145.1 122.94 11.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.808 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.6 mp0 -91.62 157.92 16.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.787 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -158.3 163.13 37.67 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.6 t -125.5 124.41 25.05 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo . . . . . 0 C--N 1.343 0.242 0 C-N-CA 123.075 2.517 . . . . 0.0 113.023 -173.392 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 87' ' ' LEU . 12.2 p . . . . . 0 N--CA 1.451 -0.381 0 CA-C-O 120.682 0.277 . . . . 0.0 110.63 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.442 HG22 ' HB3' ' A' ' 108' ' ' SER . 2.0 mm -78.79 117.01 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.429 -173.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 108' ' ' SER . 1.2 mtmt -100.01 150.11 22.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.092 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.573 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 9.2 m-20 -90.5 176.64 6.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.516 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.6 t -77.09 -7.97 56.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.722 0.772 . . . . 0.0 110.761 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.602 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.1 p -97.3 -2.25 10.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.18 0.99 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.01 3.92 79.06 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.976 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.602 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -92.91 154.76 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.685 0.743 . . . . 0.0 111.017 177.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.3 109.94 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.612 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 113' ' ' LYS . 94.2 mt -58.76 145.7 39.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.383 175.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -120.51 148.94 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.709 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 1.2 t70 -63.94 126.36 27.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 88.66 2.01 79.63 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.816 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 173.64 12.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.967 0.383 . . . . 0.0 110.473 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 11.4 m -101.59 139.82 36.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.569 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.45 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -124.47 165.39 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.448 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.7 m -150.61 115.6 5.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.438 175.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.679 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.07 129.97 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.543 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -103.06 17.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.468 178.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.444 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.26 161.44 34.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.5 p-10 -85.55 111.31 19.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.938 0.875 . . . . 0.0 111.156 169.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.475 HD11 ' CB ' ' A' ' 110' ' ' PHE . 20.1 mt -124.43 133.88 53.25 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.145 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -88.28 173.2 8.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.749 -0.594 . . . . 0.0 109.963 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 72' ' ' SER . 21.7 t -128.92 120.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -93.36 -2.83 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.475 -170.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.14 26.31 6.45 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . 0.485 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 58.2 m -146.49 -177.69 5.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -177.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -100.87 -12.12 19.25 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 101' ' ' ILE . 9.8 mp -79.22 142.45 36.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.786 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.98 126.64 67.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.359 167.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.679 HG12 HG11 ' A' ' 63' ' ' VAL . 76.0 t -77.73 104.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.44 150.39 26.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.448 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.543 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -52.34 96.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 121.776 0.798 . . . . 0.0 110.501 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.32 4.13 3.68 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.23 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' THR . 89.8 m -62.76 105.1 0.61 Allowed 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.478 0.656 . . . . 0.0 110.67 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -91.07 120.53 32.11 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.551 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 96' ' ' CYS . 59.8 t -129.7 116.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.745 174.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.8 pttm -102.92 159.51 15.43 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.253 -175.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.589 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 46.5 m-80 65.25 48.53 2.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.453 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.9 pt -67.94 -178.95 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 11.1 tpp85 -136.44 124.39 22.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.602 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HB3' HG12 ' A' ' 47' ' ' ILE . 36.9 mt -79.83 125.38 29.63 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.042 -0.411 . . . . 0.0 110.086 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.107 -177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.3 m-20 . . . . . 0 N--CA 1.47 0.549 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.533 ' CD1' HG21 ' A' ' 111' ' ' VAL . 27.7 mt -139.36 115.17 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.07 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 20.5 t70 -92.73 133.99 35.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.313 0.578 . . . . 0.0 110.349 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.553 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -142.8 154.31 44.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.602 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 96.1 mttt -125.46 132.22 52.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mt -122.38 113.63 39.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.705 -167.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.75 100.69 0.95 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.215 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.75 -62.91 0.42 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.558 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 74' ' ' LEU . 20.0 pt -95.9 -46.19 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.986 0.422 . . . . 0.0 110.483 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 141.76 -155.82 25.56 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.607 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -81.85 144.75 30.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.757 0.279 . . . . 0.0 110.801 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.3 ttt -138.52 158.83 43.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 110.827 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.2 OUTLIER -111.16 137.17 49.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.816 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 86.3 mt -123.85 142.01 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.493 0.664 . . . . 0.0 111.455 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 6.5 mptt -92.9 121.24 34.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.256 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.3 p -51.88 -37.56 52.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.172 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -72.06 -6.75 44.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.844 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.475 ' CB ' HD11 ' A' ' 67' ' ' LEU . 60.5 m-85 -111.71 -4.13 14.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.891 -0.506 . . . . 0.0 111.995 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 34.8 m -114.88 175.36 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.492 ' HG3' HG11 ' A' ' 51' ' ' VAL . 26.7 ttt180 -151.46 130.98 12.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.423 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.479 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.1 tttt -66.63 122.21 17.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.338 175.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.44 -44.28 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.271 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.87 9.81 85.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.298 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.85 -178.51 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 121.39 0.614 . . . . 0.0 111.303 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.4 p -104.52 151.93 6.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.563 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 p -83.74 134.13 34.76 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.058 0.456 . . . . 0.0 111.163 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 t -94.05 17.22 12.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 122.331 1.062 . . . . 0.0 108.705 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.562 HD13 HD22 ' A' ' 23' ' ' LEU . 11.2 mt -87.2 160.75 48.13 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 114.007 -1.451 . . . . 0.0 109.742 -176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 41.8 Cg_endo -64.89 160.01 43.19 Favored 'Trans proline' 0 C--O 1.236 0.407 0 C-N-CA 122.319 2.013 . . . . 0.0 111.423 177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.78 -169.69 0.16 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.079 1.853 . . . . 0.0 112.161 175.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 8.4 t -97.35 123.61 52.0 Favored Pre-proline 0 C--N 1.315 -0.934 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -68.19 11.31 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.961 2.441 . . . . 0.0 111.806 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.491 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 37.8 mt-30 -122.73 -34.7 3.18 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.403 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.9 m -112.68 -45.13 3.25 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 121.785 -0.572 . . . . 0.0 110.489 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.9 t30 70.45 12.91 7.49 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.02 0.914 . . . . 0.0 110.511 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.602 ' HB2' ' HD1' ' A' ' 15' ' ' TYR . 20.9 p -67.12 -32.19 73.15 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.926 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 84.85 5.76 0.55 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.011 177.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.602 ' HD1' ' HB2' ' A' ' 13' ' ' SER . 83.7 m-85 -82.7 47.32 1.17 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 121.689 0.757 . . . . 0.0 109.804 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 m -102.65 150.23 23.65 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.121 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.4 p90 -142.0 169.11 18.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.68 117.78 35.4 Favored 'General case' 0 C--N 1.318 -0.792 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.178 179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.532 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 39.1 t70 -110.04 74.76 0.9 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.99 -102.8 2.72 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.208 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.85 18.69 15.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 -170.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.08 -175.42 5.26 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 110.116 -0.328 . . . . 0.0 110.116 -178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.562 HD22 HD13 ' A' ' 5' ' ' LEU . 5.8 mt -108.93 133.99 52.2 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.484 HG22 ' HB3' ' A' ' 31' ' ' GLU . 49.9 t -118.66 128.04 75.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 52.3 t -97.9 108.34 45.64 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.33 -7.21 20.84 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.596 2.197 . . . . 0.0 111.387 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.4 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 48.2 tt0 -79.22 -67.48 0.75 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.65 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -90.05 9.19 29.0 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.339 -0.544 . . . . 0.0 112.297 -175.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.14 46.79 12.66 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.997 0.427 . . . . 0.0 112.007 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.428 ' HB3' HE22 ' A' ' 10' ' ' GLN . 2.2 t-160 -144.18 125.91 15.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.984 0.421 . . . . 0.0 110.415 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.484 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.5 OUTLIER -93.44 149.03 21.54 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.553 176.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -153.27 161.84 41.94 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.558 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 8.7 t -119.58 129.94 25.1 Favored Pre-proline 0 C--N 1.311 -1.077 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.484 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 12.0 Cg_endo -54.33 -54.98 3.78 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.893 2.396 . . . . 0.0 112.826 -170.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -96.99 -35.12 10.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.516 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 37.0 tt0 -69.06 -15.06 63.36 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.305 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.84 -30.55 71.63 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.815 0.341 . . . . 0.0 110.379 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.23 -40.75 58.77 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 174.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.7 m 70.41 150.21 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.788 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.15 162.7 39.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.437 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 22.5 m -81.17 96.19 7.14 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.106 0.479 . . . . 0.0 110.846 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -99.52 172.73 7.12 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 58.19 37.02 26.22 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -172.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -104.64 26.42 22.62 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.568 -173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -96.57 5.27 51.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.51 0.672 . . . . 0.0 109.694 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.59 HG13 HD13 ' A' ' 87' ' ' LEU . 6.2 t -63.65 142.09 17.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.115 172.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.822 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -69.69 119.37 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 123.191 0.307 . . . . 0.0 110.655 -169.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.689 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.7 OUTLIER -106.78 146.35 30.99 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.524 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.47 ' OD1' HG23 ' A' ' 111' ' ' VAL . 12.8 m-20 -90.0 175.51 7.15 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.621 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 7.0 t -74.37 -4.0 33.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 122.094 0.95 . . . . 0.0 110.12 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.493 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.5 t -87.88 -14.42 9.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.0 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 89.77 7.97 68.03 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.541 -1.209 . . . . 0.0 111.823 -178.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.493 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -104.48 164.54 11.68 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.266 0.555 . . . . 0.0 111.678 178.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.443 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.7 t -109.65 140.14 29.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.304 -1.317 . . . . 0.0 110.045 -173.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.598 HD22 HG22 ' A' ' 61' ' ' ILE . 24.9 mt -95.73 172.73 7.86 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.332 0.587 . . . . 0.0 111.136 -176.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.436 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.3 tt0 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.267 -0.879 . . . . 0.0 108.712 177.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.497 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 13.6 t70 -69.13 94.96 0.71 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.193 0.52 . . . . 0.0 109.617 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.555 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.65 -11.0 6.72 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 111.216 -0.754 . . . . 0.0 111.216 -175.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.2 t70 -72.04 169.51 15.82 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.744 0.307 . . . . 0.0 110.304 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.781 HG23 ' HB3' ' A' ' 83' ' ' LYS . 3.0 m -100.49 135.43 41.93 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.598 HG22 HD22 ' A' ' 55' ' ' LEU . 1.8 pp -121.42 163.46 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 120.318 -0.553 . . . . 0.0 110.0 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -150.27 119.91 7.0 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.172 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.875 HG11 HG12 ' A' ' 76' ' ' VAL . 0.3 OUTLIER -60.76 128.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 176.747 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.55 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -98.92 17.45 2.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 178.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 4.3 mptp? -142.09 166.57 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.547 -0.721 . . . . 0.0 109.404 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -77.12 105.89 8.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 122.102 0.953 . . . . 0.0 111.101 170.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.529 ' O ' ' HB ' ' A' ' 76' ' ' VAL . 2.4 mm? -114.84 126.44 54.82 Favored 'General case' 0 C--O 1.208 -1.098 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.675 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -81.87 171.7 14.18 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 174.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.407 HG11 ' HB2' ' A' ' 72' ' ' SER . 40.2 t -126.78 120.56 56.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 172.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -69.51 -45.0 69.9 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -168.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.64 -10.39 57.95 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.932 -174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.407 ' HB2' HG11 ' A' ' 69' ' ' VAL . 26.1 m -111.93 153.65 26.42 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.951 0.405 . . . . 0.0 111.144 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.7 m -71.04 -12.01 61.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.9 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.5 mp -79.44 137.92 37.42 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.213 0.53 . . . . 0.0 111.121 -174.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.2 t -109.13 127.21 66.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.193 171.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.875 HG12 HG11 ' A' ' 63' ' ' VAL . 69.7 t -81.97 116.42 26.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.764 0.793 . . . . 0.0 110.479 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -109.07 149.2 29.64 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.516 -176.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.55 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -50.04 97.27 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 121.838 0.828 . . . . 0.0 110.266 177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.69 3.43 5.05 Favored Glycine 0 CA--C 1.524 0.596 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.081 -176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.2 m -62.57 105.76 0.68 Allowed 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 122.071 0.938 . . . . 0.0 110.163 175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -88.36 116.85 26.87 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.867 -1.06 . . . . 0.0 111.086 -174.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.535 ' O ' HG13 ' A' ' 61' ' ' ILE . 93.5 t -129.09 110.16 20.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.781 ' HB3' HG23 ' A' ' 60' ' ' THR . 26.2 pttm -102.07 165.77 10.98 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 120.908 0.385 . . . . 0.0 111.624 -174.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.555 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 63.57 44.06 5.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.959 -1.018 . . . . 0.0 110.739 175.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 55' ' ' LEU . 39.6 pt -65.83 174.23 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-O 122.048 0.928 . . . . 0.0 113.064 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 2.2 tpp180 -122.56 123.93 42.35 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 113.941 -1.482 . . . . 0.0 108.236 176.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.59 HD13 HG13 ' A' ' 46' ' ' VAL . 42.5 mt -83.0 119.39 24.4 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 177.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 89' ' ' ASP . 0.9 OUTLIER -86.87 179.4 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 -177.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.562 ' H ' HG12 ' A' ' 88' ' ' VAL . 15.3 t70 -60.13 -49.15 78.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.844 0.354 . . . . 0.0 111.521 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . -82.3 138.59 18.68 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.677 -177.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.98 -18.33 44.99 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.475 0.655 . . . . 0.0 111.876 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.448 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 1.0 OUTLIER -100.64 51.56 0.87 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.525 178.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 88' ' ' VAL . 9.4 m-20 -161.53 102.15 1.2 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -166.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.822 HG13 HG21 ' A' ' 47' ' ' ILE . 3.9 mp -110.55 116.6 52.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 170.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 28.1 t70 -94.1 130.36 40.3 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.47 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -144.22 154.58 43.25 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.567 -174.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 98.7 mttt -121.18 129.5 53.26 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 40.0 mt -121.37 118.93 57.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.419 -170.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -56.11 120.91 8.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.743 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 118.35 -80.77 0.31 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.227 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.406 HG13 ' N ' ' A' ' 102' ' ' GLY . 26.1 pt -74.93 -46.03 41.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.733 0.301 . . . . 0.0 111.476 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.406 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 137.27 -150.84 20.86 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.89 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.86 146.82 24.72 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.656 0.265 . . . . 0.0 110.85 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.9 ttt -142.31 163.39 32.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.236 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.25 140.03 49.74 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.6 mt -120.04 144.1 47.73 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.121 0.486 . . . . 0.0 111.419 -172.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.416 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 16.9 ttmt -80.89 118.76 22.67 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.977 177.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.689 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 3.3 m -49.08 -37.59 21.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.48 -178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 50' ' ' SER . 27.7 mt-10 -72.08 -8.62 55.63 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.279 -176.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.454 ' CG ' HD21 ' A' ' 67' ' ' LEU . 33.9 m-85 -113.46 -0.62 14.39 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.418 -0.513 . . . . 0.0 112.174 178.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 21.9 m -113.51 171.69 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.45 -0.5 . . . . 0.0 111.798 -175.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.483 ' HD2' HG21 ' A' ' 51' ' ' VAL . 13.5 ttt180 -150.29 138.21 20.1 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.641 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 113' ' ' LYS . 26.5 ttpt -62.88 117.11 5.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.857 165.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 60.0 t -55.59 -56.05 14.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.883 0.373 . . . . 0.0 111.153 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 120.14 -0.05 13.03 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.694 -0.669 . . . . 0.0 109.325 176.431 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.966 0.413 . . . . 0.0 111.823 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.29 127.03 39.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-O 121.022 0.439 . . . . 0.0 110.659 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.5 m -71.24 147.08 48.56 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.336 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.1 p -101.05 34.99 2.33 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.434 0.635 . . . . 0.0 110.627 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.572 HD13 HD22 ' A' ' 23' ' ' LEU . 31.9 mt -89.1 168.58 15.06 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.56 -176.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 61.1 Cg_endo -69.43 158.35 57.72 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 121.868 1.712 . . . . 0.0 110.742 171.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 6.5 Cg_exo -73.06 -167.51 0.36 Allowed 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.461 2.107 . . . . 0.0 112.4 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.4 t -98.36 125.68 42.34 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.522 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.44 7.76 0.64 Allowed 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.804 2.336 . . . . 0.0 112.314 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.452 HE22 ' HB3' ' A' ' 30' ' ' HIS . 36.9 mt-30 -119.36 -38.44 3.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 60.8 m -107.23 -46.95 3.77 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 121.311 0.577 . . . . 0.0 109.917 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.36 0.81 2.66 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.414 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 m -57.88 -77.4 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.354 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 171.15 -21.07 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -174.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 73.2 m-85 -78.87 36.99 0.29 Allowed 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -167.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -101.01 144.34 30.06 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.263 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.575 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -146.12 173.41 12.22 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -178.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.453 ' CD ' HD11 ' A' ' 5' ' ' LEU . 1.2 pm0 -101.7 119.42 38.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.837 0.351 . . . . 0.0 110.957 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.575 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 15.7 t70 -120.18 75.42 1.1 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 173.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.12 -119.64 6.58 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.903 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.64 16.46 25.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.723 0.297 . . . . 0.0 111.72 -172.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.6 pt? -152.24 -176.54 5.72 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.737 0.303 . . . . 0.0 110.293 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.572 HD22 HD13 ' A' ' 5' ' ' LEU . 17.0 mt -111.69 130.7 55.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 175.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 48.9 t -116.17 127.94 73.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.624 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.2 t -102.6 103.98 35.56 Favored Pre-proline 0 C--N 1.317 -0.814 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 50.9 Cg_endo -70.07 -9.86 26.96 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.836 2.357 . . . . 0.0 110.65 176.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.624 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 74.0 tt0 -70.08 -65.02 0.78 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.991 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.3 p -95.12 11.41 32.31 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 43.69 19.14 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.061 0.458 . . . . 0.0 111.824 176.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.452 ' HB3' HE22 ' A' ' 10' ' ' GLN . 54.3 t60 -150.1 136.33 18.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.928 179.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.404 ' HB2' ' CD1' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -107.63 166.77 10.43 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.971 -179.504 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -162.3 161.85 27.79 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -177.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 7.9 t -112.93 124.73 31.06 Favored Pre-proline 0 C--N 1.312 -1.042 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.57 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.5 Cg_endo -57.72 -45.48 32.98 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.304 2.669 . . . . 0.0 113.815 -168.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -105.18 -32.84 8.47 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.911 0.386 . . . . 0.0 110.961 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 36.0 tt0 -65.42 -32.79 74.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.955 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.77 -34.61 77.6 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.962 0.411 . . . . 0.0 110.738 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -83.09 -41.74 18.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.455 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.9 m 69.54 -67.55 0.22 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.766 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.03 135.13 43.15 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.929 0.395 . . . . 0.0 111.054 -176.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.0 m -101.13 28.67 5.17 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.164 177.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 68.65 153.51 0.1 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.764 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -82.15 -47.0 13.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.378 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -150.84 106.58 0.31 Allowed Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.993 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.787 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 7.4 mmpt? -89.73 -3.35 58.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.891 0.377 . . . . 0.0 110.638 178.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.505 HG13 HD13 ' A' ' 87' ' ' LEU . 2.8 t -121.88 148.38 25.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.697 -178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.61 HD11 ' O ' ' A' ' 88' ' ' VAL . 3.1 mm -91.17 138.1 20.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 -175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.5 ttmt -121.06 149.49 42.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.449 -0.342 . . . . 0.0 111.316 -174.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.588 ' OD1' HG23 ' A' ' 111' ' ' VAL . 6.8 m-20 -90.05 -179.79 5.77 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.273 0.559 . . . . 0.0 111.542 -173.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 28.4 t -83.85 -3.21 57.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.014 0.911 . . . . 0.0 110.005 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.503 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 4.6 t -92.39 -14.42 8.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.819 177.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.62 3.28 59.67 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 114.452 -1.249 . . . . 0.0 112.688 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.594 ' ND2' ' H ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -87.68 163.39 16.57 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.933 0.873 . . . . 0.0 111.423 178.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.431 HG22 ' HG3' ' A' ' 48' ' ' LYS . 2.6 t -117.69 135.18 58.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-N 113.359 -1.746 . . . . 0.0 108.663 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' HB2' HD21 ' A' ' 87' ' ' LEU . 1.4 mm? -95.79 -157.89 0.61 Allowed 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.849 -0.532 . . . . 0.0 111.278 -172.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.592 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 5.9 tt0 -159.56 146.34 16.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -175.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -70.59 97.85 1.39 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.811 0.815 . . . . 0.0 110.012 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 125.34 -6.6 8.09 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.941 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.592 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 40.9 t0 -73.87 167.8 20.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.872 0.367 . . . . 0.0 110.719 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.2 m -110.88 134.2 52.74 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.9 pp -125.47 171.86 13.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' A' ' 112' ' ' ARG . 6.0 m -150.12 119.34 6.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.789 0.328 . . . . 0.0 111.56 177.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.651 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -59.82 132.16 24.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 122.886 0.474 . . . . 0.0 110.155 176.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.727 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -104.68 19.59 4.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 178.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.727 ' HD2' HG12 ' A' ' 64' ' ' ILE . 4.9 mptp? -138.26 161.88 35.76 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -84.83 101.4 12.25 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.294 171.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.434 HD21 ' CG ' ' A' ' 110' ' ' PHE . 6.3 mp -112.96 145.66 40.41 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.86 175.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.37 173.97 8.42 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 120.876 0.369 . . . . 0.0 111.238 173.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 60.7 t -126.68 137.78 56.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 175.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 46.5 tptt -104.03 138.51 40.45 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.97 -37.45 3.5 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.69 -0.766 . . . . 0.0 111.36 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 36.9 m -110.56 155.62 22.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.9 m -80.35 -0.96 39.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.136 0.493 . . . . 0.0 110.479 178.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.486 ' O ' ' HB ' ' A' ' 69' ' ' VAL . 2.2 mm? -80.91 141.64 34.36 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 121.195 0.521 . . . . 0.0 111.409 -177.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.2 t -112.71 134.83 54.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.466 170.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.651 HG12 HG11 ' A' ' 63' ' ' VAL . 78.6 t -83.68 99.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.028 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -102.15 148.64 25.17 Favored 'General case' 0 C--N 1.315 -0.922 0 C-N-CA 120.588 -0.445 . . . . 0.0 111.265 -174.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.563 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.98 96.54 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 122.038 0.923 . . . . 0.0 111.063 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.93 3.95 3.47 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 111.123 -177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 86.1 m -62.17 104.5 0.49 Allowed 'General case' 0 C--O 1.223 -0.319 0 CA-C-O 121.522 0.677 . . . . 0.0 110.294 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -87.17 116.2 25.08 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.651 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.594 HG11 ' HB2' ' A' ' 96' ' ' CYS . 18.2 t -125.31 116.58 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 pttm -104.71 162.51 13.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.869 -0.605 . . . . 0.0 112.564 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.408 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 74.6 m-20 66.81 38.65 3.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.341 170.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.5 pt -67.58 -178.72 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 122.168 0.985 . . . . 0.0 113.486 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 16.5 tpp180 -130.05 129.63 43.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 114.025 -1.443 . . . . 0.0 108.611 174.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.505 HD13 HG13 ' A' ' 46' ' ' VAL . 82.3 mt -84.88 123.74 30.82 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.765 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -93.33 163.98 2.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -177.46 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.14 102.63 5.82 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.247 -0.581 . . . . 0.0 109.85 177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 164.09 -168.27 38.47 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.951 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -102.24 -45.4 5.14 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.289 0.566 . . . . 0.0 111.606 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.446 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 30.7 m80 -106.91 54.17 0.68 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.502 -177.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.765 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.4 m-20 -135.26 93.98 3.06 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -161.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 106' ' ' LEU . 51.6 mt -125.96 117.41 48.86 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.328 0.585 . . . . 0.0 111.334 175.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 26.2 t70 -94.57 131.97 39.76 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.544 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.594 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.8 p -134.16 138.83 45.45 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.857 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -112.58 127.13 56.0 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -176.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 19.3 mt -125.11 109.54 22.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.893 -173.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -73.58 94.98 2.23 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 161.42 -56.39 0.31 Allowed Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.207 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.465 HG21 HD21 ' A' ' 74' ' ' LEU . 48.1 pt -104.39 -42.28 7.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 120.836 0.351 . . . . 0.0 110.339 175.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.464 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 143.09 -158.87 27.35 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.024 -0.607 . . . . 0.0 111.698 175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -87.2 144.42 26.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.728 0.299 . . . . 0.0 110.629 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.3 tpt -134.64 155.58 50.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.856 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.45 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -101.41 144.0 30.75 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.915 177.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 99.0 mt -130.85 136.6 48.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.674 0.75 . . . . 0.0 111.504 -176.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.61 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 30.9 mttm -84.82 114.68 22.26 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.463 175.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.723 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.7 p -53.5 -35.76 60.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.137 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.61 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 5.9 pt-20 -61.31 -14.73 29.06 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.222 -0.899 . . . . 0.0 112.497 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.453 ' O ' HD13 ' A' ' 64' ' ' ILE . 56.6 m-85 -112.72 2.3 16.01 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.969 -0.457 . . . . 0.0 112.224 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.686 HG22 ' HA ' ' A' ' 108' ' ' SER . 17.8 m -114.14 170.3 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.38 0.609 . . . . 0.0 112.297 -173.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.495 ' HB2' HG21 ' A' ' 51' ' ' VAL . 7.5 ttt180 -142.09 141.22 32.72 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.291 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.594 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 36.1 tttp -71.03 140.76 50.86 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.205 0.526 . . . . 0.0 111.369 176.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.0 t -105.03 -49.41 9.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.285 173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 68.78 31.45 73.07 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.814 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--O 1.248 0.985 0 CA-C-O 118.851 -0.595 . . . . 0.0 109.992 179.812 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.422 ' HE3' ' HB2' ' A' ' 1' ' ' MET . 19.4 ptm . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.1 t 50.24 40.52 0.34 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-O 122.085 0.945 . . . . 0.0 109.046 -172.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.558 ' HB3' ' HG ' ' A' ' 5' ' ' LEU . 16.3 m -103.32 139.54 38.61 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.362 -172.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 45.1 p -107.19 30.78 5.9 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.283 0.563 . . . . 0.0 110.279 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.558 ' HG ' ' HB3' ' A' ' 3' ' ' SER . 12.4 mt -63.7 146.04 97.09 Favored Pre-proline 0 CA--C 1.518 -0.275 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.277 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.78 161.48 45.28 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.501 2.134 . . . . 0.0 111.201 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.28 -167.03 0.26 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 122.354 2.036 . . . . 0.0 111.769 175.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 10.7 t -98.47 129.2 30.89 Favored Pre-proline 0 C--N 1.313 -0.981 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.628 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.98 8.47 1.67 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.581 2.188 . . . . 0.0 111.34 178.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.633 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 13.3 mt-30 -119.36 -38.45 3.02 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.555 -178.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.4 m -108.63 -52.89 2.71 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.589 0.709 . . . . 0.0 109.53 176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 71.76 3.22 4.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 114.173 -1.376 . . . . 0.0 111.474 -176.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.684 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 14.8 m -59.5 -77.93 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 119.223 -0.417 . . . . 0.0 111.615 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' HB3' ' O ' ' A' ' 13' ' ' SER . 16.3 pt-20 176.91 -15.59 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 177.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.518 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 25.8 m-85 -81.81 32.74 0.37 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.386 0.539 . . . . 0.0 112.007 -169.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.5 m -91.9 135.72 33.71 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.536 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.0 p90 -143.62 170.07 16.54 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.551 -0.536 . . . . 0.0 109.551 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -98.66 118.92 36.47 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.722 0.296 . . . . 0.0 111.296 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.536 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 32.9 t70 -123.3 86.15 2.53 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 171.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.61 -111.79 3.99 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.435 -0.888 . . . . 0.0 113.406 175.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.1 18.86 18.99 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -172.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.7 -175.08 5.23 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.815 0.341 . . . . 0.0 110.39 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' HB2' ' CD1' ' A' ' 32' ' ' TRP . 43.9 mt -110.1 131.24 55.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.633 174.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG13 ' HG3' ' A' ' 31' ' ' GLU . 57.6 t -114.99 126.01 72.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.949 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 41.7 t -104.24 103.16 37.09 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.518 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.2 Cg_endo -69.73 -15.43 37.18 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.366 2.044 . . . . 0.0 109.645 173.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.949 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 28.2 tt0 -64.16 -44.46 92.0 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.657 -176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.414 ' SG ' ' NE2' ' A' ' 10' ' ' GLN . 22.4 p -118.06 11.83 13.45 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 171.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.21 47.19 14.67 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.438 ' HB3' HE22 ' A' ' 10' ' ' GLN . 38.0 t-80 -143.61 131.49 21.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.493 178.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.565 ' HG3' HG13 ' A' ' 24' ' ' VAL . 2.0 mp0 -91.73 145.34 24.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.446 179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.445 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.2 OUTLIER -150.16 160.99 43.26 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.222 0.534 . . . . 0.0 110.933 -179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 30.8 t -118.15 124.51 28.61 Favored Pre-proline 0 C--N 1.31 -1.116 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 175.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 18.3 Cg_endo -57.95 -23.24 58.84 Favored 'Trans proline' 0 C--N 1.34 0.106 0 C-N-CA 122.672 2.248 . . . . 0.0 111.745 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -100.92 -56.64 2.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.89 -178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 39' ' ' THR . 34.0 tt0 -67.81 -19.07 65.04 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.069 -171.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.58 -56.14 20.69 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.015 0.436 . . . . 0.0 110.691 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.48 -46.32 10.98 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.235 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 11.1 m -114.16 155.53 25.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.851 -172.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.69 146.03 38.34 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.759 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 48.7 m -81.77 12.45 3.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.096 0.474 . . . . 0.0 111.416 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -106.73 141.78 37.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.956 175.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.581 ' OD1' ' HE2' ' A' ' 45' ' ' LYS . 9.9 t70 -156.94 -78.17 0.08 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 124.32 -31.63 4.38 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.58 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.581 ' HE2' ' OD1' ' A' ' 43' ' ' ASP . 33.7 mtmt -85.37 115.44 23.11 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.943 0.401 . . . . 0.0 110.438 -179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.577 HG13 HD13 ' A' ' 87' ' ' LEU . 10.3 t -131.47 149.39 33.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.91 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.512 HD11 ' O ' ' A' ' 88' ' ' VAL . 2.2 mm -101.34 140.12 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.545 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -107.13 179.71 4.18 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.886 179.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.792 ' OD2' HD11 ' A' ' 55' ' ' LEU . 84.0 m-20 -120.35 -179.65 4.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.26 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.514 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 8.6 t -75.44 -6.44 50.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 122.257 1.027 . . . . 0.0 109.161 174.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.53 HG21 ' HD2' ' A' ' 112' ' ' ARG . 4.2 t -92.53 -15.55 8.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 114.02 -1.445 . . . . 0.0 109.884 -178.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.38 -1.4 76.32 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.2 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.518 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.2 OUTLIER -88.54 161.04 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.237 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.545 HG22 ' HG3' ' A' ' 48' ' ' LYS . 16.6 t -115.04 135.35 55.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.48 -173.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.792 HD11 ' OD2' ' A' ' 49' ' ' ASP . 3.1 mp -103.18 -178.19 3.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.937 0.399 . . . . 0.0 110.853 -168.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.533 ' HA ' HD11 ' A' ' 87' ' ' LEU . 8.5 tt0 -132.07 157.82 43.18 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.425 175.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.401 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 16.7 p-10 -73.87 133.85 43.2 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 108.812 -0.811 . . . . 0.0 108.812 172.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 90.07 -9.47 77.25 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.573 -171.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -74.06 169.2 18.0 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.709 0.29 . . . . 0.0 110.909 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 4.6 m -105.02 135.98 45.34 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.435 ' CG2' HD13 ' A' ' 85' ' ' ILE . 1.8 pp -124.04 168.96 15.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.8 m -150.14 117.92 6.22 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 122.48 0.312 . . . . 0.0 110.675 178.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.715 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.01 131.24 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 176.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.523 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -100.11 16.88 3.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 178.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 4.9 mptp? -135.73 158.15 45.1 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -85.94 104.83 15.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.983 0.897 . . . . 0.0 111.361 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD11 ' CB ' ' A' ' 110' ' ' PHE . 18.5 mt -119.98 146.44 45.84 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.474 178.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -85.62 175.13 8.94 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.378 0.608 . . . . 0.0 111.415 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' CG2' HG23 ' A' ' 76' ' ' VAL . 85.3 t -120.99 128.82 76.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 22.5 tptm -92.08 113.8 26.16 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.314 0.506 . . . . 0.0 110.635 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 111.35 -21.22 22.23 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.588 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 50.5 m -115.95 157.94 23.8 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.0 p -87.59 5.47 39.26 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.039 0.447 . . . . 0.0 110.867 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.73 136.6 34.11 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.565 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -104.32 134.79 44.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.166 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.715 HG12 HG11 ' A' ' 63' ' ' VAL . 59.2 t -85.92 101.71 10.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.536 0.684 . . . . 0.0 109.665 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -102.65 148.46 25.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.438 -173.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.92 96.99 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.874 0.845 . . . . 0.0 110.647 178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.415 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.04 6.22 4.06 Favored Glycine 0 CA--C 1.524 0.636 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.9 -177.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.0 m -62.19 103.97 0.43 Allowed 'General case' 0 C--O 1.225 -0.22 0 CA-C-O 121.695 0.76 . . . . 0.0 109.669 176.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -90.75 111.85 23.39 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.127 -174.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.425 HG11 ' HB3' ' A' ' 96' ' ' CYS . 46.2 t -117.62 115.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 50.1 pttt -101.8 149.87 23.74 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.779 -176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.444 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 46.7 m-80 68.91 48.05 0.75 Allowed 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.098 0.874 . . . . 0.0 111.245 176.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.605 HG22 ' SG ' ' A' ' 96' ' ' CYS . 44.5 pt -66.58 -175.53 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 CA-C-O 122.064 0.935 . . . . 0.0 112.085 173.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.0 tpt180 -136.24 129.21 31.22 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.541 -1.209 . . . . 0.0 108.276 173.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.577 HD13 HG13 ' A' ' 46' ' ' VAL . 60.9 mt -83.06 122.55 28.48 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.512 ' O ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -101.7 178.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.355 -176.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -79.92 91.94 5.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.761 0.791 . . . . 0.0 112.496 -174.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 167.35 -173.82 42.5 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.395 177.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -102.33 -29.21 11.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.515 0.658 . . . . 0.0 110.736 176.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.491 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 52.0 m80 -108.33 52.16 0.72 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.122 -177.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.467 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.9 m-20 -142.53 93.18 2.49 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 113.453 0.909 . . . . 0.0 113.453 -158.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.634 ' CD1' HG21 ' A' ' 111' ' ' VAL . 42.5 mt -124.31 112.43 32.42 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 121.617 0.722 . . . . 0.0 112.004 177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -96.18 133.77 40.09 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 115.286 -0.87 . . . . 0.0 108.662 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.605 ' SG ' HG22 ' A' ' 85' ' ' ILE . 16.1 m -143.75 146.37 33.09 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.339 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.0 tttm -106.12 129.63 54.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.707 -176.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 18.3 mt -130.24 107.35 14.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -76.18 96.07 3.82 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.594 0.711 . . . . 0.0 110.75 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 165.03 -63.64 0.23 Allowed Glycine 0 N--CA 1.442 -0.941 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.168 -176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.9 pt -98.56 -42.25 10.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 174.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 144.05 -158.65 27.49 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.517 -0.633 . . . . 0.0 111.517 175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.76 145.75 32.71 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.5 ttp -135.2 155.37 50.77 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.18 142.6 43.15 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.892 178.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 85.1 mt -124.74 139.42 53.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.732 0.777 . . . . 0.0 111.872 -172.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -76.8 116.4 17.43 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-N 114.419 -1.264 . . . . 0.0 109.892 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.491 ' HB3' ' HA ' ' A' ' 92' ' ' HIS . 2.8 t -46.89 -42.7 17.93 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.961 175.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.514 ' O ' ' HB2' ' A' ' 50' ' ' SER . 9.5 mt-10 -67.87 -13.34 62.07 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.778 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.446 ' CB ' HD11 ' A' ' 67' ' ' LEU . 42.0 m-85 -113.03 3.16 16.02 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.634 HG21 ' CD1' ' A' ' 94' ' ' ILE . 32.9 m -114.24 168.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.294 -175.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.53 ' HD2' HG21 ' A' ' 51' ' ' VAL . 18.4 ttt180 -149.24 128.44 12.84 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.53 177.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 9.9 tttp -59.5 132.78 55.03 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.478 173.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.7 -56.08 10.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 115.75 -8.09 19.58 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -174.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.485 -0.769 . . . . 0.0 109.417 177.405 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.969 0.414 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.19 134.99 54.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.666 172.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.6 m -67.72 145.37 54.82 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.88 0.371 . . . . 0.0 110.849 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 t -83.54 33.04 0.46 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.607 0.718 . . . . 0.0 110.741 -178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.617 HD13 HD22 ' A' ' 23' ' ' LEU . 20.5 mt -109.22 167.76 8.67 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.528 -174.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 72.6 Cg_endo -72.74 159.35 48.72 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.378 2.052 . . . . 0.0 111.033 171.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.5 -163.93 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.578 2.185 . . . . 0.0 112.709 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 5.0 t -98.88 128.24 32.95 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.062 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.1 8.55 1.04 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.789 2.326 . . . . 0.0 112.464 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.446 HE22 ' HB3' ' A' ' 30' ' ' HIS . 44.7 mt-30 -119.18 -37.84 3.13 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.848 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 33.9 m -110.03 -45.99 3.53 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-O 120.984 0.421 . . . . 0.0 109.886 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.2 t30 68.86 2.23 3.44 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.592 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 m -48.47 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 169.86 -27.83 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 112.265 0.469 . . . . 0.0 112.265 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.624 ' HE1' ' HB2' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -87.57 57.42 4.39 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 121.867 0.841 . . . . 0.0 110.765 -168.651 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.0 m -105.84 140.47 38.82 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.305 174.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.56 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 37.5 p90 -141.16 171.18 14.41 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 -172.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.468 ' HB3' HD11 ' A' ' 5' ' ' LEU . 1.3 pm0 -100.94 114.56 28.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.928 0.394 . . . . 0.0 110.755 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.56 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 26.7 t70 -113.38 83.03 1.77 Allowed 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 173.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.08 -108.35 3.65 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.339 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -113.87 19.65 16.44 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -170.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.551 HD11 ' HB3' ' A' ' 31' ' ' GLU . 1.4 pt? -162.3 -174.68 4.17 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.472 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.617 HD22 HD13 ' A' ' 5' ' ' LEU . 8.3 mt -106.39 132.58 52.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.705 -0.479 . . . . 0.0 109.705 177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG13 ' HG3' ' A' ' 31' ' ' GLU . 58.0 t -117.76 129.56 73.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 53.0 t -100.71 109.97 59.23 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 176.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 38.3 Cg_endo -67.64 -16.31 46.44 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.703 2.268 . . . . 0.0 111.193 -179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.624 ' HB2' ' HE1' ' A' ' 15' ' ' TYR . 9.9 tp10 -69.36 -73.46 0.15 Allowed 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.558 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.2 p -88.12 10.35 19.61 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.47 45.47 16.48 Favored 'General case' 0 C--O 1.231 0.103 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 174.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.446 ' HB3' HE22 ' A' ' 10' ' ' GLN . 38.9 t-80 -144.61 129.45 18.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.85 0.357 . . . . 0.0 110.23 177.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' HB3' HD11 ' A' ' 22' ' ' LEU . 1.9 mp0 -90.42 152.68 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.441 ' NE1' HD12 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -155.26 161.31 41.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -176.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.556 ' HB3' ' OE1' ' A' ' 36' ' ' GLU . 59.3 m -121.66 130.42 24.78 Favored Pre-proline 0 C--N 1.303 -1.451 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.555 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 14.3 Cg_endo -55.53 -38.55 93.97 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.412 2.741 . . . . 0.0 113.295 -169.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.29 -36.76 3.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.5 0.667 . . . . 0.0 109.783 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 36' ' ' GLU . 17.2 mp0 -67.09 -22.71 65.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.385 -1.28 . . . . 0.0 111.15 -169.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.91 -33.38 75.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.957 0.408 . . . . 0.0 110.297 176.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.84 -62.25 1.59 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.092 177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 t -179.1 178.62 0.71 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.141 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.68 95.25 3.68 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.908 0.385 . . . . 0.0 110.573 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 45.5 m -100.47 14.3 31.67 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.455 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -130.7 141.63 50.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.113 0.483 . . . . 0.0 110.542 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -127.24 -1.45 6.37 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.957 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.4 41.36 2.48 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.114 -177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.74 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -111.74 -41.29 4.08 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.871 0.367 . . . . 0.0 110.414 -179.363 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 87' ' ' LEU . 7.3 t -127.39 155.4 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.087 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.492 HG21 HG13 ' A' ' 94' ' ' ILE . 6.9 mm -93.35 138.75 19.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -177.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.635 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.4 ttmt -127.75 142.65 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.719 -177.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 71.4 m-20 -100.28 -179.42 4.12 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -170.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 21.2 t -77.29 -5.65 50.25 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.867 0.842 . . . . 0.0 110.533 -174.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.9 t -88.57 -16.1 8.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.727 178.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.8 -3.23 67.5 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.171 -177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -87.07 149.37 24.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.643 0.735 . . . . 0.0 111.859 -179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.551 HG22 ' HG3' ' A' ' 48' ' ' LYS . 3.6 t -104.7 136.45 38.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 113.631 -1.622 . . . . 0.0 109.345 -176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.601 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.1 mp -100.35 179.74 4.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.205 0.526 . . . . 0.0 111.449 -169.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.449 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 12.4 tt0 -132.0 156.17 46.69 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.251 175.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 0.7 OUTLIER -69.74 138.34 52.73 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 172.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 82.21 -4.91 74.52 Favored Glycine 0 C--N 1.316 -0.562 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.538 -177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -72.78 171.53 12.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.727 0.299 . . . . 0.0 110.337 178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.638 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 91.9 m -109.27 137.15 47.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.9 169.54 12.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 80' ' ' THR . 3.0 m -149.4 117.17 6.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.942 0.401 . . . . 0.0 110.859 176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -62.15 128.9 24.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 178.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.596 HG12 ' CD ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -100.51 15.56 4.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.596 ' CD ' HG12 ' A' ' 64' ' ' ILE . 2.4 mptm? -135.79 165.1 26.4 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 121.588 -0.695 . . . . 0.0 109.168 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -86.85 116.05 24.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.802 0.811 . . . . 0.0 111.51 169.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.403 HD21 ' CG ' ' A' ' 110' ' ' PHE . 5.1 mp -130.08 147.6 51.84 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.281 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.28 175.32 6.89 Favored 'General case' 0 C--N 1.314 -0.962 0 O-C-N 122.117 -0.364 . . . . 0.0 110.343 172.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 93.9 t -118.49 134.49 61.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.476 ' HB3' ' NZ ' ' A' ' 70' ' ' LYS . 2.2 mmmp? -43.14 -88.84 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.46 21.78 42.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.383 -172.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 44.5 m -122.67 153.62 39.13 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.898 0.38 . . . . 0.0 110.627 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.9 m -83.31 6.57 19.32 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.882 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.1 131.23 34.76 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-O 120.865 0.364 . . . . 0.0 110.052 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.7 t -100.67 133.53 43.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.454 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.579 HG12 HG11 ' A' ' 63' ' ' VAL . 53.8 t -85.85 99.73 8.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.38 177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.11 152.09 25.0 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.684 -172.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -52.12 97.48 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.918 0.866 . . . . 0.0 110.991 -177.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.65 4.73 3.81 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.491 -178.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.0 m -62.38 105.68 0.65 Allowed 'General case' 0 C--O 1.224 -0.278 0 CA-C-O 121.672 0.748 . . . . 0.0 110.627 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -89.31 113.34 24.6 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.052 -175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.479 HG11 ' HB2' ' A' ' 96' ' ' CYS . 43.0 t -122.02 117.01 50.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 175.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 13.4 ptmm? -106.23 153.68 21.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.199 -174.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.497 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 71.95 42.38 0.61 Allowed 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 114.513 -1.221 . . . . 0.0 111.337 173.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 94' ' ' ILE . 42.6 pt -67.27 -177.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-O 122.25 1.024 . . . . 0.0 113.602 178.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 13.7 tpp180 -128.9 126.21 39.23 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 113.765 -1.561 . . . . 0.0 108.429 173.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD13 HG13 ' A' ' 46' ' ' VAL . 81.8 mt -80.26 122.87 27.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 172.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.505 HG21 ' HB2' ' A' ' 93' ' ' ASP . 2.6 t -76.32 132.92 32.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.294 0.569 . . . . 0.0 110.488 -173.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -75.14 78.68 2.29 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.17 -169.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 138.56 -65.58 0.54 Allowed Glycine 0 C--N 1.297 -1.631 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.2 169.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -79.59 151.15 30.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -84.34 45.98 1.17 Allowed 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -168.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.505 ' HB2' HG21 ' A' ' 88' ' ' VAL . 10.7 m-20 -98.26 165.78 11.71 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 119.191 0.905 . . . . 0.0 111.543 176.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.591 ' CD1' HG21 ' A' ' 111' ' ' VAL . 63.4 mt -114.33 116.52 52.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.146 171.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -94.69 133.27 38.54 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.357 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.479 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.1 p -145.46 159.86 42.45 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.151 0.5 . . . . 0.0 110.853 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.621 ' O ' ' HD2' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -118.36 134.57 54.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.006 176.4 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.0 mt -120.57 107.16 20.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.934 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -63.35 107.17 1.03 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.254 -175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.94 -46.34 0.86 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.937 -177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 18.3 pt -117.98 -38.83 2.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.69 0.281 . . . . 0.0 110.826 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.85 -157.09 24.62 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.378 177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.8 149.62 23.32 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.734 0.302 . . . . 0.0 110.969 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -153.99 171.54 18.87 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 -176.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.466 ' HB2' ' HE3' ' A' ' 105' ' ' LYS . 19.0 ptmt -120.74 151.27 39.76 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.717 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.1 mt -127.32 140.32 52.28 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.27 -173.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.436 ' HD3' ' CE2' ' A' ' 110' ' ' PHE . 76.5 tttt -82.31 117.61 22.52 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.132 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.635 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 1.4 p -50.86 -37.06 41.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.625 -177.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.401 ' O ' ' HB2' ' A' ' 50' ' ' SER . 31.2 mt-10 -69.5 -7.33 37.28 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.309 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.45 ' O ' HD13 ' A' ' 64' ' ' ILE . 66.6 m-85 -113.46 -2.87 13.81 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.761 -0.587 . . . . 0.0 112.001 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.9 m -116.94 173.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.298 0.571 . . . . 0.0 112.38 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.479 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.8 ttt180 -143.22 137.19 28.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.023 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.601 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 14.3 tttp -70.55 135.81 48.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.695 175.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.77 -58.56 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.905 176.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.75 34.93 3.91 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.376 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.6 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.613 -0.708 . . . . 0.0 110.235 178.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.88 0.371 . . . . 0.0 111.657 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -82.92 3.52 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.558 0.694 . . . . 0.0 110.92 -175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.7 m -66.01 138.02 57.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.909 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.3 t -103.56 16.52 26.24 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.558 0.694 . . . . 0.0 109.754 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.1 mt -75.15 150.86 85.73 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.164 -175.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.69 161.83 42.88 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 122.863 2.375 . . . . 0.0 111.748 175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.441 ' HB2' ' HA ' ' A' ' 12' ' ' ASN . 19.8 Cg_endo -64.57 -169.43 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.353 2.036 . . . . 0.0 112.385 174.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.7 t -98.81 129.13 30.57 Favored Pre-proline 0 C--N 1.314 -0.943 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.969 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HG3' ' CE3' ' A' ' 32' ' ' TRP . 55.8 Cg_endo -69.11 7.25 0.85 Allowed 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.692 2.261 . . . . 0.0 112.214 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.524 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 44.5 mt-30 -117.7 -39.32 3.15 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.479 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.7 m -106.2 -45.83 4.21 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.441 ' HA ' ' HB2' ' A' ' 7' ' ' PRO . 64.5 t30 70.44 -3.3 1.91 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.851 -178.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.502 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.7 m -55.34 -77.68 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.711 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.2 pt-20 164.31 -7.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 O-C-N 123.69 0.618 . . . . 0.0 112.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.662 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 61.1 m-85 -80.64 41.56 0.56 Allowed 'General case' 0 CA--C 1.519 -0.25 0 CA-C-O 121.24 0.543 . . . . 0.0 111.406 -173.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -104.24 148.1 26.72 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.453 174.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 41.2 p90 -148.9 174.79 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.92 117.76 34.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.808 0.337 . . . . 0.0 111.108 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.537 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 14.7 t70 -115.75 79.07 1.24 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.97 -107.97 3.59 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.319 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.19 17.71 19.27 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -171.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.3 pt? -157.75 -175.46 5.39 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 16.2 mt -107.92 130.06 55.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 174.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' HB3' ' A' ' 31' ' ' GLU . 52.2 t -116.9 127.39 74.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -178.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.2 t -102.7 105.41 44.43 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.662 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 44.8 Cg_endo -69.76 -12.5 33.02 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.565 2.177 . . . . 0.0 110.785 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.536 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 36.0 tt0 -68.7 -59.06 3.37 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.081 -178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.1 p -101.09 14.52 31.7 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 178.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.6 27.77 16.35 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.446 ' HB3' HE22 ' A' ' 10' ' ' GLN . 29.1 t-80 -140.66 142.25 34.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -98.15 177.38 5.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 178.657 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.505 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.4 OUTLIER -172.28 161.88 5.41 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.605 ' HB3' ' HB2' ' A' ' 36' ' ' GLU . 1.8 t -119.07 129.85 25.17 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.505 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 12.2 Cg_endo -54.82 -47.79 24.77 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 123.274 2.649 . . . . 0.0 113.338 -170.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -104.91 -31.37 9.29 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.389 0.614 . . . . 0.0 110.811 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 33' ' ' SER . 16.8 mp0 -77.88 -3.07 39.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.542 -175.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.15 -49.78 63.58 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.68 -32.75 31.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.089 0.471 . . . . 0.0 109.92 173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 40' ' ' ALA . 3.7 m 67.4 -85.17 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.58 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.415 ' H ' ' HB ' ' A' ' 39' ' ' THR . . . 175.1 50.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 -174.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.0 p -69.03 88.54 0.4 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.989 -174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.4 t70 68.11 177.99 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.847 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 45' ' ' LYS . 15.5 m-20 -109.49 -18.35 13.54 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.622 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 83.58 57.16 2.5 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.879 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.565 ' HD2' ' HB2' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -82.65 -37.36 24.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.092 0.472 . . . . 0.0 110.331 -178.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.7 p -87.91 125.98 41.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.604 HG21 HG13 ' A' ' 94' ' ' ILE . 5.3 mm -76.97 137.38 22.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.823 -170.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 54' ' ' VAL . 1.6 ttmt -124.86 177.37 6.06 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.661 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' CG ' HD22 ' A' ' 53' ' ' ASN . 19.2 m-20 -113.16 179.26 4.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.478 0.656 . . . . 0.0 112.106 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 44.8 t -82.16 -8.29 59.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.015 171.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.518 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 2.9 t -91.07 -17.82 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.141 -1.39 . . . . 0.0 109.347 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.68 -0.8 52.57 Favored Glycine 0 N--CA 1.44 -1.054 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.235 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.518 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -83.46 167.33 17.55 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-O 122.022 0.915 . . . . 0.0 111.283 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 48' ' ' LYS . 10.0 t -116.84 136.53 53.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-N 112.787 -2.006 . . . . 0.0 108.775 177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 87' ' ' LEU . 2.1 mm? -97.04 175.83 6.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.342 0.591 . . . . 0.0 110.64 -172.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -131.4 151.12 51.82 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.024 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.543 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 15.6 t70 -72.62 91.92 1.48 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 133.69 -14.29 4.73 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 -176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -68.75 169.11 11.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.7 0.286 . . . . 0.0 111.013 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 22.2 m -100.12 137.27 38.79 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 176.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.409 HG21 HD13 ' A' ' 85' ' ' ILE . 1.5 pp -125.81 165.43 23.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.172 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.4 m -147.31 125.39 12.11 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.052 0.453 . . . . 0.0 111.894 176.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -67.77 129.57 32.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.611 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.648 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.72 19.31 3.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.648 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.2 mptm? -138.69 160.81 38.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.964 0.802 . . . . 0.0 108.876 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -87.67 114.07 23.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.141 0.972 . . . . 0.0 112.433 173.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.536 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 3.8 mp -124.88 149.74 47.21 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.308 170.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -89.41 179.07 6.16 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.778 -0.576 . . . . 0.0 111.153 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.635 HG22 HG23 ' A' ' 76' ' ' VAL . 9.6 t -132.05 130.67 61.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 141.15 33.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.073 0.463 . . . . 0.0 111.352 -173.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 75.32 -16.35 3.79 Favored Glycine 0 CA--C 1.52 0.382 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.881 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 98.9 p -106.7 172.79 6.62 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.136 0.493 . . . . 0.0 111.158 -175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.0 t -97.12 16.79 18.71 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 172.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.6 mp -91.75 171.79 8.92 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.5 t -159.27 117.49 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -171.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.635 HG23 HG22 ' A' ' 69' ' ' VAL . 93.9 t -82.01 94.52 2.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 CA-C-O 121.785 0.802 . . . . 0.0 109.497 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.69 146.78 32.93 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.362 -173.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.551 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -47.98 97.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.937 0.875 . . . . 0.0 110.896 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.09 7.74 3.96 Favored Glycine 0 CA--C 1.524 0.611 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.179 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.4 m -62.7 104.21 0.51 Allowed 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 121.694 0.759 . . . . 0.0 109.52 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.2 113.93 26.34 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.346 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.76 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -132.02 118.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.129 176.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 61.9 pttt -110.04 170.39 8.11 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.57 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 89.9 m-20 66.82 34.17 5.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.216 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 61' ' ' ILE . 23.2 pt -64.57 175.5 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 122.195 0.997 . . . . 0.0 113.513 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.568 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -119.16 122.18 41.43 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.232 174.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.409 HD21 ' HB2' ' A' ' 55' ' ' LEU . 89.7 mt -74.83 118.92 18.33 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 170.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.558 HG23 ' O ' ' A' ' 93' ' ' ASP . 5.3 t -74.45 136.67 24.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-O 121.633 0.73 . . . . 0.0 111.637 -171.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -89.33 33.05 0.82 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.625 -173.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -141.52 -88.86 0.13 Allowed Glycine 0 C--N 1.303 -1.273 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.999 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -94.6 -179.05 4.75 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.514 ' HD2' ' HB3' ' A' ' 108' ' ' SER . 38.5 p-80 -89.09 46.58 1.4 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.763 0.316 . . . . 0.0 111.577 -175.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.558 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.6 m-20 -100.49 162.89 12.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.377 0.608 . . . . 0.0 111.944 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.604 HG13 HG21 ' A' ' 47' ' ' ILE . 4.9 mp -105.44 119.91 55.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.464 172.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.3 t70 -94.31 130.78 40.47 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.887 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.76 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.1 p -140.37 151.4 44.94 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.284 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -105.43 122.13 45.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.432 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.0 mt -122.63 107.78 20.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.255 0.55 . . . . 0.0 110.585 -176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -69.34 105.72 2.66 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.522 -177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.3 -37.96 0.79 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.234 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 17.3 pt -132.28 -38.49 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.863 0.363 . . . . 0.0 110.688 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.89 -153.67 23.92 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.018 -0.611 . . . . 0.0 111.734 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.22 150.57 24.71 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.722 0.261 . . . . 0.0 110.698 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.462 ' HG2' ' N ' ' A' ' 105' ' ' LYS . 49.4 ttm -142.0 164.05 31.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.143 -177.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.544 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -117.57 139.08 51.44 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 175.843 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 61.7 mt -119.05 138.76 52.63 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.499 -173.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 109' ' ' GLU . 14.6 tptm -72.25 125.03 26.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.884 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' ' HD2' ' A' ' 92' ' ' HIS . 28.8 t -52.1 -27.63 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.179 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 107' ' ' LYS . 10.9 pt-20 -87.1 -5.27 59.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.997 -175.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.403 ' HD2' ' HB3' ' A' ' 107' ' ' LYS . 35.5 m-85 -116.59 7.69 13.69 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.407 -0.517 . . . . 0.0 112.341 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 94' ' ' ILE . 34.0 m -111.91 162.46 9.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.421 ' CG ' HG21 ' A' ' 51' ' ' VAL . 28.2 ttt180 -141.25 135.26 30.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.97 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 27.1 tttm -67.46 140.88 57.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.178 0.513 . . . . 0.0 110.914 177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 36.5 t -115.99 -69.62 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.816 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 73.99 51.14 9.34 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.838 -174.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 60.0 m . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.614 -0.708 . . . . 0.0 110.071 178.866 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.695 0.283 . . . . 0.0 110.278 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.0 t -102.35 125.25 56.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.685 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.8 t -165.15 176.28 8.61 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.693 177.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 68.4 p -117.24 15.16 14.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.412 0.625 . . . . 0.0 110.231 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.466 HD13 HD22 ' A' ' 23' ' ' LEU . 60.9 mt -90.15 163.17 32.72 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.143 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 68.5 Cg_endo -71.2 159.99 50.33 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.264 1.976 . . . . 0.0 111.264 175.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -76.73 -163.67 0.22 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.649 2.233 . . . . 0.0 112.376 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 7.9 t -98.49 127.64 35.4 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.693 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 7.89 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 0.0 112.329 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.456 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 9.7 tt0 -122.05 -32.84 3.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.278 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.1 m -110.14 -45.25 3.62 Favored 'General case' 0 C--N 1.34 0.194 0 O-C-N 121.667 -0.645 . . . . 0.0 109.984 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 t30 69.95 -2.81 1.92 Allowed 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.698 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 11.9 p -45.27 -77.06 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 13' ' ' SER . 10.7 pt-20 161.85 -15.75 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.808 0.693 . . . . 0.0 111.06 -178.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.605 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 98.9 m-85 -81.97 45.57 0.93 Allowed 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.374 0.606 . . . . 0.0 111.043 -171.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.2 m -104.85 143.2 33.46 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.693 176.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -149.74 176.6 10.55 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.31 126.77 53.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.382 0.611 . . . . 0.0 110.819 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -117.27 82.07 1.75 Allowed 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.112 173.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.58 -112.58 4.33 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.584 -0.817 . . . . 0.0 113.39 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.79 17.32 22.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -172.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.55 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -154.0 -174.57 5.01 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.554 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 15.9 mt -114.5 136.46 52.99 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 174.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.741 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -127.87 142.01 44.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 O-C-N 121.67 -0.644 . . . . 0.0 109.861 178.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 46.6 t -104.62 106.99 56.9 Favored Pre-proline 0 C--N 1.313 -1.016 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.804 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.8 Cg_endo -66.88 -14.0 42.09 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.763 2.309 . . . . 0.0 111.423 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.488 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 29.8 tt0 -73.15 -61.32 1.86 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.02 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 28.9 p -97.81 10.9 38.99 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.33 45.41 20.16 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 176.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -135.88 124.12 23.16 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.729 0.299 . . . . 0.0 110.516 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.741 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 34.6 mt-10 -93.3 143.57 26.14 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -152.11 161.99 41.79 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 120.807 0.337 . . . . 0.0 110.121 -176.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.3 p -112.05 132.76 21.88 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 174.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.554 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 9.9 Cg_endo -52.95 -44.48 48.27 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.336 2.69 . . . . 0.0 113.284 -169.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.448 HD22 ' C ' ' A' ' 34' ' ' PRO . 0.9 OUTLIER -124.61 -27.58 3.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.254 0.549 . . . . 0.0 110.757 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 33' ' ' SER . 2.4 mp0 -67.12 -24.41 65.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.372 -176.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.48 -37.35 86.59 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.992 0.425 . . . . 0.0 110.574 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.07 -36.44 35.59 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.4 m 70.24 151.22 0.09 Allowed 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.281 178.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.92 99.88 12.17 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.771 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.2 t -77.09 100.36 5.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.84 162.14 35.87 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.594 -175.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.56 -12.88 38.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.647 0.261 . . . . 0.0 111.062 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.638 ' HA3' ' HA2' ' A' ' 90' ' ' GLY . . . 90.92 58.37 1.5 Allowed Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -174.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -86.92 -28.2 22.91 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.741 0.305 . . . . 0.0 111.225 -174.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.519 HG23 HD13 ' A' ' 87' ' ' LEU . 13.7 p -136.59 148.12 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.936 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.681 HG21 HG13 ' A' ' 94' ' ' ILE . 1.9 mm -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.144 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.516 ' N ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -107.27 177.22 4.91 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 0.0 111.202 178.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.59 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 6.6 m-20 -118.22 174.45 6.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.867 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.46 ' HB3' HD11 ' A' ' 64' ' ' ILE . 27.5 t -70.62 -7.11 41.82 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.836 0.827 . . . . 0.0 110.696 178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.478 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.0 t -88.93 -16.62 8.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.341 -1.299 . . . . 0.0 109.854 -177.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.66 2.22 65.35 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 114.444 -1.253 . . . . 0.0 111.668 -177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.519 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -93.66 162.82 13.79 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.332 0.587 . . . . 0.0 111.477 178.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.8 t -114.46 136.25 51.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.454 -173.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.628 HD22 HG22 ' A' ' 61' ' ' ILE . 13.1 mt -93.57 174.96 6.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.398 0.618 . . . . 0.0 112.002 -170.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 7.3 tt0 -125.64 147.18 49.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.933 -1.031 . . . . 0.0 108.581 175.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.4 105.68 2.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 122.045 0.926 . . . . 0.0 109.436 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 114.14 -2.46 23.99 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.0 -177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 2.8 t70 -76.59 169.31 18.51 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.6 m -105.53 137.03 44.03 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.628 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -120.7 166.4 15.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -177.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.5 m -148.08 119.84 8.09 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.929 0.395 . . . . 0.0 110.773 174.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.623 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -62.39 126.34 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.624 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -100.12 17.2 3.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -179.227 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.575 ' HD3' HG12 ' A' ' 64' ' ' ILE . 1.8 mppt? -141.77 165.18 28.19 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.75 -0.594 . . . . 0.0 109.517 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.514 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.0 p-10 -83.21 113.94 21.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.596 0.713 . . . . 0.0 111.484 172.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.551 HD21 ' CD1' ' A' ' 110' ' ' PHE . 23.9 mt -126.53 140.44 52.45 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.694 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -91.22 174.16 7.54 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 120.389 -0.524 . . . . 0.0 110.225 173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 72' ' ' SER . 38.7 t -124.91 126.37 71.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -88.49 -36.19 16.59 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -172.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.14 -32.37 52.63 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.125 -1.035 . . . . 0.0 111.575 178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.511 ' H ' HG12 ' A' ' 69' ' ' VAL . 37.2 m -107.04 175.74 5.4 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.343 -0.429 . . . . 0.0 111.145 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 m -98.19 -4.78 34.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.058 0.456 . . . . 0.0 110.561 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.9 mp -77.3 143.25 38.97 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.829 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.5 t -109.64 125.73 66.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.284 174.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.623 HG12 HG11 ' A' ' 63' ' ' VAL . 69.5 t -78.72 116.7 22.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.557 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.433 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -111.76 147.45 35.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.41 -175.096 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.31 98.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 121.924 0.868 . . . . 0.0 110.654 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.28 7.51 3.96 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.716 -178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 85.8 m -62.84 104.64 0.57 Allowed 'General case' 0 C--O 1.223 -0.321 0 CA-C-O 121.536 0.684 . . . . 0.0 109.657 174.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -89.67 115.83 27.34 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.847 -176.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 96' ' ' CYS . 38.5 t -125.01 115.16 43.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 21.4 ptmt -99.87 157.15 16.72 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.382 -174.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.589 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 93.6 m-20 66.27 45.17 2.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.659 173.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.41 HD11 ' HB3' ' A' ' 55' ' ' LEU . 31.1 pt -65.57 176.22 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 122.0 0.905 . . . . 0.0 113.38 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.534 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 21.8 tpp180 -130.26 131.95 45.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.602 -1.181 . . . . 0.0 108.831 175.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.519 HD13 HG23 ' A' ' 46' ' ' VAL . 15.8 mt -79.18 114.7 18.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.571 HG23 ' HB3' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -115.52 126.02 72.93 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.54 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.344 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.88 29.05 5.6 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 154.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.638 ' HA2' ' HA3' ' A' ' 44' ' ' GLY . . . 139.42 -137.86 8.86 Favored Glycine 0 C--N 1.304 -1.2 0 C-N-CA 119.215 -1.469 . . . . 0.0 115.885 171.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -104.19 -34.62 8.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.111 -0.544 . . . . 0.0 112.079 -175.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -105.53 55.16 0.69 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.273 -173.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.571 ' HB3' HG23 ' A' ' 88' ' ' VAL . 0.2 OUTLIER -163.98 98.22 0.85 Allowed 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -167.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.681 HG13 HG21 ' A' ' 47' ' ' ILE . 3.7 mp -112.15 117.21 54.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.98 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.2 t70 -93.78 131.68 38.91 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.621 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.579 ' HB2' HG11 ' A' ' 82' ' ' VAL . 18.3 p -144.74 156.15 43.91 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.91 -174.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.56 131.39 55.63 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.893 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -122.44 110.5 27.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.944 0.402 . . . . 0.0 110.028 -177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -68.16 102.94 1.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.299 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 149.09 -42.86 0.8 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.634 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 23.3 pt -120.31 -42.19 2.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.06 0.457 . . . . 0.0 110.398 178.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 140.05 -154.17 23.75 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.86 149.44 23.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 117.312 0.556 . . . . 0.0 110.453 179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.1 ttp -146.45 165.08 30.45 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.049 0.452 . . . . 0.0 110.95 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -114.03 138.65 50.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.866 -178.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.47 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 81.0 mt -119.15 142.11 48.24 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.311 0.577 . . . . 0.0 111.437 -174.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 66.1 mmtt -80.65 124.72 29.24 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.042 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.4 t -48.96 -43.66 40.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.981 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.452 ' C ' ' HB2' ' A' ' 50' ' ' SER . 1.5 pm0 -74.71 0.44 15.22 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.576 -174.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.551 ' CD1' HD21 ' A' ' 67' ' ' LEU . 76.8 m-85 -119.72 2.64 11.13 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.45 -0.781 . . . . 0.0 112.993 175.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.59 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 34.1 m -114.04 172.93 3.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.403 -0.519 . . . . 0.0 112.193 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.454 ' HD2' HG21 ' A' ' 51' ' ' VAL . 10.9 ttt-85 -149.83 138.1 20.53 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.58 -178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -73.97 120.44 19.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.212 177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.1 t -82.15 -46.55 19.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.907 174.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 82.49 11.35 82.11 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.177 -178.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 C--O 1.247 0.924 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.228 -179.304 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.5 ttp . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.04 144.87 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -67.46 130.84 44.34 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.0 t -147.34 10.41 0.98 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.415 0.626 . . . . 0.0 110.632 -175.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' HB3' ' HD2' ' A' ' 6' ' ' PRO . 84.9 mt -102.0 157.21 34.13 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 58.0 Cg_endo -67.75 155.12 71.2 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 121.81 1.673 . . . . 0.0 111.278 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -72.58 -170.85 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.71 2.273 . . . . 0.0 112.371 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 2.6 t -97.94 123.41 51.48 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.767 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.16 6.96 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.814 2.343 . . . . 0.0 112.269 -179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 49.2 mt-30 -115.36 -38.7 3.74 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.388 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.3 m -109.42 -48.19 3.28 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.757 -0.461 . . . . 0.0 109.757 -177.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 72.03 -1.97 2.7 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 114.772 -1.103 . . . . 0.0 111.81 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.517 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 23.5 p -48.73 -76.96 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 112.53 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.517 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.5 pt-20 164.98 -13.38 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.584 0.553 . . . . 0.0 111.589 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 56.6 m-85 -78.7 35.32 0.24 Allowed 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 121.083 0.468 . . . . 0.0 111.541 -171.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -97.83 138.94 34.43 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.047 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.1 p90 -147.26 174.8 11.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -176.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -108.06 130.84 55.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.254 0.55 . . . . 0.0 110.97 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -122.87 84.47 2.27 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.535 172.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.91 -110.27 3.95 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.363 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.09 19.92 17.94 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.822 0.344 . . . . 0.0 111.872 -171.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -157.59 -173.82 4.57 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.577 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 23.7 mt -114.21 137.42 51.79 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 173.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -127.83 142.41 43.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.071 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 44.0 t -106.3 106.7 58.14 Favored Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.908 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.584 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 39.0 Cg_endo -67.84 -10.16 27.93 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.804 2.336 . . . . 0.0 111.212 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.499 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 31.6 tt0 -75.74 -61.41 1.93 Allowed 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.679 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 27.7 p -98.58 9.78 42.47 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.37 26.55 15.86 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.448 ' HB3' HE22 ' A' ' 10' ' ' GLN . 47.3 m-70 -123.12 133.68 54.26 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.113 0.482 . . . . 0.0 111.214 175.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.0 OUTLIER -91.28 162.6 14.55 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.265 -0.879 . . . . 0.0 109.607 176.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -162.09 162.54 28.68 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.469 ' H ' ' HB2' ' A' ' 37' ' ' ALA . 31.0 t -109.65 134.84 20.46 Favored Pre-proline 0 C--N 1.31 -1.15 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.577 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.2 Cg_endo -60.49 -23.85 76.38 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.489 2.126 . . . . 0.0 112.533 -177.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 -131.2 -41.79 1.1 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.887 0.375 . . . . 0.0 111.524 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -80.08 -0.9 37.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.04 0.447 . . . . 0.0 111.28 -171.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' HB2' ' H ' ' A' ' 33' ' ' SER . . . -72.83 -5.5 38.56 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 122.129 -0.357 . . . . 0.0 111.042 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.15 -20.28 64.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.571 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.2 m -67.08 153.49 43.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.465 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -130.97 111.09 11.74 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.811 0.339 . . . . 0.0 110.636 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.7 m -81.71 100.31 9.42 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.042 0.449 . . . . 0.0 109.993 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.424 ' HA ' ' NZ ' ' A' ' 45' ' ' LYS . 37.0 t70 -144.68 147.99 33.7 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.301 0.572 . . . . 0.0 111.801 -178.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -129.35 -41.61 1.38 Allowed 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.966 175.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.7 39.99 0.47 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.726 -0.75 . . . . 0.0 113.17 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' NZ ' ' HA ' ' A' ' 42' ' ' ASP . 29.2 mtmm -110.88 -31.65 7.09 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.332 0.587 . . . . 0.0 109.666 174.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.579 HG13 HD13 ' A' ' 87' ' ' LEU . 20.3 t -105.33 146.78 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.211 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.511 HG21 ' CG1' ' A' ' 94' ' ' ILE . 5.9 mm -85.22 134.71 26.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.807 0.337 . . . . 0.0 110.987 -174.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.672 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -112.18 149.36 32.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.211 177.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.6 m-20 -94.97 177.88 5.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.797 0.332 . . . . 0.0 110.633 -175.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 32.8 t -72.57 -7.44 50.16 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.965 0.888 . . . . 0.0 110.536 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.469 HG21 ' CG ' ' A' ' 112' ' ' ARG . 3.0 t -88.23 -14.42 9.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.944 -178.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.58 1.74 68.22 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.631 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -94.5 159.2 15.2 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.371 0.605 . . . . 0.0 111.6 179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.473 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.8 t -108.75 135.14 48.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.053 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.58 HD22 HG22 ' A' ' 61' ' ' ILE . 12.7 mt -92.14 178.96 5.71 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.053 0.454 . . . . 0.0 110.715 -175.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.946 ' HG2' ' HB2' ' A' ' 59' ' ' ASP . 9.1 pt20 -126.03 154.77 42.51 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 170.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.488 ' OD1' ' HD3' ' A' ' 86' ' ' ARG . 19.4 t70 -66.59 104.4 1.27 Allowed 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 173.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 112.71 -0.28 26.02 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.787 -177.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.946 ' HB2' ' HG2' ' A' ' 56' ' ' GLN . 2.7 t0 -78.96 171.59 14.99 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 177.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 33.0 m -106.22 137.52 44.02 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -178.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.58 HG22 HD22 ' A' ' 55' ' ' LEU . 2.1 pp -120.82 167.71 13.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 -177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.6 m -149.38 117.17 6.25 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.824 0.345 . . . . 0.0 110.382 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.752 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -59.69 128.89 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.439 176.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -100.65 17.32 3.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 112.443 0.535 . . . . 0.0 112.443 178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 5.3 mptp? -137.38 161.91 35.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 O-C-N 121.678 -0.639 . . . . 0.0 109.321 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.51 ' O ' HD23 ' A' ' 67' ' ' LEU . 10.2 p-10 -84.13 109.77 17.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.744 0.783 . . . . 0.0 111.467 170.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 66' ' ' ASP . 21.7 mt -127.05 145.93 50.55 Favored 'General case' 0 C--O 1.22 -0.477 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.616 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -90.51 174.75 7.37 Favored 'General case' 0 C--N 1.315 -0.917 0 O-C-N 121.948 -0.47 . . . . 0.0 111.382 173.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.46 ' CG2' HG23 ' A' ' 76' ' ' VAL . 49.7 t -123.25 130.21 74.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 175.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 40.5 mtmt -73.76 -63.31 1.23 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 118.165 0.439 . . . . 0.0 112.016 -173.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -69.57 -23.01 76.81 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.029 -0.605 . . . . 0.0 113.37 -174.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.444 ' HB2' HG11 ' A' ' 69' ' ' VAL . 66.9 m -112.59 151.02 30.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.751 0.31 . . . . 0.0 110.967 -175.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.8 m -74.47 -0.22 16.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.17 0.51 . . . . 0.0 110.959 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.475 ' CD2' HG21 ' A' ' 101' ' ' ILE . 3.1 mm? -78.55 143.39 36.56 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.474 -178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.0 t -107.55 134.61 48.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.804 173.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.752 HG12 HG11 ' A' ' 63' ' ' VAL . 75.5 t -89.2 101.62 12.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.025 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.6 147.89 27.13 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.593 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.539 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.3 p -51.45 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 CA-C-O 121.855 0.836 . . . . 0.0 110.935 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.84 4.52 4.21 Favored Glycine 0 CA--C 1.525 0.66 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.914 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.5 105.02 0.57 Allowed 'General case' 0 C--O 1.223 -0.298 0 CA-C-O 121.633 0.73 . . . . 0.0 110.368 175.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -91.47 114.16 26.61 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.158 -176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 96' ' ' CYS . 43.2 t -122.08 118.46 55.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.861 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.598 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.1 ptmt -98.53 156.22 16.89 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.435 -175.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.468 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 85.3 m-20 63.08 49.91 3.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.325 173.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.8 pt -64.86 176.24 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' HD3' ' OD1' ' A' ' 57' ' ' ASP . 11.7 tpp180 -131.59 121.89 25.13 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.382 -1.281 . . . . 0.0 108.269 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.579 HD13 HG13 ' A' ' 46' ' ' VAL . 22.8 mt -85.96 126.24 33.97 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.091 0.405 . . . . 0.0 109.919 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.1 OUTLIER -103.42 -179.97 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.763 -178.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -62.49 -42.62 99.62 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -171.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.593 ' O ' ' HB2' ' A' ' 93' ' ' ASP . . . -82.72 162.12 40.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.572 -176.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -72.07 -31.47 66.14 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.52 0.676 . . . . 0.0 110.017 179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.416 ' CD2' ' H ' ' A' ' 92' ' ' HIS . 9.4 p80 -89.8 46.25 1.35 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.788 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.671 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 5.0 m-20 -145.57 88.02 1.82 Allowed 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -164.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 106' ' ' LEU . 30.9 mt -119.96 108.9 24.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.217 169.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 86' ' ' ARG . 16.6 t70 -95.72 103.77 15.66 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.53 0.681 . . . . 0.0 109.263 -177.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.578 ' HB2' HG11 ' A' ' 82' ' ' VAL . 28.6 p -107.35 157.79 17.67 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.344 -178.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 21.6 pttp -118.03 138.47 52.19 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.505 178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -124.2 104.92 14.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.86 100.54 0.21 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.176 -173.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 146.16 -64.86 0.44 Allowed Glycine 0 N--CA 1.442 -0.966 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.647 -176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.475 HG21 ' CD2' ' A' ' 74' ' ' LEU . 40.5 pt -89.88 -46.71 15.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.903 0.383 . . . . 0.0 110.175 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.465 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.15 -162.21 27.86 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.45 -0.66 . . . . 0.0 111.45 176.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -83.61 149.66 26.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.025 0.441 . . . . 0.0 110.985 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.9 ttp -136.82 153.51 50.78 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.556 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 21.6 mmmt -98.84 146.44 25.95 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.602 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 95.5 mt -129.75 134.31 47.53 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.502 0.668 . . . . 0.0 111.765 -176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 14.3 tttm -81.28 114.73 20.27 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.596 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.672 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.4 p -52.69 -37.46 58.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.421 -176.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' SER . 39.1 mt-10 -71.37 -3.84 22.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.863 -178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.444 ' HB3' HD11 ' A' ' 67' ' ' LEU . 66.6 m-85 -118.58 4.5 11.69 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 177.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.4 m -117.24 175.28 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 120.935 0.398 . . . . 0.0 112.064 -177.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.469 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.4 ttt180 -147.7 141.59 25.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.562 -178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -72.52 121.9 20.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.995 174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.1 t -81.08 -54.59 9.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.031 174.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.71 -9.34 55.38 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.571 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 37.5 m . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.51 -0.757 . . . . 0.0 110.344 179.004 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.31 0 CA-C-O 121.342 0.591 . . . . 0.0 111.088 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.69 126.34 47.14 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.57 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.4 m -88.6 70.07 8.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.181 0.515 . . . . 0.0 110.816 -175.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 26.3 p -126.9 117.75 23.2 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 176.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 42.7 mt -110.1 152.3 43.03 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.825 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.22 157.76 56.4 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.276 1.984 . . . . 0.0 111.243 176.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -66.3 -168.01 0.13 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.446 2.097 . . . . 0.0 112.72 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 44.5 t -99.55 123.87 46.49 Favored Pre-proline 0 C--N 1.312 -1.057 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.713 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -70.26 5.53 1.85 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.32 2.013 . . . . 0.0 111.724 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.661 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 42.2 mt-30 -105.44 -47.19 4.0 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.48 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 28.4 p -124.32 -33.42 3.05 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 120.595 -0.442 . . . . 0.0 111.891 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.416 ' H ' ' HB3' ' A' ' 8' ' ' CYS . 8.3 t-20 70.81 11.84 7.15 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-O 121.402 0.62 . . . . 0.0 111.026 178.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 38.7 m -58.0 -25.76 61.49 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.454 -0.793 . . . . 0.0 111.285 175.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 13' ' ' SER . 89.2 mt-10 86.39 10.42 0.21 Allowed 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 124.45 1.1 . . . . 0.0 111.504 172.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.435 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 85.5 m-85 -89.11 52.1 2.31 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.558 0.694 . . . . 0.0 109.387 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 m -105.24 149.8 25.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.713 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.448 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 48.3 p90 -150.52 177.1 10.34 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -175.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.83 128.24 52.94 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.794 0.33 . . . . 0.0 110.175 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -113.78 25.68 11.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.703 0.763 . . . . 0.0 109.901 177.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.75 -114.82 0.85 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.388 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -98.88 14.38 29.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.645 -176.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.513 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.2 pt? -150.0 -175.69 5.15 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.042 -177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 11.0 mt -118.23 141.07 48.89 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 176.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -130.88 147.02 33.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 121.703 -0.623 . . . . 0.0 109.792 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 43.6 t -101.74 111.48 64.05 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 177.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' A' ' 17' ' ' TYR . 23.6 Cg_endo -62.01 -22.64 74.63 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.882 2.388 . . . . 0.0 111.454 178.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 22.4 tt0 -76.79 -59.61 2.7 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.022 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.9 m -76.86 -4.85 45.82 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 56.63 37.32 28.72 Favored 'General case' 0 N--CA 1.461 0.087 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -176.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -141.25 135.22 30.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.011 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.513 ' HB3' HD11 ' A' ' 22' ' ' LEU . 21.6 mp0 -91.87 160.88 15.08 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.013 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -159.55 162.0 35.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.908 0.385 . . . . 0.0 110.368 177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.2 t -117.53 134.18 23.19 Favored Pre-proline 0 C--N 1.313 -0.983 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 177.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -63.93 -26.92 66.69 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 122.607 2.205 . . . . 0.0 113.352 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -133.63 -44.74 0.82 Allowed 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.76 0.314 . . . . 0.0 111.597 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -64.1 -17.85 63.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.075 -0.512 . . . . 0.0 112.065 -174.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.69 -19.73 65.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.482 -179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.3 -49.31 50.92 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.246 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 36.6 p -127.94 111.6 13.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.899 0.381 . . . . 0.0 111.524 -176.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -129.67 16.56 5.86 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.304 0.573 . . . . 0.0 110.203 177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.1 m -94.83 16.71 15.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.16 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -143.03 152.97 42.49 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.493 ' OD2' ' HB3' ' A' ' 45' ' ' LYS . 25.5 t70 -101.87 -19.25 15.36 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.323 0.582 . . . . 0.0 110.675 -178.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.72 27.7 60.43 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.695 -175.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HB3' ' OD2' ' A' ' 43' ' ' ASP . 57.2 pttt -97.33 -21.27 17.31 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.641 0.257 . . . . 0.0 111.271 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.52 134.75 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.218 -176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.551 HG21 HG12 ' A' ' 94' ' ' ILE . 32.3 mm -73.54 122.02 25.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.404 -174.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 6.1 ttmt -119.03 137.39 53.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.613 -177.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.595 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 80.8 m-20 -92.88 -175.84 4.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.345 -169.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 16.7 t -77.1 -5.9 50.72 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 122.219 1.009 . . . . 0.0 110.269 -176.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.489 HG21 ' HD2' ' A' ' 112' ' ' ARG . 6.5 t -89.02 -21.16 6.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.635 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.18 -6.46 68.86 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.472 -1.24 . . . . 0.0 110.821 -174.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.595 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -79.13 146.35 33.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.539 0.685 . . . . 0.0 111.179 178.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.421 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.3 t -102.94 134.74 43.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.522 -175.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.649 ' HA ' ' HD2' ' A' ' 113' ' ' LYS . 7.1 mp -96.42 173.61 7.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.318 0.58 . . . . 0.0 111.28 -169.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.595 HE21 ' H ' ' A' ' 57' ' ' ASP . 29.9 tp60 -126.04 149.26 48.98 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.034 -0.984 . . . . 0.0 108.373 178.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.595 ' H ' HE21 ' A' ' 56' ' ' GLN . 13.4 t70 -65.15 130.16 42.34 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.27 -4.55 86.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.231 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 56' ' ' GLN . 1.1 t70 -73.52 175.73 6.77 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 117.129 0.465 . . . . 0.0 110.911 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.674 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.0 m -106.31 138.69 42.05 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 pp -120.73 166.14 15.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -150.47 113.84 4.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 120.717 0.294 . . . . 0.0 110.512 176.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.6 OUTLIER -61.05 125.82 17.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.538 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -97.43 14.35 3.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.506 ' HD2' ' O ' ' A' ' 64' ' ' ILE . 2.4 mptm? -137.81 160.71 38.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -178.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.16 116.17 24.18 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.547 0.689 . . . . 0.0 111.848 173.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 5.1 mp -129.63 146.51 51.42 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.737 -1.119 . . . . 0.0 108.973 173.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 68' ' ' LYS . 18.1 ptmt -92.76 179.38 5.5 Favored 'General case' 0 C--N 1.316 -0.853 0 O-C-N 121.507 -0.746 . . . . 0.0 110.574 173.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 25.9 t -130.94 128.2 62.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 175.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 17.1 ttpt -91.6 136.95 32.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.698 -172.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.58 -27.19 3.36 Favored Glycine 0 CA--C 1.517 0.185 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.494 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.672 ' HB3' HD23 ' A' ' 74' ' ' LEU . 66.2 m -105.32 155.36 19.17 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.624 0.249 . . . . 0.0 110.374 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.3 m -84.15 12.23 6.81 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.234 0.54 . . . . 0.0 110.374 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.672 HD23 ' HB3' ' A' ' 72' ' ' SER . 3.9 mm? -78.35 170.83 15.99 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.002 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -158.93 117.02 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -171.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.548 HG12 HG11 ' A' ' 63' ' ' VAL . 86.5 t -91.73 95.92 5.87 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.599 0.714 . . . . 0.0 110.564 -176.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.24 145.8 33.77 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 122.038 -0.414 . . . . 0.0 111.17 -176.048 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -47.63 98.04 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 124.074 0.858 . . . . 0.0 111.392 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.07 7.14 3.76 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.262 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 62' ' ' THR . 87.0 m -63.07 104.19 0.54 Allowed 'General case' 0 C--O 1.224 -0.279 0 CA-C-O 121.759 0.79 . . . . 0.0 110.032 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -92.92 114.59 27.19 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.098 -174.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.679 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.4 t -131.37 121.06 47.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.662 176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.674 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 56.8 pttt -107.9 166.99 10.3 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.731 0.777 . . . . 0.0 112.959 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.522 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 1.0 OUTLIER 71.1 36.7 1.35 Allowed 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 113.215 -1.811 . . . . 0.0 111.203 172.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 43.3 pt -66.71 -178.11 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -178.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.808 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 0.3 OUTLIER -130.63 131.05 44.71 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.895 174.802 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.3 mt -71.7 110.83 6.51 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 90' ' ' GLY . 1.5 t -77.5 148.28 6.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.513 -173.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -78.12 -20.36 52.28 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 172.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.631 ' H ' HG12 ' A' ' 88' ' ' VAL . . . -59.29 137.01 50.48 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.571 170.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -24.23 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -166.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.509 ' O ' HG23 ' A' ' 47' ' ' ILE . 54.6 m170 -109.92 2.67 19.93 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -86.49 -169.72 2.76 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -160.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.551 HG12 HG21 ' A' ' 47' ' ' ILE . 69.7 mt -140.62 126.64 20.63 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.636 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.694 -173.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.808 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 12.8 t70 -93.04 126.29 38.06 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 175.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.679 ' HB2' HG11 ' A' ' 82' ' ' VAL . 20.1 p -134.58 141.6 46.7 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.009 -176.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 84' ' ' ASN . 11.4 ptpt -98.93 114.73 27.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.49 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 38.7 mt -116.98 104.94 17.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.403 -174.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -47.66 130.35 14.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.639 -178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.2 -73.93 0.21 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.864 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 102' ' ' GLY . 32.6 pt -80.67 -46.27 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.774 0.321 . . . . 0.0 111.203 -178.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 134.44 -146.33 18.33 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -88.57 155.97 19.33 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 117.101 0.45 . . . . 0.0 111.031 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.0 ttp -149.37 164.61 34.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.21 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 72.6 mttt -118.73 119.26 33.9 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.977 0.418 . . . . 0.0 110.704 -177.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 18.5 mt -105.13 153.86 20.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.116 -174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 13.5 tptt -83.9 114.22 21.52 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.072 174.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.704 ' HA ' HG22 ' A' ' 111' ' ' VAL . 88.7 p -53.88 -39.54 65.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 122.132 0.968 . . . . 0.0 109.627 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 50' ' ' SER . 41.1 mt-10 -64.86 -3.39 3.34 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.329 -1.305 . . . . 0.0 112.539 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.474 ' O ' HD13 ' A' ' 64' ' ' ILE . 35.7 m-85 -117.23 0.74 12.35 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 171.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.704 HG22 ' HA ' ' A' ' 108' ' ' SER . 19.2 m -121.24 178.23 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.467 0.651 . . . . 0.0 112.396 -177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 51' ' ' VAL . 6.9 ttt180 -144.11 133.12 22.76 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.944 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.649 ' HD2' ' HA ' ' A' ' 55' ' ' LEU . 88.0 tttt -65.87 121.3 14.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.526 173.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.6 -65.15 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.971 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.29 33.01 6.41 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.951 -0.642 . . . . 0.0 111.804 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.507 -0.759 . . . . 0.0 110.189 -179.825 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.479 1.002 0 CA-C-O 120.826 0.346 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.6 p -148.65 135.53 13.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.929 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -73.65 120.33 19.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.193 0.521 . . . . 0.0 111.422 -175.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 t -102.94 107.81 18.76 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 170.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.9 mt -101.02 151.49 37.64 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.382 -174.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.7 160.21 46.86 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.643 2.229 . . . . 0.0 111.345 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -67.56 -166.44 0.13 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.44 2.093 . . . . 0.0 112.432 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.559 ' SG ' ' HB3' ' A' ' 10' ' ' GLN . 8.5 t -98.17 121.95 55.62 Favored Pre-proline 0 C--N 1.318 -0.794 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.11 6.61 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.681 2.254 . . . . 0.0 112.199 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.559 ' HB3' ' SG ' ' A' ' 8' ' ' CYS . 9.1 tt0 -119.89 -34.28 3.77 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.366 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.4 m -112.22 -43.53 3.53 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.816 0.735 . . . . 0.0 110.15 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.7 t30 73.19 2.9 4.5 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.889 -176.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 14' ' ' GLU . 23.3 p -65.0 -35.44 81.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.696 178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 13' ' ' SER . 2.4 mt-10 85.74 25.5 0.07 Allowed 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 114.81 -1.086 . . . . 0.0 113.13 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -70.92 2.25 4.56 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.788 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.415 HG22 ' HB3' ' A' ' 23' ' ' LEU . 1.4 m -58.42 145.73 37.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.807 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 46.3 p90 -153.27 174.82 13.8 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.85 111.36 23.85 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.104 0.478 . . . . 0.0 111.26 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.505 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.9 t0 -108.49 74.16 0.91 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 174.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.39 -112.82 4.56 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.493 -0.86 . . . . 0.0 112.828 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.69 16.96 23.16 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -172.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -156.01 -174.45 4.96 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.092 -0.243 . . . . 0.0 110.415 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' HG22 ' A' ' 16' ' ' THR . 22.6 mt -110.51 134.23 52.56 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 177.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.47 HG13 ' HG3' ' A' ' 31' ' ' GLU . 85.9 t -118.66 132.45 68.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 O-C-N 122.114 -0.366 . . . . 0.0 110.208 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.8 t -99.45 109.88 56.54 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 175.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.44 -3.09 12.32 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.815 2.343 . . . . 0.0 112.109 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -89.82 -61.07 1.77 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.26 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -93.05 12.04 25.49 Favored 'General case' 0 C--O 1.231 0.082 0 O-C-N 121.748 -0.595 . . . . 0.0 112.524 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.92 31.76 18.06 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -138.96 131.95 29.49 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.181 0.515 . . . . 0.0 110.792 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HG3' HG13 ' A' ' 24' ' ' VAL . 1.1 mp0 -91.6 171.0 9.47 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.516 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -167.36 161.5 14.18 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.9 m -124.81 125.23 25.47 Favored Pre-proline 0 C--N 1.306 -1.326 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -56.5 -36.71 97.9 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.905 2.404 . . . . 0.0 112.869 -172.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -124.45 -44.7 1.98 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.514 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.56 ' OE1' ' HB ' ' A' ' 39' ' ' THR . 9.9 tp10 -60.55 -25.47 66.18 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -176.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.17 -14.34 24.45 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 121.987 -0.445 . . . . 0.0 111.563 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.87 -21.53 43.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.068 177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.56 ' HB ' ' OE1' ' A' ' 36' ' ' GLU . 16.1 m -115.32 -70.75 0.78 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.194 -177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 36' ' ' GLU . . . -144.09 -160.72 1.16 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.788 0.328 . . . . 0.0 111.038 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -102.19 15.99 27.46 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.05 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.6 t70 67.14 127.84 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 122.129 0.966 . . . . 0.0 111.525 -172.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -133.1 -34.63 1.08 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.478 -1.237 . . . . 0.0 110.528 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 132.41 16.72 1.31 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.294 -0.955 . . . . 0.0 112.979 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 45.1 mtpt -78.22 -29.52 48.34 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 174.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.8 t -86.97 139.69 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.447 HG21 HG13 ' A' ' 94' ' ' ILE . 16.3 mm -78.58 132.73 31.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.424 -172.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' O ' ' HB2' ' A' ' 108' ' ' SER . 4.1 ttmt -122.47 135.67 54.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.063 -177.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 84.0 m-20 -99.17 -178.99 4.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -169.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 23.1 t -74.06 -5.31 40.75 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.786 0.803 . . . . 0.0 110.971 -173.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 4.4 t -87.71 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.487 178.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.11 -8.86 63.17 Favored Glycine 0 N--CA 1.442 -0.909 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.448 -175.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.549 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -80.32 148.68 30.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.781 0.801 . . . . 0.0 112.07 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' A' ' 48' ' ' LYS . 3.7 t -102.88 137.26 31.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.044 -178.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.826 ' HG ' ' HG3' ' A' ' 113' ' ' LYS . 7.3 mp -95.84 174.0 7.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.469 0.652 . . . . 0.0 111.925 -169.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.496 HE21 ' N ' ' A' ' 57' ' ' ASP . 30.1 tp60 -122.32 139.08 54.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.785 -1.098 . . . . 0.0 108.406 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' N ' HE21 ' A' ' 56' ' ' GLN . 22.7 t70 -66.56 102.99 0.97 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 84' ' ' ASN . . . 116.34 -2.52 20.51 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.945 -0.645 . . . . 0.0 111.574 -176.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 1.3 t70 -77.18 175.21 9.88 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.695 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 10.3 m -103.67 139.07 39.45 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -120.99 166.73 15.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.8 m -149.04 117.04 6.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.767 0.317 . . . . 0.0 110.474 176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.709 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.54 124.86 13.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 175.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.577 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -96.46 13.71 3.67 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 120.325 -0.55 . . . . 0.0 110.565 178.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.62 ' HA ' ' HE2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -134.74 159.1 42.37 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-O 121.188 0.518 . . . . 0.0 109.742 -172.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.05 103.43 7.98 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 121.66 0.743 . . . . 0.0 111.544 170.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.458 HD23 ' HB3' ' A' ' 65' ' ' LYS . 2.2 mm? -115.68 128.91 56.26 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.145 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -88.06 174.09 8.48 Favored 'General case' 0 C--N 1.311 -1.091 0 O-C-N 120.911 -1.118 . . . . 0.0 109.573 171.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.63 123.68 67.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -79.72 -41.99 25.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -171.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -80.34 -20.45 66.84 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.558 -177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 59.2 m -113.8 173.69 6.3 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.913 0.387 . . . . 0.0 111.296 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 m -98.28 2.1 47.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.15 0.5 . . . . 0.0 110.363 177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.3 mp -79.9 141.08 36.43 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.314 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.3 t -109.92 140.8 27.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.163 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.709 HG12 HG11 ' A' ' 63' ' ' VAL . 69.8 t -99.4 119.9 48.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.261 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.2 149.93 36.91 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.829 -175.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.51 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -49.39 97.45 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.539 178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.09 5.14 3.92 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-N 115.377 -0.828 . . . . 0.0 111.635 -177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 93.1 m -62.33 105.16 0.57 Allowed 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 121.811 0.815 . . . . 0.0 110.224 175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -93.53 112.95 24.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.976 -173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.584 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.5 t -124.45 119.35 56.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.374 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.695 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 16.8 pttm -106.19 159.45 16.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -176.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 45.1 m-80 65.4 43.94 3.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.24 -1.345 . . . . 0.0 110.892 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 45.5 pt -64.89 -179.78 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.427 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 6.2 tpp180 -125.52 125.38 43.16 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.281 173.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.1 mt -80.33 118.05 21.63 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 93' ' ' ASP . 1.9 t -79.7 128.14 38.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -102.55 80.22 1.9 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 123.37 1.557 . . . . 0.0 112.954 -172.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.57 -76.55 0.04 OUTLIER Glycine 0 C--N 1.296 -1.677 0 CA-C-N 112.812 -1.995 . . . . 0.0 110.3 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 92' ' ' HIS . 14.5 t70 -87.85 -167.01 1.74 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 168.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.409 ' H ' ' CG ' ' A' ' 91' ' ' ASP . 53.5 m80 -105.66 46.66 0.91 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 119.262 -0.399 . . . . 0.0 111.718 -175.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.482 ' O ' HG23 ' A' ' 88' ' ' VAL . 53.4 m-20 -97.1 165.7 11.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 119.418 1.008 . . . . 0.0 112.725 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.587 ' CD1' HG21 ' A' ' 111' ' ' VAL . 49.1 mt -115.52 119.93 63.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.652 -1.158 . . . . 0.0 110.475 174.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -95.28 135.93 36.27 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.584 ' HB2' HG11 ' A' ' 82' ' ' VAL . 22.1 p -143.13 153.68 43.13 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.775 -172.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -110.56 125.35 53.27 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.9 mt -126.16 115.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.726 0.298 . . . . 0.0 110.478 -174.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -74.14 104.49 4.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.086 0.47 . . . . 0.0 110.54 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.57 -44.35 0.57 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.066 -178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 21.1 pt -125.51 -38.55 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.905 0.383 . . . . 0.0 110.496 178.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 138.25 -151.38 21.44 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -82.26 145.24 30.12 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.4 tpt -136.34 156.63 48.36 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.997 0.427 . . . . 0.0 111.123 -177.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -108.64 128.5 54.89 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.713 178.011 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 59.8 mt -115.35 140.99 48.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.43 0.633 . . . . 0.0 111.292 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mmtt -78.74 113.97 17.26 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.674 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.614 ' HA ' HG22 ' A' ' 111' ' ' VAL . 4.3 p -52.42 -38.81 59.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.804 0.811 . . . . 0.0 109.77 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.453 ' O ' ' HB2' ' A' ' 50' ' ' SER . 33.2 mt-10 -60.08 -15.13 20.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.64 177.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.457 ' CG ' HD21 ' A' ' 67' ' ' LEU . 27.6 m-85 -114.96 4.86 14.88 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.506 -0.478 . . . . 0.0 112.085 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 33.3 m -126.1 179.11 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.394 0.616 . . . . 0.0 112.422 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.532 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 9.7 ttt180 -145.86 137.82 25.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.944 -179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.826 ' HG3' ' HG ' ' A' ' 55' ' ' LEU . 2.0 ttpp -73.3 125.01 26.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.786 173.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.3 t -87.81 -61.26 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.46 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.97 40.34 8.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.7 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.251 1.149 0 CA-C-O 118.541 -0.743 . . . . 0.0 109.817 -178.161 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.7 p -139.13 124.91 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-O 121.197 0.522 . . . . 0.0 111.137 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m -148.65 86.61 1.53 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.83 174.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 21.2 p -117.58 -54.03 2.38 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.127 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.404 HD11 ' CD ' ' A' ' 18' ' ' GLU . 21.3 mt -83.57 151.06 61.19 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.086 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 73.3 Cg_endo -73.61 158.24 47.62 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.504 2.136 . . . . 0.0 110.989 175.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 16.2 Cg_exo -68.28 -166.6 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.369 2.046 . . . . 0.0 112.057 177.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.0 t -97.93 120.89 59.11 Favored Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.508 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -67.23 9.24 0.31 Allowed 'Trans proline' 0 N--CA 1.474 0.339 0 C-N-CA 122.801 2.334 . . . . 0.0 112.141 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.578 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 33.8 mt-30 -117.6 -35.19 4.02 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.4 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.6 m -111.53 -48.53 3.07 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 121.0 0.429 . . . . 0.0 110.123 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.5 t30 69.9 -3.05 1.83 Allowed 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.025 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 38.9 t -53.29 -76.45 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.944 179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 173.06 -19.26 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.718 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 93.3 m-85 -82.5 48.62 1.32 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.051 0.453 . . . . 0.0 111.637 -167.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.4 m -109.23 146.25 34.54 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.334 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 24.4 p90 -152.88 178.45 9.65 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.471 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -103.58 118.78 37.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.001 0.429 . . . . 0.0 110.762 177.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.489 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 37.8 t70 -116.78 80.86 1.54 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.99 -113.03 4.55 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.535 -0.841 . . . . 0.0 113.213 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -110.26 21.45 16.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -172.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD11 ' HG3' ' A' ' 31' ' ' GLU . 2.4 pt? -158.47 -175.01 5.08 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.342 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 17.0 mt -107.25 130.29 54.77 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.454 HG21 ' HB3' ' A' ' 19' ' ' ASP . 52.9 t -118.0 132.97 66.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 O-C-N 122.103 -0.373 . . . . 0.0 110.43 -177.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 42.0 t -103.35 105.16 45.27 Favored Pre-proline 0 C--N 1.319 -0.732 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 176.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.718 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 40.1 Cg_endo -68.14 -11.07 30.87 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.883 2.389 . . . . 0.0 111.176 178.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.616 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 10.2 tp10 -72.52 -66.49 0.65 Allowed 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.675 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.6 p -95.35 12.54 28.82 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 60.91 32.6 20.01 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.109 0.481 . . . . 0.0 111.915 175.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.463 ' HB3' HE22 ' A' ' 10' ' ' GLN . 40.2 t60 -136.64 133.24 36.03 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.193 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -105.87 167.47 9.76 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.798 179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -165.57 162.2 18.91 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.603 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 31.3 t -116.93 136.92 23.39 Favored Pre-proline 0 C--N 1.31 -1.137 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 19.6 Cg_endo -59.46 -22.8 67.83 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.798 2.332 . . . . 0.0 112.97 -176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.3 p-10 -124.19 -40.42 2.27 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.603 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 35.2 tt0 -67.91 -21.88 65.1 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-O 120.736 0.303 . . . . 0.0 111.323 -175.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.95 -32.34 71.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.772 0.32 . . . . 0.0 110.49 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.1 -43.51 52.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.977 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.5 t 49.25 -165.67 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 O-C-N 124.345 1.028 . . . . 0.0 112.34 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 58.25 41.98 22.58 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.332 0.586 . . . . 0.0 111.064 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.9 m -98.38 33.23 2.27 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.567 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -153.98 164.21 38.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.615 178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -79.23 -30.38 43.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.946 0.403 . . . . 0.0 110.304 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 100.88 -28.37 16.29 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.457 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 89' ' ' ASP . 44.7 mtpt -84.25 8.78 14.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.814 0.34 . . . . 0.0 111.849 -178.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.3 t -93.66 105.37 16.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.533 HG12 HD22 ' A' ' 87' ' ' LEU . 1.4 mm -80.45 130.62 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.925 -170.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.444 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 3.5 ttmt -109.02 166.83 10.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.565 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.469 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 14.3 m-20 -106.08 170.48 7.89 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.806 178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 9.2 t -82.65 -9.95 59.15 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 122.096 0.95 . . . . 0.0 110.236 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.566 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.6 p -89.09 4.13 5.39 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.403 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.11 -1.88 80.74 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 114.552 -1.203 . . . . 0.0 113.511 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.566 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -103.62 161.96 13.46 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 119.591 -0.844 . . . . 0.0 112.327 -178.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG22 ' HE2' ' A' ' 48' ' ' LYS . 11.6 t -102.4 142.85 15.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 113.983 -1.462 . . . . 0.0 110.175 -177.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.614 HD22 HG22 ' A' ' 61' ' ' ILE . 17.9 mt -94.48 174.97 6.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.391 0.615 . . . . 0.0 111.319 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.434 ' HG2' ' N ' ' A' ' 57' ' ' ASP . 14.0 tt0 -138.53 159.49 41.95 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.09 -0.959 . . . . 0.0 108.483 172.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 10.0 p-10 -69.69 130.47 42.44 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.416 0.627 . . . . 0.0 109.712 177.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 91.57 -7.94 79.29 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.122 -0.945 . . . . 0.0 113.173 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.484 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 1.7 t70 -77.98 167.39 21.55 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.318 -0.519 . . . . 0.0 110.707 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.709 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 28.2 m -96.53 140.08 31.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.953 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.614 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -123.86 165.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.082 0.468 . . . . 0.0 110.069 179.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.8 m -149.72 121.12 7.9 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.203 174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.746 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.28 127.58 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 176.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.557 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -99.34 17.24 3.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.043 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.557 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.6 mptm? -140.81 161.46 37.75 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 121.459 -0.775 . . . . 0.0 109.041 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.537 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.0 p-10 -81.28 115.25 20.57 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.706 0.765 . . . . 0.0 111.926 172.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 13.7 mt -130.17 144.19 51.22 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.064 175.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -95.14 178.59 5.49 Favored 'General case' 0 C--N 1.311 -1.105 0 O-C-N 121.866 -0.521 . . . . 0.0 111.14 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 72' ' ' SER . 47.0 t -127.45 127.63 69.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' H ' ' HG2' ' A' ' 70' ' ' LYS . 39.4 pttt -82.26 -45.72 14.63 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -170.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.4 -26.28 57.49 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.116 -1.04 . . . . 0.0 112.567 -177.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.821 ' HB3' HD23 ' A' ' 74' ' ' LEU . 58.3 m -110.03 165.73 11.5 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -175.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.4 t -86.7 11.99 11.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.785 0.803 . . . . 0.0 109.201 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.821 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.12 172.71 12.34 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.962 177.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.2 t -159.03 115.69 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 -166.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.746 HG12 HG11 ' A' ' 63' ' ' VAL . 85.1 t -93.27 96.18 5.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.89 0.852 . . . . 0.0 110.611 -173.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.456 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.4 pptp? -102.64 146.18 28.56 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.153 -175.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.537 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -49.57 97.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 CA-C-O 121.913 0.863 . . . . 0.0 110.774 177.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 131.36 3.36 4.3 Favored Glycine 0 CA--C 1.524 0.621 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.013 -177.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.458 ' O ' ' HA ' ' A' ' 62' ' ' THR . 94.9 m -62.12 103.81 0.41 Allowed 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 121.868 0.842 . . . . 0.0 109.65 177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -90.85 114.74 27.24 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.226 -173.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 96' ' ' CYS . 42.6 t -126.14 113.72 35.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 175.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.709 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.6 ptmt -96.59 161.47 13.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.032 -176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.585 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 86.7 m-20 63.52 44.92 5.0 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 123.839 0.712 . . . . 0.0 111.526 174.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.423 HD13 ' CG2' ' A' ' 61' ' ' ILE . 34.2 pt -65.7 175.64 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 121.911 0.862 . . . . 0.0 113.042 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 19.3 tpp180 -130.17 129.89 44.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.454 -1.248 . . . . 0.0 109.378 178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.533 HD22 HG12 ' A' ' 47' ' ' ILE . 63.0 mt -81.17 113.07 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 174.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -88.63 178.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.967 0.413 . . . . 0.0 110.833 -174.408 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.537 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 5.5 m-20 -81.18 80.38 7.64 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.247 0.546 . . . . 0.0 110.767 -178.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . 172.21 -175.1 45.52 Favored Glycine 0 C--N 1.304 -1.209 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -101.15 -29.62 12.02 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.452 0.644 . . . . 0.0 110.7 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.415 ' HA ' ' HB2' ' A' ' 108' ' ' SER . 42.5 p-80 -107.03 51.69 0.73 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.287 -174.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.8 m-20 -149.67 91.79 1.85 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -159.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.516 HG13 HG21 ' A' ' 47' ' ' ILE . 3.9 mp -109.0 113.63 44.66 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.743 170.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 36.6 t70 -94.69 136.9 34.47 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.488 ' HB2' HG11 ' A' ' 82' ' ' VAL . 17.4 p -138.03 143.46 40.57 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.505 -178.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.71 121.01 43.83 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 26.5 mt -120.53 107.32 20.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -172.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.62 117.25 6.54 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.86 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 136.15 -65.26 0.57 Allowed Glycine 0 N--CA 1.432 -1.618 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.477 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.47 HG21 HD21 ' A' ' 74' ' ' LEU . 26.7 pt -95.78 -47.65 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.88 0.371 . . . . 0.0 110.369 178.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 144.99 -161.18 28.12 Favored Glycine 0 N--CA 1.445 -0.766 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -85.39 148.33 26.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.702 0.287 . . . . 0.0 111.009 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 43.9 ttm -138.79 158.09 44.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.767 0.318 . . . . 0.0 110.58 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 49.7 mttt -117.94 134.88 54.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.087 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.2 mt -118.83 142.44 47.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.203 -171.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.529 ' HB3' ' OE1' ' A' ' 109' ' ' GLU . 30.0 mtpt -74.41 130.86 40.43 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.966 -178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.415 ' HB2' ' HA ' ' A' ' 92' ' ' HIS . 28.7 t -59.49 -32.98 70.76 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.842 -1.072 . . . . 0.0 111.478 -176.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.529 ' OE1' ' HB3' ' A' ' 107' ' ' LYS . 3.4 pm0 -85.55 -0.16 54.19 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 -176.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.443 ' HD2' ' HB2' ' A' ' 107' ' ' LYS . 33.3 m-85 -115.8 3.06 13.75 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 119.47 -0.892 . . . . 0.0 112.891 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 28.9 m -111.8 168.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 120.328 -0.549 . . . . 0.0 112.269 -174.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.517 ' HG3' HG11 ' A' ' 51' ' ' VAL . 25.1 ttt180 -150.64 132.49 15.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.282 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.498 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.2 tttt -65.48 121.08 14.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.092 174.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.1 t -85.47 -48.76 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 79.81 10.81 85.3 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.867 -174.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.5 m . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.909 -179.369 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptm . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.4 p 178.26 138.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 -176.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.0 m -73.9 95.02 2.39 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.987 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.1 p -116.48 95.49 5.08 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.423 0.63 . . . . 0.0 109.896 176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.446 HD13 HD22 ' A' ' 23' ' ' LEU . 30.2 mt -96.59 161.96 24.94 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.039 -171.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 54.3 Cg_endo -69.22 160.0 51.57 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.215 1.943 . . . . 0.0 111.139 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -68.22 -172.39 0.43 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.357 2.038 . . . . 0.0 112.031 176.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.09 127.03 38.05 Favored Pre-proline 0 C--N 1.313 -1.0 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.57 178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.69 6.82 1.46 Allowed 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.541 2.16 . . . . 0.0 111.722 178.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.616 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 40.0 mt-30 -115.54 -39.21 3.59 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.431 -179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.1 m -109.67 -52.01 2.82 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-O 120.908 0.385 . . . . 0.0 110.268 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.74 -0.82 3.25 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.611 -176.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.632 ' HB2' ' OE2' ' A' ' 27' ' ' GLU . 45.2 m -60.87 -78.78 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 119.012 -0.518 . . . . 0.0 111.994 -178.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HB3' ' O ' ' A' ' 13' ' ' SER . 12.1 pt-20 176.77 -12.17 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.729 ' HB2' ' HB2' ' A' ' 27' ' ' GLU . 23.8 m-85 -82.2 33.58 0.4 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 118.584 0.629 . . . . 0.0 111.827 -171.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -91.48 135.22 34.0 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.766 175.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CE1' ' HD3' ' A' ' 26' ' ' PRO . 22.0 p90 -146.04 170.17 17.2 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -176.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -101.0 123.85 45.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.894 0.378 . . . . 0.0 110.83 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -120.03 79.81 1.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 173.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 96.09 -112.9 4.52 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.621 -0.799 . . . . 0.0 113.076 176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.03 16.13 25.48 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -171.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -156.12 -175.5 5.47 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.725 0.298 . . . . 0.0 110.248 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 19.9 mt -110.05 129.15 55.73 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 174.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.881 ' HB ' ' HG2' ' A' ' 31' ' ' GLU . 0.6 OUTLIER -123.59 138.66 52.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -179.037 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.97 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 47.1 t -110.72 104.2 55.66 Favored Pre-proline 0 C--N 1.301 -1.527 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.352 -175.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 56.1 Cg_endo -70.78 -9.81 26.49 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.836 2.358 . . . . 0.0 109.913 174.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.97 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 30.7 tt0 -70.75 -45.13 65.37 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.482 -1.69 . . . . 0.0 110.206 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 23.0 p -117.88 15.17 14.32 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 171.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.08 39.9 28.82 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 118.157 0.435 . . . . 0.0 111.874 177.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -141.78 127.62 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.85 0.357 . . . . 0.0 111.399 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.881 ' HG2' ' HB ' ' A' ' 24' ' ' VAL . 27.1 mt-10 -91.18 156.37 17.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.129 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -159.39 162.24 35.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.021 0.438 . . . . 0.0 110.726 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 7.6 t -110.44 130.87 22.41 Favored Pre-proline 0 C--N 1.317 -0.845 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.506 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 18.4 Cg_endo -59.65 -34.32 96.46 Favored 'Trans proline' 0 CA--C 1.529 0.264 0 C-N-CA 122.887 2.391 . . . . 0.0 113.576 -171.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -119.43 -42.92 2.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.962 0.411 . . . . 0.0 111.113 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -63.62 -18.24 63.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.546 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.15 61.22 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.595 0.236 . . . . 0.0 111.397 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.77 -30.86 71.77 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.51 177.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.4 m 69.23 163.19 0.23 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.074 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.25 -179.85 3.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.862 0.363 . . . . 0.0 110.769 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.8 m -91.45 -177.67 4.89 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.359 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -150.87 156.56 41.48 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -69.02 -29.56 67.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.362 . . . . 0.0 111.434 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 172.66 95.21 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.922 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.694 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 9.8 mmpt? -90.97 -53.19 4.49 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.47 0.652 . . . . 0.0 109.396 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.572 HG23 HD13 ' A' ' 87' ' ' LEU . 7.8 p -142.34 146.94 21.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.83 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.424 HG21 HG13 ' A' ' 94' ' ' ILE . 4.4 mm -85.75 138.77 18.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 120.456 0.17 . . . . 0.0 110.649 -172.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.683 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -109.62 155.78 21.03 Favored 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.157 0.503 . . . . 0.0 111.119 179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.551 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 5.0 m-20 -98.73 167.19 10.93 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.682 177.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.688 ' OG ' HD11 ' A' ' 64' ' ' ILE . 89.8 p -76.68 -10.63 59.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.904 0.859 . . . . 0.0 110.867 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.55 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.1 p -85.4 1.06 5.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 114.2 -1.364 . . . . 0.0 109.451 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.23 7.15 73.62 Favored Glycine 0 N--CA 1.446 -0.7 0 CA-C-N 114.577 -1.192 . . . . 0.0 113.504 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.55 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -108.45 168.39 9.36 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.0 -0.68 . . . . 0.0 111.942 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 48' ' ' LYS . 9.4 t -113.7 142.51 25.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.931 -175.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 113' ' ' LYS . 13.9 mt -96.64 175.95 6.19 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.547 0.689 . . . . 0.0 111.204 -178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.478 ' HB3' ' OD1' ' A' ' 59' ' ' ASP . 16.8 tt0 -131.91 154.21 49.46 Favored 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 172.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -67.54 96.46 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.955 0.407 . . . . 0.0 109.944 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 127.83 -7.11 6.92 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.974 -176.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 56' ' ' GLN . 32.0 m-20 -71.13 165.27 23.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.112 0.482 . . . . 0.0 111.167 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.614 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 2.8 m -99.37 136.09 39.83 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.585 176.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.472 HG22 HD22 ' A' ' 55' ' ' LEU . 1.9 pp -120.76 166.01 15.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -177.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.0 m -150.46 118.78 6.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.851 175.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.74 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -60.73 126.4 18.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 175.295 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.688 HD11 ' OG ' ' A' ' 50' ' ' SER . 0.2 OUTLIER -99.54 19.01 2.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.079 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -179.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' HD2' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -143.48 166.41 24.86 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.592 -0.692 . . . . 0.0 109.332 178.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -83.77 113.96 21.28 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.894 0.854 . . . . 0.0 111.343 171.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.45 HD21 ' CG ' ' A' ' 110' ' ' PHE . 7.2 mp -126.0 141.19 52.07 Favored 'General case' 0 C--O 1.214 -0.778 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.485 175.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.428 ' HE2' ' HB2' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -88.52 171.37 10.12 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.31 173.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.502 ' CG2' HG23 ' A' ' 76' ' ' VAL . 47.8 t -120.25 133.55 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -78.57 -57.49 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -174.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -76.78 -17.55 79.76 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.968 -0.635 . . . . 0.0 113.094 -174.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.471 ' HB2' HG11 ' A' ' 69' ' ' VAL . 55.5 m -115.0 155.13 27.54 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 120.746 0.308 . . . . 0.0 110.869 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 15.0 m -79.79 -1.13 37.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.47 HD22 HD13 ' A' ' 101' ' ' ILE . 9.5 mp -78.83 146.61 33.6 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.06 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 66.9 t -107.78 134.3 50.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.318 171.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.74 HG12 HG11 ' A' ' 63' ' ' VAL . 63.1 t -84.1 104.25 12.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.837 178.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -105.09 149.87 25.48 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.469 -174.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.568 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -51.73 96.96 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.99 0.9 . . . . 0.0 111.083 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.64 5.82 3.12 Favored Glycine 0 CA--C 1.525 0.711 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.057 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 62' ' ' THR . 90.1 m -62.58 104.07 0.48 Allowed 'General case' 0 C--O 1.223 -0.326 0 CA-C-O 121.717 0.77 . . . . 0.0 109.87 176.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.25 121.3 33.63 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.174 -174.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG11 ' HB2' ' A' ' 96' ' ' CYS . 30.6 t -133.88 116.39 23.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.627 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 51.9 pttt -100.35 158.88 15.56 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.726 -176.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.495 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 56.0 m-80 63.32 47.49 3.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.8 175.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 35.6 pt -64.88 178.24 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-O 122.005 0.907 . . . . 0.0 113.347 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.653 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 11.0 tpp85 -129.96 124.65 33.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.823 177.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.572 HD13 HG23 ' A' ' 46' ' ' VAL . 34.5 mt -78.92 116.05 18.99 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.6 t -82.12 163.02 3.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.384 -176.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -76.44 89.93 3.24 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-O 121.539 0.685 . . . . 0.0 109.928 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 143.38 126.56 2.02 Favored Glycine 0 C--N 1.306 -1.138 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -59.63 -13.72 10.73 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.249 0.547 . . . . 0.0 112.237 -170.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -106.43 51.34 0.75 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -173.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.475 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -174.49 143.02 0.79 Allowed 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 118.732 -1.187 . . . . 0.0 114.082 -170.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.556 ' CD1' HG21 ' A' ' 111' ' ' VAL . 36.6 mt -144.34 120.61 4.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.471 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.513 -178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 33.9 t70 -95.53 136.72 35.56 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.167 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.536 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -154.18 163.26 40.4 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.704 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 87.9 tttt -124.7 147.26 48.69 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 120.976 0.417 . . . . 0.0 110.04 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.32 105.33 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 175.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.57 103.87 0.29 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.795 -176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 144.27 -70.3 0.4 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.215 -175.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.47 HD13 HD22 ' A' ' 74' ' ' LEU . 25.4 pt -84.77 -46.5 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.542 0.21 . . . . 0.0 111.173 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.425 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 146.94 -162.62 28.58 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.893 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.772 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -86.72 149.91 24.55 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.829 0.315 . . . . 0.0 110.699 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.4 ttt -140.29 156.89 46.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.946 0.403 . . . . 0.0 110.671 -177.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 18.5 mtpp -113.83 139.03 49.5 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.583 -177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 53.9 mt -123.08 141.16 52.27 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.669 0.747 . . . . 0.0 111.732 -170.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 mptp? -84.83 119.61 25.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.973 177.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.683 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -47.82 -39.71 19.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.7 -176.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -64.77 -11.15 33.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.61 -177.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.45 ' CG ' HD21 ' A' ' 67' ' ' LEU . 86.4 m-85 -112.91 1.8 15.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.556 HG21 ' CD1' ' A' ' 94' ' ' ILE . 13.5 m -113.4 169.51 4.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.374 -0.531 . . . . 0.0 112.37 -172.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.573 ' HB3' HG23 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -155.13 129.77 9.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.07 179.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.482 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.7 tttt -59.97 123.25 16.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.786 0.327 . . . . 0.0 110.31 171.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -60.53 -44.8 97.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.223 0.535 . . . . 0.0 110.429 176.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 138.98 -21.13 3.01 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.184 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.236 -0.887 . . . . 0.0 109.47 176.19 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.812 0.339 . . . . 0.0 110.965 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.23 -17.68 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.622 0.725 . . . . 0.0 110.884 -177.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -103.27 97.02 7.16 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.245 -0.889 . . . . 0.0 109.697 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.7 p -126.25 25.27 6.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.564 0.697 . . . . 0.0 110.331 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.428 HD22 HD12 ' A' ' 23' ' ' LEU . 16.2 mt -78.48 157.79 77.08 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.406 -178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 72.4 Cg_endo -72.47 155.95 54.7 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.925 1.75 . . . . 0.0 110.783 175.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 15.6 Cg_exo -67.84 -175.44 0.76 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.31 2.007 . . . . 0.0 111.882 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 4.7 t -97.65 123.0 53.56 Favored Pre-proline 0 C--N 1.313 -0.982 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -68.46 10.94 0.3 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.73 2.287 . . . . 0.0 111.919 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.572 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 36.5 mt-30 -118.9 -40.57 2.84 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.147 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.4 m -108.98 -50.86 2.95 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-O 121.185 0.516 . . . . 0.0 110.265 179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.9 t30 70.78 2.07 4.0 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.871 -176.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.413 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 4.8 m -58.95 -78.34 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.3 pt-20 175.66 -18.06 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.516 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.7 m-85 -79.21 31.11 0.22 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.207 0.527 . . . . 0.0 112.132 -169.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.6 m -94.17 136.19 34.73 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.825 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -139.05 169.87 17.0 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -174.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -107.19 122.03 45.71 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.11 0.481 . . . . 0.0 111.205 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -111.27 71.75 0.75 Allowed 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 98.53 -107.99 3.53 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.612 -0.804 . . . . 0.0 113.382 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.9 19.4 19.11 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -171.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.406 ' C ' HD13 ' A' ' 23' ' ' LEU . 2.6 pt? -155.41 -179.44 8.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.171 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.706 ' CD2' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -109.24 134.03 52.28 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 173.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.45 HG13 ' HB3' ' A' ' 31' ' ' GLU . 57.7 t -115.14 127.15 72.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 49.4 t -103.95 103.91 40.22 Favored Pre-proline 0 C--N 1.314 -0.937 0 C-N-CA 120.52 -0.472 . . . . 0.0 109.738 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.516 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 53.4 Cg_endo -71.61 -8.88 24.06 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.549 2.166 . . . . 0.0 110.412 176.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.507 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 20.2 tt0 -69.27 -62.59 1.32 Allowed 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.559 -1.2 . . . . 0.0 110.017 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.2 p -98.47 9.59 42.8 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.71 46.05 12.16 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.959 0.409 . . . . 0.0 111.771 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.494 ' HB3' HE22 ' A' ' 10' ' ' GLN . 3.6 t-80 -150.59 135.02 17.16 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HB3' HG13 ' A' ' 24' ' ' VAL . 10.1 pt-20 -114.36 163.53 15.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.733 0.301 . . . . 0.0 110.882 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.564 ' NE1' HD23 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -163.11 162.64 25.77 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -178.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 36' ' ' GLU . 32.7 t -112.18 139.79 22.86 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.706 ' HD3' ' CD2' ' A' ' 23' ' ' LEU . 19.7 Cg_endo -58.19 -48.87 14.18 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.403 2.069 . . . . 0.0 112.452 -173.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -101.32 -37.88 8.3 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.48 -178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.535 ' HA ' ' OG1' ' A' ' 39' ' ' THR . 15.0 mm-40 -69.1 -12.28 61.54 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -174.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.35 -34.66 74.94 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.09 0.471 . . . . 0.0 109.951 174.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.22 -45.67 11.09 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.316 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.535 ' OG1' ' HA ' ' A' ' 36' ' ' GLU . 2.7 p -76.1 -35.82 59.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 70.26 112.12 0.05 Allowed 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.816 0.697 . . . . 0.0 111.009 -176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.5 m -60.6 111.57 1.65 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.455 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 43' ' ' ASP . 12.0 t70 -149.1 -154.22 0.54 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.431 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 33.7 t70 -59.89 -39.3 84.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.893 0.378 . . . . 0.0 110.958 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.47 45.55 1.05 Allowed Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.349 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 45' ' ' LYS . 30.5 mmmt -76.58 94.29 3.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.346 0.593 . . . . 0.0 110.632 176.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.615 HG13 HD13 ' A' ' 87' ' ' LEU . 15.8 t -130.84 155.75 42.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.637 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.686 HG21 HG13 ' A' ' 94' ' ' ILE . 2.5 mm -86.18 135.62 24.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -104.52 177.36 4.87 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.303 0.573 . . . . 0.0 111.691 -179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 112' ' ' ARG . 6.3 m-20 -114.42 169.99 8.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.611 174.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.468 ' OG ' HD11 ' A' ' 64' ' ' ILE . 90.3 p -70.47 -6.23 34.46 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 122.123 0.963 . . . . 0.0 110.51 178.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.47 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.1 t -86.45 -13.52 10.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 113.844 -1.525 . . . . 0.0 109.642 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.79 5.68 64.33 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.886 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.47 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -97.1 168.24 10.57 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.543 0.687 . . . . 0.0 111.561 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' A' ' 48' ' ' LYS . 16.4 t -113.97 144.64 21.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.787 -177.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.591 HD22 HG22 ' A' ' 61' ' ' ILE . 24.2 mt -101.1 173.2 6.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.46 0.647 . . . . 0.0 111.69 -174.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.556 ' HB3' ' HB2' ' A' ' 59' ' ' ASP . 33.7 tp60 -124.89 145.71 49.68 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.501 ' H ' HE21 ' A' ' 56' ' ' GLN . 15.1 t70 -71.23 97.1 1.49 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.017 0.436 . . . . 0.0 109.902 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 123.51 -6.5 9.15 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.556 ' HB2' ' HB3' ' A' ' 56' ' ' GLN . 42.2 t0 -68.62 166.53 17.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.116 -0.542 . . . . 0.0 110.899 177.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.66 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 34.5 m -104.89 136.51 44.24 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.591 HG22 HD22 ' A' ' 55' ' ' LEU . 1.8 pp -123.71 171.85 12.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 m -150.19 123.34 8.87 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 0.0 111.102 175.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.614 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -65.8 126.91 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 175.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -97.7 14.06 4.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HG3' HG12 ' A' ' 64' ' ' ILE . 54.8 mttt -143.64 164.99 28.86 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 119.094 0.861 . . . . 0.0 109.634 -176.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -85.69 117.15 24.39 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 122.082 0.944 . . . . 0.0 112.648 177.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.461 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.6 mp -134.79 150.66 50.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.307 172.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -92.32 178.27 5.89 Favored 'General case' 0 C--N 1.317 -0.846 0 O-C-N 121.703 -0.623 . . . . 0.0 111.502 171.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' A' ' 74' ' ' LEU . 46.7 t -120.06 129.07 75.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -56.51 108.36 0.48 Allowed 'General case' 0 C--O 1.234 0.277 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 -170.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.22 3.88 26.57 Favored Glycine 0 C--N 1.331 0.274 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.005 172.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.8 m -101.0 166.69 10.69 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.982 0.42 . . . . 0.0 111.122 -176.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 p -84.92 -3.84 58.88 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.56 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.512 ' HB3' HG21 ' A' ' 69' ' ' VAL . 12.1 tp -81.85 171.66 14.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.661 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.473 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 70.0 t -158.72 120.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -169.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.614 HG12 HG11 ' A' ' 63' ' ' VAL . 64.9 t -89.65 97.52 7.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.715 0.769 . . . . 0.0 110.61 -174.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.478 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -108.21 145.47 34.2 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.329 -176.698 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.533 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -48.01 97.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 CA-C-O 121.868 0.842 . . . . 0.0 111.19 177.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.52 4.09 4.48 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.251 -178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 50.4 m -62.53 104.95 0.57 Allowed 'General case' 0 C--O 1.224 -0.275 0 CA-C-O 122.089 0.947 . . . . 0.0 110.009 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tmmm? -89.35 120.75 30.97 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.895 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.693 HG11 ' HB2' ' A' ' 96' ' ' CYS . 22.2 t -131.9 113.41 22.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.398 177.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.7 ptmt -100.55 154.04 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.714 -174.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.504 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 50.6 m-80 62.76 53.22 2.56 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.038 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.453 HD11 ' HB3' ' A' ' 55' ' ' LEU . 32.4 pt -64.56 174.56 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-O 121.815 0.817 . . . . 0.0 112.43 173.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 20.4 tpp180 -129.22 123.01 30.89 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.879 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG13 ' A' ' 46' ' ' VAL . 39.7 mt -78.24 113.39 16.16 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -91.05 176.69 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 C-N-CA 120.736 -0.385 . . . . 0.0 110.021 -178.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -85.09 86.2 7.41 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-O 122.121 0.962 . . . . 0.0 111.407 -173.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.14 -172.11 45.07 Favored Glycine 0 C--N 1.293 -1.806 0 CA-C-N 113.593 -1.639 . . . . 0.0 109.68 175.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.66 -20.59 14.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 118.056 0.928 . . . . 0.0 110.173 172.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -107.08 50.39 0.77 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.792 -175.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.556 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.3 m-20 -150.8 89.78 1.57 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -160.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.686 HG13 HG21 ' A' ' 47' ' ' ILE . 2.8 mp -110.41 113.1 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.65 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 170.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 15.5 t70 -95.0 138.96 32.03 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.693 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -147.35 156.52 42.98 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.406 -173.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -116.64 130.03 56.5 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.406 179.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.3 mp -120.46 109.85 26.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.87 97.31 1.8 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.287 0.565 . . . . 0.0 110.134 -177.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.93 -40.53 0.42 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 102' ' ' GLY . 43.2 pt -122.62 -37.7 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.056 0.455 . . . . 0.0 110.21 175.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.477 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 138.15 -150.99 21.23 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -91.01 149.13 21.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.759 0.314 . . . . 0.0 110.744 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 28.3 ttt -140.57 159.75 41.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.187 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -116.78 143.23 45.92 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 176.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 51.2 mt -125.73 146.91 49.55 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.294 0.568 . . . . 0.0 111.984 -169.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.632 ' HB3' ' HG2' ' A' ' 109' ' ' GLU . 1.7 mptm? -75.26 128.33 35.19 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.855 174.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 29.6 t -53.31 -40.8 65.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.277 176.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.632 ' HG2' ' HB3' ' A' ' 107' ' ' LYS . 8.6 pt-20 -66.88 -12.29 58.8 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.066 -177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.473 ' O ' HD13 ' A' ' 64' ' ' ILE . 64.7 m-85 -111.87 4.8 18.56 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.459 -0.776 . . . . 0.0 112.777 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.504 ' O ' ' HB3' ' A' ' 49' ' ' ASP . 24.2 m -114.4 169.84 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.505 -173.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 15.8 ttt180 -147.88 142.59 26.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.639 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.748 ' HB2' ' HZ2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -65.58 140.83 58.57 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.692 -0.686 . . . . 0.0 112.254 174.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 116' ' ' SER . 94.0 t -107.84 -57.83 4.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.129 -0.941 . . . . 0.0 109.963 170.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.57 -3.51 71.73 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.744 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 114' ' ' VAL . 31.1 m . . . . . 0 C--O 1.244 0.809 0 CA-C-O 118.629 -0.7 . . . . 0.0 110.337 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 120.803 0.335 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.2 p -99.7 -15.03 7.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.79 0.805 . . . . 0.0 110.522 175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.9 m -84.85 83.04 8.18 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.865 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -107.89 -12.98 15.08 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.433 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.454 HD13 HD22 ' A' ' 23' ' ' LEU . 72.8 mt -110.02 157.01 39.03 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.574 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.9 Cg_endo -70.65 158.29 56.22 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.155 1.903 . . . . 0.0 111.131 176.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 13.1 Cg_exo -70.18 -171.65 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.519 2.146 . . . . 0.0 112.677 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.421 ' C ' ' H ' ' A' ' 10' ' ' GLN . 33.8 t -99.1 122.04 53.64 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.205 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.84 7.49 0.58 Allowed 'Trans proline' 0 C--O 1.23 0.113 0 C-N-CA 122.613 2.208 . . . . 0.0 112.284 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 8' ' ' CYS . 8.4 tt0 -113.94 -39.54 3.94 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.095 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 32.0 p -126.14 -35.15 2.46 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.553 -0.717 . . . . 0.0 111.468 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.1 t30 72.53 1.84 4.12 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 122.92 0.488 . . . . 0.0 111.634 175.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.584 ' HB2' ' HD2' ' A' ' 15' ' ' TYR . 4.8 m -53.93 -78.43 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 -174.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 171.85 35.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.725 0.774 . . . . 0.0 109.164 -176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.793 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 79.0 m-85 -118.06 24.95 10.67 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.296 -171.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.404 HG22 ' HB3' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -93.54 132.38 37.89 Favored 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 119.991 -0.684 . . . . 0.0 111.389 172.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.57 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 38.3 p90 -144.9 171.27 14.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 175.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.3 pm0 -100.8 117.54 35.08 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.884 0.373 . . . . 0.0 110.715 178.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.57 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 35.1 t70 -115.69 69.99 0.74 Allowed 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 171.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.02 -113.44 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.91 179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.48 18.91 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.883 0.373 . . . . 0.0 111.645 -172.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' CD1' ' HB2' ' A' ' 31' ' ' GLU . 2.4 pt? -154.96 -174.83 5.14 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.349 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.577 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 24.1 mt -113.46 137.1 52.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 31' ' ' GLU . 46.1 t -121.27 136.61 57.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 O-C-N 122.231 -0.293 . . . . 0.0 110.375 -177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 48.6 t -102.58 105.14 42.53 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 120.996 -0.281 . . . . 0.0 110.349 173.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.793 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 20.8 Cg_endo -61.64 -25.45 79.11 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.63 2.22 . . . . 0.0 111.66 176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.13 -58.95 3.39 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 71.7 m -75.92 -9.13 58.36 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.7 39.54 24.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.21 0.529 . . . . 0.0 111.466 -173.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 43.5 t-80 -149.17 136.92 20.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.534 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.475 ' HB3' HG22 ' A' ' 24' ' ' VAL . 0.0 OUTLIER -103.69 174.76 5.73 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.277 -178.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -166.94 161.87 15.34 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' A' ' 36' ' ' GLU . 20.6 t -106.18 135.11 19.5 Favored Pre-proline 0 C--N 1.311 -1.099 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.577 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.9 Cg_endo -58.52 -52.23 5.86 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.868 2.379 . . . . 0.0 112.855 -173.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -121.98 -20.56 6.28 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.921 -0.312 . . . . 0.0 111.779 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.491 ' HB2' ' OG ' ' A' ' 33' ' ' SER . 21.1 mm-40 -81.38 -14.09 57.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.585 0.231 . . . . 0.0 111.08 -175.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.89 -54.47 46.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.543 -177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.22 -56.78 7.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.973 -177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.08 121.13 12.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.212 0.53 . . . . 0.0 111.56 178.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 36' ' ' GLU . . . -137.34 32.92 2.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.471 176.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.5 m -70.49 103.94 2.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.654 -174.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -121.15 4.21 10.37 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.98 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.443 ' OD1' HG23 ' A' ' 46' ' ' VAL . 10.9 t0 64.98 93.18 0.07 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 114.06 -1.427 . . . . 0.0 109.615 -174.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 91' ' ' ASP . . . -98.03 -5.96 57.13 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.375 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -74.41 -21.04 59.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.607 0.241 . . . . 0.0 111.304 -176.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.443 HG23 ' OD1' ' A' ' 43' ' ' ASP . 61.7 t -85.18 122.71 38.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.124 0.488 . . . . 0.0 109.808 175.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.599 HG21 HG13 ' A' ' 94' ' ' ILE . 5.1 mm -81.3 139.85 17.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 -173.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.452 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -114.8 176.25 5.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.3 -178.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.416 ' OD1' HG23 ' A' ' 111' ' ' VAL . 15.6 m-20 -112.05 172.41 6.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.995 0.426 . . . . 0.0 111.25 177.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.448 ' OG ' HD11 ' A' ' 64' ' ' ILE . 81.6 p -74.66 -8.33 56.04 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.039 0.923 . . . . 0.0 110.678 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.449 ' HB ' ' OD1' ' A' ' 53' ' ' ASN . 2.7 t -89.24 -11.13 10.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.026 -1.443 . . . . 0.0 110.406 -174.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.65 -2.63 64.85 Favored Glycine 0 C--N 1.314 -0.686 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.773 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.449 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -91.52 166.39 12.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.775 0.798 . . . . 0.0 111.584 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG22 ' HG3' ' A' ' 48' ' ' LYS . 11.3 t -117.05 139.75 42.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.923 -177.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD22 HG22 ' A' ' 61' ' ' ILE . 17.8 mt -94.9 172.98 7.82 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.238 0.542 . . . . 0.0 110.564 -173.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -129.36 150.48 50.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.645 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -69.71 96.02 0.93 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.121 0.486 . . . . 0.0 109.929 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 124.67 -7.83 8.31 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.045 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.468 ' OD2' ' HE3' ' A' ' 113' ' ' LYS . 2.1 t0 -72.16 175.81 5.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.823 0.344 . . . . 0.0 111.02 179.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 25.3 m -105.46 137.19 43.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.603 HG22 HD22 ' A' ' 55' ' ' LEU . 1.5 pp -123.35 164.49 20.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.772 0.32 . . . . 0.0 110.279 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 80' ' ' THR . 1.9 m -148.53 124.88 10.9 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.916 0.389 . . . . 0.0 110.793 174.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.712 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -66.71 124.79 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.76 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -96.13 17.19 2.06 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.904 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 6.7 mttt -143.5 163.71 32.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 119.03 0.832 . . . . 0.0 109.643 -179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.538 ' O ' HD23 ' A' ' 67' ' ' LEU . 2.5 p-10 -83.67 115.89 22.38 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.087 0.946 . . . . 0.0 111.995 173.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 15.2 mt -129.17 143.92 51.03 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.336 -1.302 . . . . 0.0 108.359 173.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -91.87 178.31 5.93 Favored 'General case' 0 C--N 1.309 -1.194 0 O-C-N 121.618 -0.676 . . . . 0.0 110.525 173.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.464 HG22 HG23 ' A' ' 76' ' ' VAL . 8.0 t -129.15 130.4 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 178.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.455 ' HD3' ' HA ' ' A' ' 70' ' ' LYS . 13.9 tppt? -78.63 -60.04 2.54 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 111.757 0.281 . . . . 0.0 111.757 -172.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -90.69 37.62 3.35 Favored Glycine 0 CA--C 1.517 0.202 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.515 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.424 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 69.6 m -144.73 166.85 24.03 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.2 p -95.62 2.88 54.36 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 167.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.4 mp -78.6 175.25 10.55 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.396 -1.274 . . . . 0.0 111.452 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.8 t -158.69 116.93 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.712 HG12 HG11 ' A' ' 63' ' ' VAL . 88.1 t -87.32 98.56 7.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 CA-C-O 121.682 0.753 . . . . 0.0 110.753 -173.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.404 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.6 pptp? -105.83 145.01 31.76 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.41 -175.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -48.65 98.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.925 0.869 . . . . 0.0 111.228 177.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 129.23 5.5 4.67 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.072 -176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 62' ' ' THR . 93.2 m -62.47 104.39 0.5 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.807 0.813 . . . . 0.0 109.555 176.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tmmm? -94.79 115.02 26.99 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.431 -173.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.746 HG11 ' HB2' ' A' ' 96' ' ' CYS . 68.0 t -132.22 117.31 32.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.895 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.666 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 59.8 pttt -107.89 169.67 8.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.682 0.753 . . . . 0.0 112.903 -177.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.524 ' HB3' ' HD2' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 69.62 36.13 2.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.22 -1.809 . . . . 0.0 110.426 174.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 55' ' ' LEU . 37.2 pt -60.74 175.83 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.156 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -176.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.645 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 9.0 tpp85 -131.25 123.08 27.65 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.156 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 47.1 mt -75.25 109.08 8.46 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.624 HG22 ' HB2' ' A' ' 95' ' ' ASP . 2.6 t -74.32 161.44 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.152 0.501 . . . . 0.0 111.93 -170.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.76 35.01 0.19 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.868 0.842 . . . . 0.0 110.649 177.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 88' ' ' VAL . . . -137.62 132.79 6.07 Favored Glycine 0 C--N 1.301 -1.382 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 6.1 p-10 -66.86 -6.23 15.53 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -168.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -108.78 -46.0 3.72 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -91.46 153.3 19.92 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 -158.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.704 ' CD1' HG21 ' A' ' 111' ' ' VAL . 25.7 mt -110.4 129.69 65.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 113.478 -1.692 . . . . 0.0 110.435 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.624 ' HB2' HG22 ' A' ' 88' ' ' VAL . 9.9 t70 -96.42 132.81 41.57 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 174.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.746 ' HB2' HG11 ' A' ' 82' ' ' VAL . 27.6 p -138.27 145.21 41.01 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.832 -168.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.562 ' O ' HG13 ' A' ' 82' ' ' VAL . 96.3 mttt -93.45 107.84 19.61 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.498 -178.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.6 mt -104.51 155.32 6.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -101.09 130.5 47.14 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -163.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 103.64 -52.42 0.77 Allowed Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 119.555 -1.307 . . . . 0.0 111.988 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.413 HG13 ' N ' ' A' ' 102' ' ' GLY . 44.7 pt -95.83 -40.32 10.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.413 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 126.96 -138.32 10.49 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.791 -176.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -100.34 159.68 14.94 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.11 0.455 . . . . 0.0 111.377 -173.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 38.8 ttm -154.2 165.75 35.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.121 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 94' ' ' ILE . 80.6 mttt -113.69 126.08 54.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.879 0.371 . . . . 0.0 110.572 -176.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 16.9 mt -113.44 146.72 39.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -174.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.646 ' HG2' ' HG2' ' A' ' 109' ' ' GLU . 25.9 ttmt -76.68 125.25 28.93 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.218 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 16.1 t -47.94 -37.96 15.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.093 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.646 ' HG2' ' HG2' ' A' ' 107' ' ' LYS . 11.4 pt-20 -75.41 -5.33 44.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -175.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.904 ' HD1' ' HD3' ' A' ' 65' ' ' LYS . 30.7 m-85 -113.72 7.44 17.2 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.023 -0.671 . . . . 0.0 112.531 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.704 HG21 ' CD1' ' A' ' 94' ' ' ILE . 30.3 m -116.62 171.83 5.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -174.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -150.32 133.83 16.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.012 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.468 ' HE3' ' OD2' ' A' ' 59' ' ' ASP . 87.4 tttt -70.46 120.38 16.03 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.79 174.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.7 t -93.86 -70.19 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.52 176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 125.72 -42.33 1.52 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.769 -175.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.291 -179.351 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.964 0.411 . . . . 0.0 111.487 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.5 p -155.92 153.07 7.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.56 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.6 m 69.31 43.13 1.1 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.207 0.527 . . . . 0.0 111.349 175.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 t -153.24 136.76 15.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.925 178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.49 HD11 ' HG2' ' A' ' 18' ' ' GLU . 52.7 mt -110.44 148.96 39.52 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-O 120.709 0.29 . . . . 0.0 110.766 -178.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.414 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.1 Cg_endo -73.63 162.49 39.65 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 123.042 2.495 . . . . 0.0 111.714 176.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 6.6 Cg_exo -73.39 -169.45 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.54 2.16 . . . . 0.0 112.328 178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 t -98.68 130.68 27.32 Favored Pre-proline 0 C--N 1.318 -0.776 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.9 179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.96 8.98 0.88 Allowed 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.638 2.225 . . . . 0.0 112.553 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.46 HE22 ' HB3' ' A' ' 30' ' ' HIS . 44.2 mt-30 -123.04 -37.08 2.76 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.393 178.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.6 m -107.04 -45.94 4.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 71.24 -9.66 0.86 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.232 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.49 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 1.4 m -43.86 -75.68 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.004 0.522 . . . . 0.0 111.974 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 13' ' ' SER . 13.0 pt-20 159.04 -3.49 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 O-C-N 124.005 0.816 . . . . 0.0 111.569 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.591 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 63.2 m-85 -77.26 34.58 0.16 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.9 0.381 . . . . 0.0 111.628 -176.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -100.85 141.08 34.23 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.159 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -151.89 177.15 10.73 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HG2' HD11 ' A' ' 5' ' ' LEU . 1.0 OUTLIER -110.42 124.61 52.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.418 0.628 . . . . 0.0 111.61 179.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -111.66 70.05 0.7 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.674 174.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 103.19 -107.66 3.1 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.112 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.8 18.03 21.82 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -171.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.5 pt? -159.96 -174.32 4.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.159 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 27.2 mt -111.92 134.45 53.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 174.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -124.97 141.07 46.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 50.4 t -104.63 105.81 51.94 Favored Pre-proline 0 C--N 1.312 -1.045 0 CA-C-N 116.121 -0.491 . . . . 0.0 109.758 178.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 37.7 Cg_endo -66.85 -14.26 43.09 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.658 2.239 . . . . 0.0 110.968 178.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.483 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 33.2 tt0 -70.29 -58.97 3.17 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.633 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.4 p -102.34 10.29 39.24 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.5 46.11 12.63 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.46 ' HB3' HE22 ' A' ' 10' ' ' GLN . 24.8 t-80 -142.91 127.41 17.89 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.678 175.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.539 ' HB3' HD11 ' A' ' 22' ' ' LEU . 2.3 mp0 -91.4 157.07 17.29 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.023 177.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -159.07 162.08 36.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.0 110.176 -178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.508 ' OG ' ' HB3' ' A' ' 36' ' ' GLU . 14.9 t -115.98 127.76 26.51 Favored Pre-proline 0 C--N 1.317 -0.833 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.87 -47.79 12.17 Favored 'Trans proline' 0 CA--C 1.528 0.223 0 C-N-CA 122.786 2.324 . . . . 0.0 113.192 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -116.3 -34.64 4.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -175.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.508 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 26.2 tt0 -67.26 -27.14 66.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.649 0.262 . . . . 0.0 111.459 -176.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -66.42 -30.76 71.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.109 0.48 . . . . 0.0 110.201 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.02 -62.15 1.6 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.425 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.9 p -99.72 112.6 24.82 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.586 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.31 174.78 10.17 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.53 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.9 m -99.03 122.83 42.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 177.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -92.91 126.34 37.95 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.632 0.729 . . . . 0.0 111.417 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.1 t70 178.66 96.07 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.514 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.2 39.44 2.99 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.346 -171.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -99.78 -35.9 9.63 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.993 0.425 . . . . 0.0 110.26 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.74 HG12 HG22 ' A' ' 54' ' ' VAL . 5.5 t -108.11 125.68 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.879 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.707 HG21 HG13 ' A' ' 94' ' ' ILE . 2.1 mm -91.09 131.51 38.05 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.681 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.413 -170.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.582 ' HA ' ' HA ' ' A' ' 54' ' ' VAL . 0.0 OUTLIER -92.51 176.58 6.41 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.997 0.427 . . . . 0.0 111.84 -179.226 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 15.2 m-20 -116.23 178.26 4.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.109 179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.498 ' HB3' HD11 ' A' ' 64' ' ' ILE . 9.3 t -77.03 -5.22 47.92 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 122.243 1.02 . . . . 0.0 109.968 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.48 HG21 ' CG ' ' A' ' 112' ' ' ARG . 2.5 t -91.03 -8.18 10.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.037 -1.438 . . . . 0.0 110.602 -177.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 92.28 -6.22 78.26 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.461 -1.245 . . . . 0.0 111.714 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.439 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -90.3 165.41 13.91 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.473 0.654 . . . . 0.0 110.941 179.538 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.74 HG22 HG12 ' A' ' 46' ' ' VAL . 2.9 p -119.79 147.63 23.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.917 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.841 ' HA ' ' HD3' ' A' ' 113' ' ' LYS . 1.8 mt -96.54 178.23 5.41 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.411 -169.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -127.79 147.95 50.43 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.596 ' OD2' ' HA ' ' A' ' 86' ' ' ARG . 13.3 t70 -69.19 99.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.192 0.52 . . . . 0.0 109.8 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.77 -6.91 9.58 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.523 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -73.91 175.44 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.96 0.41 . . . . 0.0 110.691 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.629 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 41.4 m -103.01 137.47 41.15 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.595 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.712 HG22 HD22 ' A' ' 55' ' ' LEU . 1.4 pp -121.84 164.43 18.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.423 HG23 ' HA2' ' A' ' 79' ' ' GLY . 2.7 m -149.16 117.95 6.65 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.12 175.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.632 HG11 HG12 ' A' ' 76' ' ' VAL . 0.7 OUTLIER -63.48 129.45 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.561 HG12 ' HD3' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -102.86 17.19 4.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.712 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.561 ' HD3' HG12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -140.7 164.46 30.14 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.76 0.709 . . . . 0.0 109.1 -179.262 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.646 ' O ' HD23 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -82.94 118.44 23.48 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.885 0.85 . . . . 0.0 112.656 174.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 66' ' ' ASP . 11.7 mt -135.4 142.29 45.63 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 114.466 -1.243 . . . . 0.0 108.758 173.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -92.54 178.32 5.85 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.399 -0.813 . . . . 0.0 111.29 173.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.6 t -126.76 131.98 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 70' ' ' LYS . 17.0 tptm -93.02 130.2 38.68 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.742 0.306 . . . . 0.0 110.763 -176.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.56 -26.82 18.14 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.083 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.692 ' HB3' HD23 ' A' ' 74' ' ' LEU . 39.5 m -115.37 155.97 26.39 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.689 0.28 . . . . 0.0 110.816 -178.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.6 m -85.18 18.88 2.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.603 0.716 . . . . 0.0 109.943 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.692 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -79.36 171.87 14.58 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.258 175.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.3 t -159.29 118.56 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -169.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.632 HG12 HG11 ' A' ' 63' ' ' VAL . 84.8 t -92.13 95.16 5.23 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.2 0 CA-C-O 122.069 0.938 . . . . 0.0 109.95 -175.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.36 146.41 34.44 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.252 -175.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -46.54 97.16 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 O-C-N 124.097 0.873 . . . . 0.0 110.955 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.423 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.04 2.73 5.07 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.487 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 52.5 m -61.85 104.51 0.46 Allowed 'General case' 0 C--O 1.226 -0.178 0 CA-C-O 121.904 0.859 . . . . 0.0 109.732 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.6 tmmm? -90.77 115.62 27.99 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.034 -173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.592 HG11 ' HB2' ' A' ' 96' ' ' CYS . 77.7 t -131.91 113.45 22.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.213 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.629 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 60.1 pttt -107.88 164.05 12.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.329 0.585 . . . . 0.0 112.324 -176.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.577 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 47.3 m-80 70.26 42.04 0.98 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.892 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 41.3 pt -65.39 175.51 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.523 -0.092 0 CA-C-O 121.987 0.899 . . . . 0.0 112.904 177.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.596 ' HA ' ' OD2' ' A' ' 57' ' ' ASP . 7.3 tpp180 -126.66 126.07 42.94 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.027 -1.442 . . . . 0.0 108.212 176.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.489 HD22 HG12 ' A' ' 47' ' ' ILE . 38.1 mt -81.54 117.5 21.98 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.785 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 1.0 OUTLIER -85.51 177.89 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -176.421 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.531 ' H ' HG12 ' A' ' 88' ' ' VAL . 30.0 t70 -89.82 84.58 6.26 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 122.408 1.099 . . . . 0.0 110.087 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.537 ' O ' HD12 ' A' ' 47' ' ' ILE . . . 159.33 141.46 3.14 Favored Glycine 0 C--N 1.294 -1.777 0 CA-C-N 113.296 -1.774 . . . . 0.0 110.431 -177.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.25 -19.61 61.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 117.611 0.706 . . . . 0.0 110.944 -171.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.5 p-80 -106.29 50.65 0.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.509 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.785 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 6.0 m-20 -149.5 93.24 2.03 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -163.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.707 HG13 HG21 ' A' ' 47' ' ' ILE . 9.6 mt -114.44 115.53 49.84 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.716 0 CA-C-O 121.16 0.505 . . . . 0.0 110.706 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 11.7 t70 -96.39 134.06 40.01 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.592 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.4 p -129.88 134.91 47.8 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 120.067 -0.653 . . . . 0.0 110.779 -176.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -101.29 111.66 23.95 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 30.5 mt -114.79 108.5 25.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.956 0.408 . . . . 0.0 110.858 -171.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.81 101.46 1.34 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.938 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 152.31 -39.42 0.76 Allowed Glycine 0 N--CA 1.443 -0.837 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.493 -176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.428 HG21 HD21 ' A' ' 74' ' ' LEU . 23.8 pt -130.35 -39.07 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.861 0.362 . . . . 0.0 110.901 178.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.62 -149.02 20.01 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 96' ' ' CYS . . . -91.31 148.53 22.27 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.965 0.412 . . . . 0.0 110.939 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . 0.48 ' HB3' ' SG ' ' A' ' 96' ' ' CYS . 50.7 ttm -136.3 157.24 47.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.194 178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.515 ' HD2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -99.86 141.82 32.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.876 0.369 . . . . 0.0 110.698 175.614 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.484 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 93.7 mt -132.48 138.08 47.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.172 0.511 . . . . 0.0 111.492 -176.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HB2' ' HD2' ' A' ' 110' ' ' PHE . 43.5 mtpt -81.95 125.79 31.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.423 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.3 t -48.07 -42.62 29.18 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.945 177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.17 -7.76 20.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.333 -0.849 . . . . 0.0 113.091 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.498 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 33.6 m-85 -115.93 2.4 13.52 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 94' ' ' ILE . 33.8 m -113.33 170.13 4.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -171.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.48 ' CG ' HG21 ' A' ' 51' ' ' VAL . 8.2 ttt-85 -150.87 131.32 13.79 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.819 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.841 ' HD3' ' HA ' ' A' ' 55' ' ' LEU . 35.1 ttpt -75.94 123.64 26.04 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.068 0.461 . . . . 0.0 110.554 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 23.6 t -76.21 -41.4 37.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.577 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.46 11.15 80.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.975 -177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 59.8 m . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.577 -0.725 . . . . 0.0 109.889 179.296 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 CA-C-O 120.825 0.345 . . . . 0.0 110.299 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.5 HG22 HG23 ' A' ' 4' ' ' THR . 14.1 p -63.17 127.61 23.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.317 0.58 . . . . 0.0 110.721 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 29.7 m -95.06 60.7 2.4 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.283 0.563 . . . . 0.0 110.95 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.5 HG23 HG22 ' A' ' 2' ' ' VAL . 16.7 p -108.17 -1.99 19.81 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.945 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 54.5 mt -107.73 148.17 36.81 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.618 178.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.28 160.92 47.42 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.606 2.204 . . . . 0.0 111.609 -179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -66.46 -172.8 0.32 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.344 2.03 . . . . 0.0 111.79 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 7.5 t -97.89 125.93 42.46 Favored Pre-proline 0 C--N 1.315 -0.921 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -69.34 10.87 0.39 Allowed 'Trans proline' 0 N--CA 1.469 0.052 0 C-N-CA 122.547 2.165 . . . . 0.0 111.81 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.508 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 34.9 mt-30 -125.3 -31.11 3.08 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.991 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.8 m -116.07 -40.25 3.32 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 121.843 -0.536 . . . . 0.0 110.37 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 75.76 -26.83 0.19 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.272 1.029 . . . . 0.0 113.004 176.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.4 m -45.7 -77.62 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 173.59 30.64 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.594 0.712 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.736 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 64.7 m-85 -96.63 27.8 3.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.073 -0.967 . . . . 0.0 112.125 -172.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.403 HG22 ' HB3' ' A' ' 23' ' ' LEU . 1.7 m -101.91 141.42 34.79 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.674 -0.41 . . . . 0.0 111.451 174.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 36.8 p90 -148.12 175.82 10.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 173.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -111.17 121.41 45.22 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 118.75 0.705 . . . . 0.0 111.487 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.431 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 33.0 t70 -113.52 75.28 0.91 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.269 0.556 . . . . 0.0 109.59 174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 99.18 -108.75 3.63 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.118 177.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -109.24 20.38 18.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -171.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.471 HD11 ' HB3' ' A' ' 31' ' ' GLU . 2.2 pt? -160.49 -174.17 4.35 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.592 ' HG ' ' HD3' ' A' ' 34' ' ' PRO . 25.0 mt -109.06 136.57 48.35 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.143 -0.481 . . . . 0.0 109.731 174.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.462 HG13 ' HG3' ' A' ' 31' ' ' GLU . 60.2 t -122.19 131.35 73.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 O-C-N 122.296 -0.253 . . . . 0.0 110.385 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.538 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -101.28 108.96 57.34 Favored Pre-proline 0 C--N 1.321 -0.655 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 176.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 58.7 Cg_endo -71.7 -8.42 23.09 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.907 2.404 . . . . 0.0 111.216 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.538 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 13.8 tp10 -75.87 -70.49 0.43 Allowed 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.313 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.7 p -90.12 10.55 23.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.33 41.34 23.34 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.092 0.472 . . . . 0.0 111.992 175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.439 ' HB3' HE22 ' A' ' 10' ' ' GLN . 17.8 t-160 -138.74 128.46 24.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.867 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB3' HD11 ' A' ' 22' ' ' LEU . 2.2 mp0 -91.1 161.31 15.15 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -165.84 161.52 17.84 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-O 120.947 0.404 . . . . 0.0 110.41 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.543 ' OG ' ' HB3' ' A' ' 36' ' ' GLU . 32.7 t -115.14 137.91 23.23 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 177.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.592 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 11.5 Cg_endo -56.47 -33.14 91.58 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 123.169 2.579 . . . . 0.0 113.219 -173.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -136.98 -45.31 0.57 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.519 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.543 ' HB3' ' OG ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -52.05 -39.67 59.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.78 -179.005 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.473 ' H ' ' HB3' ' A' ' 33' ' ' SER . . . -64.88 -25.92 68.1 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 -177.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.99 -9.71 59.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.86 0.362 . . . . 0.0 110.86 -178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.6 m -116.25 -65.93 1.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.717 -178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -176.26 124.74 0.19 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.295 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.0 m -72.11 97.16 1.88 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.049 0.452 . . . . 0.0 110.612 177.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -147.84 173.52 12.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.77 -178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -73.57 -23.98 60.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.27 0.557 . . . . 0.0 109.911 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.83 25.65 26.73 Favored Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 -173.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -83.47 6.16 21.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 114.871 -0.665 . . . . 0.0 111.483 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.407 HG12 ' CG1' ' A' ' 54' ' ' VAL . 14.5 t -96.41 102.53 13.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.506 177.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.449 HG23 ' O ' ' A' ' 91' ' ' ASP . 9.6 mm -75.58 137.83 22.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.627 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.579 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.1 OUTLIER -119.17 156.6 29.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.631 -0.713 . . . . 0.0 112.0 176.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.535 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 5.9 m-20 -96.92 -179.01 4.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.224 -176.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 30.7 t -80.13 -6.54 57.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.964 0.888 . . . . 0.0 109.538 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.7 t -90.95 -17.19 7.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.716 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.13 3.14 57.92 Favored Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.391 -1.277 . . . . 0.0 112.211 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.508 HD22 ' CG ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -84.31 167.44 16.57 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 122.036 0.922 . . . . 0.0 110.819 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.54 HG22 ' HG3' ' A' ' 48' ' ' LYS . 24.0 t -117.05 139.28 44.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 CA-C-N 112.887 -1.96 . . . . 0.0 108.255 176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.418 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 2.1 mm? -97.33 174.55 6.64 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.37 0.605 . . . . 0.0 110.704 -174.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 57' ' ' ASP . 30.4 tp60 -125.24 145.67 49.88 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.717 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 14.9 t70 -67.76 99.51 0.82 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.643 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 122.62 -7.21 9.63 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -71.17 174.99 5.64 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.944 0.402 . . . . 0.0 110.937 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.649 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 14.5 m -106.91 135.24 48.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.6 pp -124.67 166.89 19.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.1 m -150.54 119.1 6.48 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.851 0.358 . . . . 0.0 111.355 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.717 HG11 HG12 ' A' ' 76' ' ' VAL . 0.8 OUTLIER -63.66 126.65 22.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.19 22.48 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.627 ' HD3' ' HD1' ' A' ' 110' ' ' PHE . 0.1 OUTLIER -143.24 159.53 42.15 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.534 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -84.48 100.53 11.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.952 0.882 . . . . 0.0 112.707 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.629 HD21 ' CD2' ' A' ' 110' ' ' PHE . 6.6 mp -110.63 153.71 24.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.038 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -98.76 179.33 4.69 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.777 0.322 . . . . 0.0 111.385 171.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.61 HG21 ' HB2' ' A' ' 72' ' ' SER . 33.7 m -119.55 147.2 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 177.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.7 ' HG3' ' H ' ' A' ' 71' ' ' GLY . 18.2 ptmt -77.84 -76.81 0.17 Allowed 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.7 ' H ' ' HG3' ' A' ' 70' ' ' LYS . . . -92.07 47.96 2.69 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.969 -173.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.61 ' HB2' HG21 ' A' ' 69' ' ' VAL . 74.6 m -144.33 176.76 9.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 120.786 0.327 . . . . 0.0 110.709 -178.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.7 m -104.96 6.43 33.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.604 1.192 . . . . 0.0 108.03 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.578 ' O ' HG22 ' A' ' 69' ' ' VAL . 4.5 mm? -77.91 176.67 8.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 112.929 -1.941 . . . . 0.0 112.224 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 41.1 t -160.02 113.34 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 -175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.717 HG12 HG11 ' A' ' 63' ' ' VAL . 87.2 t -85.68 93.97 3.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.56 0.695 . . . . 0.0 109.503 -173.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.401 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -106.48 148.15 28.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.601 -171.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -48.29 97.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 121.92 0.867 . . . . 0.0 111.348 -179.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.59 8.0 3.28 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.107 -178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 62' ' ' THR . 85.7 m -63.92 103.19 0.55 Allowed 'General case' 0 C--O 1.223 -0.322 0 CA-C-O 122.153 0.978 . . . . 0.0 109.653 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 81' ' ' LYS . 5.6 ttpm? -92.5 110.48 21.89 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.096 -174.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.418 HG11 ' HB2' ' A' ' 96' ' ' CYS . 56.8 t -126.49 117.88 49.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.758 177.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 55.6 pttt -105.1 163.02 12.88 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.662 . . . . 0.0 112.11 -178.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.643 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.8 OUTLIER 67.81 42.87 1.86 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.298 174.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.518 HG22 ' HB3' ' A' ' 96' ' ' CYS . 36.1 pt -65.63 -175.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 114.044 1.128 . . . . 0.0 114.044 178.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.717 ' HA ' ' OD1' ' A' ' 57' ' ' ASP . 12.2 tpp85 -135.01 122.82 22.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.423 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.41 HD22 HG12 ' A' ' 47' ' ' ILE . 71.0 mt -76.4 118.91 19.57 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -90.1 173.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.879 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.41 -44.72 95.45 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.826 0.346 . . . . 0.0 111.557 -176.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.15 132.98 11.49 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.274 178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 47' ' ' ILE . 15.8 t70 -57.43 -31.77 66.22 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.286 0.565 . . . . 0.0 110.803 176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -81.23 52.1 1.74 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.081 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -167.27 138.12 3.05 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-O 121.319 0.58 . . . . 0.0 112.059 -169.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.437 HD11 ' HA ' ' A' ' 108' ' ' SER . 63.6 mt -142.72 125.66 13.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.204 175.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 4.5 t70 -104.98 139.04 40.27 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 173.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.518 ' HB3' HG22 ' A' ' 85' ' ' ILE . 27.2 p -155.05 165.56 36.33 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -112.07 135.77 52.3 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.517 HG13 HD11 ' A' ' 101' ' ' ILE . 2.2 mm -100.84 98.72 7.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -52.9 105.88 0.14 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.723 178.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 133.96 -59.25 0.68 Allowed Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.356 -177.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.574 HG21 HD21 ' A' ' 74' ' ' LEU . 34.2 pt -96.07 -42.63 12.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.458 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 145.06 -166.11 27.59 Favored Glycine 0 C--O 1.219 -0.785 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 -174.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.599 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -88.0 148.38 24.57 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.998 0.899 . . . . 0.0 110.874 -176.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 45.3 ttm -140.02 158.61 43.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 29.2 mttm -117.05 138.37 51.64 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.5 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 15.3 mt -123.96 147.88 47.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.434 -171.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 13.6 tptm -84.82 122.37 29.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.812 176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.579 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 0.7 OUTLIER -50.97 -39.76 56.05 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.745 -178.032 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 50' ' ' SER . 10.4 pt-20 -66.02 -9.05 26.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.294 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.629 ' CD2' HD21 ' A' ' 67' ' ' LEU . 42.1 m-85 -110.74 0.62 17.44 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 120.289 -0.565 . . . . 0.0 112.165 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 15.4 m -112.5 170.77 3.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -174.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.475 ' HD2' HG21 ' A' ' 51' ' ' VAL . 22.0 ttt180 -145.66 138.28 25.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.457 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.418 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 87.8 tttt -68.83 119.13 12.7 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.612 173.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.3 t -73.17 -47.36 47.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.912 176.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 72.02 48.63 25.66 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.052 -175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.681 -0.676 . . . . 0.0 109.427 -178.397 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.193 0 CA-C-O 121.165 0.507 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.0 p -90.51 130.13 40.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.508 178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.9 m 58.49 31.8 21.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.38 176.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 61.1 p -85.18 -39.99 17.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.128 0.49 . . . . 0.0 110.476 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 34.7 mt -92.61 150.68 40.18 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 174.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 72.9 Cg_endo -73.11 156.9 51.36 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.223 1.949 . . . . 0.0 111.133 176.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 8.0 Cg_exo -72.49 -163.3 0.14 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.9 2.4 . . . . 0.0 112.603 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.4 t -98.32 130.56 28.03 Favored Pre-proline 0 C--N 1.319 -0.726 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.059 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.47 5.28 2.03 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.731 2.287 . . . . 0.0 112.927 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -121.2 -35.13 3.35 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.241 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.407 ' C ' ' H ' ' A' ' 13' ' ' SER . 58.0 m -104.79 -47.31 4.08 Favored 'General case' 0 N--CA 1.455 -0.205 0 O-C-N 121.49 -0.756 . . . . 0.0 109.511 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 67.54 -2.35 1.34 Allowed 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.08 -175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.407 ' H ' ' C ' ' A' ' 11' ' ' CYS . 15.0 p -48.32 -78.39 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.97 -1.014 . . . . 0.0 113.095 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 170.03 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.263 0.352 . . . . 0.0 111.681 -173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.657 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 80.8 m-85 -77.79 39.48 0.29 Allowed 'General case' 0 N--CA 1.465 0.302 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -171.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.0 m -103.28 143.31 32.82 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.574 -0.285 . . . . 0.0 110.515 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.6 p90 -153.88 176.73 11.82 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -105.71 123.47 47.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.838 0.352 . . . . 0.0 111.441 -178.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -121.17 86.43 2.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.43 -116.16 5.01 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.132 176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.77 18.23 22.14 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.902 0.382 . . . . 0.0 111.789 -172.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -156.4 -173.49 4.52 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.6 mt -112.86 138.39 49.78 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.651 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -126.75 142.75 42.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 51.7 t -104.5 105.48 50.2 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.733 177.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.7 Cg_endo -65.84 -15.95 51.02 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.816 2.344 . . . . 0.0 111.512 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.449 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 26.1 tt0 -71.21 -61.39 1.79 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.93 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 31.0 p -98.82 12.76 34.69 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 61.95 29.54 17.81 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 173.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -135.75 133.92 38.49 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.131 177.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.651 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.4 mp0 -95.11 171.68 8.6 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.642 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -166.22 161.83 17.09 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-O 120.932 0.396 . . . . 0.0 110.558 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 t -115.57 113.79 42.65 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.59 -56.79 2.52 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 123.201 2.601 . . . . 0.0 113.195 -168.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -85.79 -28.14 24.72 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.597 -173.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -76.43 -31.29 57.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.842 0.354 . . . . 0.0 110.482 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.61 -31.13 72.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.212 174.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.92 -32.44 51.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.262 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.7 m 66.04 -84.56 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.027 175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -139.78 15.94 2.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.162 0.506 . . . . 0.0 110.95 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 16.5 m -100.23 12.0 38.08 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.663 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 43' ' ' ASP . 12.9 t70 60.74 -170.75 0.15 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.937 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.424 ' H ' ' CG ' ' A' ' 42' ' ' ASP . 35.0 t70 -144.14 89.46 2.03 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.352 0.596 . . . . 0.0 110.397 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 134.03 -60.06 0.66 Allowed Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.434 176.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.882 ' HD3' ' HA ' ' A' ' 89' ' ' ASP . 0.0 OUTLIER -101.65 111.7 24.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.774 0.797 . . . . 0.0 111.801 -174.536 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t -142.37 143.34 26.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.662 HG21 HG13 ' A' ' 94' ' ' ILE . 3.0 mm -89.93 135.44 26.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.079 -172.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.733 ' O ' ' HB2' ' A' ' 108' ' ' SER . 0.1 OUTLIER -115.0 145.71 41.99 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.829 179.396 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.602 ' HB2' ' ND2' ' A' ' 53' ' ' ASN . 70.4 m-20 -104.5 179.43 4.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.515 -172.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 5.0 t -73.93 -9.22 58.42 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 121.93 0.872 . . . . 0.0 110.315 -175.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.506 ' CG2' ' HB2' ' A' ' 112' ' ' ARG . 3.1 t -84.91 -18.88 9.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.657 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.58 12.7 60.66 Favored Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.5 -175.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.602 ' ND2' ' HB2' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -99.72 153.38 19.15 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.257 0.551 . . . . 0.0 111.112 178.325 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.4 t -109.41 133.37 54.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.339 -1.301 . . . . 0.0 109.328 -175.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.557 ' CD1' ' HB2' ' A' ' 113' ' ' LYS . 6.3 mp -96.67 175.17 6.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.25 0.548 . . . . 0.0 111.724 -168.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -124.81 146.98 48.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.126 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.687 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 17.8 t70 -70.65 102.21 2.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.035 0.445 . . . . 0.0 110.625 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.48 -3.98 13.53 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -71.27 171.61 10.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.969 -0.615 . . . . 0.0 110.833 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.616 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 31.1 m -104.75 137.64 42.25 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 174.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 pp -121.16 168.56 13.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.7 m -148.96 118.3 6.87 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 120.888 0.375 . . . . 0.0 110.868 175.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 1.1 p -62.91 129.48 26.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.534 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -95.14 10.41 4.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 179.557 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.467 ' HG2' HG12 ' A' ' 64' ' ' ILE . 74.9 mmtt -138.0 171.1 14.92 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 119.83 1.195 . . . . 0.0 110.255 -177.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -87.78 112.23 22.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.044 -1.435 . . . . 0.0 112.496 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.454 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.9 mp -130.23 143.44 50.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.984 172.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.6 ptmt -90.99 178.76 5.92 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 121.793 -0.567 . . . . 0.0 110.343 172.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 74' ' ' LEU . 57.8 t -122.24 115.68 46.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 177.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 tptm -79.16 117.87 20.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.85 0.357 . . . . 0.0 110.86 -166.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.99 -20.9 45.76 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.08 178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 49.9 m -110.86 172.86 6.62 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.961 0.41 . . . . 0.0 111.343 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 t -98.01 9.16 43.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.532 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.468 ' HB3' HG21 ' A' ' 69' ' ' VAL . 14.8 tp -78.85 170.66 16.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.331 -0.849 . . . . 0.0 108.734 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.416 ' H ' ' HG ' ' A' ' 74' ' ' LEU . 72.5 t -158.13 117.21 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -168.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.528 HG12 HG11 ' A' ' 63' ' ' VAL . 94.3 t -93.48 95.76 5.58 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 CA-C-O 121.851 0.834 . . . . 0.0 110.544 -177.016 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.12 151.61 27.04 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.473 -176.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.534 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.7 p -52.18 98.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 121.824 0.821 . . . . 0.0 110.817 -177.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 133.16 4.89 3.16 Favored Glycine 0 CA--C 1.522 0.524 0 CA-C-N 114.97 -1.014 . . . . 0.0 111.174 -177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.5 m -61.92 104.74 0.49 Allowed 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 122.032 0.92 . . . . 0.0 110.148 178.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HB3' ' HE2' ' A' ' 81' ' ' LYS . 30.0 ttpt -89.97 112.65 24.12 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.921 -175.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.488 HG11 ' HB2' ' A' ' 96' ' ' CYS . 39.1 t -123.67 114.39 41.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 20.1 ptmt -104.28 151.29 23.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.642 -175.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 68.88 47.31 0.8 Allowed 'General case' 0 C--N 1.33 -0.245 0 O-C-N 124.33 1.019 . . . . 0.0 111.468 177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.3 pt -65.89 -179.5 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 122.058 0.932 . . . . 0.0 113.193 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.687 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 19.4 tpt180 -129.15 122.37 29.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.14 -1.391 . . . . 0.0 108.636 174.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.576 HD22 HG12 ' A' ' 47' ' ' ILE . 79.6 mt -83.07 119.64 24.75 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -96.01 169.26 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -175.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.882 ' HA ' ' HD3' ' A' ' 45' ' ' LYS . 1.3 m-20 -75.13 92.73 2.7 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.657 0.741 . . . . 0.0 111.501 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.431 ' HA3' ' OD1' ' A' ' 93' ' ' ASP . . . 171.23 -174.07 44.85 Favored Glycine 0 C--N 1.303 -1.277 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.04 176.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -103.09 -25.57 13.36 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.623 0.725 . . . . 0.0 110.101 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.455 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 13.8 p-80 -108.35 50.86 0.76 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.931 -176.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 88' ' ' VAL . 6.0 m-20 -143.94 89.65 2.06 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -160.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.662 HG13 HG21 ' A' ' 47' ' ' ILE . 38.1 mt -120.09 113.69 41.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 120.164 -0.614 . . . . 0.0 111.322 174.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 13.4 t70 -95.63 139.79 31.38 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.802 179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.488 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.7 p -149.39 159.79 43.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.069 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 14.2 mptt -112.32 135.13 53.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 178.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.686 HG13 HD11 ' A' ' 101' ' ' ILE . 1.8 mm -114.07 109.01 26.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -59.6 102.02 0.13 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.982 0.42 . . . . 0.0 110.481 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.94 -66.48 0.51 Allowed Glycine 0 N--CA 1.443 -0.842 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.829 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.686 HD11 HG13 ' A' ' 98' ' ' ILE . 45.7 pt -86.9 -48.82 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.013 0.435 . . . . 0.0 110.73 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.545 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 141.63 -157.72 26.34 Favored Glycine 0 C--O 1.221 -0.66 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 -176.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -77.37 144.03 38.27 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 117.939 0.869 . . . . 0.0 110.529 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 52.9 ttp -133.69 151.88 51.75 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 -178.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.487 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -112.11 140.67 46.61 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 82.1 mt -120.96 139.58 53.07 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.464 0.649 . . . . 0.0 111.528 -171.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.405 ' HB3' ' HD2' ' A' ' 110' ' ' PHE . 22.2 tptm -80.83 116.23 20.71 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.824 177.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.733 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 7.5 p -53.98 -34.52 60.01 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.602 -176.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 50' ' ' SER . 37.5 mt-10 -68.94 -9.87 54.27 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.47 ' O ' HD13 ' A' ' 64' ' ' ILE . 63.8 m-85 -109.41 -4.46 16.34 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.308 -0.557 . . . . 0.0 112.049 178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.65 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 32.9 m -113.6 173.59 2.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.314 0.578 . . . . 0.0 112.12 -174.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.506 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.9 ttt180 -147.07 133.14 19.26 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.002 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.557 ' HB2' ' CD1' ' A' ' 55' ' ' LEU . 27.8 tttp -65.1 136.87 57.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.009 176.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 82.3 t -97.2 -56.56 5.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.588 177.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 74.54 49.62 10.98 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.063 -172.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 12.4 p . . . . . 0 C--O 1.252 1.193 0 CA-C-O 118.678 -0.677 . . . . 0.0 111.589 -178.015 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.211 0 CA-C-O 121.143 0.497 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.6 m -117.61 153.57 19.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.825 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -148.68 101.85 3.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.017 0.437 . . . . 0.0 110.489 177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.5 p -124.79 -55.17 1.62 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.016 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.407 HD13 HD22 ' A' ' 23' ' ' LEU . 51.0 mt -79.38 154.38 76.71 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.242 173.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.46 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 62.8 Cg_endo -70.95 156.85 59.49 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.029 1.82 . . . . 0.0 111.344 177.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 4.4 Cg_exo -73.91 -163.55 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.843 2.362 . . . . 0.0 112.7 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.9 t -98.29 124.2 47.89 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.406 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.45 11.27 0.63 Allowed 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 122.899 2.399 . . . . 0.0 111.563 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 12.1 mt-30 -120.8 -38.32 2.87 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.234 -178.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m -108.26 -50.29 3.06 Favored 'General case' 0 N--CA 1.457 -0.105 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t30 70.0 7.18 6.11 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.368 -176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.51 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 5.1 m -54.32 -76.6 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.982 178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.51 ' HB3' ' O ' ' A' ' 13' ' ' SER . 15.5 pt-20 165.66 -16.12 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 O-C-N 123.327 0.392 . . . . 0.0 111.977 -178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.501 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 87.6 m-85 -78.43 33.67 0.2 Allowed 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -169.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.6 m -95.71 139.89 31.29 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-O 120.587 0.232 . . . . 0.0 110.563 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 19' ' ' ASP . 20.9 p90 -147.48 178.09 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 -177.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -111.1 122.19 47.26 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.156 -0.618 . . . . 0.0 111.206 176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.539 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 24.0 t70 -118.35 89.28 3.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.879 175.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 93.46 -106.58 3.43 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.196 176.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -114.36 17.34 17.55 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -170.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 31' ' ' GLU . 1.3 pt? -163.91 -175.05 3.88 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.249 -177.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.409 ' CD1' ' HG2' ' A' ' 6' ' ' PRO . 22.4 mt -101.36 135.56 42.65 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 173.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.561 HG13 ' HG3' ' A' ' 31' ' ' GLU . 64.8 t -117.62 130.24 72.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -178.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 50.4 t -101.6 103.93 31.1 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 173.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 36.0 Cg_endo -65.89 -18.65 57.96 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.508 2.139 . . . . 0.0 110.969 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.59 -61.73 1.7 Allowed 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.194 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.401 ' SG ' ' NE2' ' A' ' 10' ' ' GLN . 28.4 p -95.44 11.35 33.18 Favored 'General case' 0 C--O 1.23 0.055 0 O-C-N 121.649 -0.657 . . . . 0.0 112.313 -178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 62.63 26.0 15.43 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.421 ' HB3' HE22 ' A' ' 10' ' ' GLN . 17.0 t-80 -125.94 135.83 52.31 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.506 178.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.561 ' HG3' HG13 ' A' ' 24' ' ' VAL . 6.2 mp0 -96.54 158.27 15.51 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.545 ' CH2' ' HA ' ' A' ' 34' ' ' PRO . 0.3 OUTLIER -158.9 161.32 36.78 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.034 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.529 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 1.9 p -120.15 128.63 25.74 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 174.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.545 ' HA ' ' CH2' ' A' ' 32' ' ' TRP . 8.6 Cg_endo -52.26 -47.0 29.14 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.412 2.741 . . . . 0.0 113.215 -170.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -125.62 -26.79 3.48 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 39' ' ' THR . 2.3 mp0 -68.96 -17.3 63.92 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.571 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.01 -41.19 67.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.022 0.439 . . . . 0.0 110.526 177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.69 -37.89 20.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.096 -178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.573 ' O ' ' HA ' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -141.65 136.79 31.28 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.157 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -116.19 9.57 14.68 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.327 0.584 . . . . 0.0 110.5 -178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.5 m -82.07 115.67 21.31 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.071 178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.6 t70 60.27 -150.66 0.42 Allowed 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.753 0.658 . . . . 0.0 109.226 -176.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -66.69 -28.57 68.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.984 0.421 . . . . 0.0 111.067 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.37 35.27 10.87 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.663 -0.78 . . . . 0.0 111.609 -176.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -64.22 -27.32 68.98 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 123.121 0.568 . . . . 0.0 112.053 -175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.558 HG23 HD13 ' A' ' 87' ' ' LEU . 14.4 p -61.47 138.99 21.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.034 -172.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.444 HD12 ' C ' ' A' ' 92' ' ' HIS . 6.3 mm -72.84 139.34 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.904 -172.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.549 ' HG3' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -126.48 154.44 43.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.11 -177.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.522 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 8.3 m-20 -99.95 179.99 4.34 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.189 0.518 . . . . 0.0 111.467 -174.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.55 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 14.7 t -82.8 -13.02 56.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 122.023 0.916 . . . . 0.0 110.342 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.604 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.0 p -89.24 -0.57 8.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.097 -179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.81 5.37 68.6 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 114.6 -1.182 . . . . 0.0 113.277 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.604 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -108.32 173.16 6.44 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 119.952 -0.699 . . . . 0.0 112.536 -178.851 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.549 HG22 ' HG3' ' A' ' 48' ' ' LYS . 4.9 t -115.17 142.31 28.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.254 -175.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.728 ' HA ' ' HG3' ' A' ' 113' ' ' LYS . 0.7 OUTLIER -98.7 -177.47 3.67 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.144 0.497 . . . . 0.0 110.251 -177.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.445 ' HA ' HD11 ' A' ' 87' ' ' LEU . 14.5 tt0 -136.69 163.41 30.65 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 173.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 56' ' ' GLN . 16.5 t70 -65.26 130.73 44.38 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 172.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 87.83 -6.96 82.71 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.351 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -68.87 165.24 20.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.68 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 61.4 m -103.81 137.2 42.15 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.575 HG22 HD22 ' A' ' 55' ' ' LEU . 1.6 pp -117.72 164.67 13.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -177.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 80' ' ' THR . 3.8 m -149.92 112.12 4.65 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -59.8 129.23 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.667 179.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.558 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -99.23 15.2 4.11 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 C-N-CA 120.016 -0.674 . . . . 0.0 112.801 179.622 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.471 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.37 157.79 45.49 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -179.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 -89.78 109.18 20.19 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.967 0.889 . . . . 0.0 112.135 172.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.414 HD21 ' CD2' ' A' ' 110' ' ' PHE . 12.4 mt -124.59 152.44 43.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.25 177.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -95.81 178.52 5.42 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 121.997 -0.44 . . . . 0.0 111.291 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 47.7 t -124.11 130.81 73.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -74.82 128.53 35.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.837 0.351 . . . . 0.0 111.529 -173.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.15 -13.12 3.6 Favored Glycine 0 CA--C 1.517 0.213 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.574 173.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.524 ' HB3' HD23 ' A' ' 74' ' ' LEU . 37.3 m -107.58 155.15 20.43 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 122.643 -0.328 . . . . 0.0 110.877 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.9 m -81.5 8.28 9.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.242 0.544 . . . . 0.0 110.495 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 72' ' ' SER . 3.8 mm? -78.6 170.37 16.76 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.604 177.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -159.88 117.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -169.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.606 HG12 HG11 ' A' ' 63' ' ' VAL . 86.5 t -93.66 95.69 5.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.612 0.72 . . . . 0.0 110.368 -175.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.84 150.23 27.28 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.048 -175.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.6 p -49.94 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-O 121.948 0.88 . . . . 0.0 110.759 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' HG23 ' A' ' 62' ' ' THR . . . 130.72 4.79 4.19 Favored Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.475 -177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 62' ' ' THR . 91.8 m -62.36 105.32 0.6 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 121.871 0.843 . . . . 0.0 110.059 176.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -89.27 112.68 23.79 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.75 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 96' ' ' CYS . 44.7 t -124.59 113.18 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.249 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 19.3 ptmt -96.12 167.76 11.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.763 -174.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.64 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 9.1 p30 60.04 39.66 19.57 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 113.943 -1.48 . . . . 0.0 112.314 170.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 24.3 pt -64.18 179.24 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 12.0 tpp85 -128.69 126.84 40.94 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.077 175.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.558 HD13 HG23 ' A' ' 46' ' ' VAL . 58.2 mt -80.58 120.16 24.17 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 173.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 93' ' ' ASP . 5.3 t -76.2 134.81 28.2 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.114 0.483 . . . . 0.0 110.742 -172.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.22 -58.9 6.61 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.371 -172.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -95.3 -46.35 2.82 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.084 -1.055 . . . . 0.0 112.319 -175.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.535 ' O ' ' HB ' ' A' ' 88' ' ' VAL . 12.3 m-20 -75.65 132.29 40.49 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.444 ' C ' HD12 ' A' ' 47' ' ' ILE . 14.2 m-70 -80.74 47.91 1.02 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.466 0.65 . . . . 0.0 110.175 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.598 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.5 m-20 -120.6 178.87 4.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.473 -176.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.635 ' CD1' HG21 ' A' ' 111' ' ' VAL . 66.7 mt -116.23 122.35 69.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.79 0 CA-C-O 121.592 0.711 . . . . 0.0 111.791 -178.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -96.51 132.4 42.13 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.091 174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.458 ' HB2' HG11 ' A' ' 82' ' ' VAL . 24.8 p -134.18 142.72 47.52 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.097 0.475 . . . . 0.0 111.02 -174.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 55.1 mttp -105.32 117.02 32.96 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.5 mt -117.28 113.33 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.974 -0.291 . . . . 0.0 111.167 -171.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -61.28 110.64 1.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 176.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 143.95 -62.19 0.5 Allowed Glycine 0 N--CA 1.433 -1.508 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.815 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 35.5 pt -110.12 -35.85 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.596 0.236 . . . . 0.0 111.392 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.94 -147.88 19.46 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.66 147.02 23.56 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.977 0.418 . . . . 0.0 111.065 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 61.2 ttp -144.46 165.87 26.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.881 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.418 ' N ' ' HD3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -111.98 148.01 34.71 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.897 0.38 . . . . 0.0 110.195 177.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.0 mt -130.08 140.37 50.83 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.912 -175.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.45 ' HG3' ' OE1' ' A' ' 109' ' ' GLU . 9.3 tptp -80.0 115.07 19.37 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.675 -178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 1.7 m -50.36 -40.19 48.71 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.624 -1.171 . . . . 0.0 111.024 -179.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 50' ' ' SER . 1.6 mp0 -69.6 -10.01 56.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.421 -178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.425 ' HD1' ' HB3' ' A' ' 107' ' ' LYS . 75.3 m-85 -112.09 -0.12 15.74 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 35.0 m -115.62 174.5 3.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.259 0.552 . . . . 0.0 112.163 -175.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.478 ' HG3' HG11 ' A' ' 51' ' ' VAL . 19.9 ttt180 -143.22 131.78 22.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.173 -0.921 . . . . 0.0 111.273 178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.728 ' HG3' ' HA ' ' A' ' 55' ' ' LEU . 1.9 tmtp? -70.43 119.97 15.39 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.381 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 38.4 t -79.25 -48.89 20.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.515 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.52 ' HA2' ' HE3' ' A' ' 113' ' ' LYS . . . 88.49 44.72 5.17 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.587 -0.815 . . . . 0.0 111.831 -177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.3 m . . . . . 0 C--O 1.247 0.966 0 CA-C-O 118.989 -0.529 . . . . 0.0 110.455 177.014 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HG3' HG23 ' A' ' 2' ' ' VAL . 11.7 ptm . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 121.745 0.783 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.48 HG23 ' HG3' ' A' ' 1' ' ' MET . 14.2 t -86.88 60.58 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 172.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -128.28 142.34 51.18 Favored 'General case' 0 N--CA 1.434 -1.27 0 CA-C-N 115.098 -0.955 . . . . 0.0 111.051 -168.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.0 t -132.6 30.39 4.11 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.608 HD13 HD22 ' A' ' 23' ' ' LEU . 17.8 mt -73.39 161.02 81.02 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 114.297 -1.319 . . . . 0.0 110.896 -174.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 36.6 Cg_endo -63.45 161.63 30.57 Favored 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 122.551 2.167 . . . . 0.0 111.808 177.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.536 ' HB3' ' HG3' ' A' ' 14' ' ' GLU . 11.5 Cg_exo -70.44 -170.7 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.775 2.316 . . . . 0.0 112.496 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 6.2 t -98.46 123.68 49.39 Favored Pre-proline 0 C--N 1.318 -0.803 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 175.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.08 9.04 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.545 2.163 . . . . 0.0 111.866 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.581 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 14.5 mt-30 -119.42 -36.21 3.4 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.889 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.5 m -110.82 -46.99 3.28 Favored 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 121.265 0.555 . . . . 0.0 109.727 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 t30 73.21 5.83 5.13 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.91 -175.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 26.2 m -61.41 -27.5 68.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.342 -0.845 . . . . 0.0 112.043 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.536 ' HG3' ' HB3' ' A' ' 7' ' ' PRO . 4.4 mt-10 78.06 13.54 1.63 Allowed 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 174.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -81.03 47.46 1.0 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.717 0.77 . . . . 0.0 109.039 170.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 m -99.18 147.12 25.44 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.961 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -148.08 173.92 12.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -100.43 116.05 31.48 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.86 0.362 . . . . 0.0 110.582 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -96.94 28.27 3.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.049 0.928 . . . . 0.0 109.675 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 131.82 -99.7 0.41 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.546 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -107.27 17.64 22.63 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.916 0.389 . . . . 0.0 111.577 -173.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.442 HD11 ' HB2' ' A' ' 31' ' ' GLU . 2.2 pt? -159.83 -176.67 5.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.828 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.608 HD22 HD13 ' A' ' 5' ' ' LEU . 3.5 mt -109.98 135.04 51.45 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.9 OUTLIER -125.76 140.52 48.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.192 0.52 . . . . 0.0 109.599 177.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 45.9 t -102.36 106.19 47.37 Favored Pre-proline 0 C--N 1.312 -1.042 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.475 179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 25' ' ' CYS . 33.9 Cg_endo -65.2 -14.66 46.3 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.679 2.253 . . . . 0.0 111.361 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -74.07 -59.36 2.76 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.891 -177.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 29.1 p -99.08 10.14 42.07 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 59.59 39.85 20.95 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 176.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.406 ' HB3' HE22 ' A' ' 10' ' ' GLN . 20.8 t60 -139.47 126.72 21.32 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.585 178.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -100.47 164.66 11.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.778 177.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -163.99 162.05 23.03 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.128 0.489 . . . . 0.0 111.026 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 48.2 t -104.68 123.26 40.79 Favored Pre-proline 0 C--N 1.315 -0.895 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 171.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD3' ' HG ' ' A' ' 23' ' ' LEU . 17.8 Cg_endo -56.82 -36.52 98.77 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.952 2.435 . . . . 0.0 113.112 -171.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -104.41 -43.89 5.07 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.225 -176.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.457 ' HG3' ' HB2' ' A' ' 40' ' ' ALA . 42.0 tt0 -64.74 -27.38 68.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.355 -174.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.75 -39.06 90.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.998 0.428 . . . . 0.0 110.602 177.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.53 -52.82 12.21 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.198 179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 41' ' ' SER . 5.2 m -152.84 147.2 25.74 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.081 177.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.457 ' HB2' ' HG3' ' A' ' 36' ' ' GLU . . . -135.08 7.69 3.43 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.658 0.742 . . . . 0.0 109.729 175.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.611 ' H ' HG22 ' A' ' 39' ' ' THR . 38.5 t -100.49 2.24 41.88 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.007 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -105.28 165.54 11.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.741 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.595 ' HB2' ' HE3' ' A' ' 48' ' ' LYS . 11.4 t70 -114.11 -47.68 2.93 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.11 -45.13 1.96 Allowed Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.767 176.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.661 ' HG3' HG23 ' A' ' 46' ' ' VAL . 20.1 pttm -100.28 -28.75 12.82 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 122.772 -0.252 . . . . 0.0 111.332 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.661 HG23 ' HG3' ' A' ' 45' ' ' LYS . 6.1 t -121.56 153.99 25.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.59 HG21 HG13 ' A' ' 94' ' ' ILE . 2.8 mm -91.66 135.23 27.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -176.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.667 ' O ' ' HB2' ' A' ' 108' ' ' SER . 11.7 ttmt -121.09 155.0 35.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -174.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 111' ' ' VAL . 9.0 m-20 -92.98 176.83 6.27 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.304 0.573 . . . . 0.0 111.449 -174.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 13.5 t -79.0 -7.37 58.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.642 174.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.52 ' HB ' ' ND2' ' A' ' 53' ' ' ASN . 3.0 t -91.02 -15.37 8.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.347 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 96.98 0.39 60.16 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 114.292 -1.322 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.52 ' ND2' ' HB ' ' A' ' 51' ' ' VAL . 0.0 OUTLIER -83.45 162.67 20.89 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.901 0.857 . . . . 0.0 110.767 178.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.494 HG22 ' HE2' ' A' ' 48' ' ' LYS . 2.9 t -118.19 130.64 72.76 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.909 -179.216 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.411 ' HB2' HD21 ' A' ' 87' ' ' LEU . 1.5 mm? -93.76 173.19 7.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.377 0.608 . . . . 0.0 110.645 -171.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.29 150.72 48.27 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.147 -0.933 . . . . 0.0 108.692 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.583 ' OD2' ' HD3' ' A' ' 86' ' ' ARG . 17.7 t70 -67.43 99.14 0.71 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.044 0.449 . . . . 0.0 109.891 177.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.58 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 121.72 -7.45 10.27 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.385 -178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -68.67 167.96 14.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.698 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 23.5 m -106.45 131.65 53.4 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.795 HG13 HG23 ' A' ' 82' ' ' VAL . 1.9 pp -127.57 169.11 19.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.721 0.296 . . . . 0.0 110.311 -174.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.8 m -150.6 121.68 7.72 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.574 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -61.93 131.04 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 109.867 176.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.537 HD13 ' H ' ' A' ' 64' ' ' ILE . 0.2 OUTLIER -94.98 10.14 4.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.454 ' HD3' ' O ' ' A' ' 64' ' ' ILE . 58.1 mmtt -139.18 167.63 21.63 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 119.843 1.201 . . . . 0.0 110.034 -176.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -89.4 109.86 20.73 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 114.701 -1.136 . . . . 0.0 112.176 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 4.7 mp -123.95 138.54 54.45 Favored 'General case' 0 C--O 1.219 -0.518 0 CA-C-N 114.605 -1.18 . . . . 0.0 108.466 173.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -96.02 177.7 5.66 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 121.651 -0.656 . . . . 0.0 110.265 176.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.427 HG11 ' HB2' ' A' ' 72' ' ' SER . 39.0 t -128.83 120.98 53.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HD3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -84.77 -32.77 23.22 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -168.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.559 ' N ' ' HD3' ' A' ' 70' ' ' LYS . . . -86.4 -26.82 32.02 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.861 -1.161 . . . . 0.0 111.924 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.698 ' HB3' HD23 ' A' ' 74' ' ' LEU . 60.8 m -110.42 163.71 13.41 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -175.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.9 m -81.37 8.66 8.71 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.57 0.7 . . . . 0.0 109.96 173.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.698 HD23 ' HB3' ' A' ' 72' ' ' SER . 4.3 mm? -76.93 172.35 13.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.107 178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 82.4 t -159.35 113.81 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 -166.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.495 HG12 HG11 ' A' ' 63' ' ' VAL . 94.8 t -90.97 96.78 6.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-O 121.828 0.823 . . . . 0.0 110.246 -176.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.459 ' O ' ' HD2' ' A' ' 77' ' ' LYS . 1.3 pptp? -106.04 148.2 28.02 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.79 -175.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -52.54 96.77 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-O 121.974 0.893 . . . . 0.0 110.605 178.178 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.4 ' HA2' ' CG2' ' A' ' 62' ' ' THR . . . 133.09 4.76 3.21 Favored Glycine 0 CA--C 1.525 0.657 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.005 -177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 62' ' ' THR . 88.7 m -63.53 103.46 0.53 Allowed 'General case' 0 C--O 1.224 -0.256 0 CA-C-O 121.959 0.885 . . . . 0.0 109.956 176.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -92.29 115.3 27.96 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.654 -173.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.795 HG23 HG13 ' A' ' 61' ' ' ILE . 2.6 m -120.04 119.87 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-O 121.808 0.813 . . . . 0.0 110.519 171.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.623 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 22.0 pttp -103.82 148.8 25.69 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.465 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.58 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 0.9 OUTLIER 71.54 43.29 0.61 Allowed 'General case' 0 C--N 1.328 -0.369 0 O-C-N 124.127 0.892 . . . . 0.0 111.284 176.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 46.0 pt -64.31 -178.25 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 122.098 0.951 . . . . 0.0 113.016 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.625 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 1.4 tpp180 -129.74 124.69 34.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.077 -1.419 . . . . 0.0 108.867 174.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.475 HD13 HG13 ' A' ' 46' ' ' VAL . 71.3 mt -82.63 117.51 22.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 174.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.9 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.9 OUTLIER -88.97 167.09 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.12 -173.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -79.25 70.76 5.7 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 122.687 1.232 . . . . 0.0 110.717 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.418 ' HA3' ' OD1' ' A' ' 93' ' ' ASP . . . -163.95 -167.53 24.58 Favored Glycine 0 C--N 1.296 -1.644 0 CA-C-N 113.22 -1.809 . . . . 0.0 112.773 178.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -102.66 -42.85 5.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.503 0.668 . . . . 0.0 110.903 177.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.412 ' HA ' ' OG ' ' A' ' 108' ' ' SER . 83.3 m-70 -104.24 55.06 0.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.803 -178.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.9 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 4.6 m-20 -137.8 88.67 2.35 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 -160.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.59 HG13 HG21 ' A' ' 47' ' ' ILE . 30.5 mt -120.94 111.06 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.557 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.625 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 24.7 t70 -94.47 135.31 36.05 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 14.1 p -134.42 142.07 47.02 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.927 -0.578 . . . . 0.0 109.955 -175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 mtpt -104.89 119.29 38.65 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 35.7 mt -118.72 108.81 25.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.292 -172.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -54.66 126.17 22.8 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.382 179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 125.87 -53.45 0.78 Allowed Glycine 0 N--CA 1.431 -1.64 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.745 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.422 HG13 ' N ' ' A' ' 102' ' ' GLY . 40.6 pt -112.18 -39.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.782 0.325 . . . . 0.0 110.961 -178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.422 ' N ' HG13 ' A' ' 101' ' ' ILE . . . 135.3 -149.21 19.89 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -88.98 155.01 19.76 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.015 0.407 . . . . 0.0 110.863 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.4 ttt -147.21 161.93 39.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.431 -178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -107.69 146.89 31.46 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 93.5 mt -130.26 142.18 50.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.398 0.618 . . . . 0.0 111.452 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -78.05 120.05 22.34 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.671 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.667 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 4.9 p -57.11 -34.57 68.49 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.988 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 50' ' ' SER . 4.8 pm0 -70.23 -7.22 40.35 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.421 ' O ' HD13 ' A' ' 64' ' ' ILE . 55.0 m-85 -112.75 3.63 16.61 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 49' ' ' ASP . 29.1 m -110.48 166.53 5.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.422 0.63 . . . . 0.0 112.531 -174.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.2 ttt180 -141.3 133.51 27.95 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.356 178.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.495 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 33.0 tttp -65.95 139.49 58.25 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.899 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.3 t -103.22 -42.78 8.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.458 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.491 ' CA ' ' HE3' ' A' ' 113' ' ' LYS . . . 79.54 29.56 48.24 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.143 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 56.2 m . . . . . 0 C--O 1.251 1.182 0 CA-C-O 118.641 -0.695 . . . . 0.0 109.85 176.816 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptm . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.176 0.512 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.2 t -76.53 115.02 17.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.512 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -150.73 116.68 5.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.135 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.631 HG23 ' HG ' ' A' ' 5' ' ' LEU . 1.7 t -79.65 -36.11 38.27 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.543 0.687 . . . . 0.0 109.989 175.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.631 ' HG ' HG23 ' A' ' 4' ' ' THR . 21.9 mt -82.94 168.7 21.2 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.59 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 5' ' ' LEU . 63.2 Cg_endo -68.88 154.61 70.68 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 121.552 1.501 . . . . 0.0 110.741 175.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 7.7 Cg_exo -71.77 -165.78 0.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.669 2.246 . . . . 0.0 112.294 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 11.7 t -97.75 123.26 52.41 Favored Pre-proline 0 C--N 1.316 -0.867 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.046 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -68.39 11.21 0.29 Allowed 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.895 2.397 . . . . 0.0 111.739 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.596 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 13.7 mt-30 -122.22 -37.68 2.79 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.891 -179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 66.3 m -107.09 -49.12 3.34 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 121.247 0.546 . . . . 0.0 109.721 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 65.8 t30 70.51 -3.73 1.82 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.627 -1.17 . . . . 0.0 112.249 -177.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 8.3 t -54.68 -76.36 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 119.547 -0.263 . . . . 0.0 111.371 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 13' ' ' SER . 11.3 pt-20 171.68 -8.93 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.673 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 96.7 m-85 -78.8 35.42 0.24 Allowed 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 120.988 0.423 . . . . 0.0 112.017 -171.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -97.82 134.98 40.23 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.307 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CE2' ' HD3' ' A' ' 26' ' ' PRO . 27.5 p90 -145.52 171.66 14.35 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -176.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -104.12 123.22 46.88 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.067 0.46 . . . . 0.0 110.916 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -114.69 84.08 2.0 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 171.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.02 -114.03 4.4 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.225 177.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -106.93 20.66 18.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -171.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -159.72 -174.82 4.8 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.495 HD22 HD13 ' A' ' 5' ' ' LEU . 35.0 mt -110.58 135.61 50.96 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 174.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.7 OUTLIER -126.31 140.65 48.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.792 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 27' ' ' GLU . 54.0 t -107.49 106.22 57.88 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.176 -178.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.673 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 43.3 Cg_endo -68.46 -14.31 39.58 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.704 2.27 . . . . 0.0 110.79 176.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.601 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 32.6 tt0 -66.09 -58.78 4.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.076 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.18 8.74 36.31 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 57.46 49.36 13.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 118.429 0.559 . . . . 0.0 112.112 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.435 ' HB3' HE22 ' A' ' 10' ' ' GLN . 13.6 t-80 -147.72 128.09 13.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.356 175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.0 OUTLIER -97.01 171.62 8.37 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 178.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -168.75 162.16 11.48 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.452 ' CB ' ' HB2' ' A' ' 36' ' ' GLU . 5.9 m -119.81 116.31 33.08 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.63 -37.19 98.15 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.319 2.68 . . . . 0.0 113.106 -170.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 12.9 m-80 -112.51 -37.85 4.82 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.657 -178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.452 ' HB2' ' CB ' ' A' ' 33' ' ' SER . 20.7 mp0 -70.0 -15.47 63.03 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.66 -171.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -83.34 -49.98 8.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.088 0.471 . . . . 0.0 110.8 177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.11 -37.14 46.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.33 -177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.464 HG22 ' H ' ' A' ' 40' ' ' ALA . 2.0 m -103.74 173.71 6.19 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.549 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' H ' HG22 ' A' ' 39' ' ' THR . . . -58.33 143.19 45.75 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.4 m -84.8 7.86 19.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.145 0.498 . . . . 0.0 111.307 -175.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -110.59 155.39 22.41 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.441 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 37.5 t70 179.38 -37.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.686 -178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 121.96 47.56 0.28 Allowed Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.314 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HE2' ' HA ' ' A' ' 45' ' ' LYS . 3.3 mmpt? -97.05 -9.37 28.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.808 0.337 . . . . 0.0 110.846 -175.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.501 HG13 HD13 ' A' ' 87' ' ' LEU . 2.6 t -121.87 136.49 58.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.045 0.45 . . . . 0.0 110.96 -174.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 93' ' ' ASP . 2.5 mm -105.32 141.22 21.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.058 -172.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -105.03 165.79 10.83 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.021 0.439 . . . . 0.0 111.739 -178.102 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.594 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 7.9 m-20 -109.97 172.7 6.7 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.784 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.557 ' HB3' HD11 ' A' ' 64' ' ' ILE . 36.1 t -77.22 -7.46 55.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.703 0.763 . . . . 0.0 110.958 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.594 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.4 p -93.2 0.31 9.94 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.257 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.88 4.08 69.86 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.285 171.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.594 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.3 OUTLIER -105.02 168.25 9.17 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 119.829 -0.748 . . . . 0.0 112.14 -178.368 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG12 HG12 ' A' ' 46' ' ' VAL . 2.4 t -113.66 137.08 48.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.847 -174.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 61' ' ' ILE . 9.2 mt -89.88 172.84 8.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.581 0.705 . . . . 0.0 112.097 -171.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.435 HE21 ' HB3' ' A' ' 56' ' ' GLN . 2.2 tt0 -121.84 142.63 50.05 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.571 173.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.635 ' OD2' ' HD2' ' A' ' 86' ' ' ARG . 6.4 t70 -67.03 105.63 1.71 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.041 0.448 . . . . 0.0 110.375 178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.424 ' C ' ' HA ' ' A' ' 84' ' ' ASN . . . 114.49 -0.84 23.55 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -80.2 174.25 11.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.89 0.376 . . . . 0.0 110.306 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 26.9 m -102.56 139.18 38.49 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 178.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.6 HG22 HD22 ' A' ' 55' ' ' LEU . 2.1 pp -118.66 165.51 13.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.7 m -147.97 118.39 7.4 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 120.835 0.35 . . . . 0.0 110.084 175.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.662 HG11 HG12 ' A' ' 76' ' ' VAL . 0.5 OUTLIER -62.22 127.51 22.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.793 HG12 ' HD2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -101.42 19.16 3.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.793 ' HD2' HG12 ' A' ' 64' ' ' ILE . 2.1 mptp? -135.62 163.93 29.0 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.436 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.6 p-10 -86.83 113.39 22.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.933 0.873 . . . . 0.0 111.72 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 66' ' ' ASP . 18.3 mt -125.4 148.05 48.94 Favored 'General case' 0 C--O 1.218 -0.604 0 CA-C-N 114.737 -1.12 . . . . 0.0 108.98 175.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.5 ptpt -98.31 177.12 5.47 Favored 'General case' 0 C--N 1.313 -0.992 0 C-N-CA 120.141 -0.624 . . . . 0.0 110.8 170.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.418 HG12 ' H ' ' A' ' 72' ' ' SER . 57.3 t -125.15 131.42 72.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -83.1 -38.96 21.75 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.48 -25.03 59.66 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.388 -0.91 . . . . 0.0 112.254 -177.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.418 ' H ' HG12 ' A' ' 69' ' ' VAL . 71.8 m -115.11 171.6 7.57 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.234 0.54 . . . . 0.0 111.774 -177.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.0 t -92.07 1.9 56.91 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.398 175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.45 HD22 HD13 ' A' ' 101' ' ' ILE . 10.7 mp -79.68 136.49 36.81 Favored 'General case' 0 C--O 1.215 -0.737 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.464 -178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 62.0 t -101.03 133.69 43.49 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.006 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.662 HG12 HG11 ' A' ' 63' ' ' VAL . 53.5 t -89.03 100.56 10.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.615 0.722 . . . . 0.0 109.925 178.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -105.18 150.44 25.08 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.721 -173.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.569 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.5 p -51.31 96.81 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-O 121.848 0.832 . . . . 0.0 110.417 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 130.89 2.13 4.82 Favored Glycine 0 CA--C 1.525 0.688 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.16 -176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 18.0 m -61.29 105.45 0.5 Allowed 'General case' 0 C--O 1.226 -0.157 0 CA-C-O 122.147 0.975 . . . . 0.0 110.129 176.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 81' ' ' LYS . 36.3 ttpt -90.84 114.24 26.61 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 114.814 -1.085 . . . . 0.0 111.206 -173.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.823 HG11 ' HB2' ' A' ' 96' ' ' CYS . 21.5 t -123.72 117.26 50.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.027 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 11.3 ptmm? -99.92 154.03 18.69 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.558 -173.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.424 ' HA ' ' C ' ' A' ' 58' ' ' GLY . 16.2 m-80 64.25 50.01 2.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.685 175.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.8 pt -65.66 177.07 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.826 0.822 . . . . 0.0 112.725 174.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.635 ' HD2' ' OD2' ' A' ' 57' ' ' ASP . 10.3 tpt180 -131.69 125.52 32.3 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.076 175.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.501 HD13 HG13 ' A' ' 46' ' ' VAL . 36.3 mt -84.25 118.33 24.1 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.542 ' O ' HD11 ' A' ' 47' ' ' ILE . 0.1 OUTLIER -100.06 179.16 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.48 -175.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.14 93.91 7.73 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.15 0.976 . . . . 0.0 111.915 -171.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 160.52 -174.43 37.21 Favored Glycine 0 C--N 1.298 -1.547 0 CA-C-N 113.669 -1.605 . . . . 0.0 110.403 175.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -102.12 -20.51 14.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.782 0.791 . . . . 0.0 110.578 175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -106.61 47.86 0.86 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.031 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.566 ' O ' HG13 ' A' ' 47' ' ' ILE . 3.3 m-20 -142.0 89.81 2.21 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -160.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.596 ' CD1' HG21 ' A' ' 111' ' ' VAL . 50.5 mt -121.22 116.49 49.86 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.735 0 C-N-CA 119.871 -0.731 . . . . 0.0 111.388 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 30.8 t70 -93.96 128.42 40.27 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.77 177.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.823 ' HB2' HG11 ' A' ' 82' ' ' VAL . 25.3 p -130.86 137.12 49.22 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.071 -176.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -107.72 118.85 37.8 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 29.8 mt -117.84 108.27 24.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.608 -171.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -63.93 107.61 1.28 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.434 -179.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 142.27 -45.04 0.95 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.394 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.45 HD13 HD22 ' A' ' 74' ' ' LEU . 15.6 pt -120.29 -37.54 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 120.87 0.366 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.27 -153.33 21.85 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.352 -0.699 . . . . 0.0 111.352 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -90.26 151.92 21.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.092 0.446 . . . . 0.0 110.503 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.8 ttp -143.15 164.17 30.88 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.95 147.92 37.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.873 0.368 . . . . 0.0 110.379 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.439 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 90.1 mt -129.52 144.01 51.08 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.377 0.608 . . . . 0.0 111.791 -171.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -81.5 120.44 25.02 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.279 175.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.71 ' HB3' ' O ' ' A' ' 48' ' ' LYS . 2.5 m -50.89 -36.91 40.58 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.328 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 50' ' ' SER . 42.8 mt-10 -71.32 -5.4 32.13 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.435 ' CG ' HD11 ' A' ' 67' ' ' LEU . 55.0 m-85 -114.36 -2.75 13.2 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 119.857 -0.737 . . . . 0.0 112.749 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.596 HG21 ' CD1' ' A' ' 94' ' ' ILE . 34.8 m -113.72 172.7 3.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -172.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.474 ' HA ' ' HB3' ' A' ' 49' ' ' ASP . 25.0 ttt180 -151.74 133.94 15.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.582 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.408 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.4 tttt -65.28 123.16 18.85 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.19 174.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.9 t -73.47 -51.91 23.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.871 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.16 39.06 16.83 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.318 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.389 179.172 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.927 0.394 . . . . 0.0 111.698 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 p -118.48 111.29 33.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.383 0.611 . . . . 0.0 110.569 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.6 m -75.69 142.34 42.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.903 -178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 38.2 p -97.84 0.64 47.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.349 -175.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.412 HD11 ' CD ' ' A' ' 18' ' ' GLU . 55.2 mt -110.29 158.77 34.33 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.97 178.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 60.2 Cg_endo -71.49 157.45 56.26 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 122.1 1.867 . . . . 0.0 110.688 174.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 6' ' ' PRO . 19.0 Cg_exo -66.6 -174.64 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.439 2.093 . . . . 0.0 113.258 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.764 ' SG ' ' HB2' ' A' ' 10' ' ' GLN . 34.3 t -99.6 123.22 48.76 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HG2' ' OE1' ' A' ' 10' ' ' GLN . 39.2 Cg_endo -70.01 7.27 1.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 121.887 1.725 . . . . 0.0 112.059 178.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.764 ' HB2' ' SG ' ' A' ' 8' ' ' CYS . 1.2 mp0 -103.0 -54.26 2.66 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.307 175.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.414 ' C ' ' H ' ' A' ' 13' ' ' SER . 28.4 p -117.77 -28.29 6.01 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -175.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 66.0 t30 75.88 -28.55 0.18 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.287 0.635 . . . . 0.0 112.287 173.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 14' ' ' GLU . 63.5 p -32.5 -76.56 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 O-C-N 124.574 1.171 . . . . 0.0 113.401 -177.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.443 ' HB3' ' O ' ' A' ' 13' ' ' SER . 9.0 pt-20 169.35 -4.93 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.533 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 77.6 m-85 -81.16 42.41 0.65 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 121.27 0.557 . . . . 0.0 111.747 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 m -109.26 148.56 30.8 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.853 176.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' CE1' ' HB2' ' A' ' 19' ' ' ASP . 32.8 p90 -150.09 174.1 13.13 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 -176.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' GLU . 1.2 pm0 -102.77 115.61 30.94 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.377 0.608 . . . . 0.0 111.268 -176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.514 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 10.7 t70 -122.86 83.65 2.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.207 -0.452 . . . . 0.0 109.824 174.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 95.97 -126.38 8.77 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.336 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -102.47 17.61 23.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.962 0.41 . . . . 0.0 111.372 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.7 -174.07 4.38 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.1 mt -120.23 136.82 54.52 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 173.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.808 ' HB ' ' HG3' ' A' ' 31' ' ' GLU . 0.8 OUTLIER -125.12 143.58 38.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 C-N-CA 119.763 -0.775 . . . . 0.0 109.259 -179.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 53.1 t -104.22 104.21 42.84 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 15' ' ' TYR . 23.0 Cg_endo -61.49 -22.1 73.64 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.843 2.362 . . . . 0.0 111.179 178.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . 17.0 tp10 -74.15 -59.7 2.6 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.7 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 92.2 m -74.48 -9.91 59.05 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.72 44.83 25.64 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 121.314 0.578 . . . . 0.0 110.433 -170.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -145.1 122.94 11.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.754 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.808 ' HG3' ' HB ' ' A' ' 24' ' ' VAL . 3.6 mp0 -91.62 157.92 16.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.787 -179.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -158.3 163.13 37.67 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 109.819 -0.438 . . . . 0.0 109.819 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.534 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 22.6 t -125.5 124.41 25.05 Favored Pre-proline 0 C--N 1.31 -1.121 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.57 -30.96 90.36 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.075 2.517 . . . . 0.0 113.023 -173.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -111.86 -29.89 7.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.626 -177.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' ' 33' ' ' SER . 28.3 tt0 -90.04 -4.62 57.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.474 -173.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.22 -32.91 74.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 111.074 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -60.82 -51.11 70.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.794 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.1 m 69.96 -73.85 0.09 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.226 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.86 113.49 3.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.225 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 24.1 m -82.59 90.17 6.77 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.337 0.589 . . . . 0.0 110.237 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -69.56 150.52 47.02 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.455 -179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -118.98 81.46 1.7 Allowed 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.449 0.642 . . . . 0.0 110.513 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -101.28 41.88 2.04 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.447 170.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -104.26 -20.23 13.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.716 0.294 . . . . 0.0 110.985 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.41 HG23 HD13 ' A' ' 87' ' ' LEU . 12.2 p -146.01 139.83 21.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.63 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.499 HD13 ' C ' ' A' ' 90' ' ' GLY . 2.0 mm -78.79 117.01 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.429 -173.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.529 ' O ' ' HB2' ' A' ' 108' ' ' SER . 1.2 mtmt -100.01 150.11 22.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.092 176.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.573 ' HB3' ' O ' ' A' ' 111' ' ' VAL . 9.2 m-20 -90.5 176.64 6.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.516 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.6 t -77.09 -7.97 56.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.722 0.772 . . . . 0.0 110.761 -178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.602 HG13 ' ND2' ' A' ' 53' ' ' ASN . 2.1 p -97.3 -2.25 10.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-O 122.18 0.99 . . . . 0.0 109.188 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.01 3.92 79.06 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.976 172.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.602 ' ND2' HG13 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -92.91 154.76 18.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.685 0.743 . . . . 0.0 111.017 177.803 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.3 109.94 24.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.196 -0.911 . . . . 0.0 112.612 -171.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.479 HD23 ' HB2' ' A' ' 113' ' ' LYS . 94.2 mt -58.76 145.7 39.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.014 -1.448 . . . . 0.0 112.383 175.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -120.51 148.94 43.18 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 107.709 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' OD1' ' HA ' ' A' ' 86' ' ' ARG . 1.2 t70 -63.94 126.36 27.4 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 84' ' ' ASN . . . 88.66 2.01 79.63 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.816 -177.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -81.65 173.64 12.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.967 0.383 . . . . 0.0 110.473 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 11.4 m -101.59 139.82 36.72 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.569 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.45 HG22 HD22 ' A' ' 55' ' ' LEU . 2.0 pp -124.47 165.39 21.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.936 0.398 . . . . 0.0 110.448 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 80' ' ' THR . 2.7 m -150.61 115.6 5.31 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.438 175.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.679 HG11 HG12 ' A' ' 76' ' ' VAL . 0.4 OUTLIER -58.07 129.97 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.543 ' HA ' HG23 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -103.06 17.48 4.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.468 178.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.444 ' CD ' HG12 ' A' ' 64' ' ' ILE . 5.0 mptp? -134.26 161.44 34.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.457 ' O ' HD23 ' A' ' 67' ' ' LEU . 5.5 p-10 -85.55 111.31 19.9 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.938 0.875 . . . . 0.0 111.156 169.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.475 HD11 ' CB ' ' A' ' 110' ' ' PHE . 20.1 mt -124.43 133.88 53.25 Favored 'General case' 0 C--O 1.213 -0.837 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.145 176.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -88.28 173.2 8.9 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.749 -0.594 . . . . 0.0 109.963 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.485 ' CG1' ' HB2' ' A' ' 72' ' ' SER . 21.7 t -128.92 120.17 51.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 177.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.442 ' HE2' ' HB2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -93.36 -2.83 54.34 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.411 -0.515 . . . . 0.0 111.475 -170.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -122.14 26.31 6.45 Favored Glycine 0 N--CA 1.451 -0.305 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 177.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.485 ' HB2' ' CG1' ' A' ' 69' ' ' VAL . 58.2 m -146.49 -177.69 5.76 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 -177.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -100.87 -12.12 19.25 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 165.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 101' ' ' ILE . 9.8 mp -79.22 142.45 36.25 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.786 -176.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.0 t -109.98 126.64 67.19 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.359 167.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.679 HG12 HG11 ' A' ' 63' ' ' VAL . 76.0 t -77.73 104.91 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.536 0.684 . . . . 0.0 110.378 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.44 150.39 26.1 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.448 -174.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.543 HG23 ' HA ' ' A' ' 64' ' ' ILE . 2.4 p -52.34 96.23 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 CA-C-O 121.776 0.798 . . . . 0.0 110.501 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 132.32 4.13 3.68 Favored Glycine 0 CA--C 1.527 0.823 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.23 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' THR . 89.8 m -62.76 105.1 0.61 Allowed 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.478 0.656 . . . . 0.0 110.67 176.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -91.07 120.53 32.11 Favored 'General case' 0 C--N 1.317 -0.846 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.551 -175.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.553 HG11 ' HB2' ' A' ' 96' ' ' CYS . 59.8 t -129.7 116.62 38.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.745 174.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 60' ' ' THR . 23.8 pttm -102.92 159.51 15.43 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.253 -175.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.589 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 46.5 m-80 65.25 48.53 2.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.453 177.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.9 pt -67.94 -178.95 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 176.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HB3' ' HB3' ' A' ' 95' ' ' ASP . 11.1 tpp85 -136.44 124.39 22.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.208 -1.36 . . . . 0.0 108.602 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HB3' HG12 ' A' ' 47' ' ' ILE . 36.9 mt -79.83 125.38 29.63 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.042 -0.411 . . . . 0.0 110.086 -177.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 93' ' ' ASP . 0.2 OUTLIER -105.74 121.68 58.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 C-N-CA 121.103 -0.239 . . . . 0.0 111.107 -177.398 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 69.51 -0.76 2.47 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.594 176.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.499 ' C ' HD13 ' A' ' 47' ' ' ILE . . . 57.99 0.98 0.53 Allowed Glycine 0 CA--C 1.526 0.738 0 CA-C-N 115.834 -0.621 . . . . 0.0 113.178 -169.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 92' ' ' HIS . 31.2 t70 -104.16 -98.32 0.31 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -173.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.493 ' HB2' ' OD2' ' A' ' 91' ' ' ASP . 1.5 t60 -109.67 53.6 0.68 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -166.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.3 m-20 -173.28 143.17 1.07 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.103 1.149 . . . . 0.0 114.103 -165.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.533 ' CD1' HG21 ' A' ' 111' ' ' VAL . 27.7 mt -139.36 115.17 8.92 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.07 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 86' ' ' ARG . 20.5 t70 -92.73 133.99 35.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 121.313 0.578 . . . . 0.0 110.349 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.553 ' HB2' HG11 ' A' ' 82' ' ' VAL . 26.4 p -142.8 154.31 44.08 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.602 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.621 ' HA ' ' HA ' ' A' ' 103' ' ' ALA . 96.1 mttt -125.46 132.22 52.72 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.0 mt -122.38 113.63 39.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.705 -167.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -67.75 100.69 0.95 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.215 -176.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 148.75 -62.91 0.42 Allowed Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.558 -177.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 74' ' ' LEU . 20.0 pt -95.9 -46.19 13.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.986 0.422 . . . . 0.0 110.483 177.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 141.76 -155.82 25.56 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.607 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.621 ' HA ' ' HA ' ' A' ' 97' ' ' LYS . . . -81.85 144.75 30.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.757 0.279 . . . . 0.0 110.801 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.3 ttt -138.52 158.83 43.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 0.0 110.827 -177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.431 ' HD3' ' H ' ' A' ' 105' ' ' LYS . 0.2 OUTLIER -111.16 137.17 49.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.816 178.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 94' ' ' ILE . 86.3 mt -123.85 142.01 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.493 0.664 . . . . 0.0 111.455 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.406 ' HA ' ' HD2' ' A' ' 107' ' ' LYS . 6.5 mptt -92.9 121.24 34.06 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.715 -1.129 . . . . 0.0 111.256 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 48' ' ' LYS . 3.3 p -51.88 -37.56 52.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.006 -1.452 . . . . 0.0 112.172 -175.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -72.06 -6.75 44.63 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.844 -177.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.475 ' CB ' HD11 ' A' ' 67' ' ' LEU . 60.5 m-85 -111.71 -4.13 14.79 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.891 -0.506 . . . . 0.0 111.995 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 63' ' ' VAL . 34.8 m -114.88 175.36 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -172.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.492 ' HG3' HG11 ' A' ' 51' ' ' VAL . 26.7 ttt180 -151.46 130.98 12.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.423 -177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.479 ' HB2' HD23 ' A' ' 55' ' ' LEU . 88.1 tttt -66.63 122.21 17.1 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.338 175.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 41.7 t -80.44 -44.28 21.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.271 174.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.87 9.81 85.85 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.298 -177.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 17.7 t . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.459 -0.781 . . . . 0.0 109.85 -178.51 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_